data_2m48_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m48 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.918 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 0.481 HG22 ' H ' ' A' ' 352' ' ' LEU . 9.8 p -166.39 174.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . 0.481 ' H ' HG22 ' A' ' 351' ' ' VAL . 6.4 mp -125.85 151.74 46.43 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.1 t -63.26 126.39 89.13 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.87 16.97 1.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.961 2.441 . . . . 0.0 113.623 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -86.46 132.99 41.22 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.21 -20.56 62.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.729 2.286 . . . . 0.0 112.656 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -100.25 3.61 56.79 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.685 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 9.5 t -115.35 -147.93 0.42 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.362 0.601 . . . . 0.0 110.422 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.13 23.65 5.14 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.009 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 39.7 mtm -61.0 -44.93 96.7 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.975 0.417 . . . . 0.0 110.505 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.39 129.37 3.28 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.145 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.01 127.09 53.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.238 0.542 . . . . 0.0 110.384 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -100.85 114.29 27.99 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.467 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.25 119.4 50.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 120.97 0.414 . . . . 0.0 110.703 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -81.07 149.72 67.04 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.032 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.72 -30.0 87.57 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.594 2.196 . . . . 0.0 112.243 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -101.11 15.18 29.57 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.463 0.649 . . . . 0.0 110.812 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 51.6 t -104.09 134.63 47.02 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.09 -0.381 . . . . 0.0 110.046 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 29.63 5.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 370' ' ' LYS . 1.9 tpmt? -144.47 102.3 3.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.781 0.324 . . . . 0.0 110.423 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.48 124.38 51.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.239 0.542 . . . . 0.0 110.845 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.5 m -152.38 141.38 21.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.92 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.45 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 3.5 t -76.86 62.03 2.0 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.16 -22.7 67.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.134 0.492 . . . . 0.0 110.749 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -88.21 -13.3 41.42 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.041 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -143.11 -124.31 1.86 Allowed Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.297 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.45 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -76.42 85.14 3.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.141 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -70.9 109.48 2.86 Favored Glycine 0 N--CA 1.435 -1.404 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -147.12 144.82 29.3 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 18.1 t -84.88 136.23 23.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.098 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -146.01 -175.67 4.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 19.4 t -94.81 162.56 13.71 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.884 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -86.25 -20.4 28.52 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.038 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.529 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 82.4 m-20 -105.47 -26.47 11.91 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.627 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 4.8 p -141.24 178.84 7.13 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.416 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.78 30.76 6.02 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -70.47 -2.74 14.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.312 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 82.94 27.4 41.4 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.537 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 53.1 t80 76.62 138.51 0.06 Allowed 'General case' 0 C--N 1.338 0.108 0 C-N-CA 124.402 1.081 . . . . 0.0 111.514 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -161.04 176.32 11.49 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 50.6 mm -114.6 132.15 64.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 129.66 -156.58 21.44 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.218 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -90.54 159.34 16.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.407 0.622 . . . . 0.0 111.801 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.7 p . . . . . 0 CA--C 1.501 -0.935 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.402 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 121.066 0.46 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.8 p -117.2 -2.25 11.68 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.19 0.519 . . . . 0.0 111.014 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 20.4 p -105.84 149.14 26.79 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -114.08 141.64 26.64 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.028 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.7 129.9 20.87 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.352 2.034 . . . . 0.0 112.738 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 24.3 t -59.1 140.32 87.34 Favored Pre-proline 0 C--N 1.333 -0.119 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.573 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.31 -16.71 39.64 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.127 1.885 . . . . 0.0 111.962 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -101.3 -66.64 0.9 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.542 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 15.6 p -93.57 -10.8 33.51 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 26.6 mmm180 70.03 20.57 6.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.074 0.55 . . . . 0.0 111.922 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 42.4 p -81.23 149.44 65.85 Favored Pre-proline 0 C--N 1.322 -0.622 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.703 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.71 103.12 0.55 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.605 2.203 . . . . 0.0 112.403 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 89.8 m -95.87 122.69 38.93 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -95.75 156.77 16.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.61 156.4 18.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.724 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.78 107.58 16.26 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.182 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -57.95 124.9 37.71 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.003 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.87 -13.2 13.03 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.224 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 11.0 p -142.56 142.59 32.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.713 0.292 . . . . 0.0 110.96 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.674 ' O ' ' HB3' ' A' ' 465' ' ' TRP . 14.2 ptp -99.36 29.83 3.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.31 0.576 . . . . 0.0 111.338 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -123.38 138.25 54.64 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.433 174.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 3.7 ptp -143.06 124.54 14.79 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.18 0.514 . . . . 0.0 110.656 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 8.5 m -114.38 150.82 16.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.3 t -85.38 101.41 12.56 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.472 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 21.2 p -87.7 92.51 9.13 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.539 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.7 OUTLIER -128.83 146.98 50.77 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -177.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -50.74 -44.03 58.3 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.324 0.39 . . . . 0.0 111.809 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -124.6 61.37 0.6 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.612 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 36.4 t -151.34 -90.61 0.06 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.605 0.241 . . . . 0.0 110.519 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 73.45 38.78 51.95 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.704 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -99.55 118.65 36.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.94 0.4 . . . . 0.0 111.016 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -90.33 139.94 30.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.738 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -148.72 154.44 39.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 49.2 t -73.09 139.49 46.52 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.008 0.432 . . . . 0.0 111.191 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . 0.674 ' HB3' ' O ' ' A' ' 450' ' ' MET . 11.3 t-105 -75.02 -51.58 13.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.602 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.45 -51.48 71.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.017 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.551 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.8 p -120.87 107.11 12.31 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -74.23 111.35 9.31 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.875 0.845 . . . . 0.0 111.246 -174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.0 p -154.67 169.92 22.76 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.542 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.69 143.46 36.23 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.006 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -61.55 104.29 0.41 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.407 0.622 . . . . 0.0 110.46 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.5 p -134.43 -163.7 1.41 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.114 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 50.6 mmm-85 -80.75 -21.9 40.67 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.972 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.44 -59.27 4.89 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 13.2 t -120.57 83.65 2.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 46.1 ttp -88.2 5.68 40.34 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.752 0.787 . . . . 0.0 109.209 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . 0.512 ' CA ' ' HB2' ' A' ' 480' ' ' TRP . . . 118.39 37.9 0.82 Allowed Glycine 0 N--CA 1.428 -1.852 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.83 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -57.34 -39.55 76.13 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.185 0.517 . . . . 0.0 110.743 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -118.59 37.28 4.11 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.061 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . 0.512 ' HB2' ' CA ' ' A' ' 477' ' ' GLY . 20.5 t-105 -82.41 45.45 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.306 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -146.51 124.78 12.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.478 . . . . 0.0 111.279 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.223 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.548 179.422 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.268 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 352' ' ' LEU . 9.3 p -142.92 177.37 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . 0.535 ' H ' HG23 ' A' ' 351' ' ' VAL . 71.0 mt -130.37 145.72 51.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.647 0.261 . . . . 0.0 110.9 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.33 132.23 94.35 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.34 -7.93 22.32 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.035 2.49 . . . . 0.0 113.502 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -72.96 124.35 90.62 Favored Pre-proline 0 N--CA 1.447 -0.588 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.746 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.75 -30.78 77.58 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.934 2.423 . . . . 0.0 112.509 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -79.79 -17.19 75.71 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.875 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 33.8 t -89.03 -96.71 0.1 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.797 0.298 . . . . 0.0 110.679 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.09 19.36 59.12 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 35.7 ttp -65.7 -67.37 0.45 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.994 0.518 . . . . 0.0 111.544 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 147.12 122.5 1.36 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.109 -1.043 . . . . 0.0 112.346 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.45 135.85 54.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.954 0.406 . . . . 0.0 110.269 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -97.04 118.97 34.64 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.895 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 56.2 t -88.42 97.5 6.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.0 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.92 141.09 97.43 Favored Pre-proline 0 C--N 1.312 -1.027 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -51.9 -20.49 10.13 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.785 2.323 . . . . 0.0 112.639 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -114.97 24.11 12.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 45.8 t -71.16 110.87 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.42 . . . . 0.0 110.491 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -83.92 -39.9 19.23 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.025 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -140.26 108.28 5.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.108 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 12.8 p -83.08 128.47 38.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.386 0.612 . . . . 0.0 110.468 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 86.7 m -153.11 144.56 23.3 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.518 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 1.8 t -76.16 61.99 1.66 Allowed 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -69.96 -8.73 51.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.619 0.723 . . . . 0.0 109.888 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.73 0.17 32.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.871 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -155.93 -124.66 0.87 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 0.8 OUTLIER -85.42 98.84 10.81 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.9 111.12 3.74 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 114.434 0.534 . . . . 0.0 114.434 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -141.8 143.6 33.51 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.05 129.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.03 0.443 . . . . 0.0 110.969 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.405 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 20.0 p90 -143.93 -175.84 4.76 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 17.2 t -80.75 168.61 18.62 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.85 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -101.64 -13.86 17.64 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.506 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.563 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 4.3 m-20 -104.23 -26.32 12.55 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 21.1 p -145.5 -164.46 1.95 Allowed 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.384 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.05 27.07 9.5 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.614 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 387' ' ' GLN . 14.8 mm-40 -87.25 32.75 0.69 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 70.37 18.31 75.11 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 121.073 -0.584 . . . . 0.0 114.286 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 69.19 121.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.632 0.773 . . . . 0.0 110.382 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -145.89 -176.25 5.07 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.4 tt -112.67 153.15 14.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 99.24 -146.76 18.17 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.139 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -102.13 154.01 19.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.895 0.379 . . . . 0.0 110.99 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 35.0 m . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.537 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.414 0.626 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.49 ' O ' ' HE3' ' A' ' 434' ' ' LYS . 18.1 m -82.27 -29.07 31.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.237 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' THR . . . . . 0.596 ' HA ' ' HB2' ' A' ' 444' ' ' GLU . 5.8 p -78.8 150.2 32.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.346 0.593 . . . . 0.0 112.036 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 432' ' ' SER . 15.8 mmtp -99.93 147.52 33.57 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.694 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -82.62 129.78 5.78 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.03 1.82 . . . . 0.0 112.073 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 42.0 t -66.88 140.95 96.45 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.43 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.416 ' HD2' ' SG ' ' A' ' 436' ' ' CYS . 36.6 Cg_endo -67.51 -19.28 48.93 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.25 1.967 . . . . 0.0 112.241 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . 0.491 ' HZ2' ' HB3' ' A' ' 438' ' ' LYS . 9.1 mtpm? -103.24 -73.56 0.66 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 10.0 p -79.15 -17.71 54.51 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 44.5 mtt180 62.18 33.71 16.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.416 0.627 . . . . 0.0 111.126 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.2 p -90.44 154.34 46.4 Favored Pre-proline 0 N--CA 1.434 -1.24 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.782 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.78 110.53 1.7 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.73 2.287 . . . . 0.0 111.787 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 88.7 m -129.49 123.14 30.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.339 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . 0.596 ' HB2' ' HA ' ' A' ' 433' ' ' THR . 4.7 tp10 -134.6 142.67 46.99 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -111.92 106.61 15.36 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.107 0.48 . . . . 0.0 110.677 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -90.81 102.4 15.16 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.997 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 81.61 149.19 6.91 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.306 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 123.87 -165.58 16.66 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.285 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 8.2 t -82.99 -175.77 6.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.031 0.443 . . . . 0.0 110.787 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -80.14 50.04 1.18 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.075 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -119.48 139.34 52.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.346 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 1.1 mmt -119.78 80.25 1.56 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 36.4 t -94.87 117.51 38.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.257 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 48.0 t -80.86 99.7 8.46 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.46 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 2.1 p -82.2 89.14 6.48 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.611 0.719 . . . . 0.0 109.136 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 1.4 tmt_? -132.16 135.82 46.64 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.826 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.446 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -65.07 105.73 1.12 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.913 0.387 . . . . 0.0 110.2 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 106.54 -1.02 36.85 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.365 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 47.6 t -110.22 -90.89 0.47 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.34 . . . . 0.0 110.236 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 73.77 28.27 65.38 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.113 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -96.73 131.13 43.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.97 0.414 . . . . 0.0 110.083 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -117.27 136.87 52.78 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.117 0.484 . . . . 0.0 111.073 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -131.63 177.7 7.31 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.551 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 60.6 m -81.3 142.04 33.48 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -175.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -76.32 -56.62 4.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.566 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . 0.45 HG21 ' H ' ' A' ' 467' ' ' CYS . 3.2 m -71.26 -60.23 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.45 ' H ' HG21 ' A' ' 466' ' ' VAL . 16.1 p -93.73 170.15 9.78 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -111.63 109.22 19.0 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.245 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.52 160.12 40.28 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.586 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.15 149.89 25.88 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -56.41 108.12 0.45 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.627 0.727 . . . . 0.0 110.942 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 p -132.97 -179.17 5.32 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.121 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -70.21 -22.69 62.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.244 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.17 -54.07 7.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.186 0.517 . . . . 0.0 110.771 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 480' ' ' TRP . 85.1 m -85.01 8.25 18.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.933 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.5 ttt -53.95 -53.47 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.78 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -137.59 -0.47 2.61 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.031 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -58.84 -64.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.463 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -113.56 -4.88 13.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.88 0.372 . . . . 0.0 110.709 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . 0.404 ' HB2' ' O ' ' A' ' 475' ' ' CYS . 35.0 t-105 -68.19 -28.73 67.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.369 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -97.45 106.39 18.7 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.525 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 CA-C-O 118.886 -0.952 . . . . 0.0 111.887 -179.58 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . 0.46 ' HA2' HG11 ' A' ' 364' ' ' VAL . . . . . . . . 0 N--CA 1.434 -1.451 0 CA-C-O 121.307 0.393 . . . . 0.0 113.424 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 0.48 HG21 ' H ' ' A' ' 352' ' ' LEU . 10.5 p -129.63 175.06 11.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . 0.48 ' H ' HG21 ' A' ' 351' ' ' VAL . 6.5 mp -130.79 151.7 50.94 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.796 -0.565 . . . . 0.0 111.865 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 34.3 t -57.12 141.01 77.47 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.398 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.513 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 28.2 Cg_endo -61.75 -10.81 18.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.417 2.745 . . . . 0.0 114.515 -176.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -111.02 136.46 20.8 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.129 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.76 -19.83 30.88 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.053 2.502 . . . . 0.0 112.437 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -70.26 -17.44 74.13 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.253 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 41.1 t -86.55 -82.79 0.2 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.42 -0.39 . . . . 0.0 110.467 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 61.28 27.48 67.67 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.182 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -75.45 -40.09 57.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.653 0.263 . . . . 0.0 111.26 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.7 121.37 4.25 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.974 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -111.11 109.93 20.22 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.267 0.556 . . . . 0.0 110.411 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -88.01 112.48 22.65 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.65 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . 0.46 HG11 ' HA2' ' A' ' 350' ' ' GLY . 7.7 p -83.63 104.73 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 121.865 0.84 . . . . 0.0 110.661 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' A' ' 368' ' ' CYS . 8.6 pt-20 -90.26 159.79 41.22 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.667 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.81 -20.78 72.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.464 2.109 . . . . 0.0 111.305 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -99.37 3.67 46.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.418 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . 0.517 ' N ' ' HG3' ' A' ' 365' ' ' GLU . 53.5 t -63.38 106.05 0.85 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 111.044 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . 0.642 ' NE ' ' H ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -80.11 -37.92 32.65 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.069 0.462 . . . . 0.0 110.562 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -145.12 143.86 30.6 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.521 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.61 119.95 50.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.294 0.569 . . . . 0.0 110.137 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 50.5 m -152.26 139.69 19.56 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.646 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 12.6 t -77.81 47.47 0.63 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 121.14 0.495 . . . . 0.0 110.266 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.19 -11.9 45.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.925 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -96.23 -10.67 27.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.028 0.442 . . . . 0.0 110.739 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -133.42 -79.79 0.15 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.441 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 3.4 m -100.4 -131.28 0.24 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -168.87 104.11 0.2 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 173.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -162.66 145.98 11.22 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 17.8 m -108.28 127.58 64.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -141.39 -177.7 5.27 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.097 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 44.5 t -80.99 159.97 24.72 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.611 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . 0.449 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 29.0 ptt180 -88.41 -15.42 35.53 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.215 0.531 . . . . 0.0 109.628 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.449 ' OD1' ' HG3' ' A' ' 383' ' ' ARG . 4.6 m-20 -106.03 -29.62 9.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.112 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 31.4 p -143.02 -159.66 1.0 Allowed 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.159 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.13 18.48 14.56 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.064 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -76.18 25.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 72.76 31.34 62.58 Favored Glycine 0 N--CA 1.463 0.485 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.53 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.4 100.49 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.407 0.622 . . . . 0.0 111.252 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -126.61 161.12 28.78 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.223 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.29 160.43 3.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.478 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.61 -146.29 25.75 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.88 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -124.11 162.28 23.88 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.739 0.304 . . . . 0.0 110.804 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.32 -0.717 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.066 -179.901 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 121.509 0.671 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.8 p -96.51 2.09 52.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.696 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 8.6 p -117.04 -177.0 3.1 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.135 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -122.83 110.77 31.39 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -63.69 125.84 16.29 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.968 1.778 . . . . 0.0 111.84 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 38.9 t -56.03 139.13 71.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.787 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.39 -1.83 11.82 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.205 1.937 . . . . 0.0 111.729 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . 0.407 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 1.7 tppm? -109.87 -61.25 1.68 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.557 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 23.9 p -101.46 -10.94 19.73 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.794 0.331 . . . . 0.0 111.375 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 69.0 mtt180 67.4 28.53 7.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.621 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 25.2 p -85.96 147.95 46.86 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.484 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.64 98.26 0.57 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.494 2.129 . . . . 0.0 112.355 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 16.9 m -85.96 124.34 32.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.027 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.35 131.05 35.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.394 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.46 ' CB ' ' HE3' ' A' ' 452' ' ' MET . 15.1 ptt-85 -95.7 98.76 10.71 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.271 0.558 . . . . 0.0 111.271 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -107.49 155.3 20.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.132 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 80.85 -82.71 1.5 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.241 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 127.65 3.29 6.05 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.168 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 7.0 p -68.56 161.18 28.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.564 0.221 . . . . 0.0 110.426 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.581 ' SD ' ' HA3' ' A' ' 482' ' ' GLY . 67.3 mtt -78.01 -10.29 59.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.143 0.497 . . . . 0.0 110.77 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -96.72 105.6 17.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.46 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' MET . . . . . 0.46 ' HE3' ' CB ' ' A' ' 445' ' ' ARG . 5.9 ptp -147.1 135.88 22.15 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.549 173.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.06 140.74 44.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.159 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 35.0 t -59.54 103.16 0.18 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.993 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 6.3 t -85.61 90.81 8.09 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 122.408 1.099 . . . . 0.0 109.559 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.492 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -129.45 138.22 51.31 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.423 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -52.67 -47.12 67.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.809 0.337 . . . . 0.0 111.183 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -104.0 49.43 0.93 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.97 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 21.5 t -152.09 -90.33 0.06 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.941 0.371 . . . . 0.0 111.508 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.14 38.16 63.54 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -90.85 118.3 30.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.747 0.308 . . . . 0.0 110.905 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -87.35 122.52 31.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.226 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -129.62 156.46 44.18 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 42.4 t -67.34 136.58 55.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.622 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -75.07 -36.96 61.76 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.543 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.19 -64.04 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.873 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.9 p -109.48 155.51 21.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.36 107.8 8.87 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 118.687 -1.205 . . . . 0.0 108.256 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.12 151.77 23.62 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.337 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.33 158.37 24.75 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -48.35 110.56 0.35 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.627 0.727 . . . . 0.0 111.382 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.6 m -138.87 154.7 48.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.639 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -61.99 -36.58 81.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.05 -32.1 72.58 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.222 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 88.0 m -87.72 -37.21 16.87 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 43.9 tpp -50.72 -54.65 21.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.272 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -90.56 7.47 81.32 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.169 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -111.13 -64.77 1.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -137.62 31.22 2.55 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -91.36 -34.04 15.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.03 0.443 . . . . 0.0 110.873 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -96.28 100.16 11.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.002 0.43 . . . . 0.0 110.978 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . 0.581 ' HA3' ' SD ' ' A' ' 450' ' ' MET . . . . . . . . 0 N--CA 1.437 -1.239 0 CA-C-O 118.425 -1.208 . . . . 0.0 112.072 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.558 0 N-CA-C 112.329 -0.308 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 352' ' ' LEU . 10.0 p -124.81 177.64 4.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . 0.518 ' H ' HG22 ' A' ' 351' ' ' VAL . 85.9 mt -126.77 149.45 49.63 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 122.126 -0.359 . . . . 0.0 111.026 -177.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 355' ' ' GLN . 51.0 t -65.19 138.07 97.13 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.692 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.83 -14.25 40.95 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.924 2.416 . . . . 0.0 112.279 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.494 ' HB2' ' SG ' ' A' ' 353' ' ' CYS . 1.4 mp0 -75.48 123.68 88.66 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-O 120.92 0.39 . . . . 0.0 110.766 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.3 -22.21 46.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.097 2.532 . . . . 0.0 112.959 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -88.64 1.85 84.11 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.697 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 48.3 t -104.47 -93.56 0.35 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.921 0.391 . . . . 0.0 110.585 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.15 23.51 64.13 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.307 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' MET . . . . . 0.432 ' HG3' ' SG ' ' A' ' 358' ' ' CYS . 47.4 mtm -61.74 -72.49 0.12 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.859 0.361 . . . . 0.0 110.844 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 145.9 109.92 0.63 Allowed Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.117 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -101.75 109.98 21.87 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 364' ' ' VAL . 3.0 tt -82.91 135.67 34.84 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.017 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . 0.505 ' N ' HD23 ' A' ' 363' ' ' LEU . 39.2 t -90.96 86.6 2.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.263 0.554 . . . . 0.0 109.986 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -80.97 139.56 49.71 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.634 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.62 -21.76 70.18 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.514 2.143 . . . . 0.0 111.308 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -88.58 -7.47 56.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.46 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 7.5 t -107.82 105.0 14.61 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.715 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -93.76 15.18 17.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -155.76 144.34 20.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.017 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.22 120.96 64.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.434 0.635 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' THR . . . . . 0.476 ' OG1' HG13 ' A' ' 380' ' ' VAL . 62.1 m -147.47 136.96 22.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.916 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.6 t -78.2 67.16 3.96 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.171 0.51 . . . . 0.0 109.969 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -85.43 -7.01 59.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.381 0.61 . . . . 0.0 109.816 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -90.44 -17.11 27.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.441 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -140.17 -78.65 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.49 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 3.2 m -89.03 -127.2 0.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -171.21 104.55 0.2 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.408 ' CE2' ' HB3' ' A' ' 381' ' ' PHE . 55.1 t80 -163.24 137.43 6.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.484 0.142 . . . . 0.0 111.115 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.476 HG13 ' OG1' ' A' ' 372' ' ' THR . 35.1 m -100.29 128.82 51.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.422 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 7.4 p90 -142.56 -176.68 4.95 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.326 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 31.6 t -86.85 171.71 10.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -97.33 -16.37 20.31 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.486 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.465 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 4.6 m-20 -105.01 -28.31 11.14 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.753 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 24.5 p -143.21 -170.79 3.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.159 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.9 mp -110.62 24.06 13.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.912 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -75.58 15.58 0.47 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 76.33 29.1 58.8 Favored Glycine 0 N--CA 1.46 0.282 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.579 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 19.1 t80 63.2 101.05 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.335 0.654 . . . . 0.0 110.756 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -127.11 179.75 5.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.579 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.85 166.21 5.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.106 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.65 -132.19 11.1 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.618 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.33 149.65 49.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.781 0.324 . . . . 0.0 110.379 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 6.6 m . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.698 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 121.145 0.497 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.6 m -104.56 -15.07 15.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.573 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.5 p -94.12 138.91 31.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.552 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -108.76 140.24 21.65 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.31 125.29 11.19 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.228 1.952 . . . . 0.0 112.708 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 42.0 t -58.13 139.68 83.45 Favored Pre-proline 0 N--CA 1.456 -0.126 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.278 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -70.39 -20.91 31.27 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.942 1.762 . . . . 0.0 111.335 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 438' ' ' LYS . 0.1 OUTLIER -96.29 -67.49 0.85 Allowed 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.08 -177.027 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . 0.539 ' SG ' ' HG3' ' A' ' 456' ' ' ARG . 21.3 p -93.09 -8.33 43.03 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.69 ' HD3' ' O ' ' A' ' 440' ' ' ARG . 1.0 OUTLIER 65.23 23.05 12.21 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.586 0.754 . . . . 0.0 111.435 177.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 39.2 p -82.56 162.74 54.83 Favored Pre-proline 0 C--N 1.31 -1.122 0 O-C-N 121.967 -0.458 . . . . 0.0 110.359 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -79.21 100.7 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.243 1.962 . . . . 0.0 112.53 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 12.1 m -92.42 128.21 38.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.193 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -86.55 160.03 19.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.607 0.242 . . . . 0.0 110.97 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.43 ' C ' ' HD2' ' A' ' 445' ' ' ARG . 7.0 tmm_? -118.06 108.69 15.54 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.61 141.95 33.69 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.315 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 71.92 -143.52 35.04 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.568 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -139.53 26.64 2.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.685 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 8.8 p -87.21 155.76 19.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.853 0.358 . . . . 0.0 111.088 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -82.79 -16.31 48.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.096 0.474 . . . . 0.0 109.932 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -86.38 96.89 10.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.199 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 3.7 ptp -117.59 111.07 18.71 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.06 129.15 41.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.177 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 43.0 t -70.39 105.2 2.95 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.645 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 5.1 t -87.01 90.27 8.29 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 122.073 0.939 . . . . 0.0 108.948 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.539 ' HG3' ' SG ' ' A' ' 439' ' ' CYS . 0.0 OUTLIER -130.97 139.18 49.99 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.406 -177.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.65 87.31 0.13 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.872 0.368 . . . . 0.0 110.247 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.45 39.69 1.45 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.088 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 461' ' ' PHE . 19.5 t -145.78 -91.9 0.09 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.624 -0.339 . . . . 0.0 110.921 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 459' ' ' CYS . . . 72.57 27.19 69.9 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . 0.605 ' HB2' ' SG ' ' A' ' 459' ' ' CYS . 9.8 t80 -72.6 128.2 34.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.06 0.457 . . . . 0.0 110.887 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.53 134.75 49.18 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -150.5 159.12 44.71 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.875 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 76.4 m -70.3 140.99 52.39 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.215 0.531 . . . . 0.0 110.951 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -74.31 -40.22 62.38 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.221 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 23.1 t -85.53 -58.87 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.202 -174.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 6.9 p -91.81 152.87 19.92 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -93.45 110.05 21.62 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.345 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' THR . . . . . 0.5 HG21 ' SG ' ' A' ' 475' ' ' CYS . 13.0 t -157.65 178.48 10.22 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.609 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.22 156.89 22.47 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 32.2 p-90 -51.89 117.74 2.94 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.332 0.587 . . . . 0.0 110.362 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 10.8 t -156.99 179.15 9.58 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.53 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -71.5 -23.38 61.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.978 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -62.64 -54.19 43.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.819 0.342 . . . . 0.0 111.3 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . 0.5 ' SG ' HG21 ' A' ' 469' ' ' THR . 70.8 m -98.94 24.56 7.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.631 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -61.26 -36.92 81.33 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.896 0.379 . . . . 0.0 111.271 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -167.9 26.15 0.13 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.773 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -78.32 -62.12 1.78 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.195 0.521 . . . . 0.0 110.681 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -110.77 -4.82 15.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.788 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -73.86 86.18 1.73 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.76 95.64 2.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.653 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.225 0 CA-C-O 118.321 -1.266 . . . . 0.0 111.042 -178.611 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.361 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 352' ' ' LEU . 7.8 p -155.81 175.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . 0.463 ' H ' HG23 ' A' ' 351' ' ' VAL . 6.7 mp -129.14 150.85 50.36 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.784 -0.572 . . . . 0.0 111.337 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.3 t -63.75 128.33 92.67 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.446 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.38 -9.38 25.08 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.19 2.593 . . . . 0.0 113.129 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.444 ' HB3' ' HB2' ' A' ' 358' ' ' CYS . 10.3 tm0? -65.0 122.53 80.06 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.1 -28.6 51.7 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 123.765 2.977 . . . . 0.0 114.964 -174.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -108.19 16.97 35.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.702 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.738 ' SG ' ' HG3' ' A' ' 360' ' ' MET . 12.2 t -106.04 -97.27 0.34 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.27 32.38 71.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.078 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' MET . . . . . 0.738 ' HG3' ' SG ' ' A' ' 358' ' ' CYS . 0.6 OUTLIER -65.86 -32.98 74.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.83 107.63 2.94 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.955 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.422 HD22 ' SD ' ' A' ' 360' ' ' MET . 3.9 mm? -99.45 135.46 40.83 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.82 128.68 55.11 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 79.7 t -77.9 91.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.409 0.623 . . . . 0.0 109.781 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -90.07 148.29 39.11 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.368 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.67 -22.75 74.26 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.478 2.119 . . . . 0.0 111.62 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -99.52 9.85 42.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.419 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 37.2 t -89.7 78.95 6.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.445 0.64 . . . . 0.0 109.698 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . 0.424 ' HD2' ' H ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -72.76 -22.59 60.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.758 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.464 ' HZ1' ' HB3' ' A' ' 370' ' ' LYS . 3.7 mmmp? -135.26 113.63 11.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.169 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.84 112.66 23.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.566 0.698 . . . . 0.0 110.041 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 94.9 m -147.44 138.86 23.86 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.92 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.433 ' SG ' ' HA3' ' A' ' 376' ' ' GLY . 21.6 t -74.86 76.8 2.13 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.225 0.536 . . . . 0.0 109.69 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -86.08 -38.7 17.53 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.048 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.53 -18.35 54.86 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.098 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . 0.433 ' HA3' ' SG ' ' A' ' 373' ' ' CYS . . . -101.32 -89.98 2.08 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.925 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.2 p -124.7 -91.52 0.54 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.013 0.435 . . . . 0.0 110.567 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -172.52 107.23 0.25 Allowed Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -161.02 131.81 5.31 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.872 0.336 . . . . 0.0 110.308 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.88 124.38 65.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.412 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 6.2 p90 -152.66 179.49 8.56 Favored 'General case' 0 C--O 1.21 -0.999 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.253 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 24.5 t -84.43 167.78 16.12 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -95.4 -16.6 22.19 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.323 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -104.31 -32.8 8.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.872 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 27.8 p -137.59 -166.38 1.93 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.101 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.9 mp -115.06 27.51 9.35 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.774 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -78.16 16.03 0.83 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 79.18 17.47 76.51 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.609 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 73.45 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.512 0.725 . . . . 0.0 111.244 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -148.23 -46.81 0.16 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.045 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.9 tt -150.3 158.04 5.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -87.91 6.24 83.75 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.767 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -136.03 115.59 12.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.136 0.468 . . . . 0.0 111.327 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 59.2 m . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.949 -179.053 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 121.264 0.554 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.1 m -107.63 -31.22 8.18 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.693 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.2 p -80.12 -178.58 6.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.234 0.54 . . . . 0.0 111.413 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . 0.531 ' HG2' ' CH2' ' A' ' 463' ' ' TRP . 1.6 tpmt? -112.84 108.82 53.27 Favored Pre-proline 0 C--N 1.312 -1.047 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.05 130.69 29.81 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.117 1.878 . . . . 0.0 111.739 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 45.5 t -57.36 134.93 81.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.358 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.36 -7.64 21.47 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.365 2.043 . . . . 0.0 111.746 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -107.59 -63.99 1.25 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.83 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 6.2 p -95.47 -3.11 47.41 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 60.7 26.05 15.82 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 21.4 p -87.22 143.11 34.13 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.73 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -63.75 104.73 0.48 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.345 2.03 . . . . 0.0 111.449 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 37.9 m -96.4 133.6 40.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.939 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.21 163.98 23.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.761 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.483 ' HA ' ' HE3' ' A' ' 452' ' ' MET . 9.4 ptt180 -120.58 162.43 19.64 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.122 0.487 . . . . 0.0 111.647 -176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -99.79 162.57 12.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.059 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -63.04 -50.87 59.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.854 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -151.3 52.8 0.49 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.351 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 61.6 m -118.91 137.35 53.52 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -17.45 27.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.85 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.32 96.95 10.53 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' MET . . . . . 0.483 ' HE3' ' HA ' ' A' ' 445' ' ' ARG . 70.0 mmm -106.51 112.53 25.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 462' ' ' GLU . 21.3 t -115.6 141.37 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.996 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 28.8 t -83.03 125.66 31.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.06 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 19.9 p -101.54 89.96 3.9 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 121.833 0.825 . . . . 0.0 110.338 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.481 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 2.7 tmt_? -131.97 135.39 46.54 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.33 97.65 0.1 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.695 0.284 . . . . 0.0 110.954 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.06 22.24 8.44 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.581 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.481 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 51.4 t -114.36 -80.93 0.6 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.429 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.72 24.12 76.45 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.25 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -93.91 139.25 31.13 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.404 ' HB3' HG13 ' A' ' 453' ' ' VAL . 7.3 pt-20 -126.55 157.71 38.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.301 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . 0.531 ' CH2' ' HG2' ' A' ' 434' ' ' LYS . 7.4 p-90 -147.4 163.43 36.51 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.12 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 43.9 t -70.49 143.24 51.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.682 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -75.75 -42.09 51.44 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.609 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.79 -48.05 24.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 27.4 p -118.96 143.79 46.83 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.52 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -77.09 111.65 12.91 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.378 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 3.7 p -152.85 174.99 13.39 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.995 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -96.48 152.44 18.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -54.1 122.9 11.17 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.02 0.438 . . . . 0.0 111.748 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.8 t -160.43 153.62 21.78 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.592 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -66.67 -25.42 66.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.3 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.83 -34.71 69.98 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.472 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.65 -27.59 14.72 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.7 ttt -53.81 -44.6 70.34 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.452 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -100.85 20.25 48.73 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.669 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -105.71 -64.94 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.681 -0.306 . . . . 0.0 111.44 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -148.68 28.76 0.85 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.275 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -69.45 -29.86 67.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.176 0.512 . . . . 0.0 109.884 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -92.9 111.67 23.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.445 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.038 0 CA-C-O 118.461 -1.188 . . . . 0.0 112.058 -179.161 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.914 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 9.9 p -126.72 167.68 21.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 5.8 mp -137.41 152.28 49.45 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.914 0.388 . . . . 0.0 111.716 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 18.5 t -59.41 135.68 88.77 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.698 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.73 -15.57 47.77 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.913 2.409 . . . . 0.0 113.785 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -99.0 134.45 21.42 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 120.822 0.344 . . . . 0.0 111.788 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.81 -15.65 44.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.216 2.611 . . . . 0.0 112.729 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -79.71 16.12 12.25 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.831 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.7 t -126.68 -87.3 0.59 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 64.43 21.13 66.32 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.827 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 37.5 ttp -67.59 -43.65 80.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.832 0.348 . . . . 0.0 111.172 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.72 118.92 4.44 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.007 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.8 155.62 24.29 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.796 0.332 . . . . 0.0 110.456 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.404 ' HG ' ' N ' ' A' ' 364' ' ' VAL . 26.7 tp -102.61 157.06 17.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.66 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . 0.404 ' N ' ' HG ' ' A' ' 363' ' ' LEU . 48.8 t -121.85 90.88 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 120.954 0.407 . . . . 0.0 110.563 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.33 152.22 96.6 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.41 -30.15 86.63 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.073 1.849 . . . . 0.0 111.139 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.57 15.0 28.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.115 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.35 101.77 3.54 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -111.7 -3.32 15.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 370' ' ' LYS . 5.5 mmpt? -144.95 91.53 2.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.835 177.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.78 129.06 46.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.5 0.667 . . . . 0.0 110.513 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 374' ' ' GLN . 61.6 m -152.45 145.11 24.23 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.296 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 8.7 t -76.12 45.99 0.38 Allowed 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 121.326 0.584 . . . . 0.0 109.786 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . 0.411 ' H ' ' C ' ' A' ' 372' ' ' THR . 2.1 pp0? -63.75 -12.38 34.49 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -98.62 -2.64 37.99 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -143.13 -75.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.101 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.1 m -99.72 -132.64 0.25 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -170.83 103.97 0.2 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -162.14 139.56 8.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 26.2 m -95.04 126.11 47.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.425 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 16.7 p90 -138.51 -176.57 4.51 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 16.4 t -82.27 164.05 21.42 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.706 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -92.28 -18.9 22.75 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.097 0.475 . . . . 0.0 110.352 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.563 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 62.0 t30 -106.57 -29.22 9.78 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.174 0.511 . . . . 0.0 109.927 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 29.3 p -136.39 -165.2 1.68 Allowed 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.739 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 62.8 mt -117.51 25.71 10.23 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.878 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -86.55 30.41 0.72 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 70.26 23.16 77.52 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.573 175.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 381' ' ' PHE . 0.3 OUTLIER 64.92 113.03 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.762 0.825 . . . . 0.0 112.14 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -131.91 168.44 17.87 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.841 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.71 147.87 6.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.273 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 100.02 173.97 30.35 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.445 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -100.44 128.97 46.36 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.803 0.335 . . . . 0.0 110.214 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 1.3 m . . . . . 0 C--N 1.316 -0.879 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.386 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 121.048 0.451 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 22.2 m -91.32 -13.38 32.69 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.844 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 4.0 p -82.92 138.72 33.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.591 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 1.7 tpmt? -90.91 124.67 61.35 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 5.8 Cg_exo -73.54 122.71 8.08 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.097 1.865 . . . . 0.0 111.764 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 440' ' ' ARG . 35.1 t -53.25 136.66 49.81 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.103 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.85 -14.69 46.42 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.712 2.275 . . . . 0.0 112.4 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.69 -67.86 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 7.8 p -86.45 -8.5 57.56 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 436' ' ' CYS . 18.7 mmm180 64.14 26.01 13.81 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.643 0.377 . . . . 0.0 111.628 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 29.3 p -87.29 141.82 32.95 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.632 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 11.9 Cg_exo -69.49 104.36 1.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.597 2.198 . . . . 0.0 112.094 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 18.0 m -81.16 119.69 23.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.335 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.64 95.44 4.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.362 0.601 . . . . 0.0 109.711 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -137.07 156.58 48.22 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.741 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.18 151.39 22.72 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -81.95 59.04 4.9 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.34 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -72.38 -35.61 59.89 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 27.1 p -140.34 175.46 9.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.47 ' HA ' ' HB3' ' A' ' 465' ' ' TRP . 1.0 OUTLIER -83.72 0.89 45.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.781 0.324 . . . . 0.0 111.271 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -93.2 100.48 12.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.774 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 10.3 mmt -100.1 107.01 18.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.345 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.428 HG21 ' HG2' ' A' ' 462' ' ' GLU . 21.7 t -105.73 124.8 61.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.044 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 52.4 t -78.83 99.7 6.85 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.994 0.426 . . . . 0.0 109.954 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 13.0 p -83.49 90.25 7.19 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 121.623 0.725 . . . . 0.0 110.111 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.469 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 4.0 tmm_? -130.76 145.61 52.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -69.61 93.26 0.69 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.769 0.318 . . . . 0.0 110.683 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 111.66 13.22 13.11 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.748 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.469 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 49.6 t -114.12 -88.4 0.56 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 122.788 -0.242 . . . . 0.0 110.566 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.16 27.17 70.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.145 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -88.28 142.91 27.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.918 0.39 . . . . 0.0 110.451 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 471' ' ' TRP . 51.7 mt-10 -114.85 133.24 56.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.296 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -133.74 164.75 26.54 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.976 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 13.8 t -77.97 136.01 37.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.316 0.579 . . . . 0.0 111.962 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 21.4 t-105 -77.51 -44.1 29.88 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.274 177.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 22.7 m -78.57 -17.18 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -173.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 18.5 p -145.19 148.99 34.15 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -82.52 108.67 16.1 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.718 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.3 p -155.82 178.1 10.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.246 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.04 157.62 17.39 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . 0.451 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 45.6 t90 -53.04 104.45 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 109.897 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 p -134.07 152.82 52.01 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.07 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . 0.589 ' HG3' ' SD ' ' A' ' 476' ' ' MET . 14.9 ttm180 -70.12 -23.0 62.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.102 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.0 -28.46 68.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.23 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 2.8 t -100.47 -27.34 13.49 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' MET . . . . . 0.589 ' SD ' ' HG3' ' A' ' 473' ' ' ARG . 14.2 ptm -55.74 -29.49 59.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.858 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -111.04 12.1 29.19 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.216 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -100.16 -65.91 0.94 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.805 0.336 . . . . 0.0 110.841 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -146.27 21.42 1.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.662 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -72.87 -11.75 60.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.776 0.798 . . . . 0.0 108.878 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -119.56 151.82 38.02 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.767 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.476 -1.18 . . . . 0.0 112.131 -179.548 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.358 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 6.2 p -101.32 166.01 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.86 141.5 47.82 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 30.0 t -66.6 118.58 55.54 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.925 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.503 ' CG ' HD11 ' A' ' 386' ' ' LEU . 92.3 Cg_endo -81.9 4.98 6.62 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.518 2.812 . . . . 0.0 112.195 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -87.12 121.2 71.6 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.79 111.9 0.98 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.928 2.419 . . . . 0.0 112.816 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 126.39 3.07 6.8 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.343 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.708 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 36.6 t -113.08 -90.22 0.52 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 120.768 0.318 . . . . 0.0 111.089 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 60.55 22.85 59.8 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 43.5 ttp -72.37 -73.1 0.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.489 0.316 . . . . 0.0 111.36 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 148.36 121.63 1.2 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.737 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.5 129.11 56.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.973 0.416 . . . . 0.0 110.201 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 51.9 tp -86.51 129.82 34.72 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.676 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.22 87.43 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.485 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.61 166.58 44.09 Favored Pre-proline 0 C--N 1.313 -0.989 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.781 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.26 -23.88 64.65 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.236 1.957 . . . . 0.0 111.75 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.24 2.5 42.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.128 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.76 86.84 7.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -104.69 21.7 16.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.1 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -156.0 110.89 2.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.382 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.8 128.07 60.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.609 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 48.9 m -152.64 137.24 16.87 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.218 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.52 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 2.4 t -79.82 61.23 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.193 0.52 . . . . 0.0 110.17 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -70.71 -6.39 36.93 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.296 0.57 . . . . 0.0 110.187 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -99.67 -3.83 32.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.519 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -158.67 -115.79 0.44 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.964 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.708 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.3 p -86.66 94.89 9.61 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.84 113.77 5.45 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.922 -0.581 . . . . 0.0 114.495 -172.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -150.92 133.76 15.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.79 133.51 29.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 120.828 0.347 . . . . 0.0 110.08 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 389' ' ' TYR . 30.8 p90 -148.38 176.04 10.61 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 29.8 t -85.98 151.7 23.52 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -80.76 -11.59 59.59 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.028 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.445 ' CG ' ' H ' ' A' ' 394' ' ' CYS . 13.5 m-80 -105.47 -37.91 6.64 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.888 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 27.0 p -140.52 -159.21 0.93 Allowed 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.93 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.503 HD11 ' CG ' ' A' ' 354' ' ' PRO . 3.9 mm? -116.33 23.6 11.99 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . 0.518 ' HB2' ' CD2' ' A' ' 390' ' ' HIS . 75.2 mm-40 -83.07 28.0 0.53 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 69.5 25.5 75.44 Favored Glycine 0 N--CA 1.469 0.891 0 C-N-CA 121.478 -0.391 . . . . 0.0 114.05 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 381' ' ' PHE . 13.7 t80 63.31 105.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.409 0.684 . . . . 0.0 110.92 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.576 ' CG ' ' H ' ' A' ' 391' ' ' ILE . 2.3 p80 -132.63 -72.97 0.51 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.529 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.576 ' H ' ' CG ' ' A' ' 390' ' ' HIS . 50.7 mm -88.49 149.4 4.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -57.78 -54.23 38.97 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.81 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -130.72 122.41 27.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.877 0.37 . . . . 0.0 110.661 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.445 ' H ' ' CG ' ' A' ' 384' ' ' ASN . 62.3 m . . . . . 0 C--N 1.313 -0.992 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.069 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.651 0.262 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 19.9 m -72.46 -28.64 63.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.873 0.368 . . . . 0.0 110.6 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 11.8 p -78.73 115.33 18.35 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.197 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -92.39 143.89 28.04 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.304 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.58 127.25 15.25 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.461 2.107 . . . . 0.0 111.87 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 30.3 t -57.08 139.29 79.21 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.949 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.2 -15.74 46.92 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.134 1.889 . . . . 0.0 112.055 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -103.2 -60.17 1.6 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.0 p -99.68 -8.04 24.88 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' A' ' 440' ' ' ARG . 3.1 mpt_? 63.4 24.77 14.3 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 34.3 p -82.95 157.68 65.98 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.84 103.85 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.121 1.881 . . . . 0.0 111.22 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 26.9 m -77.27 112.47 14.01 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.571 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.15 108.93 14.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.975 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -111.25 125.81 54.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.176 0.512 . . . . 0.0 110.73 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -141.87 104.05 4.44 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 78.4 52.48 5.15 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -53.03 126.35 33.04 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.357 -0.422 . . . . 0.0 112.895 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 13.1 t -93.83 24.57 4.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.73 0.3 . . . . 0.0 110.365 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 43.1 ttm 72.82 -40.19 0.47 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.851 0.86 . . . . 0.0 111.271 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -84.32 105.0 14.82 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 87.2 mmm -98.73 120.51 39.29 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.725 0.298 . . . . 0.0 111.169 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.57 128.41 76.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.348 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.5 t -92.73 106.21 18.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.994 0.426 . . . . 0.0 110.403 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.0 p -87.87 90.77 8.51 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.296 0.57 . . . . 0.0 110.129 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.537 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 2.5 tmm_? -130.74 138.94 50.21 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -62.36 98.43 0.11 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.719 0.295 . . . . 0.0 110.59 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.71 9.11 29.25 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.086 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 45.2 t -113.86 -91.8 0.5 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 122.431 -0.452 . . . . 0.0 110.758 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.71 23.95 77.35 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . 0.411 ' CD2' ' HZ3' ' A' ' 471' ' ' TRP . 27.5 t80 -84.2 108.77 17.28 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.158 0.504 . . . . 0.0 110.372 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.459 ' HG3' ' HB3' ' A' ' 471' ' ' TRP . 6.3 pt-20 -97.98 126.24 43.3 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.731 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -128.86 166.44 19.07 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.791 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 27.2 t -78.77 144.04 35.54 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.311 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -76.5 -39.21 53.73 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.165 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.71 -8.18 9.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 17.9 p -148.95 155.87 41.46 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -91.38 107.74 19.41 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.104 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 5.0 p -155.6 169.98 23.04 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.223 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -96.14 157.05 16.08 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . 0.459 ' HB3' ' HG3' ' A' ' 462' ' ' GLU . 20.3 p90 -48.92 111.97 0.55 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.595 0.712 . . . . 0.0 111.333 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 5.4 p -134.35 148.9 50.8 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.107 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -74.95 -22.14 58.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.129 0.49 . . . . 0.0 110.055 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.82 -50.51 70.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.913 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 18.7 t -74.68 -30.19 61.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.628 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' MET . . . . . 0.532 ' HA ' ' CB ' ' A' ' 480' ' ' TRP . 28.1 ttt -52.76 -38.04 60.42 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.729 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -100.83 13.05 59.33 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.159 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.41 -66.17 1.08 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.818 -0.225 . . . . 0.0 111.346 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -153.79 12.45 0.45 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.892 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . 0.532 ' CB ' ' HA ' ' A' ' 476' ' ' MET . 76.6 t-105 -56.64 -43.24 80.08 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.273 0.559 . . . . 0.0 110.497 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -147.44 89.4 1.78 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.019 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.115 0 CA-C-O 118.573 -1.126 . . . . 0.0 111.449 -178.319 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.562 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 0.516 HG23 ' H ' ' A' ' 352' ' ' LEU . 5.8 p -122.66 176.19 4.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . 0.516 ' H ' HG23 ' A' ' 351' ' ' VAL . 3.6 mm? -112.88 146.7 38.46 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.3 t -62.49 138.97 96.64 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.23 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.64 -4.21 14.93 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.856 2.371 . . . . 0.0 112.304 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -86.46 124.76 69.27 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.239 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.45 112.99 3.48 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.563 2.176 . . . . 0.0 112.012 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 120.29 -6.39 11.84 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.831 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.42 ' SG ' ' HE1' ' A' ' 360' ' ' MET . 47.5 t -84.5 -79.92 0.21 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.43 20.88 52.77 Favored Glycine 0 C--O 1.228 -0.236 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.648 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' MET . . . . . 0.42 ' HE1' ' SG ' ' A' ' 358' ' ' CYS . 34.2 mtm -68.01 -56.95 7.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.012 0.406 . . . . 0.0 111.024 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 124.67 114.16 2.03 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.71 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.3 mm? -98.45 134.77 40.97 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.058 0.456 . . . . 0.0 111.355 -177.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -93.03 124.08 36.75 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.35 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.28 116.97 48.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.975 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.31 155.5 66.51 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -42.91 -51.12 5.67 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.36 2.707 . . . . 0.0 113.656 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -106.86 28.8 7.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.852 0.358 . . . . 0.0 111.85 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 37.1 t -67.31 -52.79 36.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.613 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 67.03 -59.42 0.38 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.672 0.789 . . . . 0.0 111.98 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -72.98 116.73 13.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.44 0.638 . . . . 0.0 111.126 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 381' ' ' PHE . 0.0 OUTLIER -116.79 125.19 73.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.819 176.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 81.6 m -153.07 142.22 21.42 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.279 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.455 ' HA ' HD11 ' A' ' 362' ' ' LEU . 5.2 t -73.22 74.52 1.29 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.34 -18.8 61.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.393 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -99.3 -11.04 21.6 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.131 0.491 . . . . 0.0 110.807 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -141.79 -129.6 2.45 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.759 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.4 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.9 OUTLIER -74.98 91.18 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.829 0.452 . . . . 0.0 111.017 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.72 119.23 9.75 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.9 -174.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -142.2 139.82 32.16 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.509 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 14.5 m -83.09 124.65 39.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.204 0.526 . . . . 0.0 111.186 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.474 ' O ' HG21 ' A' ' 371' ' ' VAL . 5.4 p90 -141.36 -176.9 4.89 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.469 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 36.4 t -105.46 169.96 8.16 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . 0.452 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 7.1 ptt180 -87.93 -27.02 22.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.285 0.564 . . . . 0.0 109.805 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.452 ' OD1' ' HG3' ' A' ' 383' ' ' ARG . 5.6 m-20 -103.55 -19.73 14.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.431 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' ' 394' ' ' CYS . 1.4 m -138.02 165.86 25.54 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.378 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.3 mp -111.89 34.83 3.98 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -86.97 2.13 50.49 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 100.67 27.75 7.38 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 119.565 -1.303 . . . . 0.0 114.04 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 47.2 t80 72.73 121.35 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.291 0.636 . . . . 0.0 111.921 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -167.92 176.86 5.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.932 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.457 ' O ' HD13 ' A' ' 391' ' ' ILE . 2.4 pp -139.51 148.93 22.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.757 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.95 -33.62 2.63 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.657 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -70.97 -20.26 62.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.567 0.698 . . . . 0.0 111.346 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.56 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 2.7 p . . . . . 0 C--N 1.291 -1.938 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.977 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.984 0.421 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 47.9 m -113.55 -0.49 14.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.379 0.609 . . . . 0.0 110.541 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 7.4 p -101.97 172.43 6.93 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.696 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -122.1 127.58 25.87 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.367 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.18 122.88 10.75 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.161 1.907 . . . . 0.0 111.77 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.603 ' O ' ' HD3' ' A' ' 440' ' ' ARG . 41.6 t -56.41 137.26 76.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.465 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.22 -14.8 41.43 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.212 1.941 . . . . 0.0 111.605 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -99.79 -78.04 0.51 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.667 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.0 p -81.41 -9.37 59.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.603 ' HD3' ' O ' ' A' ' 436' ' ' CYS . 38.4 mmt180 64.98 25.59 12.69 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.777 0.431 . . . . 0.0 111.875 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 39.3 p -88.76 151.88 48.18 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.44 102.12 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.525 2.15 . . . . 0.0 111.944 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 51.7 m -94.11 130.23 40.38 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.396 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -74.75 146.32 42.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.014 0.435 . . . . 0.0 111.051 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -95.71 162.13 13.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.134 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -117.9 141.77 48.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -97.82 4.12 61.11 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.118 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -127.17 -49.23 0.17 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.656 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.7 t -96.16 136.43 36.64 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.856 0.36 . . . . 0.0 110.548 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.76 19.81 3.3 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.574 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -104.01 111.97 24.75 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' MET . . . . . 0.456 ' HG2' ' HB2' ' A' ' 465' ' ' TRP . 79.2 mmm -99.83 111.83 24.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 0.0 110.923 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.84 130.07 60.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.823 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.1 t -91.38 130.39 37.24 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 3.4 p -109.62 88.85 2.84 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 121.561 0.696 . . . . 0.0 110.084 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.46 135.78 44.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.52 95.25 0.32 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.961 0.41 . . . . 0.0 110.086 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 123.94 -9.99 8.44 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.527 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . . . . . . . . . 48.1 t -97.22 -88.34 0.3 Allowed 'General case' 0 C--O 1.239 0.503 0 O-C-N 122.673 -0.31 . . . . 0.0 111.009 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.27 31.43 63.69 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.821 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -95.18 142.12 28.0 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.973 0.416 . . . . 0.0 110.514 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.01 135.97 55.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.583 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -143.45 165.92 26.21 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.523 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 61.2 m -73.59 144.72 45.89 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.312 0.577 . . . . 0.0 112.018 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . 0.456 ' HB2' ' HG2' ' A' ' 452' ' ' MET . 26.1 t-105 -76.7 -51.33 11.67 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.046 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.36 -35.7 63.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 26.3 p -116.74 -161.65 0.81 Allowed 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -142.62 109.55 5.51 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' THR . . . . . 0.452 HG21 ' SG ' ' A' ' 475' ' ' CYS . 13.4 t -158.02 177.88 10.83 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.386 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -87.74 150.43 23.6 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -52.74 101.73 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.584 0.707 . . . . 0.0 110.14 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.8 p -130.57 171.9 12.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.621 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -73.93 -21.73 59.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.144 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.96 -52.76 63.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.495 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . 0.452 ' SG ' HG21 ' A' ' 469' ' ' THR . 72.5 m -84.0 -18.7 36.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.112 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 24.2 ttt -46.68 -54.13 10.24 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.728 0.643 . . . . 0.0 111.632 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -97.98 17.77 58.22 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.356 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -110.01 -66.28 1.08 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.695 0.283 . . . . 0.0 111.4 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -144.67 12.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -68.09 -28.17 67.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.484 0.659 . . . . 0.0 109.812 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -132.14 105.73 7.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.386 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-O 118.712 -1.049 . . . . 0.0 112.502 -178.173 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.085 0 CA-C-O 120.958 0.199 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 0.426 HG22 ' HB2' ' A' ' 362' ' ' LEU . 29.6 m -120.58 -178.25 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 C-N-CA 123.339 0.656 . . . . 0.0 109.879 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 22.4 mt -126.6 150.45 48.87 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 54.0 t -57.98 137.37 83.79 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.436 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.02 -17.16 51.0 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.984 2.456 . . . . 0.0 112.299 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.45 121.29 84.44 Favored Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.3 -39.46 91.14 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.094 2.53 . . . . 0.0 112.599 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -78.69 -10.75 85.92 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.348 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 7.1 t -88.58 -76.65 0.39 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.971 0.415 . . . . 0.0 110.03 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 68.72 27.23 74.0 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.645 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 35.2 ttp -88.62 153.09 21.39 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -88.6 115.16 4.37 Favored Glycine 0 C--N 1.284 -2.335 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.534 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.426 ' HB2' HG22 ' A' ' 351' ' ' VAL . 4.5 mm? -94.59 134.22 37.39 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 364' ' ' VAL . 1.1 tm? -92.68 139.63 30.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . 0.503 ' N ' HD11 ' A' ' 363' ' ' LEU . 43.7 t -108.89 91.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 120.851 0.357 . . . . 0.0 110.262 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -71.38 145.92 91.17 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.57 -22.47 58.33 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 121.948 1.765 . . . . 0.0 110.341 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -108.38 23.05 15.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.066 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 51.5 t -56.51 124.07 16.93 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.461 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -83.19 -48.63 10.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.692 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -148.72 118.19 6.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.633 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 381' ' ' PHE . 2.0 p -84.6 111.8 20.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.483 0.659 . . . . 0.0 109.539 176.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 91.4 m -152.78 144.22 23.33 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.98 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 19.9 t -75.57 69.66 2.33 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.345 0.593 . . . . 0.0 110.064 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -83.8 -6.55 59.45 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.567 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -111.25 5.77 20.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.934 -177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -133.79 -75.87 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.566 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.5 p -124.6 -102.72 0.37 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.873 0.368 . . . . 0.0 110.37 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -173.0 106.07 0.22 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -163.39 123.36 2.19 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.97 129.26 49.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.454 ' O ' HG11 ' A' ' 371' ' ' VAL . 8.1 p90 -140.0 -177.34 4.95 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.887 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 27.9 t -83.44 172.78 12.11 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -100.42 -14.66 18.23 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.639 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.532 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 8.6 t30 -105.21 -26.86 11.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.434 0.635 . . . . 0.0 109.483 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 28.8 p -143.31 -169.84 3.14 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.724 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 11.1 mp -116.47 26.4 9.91 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.561 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -76.56 11.54 1.6 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 86.62 21.07 52.52 Favored Glycine 0 N--CA 1.459 0.205 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.398 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 72.95 120.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.696 0.798 . . . . 0.0 111.631 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -150.6 166.6 29.81 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.791 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.71 143.09 24.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 111.41 23.08 5.86 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.087 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 61.64 -178.88 0.12 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.5 0.72 . . . . 0.0 111.827 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 2.5 m . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.196 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 121.35 0.595 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.416 ' O ' ' HD2' ' A' ' 445' ' ' ARG . 3.2 p -115.26 3.63 14.31 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.45 0.643 . . . . 0.0 110.489 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.68 152.14 20.96 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.097 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 434' ' ' LYS . 0.0 OUTLIER -118.93 119.15 32.51 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -68.52 126.18 13.8 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 122.006 1.804 . . . . 0.0 112.206 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 438' ' ' LYS . 43.6 t -57.91 131.26 83.08 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.431 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.47 ' HG2' ' CE2' ' A' ' 461' ' ' PHE . 64.6 Cg_endo -74.64 -1.24 10.83 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.322 2.014 . . . . 0.0 111.391 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . 0.557 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 27.7 tptp -102.81 -64.7 1.05 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.971 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 11.0 p -103.59 -3.46 25.17 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 68.58 29.16 5.6 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 34.7 p -90.27 141.38 27.56 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -75.63 94.52 0.99 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.916 1.744 . . . . 0.0 111.398 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 30.4 m -89.64 128.21 36.02 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.016 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.62 151.11 44.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.904 0.383 . . . . 0.0 111.338 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.423 ' HD3' ' H ' ' A' ' 445' ' ' ARG . 0.3 OUTLIER -82.57 146.14 29.34 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.574 177.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -117.43 89.45 3.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.88 0.371 . . . . 0.0 110.955 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 60.03 -134.88 50.68 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.623 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -112.99 18.24 21.79 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.681 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 43.3 t -63.95 129.46 40.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 60.6 mtt -75.99 -25.68 56.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.977 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -79.22 96.2 5.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' MET . . . . . 0.418 ' HE2' ' HA ' ' A' ' 445' ' ' ARG . 40.6 mmm -118.43 109.68 16.53 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.68 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.414 ' CG1' ' HG2' ' A' ' 462' ' ' GLU . 4.0 m -121.66 150.87 24.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 120.952 0.406 . . . . 0.0 110.275 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 456' ' ' ARG . 42.8 t -83.68 100.65 11.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.499 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 5.9 p -81.45 92.15 6.42 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -128.9 139.64 52.04 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -177.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -45.71 -45.57 14.38 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.486 0.491 . . . . 0.0 112.231 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -122.56 59.34 0.59 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.749 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 45.4 t -146.38 -83.54 0.13 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.83 0.315 . . . . 0.0 110.793 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.88 49.52 41.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.375 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . 0.47 ' CE2' ' HG2' ' A' ' 437' ' ' PRO . 65.1 t80 -99.8 120.53 39.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.825 0.345 . . . . 0.0 111.097 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.414 ' HG2' ' CG1' ' A' ' 453' ' ' VAL . 41.1 mt-10 -94.22 134.17 36.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.842 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -144.29 161.28 39.33 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.889 0.376 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . 0.783 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 19.8 m -76.61 137.35 39.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.313 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -68.45 -45.55 72.19 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.689 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.39 -63.92 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.237 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.783 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 17.1 p -98.79 126.34 44.39 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.55 109.37 7.97 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.579 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.5 156.21 36.28 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.046 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -85.97 135.84 33.5 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -55.76 106.97 0.29 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.2 p -140.52 -164.96 1.83 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.589 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -73.58 -29.31 62.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 109.817 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -72.06 -58.45 3.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.158 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 34.3 m -97.54 70.05 2.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.497 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.58 4.15 53.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.46 0.648 . . . . 0.0 109.453 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . 121.38 12.68 5.58 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.271 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -61.93 -19.42 62.71 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -121.91 9.46 10.02 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.178 0.513 . . . . 0.0 109.911 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -86.43 86.24 7.33 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.166 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -149.9 121.19 7.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.385 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.101 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.227 179.09 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.972 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.01 165.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.74 148.26 33.87 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 122.207 -0.308 . . . . 0.0 110.965 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 34.2 t -68.53 122.04 83.09 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.454 ' CG ' HD12 ' A' ' 386' ' ' LEU . 92.4 Cg_endo -79.5 0.03 10.34 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.936 2.424 . . . . 0.0 112.748 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -81.06 120.2 78.04 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.0 106.52 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.796 2.331 . . . . 0.0 112.325 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 128.39 -6.54 6.69 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.768 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.3 t -94.42 -94.04 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.898 0.349 . . . . 0.0 110.557 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 71.07 16.21 74.83 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.006 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 41.6 ttp -67.06 -54.88 17.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.98 0.419 . . . . 0.0 111.198 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.63 122.49 2.56 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.653 -0.785 . . . . 0.0 111.695 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 373' ' ' CYS . 4.3 mm? -109.03 132.61 53.95 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.515 0.674 . . . . 0.0 111.325 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.81 106.22 18.22 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.778 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 11.4 p -116.41 127.42 74.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.289 0.566 . . . . 0.0 110.25 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -94.49 162.61 25.37 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.992 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.04 -26.32 81.21 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.472 2.115 . . . . 0.0 111.645 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.18 5.63 40.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.305 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 46.6 t -88.18 108.04 19.08 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.954 0.407 . . . . 0.0 110.693 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . 0.437 ' O ' ' HE1' ' A' ' 389' ' ' TYR . 0.7 OUTLIER -94.08 -33.13 13.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.656 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -85.75 104.6 15.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.207 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 14.4 p -103.7 122.81 56.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.267 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 96.7 m -153.27 139.49 18.43 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.075 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.489 ' HA ' HD12 ' A' ' 362' ' ' LEU . 2.5 t -74.83 69.89 1.88 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -68.7 -13.26 62.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.559 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -103.9 -3.72 24.41 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.96 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -154.63 -124.63 0.93 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.87 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 1.7 p -74.85 91.68 2.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.885 0.374 . . . . 0.0 111.12 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.99 124.09 19.56 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.827 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -151.9 132.8 14.18 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 26.6 m -90.36 124.81 43.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.953 0.406 . . . . 0.0 110.67 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -145.6 -175.77 4.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.169 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 42.8 t -88.47 141.23 28.71 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -66.47 -22.13 66.2 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.616 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -105.93 -28.63 10.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.836 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 394' ' ' CYS . 5.4 m -134.11 178.73 6.74 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 121.286 0.565 . . . . 0.0 111.779 -174.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.454 HD12 ' CG ' ' A' ' 354' ' ' PRO . 4.2 mm? -110.04 30.2 6.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -77.27 3.05 13.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.716 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 76.33 40.26 28.99 Favored Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.54 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.437 ' HE1' ' O ' ' A' ' 369' ' ' ARG . 37.0 t80 69.76 110.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.787 0.835 . . . . 0.0 111.638 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -134.68 -169.13 2.28 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.52 159.91 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.824 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.69 9.6 2.58 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-N 116.277 -0.42 . . . . 0.0 114.048 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -115.59 111.81 21.22 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.168 0.508 . . . . 0.0 111.093 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.561 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 1.9 m . . . . . 0 C--N 1.314 -0.951 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.597 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 121.417 0.627 . . . . 0.0 111.683 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 31.3 m -96.77 4.96 51.48 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.3 p -115.57 155.05 28.3 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.913 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 30.3 mmmt -121.52 134.43 24.55 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 5.1 Cg_exo -74.34 118.14 5.25 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.802 1.668 . . . . 0.0 111.938 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 37.2 t -55.32 138.72 67.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.528 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.31 -1.17 10.95 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.577 2.185 . . . . 0.0 112.031 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -111.68 -60.21 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . 0.423 ' SG ' ' HG3' ' A' ' 456' ' ' ARG . 5.3 p -100.58 -3.31 30.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.78 33.7 23.53 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.072 0.463 . . . . 0.0 111.166 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 36.4 p -97.81 154.89 37.67 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.16 99.34 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.181 1.921 . . . . 0.0 112.302 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 5.8 m -85.96 121.05 28.04 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -76.21 124.35 27.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.965 0.412 . . . . 0.0 110.357 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.434 ' O ' ' HD3' ' A' ' 445' ' ' ARG . 0.0 OUTLIER -96.19 155.4 16.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.015 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -140.7 148.86 41.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -85.43 115.1 4.09 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.791 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 136.46 -12.59 4.03 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.793 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 57.9 m -112.94 110.24 20.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.406 ' HA ' ' CD1' ' A' ' 465' ' ' TRP . 0.7 OUTLIER -82.54 -12.73 57.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.195 0.521 . . . . 0.0 110.224 176.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -101.0 96.4 7.22 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 46.3 tpp -104.13 129.77 51.84 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 120.942 0.401 . . . . 0.0 111.05 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 18.6 t -134.37 137.27 51.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 48.1 t -86.52 95.04 9.59 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 20.6 p -81.96 90.23 6.46 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.496 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 0.1 OUTLIER -131.27 141.97 50.06 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.791 -176.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -64.42 106.06 1.05 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.808 0.337 . . . . 0.0 110.141 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 101.69 4.69 51.97 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.414 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.496 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 44.2 t -113.21 -90.19 0.52 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.743 0.271 . . . . 0.0 110.599 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 70.4 34.25 68.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.567 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -94.76 134.23 37.59 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.951 0.405 . . . . 0.0 111.07 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.37 128.85 52.28 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -138.58 157.98 45.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.048 0.451 . . . . 0.0 111.752 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 28.5 m -65.92 136.07 55.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.044 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . 0.406 ' CD1' ' HA ' ' A' ' 450' ' ' MET . 23.9 t-105 -74.33 -49.44 22.86 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.265 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 13.4 t -73.24 -64.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.822 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.658 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 13.9 p -93.32 133.81 36.18 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -76.8 107.64 9.27 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.798 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -155.76 176.53 12.51 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.956 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -113.9 140.84 48.04 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 63.9 t90 -59.75 103.97 0.25 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.799 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 473' ' ' ARG . 0.7 OUTLIER -142.41 -152.47 0.41 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . 0.49 ' H ' HG23 ' A' ' 472' ' ' THR . 33.4 ptt180 -82.94 -23.98 33.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.058 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.85 -50.39 56.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.901 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 66.1 m -110.89 81.17 1.39 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.116 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 92.4 mtp -89.46 -35.53 15.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.818 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . 159.26 40.45 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.555 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -90.83 -3.0 57.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.098 0.475 . . . . 0.0 110.973 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . 0.414 ' CE1' ' SG ' ' A' ' 464' ' ' CYS . 19.2 p80 -143.88 19.5 1.8 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.135 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . 0.459 ' CZ3' ' HA ' ' A' ' 464' ' ' CYS . 9.5 t-105 -87.85 3.36 48.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.299 0.571 . . . . 0.0 110.093 -176.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -64.81 115.77 5.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.091 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-O 118.677 -1.068 . . . . 0.0 111.469 179.744 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-O 121.035 0.241 . . . . 0.0 112.622 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 352' ' ' LEU . 30.0 t -100.38 163.76 2.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . 0.417 ' N ' HG11 ' A' ' 351' ' ' VAL . 4.2 mm? -113.76 143.89 43.89 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 44.5 t -64.95 139.68 97.87 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.779 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -74.66 -10.83 22.0 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.557 2.171 . . . . 0.0 112.402 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -71.42 136.13 83.94 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 110.857 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.1 -43.13 16.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.986 2.457 . . . . 0.0 113.223 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -82.27 7.14 65.04 Favored Glycine 0 CA--C 1.51 -0.279 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.3 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.596 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 43.9 t -92.4 -103.42 0.12 Allowed 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 122.667 -0.314 . . . . 0.0 110.866 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 70.03 27.91 72.4 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 37.5 ttp -79.44 -69.7 0.56 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.913 0.387 . . . . 0.0 110.643 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 139.92 131.38 2.77 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.957 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.36 140.79 48.81 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.952 0.406 . . . . 0.0 110.661 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -105.86 123.37 47.85 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.619 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 59.6 t -118.89 114.47 44.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.873 0.368 . . . . 0.0 110.629 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.67 142.64 70.47 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -46.32 -42.75 22.15 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.345 2.697 . . . . 0.0 114.014 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -80.21 -3.62 49.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 43.6 t -123.58 158.38 31.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.102 0.477 . . . . 0.0 111.131 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -134.74 9.23 3.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.064 0.459 . . . . 0.0 109.779 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -71.95 108.09 5.03 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.525 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.479 HG22 ' C ' ' A' ' 382' ' ' CYS . 0.0 OUTLIER -115.36 112.15 38.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.175 177.27 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.3 m -153.71 135.15 14.24 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.438 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.428 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 3.4 t -74.76 69.57 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.465 0.65 . . . . 0.0 109.738 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -76.03 -9.8 58.9 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.395 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -104.99 5.97 33.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.497 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -161.11 -123.0 0.65 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.583 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.1 p -84.58 92.6 8.17 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.676 0.39 . . . . 0.0 110.67 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -69.52 108.95 2.66 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.896 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -128.08 141.88 51.37 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.75 122.8 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.259 0.552 . . . . 0.0 111.88 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -151.94 -177.5 6.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.824 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . 0.479 ' C ' HG22 ' A' ' 371' ' ' VAL . 19.5 t -108.57 175.46 5.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -82.54 -39.0 22.94 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.935 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.611 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 5.2 m-20 -104.44 -5.33 21.74 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -177.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 21.3 p -151.84 173.2 15.06 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.243 0.544 . . . . 0.0 111.397 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 8.9 mp -110.36 35.38 3.46 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.992 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -79.08 3.84 16.3 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.327 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 83.79 27.58 37.8 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.941 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 25.7 t80 70.08 125.89 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.468 0.707 . . . . 0.0 111.036 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -143.96 -175.72 4.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 43.6 mm -105.52 145.49 13.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.8 -163.41 27.03 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.775 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -91.24 166.53 12.89 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.889 0.376 . . . . 0.0 110.365 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.611 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.0 m . . . . . 0 C--N 1.308 -1.213 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.768 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.451 -0.41 0 CA-C-O 121.433 0.635 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.0 m -114.82 2.04 14.26 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.675 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.1 p -105.83 126.04 51.7 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.877 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 5.2 mptp? -90.48 144.97 31.52 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 1.1 Cg_endo -80.46 121.14 4.17 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.013 1.809 . . . . 0.0 111.822 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 440' ' ' ARG . 37.1 t -54.99 135.2 67.27 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.609 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.53 -15.62 38.06 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.159 1.906 . . . . 0.0 111.651 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . 0.473 ' HA ' ' HE3' ' A' ' 438' ' ' LYS . 0.9 OUTLIER -91.85 -70.49 0.69 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.493 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.1 p -97.6 -6.09 34.12 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 436' ' ' CYS . 23.9 mmt180 67.11 26.1 8.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.771 0.429 . . . . 0.0 111.664 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 26.9 p -86.19 158.81 54.89 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.902 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.02 101.53 1.34 Allowed 'Trans proline' 0 C--O 1.239 0.53 0 C-N-CA 122.428 2.085 . . . . 0.0 112.224 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 7.3 m -90.32 113.16 24.96 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -104.09 141.1 36.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 445' ' ' ARG . 6.6 ptm180 -85.74 95.04 9.27 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.633 0.73 . . . . 0.0 110.057 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -135.47 115.3 12.98 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.892 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 84.16 20.34 59.24 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.78 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -149.89 129.2 2.91 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 76.5 m -81.84 -73.1 0.4 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.754 0.311 . . . . 0.0 110.893 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.438 ' HE1' ' H ' ' A' ' 482' ' ' GLY . 0.7 OUTLIER -112.3 -6.52 14.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.502 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -96.65 96.5 8.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.959 0.409 . . . . 0.0 110.546 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 80.0 mmm -89.51 91.85 8.87 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 23.7 t -99.95 116.76 43.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.89 99.55 12.48 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 1.3 t -87.24 92.78 9.18 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.604 0.716 . . . . 0.0 110.471 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -130.3 148.22 52.1 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.448 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -46.41 -64.76 0.68 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -93.78 37.5 3.39 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.773 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 51.1 t -130.97 -100.36 0.3 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.851 0.357 . . . . 0.0 111.073 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 78.81 22.53 66.2 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -89.28 114.88 26.3 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.361 0.601 . . . . 0.0 111.076 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 471' ' ' TRP . 4.1 pt-20 -105.58 146.19 29.97 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.62 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -146.45 159.38 43.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.941 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 41.8 m -62.51 146.95 50.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.472 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -74.87 -54.54 7.08 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.468 176.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.01 -63.83 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.626 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 28.0 p -98.67 165.96 11.55 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -106.6 111.42 23.96 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.729 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.4 p -150.64 154.75 38.06 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.387 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -73.85 154.36 39.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . 0.468 ' HB3' ' HG3' ' A' ' 462' ' ' GLU . 5.3 p-90 -60.7 91.87 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.887 0.851 . . . . 0.0 111.981 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.2 t -134.77 141.08 46.36 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.761 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . 0.46 ' HA ' ' HB3' ' A' ' 476' ' ' MET . 36.3 mtp180 -63.48 -29.38 70.67 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -174.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . 0.457 ' O ' ' HB1' ' A' ' 478' ' ' ALA . 4.9 p-10 -65.51 -18.32 65.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.293 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 8.2 t -110.61 -40.6 4.54 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' MET . . . . . 0.46 ' HB3' ' HA ' ' A' ' 473' ' ' ARG . 10.8 tpt -52.99 -41.02 64.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.26 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -106.03 16.8 42.3 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.169 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 474' ' ' ASP . . . -92.78 -65.54 0.99 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.75 0.309 . . . . 0.0 110.828 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . 0.613 ' CG ' ' H ' ' A' ' 480' ' ' TRP . 9.5 p80 -108.32 -69.62 0.84 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.031 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . 0.613 ' H ' ' CG ' ' A' ' 479' ' ' HIS . 22.0 t-105 63.51 -71.81 0.06 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.332 1.053 . . . . 0.0 111.734 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -70.23 137.07 50.54 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.416 0.286 . . . . 0.0 110.395 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . 0.438 ' H ' ' HE1' ' A' ' 450' ' ' MET . . . . . . . . 0 N--CA 1.437 -1.295 0 CA-C-O 118.435 -1.203 . . . . 0.0 111.876 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.393 0 CA-C-O 120.896 0.164 . . . . 0.0 112.846 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.34 -179.03 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 C-N-CA 123.094 0.558 . . . . 0.0 110.3 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 7.5 mp -124.35 151.53 44.24 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.872 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.9 t -54.61 138.67 60.91 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.694 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.471 ' HG3' ' CD1' ' A' ' 379' ' ' TYR . 18.6 Cg_endo -59.56 -19.69 53.63 Favored 'Trans proline' 0 N--CA 1.473 0.281 0 C-N-CA 123.195 2.597 . . . . 0.0 112.396 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -84.93 113.09 47.76 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.03 -28.22 74.44 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.46 2.106 . . . . 0.0 111.842 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -67.86 -25.3 74.24 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 40.0 t -73.95 -73.08 0.24 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 53.24 31.53 42.11 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.249 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 47.9 ttp -70.96 -62.55 1.35 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.168 0.508 . . . . 0.0 110.8 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 125.8 123.62 2.7 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.75 130.11 56.52 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.237 0.542 . . . . 0.0 110.478 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.471 HD12 ' HG2' ' A' ' 365' ' ' GLU . 0.8 OUTLIER -89.62 124.66 34.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.859 -178.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . 0.445 ' N ' HD11 ' A' ' 363' ' ' LEU . 100.0 t -93.75 100.99 12.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.102 0.477 . . . . 0.0 110.673 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.471 ' HG2' HD12 ' A' ' 363' ' ' LEU . 6.0 mm-40 -94.89 153.73 39.91 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.369 177.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.82 -11.34 31.76 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 121.785 1.657 . . . . 0.0 109.821 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -102.98 24.99 9.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.182 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 27.1 p -71.83 74.67 0.87 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.556 0.693 . . . . 0.0 110.823 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . 0.512 ' H ' ' HD3' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -64.88 -23.07 67.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.196 179.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -162.11 109.47 1.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.168 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 381' ' ' PHE . 0.6 OUTLIER -92.64 113.67 28.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.659 0.742 . . . . 0.0 110.326 176.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' THR . . . . . 0.42 ' OG1' HG11 ' A' ' 380' ' ' VAL . 92.2 m -152.54 144.93 24.03 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.443 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 9.3 t -74.62 73.24 1.98 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.444 0.64 . . . . 0.0 109.335 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -84.87 -19.48 32.3 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.988 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -96.81 -16.88 20.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.044 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -108.91 -101.26 2.68 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.918 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 4.0 p -100.2 -100.91 0.24 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.774 0.321 . . . . 0.0 110.618 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -173.32 107.06 0.24 Allowed Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.214 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.471 ' CD1' ' HG3' ' A' ' 354' ' ' PRO . 23.8 t80 -161.89 135.55 6.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.833 0.316 . . . . 0.0 110.648 177.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.42 HG11 ' OG1' ' A' ' 372' ' ' THR . 29.1 m -101.01 125.95 54.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.551 ' O ' HG12 ' A' ' 371' ' ' VAL . 23.6 p90 -146.94 -175.12 4.69 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.537 -177.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 34.2 t -77.2 -178.07 4.88 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -95.94 -32.71 12.48 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.837 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -105.57 -7.78 18.38 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.505 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.04 -170.58 3.68 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.451 0.643 . . . . 0.0 111.462 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.81 28.59 8.66 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.145 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -81.09 18.37 1.07 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 72.07 45.43 41.04 Favored Glycine 0 C--O 1.227 -0.282 0 C-N-CA 120.843 -0.694 . . . . 0.0 114.603 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 5.2 t80 59.71 94.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -133.96 -163.12 1.32 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.43 157.31 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -75.33 46.93 1.95 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.5 -0.381 . . . . 0.0 113.77 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.61 107.68 7.18 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.311 -1.068 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.643 -176.677 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 121.828 0.823 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.7 p -100.63 4.43 43.3 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.359 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.5 p -95.56 154.35 17.25 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.665 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 434' ' ' LYS . 0.0 OUTLIER -117.15 140.45 27.15 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.24 124.59 4.88 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.969 1.779 . . . . 0.0 112.499 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 438' ' ' LYS . 41.2 t -64.3 134.93 96.13 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.075 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.16 -4.87 16.01 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.108 1.872 . . . . 0.0 111.492 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 436' ' ' CYS . 6.0 mmmm -100.68 -74.46 0.61 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.101 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 3.6 p -94.99 -7.67 39.13 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.163 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 52.2 mtt180 61.57 31.93 18.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.278 0.561 . . . . 0.0 111.479 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 20.7 p -84.96 154.2 60.71 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.102 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.75 93.66 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.32 2.013 . . . . 0.0 112.855 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 14.8 m -82.92 122.55 28.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.583 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.54 155.93 39.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.584 0.231 . . . . 0.0 110.877 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -116.32 157.79 24.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.025 0.44 . . . . 0.0 111.476 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -143.06 138.04 29.65 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -88.74 51.51 3.86 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.139 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -137.88 -56.09 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.102 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.4 p -83.36 -178.97 7.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.083 0.468 . . . . 0.0 110.483 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.473 ' HE1' ' N ' ' A' ' 482' ' ' GLY . 35.8 ttm -135.57 -14.89 1.9 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.295 0.569 . . . . 0.0 110.062 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -88.56 95.18 10.14 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 70.7 mmm -100.0 115.96 30.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.476 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.84 144.84 33.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.369 0.604 . . . . 0.0 110.939 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 42.5 t -84.41 108.87 17.46 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.774 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 15.3 p -91.64 88.64 6.81 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.624 0.726 . . . . 0.0 109.351 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -132.06 126.96 35.1 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -49.6 -31.88 11.59 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -109.29 25.04 19.24 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.178 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 31.8 t -133.56 -81.18 0.47 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.148 0.474 . . . . 0.0 111.215 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.13 65.63 3.0 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -124.27 121.61 35.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.889 0.376 . . . . 0.0 111.692 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.51 157.37 18.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.577 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -166.62 158.99 13.73 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.761 0.315 . . . . 0.0 111.291 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 52.2 t -71.89 134.78 46.25 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.851 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -69.37 -43.77 72.9 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.005 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 43.1 t -69.85 -63.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 5.6 p -105.74 143.86 33.29 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.359 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -75.22 113.91 13.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.638 0.732 . . . . 0.0 110.58 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.6 p -142.85 178.03 7.93 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.682 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.31 117.88 35.28 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 65.3 m95 63.76 -168.6 0.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.593 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 476' ' ' MET . 7.0 m -109.83 30.93 6.24 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.659 0.742 . . . . 0.0 109.3 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -85.57 -57.61 2.99 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -70.28 -24.73 63.1 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.372 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 93.8 m -89.0 -8.82 53.35 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.893 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 472' ' ' THR . 25.8 ttt -50.59 -57.85 7.21 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.754 0.659 . . . . 0.0 111.491 -176.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -109.73 12.9 32.52 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.371 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -88.31 -64.94 1.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.921 0.391 . . . . 0.0 110.585 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . 0.486 ' CG ' ' H ' ' A' ' 480' ' ' TRP . 6.6 p80 -137.74 -65.39 0.52 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.104 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . 0.486 ' H ' ' CG ' ' A' ' 479' ' ' HIS . 21.4 t-105 54.53 31.27 14.57 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.984 0.897 . . . . 0.0 110.114 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -142.05 151.18 42.15 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.351 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . 0.473 ' N ' ' HE1' ' A' ' 450' ' ' MET . . . . . . . . 0 N--CA 1.437 -1.273 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.834 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 0.518 HG13 ' H ' ' A' ' 352' ' ' LEU . 4.2 t -110.03 175.41 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . 0.518 ' H ' HG13 ' A' ' 351' ' ' VAL . 5.8 mp -137.53 152.37 49.4 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.5 t -56.01 130.64 73.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.74 9.99 1.77 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.99 2.46 . . . . 0.0 113.312 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -98.56 145.56 30.1 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.638 0.256 . . . . 0.0 110.875 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.22 -26.3 30.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.833 2.355 . . . . 0.0 112.789 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.15 -28.34 64.46 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.962 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.409 ' HB3' ' H ' ' A' ' 359' ' ' GLY . 86.7 m -95.08 -151.9 0.34 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 120.929 0.395 . . . . 0.0 110.667 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 358' ' ' CYS . . . 118.96 19.48 4.37 Favored Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -65.9 -66.14 0.59 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 110.32 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 151.31 130.56 1.69 Allowed Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.164 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.06 109.94 17.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.432 0.634 . . . . 0.0 109.909 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -88.31 106.86 18.51 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.433 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 48.6 t -82.45 105.55 12.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.947 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.49 152.66 95.37 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.468 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.07 -20.53 70.05 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.002 1.801 . . . . 0.0 111.175 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.45 12.09 33.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.758 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 47.4 t -70.73 101.28 2.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.258 0.552 . . . . 0.0 110.243 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . 0.606 ' H ' ' HD3' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -91.3 0.61 57.49 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.772 -178.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -162.35 110.36 1.36 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.407 HG11 ' O ' ' A' ' 381' ' ' PHE . 2.7 p -101.09 124.96 55.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.226 0.536 . . . . 0.0 110.348 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.3 m -152.2 147.88 26.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.452 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 29.6 t -69.73 74.99 0.43 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-O 121.563 0.697 . . . . 0.0 109.154 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.52 -20.42 29.68 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.863 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -98.36 13.07 32.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.647 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -142.41 -104.8 0.53 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.158 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 378' ' ' GLY . 20.6 p -97.49 -102.45 0.19 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.233 0.539 . . . . 0.0 110.735 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . 0.453 ' N ' ' SG ' ' A' ' 377' ' ' CYS . . . -171.85 106.55 0.24 Allowed Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -160.21 117.88 2.56 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.95 132.76 38.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' A' ' 389' ' ' TYR . 30.0 p90 -140.66 176.26 8.94 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.153 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 46.9 t -88.66 165.65 14.63 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -88.55 -30.51 19.25 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.25 0.548 . . . . 0.0 110.127 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.492 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 0.9 OUTLIER -105.79 -11.05 16.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.196 178.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 394' ' ' CYS . 5.6 m -145.29 -179.13 6.44 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -174.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 8.0 tp -118.23 22.46 12.15 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.986 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -81.27 28.97 0.36 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 71.97 32.48 63.42 Favored Glycine 0 N--CA 1.465 0.576 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.596 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 381' ' ' PHE . 20.8 t80 57.95 73.5 0.47 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.334 0.588 . . . . 0.0 111.061 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.13 145.2 37.93 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.092 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 6.7 tp -77.2 131.01 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.798 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 104.95 -158.98 15.93 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.344 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -87.34 146.66 25.82 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.117 0.484 . . . . 0.0 111.162 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.757 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 3.7 m . . . . . 0 C--N 1.314 -0.953 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.168 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.442 -0.86 0 CA-C-O 121.403 0.62 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 23.6 m -86.28 -21.11 27.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.744 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.19 132.58 35.24 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.325 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -99.92 111.39 61.88 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.08 127.39 24.78 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.238 1.959 . . . . 0.0 111.94 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 44.5 t -50.96 138.12 25.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.07 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.61 -2.44 12.44 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.264 1.976 . . . . 0.0 111.476 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . 0.445 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 29.4 tptp -109.71 -61.16 1.68 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.413 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 11.8 p -102.69 -3.88 25.9 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 29.5 ttp180 65.19 21.19 12.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.66 0.784 . . . . 0.0 112.33 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.3 p -82.76 140.41 43.82 Favored Pre-proline 0 C--N 1.314 -0.963 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.082 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.4 101.97 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.467 2.111 . . . . 0.0 112.213 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 45.0 m -77.55 123.48 26.66 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.74 114.46 5.04 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.598 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -96.58 105.87 18.03 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.306 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.58 128.29 55.85 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.207 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 66.43 -116.24 8.16 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.371 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -155.81 42.99 0.56 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.945 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 47.7 t -71.67 123.77 23.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.784 0.326 . . . . 0.0 110.254 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.633 ' SD ' ' HA ' ' A' ' 480' ' ' TRP . 43.3 ttm -75.31 -20.43 59.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.781 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -86.02 96.4 9.83 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 21.5 mmt -97.34 113.44 25.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.081 0.467 . . . . 0.0 110.684 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.26 117.44 55.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.648 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 40.7 t -78.92 99.8 6.96 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.545 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 30.8 p -83.7 90.55 7.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.597 0.713 . . . . 0.0 109.35 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.572 ' HD2' ' N ' ' A' ' 457' ' ' ALA . 3.1 tmm_? -130.46 137.54 49.84 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.572 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -63.91 95.66 0.12 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.152 0.501 . . . . 0.0 110.602 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 106.39 24.14 6.93 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.383 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.501 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 29.7 t -131.02 -85.06 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.967 0.384 . . . . 0.0 110.51 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.58 35.42 91.91 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -84.92 124.68 31.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.907 0.384 . . . . 0.0 110.529 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.74 133.72 46.03 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.056 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -143.69 147.22 33.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.748 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 52.5 t -70.65 141.9 51.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.089 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 26.9 t-105 -68.31 -45.22 73.57 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.644 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 51.0 t -75.93 -59.47 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.078 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 7.4 p -101.89 99.06 9.22 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -74.14 110.94 8.83 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.448 0.642 . . . . 0.0 109.96 -175.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.77 175.45 13.71 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.544 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -74.71 139.32 43.37 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -52.7 109.9 0.46 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.074 0.464 . . . . 0.0 110.184 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 473' ' ' ARG . 13.9 p -146.8 -163.46 1.76 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.244 -176.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . 0.421 ' H ' ' HB ' ' A' ' 472' ' ' THR . 18.3 mtm180 -74.92 -21.73 59.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.395 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -46.66 -58.64 3.65 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.762 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 2.1 t -123.38 56.75 1.18 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.268 0.556 . . . . 0.0 109.903 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 60.2 ttp -70.12 -27.82 64.89 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -177.66 40.49 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.693 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -72.38 -64.31 0.97 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.093 0.473 . . . . 0.0 110.996 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -126.83 17.06 7.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.832 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . 0.633 ' HA ' ' SD ' ' A' ' 450' ' ' MET . 35.6 t-105 -62.73 -27.08 69.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.316 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -76.23 104.81 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.256 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.041 0 CA-C-O 118.855 -0.969 . . . . 0.0 111.838 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.212 0 N-CA-C 112.322 -0.311 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 0.518 HG13 ' H ' ' A' ' 352' ' ' LEU . 15.6 t -124.08 176.92 4.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . 0.518 ' H ' HG13 ' A' ' 351' ' ' VAL . 82.8 mt -118.78 151.01 38.83 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . 0.557 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 35.2 t -58.66 142.99 82.76 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.488 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.557 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 56.3 Cg_endo -70.32 -8.94 24.81 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.149 2.566 . . . . 0.0 112.442 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.412 HE21 ' HB2' ' A' ' 355' ' ' GLN . 5.1 mt-30 -94.24 130.7 33.25 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.67 -23.75 63.14 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.264 2.643 . . . . 0.0 113.087 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -83.21 5.87 74.72 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.882 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.682 ' SG ' ' HE1' ' A' ' 360' ' ' MET . 26.5 t -119.2 -99.43 0.44 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 58.63 22.05 51.71 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.273 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' MET . . . . . 0.682 ' HE1' ' SG ' ' A' ' 358' ' ' CYS . 40.8 mtm -70.75 -58.95 3.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.917 0.389 . . . . 0.0 111.117 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 156.45 125.66 0.9 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.25 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 373' ' ' CYS . 4.6 mm? -115.35 126.87 54.95 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.076 0.465 . . . . 0.0 110.051 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -84.46 104.41 14.44 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.555 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.09 104.39 16.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.274 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.25 148.24 91.02 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.939 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.93 -47.09 22.61 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 123.774 2.983 . . . . 0.0 114.146 -176.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.59 -7.8 49.14 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.884 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 51.6 t -76.94 128.41 34.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . 0.495 ' HA ' ' HD3' ' A' ' 383' ' ' ARG . 0.0 OUTLIER -114.08 19.18 16.66 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -116.53 140.77 49.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.334 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.88 130.93 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.544 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 27.4 m -153.67 131.46 11.6 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.158 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.455 ' HA ' HD13 ' A' ' 362' ' ' LEU . 4.3 t -80.29 74.66 7.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.327 0.584 . . . . 0.0 109.73 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -81.15 -6.8 59.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.647 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -95.11 -16.89 22.29 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.07 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -153.88 -117.26 0.64 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.082 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.2 p -90.13 104.13 16.73 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.097 0.559 . . . . 0.0 111.33 -178.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 373' ' ' CYS . . . -69.95 109.9 3.08 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.97 -176.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -127.78 144.33 51.09 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.96 99.84 8.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.186 0.517 . . . . 0.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -127.76 -179.0 4.71 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 7.6 t -86.83 -176.2 5.68 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . 0.495 ' HD3' ' HA ' ' A' ' 369' ' ' ARG . 17.9 ptt180 -94.24 -36.0 12.2 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.469 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.423 HD22 ' CB ' ' A' ' 394' ' ' CYS . 21.7 p-10 -104.7 -28.16 11.37 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.214 0.531 . . . . 0.0 110.759 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.459 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 23.1 p -130.73 -174.24 3.31 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.698 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 354' ' ' PRO . 10.5 mp -113.27 33.63 4.98 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.479 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . 0.459 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 12.8 mm100 -81.17 19.17 0.95 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.979 0.418 . . . . 0.0 112.029 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 71.36 31.46 65.92 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 114.35 0.5 . . . . 0.0 114.35 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 30.9 t80 67.66 110.39 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.045 0.538 . . . . 0.0 111.425 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.415 ' CD2' ' HB2' ' A' ' 387' ' ' GLN . 1.8 p80 -146.65 -53.45 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 16.7 tt -148.74 156.5 8.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.44 -47.73 48.93 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.64 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.51 110.16 21.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.142 0.496 . . . . 0.0 111.394 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.423 ' CB ' HD22 ' A' ' 384' ' ' ASN . 4.7 m . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.309 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.016 0.436 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 50.2 m -124.9 2.52 8.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.067 0.461 . . . . 0.0 110.956 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.1 p -80.24 143.63 33.56 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.135 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 434' ' ' LYS . 11.5 mmpt? -105.68 131.73 21.5 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.9 126.87 13.71 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.274 1.983 . . . . 0.0 112.449 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 437' ' ' PRO . 36.0 t -63.13 136.61 96.77 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.501 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 12.4 Cg_exo -69.82 -17.0 37.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.479 2.119 . . . . 0.0 111.614 177.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 438' ' ' LYS . 0.5 OUTLIER -96.93 -60.37 1.6 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.3 p -107.67 -3.36 19.28 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 440' ' ' ARG . 15.5 tpp85 68.1 21.13 8.8 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.153 0.501 . . . . 0.0 111.892 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 17.9 p -77.49 152.28 80.97 Favored Pre-proline 0 C--N 1.308 -1.202 0 O-C-N 122.175 -0.328 . . . . 0.0 111.157 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.58 92.57 0.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.28 1.987 . . . . 0.0 111.05 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 25.1 m -93.3 114.01 26.35 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.127 0.489 . . . . 0.0 111.339 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -102.74 121.07 41.7 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -82.71 100.69 10.39 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.225 0.536 . . . . 0.0 111.373 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -89.88 107.23 18.99 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 123.21 129.55 3.51 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -67.84 96.21 0.36 Allowed Glycine 0 C--N 1.322 -0.211 0 C-N-CA 121.465 -0.398 . . . . 0.0 113.142 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 79.9 m -153.08 144.31 23.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 122.591 0.356 . . . . 0.0 110.168 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.723 ' SD ' HG22 ' A' ' 466' ' ' VAL . 46.5 tpp -84.89 -31.29 23.79 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -85.6 96.95 9.82 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -120.26 129.66 54.14 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.766 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 5.7 m -124.18 152.5 29.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.711 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.7 t -83.87 115.51 22.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 7.7 t -98.36 91.67 5.32 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 122.2 1.0 . . . . 0.0 109.942 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -129.81 132.06 46.38 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.47 98.37 0.09 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.898 0.38 . . . . 0.0 110.514 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 117.55 -4.13 17.54 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.945 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 47.7 t -108.67 -86.58 0.51 Allowed 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.713 0.292 . . . . 0.0 110.797 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 62.48 56.28 22.52 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -105.28 129.04 53.72 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.937 0.398 . . . . 0.0 111.045 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 471' ' ' TRP . 13.5 mp0 -95.85 140.02 31.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.871 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -161.62 167.25 25.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.476 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 3.9 m -86.71 148.8 25.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.047 0.451 . . . . 0.0 110.831 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -68.63 -50.49 50.96 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.612 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . 0.723 HG22 ' SD ' ' A' ' 450' ' ' MET . 94.7 t -70.72 -64.33 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 21.7 p -90.15 133.19 35.04 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.526 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -77.57 110.0 12.01 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 119.539 -0.864 . . . . 0.0 108.806 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.1 p -153.9 178.12 10.27 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.045 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -101.79 149.91 23.69 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . 0.41 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 44.3 t90 -62.43 98.17 0.11 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 474' ' ' ASP . 11.7 t -141.99 -168.73 2.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 120.927 0.394 . . . . 0.0 111.419 -175.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -69.54 -22.09 63.59 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.541 0.736 . . . . 0.0 112.755 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . 0.462 ' H ' HG22 ' A' ' 472' ' ' THR . 26.3 t70 -67.69 -58.54 4.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.906 0.384 . . . . 0.0 111.245 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 84.2 m -91.48 15.85 11.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.653 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 24.3 ptm -51.43 -32.26 26.07 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -150.6 33.51 0.98 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -88.64 -64.78 1.09 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -142.16 67.75 1.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -85.73 -7.83 58.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.548 0.689 . . . . 0.0 109.306 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -144.4 134.62 24.27 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.507 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.363 0 CA-C-O 118.772 -1.015 . . . . 0.0 110.999 -178.411 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 113.627 0.211 . . . . 0.0 113.627 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 0.439 ' H ' ' HB ' ' A' ' 364' ' ' VAL . 9.4 p -75.61 168.21 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . 0.456 ' HB3' ' HA2' ' A' ' 361' ' ' GLY . 1.0 OUTLIER -141.11 155.41 46.12 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 13.9 t -51.65 130.72 36.44 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.142 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.16 3.36 4.66 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.217 2.611 . . . . 0.0 112.934 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -101.39 122.82 46.74 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.08 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.96 -26.68 83.57 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.055 2.503 . . . . 0.0 113.191 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.24 -13.8 67.9 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.948 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.419 ' SG ' ' HE2' ' A' ' 360' ' ' MET . 42.0 t -92.62 -85.75 0.26 Allowed 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.628 0.252 . . . . 0.0 110.581 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.34 23.5 64.52 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.704 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' MET . . . . . 0.419 ' HE2' ' SG ' ' A' ' 358' ' ' CYS . 36.3 mtm -76.01 -48.51 20.73 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.562 -0.376 . . . . 0.0 111.302 -177.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 352' ' ' LEU . . . 109.46 129.51 5.81 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.832 -177.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.66 176.97 4.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.892 0.377 . . . . 0.0 110.751 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 364' ' ' VAL . 1.7 tt -101.8 148.8 24.86 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . 0.5 ' H ' HD23 ' A' ' 363' ' ' LEU . 4.7 p -130.95 8.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -57.58 151.18 41.74 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.917 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.86 -22.72 38.89 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.967 2.444 . . . . 0.0 112.475 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.58 -7.26 54.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.471 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.68 99.65 1.04 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -64.15 -42.41 96.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.753 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -156.32 125.3 6.02 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.485 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.8 p -90.32 124.31 42.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.21 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.6 m -150.47 141.99 23.47 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.235 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 16.1 t -74.73 70.96 1.92 Allowed 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.374 0.606 . . . . 0.0 109.891 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -84.71 -6.48 59.36 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.856 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -100.02 -4.8 29.22 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.828 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -153.5 -65.84 0.01 OUTLIER Glycine 0 C--O 1.234 0.154 0 C-N-CA 119.37 -1.395 . . . . 0.0 113.603 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 4.7 m -100.3 -131.39 0.24 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.202 0.525 . . . . 0.0 109.67 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -170.3 104.75 0.21 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -162.13 130.49 4.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 32.9 t -97.8 120.65 47.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -136.3 -175.54 4.03 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.234 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 42.4 t -85.64 168.29 14.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -97.98 -14.31 20.65 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.748 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.565 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 84.1 m-20 -103.33 -32.42 9.57 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.6 p -134.23 -171.12 2.67 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.873 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.57 28.03 8.7 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.857 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -85.56 11.08 11.4 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.86 29.47 15.58 Favored Glycine 0 C--N 1.319 -0.404 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.838 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 48.4 t80 72.86 135.1 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.518 0.727 . . . . 0.0 112.573 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -165.26 171.54 13.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.593 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.95 146.65 9.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 96.53 -162.48 22.45 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.698 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.64 173.52 7.57 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.959 0.409 . . . . 0.0 110.971 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.2 m . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.926 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.237 0.424 0 CA-C-O 121.34 0.59 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 9.9 m -120.58 0.6 10.49 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.468 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 16.7 p -120.68 148.42 43.96 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.273 0.559 . . . . 0.0 112.106 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -112.64 131.89 22.48 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.36 118.9 5.95 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.083 1.855 . . . . 0.0 112.256 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 43.4 t -56.45 133.81 76.76 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.375 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.506 ' HG2' ' CE1' ' A' ' 461' ' ' PHE . 57.4 Cg_endo -72.24 -9.18 24.02 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.247 1.964 . . . . 0.0 111.445 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . 0.486 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 29.3 tptp -98.67 -70.92 0.71 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.147 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.8 p -92.62 -12.53 31.42 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 17.0 tpp180 69.17 29.54 4.63 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.554 0.742 . . . . 0.0 111.528 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 41.4 p -89.35 158.58 45.98 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.978 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -80.85 100.22 1.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.218 1.945 . . . . 0.0 112.367 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 11.4 m -84.59 118.53 24.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.855 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -64.51 121.06 13.52 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -93.51 146.67 23.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.569 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -125.49 120.04 29.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.536 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -67.11 124.18 22.54 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.932 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.9 -48.24 0.98 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.318 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 24.9 p -75.18 136.94 41.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.719 0.295 . . . . 0.0 110.591 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 59.8 mtt -97.66 -17.68 19.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.012 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -121.85 96.16 4.95 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.064 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 14.1 ptp -109.08 133.17 53.35 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.429 ' CB ' ' HB3' ' A' ' 462' ' ' GLU . 1.2 m -111.75 150.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.353 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.5 t -86.29 100.42 12.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.0 t -83.39 89.01 6.97 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.321 1.058 . . . . 0.0 109.276 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.515 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -131.22 114.26 14.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.598 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.414 ' HB3' HH21 ' A' ' 456' ' ' ARG . . . -56.52 107.37 0.37 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.33 13.17 19.93 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.123 -0.561 . . . . 0.0 111.843 -177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.515 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 43.8 t -123.64 -73.71 0.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 61.21 57.23 19.42 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . 0.506 ' CE1' ' HG2' ' A' ' 437' ' ' PRO . 50.0 t80 -136.45 129.39 31.05 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.908 0.385 . . . . 0.0 111.277 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 453' ' ' VAL . 0.0 OUTLIER -120.13 155.85 32.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 174.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -140.56 174.78 10.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 48.2 t -76.73 133.91 39.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.36 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -70.13 -56.73 6.11 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.4 -62.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.492 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 13.9 p -103.74 126.37 50.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -73.41 112.03 9.09 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 122.038 0.923 . . . . 0.0 109.549 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.0 p -150.1 177.74 9.61 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.321 -175.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -92.89 156.66 16.81 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -51.05 107.75 0.2 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.334 0.588 . . . . 0.0 110.472 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' THR . . . . . 0.436 HG21 ' H ' ' A' ' 474' ' ' ASP . 9.0 m -134.3 142.11 47.17 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.39 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . 0.484 ' O ' ' HD2' ' A' ' 473' ' ' ARG . 2.4 tmm_? -62.4 -21.32 65.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.406 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . 0.436 ' H ' HG21 ' A' ' 472' ' ' THR . 33.5 t70 -59.84 -58.79 7.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.762 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 480' ' ' TRP . 97.3 m -63.48 -26.46 68.73 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.594 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' MET . . . . . 0.465 ' HB3' ' O ' ' A' ' 473' ' ' ARG . 19.2 ttt -41.76 -46.53 3.87 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.08 0.863 . . . . 0.0 112.997 -177.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -136.89 17.63 3.63 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.19 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -86.81 -56.78 3.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.926 0.363 . . . . 0.0 111.167 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -132.56 10.01 4.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.603 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . 0.448 ' HB2' ' O ' ' A' ' 475' ' ' CYS . 61.1 t-105 -75.05 -41.31 59.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.954 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -73.88 100.79 3.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.119 0.485 . . . . 0.0 111.351 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.059 0 CA-C-O 118.934 -0.926 . . . . 0.0 111.533 179.256 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.984 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 89.2 t -130.13 154.73 40.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 68.7 mt -114.92 148.05 39.18 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 38.6 t -60.75 128.86 89.32 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.02 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.512 ' HG2' ' CD2' ' A' ' 379' ' ' TYR . 43.1 Cg_endo -68.74 1.41 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.927 2.418 . . . . 0.0 112.705 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.44 ' HG3' ' SG ' ' A' ' 377' ' ' CYS . 14.7 mm-40 -73.84 120.63 82.25 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.98 105.66 0.25 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.634 2.223 . . . . 0.0 112.106 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 109.85 -2.99 30.32 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.724 -0.751 . . . . 0.0 113.024 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 52.2 t -81.24 -82.58 0.12 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.921 0.36 . . . . 0.0 110.258 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 57.31 25.36 54.42 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.567 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' MET . . . . . 0.404 ' HE2' ' HB3' ' A' ' 360' ' ' MET . 14.8 tmm? -59.17 -48.93 79.8 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.7 0.286 . . . . 0.0 111.18 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 122.62 108.96 1.98 Allowed Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.621 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.15 139.46 46.51 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.349 0.595 . . . . 0.0 111.049 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 64.3 tp -92.76 134.67 34.82 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.8 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 364' ' ' VAL . 12.4 p -127.84 100.49 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 122.032 0.92 . . . . 0.0 111.497 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -97.42 143.55 26.37 Favored Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.315 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.29 -31.41 76.58 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.39 2.06 . . . . 0.0 111.87 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -85.22 -16.51 40.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.038 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.8 t -93.05 101.27 13.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.092 0.472 . . . . 0.0 109.853 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . 0.551 ' NH2' ' HA3' ' A' ' 392' ' ' GLY . 17.7 ttt180 -92.31 -11.85 34.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.324 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -96.48 134.63 39.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.115 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.6 126.37 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.072 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 52.6 m -152.91 136.37 15.91 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.29 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.47 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 4.1 t -77.01 64.14 2.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.64 -6.38 40.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.893 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -116.3 9.32 14.47 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.363 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -150.84 -95.78 0.13 Allowed Glycine 0 C--O 1.238 0.351 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.601 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.47 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 6.6 p -135.88 111.89 9.6 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 122.717 0.407 . . . . 0.0 110.23 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.2 108.37 2.43 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.001 -174.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . 0.512 ' CD2' ' HG2' ' A' ' 354' ' ' PRO . 89.8 t80 -120.16 151.33 39.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.443 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 11.0 m -89.03 114.63 27.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.312 0.577 . . . . 0.0 111.957 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -153.17 167.23 29.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.047 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 47.8 t -90.16 172.57 8.71 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -88.42 -23.68 23.25 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.336 0.588 . . . . 0.0 109.758 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.447 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 44.6 t30 -104.36 -37.57 7.17 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.889 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 12.5 p -129.44 -170.61 2.32 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.144 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.69 35.75 4.45 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.303 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . 0.485 ' HA ' ' OE1' ' A' ' 387' ' ' GLN . 12.7 mm-40 -79.91 13.41 2.21 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 80.66 23.76 59.59 Favored Glycine 0 N--CA 1.463 0.444 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.505 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 33.0 t80 68.23 117.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.603 0.761 . . . . 0.0 110.688 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -146.54 -162.49 1.54 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.991 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.458 ' H ' HD12 ' A' ' 391' ' ' ILE . 0.2 OUTLIER -65.84 166.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . 0.551 ' HA3' ' NH2' ' A' ' 369' ' ' ARG . . . -76.54 47.73 2.46 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 121.012 -0.613 . . . . 0.0 114.066 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -141.42 96.66 3.02 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.201 0.524 . . . . 0.0 111.042 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 3.7 m . . . . . 0 C--N 1.302 -1.459 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.254 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 120.93 0.395 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.3 t -120.63 -10.24 9.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.916 0.389 . . . . 0.0 110.472 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 3.0 p -85.91 132.82 34.01 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.519 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 434' ' ' LYS . 0.3 OUTLIER -97.9 148.27 34.24 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.33 134.5 19.12 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.324 2.016 . . . . 0.0 113.156 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 15.5 t -67.44 141.64 95.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.945 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 3.6 Cg_exo -75.77 -13.99 19.68 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.296 1.997 . . . . 0.0 111.976 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -96.76 -64.0 1.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.056 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 1.5 p -109.87 3.45 20.66 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 15.9 ttm180 60.92 25.15 15.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.361 0.665 . . . . 0.0 112.403 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.455 ' H ' ' HB3' ' A' ' 436' ' ' CYS . 2.9 p -82.74 142.34 45.41 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.361 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -63.47 105.97 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.377 2.051 . . . . 0.0 112.225 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 17.7 m -78.25 125.73 29.77 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.049 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -92.24 131.25 37.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.569 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -85.2 94.95 9.02 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -109.99 123.86 50.39 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.17 -80.22 0.96 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.933 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.66 13.46 5.63 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.012 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.7 m -81.87 38.29 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.353 . . . . 0.0 110.813 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 479' ' ' HIS . 2.1 mpt? 64.11 16.92 10.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.377 0.671 . . . . 0.0 111.499 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -88.6 96.36 10.61 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 6.7 mmt -113.69 82.13 1.63 Allowed 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.43 171.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 2.2 m -126.8 142.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.05 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 52.6 t -96.04 108.15 20.53 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.92 0.39 . . . . 0.0 111.592 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 18.7 p -89.11 90.34 8.34 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.429 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 4.6 tmt_? -130.2 145.17 51.7 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.724 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.7 94.64 0.31 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 0.0 110.483 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 109.38 24.5 5.89 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.671 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.429 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 50.0 t -126.27 -95.4 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.735 0.303 . . . . 0.0 110.632 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 70.74 46.84 43.8 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.626 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -112.1 130.36 55.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 111.488 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -100.39 137.78 38.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.999 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -139.72 155.6 47.25 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 79.1 m -66.27 130.71 44.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -75.08 -46.44 34.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.268 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.61 -65.12 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.993 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 10.1 p -95.43 133.98 38.78 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -79.47 109.81 14.19 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.836 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.9 t -156.82 158.1 36.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.858 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -87.0 113.73 23.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.223 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 25.14 81.77 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.963 1.305 . . . . 0.0 113.158 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 14.8 m -117.21 110.13 17.76 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.949 0.404 . . . . 0.0 110.841 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -71.63 -22.46 61.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.49 -49.66 74.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.568 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . 0.401 ' HB2' ' CD2' ' A' ' 479' ' ' HIS . 2.5 p -91.79 -15.24 28.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.387 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' MET . . . . . 0.411 ' O ' ' HB3' ' A' ' 480' ' ' TRP . 25.0 ttt -54.75 -45.55 74.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.555 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -71.98 0.86 35.47 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.534 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.91 -60.08 1.84 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 117.164 0.482 . . . . 0.0 112.072 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . 0.52 ' O ' ' HG2' ' A' ' 450' ' ' MET . 17.6 p80 -94.89 -25.61 16.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . 0.411 ' HB3' ' O ' ' A' ' 476' ' ' MET . 31.3 t-105 -65.58 -41.91 92.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.938 0.399 . . . . 0.0 110.948 -176.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.47 95.65 8.56 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.235 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.883 0 CA-C-O 118.854 -0.97 . . . . 0.0 111.831 -178.942 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.95 0 N-CA-C 112.223 -0.351 . . . . 0.0 112.223 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 0.442 HG21 ' H ' ' A' ' 352' ' ' LEU . 10.4 p -102.63 170.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . 0.447 ' O ' HD13 ' A' ' 386' ' ' LEU . 5.4 mp -139.63 153.27 47.29 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 122.202 -0.311 . . . . 0.0 110.371 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 355' ' ' GLN . 52.5 t -57.48 135.67 81.96 Favored Pre-proline 0 N--CA 1.452 -0.372 0 O-C-N 123.502 0.501 . . . . 0.0 110.058 177.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.29 0.09 8.96 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.649 2.233 . . . . 0.0 112.083 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.497 ' HB3' ' SG ' ' A' ' 353' ' ' CYS . 7.6 tp-100 -86.41 122.64 72.0 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.016 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.56 -20.9 70.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.639 2.226 . . . . 0.0 112.169 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.89 -17.33 79.94 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.587 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 66.2 m -100.82 -176.54 3.21 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.062 0.458 . . . . 0.0 110.862 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 156.42 37.8 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' MET . . . . . 0.416 ' HE2' ' SG ' ' A' ' 373' ' ' CYS . 2.1 mpp? -82.76 -36.11 25.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 0.0 110.407 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.17 121.35 4.79 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.413 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.24 111.65 24.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.451 0.643 . . . . 0.0 110.081 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -83.6 109.17 17.21 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.076 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . 0.42 HG23 ' HB2' ' A' ' 383' ' ' ARG . 2.7 p -85.63 110.5 19.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.48 0.657 . . . . 0.0 111.658 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -97.58 150.85 37.22 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.298 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.64 -22.94 63.13 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.313 2.009 . . . . 0.0 110.995 175.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.52 -35.93 75.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.487 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.7 t -78.39 120.73 23.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.84 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -111.76 -8.85 14.13 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.251 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 108.38 11.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.548 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 381' ' ' PHE . 2.5 t -89.88 120.33 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 CA-C-N 116.366 -0.379 . . . . 0.0 109.98 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 86.2 m -152.24 139.61 19.49 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.52 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.416 ' SG ' ' HE2' ' A' ' 360' ' ' MET . 47.8 t -72.54 74.45 1.06 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.372 0.606 . . . . 0.0 110.292 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -85.13 -6.59 59.29 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.278 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -106.66 -11.37 15.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.176 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -117.45 -77.47 0.61 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.407 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 10.8 p -125.19 -102.12 0.37 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.038 0.447 . . . . 0.0 110.925 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -172.47 106.36 0.23 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -160.53 129.63 4.89 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 58.1 t -95.22 110.52 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.436 ' O ' ' HB ' ' A' ' 371' ' ' VAL . 34.3 p90 -127.32 -177.24 3.99 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.141 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 10.9 t -82.2 177.24 8.9 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.214 0.53 . . . . 0.0 110.782 -176.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . 0.42 ' HB2' HG23 ' A' ' 364' ' ' VAL . 38.6 ptt180 -96.34 -27.81 14.78 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.889 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.437 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 6.7 t30 -104.43 -30.85 9.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.987 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.547 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 6.6 p -133.81 -172.96 3.11 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.255 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 352' ' ' LEU . 3.0 mm? -112.67 29.69 7.74 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.121 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . 0.547 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 9.3 mm100 -79.66 15.85 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 77.79 25.16 63.09 Favored Glycine 0 C--O 1.229 -0.209 0 C-N-CA 120.514 -0.851 . . . . 0.0 113.538 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 37.7 t80 72.1 134.52 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.397 0.679 . . . . 0.0 112.252 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -156.59 175.0 14.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.111 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 8.7 tp -93.13 144.95 8.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 102.13 -158.06 18.34 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.907 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -120.95 164.55 16.54 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 1.4 m . . . . . 0 C--N 1.319 -0.752 0 CA-C-O 120.883 0.373 . . . . 0.0 111.631 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 31.4 t . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.293 0.568 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 13.4 p -112.87 4.61 16.99 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.982 0.896 . . . . 0.0 108.735 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.6 p -95.09 142.68 27.27 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.002 -177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.31 136.17 25.94 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.907 177.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.31 128.59 10.57 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.172 1.915 . . . . 0.0 112.238 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 35.6 t -57.98 142.08 80.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.08 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 4.8 Cg_exo -76.4 -6.2 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.441 2.094 . . . . 0.0 111.536 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -108.97 -65.25 1.16 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.395 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.4 p -99.62 -4.75 30.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.787 0.327 . . . . 0.0 111.772 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 0.0 OUTLIER 63.09 23.41 13.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.229 178.282 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 25.4 p -80.03 155.07 75.23 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-O 120.614 0.245 . . . . 0.0 111.062 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.8 107.48 2.48 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.659 2.239 . . . . 0.0 113.529 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 41.7 m -107.1 126.06 51.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.85 144.2 55.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.79 0.328 . . . . 0.0 110.419 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -99.79 169.76 9.02 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.435 0.636 . . . . 0.0 112.326 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.45 162.47 13.44 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.819 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -66.63 -57.4 10.08 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -144.2 42.8 1.02 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.234 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 46.7 t -109.84 135.99 49.86 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -78.89 -10.28 59.76 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -77.38 99.78 5.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.978 0.418 . . . . 0.0 110.919 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' MET . . . . . 0.499 ' CG ' ' HE3' ' A' ' 465' ' ' TRP . 27.4 mmt -120.86 95.45 4.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.435 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.461 ' CG1' ' HG3' ' A' ' 462' ' ' GLU . 3.6 m -128.99 144.6 37.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.021 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 7.5 t -73.7 135.25 43.66 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.138 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.9 t -113.34 87.72 2.67 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 122.254 1.026 . . . . 0.0 109.96 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -132.4 130.44 40.63 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.31 92.57 0.09 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.984 0.421 . . . . 0.0 110.726 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 128.69 -18.91 5.63 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.45 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 45.0 t -93.51 -83.38 0.32 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.665 0.269 . . . . 0.0 110.585 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.01 51.75 32.26 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.669 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -102.39 122.38 44.17 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.861 0.362 . . . . 0.0 111.425 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.461 ' HG3' ' CG1' ' A' ' 453' ' ' VAL . 13.4 mp0 -90.32 140.25 29.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.99 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -143.23 167.36 22.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.252 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 56.6 m -81.44 143.08 32.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.45 0.643 . . . . 0.0 112.168 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . 0.499 ' HE3' ' CG ' ' A' ' 452' ' ' MET . 15.0 t-105 -75.66 -41.3 54.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.237 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.61 -64.56 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.705 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 25.3 p -91.82 177.44 6.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 110.49 15.92 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.658 0.742 . . . . 0.0 110.438 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 15.1 t -157.76 178.16 10.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.443 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.15 135.81 33.52 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 36.3 t90 -60.45 106.53 0.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.161 0.505 . . . . 0.0 109.768 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.5 p -136.28 -176.86 4.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.707 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -73.45 -24.15 60.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.19 -56.49 14.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.45 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -99.61 16.96 21.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.722 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -56.12 -57.86 10.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.07 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -135.4 17.85 3.97 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.69 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.52 -28.54 69.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.931 0.396 . . . . 0.0 111.541 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -143.78 -6.59 0.77 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.439 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -59.91 99.63 0.07 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.776 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -150.26 127.97 11.66 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.462 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.501 0 CA-C-O 118.696 -1.058 . . . . 0.0 111.066 -179.894 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.519 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 352' ' ' LEU . 10.6 p -98.39 168.09 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . 0.405 ' H ' HG23 ' A' ' 351' ' ' VAL . 2.9 mm? -125.95 145.26 50.36 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 122.011 -0.431 . . . . 0.0 110.686 -176.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 354' ' ' PRO . 50.5 t -63.01 130.71 94.34 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 353' ' ' CYS . 9.5 Cg_exo -70.88 -12.1 30.29 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.829 2.353 . . . . 0.0 113.159 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -82.16 119.75 75.68 Favored Pre-proline 0 C--N 1.317 -0.828 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.21 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.79 129.28 33.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.567 2.178 . . . . 0.0 111.128 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 116.12 -21.97 11.7 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 35.4 m -90.97 -97.0 0.11 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.034 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 53.31 29.72 38.49 Favored Glycine 0 C--O 1.225 -0.466 0 O-C-N 123.404 0.44 . . . . 0.0 112.507 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' MET . . . . . 0.47 ' HE1' ' HA3' ' A' ' 376' ' ' GLY . 25.7 mtm -74.96 -67.19 0.67 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.935 0.398 . . . . 0.0 110.433 -178.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 147.14 120.02 1.18 Allowed Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.427 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.76 116.95 32.17 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.43 122.29 19.36 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.956 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.83 100.28 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.102 0.477 . . . . 0.0 110.863 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -89.4 135.71 30.8 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.236 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.07 -36.45 99.25 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.543 2.162 . . . . 0.0 111.303 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -77.98 -22.38 49.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 41.3 t -75.48 114.45 14.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.222 0.534 . . . . 0.0 110.98 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -114.81 -0.88 13.36 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.502 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -136.35 111.56 9.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.345 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 381' ' ' PHE . 0.8 OUTLIER -105.9 151.31 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.839 -176.69 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.2 m -154.09 143.21 21.25 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.637 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 41.5 t -72.67 71.98 1.02 Allowed 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.486 0.66 . . . . 0.0 109.927 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -85.18 -6.59 59.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.0 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -88.95 -17.74 28.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.852 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . 0.47 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -138.07 -88.13 0.19 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.048 -1.073 . . . . 0.0 113.169 -177.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' A' ' 378' ' ' GLY . 25.2 p -99.14 -109.34 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.198 0.523 . . . . 0.0 111.755 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' A' ' 377' ' ' CYS . . . -172.08 108.05 0.27 Allowed Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -160.03 145.7 15.41 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.18 113.45 44.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.492 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . 0.485 ' O ' HG22 ' A' ' 371' ' ' VAL . 13.5 p90 -129.84 -174.68 3.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.144 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . 0.554 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 29.3 t -81.2 172.09 14.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -97.42 -19.05 18.71 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.478 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -104.74 -31.74 9.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.296 0.57 . . . . 0.0 110.008 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 21.1 p -135.72 179.9 6.05 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.237 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.5 mp -108.62 31.49 5.58 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.482 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . 0.488 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 77.9 mm-40 -74.66 4.42 6.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.176 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 82.3 30.36 34.16 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.132 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 31.2 t80 72.17 128.03 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.828 0.451 . . . . 0.0 110.414 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -161.67 178.59 8.88 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.217 0.532 . . . . 0.0 111.756 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 47.4 mt -98.86 150.05 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.801 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 109.87 -164.03 12.39 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.089 -1.053 . . . . 0.0 112.736 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -116.42 149.62 39.14 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.786 0.326 . . . . 0.0 110.714 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.318 -0.77 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.969 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 4.7 m -79.61 -38.82 33.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.007 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.1 174.18 11.82 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.288 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . 0.452 ' HD3' ' HD2' ' A' ' 435' ' ' PRO . 17.2 tppt? -116.6 115.96 39.13 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . 0.452 ' HD2' ' HD3' ' A' ' 434' ' ' LYS . 17.8 Cg_endo -61.28 123.36 12.67 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.925 1.75 . . . . 0.0 111.361 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 44.2 t -58.41 136.52 85.5 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.369 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.05 -3.7 14.11 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.46 2.106 . . . . 0.0 111.621 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -109.72 -68.44 0.92 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.916 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 7.6 p -95.09 -2.71 49.5 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 12.3 tpt180 62.17 23.7 14.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.009 0.524 . . . . 0.0 111.578 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.3 p -84.87 160.65 55.15 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.263 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.67 93.81 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.224 1.949 . . . . 0.0 111.809 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 4.7 m -83.7 126.02 32.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.186 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -104.63 151.74 23.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.447 ' HB3' ' HE3' ' A' ' 452' ' ' MET . 15.2 ptt180 -119.74 156.97 29.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.23 0.538 . . . . 0.0 111.458 -178.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -129.57 145.23 51.5 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.802 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 73.29 -141.6 30.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.208 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.15 72.39 0.25 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.675 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.2 p -123.71 175.71 6.69 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 47.4 mtt -97.83 -0.64 44.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.037 0.446 . . . . 0.0 110.328 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -80.03 99.41 7.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.972 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' MET . . . . . 0.447 ' HE3' ' HB3' ' A' ' 445' ' ' ARG . 96.5 mmm -112.94 97.36 6.48 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.908 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.4 t -109.42 113.93 45.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.24 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.64 111.16 14.43 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.531 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 11.9 p -93.55 90.78 6.8 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 121.411 0.624 . . . . 0.0 109.514 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.524 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 4.7 tmt_? -132.13 139.36 48.41 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.029 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.35 105.68 0.97 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.889 0.376 . . . . 0.0 110.668 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 101.33 7.14 49.86 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.249 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.524 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 53.4 t -104.51 -90.19 0.4 Allowed 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.721 -0.282 . . . . 0.0 110.592 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.29 46.2 80.65 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -113.27 130.18 56.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.908 0.385 . . . . 0.0 110.944 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -98.87 140.61 32.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.025 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 28.1 p-90 -151.35 149.95 29.92 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.413 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 53.4 m -74.24 149.66 40.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.412 0.625 . . . . 0.0 112.012 -178.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -74.71 -58.74 3.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.939 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.97 -47.29 76.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 8.1 p -104.21 125.25 50.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -75.34 110.6 9.83 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.7 p -153.51 177.85 10.47 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.476 -176.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -102.22 157.24 17.03 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -56.7 108.6 0.51 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.478 0.656 . . . . 0.0 111.189 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 476' ' ' MET . 61.1 p -123.74 175.73 6.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.532 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -85.21 -29.95 24.28 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.685 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . 0.411 ' O ' ' HB1' ' A' ' 478' ' ' ALA . 7.3 p-10 -67.54 -28.02 67.45 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.332 -178.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 47.1 m -93.36 -30.28 15.19 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 472' ' ' THR . 1.9 tmt? -51.08 -52.3 44.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.352 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -99.38 20.06 51.34 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.563 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 474' ' ' ASP . . . -111.17 -65.63 1.15 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -139.43 16.84 2.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -55.81 -38.62 70.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.253 0.549 . . . . 0.0 110.034 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -120.45 99.33 6.5 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.04 0 CA-C-O 118.434 -1.203 . . . . 0.0 111.803 -179.465 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.118 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 24.4 m -107.91 178.5 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.009 0.433 . . . . 0.0 110.334 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 6.2 mp -134.08 152.37 51.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.567 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.4 t -52.55 134.82 44.25 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.001 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.0 -16.93 48.65 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.116 2.544 . . . . 0.0 113.025 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -87.73 117.94 69.13 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.8 -27.66 84.54 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.017 2.478 . . . . 0.0 112.426 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -72.22 -16.18 76.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.543 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.2 t -86.8 -77.71 0.31 Allowed 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.05 30.4 66.79 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.024 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 9.0 ttm -70.49 -76.72 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.009 0.433 . . . . 0.0 111.174 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 143.48 121.88 1.62 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.064 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.59 130.32 55.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.11 0.481 . . . . 0.0 110.772 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 364' ' ' VAL . 1.7 tm? -95.69 128.89 42.94 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.677 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . 0.402 ' N ' HD13 ' A' ' 363' ' ' LEU . 62.9 t -114.91 103.86 15.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.286 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -84.42 154.44 62.67 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.125 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.6 -9.85 26.8 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.052 1.835 . . . . 0.0 112.335 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -99.57 -14.43 19.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 52.8 t -125.07 136.85 54.06 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.936 0.398 . . . . 0.0 110.774 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.09 10.46 8.14 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.103 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -87.5 91.26 8.67 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.626 0.727 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . 0.504 HG21 ' C ' ' A' ' 382' ' ' CYS . 0.0 OUTLIER -85.0 113.77 24.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.509 178.285 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 91.4 m -153.19 139.87 18.9 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.245 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.443 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 4.7 t -76.44 67.48 2.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -66.45 -17.8 65.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.374 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -101.91 11.49 38.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -166.08 -126.09 0.81 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.164 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.443 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -83.2 91.08 7.18 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -69.06 108.88 2.64 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.693 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -114.09 143.62 44.48 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.448 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 14.0 m -83.58 102.02 9.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.445 0.64 . . . . 0.0 111.413 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -133.82 172.33 12.93 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . 0.504 ' C ' HG21 ' A' ' 371' ' ' VAL . 10.7 t -95.62 175.98 6.33 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.059 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . 0.435 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 5.7 ptp85 -78.06 -45.26 24.05 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.879 -175.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.589 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 20.3 m120 -105.33 -9.88 17.35 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.984 0.421 . . . . 0.0 111.197 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 26.4 p -140.21 176.07 9.06 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.919 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.81 32.64 5.7 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -72.63 -1.34 15.8 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 96.39 27.33 10.02 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.465 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 46.1 t80 66.42 103.99 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.23 0.612 . . . . 0.0 111.181 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -118.42 162.34 18.48 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.087 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 48.4 mm -91.69 120.93 41.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 132.96 -140.26 11.67 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -132.97 148.93 52.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.815 0.34 . . . . 0.0 110.635 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 1.3 m . . . . . 0 C--N 1.319 -0.722 0 CA-C-O 121.48 0.657 . . . . 0.0 109.905 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.485 HG22 ' H ' ' A' ' 433' ' ' THR . 14.9 p . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.81 0.338 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.1 p -96.47 -11.54 25.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.96 0.41 . . . . 0.0 111.788 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' THR . . . . . 0.485 ' H ' HG22 ' A' ' 431' ' ' VAL . 5.1 p -110.4 170.63 7.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.874 0.369 . . . . 0.0 111.005 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -131.51 125.43 20.65 Favored Pre-proline 0 N--CA 1.436 -1.135 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.77 136.41 57.57 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.753 2.302 . . . . 0.0 113.156 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 31.2 t -63.36 141.18 97.81 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.761 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 7.1 Cg_exo -73.77 -2.23 11.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.524 2.149 . . . . 0.0 111.78 176.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -117.4 -69.92 0.82 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.578 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 17.7 p -86.33 -10.61 54.1 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.63 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 71.5 mtt85 66.52 21.46 10.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.149 0.579 . . . . 0.0 112.17 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 42.2 p -82.01 149.7 63.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.462 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.28 99.81 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.3 2.0 . . . . 0.0 111.802 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 20.3 m -81.04 125.93 30.8 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.992 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -82.35 134.7 35.26 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.248 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -91.04 143.44 26.7 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.253 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -146.37 160.81 41.56 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.264 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -67.24 148.8 50.49 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.723 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 179.36 -154.75 14.37 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.078 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 450' ' ' MET . 61.1 m -108.45 49.87 0.8 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.924 0.392 . . . . 0.0 110.337 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.703 ' SD ' ' HA ' ' A' ' 480' ' ' TRP . 14.0 ptp 57.92 11.2 1.34 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.874 1.27 . . . . 0.0 112.925 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -94.48 94.78 8.42 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 49.0 tpp -108.07 128.3 54.56 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.025 0.44 . . . . 0.0 110.776 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.465 ' CG1' ' HG2' ' A' ' 462' ' ' GLU . 3.2 m -129.86 150.34 34.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 456' ' ' ARG . 12.9 t -69.36 111.7 5.42 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.477 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.3 t -83.7 87.43 7.05 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 122.5 1.143 . . . . 0.0 109.452 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.519 ' HB2' ' SG ' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -133.16 128.1 35.29 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 91.75 0.09 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.86 0.362 . . . . 0.0 110.565 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 124.93 -11.51 7.79 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.709 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . 0.506 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 23.6 t -98.1 -77.8 0.5 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.49 32.35 83.12 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.942 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . 0.425 ' HB2' ' SG ' ' A' ' 459' ' ' CYS . 29.8 t80 -75.58 120.02 20.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.465 ' HG2' ' CG1' ' A' ' 453' ' ' VAL . 45.0 mt-10 -91.48 138.43 31.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -156.48 160.23 39.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.961 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 44.8 t -69.99 138.05 51.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.427 0.632 . . . . 0.0 112.129 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -75.18 -41.63 57.55 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.614 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 41.9 t -77.06 -64.52 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.844 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.7 p -102.29 96.91 7.27 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -74.93 109.92 8.79 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.67 1.224 . . . . 0.0 112.56 -170.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.2 t -160.18 173.67 15.4 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.551 -1.659 . . . . 0.0 106.736 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.64 111.66 12.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.445 -0.902 . . . . 0.0 108.877 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . 0.438 ' CE3' ' HB3' ' A' ' 474' ' ' ASP . 1.3 m95 -158.24 145.05 17.66 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.752 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 476' ' ' MET . 10.5 p -134.45 -72.03 0.49 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . 0.479 ' NH1' ' HG2' ' A' ' 476' ' ' MET . 29.8 mmm180 -85.13 -29.2 25.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . 0.438 ' HB3' ' CE3' ' A' ' 471' ' ' TRP . 8.0 t70 -66.0 -51.75 55.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.118 0.485 . . . . 0.0 111.051 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.6 t -78.83 -10.7 59.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.824 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' MET . . . . . 0.521 ' HA ' ' HB3' ' A' ' 480' ' ' TRP . 47.7 tpp -57.61 -53.09 62.14 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.858 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -84.75 -10.54 78.95 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.325 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -71.12 -62.55 1.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.821 0.344 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -148.0 -12.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.836 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . 0.703 ' HA ' ' SD ' ' A' ' 450' ' ' MET . 2.3 t-105 -54.92 -41.3 70.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.354 0.597 . . . . 0.0 110.321 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -70.88 96.59 1.29 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.17 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.022 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.006 -179.292 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.561 0 CA-C-O 121.012 0.229 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' VAL . . . . . 0.508 HG22 ' H ' ' A' ' 352' ' ' LEU . 7.2 p -122.21 177.53 3.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . 0.508 ' H ' HG22 ' A' ' 351' ' ' VAL . 98.4 mt -117.11 149.82 39.7 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 120.791 0.329 . . . . 0.0 110.963 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . 0.567 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 44.9 t -68.09 145.46 97.67 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.823 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' PRO . . . . . 0.567 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 27.6 Cg_endo -63.5 -14.85 44.94 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.812 2.342 . . . . 0.0 112.298 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -86.59 118.84 70.84 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.36 -30.55 91.55 Favored 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 123.159 2.573 . . . . 0.0 113.581 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -82.03 -10.22 84.2 Favored Glycine 0 C--O 1.236 0.247 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.27 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . 0.482 ' SG ' ' HE3' ' A' ' 360' ' ' MET . 47.1 t -74.24 -82.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.692 0.282 . . . . 0.0 110.289 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 60.32 22.12 58.06 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.441 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' MET . . . . . 0.482 ' HE3' ' SG ' ' A' ' 358' ' ' CYS . 34.9 mtm -74.2 -41.44 61.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.184 0.516 . . . . 0.0 110.785 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 106.51 115.02 3.97 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.569 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -99.37 144.91 27.94 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 122.528 0.331 . . . . 0.0 110.601 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.98 118.51 27.58 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 364' ' ' VAL . 9.1 p -122.03 77.71 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 122.023 0.916 . . . . 0.0 112.339 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -97.98 154.5 37.74 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.13 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.81 -14.73 42.47 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.415 2.077 . . . . 0.0 111.331 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -85.46 -2.59 58.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.066 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 46.0 t -110.12 115.47 29.8 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.637 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.4 1.88 26.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.052 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -136.48 96.58 3.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.896 0.379 . . . . 0.0 111.175 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.8 120.38 40.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.423 0.63 . . . . 0.0 110.535 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 97.1 m -152.24 143.92 23.56 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.597 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' CYS . . . . . 0.444 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 3.7 t -76.51 67.02 2.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.474 0.654 . . . . 0.0 109.688 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -72.14 -6.12 40.4 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.501 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -106.41 -12.89 15.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.066 0.46 . . . . 0.0 110.793 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -144.64 -124.1 1.72 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.921 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' CYS . . . . . 0.444 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -74.53 86.57 2.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.825 0.345 . . . . 0.0 110.553 178.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 373' ' ' CYS . . . -67.77 109.09 2.72 Favored Glycine 0 CA--C 1.495 -1.157 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.574 -172.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -147.85 134.77 20.18 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.3 p -83.64 133.16 29.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -142.03 166.62 24.22 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 11.3 t -79.87 160.13 26.16 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.236 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -92.79 -13.25 29.45 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.537 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -104.82 -30.62 9.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.277 0.56 . . . . 0.0 109.511 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 6.7 p -140.84 -165.88 2.03 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.241 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 65.1 mt -116.96 25.68 10.34 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.019 0.437 . . . . 0.0 110.942 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -75.97 20.36 0.19 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 78.89 16.85 78.32 Favored Glycine 0 N--CA 1.461 0.363 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.201 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' TYR . . . . . 0.406 ' CD1' ' HA ' ' A' ' 382' ' ' CYS . 0.3 OUTLIER 67.41 114.18 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.751 0.82 . . . . 0.0 111.477 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -141.06 -53.97 0.48 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.429 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ILE . . . . . 0.454 HG23 ' H ' ' A' ' 393' ' ' GLU . 40.8 mt -125.29 146.3 31.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -66.11 -23.75 71.5 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.292 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' GLU . . . . . 0.454 ' H ' HG23 ' A' ' 391' ' ' ILE . 31.6 mt-10 -135.36 134.76 40.11 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.45 0.3 . . . . 0.0 110.414 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 74.8 m . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 121.04 0.448 . . . . 0.0 111.498 -177.942 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.109 0.481 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.5 p -92.5 -15.63 26.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.551 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 1.1 p -102.49 163.47 12.21 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.807 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' LYS . . . . . 0.417 ' HD3' ' HD2' ' A' ' 435' ' ' PRO . 5.4 tppp? -115.66 118.52 38.94 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' PRO . . . . . 0.417 ' HD2' ' HD3' ' A' ' 434' ' ' LYS . 29.2 Cg_endo -63.58 134.16 43.07 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.249 1.966 . . . . 0.0 112.526 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 35.3 t -61.26 140.33 94.48 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.424 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.48 -11.52 31.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.341 2.027 . . . . 0.0 111.616 177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -102.45 -67.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.752 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 6.2 p -96.98 -1.25 45.97 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' ARG . . . . . 0.449 ' O ' ' HG2' ' A' ' 440' ' ' ARG . 65.8 ttt180 61.69 23.73 13.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.284 0.564 . . . . 0.0 111.557 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 17.5 p -79.13 142.22 59.14 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.975 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 11.8 Cg_exo -67.41 102.28 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.295 1.997 . . . . 0.0 111.252 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 17.7 m -106.03 128.05 53.58 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.631 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -117.68 171.84 7.76 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 120.904 0.383 . . . . 0.0 110.892 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' ARG . . . . . 0.548 ' HD3' ' CZ2' ' A' ' 465' ' ' TRP . 33.8 ptt-85 -103.5 161.99 13.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.167 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.37 114.31 25.71 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 71.88 -115.89 5.74 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.468 -176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.69 38.82 1.64 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.914 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 61.2 m -71.68 141.94 49.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.824 0.345 . . . . 0.0 111.181 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 65.4 mtt -94.2 -21.36 19.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.875 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -75.33 95.74 3.26 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.155 0.502 . . . . 0.0 110.197 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 48.5 tpp -104.08 96.63 6.79 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.287 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . 0.425 ' HB ' ' HG3' ' A' ' 462' ' ' GLU . 3.8 p -112.97 129.5 68.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.197 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.22 116.84 6.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.376 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 7.9 p -100.81 92.39 5.05 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.495 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 458' ' ' GLY . 0.0 OUTLIER -130.43 148.15 52.21 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -71.28 14.74 0.15 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.097 0.475 . . . . 0.0 111.413 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 456' ' ' ARG . . . -160.61 34.63 0.42 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' CYS . . . . . . . . . . . . . 10.0 t -154.6 -152.09 0.39 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 136.16 74.12 0.07 OUTLIER Glycine 0 C--N 1.279 -2.638 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.762 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -137.48 130.41 30.36 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.628 0.251 . . . . 0.0 111.101 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.425 ' HG3' ' HB ' ' A' ' 453' ' ' VAL . 1.9 mp0 -87.78 127.42 35.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.941 177.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -134.2 161.56 34.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.61 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . 0.434 ' HA ' ' CZ3' ' A' ' 480' ' ' TRP . 8.2 t -68.41 133.39 48.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.264 0.554 . . . . 0.0 111.666 -175.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' TRP . . . . . 0.548 ' CZ2' ' HD3' ' A' ' 445' ' ' ARG . 23.5 t-105 -76.68 -55.35 5.58 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.463 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.68 -56.56 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 28.5 p -101.17 -161.06 0.83 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -131.32 110.11 10.84 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.795 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.6 p -155.5 151.44 27.7 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.646 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.48 156.76 38.95 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -50.02 109.01 0.25 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.309 0.576 . . . . 0.0 110.82 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 2.3 p -133.73 161.63 34.17 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.579 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' ARG . . . . . 0.496 ' HA ' ' HG2' ' A' ' 476' ' ' MET . 64.4 ttt180 -73.07 -22.06 60.67 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.742 178.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.4 -51.75 68.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.375 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 98.7 m -88.11 -23.41 23.69 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' MET . . . . . 0.496 ' HG2' ' HA ' ' A' ' 473' ' ' ARG . 5.4 ptp -49.48 -36.44 22.89 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -174.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -137.95 34.83 2.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.369 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.97 -65.85 1.12 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.809 0.338 . . . . 0.0 111.304 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -127.52 20.3 6.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 111.105 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' TRP . . . . . 0.434 ' CZ3' ' HA ' ' A' ' 464' ' ' CYS . 10.1 t-105 -79.88 -9.48 59.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.604 0.716 . . . . 0.0 109.407 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -104.99 133.42 49.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.77 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.546 -1.141 . . . . 0.0 111.943 -179.46 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 121.02 0.438 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -142.14 80.5 1.71 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.624 0.726 . . . . 0.0 110.082 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -145.06 125.38 13.86 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.289 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.68 120.12 34.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.393 0.616 . . . . 0.0 111.046 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.2 pp -137.58 -176.85 4.55 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.516 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -145.67 147.29 31.83 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.807 0.337 . . . . 0.0 110.196 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -109.02 -174.76 2.59 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.146 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -79.09 127.49 8.03 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.906 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -93.2 -158.42 34.15 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.812 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 0.481 HG22 ' H ' ' A' ' 352' ' ' LEU . 9.8 p -166.39 174.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.481 ' H ' HG22 ' A' ' 351' ' ' VAL . 6.4 mp -125.85 151.74 46.43 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.1 t -63.26 126.39 89.13 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.87 16.97 1.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.961 2.441 . . . . 0.0 113.623 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -86.46 132.99 41.22 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.21 -20.56 62.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.729 2.286 . . . . 0.0 112.656 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -100.25 3.61 56.79 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.685 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 9.5 t -115.35 -147.93 0.42 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.362 0.601 . . . . 0.0 110.422 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.13 23.65 5.14 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.009 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 39.7 mtm -61.0 -44.93 96.7 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.975 0.417 . . . . 0.0 110.505 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.39 129.37 3.28 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.145 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.01 127.09 53.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.238 0.542 . . . . 0.0 110.384 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -100.85 114.29 27.99 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.467 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.25 119.4 50.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 120.97 0.414 . . . . 0.0 110.703 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -81.07 149.72 67.04 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.032 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.72 -30.0 87.57 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.594 2.196 . . . . 0.0 112.243 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -101.11 15.18 29.57 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.463 0.649 . . . . 0.0 110.812 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 51.6 t -104.09 134.63 47.02 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.09 -0.381 . . . . 0.0 110.046 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 29.63 5.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 370' ' ' LYS . 1.9 tpmt? -144.47 102.3 3.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.781 0.324 . . . . 0.0 110.423 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.48 124.38 51.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.239 0.542 . . . . 0.0 110.845 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.5 m -152.38 141.38 21.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.92 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.45 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 3.5 t -76.86 62.03 2.0 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.16 -22.7 67.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.134 0.492 . . . . 0.0 110.749 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -88.21 -13.3 41.42 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.041 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -143.11 -124.31 1.86 Allowed Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.297 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.45 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -76.42 85.14 3.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.141 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -70.9 109.48 2.86 Favored Glycine 0 N--CA 1.435 -1.404 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -147.12 144.82 29.3 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 18.1 t -84.88 136.23 23.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.098 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -146.01 -175.67 4.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 19.4 t -94.81 162.56 13.71 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.884 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -86.25 -20.4 28.52 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.038 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.529 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 82.4 m-20 -105.47 -26.47 11.91 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.627 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 4.8 p -141.24 178.84 7.13 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.416 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.78 30.76 6.02 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -70.47 -2.74 14.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.312 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 82.94 27.4 41.4 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.537 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 53.1 t80 76.62 138.51 0.06 Allowed 'General case' 0 C--N 1.338 0.108 0 C-N-CA 124.402 1.081 . . . . 0.0 111.514 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -161.04 176.32 11.49 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 50.6 mm -114.6 132.15 64.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 129.66 -156.58 21.44 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.218 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -90.54 159.34 16.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.407 0.622 . . . . 0.0 111.801 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.7 p -174.99 145.61 0.83 Allowed 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.402 177.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 3.2 tt -142.66 130.41 11.26 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.14 154.17 70.6 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.389 2.059 . . . . 0.0 111.507 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.77 21.02 12.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.75 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 97.01 143.96 16.12 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.233 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 25.7 p -78.49 -24.84 45.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.889 0.375 . . . . 0.0 111.257 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 76.57 32.14 51.85 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.859 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -122.65 107.36 11.87 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.74 0.305 . . . . 0.0 110.422 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 35.9 t -99.75 -35.38 9.81 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.295 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -153.82 176.0 12.66 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.477 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 22.2 m -148.88 -88.59 0.08 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.894 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -146.57 136.77 23.63 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 120.736 0.303 . . . . 0.0 111.119 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.2 t -166.56 97.27 0.57 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.807 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 13.2 p -159.72 123.18 3.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.22 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.02 113.31 7.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.144 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -163.56 131.05 3.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.756 0.313 . . . . 0.0 110.563 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 5.5 t -126.18 146.19 50.07 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.298 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 12.8 m -121.05 157.65 24.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.504 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -103.39 145.07 29.91 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.44 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.75 -167.79 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.732 2.288 . . . . 0.0 111.784 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -117.16 -70.77 0.77 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.646 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 60.72 28.04 17.77 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.955 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -123.54 117.71 25.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.86 0.362 . . . . 0.0 111.059 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -146.51 167.46 23.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.25 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.95 155.33 36.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.536 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -147.16 133.31 19.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.669 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -150.17 165.98 31.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.153 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -169.13 131.3 1.22 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.887 0.375 . . . . 0.0 111.075 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -105.53 130.8 53.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.625 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.91 -69.82 0.28 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -169.95 177.08 4.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.698 0.285 . . . . 0.0 111.133 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 13.4 t -149.13 146.04 27.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.124 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.3 t30 72.02 117.67 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.715 0.806 . . . . 0.0 112.226 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.79 106.48 13.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.064 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 21.2 m -101.26 118.87 37.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 55.8 mt -110.75 138.97 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.761 0.315 . . . . 0.0 110.405 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -120.13 160.03 23.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.742 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.19 123.86 72.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.191 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.8 p -117.2 -2.25 11.68 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.19 0.519 . . . . 0.0 111.014 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 20.4 p -105.84 149.14 26.79 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -114.08 141.64 26.64 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.028 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.7 129.9 20.87 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.352 2.034 . . . . 0.0 112.738 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 24.3 t -59.1 140.32 87.34 Favored Pre-proline 0 C--N 1.333 -0.119 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.573 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.31 -16.71 39.64 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.127 1.885 . . . . 0.0 111.962 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -101.3 -66.64 0.9 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.542 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 15.6 p -93.57 -10.8 33.51 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 26.6 mmm180 70.03 20.57 6.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.074 0.55 . . . . 0.0 111.922 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 42.4 p -81.23 149.44 65.85 Favored Pre-proline 0 C--N 1.322 -0.622 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.703 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.71 103.12 0.55 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.605 2.203 . . . . 0.0 112.403 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 89.8 m -95.87 122.69 38.93 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -95.75 156.77 16.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.61 156.4 18.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.724 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.78 107.58 16.26 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.182 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -57.95 124.9 37.71 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.003 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.87 -13.2 13.03 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.224 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 11.0 p -142.56 142.59 32.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.713 0.292 . . . . 0.0 110.96 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.674 ' O ' ' HB3' ' A' ' 465' ' ' TRP . 14.2 ptp -99.36 29.83 3.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.31 0.576 . . . . 0.0 111.338 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -123.38 138.25 54.64 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.433 174.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 3.7 ptp -143.06 124.54 14.79 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.18 0.514 . . . . 0.0 110.656 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 8.5 m -114.38 150.82 16.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.3 t -85.38 101.41 12.56 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.472 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 21.2 p -87.7 92.51 9.13 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.539 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.7 OUTLIER -128.83 146.98 50.77 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -177.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -50.74 -44.03 58.3 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.324 0.39 . . . . 0.0 111.809 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -124.6 61.37 0.6 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.612 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 36.4 t -151.34 -90.61 0.06 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.605 0.241 . . . . 0.0 110.519 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 73.45 38.78 51.95 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.704 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -99.55 118.65 36.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.94 0.4 . . . . 0.0 111.016 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -90.33 139.94 30.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.738 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -148.72 154.44 39.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 49.2 t -73.09 139.49 46.52 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.008 0.432 . . . . 0.0 111.191 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . 0.674 ' HB3' ' O ' ' A' ' 450' ' ' MET . 11.3 t-105 -75.02 -51.58 13.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.602 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.45 -51.48 71.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.017 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.551 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.8 p -120.87 107.11 12.31 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -74.23 111.35 9.31 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.875 0.845 . . . . 0.0 111.246 -174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.0 p -154.67 169.92 22.76 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.542 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.69 143.46 36.23 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.006 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -61.55 104.29 0.41 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.407 0.622 . . . . 0.0 110.46 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.5 p -134.43 -163.7 1.41 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.114 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 50.6 mmm-85 -80.75 -21.9 40.67 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.972 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.44 -59.27 4.89 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 13.2 t -120.57 83.65 2.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 46.1 ttp -88.2 5.68 40.34 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.752 0.787 . . . . 0.0 109.209 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . 0.512 ' CA ' ' HB2' ' A' ' 480' ' ' TRP . . . 118.39 37.9 0.82 Allowed Glycine 0 N--CA 1.428 -1.852 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.83 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -57.34 -39.55 76.13 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.185 0.517 . . . . 0.0 110.743 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -118.59 37.28 4.11 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.061 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . 0.512 ' HB2' ' CA ' ' A' ' 477' ' ' GLY . 20.5 t-105 -82.41 45.45 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.306 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -146.51 124.78 12.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.478 . . . . 0.0 111.279 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.223 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.548 179.422 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 120.781 0.324 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -82.19 144.64 30.56 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.65 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -72.73 166.98 21.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.195 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.5 p -150.79 137.16 12.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.601 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.77 147.26 11.68 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.179 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -113.36 104.56 12.43 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -124.62 70.4 1.12 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.986 0.422 . . . . 0.0 110.112 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -89.06 -25.24 29.64 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.706 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -160.5 -162.66 12.7 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.313 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 352' ' ' LEU . 9.3 p -142.92 177.37 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.535 ' H ' HG23 ' A' ' 351' ' ' VAL . 71.0 mt -130.37 145.72 51.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.647 0.261 . . . . 0.0 110.9 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.33 132.23 94.35 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.34 -7.93 22.32 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.035 2.49 . . . . 0.0 113.502 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -72.96 124.35 90.62 Favored Pre-proline 0 N--CA 1.447 -0.588 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.746 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.75 -30.78 77.58 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.934 2.423 . . . . 0.0 112.509 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -79.79 -17.19 75.71 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.875 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 33.8 t -89.03 -96.71 0.1 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.797 0.298 . . . . 0.0 110.679 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.09 19.36 59.12 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 35.7 ttp -65.7 -67.37 0.45 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.994 0.518 . . . . 0.0 111.544 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 147.12 122.5 1.36 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.109 -1.043 . . . . 0.0 112.346 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.45 135.85 54.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.954 0.406 . . . . 0.0 110.269 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -97.04 118.97 34.64 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.895 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 56.2 t -88.42 97.5 6.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.0 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.92 141.09 97.43 Favored Pre-proline 0 C--N 1.312 -1.027 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -51.9 -20.49 10.13 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.785 2.323 . . . . 0.0 112.639 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -114.97 24.11 12.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 45.8 t -71.16 110.87 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.42 . . . . 0.0 110.491 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -83.92 -39.9 19.23 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.025 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -140.26 108.28 5.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.108 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 12.8 p -83.08 128.47 38.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.386 0.612 . . . . 0.0 110.468 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 86.7 m -153.11 144.56 23.3 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.518 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 1.8 t -76.16 61.99 1.66 Allowed 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -69.96 -8.73 51.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.619 0.723 . . . . 0.0 109.888 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.73 0.17 32.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.871 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -155.93 -124.66 0.87 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 0.8 OUTLIER -85.42 98.84 10.81 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.9 111.12 3.74 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 114.434 0.534 . . . . 0.0 114.434 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -141.8 143.6 33.51 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.05 129.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.03 0.443 . . . . 0.0 110.969 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.405 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 20.0 p90 -143.93 -175.84 4.76 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 17.2 t -80.75 168.61 18.62 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.85 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -101.64 -13.86 17.64 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.506 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.563 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 4.3 m-20 -104.23 -26.32 12.55 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 21.1 p -145.5 -164.46 1.95 Allowed 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.384 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.05 27.07 9.5 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.614 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 387' ' ' GLN . 14.8 mm-40 -87.25 32.75 0.69 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 70.37 18.31 75.11 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 121.073 -0.584 . . . . 0.0 114.286 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 69.19 121.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.632 0.773 . . . . 0.0 110.382 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -145.89 -176.25 5.07 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.4 tt -112.67 153.15 14.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 99.24 -146.76 18.17 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.139 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -102.13 154.01 19.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.895 0.379 . . . . 0.0 110.99 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 35.0 m -103.1 163.18 12.38 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.537 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.511 ' H ' HD21 ' A' ' 395' ' ' LEU . 2.6 pt? -115.91 146.17 36.37 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -88.02 162.03 7.32 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.538 2.159 . . . . 0.0 112.119 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -97.54 -47.14 5.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.484 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 139.81 -129.34 4.26 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.342 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 24.2 p -113.98 168.21 10.0 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -134.05 -72.02 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.16 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . 59.53 80.16 0.21 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.22 0.533 . . . . 0.0 111.522 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.4 t -84.32 158.27 21.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.037 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -133.62 175.25 9.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.818 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 12.1 t -130.73 147.53 52.41 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.914 0.388 . . . . 0.0 110.467 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -101.96 126.52 48.9 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.9 t -149.08 139.04 22.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.535 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 45.0 t -154.59 158.22 39.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.33 -175.79 4.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.038 0.447 . . . . 0.0 111.102 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -132.23 133.82 44.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.942 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 9.0 t -97.68 139.52 33.44 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.752 0.31 . . . . 0.0 110.311 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 22.3 m -107.47 149.82 10.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.135 0.493 . . . . 0.0 111.841 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -110.92 145.6 32.74 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.389 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.22 162.26 41.06 Favored 'Trans proline' 0 C--O 1.238 0.51 0 C-N-CA 122.217 1.945 . . . . 0.0 110.335 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -74.61 -83.53 0.05 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.591 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -172.61 178.97 2.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.67 0.271 . . . . 0.0 111.172 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -107.02 165.54 11.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.98 0.419 . . . . 0.0 110.911 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -128.66 127.2 41.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.221 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.06 159.53 34.03 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.236 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -107.51 149.44 27.97 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.394 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -136.49 168.05 20.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.269 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -130.56 171.59 12.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.712 0.291 . . . . 0.0 110.599 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.4 117.75 15.53 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.066 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -100.99 -14.1 17.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.747 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -86.94 148.42 25.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.814 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 14.0 t -152.29 145.59 24.73 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -63.33 118.62 8.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.198 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.83 134.82 37.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 11.2 m -73.93 111.59 9.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.183 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.6 pp -110.01 173.91 2.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.055 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . 0.409 ' HB3' ' NZ ' ' A' ' 430' ' ' LYS . 2.5 mmmp? -122.66 144.3 49.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.456 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.6 109.0 18.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.414 0.626 . . . . 0.0 110.763 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.49 ' O ' ' HE3' ' A' ' 434' ' ' LYS . 18.1 m -82.27 -29.07 31.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.237 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' THR . . . . . 0.596 ' HA ' ' HB2' ' A' ' 444' ' ' GLU . 5.8 p -78.8 150.2 32.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.346 0.593 . . . . 0.0 112.036 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . 0.49 ' HE3' ' O ' ' A' ' 432' ' ' SER . 15.8 mmtp -99.93 147.52 33.57 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.694 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -82.62 129.78 5.78 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.03 1.82 . . . . 0.0 112.073 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 42.0 t -66.88 140.95 96.45 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.43 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.416 ' HD2' ' SG ' ' A' ' 436' ' ' CYS . 36.6 Cg_endo -67.51 -19.28 48.93 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.25 1.967 . . . . 0.0 112.241 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . 0.491 ' HZ2' ' HB3' ' A' ' 438' ' ' LYS . 9.1 mtpm? -103.24 -73.56 0.66 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 10.0 p -79.15 -17.71 54.51 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 44.5 mtt180 62.18 33.71 16.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.416 0.627 . . . . 0.0 111.126 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.2 p -90.44 154.34 46.4 Favored Pre-proline 0 N--CA 1.434 -1.24 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.782 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.78 110.53 1.7 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.73 2.287 . . . . 0.0 111.787 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 88.7 m -129.49 123.14 30.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.339 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . 0.596 ' HB2' ' HA ' ' A' ' 433' ' ' THR . 4.7 tp10 -134.6 142.67 46.99 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -111.92 106.61 15.36 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.107 0.48 . . . . 0.0 110.677 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -90.81 102.4 15.16 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.997 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 81.61 149.19 6.91 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.306 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 123.87 -165.58 16.66 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.285 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 8.2 t -82.99 -175.77 6.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.031 0.443 . . . . 0.0 110.787 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -80.14 50.04 1.18 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.075 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -119.48 139.34 52.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.346 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 1.1 mmt -119.78 80.25 1.56 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 36.4 t -94.87 117.51 38.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.257 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 48.0 t -80.86 99.7 8.46 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.46 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 2.1 p -82.2 89.14 6.48 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.611 0.719 . . . . 0.0 109.136 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 1.4 tmt_? -132.16 135.82 46.64 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.826 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.446 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -65.07 105.73 1.12 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.913 0.387 . . . . 0.0 110.2 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 106.54 -1.02 36.85 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.365 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 47.6 t -110.22 -90.89 0.47 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.34 . . . . 0.0 110.236 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 73.77 28.27 65.38 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.113 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -96.73 131.13 43.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.97 0.414 . . . . 0.0 110.083 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -117.27 136.87 52.78 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.117 0.484 . . . . 0.0 111.073 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -131.63 177.7 7.31 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.551 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 60.6 m -81.3 142.04 33.48 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -175.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -76.32 -56.62 4.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.566 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . 0.45 HG21 ' H ' ' A' ' 467' ' ' CYS . 3.2 m -71.26 -60.23 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.45 ' H ' HG21 ' A' ' 466' ' ' VAL . 16.1 p -93.73 170.15 9.78 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -111.63 109.22 19.0 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.245 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.52 160.12 40.28 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.586 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.15 149.89 25.88 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -56.41 108.12 0.45 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.627 0.727 . . . . 0.0 110.942 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 p -132.97 -179.17 5.32 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.121 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -70.21 -22.69 62.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.244 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.17 -54.07 7.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.186 0.517 . . . . 0.0 110.771 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 480' ' ' TRP . 85.1 m -85.01 8.25 18.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.933 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.5 ttt -53.95 -53.47 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.78 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -137.59 -0.47 2.61 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.031 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -58.84 -64.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.463 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -113.56 -4.88 13.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.88 0.372 . . . . 0.0 110.709 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . 0.404 ' HB2' ' O ' ' A' ' 475' ' ' CYS . 35.0 t-105 -68.19 -28.73 67.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.369 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -97.45 106.39 18.7 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.525 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 CA-C-O 118.886 -0.952 . . . . 0.0 111.887 -179.58 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.695 0.283 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.27 141.39 55.89 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.782 0.325 . . . . 0.0 110.247 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -88.19 97.22 10.89 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.277 0.561 . . . . 0.0 111.544 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 31.2 t -111.35 97.37 5.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.689 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.61 174.9 11.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.06 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -134.19 151.28 51.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.744 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -115.54 34.05 5.13 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -82.03 113.99 3.75 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.494 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . 0.46 ' HA2' HG11 ' A' ' 364' ' ' VAL . . . -153.57 -174.31 23.69 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.424 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 0.48 HG21 ' H ' ' A' ' 352' ' ' LEU . 10.5 p -129.63 175.06 11.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.48 ' H ' HG21 ' A' ' 351' ' ' VAL . 6.5 mp -130.79 151.7 50.94 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.796 -0.565 . . . . 0.0 111.865 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 34.3 t -57.12 141.01 77.47 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.398 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.513 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 28.2 Cg_endo -61.75 -10.81 18.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.417 2.745 . . . . 0.0 114.515 -176.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -111.02 136.46 20.8 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.129 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.76 -19.83 30.88 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.053 2.502 . . . . 0.0 112.437 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -70.26 -17.44 74.13 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.253 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 41.1 t -86.55 -82.79 0.2 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.42 -0.39 . . . . 0.0 110.467 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 61.28 27.48 67.67 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.182 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -75.45 -40.09 57.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.653 0.263 . . . . 0.0 111.26 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.7 121.37 4.25 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.974 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -111.11 109.93 20.22 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.267 0.556 . . . . 0.0 110.411 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -88.01 112.48 22.65 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.65 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . 0.46 HG11 ' HA2' ' A' ' 350' ' ' GLY . 7.7 p -83.63 104.73 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 121.865 0.84 . . . . 0.0 110.661 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' A' ' 368' ' ' CYS . 8.6 pt-20 -90.26 159.79 41.22 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.667 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.81 -20.78 72.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.464 2.109 . . . . 0.0 111.305 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -99.37 3.67 46.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.418 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . 0.517 ' N ' ' HG3' ' A' ' 365' ' ' GLU . 53.5 t -63.38 106.05 0.85 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 111.044 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . 0.642 ' NE ' ' H ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -80.11 -37.92 32.65 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.069 0.462 . . . . 0.0 110.562 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -145.12 143.86 30.6 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.521 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.61 119.95 50.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.294 0.569 . . . . 0.0 110.137 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 50.5 m -152.26 139.69 19.56 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.646 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 12.6 t -77.81 47.47 0.63 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 121.14 0.495 . . . . 0.0 110.266 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.19 -11.9 45.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.925 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -96.23 -10.67 27.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.028 0.442 . . . . 0.0 110.739 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -133.42 -79.79 0.15 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.441 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 3.4 m -100.4 -131.28 0.24 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -168.87 104.11 0.2 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 173.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -162.66 145.98 11.22 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 17.8 m -108.28 127.58 64.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -141.39 -177.7 5.27 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.097 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 44.5 t -80.99 159.97 24.72 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.611 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.449 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 29.0 ptt180 -88.41 -15.42 35.53 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.215 0.531 . . . . 0.0 109.628 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.449 ' OD1' ' HG3' ' A' ' 383' ' ' ARG . 4.6 m-20 -106.03 -29.62 9.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.112 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 31.4 p -143.02 -159.66 1.0 Allowed 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.159 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.13 18.48 14.56 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.064 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -76.18 25.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 72.76 31.34 62.58 Favored Glycine 0 N--CA 1.463 0.485 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.53 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.4 100.49 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.407 0.622 . . . . 0.0 111.252 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -126.61 161.12 28.78 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.223 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.29 160.43 3.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.478 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.61 -146.29 25.75 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.88 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -124.11 162.28 23.88 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.739 0.304 . . . . 0.0 110.804 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 3.1 m -85.66 143.19 28.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.066 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.26 153.41 68.85 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.19 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.05 179.12 6.2 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.755 2.303 . . . . 0.0 112.999 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -135.42 123.69 23.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.284 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -172.23 124.82 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.174 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 4.9 p -136.36 169.95 16.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.564 0.221 . . . . 0.0 110.932 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 143.99 128.72 2.17 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.157 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -158.21 143.79 16.86 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.346 0.258 . . . . 0.0 110.452 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.8 t -155.81 133.34 11.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.782 0.325 . . . . 0.0 110.673 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -128.09 153.98 46.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.911 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 63.0 m -153.78 130.23 10.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.834 0.349 . . . . 0.0 111.276 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -127.57 105.03 8.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.986 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 2.5 p -86.38 127.97 34.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.776 0.322 . . . . 0.0 111.132 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 9.6 p -137.62 152.61 49.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.029 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -146.2 174.13 11.6 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.276 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -151.31 141.15 21.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.434 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 7.9 p -107.76 154.12 21.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.975 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.43 130.15 74.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.63 120.21 69.53 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-O 121.14 0.495 . . . . 0.0 110.732 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.1 132.48 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.715 2.277 . . . . 0.0 111.428 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -127.44 144.17 51.1 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -166.05 109.24 0.78 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.357 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -147.75 118.4 7.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.806 0.336 . . . . 0.0 110.878 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -151.19 106.26 3.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.335 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -96.17 161.25 14.04 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.417 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.33 145.38 22.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.18 118.19 2.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -131.9 156.4 46.18 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.734 0.302 . . . . 0.0 110.918 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -159.27 117.91 2.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.015 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -104.86 -39.34 6.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.48 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 58.41 34.43 23.98 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.026 0.53 . . . . 0.0 111.858 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 23.7 m -67.49 123.71 21.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.678 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -165.63 152.73 10.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.093 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 16.6 m -134.72 171.79 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.903 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.6 t -138.61 133.43 32.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.695 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 46.4 pt -122.49 -172.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.924 0.392 . . . . 0.0 111.181 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -137.06 156.57 48.23 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.37 109.19 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.509 0.671 . . . . 0.0 111.23 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.8 p -96.51 2.09 52.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.696 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 8.6 p -117.04 -177.0 3.1 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.135 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -122.83 110.77 31.39 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -63.69 125.84 16.29 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.968 1.778 . . . . 0.0 111.84 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 38.9 t -56.03 139.13 71.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.787 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.39 -1.83 11.82 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.205 1.937 . . . . 0.0 111.729 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . 0.407 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 1.7 tppm? -109.87 -61.25 1.68 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.557 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 23.9 p -101.46 -10.94 19.73 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.794 0.331 . . . . 0.0 111.375 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 69.0 mtt180 67.4 28.53 7.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.621 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 25.2 p -85.96 147.95 46.86 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.484 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.64 98.26 0.57 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.494 2.129 . . . . 0.0 112.355 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 16.9 m -85.96 124.34 32.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.027 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.35 131.05 35.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.394 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.46 ' CB ' ' HE3' ' A' ' 452' ' ' MET . 15.1 ptt-85 -95.7 98.76 10.71 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.271 0.558 . . . . 0.0 111.271 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -107.49 155.3 20.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.132 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 80.85 -82.71 1.5 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.241 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 127.65 3.29 6.05 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.168 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 7.0 p -68.56 161.18 28.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.564 0.221 . . . . 0.0 110.426 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.581 ' SD ' ' HA3' ' A' ' 482' ' ' GLY . 67.3 mtt -78.01 -10.29 59.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.143 0.497 . . . . 0.0 110.77 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -96.72 105.6 17.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.46 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' MET . . . . . 0.46 ' HE3' ' CB ' ' A' ' 445' ' ' ARG . 5.9 ptp -147.1 135.88 22.15 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.549 173.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.06 140.74 44.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.159 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 35.0 t -59.54 103.16 0.18 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.993 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 6.3 t -85.61 90.81 8.09 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 122.408 1.099 . . . . 0.0 109.559 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.492 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -129.45 138.22 51.31 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.423 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -52.67 -47.12 67.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.809 0.337 . . . . 0.0 111.183 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -104.0 49.43 0.93 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.97 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 21.5 t -152.09 -90.33 0.06 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.941 0.371 . . . . 0.0 111.508 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.14 38.16 63.54 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -90.85 118.3 30.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.747 0.308 . . . . 0.0 110.905 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -87.35 122.52 31.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.226 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -129.62 156.46 44.18 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 42.4 t -67.34 136.58 55.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.622 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -75.07 -36.96 61.76 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.543 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.19 -64.04 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.873 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.9 p -109.48 155.51 21.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.36 107.8 8.87 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 118.687 -1.205 . . . . 0.0 108.256 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.12 151.77 23.62 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.337 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.33 158.37 24.75 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -48.35 110.56 0.35 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.627 0.727 . . . . 0.0 111.382 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.6 m -138.87 154.7 48.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.639 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -61.99 -36.58 81.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.05 -32.1 72.58 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.222 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 88.0 m -87.72 -37.21 16.87 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 43.9 tpp -50.72 -54.65 21.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.272 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -90.56 7.47 81.32 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.169 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -111.13 -64.77 1.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -137.62 31.22 2.55 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -91.36 -34.04 15.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.03 0.443 . . . . 0.0 110.873 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -96.28 100.16 11.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.002 0.43 . . . . 0.0 110.978 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . 0.581 ' HA3' ' SD ' ' A' ' 450' ' ' MET . . . . . . . . 0 N--CA 1.437 -1.239 0 CA-C-O 118.425 -1.208 . . . . 0.0 112.072 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 120.905 0.384 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.04 -174.54 3.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.715 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -115.98 17.31 15.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 9.0 p 46.58 26.04 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 124.116 0.966 . . . . 0.0 111.739 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 52.2 tp -112.23 116.99 31.32 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.271 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -117.22 -54.25 2.41 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -110.5 124.2 51.36 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.998 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -161.28 31.44 0.34 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -143.92 155.42 26.19 Favored Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.329 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 352' ' ' LEU . 10.0 p -124.81 177.64 4.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.518 ' H ' HG22 ' A' ' 351' ' ' VAL . 85.9 mt -126.77 149.45 49.63 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 122.126 -0.359 . . . . 0.0 111.026 -177.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 355' ' ' GLN . 51.0 t -65.19 138.07 97.13 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.692 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.83 -14.25 40.95 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.924 2.416 . . . . 0.0 112.279 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.494 ' HB2' ' SG ' ' A' ' 353' ' ' CYS . 1.4 mp0 -75.48 123.68 88.66 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-O 120.92 0.39 . . . . 0.0 110.766 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.3 -22.21 46.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.097 2.532 . . . . 0.0 112.959 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -88.64 1.85 84.11 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.697 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 48.3 t -104.47 -93.56 0.35 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.921 0.391 . . . . 0.0 110.585 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.15 23.51 64.13 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.307 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' MET . . . . . 0.432 ' HG3' ' SG ' ' A' ' 358' ' ' CYS . 47.4 mtm -61.74 -72.49 0.12 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.859 0.361 . . . . 0.0 110.844 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 145.9 109.92 0.63 Allowed Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.117 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -101.75 109.98 21.87 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 364' ' ' VAL . 3.0 tt -82.91 135.67 34.84 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.017 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . 0.505 ' N ' HD23 ' A' ' 363' ' ' LEU . 39.2 t -90.96 86.6 2.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.263 0.554 . . . . 0.0 109.986 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -80.97 139.56 49.71 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.634 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.62 -21.76 70.18 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.514 2.143 . . . . 0.0 111.308 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -88.58 -7.47 56.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.46 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 7.5 t -107.82 105.0 14.61 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.715 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -93.76 15.18 17.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -155.76 144.34 20.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.017 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.22 120.96 64.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.434 0.635 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' THR . . . . . 0.476 ' OG1' HG13 ' A' ' 380' ' ' VAL . 62.1 m -147.47 136.96 22.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.916 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.6 t -78.2 67.16 3.96 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.171 0.51 . . . . 0.0 109.969 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -85.43 -7.01 59.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.381 0.61 . . . . 0.0 109.816 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -90.44 -17.11 27.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.441 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -140.17 -78.65 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.49 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 3.2 m -89.03 -127.2 0.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -171.21 104.55 0.2 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.408 ' CE2' ' HB3' ' A' ' 381' ' ' PHE . 55.1 t80 -163.24 137.43 6.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.484 0.142 . . . . 0.0 111.115 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.476 HG13 ' OG1' ' A' ' 372' ' ' THR . 35.1 m -100.29 128.82 51.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.422 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 7.4 p90 -142.56 -176.68 4.95 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.326 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 31.6 t -86.85 171.71 10.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -97.33 -16.37 20.31 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.486 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.465 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 4.6 m-20 -105.01 -28.31 11.14 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.753 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 24.5 p -143.21 -170.79 3.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.159 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.9 mp -110.62 24.06 13.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.912 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -75.58 15.58 0.47 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 76.33 29.1 58.8 Favored Glycine 0 N--CA 1.46 0.282 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.579 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 19.1 t80 63.2 101.05 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.335 0.654 . . . . 0.0 110.756 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -127.11 179.75 5.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.579 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.85 166.21 5.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.106 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.65 -132.19 11.1 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.618 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.33 149.65 49.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.781 0.324 . . . . 0.0 110.379 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 6.6 m -88.77 -63.06 1.35 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.698 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.53 126.08 69.9 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.1 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -90.79 -174.16 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.8 2.333 . . . . 0.0 112.197 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -145.8 140.79 27.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -98.41 -173.64 32.52 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.817 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 12.6 t -177.63 -177.06 0.64 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 167.09 167.97 28.58 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -160.16 174.45 14.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.0 p -152.13 153.12 33.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.702 0.287 . . . . 0.0 110.961 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -128.92 174.64 9.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.525 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 10.0 t -171.83 133.15 0.73 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.96 0.41 . . . . 0.0 110.994 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -110.34 153.76 24.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 19.3 p -138.56 130.23 27.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.794 0.331 . . . . 0.0 111.176 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 43.3 t -162.96 141.47 8.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.59 176.85 8.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.021 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -158.03 176.16 12.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.501 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 14.7 t -154.38 160.3 41.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.617 0.246 . . . . 0.0 110.473 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.98 171.08 2.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.73 0.3 . . . . 0.0 110.626 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -109.15 148.26 37.6 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.011 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.14 148.55 27.5 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.614 2.209 . . . . 0.0 112.174 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -102.47 178.16 4.66 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -140.74 144.69 35.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.995 0.426 . . . . 0.0 111.576 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -155.49 129.07 8.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.009 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -143.54 84.23 1.8 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.193 0.52 . . . . 0.0 110.606 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -92.71 150.46 20.65 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -159.07 124.27 4.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.838 0.352 . . . . 0.0 110.845 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -125.24 144.24 50.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.57 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 30.7 m-90 -116.31 150.4 37.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.769 0.318 . . . . 0.0 110.815 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.85 125.74 41.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.542 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -106.18 -21.38 13.13 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.045 0.45 . . . . 0.0 110.31 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -61.04 119.85 9.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.827 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 25.6 t -147.92 142.55 26.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.21 128.68 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.933 0.397 . . . . 0.0 110.497 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.72 105.37 7.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.495 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.7 t -102.57 154.81 18.76 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 6.1 tp -82.31 117.54 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 121.664 0.745 . . . . 0.0 111.47 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -131.73 121.57 24.43 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.01 127.49 73.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.145 0.497 . . . . 0.0 111.734 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.6 m -104.56 -15.07 15.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.573 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.5 p -94.12 138.91 31.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.552 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -108.76 140.24 21.65 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.31 125.29 11.19 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.228 1.952 . . . . 0.0 112.708 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 42.0 t -58.13 139.68 83.45 Favored Pre-proline 0 N--CA 1.456 -0.126 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.278 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -70.39 -20.91 31.27 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.942 1.762 . . . . 0.0 111.335 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 438' ' ' LYS . 0.1 OUTLIER -96.29 -67.49 0.85 Allowed 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.08 -177.027 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . 0.539 ' SG ' ' HG3' ' A' ' 456' ' ' ARG . 21.3 p -93.09 -8.33 43.03 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.69 ' HD3' ' O ' ' A' ' 440' ' ' ARG . 1.0 OUTLIER 65.23 23.05 12.21 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.586 0.754 . . . . 0.0 111.435 177.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 39.2 p -82.56 162.74 54.83 Favored Pre-proline 0 C--N 1.31 -1.122 0 O-C-N 121.967 -0.458 . . . . 0.0 110.359 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -79.21 100.7 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.243 1.962 . . . . 0.0 112.53 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 12.1 m -92.42 128.21 38.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.193 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -86.55 160.03 19.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.607 0.242 . . . . 0.0 110.97 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.43 ' C ' ' HD2' ' A' ' 445' ' ' ARG . 7.0 tmm_? -118.06 108.69 15.54 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.61 141.95 33.69 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.315 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 71.92 -143.52 35.04 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.568 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -139.53 26.64 2.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.685 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 8.8 p -87.21 155.76 19.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.853 0.358 . . . . 0.0 111.088 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -82.79 -16.31 48.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.096 0.474 . . . . 0.0 109.932 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -86.38 96.89 10.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.199 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 3.7 ptp -117.59 111.07 18.71 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.06 129.15 41.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.177 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 43.0 t -70.39 105.2 2.95 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.645 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 5.1 t -87.01 90.27 8.29 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 122.073 0.939 . . . . 0.0 108.948 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.539 ' HG3' ' SG ' ' A' ' 439' ' ' CYS . 0.0 OUTLIER -130.97 139.18 49.99 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.406 -177.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.65 87.31 0.13 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.872 0.368 . . . . 0.0 110.247 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.45 39.69 1.45 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.088 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 461' ' ' PHE . 19.5 t -145.78 -91.9 0.09 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.624 -0.339 . . . . 0.0 110.921 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 459' ' ' CYS . . . 72.57 27.19 69.9 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . 0.605 ' HB2' ' SG ' ' A' ' 459' ' ' CYS . 9.8 t80 -72.6 128.2 34.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.06 0.457 . . . . 0.0 110.887 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.53 134.75 49.18 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -150.5 159.12 44.71 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.875 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 76.4 m -70.3 140.99 52.39 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.215 0.531 . . . . 0.0 110.951 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -74.31 -40.22 62.38 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.221 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 23.1 t -85.53 -58.87 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.202 -174.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 6.9 p -91.81 152.87 19.92 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -93.45 110.05 21.62 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.345 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' THR . . . . . 0.5 HG21 ' SG ' ' A' ' 475' ' ' CYS . 13.0 t -157.65 178.48 10.22 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.609 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.22 156.89 22.47 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 32.2 p-90 -51.89 117.74 2.94 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.332 0.587 . . . . 0.0 110.362 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 10.8 t -156.99 179.15 9.58 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.53 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -71.5 -23.38 61.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.978 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -62.64 -54.19 43.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.819 0.342 . . . . 0.0 111.3 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . 0.5 ' SG ' HG21 ' A' ' 469' ' ' THR . 70.8 m -98.94 24.56 7.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.631 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -61.26 -36.92 81.33 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.896 0.379 . . . . 0.0 111.271 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -167.9 26.15 0.13 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.773 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -78.32 -62.12 1.78 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.195 0.521 . . . . 0.0 110.681 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -110.77 -4.82 15.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.788 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -73.86 86.18 1.73 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.76 95.64 2.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.653 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.225 0 CA-C-O 118.321 -1.266 . . . . 0.0 111.042 -178.611 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 121.047 0.451 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -155.05 79.13 1.05 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.336 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -86.25 109.0 18.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.378 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 52.6 t -118.36 111.09 32.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.395 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.74 106.05 17.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -84.26 112.71 20.54 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.607 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -113.67 -168.52 1.36 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.142 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 150.24 -125.47 1.95 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.356 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -158.82 -149.76 5.6 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.556 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 352' ' ' LEU . 7.8 p -155.81 175.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.463 ' H ' HG23 ' A' ' 351' ' ' VAL . 6.7 mp -129.14 150.85 50.36 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.784 -0.572 . . . . 0.0 111.337 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.3 t -63.75 128.33 92.67 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.446 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.38 -9.38 25.08 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.19 2.593 . . . . 0.0 113.129 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.444 ' HB3' ' HB2' ' A' ' 358' ' ' CYS . 10.3 tm0? -65.0 122.53 80.06 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.1 -28.6 51.7 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 123.765 2.977 . . . . 0.0 114.964 -174.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -108.19 16.97 35.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.702 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.738 ' SG ' ' HG3' ' A' ' 360' ' ' MET . 12.2 t -106.04 -97.27 0.34 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.27 32.38 71.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.078 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' MET . . . . . 0.738 ' HG3' ' SG ' ' A' ' 358' ' ' CYS . 0.6 OUTLIER -65.86 -32.98 74.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.83 107.63 2.94 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.955 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.422 HD22 ' SD ' ' A' ' 360' ' ' MET . 3.9 mm? -99.45 135.46 40.83 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.82 128.68 55.11 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 79.7 t -77.9 91.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.409 0.623 . . . . 0.0 109.781 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -90.07 148.29 39.11 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.368 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.67 -22.75 74.26 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.478 2.119 . . . . 0.0 111.62 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -99.52 9.85 42.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.419 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 37.2 t -89.7 78.95 6.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.445 0.64 . . . . 0.0 109.698 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . 0.424 ' HD2' ' H ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -72.76 -22.59 60.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.758 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.464 ' HZ1' ' HB3' ' A' ' 370' ' ' LYS . 3.7 mmmp? -135.26 113.63 11.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.169 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.84 112.66 23.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.566 0.698 . . . . 0.0 110.041 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 94.9 m -147.44 138.86 23.86 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.92 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.433 ' SG ' ' HA3' ' A' ' 376' ' ' GLY . 21.6 t -74.86 76.8 2.13 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.225 0.536 . . . . 0.0 109.69 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -86.08 -38.7 17.53 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.048 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.53 -18.35 54.86 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.098 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . 0.433 ' HA3' ' SG ' ' A' ' 373' ' ' CYS . . . -101.32 -89.98 2.08 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.925 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.2 p -124.7 -91.52 0.54 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.013 0.435 . . . . 0.0 110.567 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -172.52 107.23 0.25 Allowed Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -161.02 131.81 5.31 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.872 0.336 . . . . 0.0 110.308 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.88 124.38 65.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.412 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 6.2 p90 -152.66 179.49 8.56 Favored 'General case' 0 C--O 1.21 -0.999 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.253 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 24.5 t -84.43 167.78 16.12 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -95.4 -16.6 22.19 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.323 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -104.31 -32.8 8.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.872 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 27.8 p -137.59 -166.38 1.93 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.101 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.9 mp -115.06 27.51 9.35 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.774 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -78.16 16.03 0.83 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 79.18 17.47 76.51 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.609 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 73.45 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.512 0.725 . . . . 0.0 111.244 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -148.23 -46.81 0.16 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.045 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.9 tt -150.3 158.04 5.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -87.91 6.24 83.75 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.767 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -136.03 115.59 12.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.136 0.468 . . . . 0.0 111.327 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 59.2 m -129.43 165.76 20.92 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.949 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.47 152.04 87.55 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.526 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.49 176.07 3.02 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 122.673 2.248 . . . . 0.0 112.392 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.96 100.76 5.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.466 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -113.81 -59.33 0.39 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.096 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 8.4 m -93.32 91.93 7.44 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.954 0.407 . . . . 0.0 110.568 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -136.52 10.56 4.04 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -90.3 141.6 28.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 47.8 m -82.06 92.64 6.85 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.195 0.522 . . . . 0.0 111.191 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -88.07 -36.35 17.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.186 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.5 m -76.58 102.99 6.33 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.541 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -79.23 -43.36 23.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.639 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.9 m -74.24 164.24 26.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.19 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 8.9 p -158.24 153.31 25.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.723 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -86.18 143.12 28.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.203 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -121.79 154.51 36.89 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.531 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 11.9 t -138.43 166.97 22.92 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 32.6 m -81.59 168.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 120.847 0.356 . . . . 0.0 110.268 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -93.83 125.32 53.69 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.32 108.07 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.694 2.263 . . . . 0.0 111.395 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -79.08 177.49 8.76 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.157 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -106.84 124.34 49.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.03 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -80.94 -44.86 17.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.23 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . 62.76 100.9 0.03 OUTLIER 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.626 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.25 148.54 32.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.419 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -145.22 130.88 18.93 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.048 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -98.41 144.95 27.23 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.772 0.32 . . . . 0.0 110.391 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -123.19 38.29 4.22 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.291 0.567 . . . . 0.0 109.845 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -85.95 122.04 29.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.191 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.79 -13.15 15.62 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 60.76 32.4 20.19 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.455 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 18.7 p -83.73 112.65 20.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.868 0.366 . . . . 0.0 110.323 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -102.92 118.83 37.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.128 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.49 154.26 22.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.882 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 8.8 t -86.45 129.07 34.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.084 0.468 . . . . 0.0 110.285 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.424 ' N ' HD13 ' A' ' 429' ' ' ILE . 3.0 mp -77.72 122.51 32.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.661 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -96.53 135.0 39.02 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p -67.21 123.98 21.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.264 0.554 . . . . 0.0 110.689 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.1 m -107.63 -31.22 8.18 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.693 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.2 p -80.12 -178.58 6.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.234 0.54 . . . . 0.0 111.413 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . 0.531 ' HG2' ' CH2' ' A' ' 463' ' ' TRP . 1.6 tpmt? -112.84 108.82 53.27 Favored Pre-proline 0 C--N 1.312 -1.047 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.05 130.69 29.81 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.117 1.878 . . . . 0.0 111.739 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 45.5 t -57.36 134.93 81.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.358 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.36 -7.64 21.47 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.365 2.043 . . . . 0.0 111.746 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -107.59 -63.99 1.25 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.83 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 6.2 p -95.47 -3.11 47.41 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 60.7 26.05 15.82 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 21.4 p -87.22 143.11 34.13 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.73 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -63.75 104.73 0.48 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.345 2.03 . . . . 0.0 111.449 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 37.9 m -96.4 133.6 40.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.939 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.21 163.98 23.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.761 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.483 ' HA ' ' HE3' ' A' ' 452' ' ' MET . 9.4 ptt180 -120.58 162.43 19.64 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.122 0.487 . . . . 0.0 111.647 -176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -99.79 162.57 12.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.059 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -63.04 -50.87 59.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.854 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -151.3 52.8 0.49 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.351 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 61.6 m -118.91 137.35 53.52 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -17.45 27.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.85 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.32 96.95 10.53 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' MET . . . . . 0.483 ' HE3' ' HA ' ' A' ' 445' ' ' ARG . 70.0 mmm -106.51 112.53 25.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 -177.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 462' ' ' GLU . 21.3 t -115.6 141.37 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.996 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 28.8 t -83.03 125.66 31.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.06 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 19.9 p -101.54 89.96 3.9 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 121.833 0.825 . . . . 0.0 110.338 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.481 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 2.7 tmt_? -131.97 135.39 46.54 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.33 97.65 0.1 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.695 0.284 . . . . 0.0 110.954 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.06 22.24 8.44 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.581 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.481 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 51.4 t -114.36 -80.93 0.6 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.429 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.72 24.12 76.45 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.25 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -93.91 139.25 31.13 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.404 ' HB3' HG13 ' A' ' 453' ' ' VAL . 7.3 pt-20 -126.55 157.71 38.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.301 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . 0.531 ' CH2' ' HG2' ' A' ' 434' ' ' LYS . 7.4 p-90 -147.4 163.43 36.51 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.12 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 43.9 t -70.49 143.24 51.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.682 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -75.75 -42.09 51.44 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.609 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.79 -48.05 24.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 27.4 p -118.96 143.79 46.83 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.52 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -77.09 111.65 12.91 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.378 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 3.7 p -152.85 174.99 13.39 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.995 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -96.48 152.44 18.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 35.4 t-105 -54.1 122.9 11.17 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.02 0.438 . . . . 0.0 111.748 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.8 t -160.43 153.62 21.78 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.592 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -66.67 -25.42 66.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.3 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.83 -34.71 69.98 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.472 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.65 -27.59 14.72 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.7 ttt -53.81 -44.6 70.34 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.452 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -100.85 20.25 48.73 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.669 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -105.71 -64.94 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.681 -0.306 . . . . 0.0 111.44 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -148.68 28.76 0.85 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.275 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -69.45 -29.86 67.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.176 0.512 . . . . 0.0 109.884 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -92.9 111.67 23.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.445 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.038 0 CA-C-O 118.461 -1.188 . . . . 0.0 112.058 -179.161 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -171.24 134.18 0.89 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -81.07 73.56 8.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.187 0.518 . . . . 0.0 111.4 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.1 p -121.25 98.38 5.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.558 0.694 . . . . 0.0 110.725 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 346' ' ' LEU . 3.7 mm? -105.29 104.78 14.58 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -154.85 148.52 25.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.711 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -155.43 167.61 29.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.048 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 130.72 -18.12 5.16 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.761 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -173.86 174.23 46.17 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.634 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 9.9 p -126.72 167.68 21.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 5.8 mp -137.41 152.28 49.45 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.914 0.388 . . . . 0.0 111.716 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 18.5 t -59.41 135.68 88.77 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.698 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.73 -15.57 47.77 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.913 2.409 . . . . 0.0 113.785 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -99.0 134.45 21.42 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 120.822 0.344 . . . . 0.0 111.788 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.81 -15.65 44.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.216 2.611 . . . . 0.0 112.729 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -79.71 16.12 12.25 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.831 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.7 t -126.68 -87.3 0.59 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 64.43 21.13 66.32 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.827 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 37.5 ttp -67.59 -43.65 80.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.832 0.348 . . . . 0.0 111.172 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.72 118.92 4.44 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.007 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.8 155.62 24.29 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.796 0.332 . . . . 0.0 110.456 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.404 ' HG ' ' N ' ' A' ' 364' ' ' VAL . 26.7 tp -102.61 157.06 17.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.66 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . 0.404 ' N ' ' HG ' ' A' ' 363' ' ' LEU . 48.8 t -121.85 90.88 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 120.954 0.407 . . . . 0.0 110.563 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.33 152.22 96.6 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.41 -30.15 86.63 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.073 1.849 . . . . 0.0 111.139 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.57 15.0 28.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.115 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.35 101.77 3.54 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -111.7 -3.32 15.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' A' ' 370' ' ' LYS . 5.5 mmpt? -144.95 91.53 2.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.835 177.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.78 129.06 46.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.5 0.667 . . . . 0.0 110.513 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 374' ' ' GLN . 61.6 m -152.45 145.11 24.23 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.296 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 8.7 t -76.12 45.99 0.38 Allowed 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 121.326 0.584 . . . . 0.0 109.786 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . 0.411 ' H ' ' C ' ' A' ' 372' ' ' THR . 2.1 pp0? -63.75 -12.38 34.49 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -98.62 -2.64 37.99 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -143.13 -75.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.101 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.1 m -99.72 -132.64 0.25 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -170.83 103.97 0.2 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -162.14 139.56 8.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 26.2 m -95.04 126.11 47.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.425 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 16.7 p90 -138.51 -176.57 4.51 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 16.4 t -82.27 164.05 21.42 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.706 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -92.28 -18.9 22.75 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.097 0.475 . . . . 0.0 110.352 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.563 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 62.0 t30 -106.57 -29.22 9.78 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.174 0.511 . . . . 0.0 109.927 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 29.3 p -136.39 -165.2 1.68 Allowed 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.739 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 62.8 mt -117.51 25.71 10.23 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.878 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -86.55 30.41 0.72 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 70.26 23.16 77.52 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.573 175.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 381' ' ' PHE . 0.3 OUTLIER 64.92 113.03 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.762 0.825 . . . . 0.0 112.14 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -131.91 168.44 17.87 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.841 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.71 147.87 6.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.273 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 100.02 173.97 30.35 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.445 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -100.44 128.97 46.36 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.803 0.335 . . . . 0.0 110.214 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 1.3 m -83.52 154.73 23.7 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.386 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.9 145.0 31.63 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.582 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -92.51 -160.05 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.908 2.405 . . . . 0.0 111.11 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.04 95.76 5.6 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -116.92 64.16 0.36 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.678 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 17.3 p -82.72 149.04 27.52 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.819 0.342 . . . . 0.0 111.021 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -142.31 143.92 13.44 Favored Glycine 0 C--O 1.24 0.488 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -168.38 -178.39 3.55 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.726 0.263 . . . . 0.0 111.024 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 31.6 t 72.99 115.94 0.05 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.044 0.937 . . . . 0.0 112.215 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -147.91 137.29 22.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.162 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 14.1 t -100.48 154.84 18.21 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.009 0.433 . . . . 0.0 111.324 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -131.68 160.63 34.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.763 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 19.5 m -149.01 165.71 30.84 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.635 0.255 . . . . 0.0 111.312 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 24.3 p -166.6 150.09 7.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.849 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.08 164.5 37.13 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.567 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -149.62 169.2 21.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 33.7 m -156.89 122.31 4.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 21.4 m -112.2 142.49 24.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.886 0.374 . . . . 0.0 110.999 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -100.86 152.93 37.97 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.417 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -84.39 150.26 11.81 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.8 2.334 . . . . 0.0 111.931 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.67 157.32 17.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.961 0.41 . . . . 0.0 111.194 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 30.7 mmm-85 -132.17 173.12 11.57 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.19 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.0 116.7 3.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.304 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -127.3 141.22 51.77 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.49 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.24 175.39 10.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.053 0.454 . . . . 0.0 111.147 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.79 120.09 4.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.452 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -128.56 145.01 51.25 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.848 0.356 . . . . 0.0 111.234 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -148.38 162.39 39.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.658 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -101.56 149.42 24.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.222 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -104.9 13.01 31.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.397 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.12 122.61 17.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.224 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 5.6 t -165.49 145.57 6.78 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.561 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -152.64 101.14 2.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.188 0.518 . . . . 0.0 110.783 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.84 175.84 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.69 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 7.6 t -154.67 125.07 6.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.341 0.591 . . . . 0.0 111.074 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.448 ' O ' HD11 ' A' ' 429' ' ' ILE . 2.2 pp -119.37 149.48 21.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -137.18 148.41 46.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.554 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.19 104.36 15.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.819 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 22.2 m -91.32 -13.38 32.69 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.844 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 4.0 p -82.92 138.72 33.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.591 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 1.7 tpmt? -90.91 124.67 61.35 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 5.8 Cg_exo -73.54 122.71 8.08 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.097 1.865 . . . . 0.0 111.764 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 440' ' ' ARG . 35.1 t -53.25 136.66 49.81 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.103 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.85 -14.69 46.42 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.712 2.275 . . . . 0.0 112.4 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.69 -67.86 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 7.8 p -86.45 -8.5 57.56 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 436' ' ' CYS . 18.7 mmm180 64.14 26.01 13.81 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.643 0.377 . . . . 0.0 111.628 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 29.3 p -87.29 141.82 32.95 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.632 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 11.9 Cg_exo -69.49 104.36 1.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.597 2.198 . . . . 0.0 112.094 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 18.0 m -81.16 119.69 23.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.335 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.64 95.44 4.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.362 0.601 . . . . 0.0 109.711 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -137.07 156.58 48.22 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.741 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.18 151.39 22.72 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -81.95 59.04 4.9 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.34 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -72.38 -35.61 59.89 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 27.1 p -140.34 175.46 9.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.47 ' HA ' ' HB3' ' A' ' 465' ' ' TRP . 1.0 OUTLIER -83.72 0.89 45.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.781 0.324 . . . . 0.0 111.271 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -93.2 100.48 12.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.774 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 10.3 mmt -100.1 107.01 18.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.345 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.428 HG21 ' HG2' ' A' ' 462' ' ' GLU . 21.7 t -105.73 124.8 61.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.044 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 52.4 t -78.83 99.7 6.85 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.994 0.426 . . . . 0.0 109.954 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 13.0 p -83.49 90.25 7.19 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 121.623 0.725 . . . . 0.0 110.111 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.469 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 4.0 tmm_? -130.76 145.61 52.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -69.61 93.26 0.69 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.769 0.318 . . . . 0.0 110.683 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 111.66 13.22 13.11 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.748 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.469 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 49.6 t -114.12 -88.4 0.56 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 122.788 -0.242 . . . . 0.0 110.566 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.16 27.17 70.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.145 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -88.28 142.91 27.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.918 0.39 . . . . 0.0 110.451 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 471' ' ' TRP . 51.7 mt-10 -114.85 133.24 56.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.296 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -133.74 164.75 26.54 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.976 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 13.8 t -77.97 136.01 37.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.316 0.579 . . . . 0.0 111.962 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 21.4 t-105 -77.51 -44.1 29.88 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.274 177.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 22.7 m -78.57 -17.18 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -173.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 18.5 p -145.19 148.99 34.15 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -82.52 108.67 16.1 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.718 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.3 p -155.82 178.1 10.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.246 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.04 157.62 17.39 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . 0.451 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 45.6 t90 -53.04 104.45 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 109.897 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 p -134.07 152.82 52.01 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.07 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . 0.589 ' HG3' ' SD ' ' A' ' 476' ' ' MET . 14.9 ttm180 -70.12 -23.0 62.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.102 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.0 -28.46 68.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.23 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 2.8 t -100.47 -27.34 13.49 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' MET . . . . . 0.589 ' SD ' ' HG3' ' A' ' 473' ' ' ARG . 14.2 ptm -55.74 -29.49 59.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.858 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -111.04 12.1 29.19 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.216 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -100.16 -65.91 0.94 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.805 0.336 . . . . 0.0 110.841 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -146.27 21.42 1.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.662 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -72.87 -11.75 60.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.776 0.798 . . . . 0.0 108.878 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -119.56 151.82 38.02 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.767 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.476 -1.18 . . . . 0.0 112.131 -179.548 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.824 0.345 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -69.31 99.29 1.16 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.109 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -89.21 80.74 6.84 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.328 0.585 . . . . 0.0 109.688 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.88 114.08 30.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.963 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -138.99 -4.85 1.51 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.933 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -108.57 152.68 24.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.409 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -93.43 -3.92 52.26 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.441 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 76.91 -124.41 6.99 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.734 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -146.03 142.3 10.44 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.662 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 6.2 p -101.32 166.01 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.86 141.5 47.82 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 30.0 t -66.6 118.58 55.54 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.925 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.503 ' CG ' HD11 ' A' ' 386' ' ' LEU . 92.3 Cg_endo -81.9 4.98 6.62 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.518 2.812 . . . . 0.0 112.195 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -87.12 121.2 71.6 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.79 111.9 0.98 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.928 2.419 . . . . 0.0 112.816 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 126.39 3.07 6.8 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.343 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.7 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 36.6 t -113.08 -90.22 0.52 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 120.768 0.318 . . . . 0.0 111.089 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 60.55 22.85 59.8 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 43.5 ttp -72.37 -73.1 0.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.489 0.316 . . . . 0.0 111.36 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 148.36 121.63 1.2 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.737 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.5 129.11 56.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.973 0.416 . . . . 0.0 110.201 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 51.9 tp -86.51 129.82 34.72 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.676 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.22 87.43 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.485 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.61 166.58 44.09 Favored Pre-proline 0 C--N 1.313 -0.989 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.781 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.26 -23.88 64.65 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.236 1.957 . . . . 0.0 111.75 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.24 2.5 42.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.128 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.76 86.84 7.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -104.69 21.7 16.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.1 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -156.0 110.89 2.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.382 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.8 128.07 60.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.609 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 48.9 m -152.64 137.24 16.87 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.218 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.52 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 2.4 t -79.82 61.23 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.193 0.52 . . . . 0.0 110.17 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -70.71 -6.39 36.93 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.296 0.57 . . . . 0.0 110.187 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -99.67 -3.83 32.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.519 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -158.67 -115.79 0.44 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.964 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.7 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.3 p -86.66 94.89 9.61 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.84 113.77 5.45 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.922 -0.581 . . . . 0.0 114.495 -172.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -150.92 133.76 15.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.79 133.51 29.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 120.828 0.347 . . . . 0.0 110.08 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 389' ' ' TYR . 30.8 p90 -148.38 176.04 10.61 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 29.8 t -85.98 151.7 23.52 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -80.76 -11.59 59.59 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.028 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.445 ' CG ' ' H ' ' A' ' 394' ' ' CYS . 13.5 m-80 -105.47 -37.91 6.64 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.888 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 27.0 p -140.52 -159.21 0.93 Allowed 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.93 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.503 HD11 ' CG ' ' A' ' 354' ' ' PRO . 3.9 mm? -116.33 23.6 11.99 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . 0.518 ' HB2' ' CD2' ' A' ' 390' ' ' HIS . 75.2 mm-40 -83.07 28.0 0.53 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 69.5 25.5 75.44 Favored Glycine 0 N--CA 1.469 0.891 0 C-N-CA 121.478 -0.391 . . . . 0.0 114.05 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 381' ' ' PHE . 13.7 t80 63.31 105.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.409 0.684 . . . . 0.0 110.92 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.576 ' CG ' ' H ' ' A' ' 391' ' ' ILE . 2.3 p80 -132.63 -72.97 0.51 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.529 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.576 ' H ' ' CG ' ' A' ' 390' ' ' HIS . 50.7 mm -88.49 149.4 4.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -57.78 -54.23 38.97 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.81 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -130.72 122.41 27.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.877 0.37 . . . . 0.0 110.661 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.445 ' H ' ' CG ' ' A' ' 384' ' ' ASN . 62.3 m -104.0 -176.69 3.15 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.069 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 79.7 mt -89.07 150.55 45.41 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.106 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.63 -170.06 0.82 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.376 2.051 . . . . 0.0 111.666 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.96 -50.36 72.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.015 0.436 . . . . 0.0 110.378 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 70.21 -96.24 0.54 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 14.8 t -124.55 0.99 8.25 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.058 0.456 . . . . 0.0 110.07 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 77.35 33.77 42.91 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.261 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -85.92 94.82 9.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.065 0.46 . . . . 0.0 110.291 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 10.0 t -78.5 89.41 4.46 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.385 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -164.76 110.86 0.98 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.697 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 20.9 p -129.87 145.35 51.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.138 0.494 . . . . 0.0 112.303 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -129.76 152.34 49.36 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 37.9 t -141.41 -48.67 0.4 Allowed 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.71 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 34.4 m -92.44 20.14 6.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.954 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -89.46 96.85 10.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.875 0.369 . . . . 0.0 110.088 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -160.53 126.01 3.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.925 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 50.2 m -153.68 96.8 2.04 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.914 0.388 . . . . 0.0 110.489 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 8.4 p -108.02 -6.82 10.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.56 0.695 . . . . 0.0 109.936 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.1 149.7 53.47 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.969 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.25 111.99 1.09 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.01 2.473 . . . . 0.0 113.447 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -93.27 112.24 24.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.679 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.77 160.97 43.12 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.431 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -152.91 106.08 3.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.749 0.309 . . . . 0.0 110.617 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -134.79 111.14 9.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.487 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -167.17 133.1 2.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.896 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -171.28 140.23 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.266 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -135.61 172.25 13.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -157.12 109.49 2.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -129.92 114.03 15.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.662 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -105.65 2.13 27.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.4 0.619 . . . . 0.0 110.262 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -92.47 -173.08 3.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.428 -177.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 40.4 t -149.23 153.04 37.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.93 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.89 153.03 26.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.47 141.56 15.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.114 0.483 . . . . 0.0 110.63 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 31.4 m -124.78 127.97 48.01 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.754 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 51.1 mt -91.46 -35.13 6.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.178 0.513 . . . . 0.0 110.175 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -84.32 43.76 0.98 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.384 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 12.1 m -76.28 160.13 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.411 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 19.9 m -72.46 -28.64 63.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.873 0.368 . . . . 0.0 110.6 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 11.8 p -78.73 115.33 18.35 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.197 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -92.39 143.89 28.04 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.304 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.58 127.25 15.25 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.461 2.107 . . . . 0.0 111.87 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 30.3 t -57.08 139.29 79.21 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.949 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.2 -15.74 46.92 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.134 1.889 . . . . 0.0 112.055 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -103.2 -60.17 1.6 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.0 p -99.68 -8.04 24.88 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' A' ' 440' ' ' ARG . 3.1 mpt_? 63.4 24.77 14.3 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 34.3 p -82.95 157.68 65.98 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.84 103.85 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.121 1.881 . . . . 0.0 111.22 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 26.9 m -77.27 112.47 14.01 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.571 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.15 108.93 14.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.975 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -111.25 125.81 54.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.176 0.512 . . . . 0.0 110.73 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -141.87 104.05 4.44 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 78.4 52.48 5.15 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -53.03 126.35 33.04 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.357 -0.422 . . . . 0.0 112.895 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 13.1 t -93.83 24.57 4.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.73 0.3 . . . . 0.0 110.365 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 43.1 ttm 72.82 -40.19 0.47 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.851 0.86 . . . . 0.0 111.271 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -84.32 105.0 14.82 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 87.2 mmm -98.73 120.51 39.29 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.725 0.298 . . . . 0.0 111.169 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.57 128.41 76.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.348 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.5 t -92.73 106.21 18.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.994 0.426 . . . . 0.0 110.403 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.0 p -87.87 90.77 8.51 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.296 0.57 . . . . 0.0 110.129 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.537 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 2.5 tmm_? -130.74 138.94 50.21 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -62.36 98.43 0.11 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.719 0.295 . . . . 0.0 110.59 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.71 9.11 29.25 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.086 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 45.2 t -113.86 -91.8 0.5 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 122.431 -0.452 . . . . 0.0 110.758 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.71 23.95 77.35 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . 0.411 ' CD2' ' HZ3' ' A' ' 471' ' ' TRP . 27.5 t80 -84.2 108.77 17.28 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.158 0.504 . . . . 0.0 110.372 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.459 ' HG3' ' HB3' ' A' ' 471' ' ' TRP . 6.3 pt-20 -97.98 126.24 43.3 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.731 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -128.86 166.44 19.07 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.791 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 27.2 t -78.77 144.04 35.54 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.311 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -76.5 -39.21 53.73 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.165 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.71 -8.18 9.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 17.9 p -148.95 155.87 41.46 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -91.38 107.74 19.41 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.104 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 5.0 p -155.6 169.98 23.04 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.223 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -96.14 157.05 16.08 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . 0.459 ' HB3' ' HG3' ' A' ' 462' ' ' GLU . 20.3 p90 -48.92 111.97 0.55 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.595 0.712 . . . . 0.0 111.333 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 5.4 p -134.35 148.9 50.8 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.107 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -74.95 -22.14 58.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.129 0.49 . . . . 0.0 110.055 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.82 -50.51 70.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.913 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 18.7 t -74.68 -30.19 61.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.628 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' MET . . . . . 0.532 ' HA ' ' CB ' ' A' ' 480' ' ' TRP . 28.1 ttt -52.76 -38.04 60.42 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.729 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -100.83 13.05 59.33 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.159 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.41 -66.17 1.08 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.818 -0.225 . . . . 0.0 111.346 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -153.79 12.45 0.45 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.892 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . 0.532 ' CB ' ' HA ' ' A' ' 476' ' ' MET . 76.6 t-105 -56.64 -43.24 80.08 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.273 0.559 . . . . 0.0 110.497 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -147.44 89.4 1.78 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.019 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.115 0 CA-C-O 118.573 -1.126 . . . . 0.0 111.449 -178.319 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.604 0.24 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -74.6 108.39 7.32 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 120.864 0.364 . . . . 0.0 110.439 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -134.08 135.25 43.13 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.196 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.81 125.1 54.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.286 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.409 ' O ' HD11 ' A' ' 346' ' ' LEU . 1.5 pp -154.76 146.46 23.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.009 0.433 . . . . 0.0 111.783 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -156.66 138.44 14.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.711 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -118.1 98.98 6.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.162 0.506 . . . . 0.0 110.82 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 177.86 38.72 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.706 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -100.87 -178.78 29.28 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.113 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 0.516 HG23 ' H ' ' A' ' 352' ' ' LEU . 5.8 p -122.66 176.19 4.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.516 ' H ' HG23 ' A' ' 351' ' ' VAL . 3.6 mm? -112.88 146.7 38.46 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.3 t -62.49 138.97 96.64 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.23 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.64 -4.21 14.93 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.856 2.371 . . . . 0.0 112.304 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -86.46 124.76 69.27 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.239 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.45 112.99 3.48 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.563 2.176 . . . . 0.0 112.012 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 120.29 -6.39 11.84 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.831 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.42 ' SG ' ' HE1' ' A' ' 360' ' ' MET . 47.5 t -84.5 -79.92 0.21 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.43 20.88 52.77 Favored Glycine 0 C--O 1.228 -0.236 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.648 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' MET . . . . . 0.42 ' HE1' ' SG ' ' A' ' 358' ' ' CYS . 34.2 mtm -68.01 -56.95 7.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.012 0.406 . . . . 0.0 111.024 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 124.67 114.16 2.03 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.71 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.3 mm? -98.45 134.77 40.97 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.058 0.456 . . . . 0.0 111.355 -177.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -93.03 124.08 36.75 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.35 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.28 116.97 48.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.975 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.31 155.5 66.51 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -42.91 -51.12 5.67 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.36 2.707 . . . . 0.0 113.656 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -106.86 28.8 7.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.852 0.358 . . . . 0.0 111.85 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 37.1 t -67.31 -52.79 36.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.613 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 67.03 -59.42 0.38 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.672 0.789 . . . . 0.0 111.98 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -72.98 116.73 13.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.44 0.638 . . . . 0.0 111.126 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 381' ' ' PHE . 0.0 OUTLIER -116.79 125.19 73.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.819 176.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 81.6 m -153.07 142.22 21.42 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.279 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.455 ' HA ' HD11 ' A' ' 362' ' ' LEU . 5.2 t -73.22 74.52 1.29 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.34 -18.8 61.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.393 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -99.3 -11.04 21.6 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.131 0.491 . . . . 0.0 110.807 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -141.79 -129.6 2.45 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.759 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.4 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.9 OUTLIER -74.98 91.18 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.829 0.452 . . . . 0.0 111.017 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.72 119.23 9.75 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.9 -174.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -142.2 139.82 32.16 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.509 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 14.5 m -83.09 124.65 39.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.204 0.526 . . . . 0.0 111.186 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.474 ' O ' HG21 ' A' ' 371' ' ' VAL . 5.4 p90 -141.36 -176.9 4.89 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.469 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 36.4 t -105.46 169.96 8.16 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.452 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 7.1 ptt180 -87.93 -27.02 22.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.285 0.564 . . . . 0.0 109.805 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.452 ' OD1' ' HG3' ' A' ' 383' ' ' ARG . 5.6 m-20 -103.55 -19.73 14.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.431 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 394' ' ' CYS . 1.4 m -138.02 165.86 25.54 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.378 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.3 mp -111.89 34.83 3.98 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -86.97 2.13 50.49 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 100.67 27.75 7.38 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 119.565 -1.303 . . . . 0.0 114.04 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 47.2 t80 72.73 121.35 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.291 0.636 . . . . 0.0 111.921 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -167.92 176.86 5.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.932 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.457 ' O ' HD13 ' A' ' 391' ' ' ILE . 2.4 pp -139.51 148.93 22.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.757 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.95 -33.62 2.63 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.657 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -70.97 -20.26 62.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.567 0.698 . . . . 0.0 111.346 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.557 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 2.7 p -121.21 152.95 38.23 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.977 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.3 158.58 48.29 Favored Pre-proline 0 C--N 1.311 -1.073 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.967 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.87 -167.58 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.643 2.228 . . . . 0.0 111.124 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -58.34 132.79 54.68 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.111 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -108.5 144.93 16.34 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.055 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 28.1 m -99.83 -43.0 6.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.7 0.286 . . . . 0.0 110.847 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.89 159.75 31.27 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.026 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -148.58 156.17 42.07 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.691 0.246 . . . . 0.0 110.498 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.4 t -168.93 139.24 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -138.93 166.74 23.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.8 0.334 . . . . 0.0 111.118 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.6 p -125.36 165.99 17.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.587 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -160.7 120.62 2.76 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.2 t -126.19 136.2 52.54 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.299 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 56.8 m -125.63 122.23 35.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.625 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -124.47 134.15 53.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.131 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -156.91 103.54 2.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.009 0.433 . . . . 0.0 111.201 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 8.6 t -144.2 138.99 28.45 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.374 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 30.7 m -132.61 179.49 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.817 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -107.49 147.65 35.71 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.349 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.69 -175.23 2.62 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.732 2.288 . . . . 0.0 111.524 177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -153.18 142.22 21.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.568 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.77 164.26 22.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.209 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -85.3 177.03 7.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.088 0.471 . . . . 0.0 111.591 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -135.26 166.79 22.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.04 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -79.39 161.74 25.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.99 0.424 . . . . 0.0 111.172 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -141.48 134.33 28.83 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.799 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -122.52 110.54 15.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.003 0.43 . . . . 0.0 111.984 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -129.54 74.23 1.57 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.324 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.56 134.69 27.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.966 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -106.54 -43.07 4.83 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.447 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 49.77 55.6 9.15 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.553 0.533 . . . . 0.0 111.586 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.7 p -153.43 147.01 25.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.05 0.452 . . . . 0.0 111.898 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -149.79 130.26 13.89 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 40.9 t -101.09 146.27 9.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.1 t -74.54 166.58 23.3 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.764 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 47.6 pt -106.22 -3.05 9.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.443 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -71.55 145.21 49.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.944 0.402 . . . . 0.0 111.19 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.21 130.93 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.647 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 47.9 m -113.55 -0.49 14.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.379 0.609 . . . . 0.0 110.541 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 7.4 p -101.97 172.43 6.93 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.696 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -122.1 127.58 25.87 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.367 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.18 122.88 10.75 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.161 1.907 . . . . 0.0 111.77 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.603 ' O ' ' HD3' ' A' ' 440' ' ' ARG . 41.6 t -56.41 137.26 76.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.465 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.22 -14.8 41.43 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.212 1.941 . . . . 0.0 111.605 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -99.79 -78.04 0.51 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.667 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.0 p -81.41 -9.37 59.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.603 ' HD3' ' O ' ' A' ' 436' ' ' CYS . 38.4 mmt180 64.98 25.59 12.69 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.777 0.431 . . . . 0.0 111.875 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 39.3 p -88.76 151.88 48.18 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.44 102.12 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.525 2.15 . . . . 0.0 111.944 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 51.7 m -94.11 130.23 40.38 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.396 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -74.75 146.32 42.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.014 0.435 . . . . 0.0 111.051 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -95.71 162.13 13.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.134 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -117.9 141.77 48.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -97.82 4.12 61.11 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.118 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -127.17 -49.23 0.17 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.656 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.7 t -96.16 136.43 36.64 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.856 0.36 . . . . 0.0 110.548 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.76 19.81 3.3 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.574 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -104.01 111.97 24.75 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' MET . . . . . 0.456 ' HG2' ' HB2' ' A' ' 465' ' ' TRP . 79.2 mmm -99.83 111.83 24.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 0.0 110.923 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.84 130.07 60.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.823 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.1 t -91.38 130.39 37.24 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 3.4 p -109.62 88.85 2.84 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 121.561 0.696 . . . . 0.0 110.084 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.46 135.78 44.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.52 95.25 0.32 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.961 0.41 . . . . 0.0 110.086 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 123.94 -9.99 8.44 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.527 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . . . . . . . . . 48.1 t -97.22 -88.34 0.3 Allowed 'General case' 0 C--O 1.239 0.503 0 O-C-N 122.673 -0.31 . . . . 0.0 111.009 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.27 31.43 63.69 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.821 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -95.18 142.12 28.0 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.973 0.416 . . . . 0.0 110.514 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.01 135.97 55.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.583 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -143.45 165.92 26.21 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.523 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 61.2 m -73.59 144.72 45.89 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.312 0.577 . . . . 0.0 112.018 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . 0.456 ' HB2' ' HG2' ' A' ' 452' ' ' MET . 26.1 t-105 -76.7 -51.33 11.67 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.046 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.36 -35.7 63.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 26.3 p -116.74 -161.65 0.81 Allowed 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -142.62 109.55 5.51 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' THR . . . . . 0.452 HG21 ' SG ' ' A' ' 475' ' ' CYS . 13.4 t -158.02 177.88 10.83 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.386 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -87.74 150.43 23.6 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -52.74 101.73 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.584 0.707 . . . . 0.0 110.14 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.8 p -130.57 171.9 12.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.621 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -73.93 -21.73 59.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.144 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.96 -52.76 63.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.495 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . 0.452 ' SG ' HG21 ' A' ' 469' ' ' THR . 72.5 m -84.0 -18.7 36.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.112 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 24.2 ttt -46.68 -54.13 10.24 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.728 0.643 . . . . 0.0 111.632 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -97.98 17.77 58.22 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.356 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -110.01 -66.28 1.08 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.695 0.283 . . . . 0.0 111.4 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -144.67 12.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -68.09 -28.17 67.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.484 0.659 . . . . 0.0 109.812 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -132.14 105.73 7.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.386 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-O 118.712 -1.049 . . . . 0.0 112.502 -178.173 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.813 0.34 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.8 178.28 4.67 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.461 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -106.34 160.15 15.59 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.451 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.415 HG11 ' ND2' ' A' ' 384' ' ' ASN . 51.0 t -68.45 -54.15 23.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -173.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -135.44 -174.79 3.73 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.395 0.617 . . . . 0.0 112.117 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -132.79 141.19 48.37 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.067 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -61.11 135.23 57.7 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.358 0.411 . . . . 0.0 111.57 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 147.77 -95.45 0.17 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.931 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -151.77 162.17 29.56 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.755 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 0.426 HG22 ' HB2' ' A' ' 362' ' ' LEU . 29.6 m -120.58 -178.25 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 C-N-CA 123.339 0.656 . . . . 0.0 109.879 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 22.4 mt -126.6 150.45 48.87 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 54.0 t -57.98 137.37 83.79 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.436 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.02 -17.16 51.0 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.984 2.456 . . . . 0.0 112.299 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.45 121.29 84.44 Favored Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.3 -39.46 91.14 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.094 2.53 . . . . 0.0 112.599 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -78.69 -10.75 85.92 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.348 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 7.1 t -88.58 -76.65 0.39 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.971 0.415 . . . . 0.0 110.03 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 68.72 27.23 74.0 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.645 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 35.2 ttp -88.62 153.09 21.39 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -88.6 115.16 4.37 Favored Glycine 0 C--N 1.284 -2.335 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.534 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.426 ' HB2' HG22 ' A' ' 351' ' ' VAL . 4.5 mm? -94.59 134.22 37.39 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 364' ' ' VAL . 1.1 tm? -92.68 139.63 30.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . 0.503 ' N ' HD11 ' A' ' 363' ' ' LEU . 43.7 t -108.89 91.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 120.851 0.357 . . . . 0.0 110.262 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -71.38 145.92 91.17 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.57 -22.47 58.33 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 121.948 1.765 . . . . 0.0 110.341 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -108.38 23.05 15.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.066 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 51.5 t -56.51 124.07 16.93 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.461 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -83.19 -48.63 10.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.692 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -148.72 118.19 6.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.633 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 381' ' ' PHE . 2.0 p -84.6 111.8 20.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.483 0.659 . . . . 0.0 109.539 176.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 91.4 m -152.78 144.22 23.33 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.98 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 19.9 t -75.57 69.66 2.33 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.345 0.593 . . . . 0.0 110.064 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -83.8 -6.55 59.45 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.567 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -111.25 5.77 20.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.934 -177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -133.79 -75.87 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.566 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.5 p -124.6 -102.72 0.37 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.873 0.368 . . . . 0.0 110.37 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -173.0 106.07 0.22 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -163.39 123.36 2.19 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.97 129.26 49.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.454 ' O ' HG11 ' A' ' 371' ' ' VAL . 8.1 p90 -140.0 -177.34 4.95 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.887 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 27.9 t -83.44 172.78 12.11 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -100.42 -14.66 18.23 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.639 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.532 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 8.6 t30 -105.21 -26.86 11.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.434 0.635 . . . . 0.0 109.483 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 28.8 p -143.31 -169.84 3.14 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.724 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 11.1 mp -116.47 26.4 9.91 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.561 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -76.56 11.54 1.6 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 86.62 21.07 52.52 Favored Glycine 0 N--CA 1.459 0.205 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.398 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 72.95 120.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.696 0.798 . . . . 0.0 111.631 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -150.6 166.6 29.81 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.791 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.71 143.09 24.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 111.41 23.08 5.86 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.087 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 61.64 -178.88 0.12 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.5 0.72 . . . . 0.0 111.827 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 2.5 m -125.06 -59.18 1.42 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.196 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -62.89 146.56 95.12 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.941 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.16 176.17 6.03 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.691 2.26 . . . . 0.0 112.143 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -105.93 -49.74 3.33 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.744 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.56 176.72 45.72 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.598 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 14.0 t -160.57 158.93 29.93 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -147.49 126.5 2.4 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -123.15 134.62 54.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.882 0.372 . . . . 0.0 111.346 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.4 p -103.82 132.45 50.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.341 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -149.3 130.25 14.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.858 0.361 . . . . 0.0 110.669 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.4 t -159.34 147.25 17.5 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.525 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -140.35 132.79 28.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.818 0.342 . . . . 0.0 110.86 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 9.5 m -134.14 113.79 12.43 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.013 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 73.2 m -111.2 131.44 55.11 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.832 0.348 . . . . 0.0 110.746 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -91.96 156.84 17.16 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.314 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -141.9 134.51 28.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 11.4 p -118.24 159.49 23.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.55 161.87 29.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.461 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.94 115.62 56.86 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -98.12 -176.42 0.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.281 2.654 . . . . 0.0 111.564 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -112.36 -178.38 3.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.233 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -131.02 -75.11 0.53 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.3 170.82 21.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.616 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.75 -171.32 1.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.842 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -89.36 166.12 13.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.458 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -164.21 120.91 1.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.899 0.38 . . . . 0.0 111.236 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -131.33 117.31 18.75 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -112.99 157.72 21.16 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.14 0.495 . . . . 0.0 111.64 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -130.7 128.52 41.03 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.06 -71.62 0.45 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.57 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -173.53 -174.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.055 0.455 . . . . 0.0 111.216 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 9.1 m -138.33 149.84 46.02 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.585 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -141.8 107.13 5.0 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.065 0.46 . . . . 0.0 110.665 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.37 87.68 2.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.719 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.1 t -101.78 119.23 38.46 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.88 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 39.3 pt -129.63 164.8 31.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.471 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -154.93 114.45 3.71 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.57 113.03 22.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.35 0.595 . . . . 0.0 111.456 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.416 ' O ' ' HD2' ' A' ' 445' ' ' ARG . 3.2 p -115.26 3.63 14.31 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.45 0.643 . . . . 0.0 110.489 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.68 152.14 20.96 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.097 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 434' ' ' LYS . 0.0 OUTLIER -118.93 119.15 32.51 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -68.52 126.18 13.8 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 122.006 1.804 . . . . 0.0 112.206 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 438' ' ' LYS . 43.6 t -57.91 131.26 83.08 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.431 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.47 ' HG2' ' CE2' ' A' ' 461' ' ' PHE . 64.6 Cg_endo -74.64 -1.24 10.83 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.322 2.014 . . . . 0.0 111.391 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . 0.557 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 27.7 tptp -102.81 -64.7 1.05 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.971 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 11.0 p -103.59 -3.46 25.17 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 68.58 29.16 5.6 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 34.7 p -90.27 141.38 27.56 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -75.63 94.52 0.99 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.916 1.744 . . . . 0.0 111.398 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 30.4 m -89.64 128.21 36.02 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.016 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.62 151.11 44.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.904 0.383 . . . . 0.0 111.338 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.423 ' HD3' ' H ' ' A' ' 445' ' ' ARG . 0.3 OUTLIER -82.57 146.14 29.34 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.574 177.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -117.43 89.45 3.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.88 0.371 . . . . 0.0 110.955 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 60.03 -134.88 50.68 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.623 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -112.99 18.24 21.79 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.681 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 43.3 t -63.95 129.46 40.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 60.6 mtt -75.99 -25.68 56.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.977 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -79.22 96.2 5.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' MET . . . . . 0.418 ' HE2' ' HA ' ' A' ' 445' ' ' ARG . 40.6 mmm -118.43 109.68 16.53 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.68 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.414 ' CG1' ' HG2' ' A' ' 462' ' ' GLU . 4.0 m -121.66 150.87 24.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 120.952 0.406 . . . . 0.0 110.275 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 456' ' ' ARG . 42.8 t -83.68 100.65 11.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.499 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 5.9 p -81.45 92.15 6.42 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -128.9 139.64 52.04 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -177.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -45.71 -45.57 14.38 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.486 0.491 . . . . 0.0 112.231 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -122.56 59.34 0.59 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.749 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 45.4 t -146.38 -83.54 0.13 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.83 0.315 . . . . 0.0 110.793 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.88 49.52 41.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.375 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . 0.47 ' CE2' ' HG2' ' A' ' 437' ' ' PRO . 65.1 t80 -99.8 120.53 39.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.825 0.345 . . . . 0.0 111.097 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.414 ' HG2' ' CG1' ' A' ' 453' ' ' VAL . 41.1 mt-10 -94.22 134.17 36.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.842 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -144.29 161.28 39.33 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.889 0.376 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . 0.783 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 19.8 m -76.61 137.35 39.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.313 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -68.45 -45.55 72.19 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.689 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.39 -63.92 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.237 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.783 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 17.1 p -98.79 126.34 44.39 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.55 109.37 7.97 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.579 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.5 156.21 36.28 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.046 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -85.97 135.84 33.5 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -55.76 106.97 0.29 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.2 p -140.52 -164.96 1.83 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.589 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -73.58 -29.31 62.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 109.817 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -72.06 -58.45 3.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.158 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 34.3 m -97.54 70.05 2.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.497 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.58 4.15 53.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.46 0.648 . . . . 0.0 109.453 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . 121.38 12.68 5.58 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.271 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -61.93 -19.42 62.71 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -121.91 9.46 10.02 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.178 0.513 . . . . 0.0 109.911 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 9.3 t-105 -86.43 86.24 7.33 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.166 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -149.9 121.19 7.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.385 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.101 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.227 179.09 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.98 139.75 51.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.006 0.432 . . . . 0.0 110.984 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -129.47 94.93 3.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.357 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 346' ' ' LEU . 3.5 p -59.6 -60.8 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.28 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 345' ' ' VAL . 0.6 OUTLIER 174.16 129.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.487 0.492 . . . . 0.0 110.64 176.529 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . 0.436 ' N ' HD11 ' A' ' 346' ' ' LEU . 28.0 tt0 -165.91 116.08 1.01 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -160.9 161.92 31.92 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.688 0.28 . . . . 0.0 110.926 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -82.74 61.61 4.73 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.599 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -98.03 -149.49 25.12 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.434 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.01 165.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.74 148.26 33.87 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 122.207 -0.308 . . . . 0.0 110.965 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 34.2 t -68.53 122.04 83.09 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.454 ' CG ' HD12 ' A' ' 386' ' ' LEU . 92.4 Cg_endo -79.5 0.03 10.34 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.936 2.424 . . . . 0.0 112.748 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -81.06 120.2 78.04 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.0 106.52 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.796 2.331 . . . . 0.0 112.325 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 128.39 -6.54 6.69 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.768 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.3 t -94.42 -94.04 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.898 0.349 . . . . 0.0 110.557 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 71.07 16.21 74.83 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.006 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 41.6 ttp -67.06 -54.88 17.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.98 0.419 . . . . 0.0 111.198 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.63 122.49 2.56 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.653 -0.785 . . . . 0.0 111.695 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 373' ' ' CYS . 4.3 mm? -109.03 132.61 53.95 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.515 0.674 . . . . 0.0 111.325 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.81 106.22 18.22 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.778 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 11.4 p -116.41 127.42 74.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.289 0.566 . . . . 0.0 110.25 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -94.49 162.61 25.37 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.992 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.04 -26.32 81.21 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.472 2.115 . . . . 0.0 111.645 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.18 5.63 40.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.305 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 46.6 t -88.18 108.04 19.08 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.954 0.407 . . . . 0.0 110.693 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . 0.437 ' O ' ' HE1' ' A' ' 389' ' ' TYR . 0.7 OUTLIER -94.08 -33.13 13.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.656 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -85.75 104.6 15.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.207 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 14.4 p -103.7 122.81 56.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.267 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 96.7 m -153.27 139.49 18.43 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.075 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.489 ' HA ' HD12 ' A' ' 362' ' ' LEU . 2.5 t -74.83 69.89 1.88 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -68.7 -13.26 62.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.559 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -103.9 -3.72 24.41 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.96 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -154.63 -124.63 0.93 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.87 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 1.7 p -74.85 91.68 2.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.885 0.374 . . . . 0.0 111.12 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.99 124.09 19.56 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.827 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -151.9 132.8 14.18 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 26.6 m -90.36 124.81 43.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.953 0.406 . . . . 0.0 110.67 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -145.6 -175.77 4.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.169 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 42.8 t -88.47 141.23 28.71 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -66.47 -22.13 66.2 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.616 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -105.93 -28.63 10.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.836 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 394' ' ' CYS . 5.4 m -134.11 178.73 6.74 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 121.286 0.565 . . . . 0.0 111.779 -174.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.454 HD12 ' CG ' ' A' ' 354' ' ' PRO . 4.2 mm? -110.04 30.2 6.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -77.27 3.05 13.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.716 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 76.33 40.26 28.99 Favored Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.54 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.437 ' HE1' ' O ' ' A' ' 369' ' ' ARG . 37.0 t80 69.76 110.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.787 0.835 . . . . 0.0 111.638 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -134.68 -169.13 2.28 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.52 159.91 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.824 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.69 9.6 2.58 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-N 116.277 -0.42 . . . . 0.0 114.048 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -115.59 111.81 21.22 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.168 0.508 . . . . 0.0 111.093 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.555 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 1.9 m -113.07 147.04 38.08 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.597 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.2 152.41 60.39 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.032 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.18 175.95 7.74 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.735 2.29 . . . . 0.0 112.022 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -115.72 137.66 51.86 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.702 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 126.16 117.39 2.14 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.494 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 8.8 t -148.87 162.66 39.4 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 172.92 139.84 2.97 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.444 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -151.84 143.22 23.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.743 0.306 . . . . 0.0 110.381 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.1 p -120.55 153.81 36.22 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.103 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -160.3 137.24 9.16 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.984 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 26.2 m -157.92 143.36 16.94 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.216 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -155.4 148.08 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 t -150.15 157.43 43.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 58.5 m -140.39 116.07 10.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.879 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -130.65 138.64 50.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.367 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -164.83 138.97 5.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.509 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 9.3 t -132.08 155.26 48.41 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.856 0.36 . . . . 0.0 110.552 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.62 126.97 74.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.019 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -87.3 148.31 44.39 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.669 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.12 -178.47 2.49 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.068 2.512 . . . . 0.0 113.106 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -119.36 173.76 6.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.512 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -133.51 135.02 44.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.528 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -125.04 144.14 50.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.912 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -129.95 141.97 50.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.707 0.289 . . . . 0.0 111.248 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -99.51 -175.37 2.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.311 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -138.37 170.11 16.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.692 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -118.54 155.83 30.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.209 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -119.85 159.47 24.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.959 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -113.59 133.1 55.47 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.1 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 423' ' ' GLU . 0.1 OUTLIER -92.47 -32.93 14.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.864 178.044 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 56.55 77.59 0.25 Allowed 'General case' 0 C--N 1.341 0.218 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.766 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 30.1 t -88.87 113.09 24.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.205 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -85.49 179.41 7.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.608 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.64 151.83 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.7 t -89.93 152.82 21.04 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.511 ' H ' HD13 ' A' ' 429' ' ' ILE . 0.2 OUTLIER -115.79 167.42 8.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.639 0.257 . . . . 0.0 111.001 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 430' ' ' LYS . 0.0 OUTLIER -86.62 159.52 19.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.955 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 33.1 m -82.36 132.39 31.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.417 0.627 . . . . 0.0 111.683 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 31.3 m -96.77 4.96 51.48 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.3 p -115.57 155.05 28.3 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.913 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 30.3 mmmt -121.52 134.43 24.55 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 5.1 Cg_exo -74.34 118.14 5.25 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.802 1.668 . . . . 0.0 111.938 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 37.2 t -55.32 138.72 67.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.528 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.31 -1.17 10.95 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.577 2.185 . . . . 0.0 112.031 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -111.68 -60.21 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . 0.423 ' SG ' ' HG3' ' A' ' 456' ' ' ARG . 5.3 p -100.58 -3.31 30.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.78 33.7 23.53 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.072 0.463 . . . . 0.0 111.166 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 36.4 p -97.81 154.89 37.67 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.16 99.34 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.181 1.921 . . . . 0.0 112.302 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 5.8 m -85.96 121.05 28.04 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -76.21 124.35 27.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.965 0.412 . . . . 0.0 110.357 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 445' ' ' ARG . 0.0 OUTLIER -96.19 155.4 16.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.015 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -140.7 148.86 41.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -85.43 115.1 4.09 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.791 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 136.46 -12.59 4.03 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.793 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 57.9 m -112.94 110.24 20.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.406 ' HA ' ' CD1' ' A' ' 465' ' ' TRP . 0.7 OUTLIER -82.54 -12.73 57.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.195 0.521 . . . . 0.0 110.224 176.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -101.0 96.4 7.22 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 46.3 tpp -104.13 129.77 51.84 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 120.942 0.401 . . . . 0.0 111.05 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 18.6 t -134.37 137.27 51.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 48.1 t -86.52 95.04 9.59 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 20.6 p -81.96 90.23 6.46 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.496 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 0.1 OUTLIER -131.27 141.97 50.06 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.791 -176.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -64.42 106.06 1.05 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.808 0.337 . . . . 0.0 110.141 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 101.69 4.69 51.97 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.414 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.496 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 44.2 t -113.21 -90.19 0.52 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.743 0.271 . . . . 0.0 110.599 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 70.4 34.25 68.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.567 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -94.76 134.23 37.59 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.951 0.405 . . . . 0.0 111.07 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.37 128.85 52.28 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -138.58 157.98 45.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.048 0.451 . . . . 0.0 111.752 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 28.5 m -65.92 136.07 55.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.044 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . 0.406 ' CD1' ' HA ' ' A' ' 450' ' ' MET . 23.9 t-105 -74.33 -49.44 22.86 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.265 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 13.4 t -73.24 -64.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.822 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.658 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 13.9 p -93.32 133.81 36.18 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -76.8 107.64 9.27 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.798 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -155.76 176.53 12.51 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.956 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -113.9 140.84 48.04 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 63.9 t90 -59.75 103.97 0.25 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.799 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 473' ' ' ARG . 0.7 OUTLIER -142.41 -152.47 0.41 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . 0.49 ' H ' HG23 ' A' ' 472' ' ' THR . 33.4 ptt180 -82.94 -23.98 33.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.058 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.85 -50.39 56.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.901 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 66.1 m -110.89 81.17 1.39 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.116 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 92.4 mtp -89.46 -35.53 15.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.818 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . 159.26 40.45 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.555 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -90.83 -3.0 57.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.098 0.475 . . . . 0.0 110.973 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . 0.414 ' CE1' ' SG ' ' A' ' 464' ' ' CYS . 19.2 p80 -143.88 19.5 1.8 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.135 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . 0.459 ' CZ3' ' HA ' ' A' ' 464' ' ' CYS . 9.5 t-105 -87.85 3.36 48.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.299 0.571 . . . . 0.0 110.093 -176.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -64.81 115.77 5.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.091 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-O 118.677 -1.068 . . . . 0.0 111.469 179.744 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 N--CA 1.468 0.47 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -104.86 128.91 53.25 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.963 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -102.69 127.03 49.99 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.8 p -94.65 113.05 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.564 ' H ' HD12 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -107.84 153.56 22.83 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.214 0.53 . . . . 0.0 112.297 -176.107 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -159.9 172.09 18.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.227 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -157.08 -171.46 3.65 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -77.86 74.71 1.95 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -83.83 -150.01 10.14 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.622 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 352' ' ' LEU . 30.0 t -100.38 163.76 2.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.417 ' N ' HG11 ' A' ' 351' ' ' VAL . 4.2 mm? -113.76 143.89 43.89 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 44.5 t -64.95 139.68 97.87 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.779 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -74.66 -10.83 22.0 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.557 2.171 . . . . 0.0 112.402 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -71.42 136.13 83.94 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 110.857 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.1 -43.13 16.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.986 2.457 . . . . 0.0 113.223 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -82.27 7.14 65.04 Favored Glycine 0 CA--C 1.51 -0.279 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.3 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.596 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 43.9 t -92.4 -103.42 0.12 Allowed 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 122.667 -0.314 . . . . 0.0 110.866 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 70.03 27.91 72.4 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 37.5 ttp -79.44 -69.7 0.56 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.913 0.387 . . . . 0.0 110.643 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 139.92 131.38 2.77 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.957 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.36 140.79 48.81 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.952 0.406 . . . . 0.0 110.661 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -105.86 123.37 47.85 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.619 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 59.6 t -118.89 114.47 44.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.873 0.368 . . . . 0.0 110.629 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.67 142.64 70.47 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -46.32 -42.75 22.15 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.345 2.697 . . . . 0.0 114.014 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -80.21 -3.62 49.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 43.6 t -123.58 158.38 31.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.102 0.477 . . . . 0.0 111.131 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -134.74 9.23 3.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.064 0.459 . . . . 0.0 109.779 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -71.95 108.09 5.03 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.525 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.479 HG22 ' C ' ' A' ' 382' ' ' CYS . 0.0 OUTLIER -115.36 112.15 38.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.175 177.27 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.3 m -153.71 135.15 14.24 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.438 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.428 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 3.4 t -74.76 69.57 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.465 0.65 . . . . 0.0 109.738 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -76.03 -9.8 58.9 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.395 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -104.99 5.97 33.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.497 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -161.11 -123.0 0.65 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.583 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.1 p -84.58 92.6 8.17 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.676 0.39 . . . . 0.0 110.67 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -69.52 108.95 2.66 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.896 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -128.08 141.88 51.37 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.75 122.8 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.259 0.552 . . . . 0.0 111.88 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -151.94 -177.5 6.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.824 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . 0.479 ' C ' HG22 ' A' ' 371' ' ' VAL . 19.5 t -108.57 175.46 5.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -82.54 -39.0 22.94 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.935 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.611 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 5.2 m-20 -104.44 -5.33 21.74 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -177.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 21.3 p -151.84 173.2 15.06 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.243 0.544 . . . . 0.0 111.397 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 8.9 mp -110.36 35.38 3.46 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.992 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -79.08 3.84 16.3 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.327 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 83.79 27.58 37.8 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.941 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 25.7 t80 70.08 125.89 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.468 0.707 . . . . 0.0 111.036 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -143.96 -175.72 4.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 43.6 mm -105.52 145.49 13.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.8 -163.41 27.03 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.775 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -91.24 166.53 12.89 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.889 0.376 . . . . 0.0 110.365 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.611 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.0 m -96.58 -58.24 2.1 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.768 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.33 124.57 82.4 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.21 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.82 -171.15 1.17 Allowed 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.687 2.258 . . . . 0.0 111.555 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.44 -64.51 1.04 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.722 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 68.1 66.73 2.21 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.48 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 45.5 m -106.75 119.0 38.16 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.945 0.403 . . . . 0.0 110.936 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -125.53 117.81 3.04 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.936 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.84 -55.39 3.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.597 0.237 . . . . 0.0 110.607 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 45.9 p 50.15 84.87 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.776 0.83 . . . . 0.0 111.998 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.78 119.29 6.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.681 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.0 t -165.84 135.75 3.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.994 0.425 . . . . 0.0 111.206 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -147.86 167.59 24.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.911 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.5 p -134.88 -70.13 0.5 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.728 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 18.4 t 54.36 85.9 0.05 Allowed 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.795 0.684 . . . . 0.0 111.085 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -136.22 132.6 36.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.239 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -175.51 132.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.711 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 15.3 t -138.29 155.22 48.8 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.753 0.311 . . . . 0.0 110.743 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.38 150.42 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.129 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -109.49 150.6 41.39 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.384 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.44 171.61 3.58 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.882 2.388 . . . . 0.0 112.594 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -148.04 145.28 28.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.556 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -154.61 130.55 10.16 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.226 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.26 134.51 10.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.443 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -164.94 119.45 1.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.479 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.4 145.46 29.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.751 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -147.19 139.95 24.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.713 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -142.68 137.26 29.78 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -135.27 156.7 48.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.764 0.316 . . . . 0.0 111.404 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -108.87 122.72 47.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.184 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -104.7 -26.53 12.26 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.212 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -62.35 120.18 10.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.984 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.5 t -163.04 146.61 10.9 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -162.27 132.74 4.82 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.118 0.485 . . . . 0.0 110.861 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.44 124.64 57.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 40.6 m -142.25 125.85 16.85 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.962 0.411 . . . . 0.0 111.02 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.14 162.51 23.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.374 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -104.96 132.99 50.5 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.311 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.1 p -56.93 110.97 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.433 0.635 . . . . 0.0 111.184 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.0 m -114.82 2.04 14.26 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.675 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.1 p -105.83 126.04 51.7 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.877 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 5.2 mptp? -90.48 144.97 31.52 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 1.1 Cg_endo -80.46 121.14 4.17 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.013 1.809 . . . . 0.0 111.822 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.488 ' O ' ' HD3' ' A' ' 440' ' ' ARG . 37.1 t -54.99 135.2 67.27 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.609 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.53 -15.62 38.06 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.159 1.906 . . . . 0.0 111.651 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . 0.473 ' HA ' ' HE3' ' A' ' 438' ' ' LYS . 0.9 OUTLIER -91.85 -70.49 0.69 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.493 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.1 p -97.6 -6.09 34.12 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.488 ' HD3' ' O ' ' A' ' 436' ' ' CYS . 23.9 mmt180 67.11 26.1 8.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.771 0.429 . . . . 0.0 111.664 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 26.9 p -86.19 158.81 54.89 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.902 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.02 101.53 1.34 Allowed 'Trans proline' 0 C--O 1.239 0.53 0 C-N-CA 122.428 2.085 . . . . 0.0 112.224 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 7.3 m -90.32 113.16 24.96 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -104.09 141.1 36.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.408 ' O ' ' HG3' ' A' ' 445' ' ' ARG . 6.6 ptm180 -85.74 95.04 9.27 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.633 0.73 . . . . 0.0 110.057 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -135.47 115.3 12.98 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.892 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 84.16 20.34 59.24 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.78 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -149.89 129.2 2.91 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 76.5 m -81.84 -73.1 0.4 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.754 0.311 . . . . 0.0 110.893 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.438 ' HE1' ' H ' ' A' ' 482' ' ' GLY . 0.7 OUTLIER -112.3 -6.52 14.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.502 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -96.65 96.5 8.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.959 0.409 . . . . 0.0 110.546 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 80.0 mmm -89.51 91.85 8.87 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 23.7 t -99.95 116.76 43.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.89 99.55 12.48 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 1.3 t -87.24 92.78 9.18 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.604 0.716 . . . . 0.0 110.471 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -130.3 148.22 52.1 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.448 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -46.41 -64.76 0.68 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -93.78 37.5 3.39 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.773 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 51.1 t -130.97 -100.36 0.3 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.851 0.357 . . . . 0.0 111.073 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 78.81 22.53 66.2 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -89.28 114.88 26.3 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.361 0.601 . . . . 0.0 111.076 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.468 ' HG3' ' HB3' ' A' ' 471' ' ' TRP . 4.1 pt-20 -105.58 146.19 29.97 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.62 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -146.45 159.38 43.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.941 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 41.8 m -62.51 146.95 50.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.472 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -74.87 -54.54 7.08 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.468 176.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.01 -63.83 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.626 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 28.0 p -98.67 165.96 11.55 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -106.6 111.42 23.96 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.729 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.4 p -150.64 154.75 38.06 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.387 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -73.85 154.36 39.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . 0.468 ' HB3' ' HG3' ' A' ' 462' ' ' GLU . 5.3 p-90 -60.7 91.87 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.887 0.851 . . . . 0.0 111.981 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.2 t -134.77 141.08 46.36 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.761 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . 0.46 ' HA ' ' HB3' ' A' ' 476' ' ' MET . 36.3 mtp180 -63.48 -29.38 70.67 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -174.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . 0.457 ' O ' ' HB1' ' A' ' 478' ' ' ALA . 4.9 p-10 -65.51 -18.32 65.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.293 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 8.2 t -110.61 -40.6 4.54 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' MET . . . . . 0.46 ' HB3' ' HA ' ' A' ' 473' ' ' ARG . 10.8 tpt -52.99 -41.02 64.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.26 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -106.03 16.8 42.3 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.169 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 474' ' ' ASP . . . -92.78 -65.54 0.99 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.75 0.309 . . . . 0.0 110.828 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . 0.613 ' CG ' ' H ' ' A' ' 480' ' ' TRP . 9.5 p80 -108.32 -69.62 0.84 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.031 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . 0.613 ' H ' ' CG ' ' A' ' 479' ' ' HIS . 22.0 t-105 63.51 -71.81 0.06 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.332 1.053 . . . . 0.0 111.734 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -70.23 137.07 50.54 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.416 0.286 . . . . 0.0 110.395 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . 0.438 ' H ' ' HE1' ' A' ' 450' ' ' MET . . . . . . . . 0 N--CA 1.437 -1.295 0 CA-C-O 118.435 -1.203 . . . . 0.0 111.876 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.595 0.236 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.73 143.92 49.99 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -97.03 83.3 3.34 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.286 0.565 . . . . 0.0 109.94 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.427 ' O ' HD22 ' A' ' 346' ' ' LEU . 3.3 p -127.07 98.38 4.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.508 0.67 . . . . 0.0 111.192 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 345' ' ' VAL . 3.3 mm? -125.46 164.87 19.52 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.17 175.79 10.23 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.715 177.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -134.63 155.46 50.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.394 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 79.81 -68.97 3.13 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.259 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -173.28 -150.25 7.35 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.846 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.34 -179.03 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 C-N-CA 123.094 0.558 . . . . 0.0 110.3 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 7.5 mp -124.35 151.53 44.24 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.872 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.9 t -54.61 138.67 60.91 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.694 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.471 ' HG3' ' CD1' ' A' ' 379' ' ' TYR . 18.6 Cg_endo -59.56 -19.69 53.63 Favored 'Trans proline' 0 N--CA 1.473 0.281 0 C-N-CA 123.195 2.597 . . . . 0.0 112.396 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -84.93 113.09 47.76 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.03 -28.22 74.44 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.46 2.106 . . . . 0.0 111.842 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -67.86 -25.3 74.24 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 40.0 t -73.95 -73.08 0.24 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 53.24 31.53 42.11 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.249 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 47.9 ttp -70.96 -62.55 1.35 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.168 0.508 . . . . 0.0 110.8 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 125.8 123.62 2.7 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.75 130.11 56.52 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.237 0.542 . . . . 0.0 110.478 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.471 HD12 ' HG2' ' A' ' 365' ' ' GLU . 0.8 OUTLIER -89.62 124.66 34.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.859 -178.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . 0.445 ' N ' HD11 ' A' ' 363' ' ' LEU . 100.0 t -93.75 100.99 12.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.102 0.477 . . . . 0.0 110.673 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.471 ' HG2' HD12 ' A' ' 363' ' ' LEU . 6.0 mm-40 -94.89 153.73 39.91 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.369 177.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.82 -11.34 31.76 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 121.785 1.657 . . . . 0.0 109.821 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -102.98 24.99 9.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.182 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 27.1 p -71.83 74.67 0.87 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.556 0.693 . . . . 0.0 110.823 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . 0.512 ' H ' ' HD3' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -64.88 -23.07 67.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.196 179.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -162.11 109.47 1.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.168 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 381' ' ' PHE . 0.6 OUTLIER -92.64 113.67 28.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.659 0.742 . . . . 0.0 110.326 176.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' THR . . . . . 0.42 ' OG1' HG11 ' A' ' 380' ' ' VAL . 92.2 m -152.54 144.93 24.03 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.443 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 9.3 t -74.62 73.24 1.98 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.444 0.64 . . . . 0.0 109.335 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -84.87 -19.48 32.3 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.988 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -96.81 -16.88 20.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.044 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -108.91 -101.26 2.68 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.918 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 4.0 p -100.2 -100.91 0.24 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.774 0.321 . . . . 0.0 110.618 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -173.32 107.06 0.24 Allowed Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.214 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.471 ' CD1' ' HG3' ' A' ' 354' ' ' PRO . 23.8 t80 -161.89 135.55 6.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.833 0.316 . . . . 0.0 110.648 177.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.42 HG11 ' OG1' ' A' ' 372' ' ' THR . 29.1 m -101.01 125.95 54.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.551 ' O ' HG12 ' A' ' 371' ' ' VAL . 23.6 p90 -146.94 -175.12 4.69 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.537 -177.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 34.2 t -77.2 -178.07 4.88 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -95.94 -32.71 12.48 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.837 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -105.57 -7.78 18.38 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.505 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.04 -170.58 3.68 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.451 0.643 . . . . 0.0 111.462 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.81 28.59 8.66 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.145 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -81.09 18.37 1.07 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 72.07 45.43 41.04 Favored Glycine 0 C--O 1.227 -0.282 0 C-N-CA 120.843 -0.694 . . . . 0.0 114.603 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 5.2 t80 59.71 94.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -133.96 -163.12 1.32 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.43 157.31 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -75.33 46.93 1.95 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.5 -0.381 . . . . 0.0 113.77 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.61 107.68 7.18 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 1.6 m -136.33 -67.6 0.51 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.643 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 98.8 mt -114.13 132.32 22.78 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.822 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.78 -164.22 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.674 2.249 . . . . 0.0 111.56 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -80.56 142.66 33.89 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.187 0.518 . . . . 0.0 111.406 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -123.29 97.05 0.56 Allowed Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.226 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 78.4 m -115.49 116.22 27.83 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -119.98 178.3 16.49 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.834 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -157.31 155.84 31.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.738 0.304 . . . . 0.0 110.491 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 17.1 p -81.85 156.44 24.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.471 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -71.55 163.57 27.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.803 0.335 . . . . 0.0 110.762 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.3 m -85.44 103.48 14.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.422 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -73.59 121.26 20.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.531 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.0 t -86.7 144.46 27.1 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.777 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 19.0 p -123.54 134.92 53.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.747 0.308 . . . . 0.0 110.735 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -122.9 169.11 11.47 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.224 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -139.17 164.58 29.42 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.948 0.404 . . . . 0.0 111.175 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 14.8 m -134.12 98.22 4.07 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 10.8 p -107.71 142.84 19.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.766 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.54 136.44 67.83 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.406 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.45 110.19 2.43 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.52 2.147 . . . . 0.0 111.093 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -77.92 126.14 30.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.084 0.469 . . . . 0.0 111.529 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -95.32 114.77 26.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.579 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -137.2 137.21 38.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.892 0.377 . . . . 0.0 111.086 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -126.92 145.02 50.83 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.343 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -96.45 -178.34 4.25 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.175 0.512 . . . . 0.0 111.674 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -141.39 137.92 32.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.805 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -158.14 133.45 8.76 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 32.9 m-90 -113.13 -25.06 9.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.449 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.2 171.46 19.16 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -95.26 -71.21 0.68 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 179.21 149.1 0.25 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.388 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 22.7 t -123.47 155.67 37.05 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -138.65 174.27 10.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.034 0.445 . . . . 0.0 111.569 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.25 -51.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.453 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.9 t -164.46 151.68 11.58 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.751 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 9.5 tp -103.59 136.64 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.005 0.431 . . . . 0.0 110.87 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -83.48 138.9 33.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.067 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.91 97.71 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.828 0.823 . . . . 0.0 110.951 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.7 p -100.63 4.43 43.3 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.359 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.5 p -95.56 154.35 17.25 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.665 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 434' ' ' LYS . 0.0 OUTLIER -117.15 140.45 27.15 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.24 124.59 4.88 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.969 1.779 . . . . 0.0 112.499 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 438' ' ' LYS . 41.2 t -64.3 134.93 96.13 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.075 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.16 -4.87 16.01 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.108 1.872 . . . . 0.0 111.492 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . 0.651 ' HB2' ' SG ' ' A' ' 436' ' ' CYS . 6.0 mmmm -100.68 -74.46 0.61 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.101 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 3.6 p -94.99 -7.67 39.13 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.163 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 52.2 mtt180 61.57 31.93 18.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.278 0.561 . . . . 0.0 111.479 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 20.7 p -84.96 154.2 60.71 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.102 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.75 93.66 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.32 2.013 . . . . 0.0 112.855 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 14.8 m -82.92 122.55 28.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.583 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.54 155.93 39.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.584 0.231 . . . . 0.0 110.877 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -116.32 157.79 24.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.025 0.44 . . . . 0.0 111.476 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -143.06 138.04 29.65 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -88.74 51.51 3.86 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.139 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -137.88 -56.09 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.102 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.4 p -83.36 -178.97 7.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.083 0.468 . . . . 0.0 110.483 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.473 ' HE1' ' N ' ' A' ' 482' ' ' GLY . 35.8 ttm -135.57 -14.89 1.9 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.295 0.569 . . . . 0.0 110.062 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -88.56 95.18 10.14 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 70.7 mmm -100.0 115.96 30.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.476 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.84 144.84 33.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.369 0.604 . . . . 0.0 110.939 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 42.5 t -84.41 108.87 17.46 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.774 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 15.3 p -91.64 88.64 6.81 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.624 0.726 . . . . 0.0 109.351 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -132.06 126.96 35.1 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -49.6 -31.88 11.59 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -109.29 25.04 19.24 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.178 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 31.8 t -133.56 -81.18 0.47 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.148 0.474 . . . . 0.0 111.215 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.13 65.63 3.0 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -124.27 121.61 35.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.889 0.376 . . . . 0.0 111.692 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.51 157.37 18.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.577 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -166.62 158.99 13.73 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.761 0.315 . . . . 0.0 111.291 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 52.2 t -71.89 134.78 46.25 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.851 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -69.37 -43.77 72.9 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.005 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 43.1 t -69.85 -63.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 5.6 p -105.74 143.86 33.29 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.359 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -75.22 113.91 13.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.638 0.732 . . . . 0.0 110.58 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.6 p -142.85 178.03 7.93 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.682 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.31 117.88 35.28 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 65.3 m95 63.76 -168.6 0.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.593 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 476' ' ' MET . 7.0 m -109.83 30.93 6.24 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.659 0.742 . . . . 0.0 109.3 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -85.57 -57.61 2.99 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -70.28 -24.73 63.1 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.372 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 93.8 m -89.0 -8.82 53.35 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.893 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 472' ' ' THR . 25.8 ttt -50.59 -57.85 7.21 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.754 0.659 . . . . 0.0 111.491 -176.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -109.73 12.9 32.52 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.371 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -88.31 -64.94 1.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.921 0.391 . . . . 0.0 110.585 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . 0.486 ' CG ' ' H ' ' A' ' 480' ' ' TRP . 6.6 p80 -137.74 -65.39 0.52 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.104 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . 0.486 ' H ' ' CG ' ' A' ' 479' ' ' HIS . 21.4 t-105 54.53 31.27 14.57 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.984 0.897 . . . . 0.0 110.114 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -142.05 151.18 42.15 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.351 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . 0.473 ' N ' ' HE1' ' A' ' 450' ' ' MET . . . . . . . . 0 N--CA 1.437 -1.273 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -100.03 150.35 22.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.906 0.384 . . . . 0.0 111.445 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -143.21 100.31 3.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.084 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.66 115.15 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.072 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.529 HD12 ' O ' ' A' ' 346' ' ' LEU . 0.6 OUTLIER -112.34 107.81 16.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.637 0.732 . . . . 0.0 111.323 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -151.36 129.33 11.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.063 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -171.48 -177.74 2.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.811 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -86.37 42.16 3.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.274 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -90.15 -173.17 44.95 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.12 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 0.518 HG13 ' H ' ' A' ' 352' ' ' LEU . 4.2 t -110.03 175.41 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.518 ' H ' HG13 ' A' ' 351' ' ' VAL . 5.8 mp -137.53 152.37 49.4 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.5 t -56.01 130.64 73.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.74 9.99 1.77 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.99 2.46 . . . . 0.0 113.312 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -98.56 145.56 30.1 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.638 0.256 . . . . 0.0 110.875 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.22 -26.3 30.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.833 2.355 . . . . 0.0 112.789 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.15 -28.34 64.46 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.962 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.409 ' HB3' ' H ' ' A' ' 359' ' ' GLY . 86.7 m -95.08 -151.9 0.34 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 120.929 0.395 . . . . 0.0 110.667 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 358' ' ' CYS . . . 118.96 19.48 4.37 Favored Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -65.9 -66.14 0.59 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 110.32 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 151.31 130.56 1.69 Allowed Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.164 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.06 109.94 17.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.432 0.634 . . . . 0.0 109.909 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -88.31 106.86 18.51 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.433 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 48.6 t -82.45 105.55 12.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.947 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.49 152.66 95.37 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.468 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.07 -20.53 70.05 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.002 1.801 . . . . 0.0 111.175 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.45 12.09 33.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.758 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 47.4 t -70.73 101.28 2.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.258 0.552 . . . . 0.0 110.243 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . 0.606 ' H ' ' HD3' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -91.3 0.61 57.49 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.772 -178.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -162.35 110.36 1.36 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.407 HG11 ' O ' ' A' ' 381' ' ' PHE . 2.7 p -101.09 124.96 55.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.226 0.536 . . . . 0.0 110.348 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.3 m -152.2 147.88 26.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.452 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 29.6 t -69.73 74.99 0.43 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-O 121.563 0.697 . . . . 0.0 109.154 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.52 -20.42 29.68 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.863 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -98.36 13.07 32.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.647 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -142.41 -104.8 0.53 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.158 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 378' ' ' GLY . 20.6 p -97.49 -102.45 0.19 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.233 0.539 . . . . 0.0 110.735 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . 0.453 ' N ' ' SG ' ' A' ' 377' ' ' CYS . . . -171.85 106.55 0.24 Allowed Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -160.21 117.88 2.56 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.95 132.76 38.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' A' ' 389' ' ' TYR . 30.0 p90 -140.66 176.26 8.94 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.153 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 46.9 t -88.66 165.65 14.63 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -88.55 -30.51 19.25 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.25 0.548 . . . . 0.0 110.127 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.492 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 0.9 OUTLIER -105.79 -11.05 16.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.196 178.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 394' ' ' CYS . 5.6 m -145.29 -179.13 6.44 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -174.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 8.0 tp -118.23 22.46 12.15 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.986 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -81.27 28.97 0.36 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 71.97 32.48 63.42 Favored Glycine 0 N--CA 1.465 0.576 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.596 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 381' ' ' PHE . 20.8 t80 57.95 73.5 0.47 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.334 0.588 . . . . 0.0 111.061 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.13 145.2 37.93 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.092 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 6.7 tp -77.2 131.01 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.798 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 104.95 -158.98 15.93 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.344 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -87.34 146.66 25.82 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.117 0.484 . . . . 0.0 111.162 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.757 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 3.7 m -79.48 -44.23 21.67 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.168 -177.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.57 131.72 82.04 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.452 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.21 175.32 10.96 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.989 2.46 . . . . 0.0 112.694 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -118.37 175.02 5.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.18 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -142.04 96.93 0.2 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.48 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 9.0 t -147.18 163.96 34.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 163.13 70.77 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.255 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -131.63 100.72 5.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 56.8 m -155.2 139.88 17.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.39 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -158.19 107.48 2.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.789 0.328 . . . . 0.0 110.766 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 50.7 m -87.19 131.44 34.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.695 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -113.3 152.75 29.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.274 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 35.5 t -119.84 154.83 33.73 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.269 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 71.1 m -84.8 124.72 31.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.963 0.411 . . . . 0.0 110.366 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -83.63 116.63 22.71 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -114.89 115.13 26.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.971 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 11.0 t -96.71 151.95 19.14 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.097 0.475 . . . . 0.0 110.987 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 33.0 m -81.39 170.55 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.517 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.16 121.92 86.33 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.408 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.16 -164.51 0.22 Allowed 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 123.155 2.57 . . . . 0.0 112.872 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 69.68 104.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.345 0.658 . . . . 0.0 110.58 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -151.71 151.06 30.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.038 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -86.39 93.02 9.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.964 0.411 . . . . 0.0 110.06 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -155.56 144.75 20.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.725 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -108.3 119.32 39.15 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.108 0.48 . . . . 0.0 110.972 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -142.9 174.13 10.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.357 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -93.6 102.38 14.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.984 0.421 . . . . 0.0 110.514 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 42.9 p-90 -161.28 156.0 23.4 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.932 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -148.55 160.17 43.35 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.028 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -102.17 -50.87 3.52 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.252 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 63.91 17.21 10.4 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.235 0.614 . . . . 0.0 112.435 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 38.6 m -104.3 132.05 50.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.555 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -151.22 95.64 2.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.331 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 31.9 m -100.14 158.91 3.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.008 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.7 m -104.97 83.92 2.06 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.132 0.491 . . . . 0.0 110.247 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 45.0 mm -129.51 113.87 29.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.132 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt 61.38 45.15 8.84 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.087 0.47 . . . . 0.0 110.768 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.08 110.68 8.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.37 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 23.6 m -86.28 -21.11 27.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.744 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.19 132.58 35.24 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.325 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -99.92 111.39 61.88 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.08 127.39 24.78 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.238 1.959 . . . . 0.0 111.94 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 44.5 t -50.96 138.12 25.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.07 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.61 -2.44 12.44 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.264 1.976 . . . . 0.0 111.476 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . 0.445 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 29.4 tptp -109.71 -61.16 1.68 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.413 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 11.8 p -102.69 -3.88 25.9 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 29.5 ttp180 65.19 21.19 12.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.66 0.784 . . . . 0.0 112.33 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.3 p -82.76 140.41 43.82 Favored Pre-proline 0 C--N 1.314 -0.963 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.082 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.4 101.97 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.467 2.111 . . . . 0.0 112.213 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 45.0 m -77.55 123.48 26.66 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.74 114.46 5.04 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.598 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -96.58 105.87 18.03 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.306 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.58 128.29 55.85 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.207 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 66.43 -116.24 8.16 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.371 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -155.81 42.99 0.56 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.945 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 47.7 t -71.67 123.77 23.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.784 0.326 . . . . 0.0 110.254 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.633 ' SD ' ' HA ' ' A' ' 480' ' ' TRP . 43.3 ttm -75.31 -20.43 59.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.781 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -86.02 96.4 9.83 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 21.5 mmt -97.34 113.44 25.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.081 0.467 . . . . 0.0 110.684 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.26 117.44 55.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.648 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 40.7 t -78.92 99.8 6.96 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.545 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 30.8 p -83.7 90.55 7.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.597 0.713 . . . . 0.0 109.35 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.572 ' HD2' ' N ' ' A' ' 457' ' ' ALA . 3.1 tmm_? -130.46 137.54 49.84 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.572 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -63.91 95.66 0.12 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.152 0.501 . . . . 0.0 110.602 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 106.39 24.14 6.93 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.383 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.501 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 29.7 t -131.02 -85.06 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.967 0.384 . . . . 0.0 110.51 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.58 35.42 91.91 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -84.92 124.68 31.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.907 0.384 . . . . 0.0 110.529 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.74 133.72 46.03 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.056 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -143.69 147.22 33.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.748 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 52.5 t -70.65 141.9 51.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.089 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 26.9 t-105 -68.31 -45.22 73.57 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.644 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 51.0 t -75.93 -59.47 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.078 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 7.4 p -101.89 99.06 9.22 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -74.14 110.94 8.83 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.448 0.642 . . . . 0.0 109.96 -175.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.77 175.45 13.71 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.544 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -74.71 139.32 43.37 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -52.7 109.9 0.46 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.074 0.464 . . . . 0.0 110.184 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 473' ' ' ARG . 13.9 p -146.8 -163.46 1.76 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.244 -176.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . 0.421 ' H ' ' HB ' ' A' ' 472' ' ' THR . 18.3 mtm180 -74.92 -21.73 59.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.395 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -46.66 -58.64 3.65 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.762 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 2.1 t -123.38 56.75 1.18 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.268 0.556 . . . . 0.0 109.903 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 60.2 ttp -70.12 -27.82 64.89 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -177.66 40.49 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.693 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -72.38 -64.31 0.97 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.093 0.473 . . . . 0.0 110.996 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -126.83 17.06 7.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.832 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . 0.633 ' HA ' ' SD ' ' A' ' 450' ' ' MET . 35.6 t-105 -62.73 -27.08 69.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.316 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -76.23 104.81 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.256 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.041 0 CA-C-O 118.855 -0.969 . . . . 0.0 111.838 179.924 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 120.729 0.3 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.05 146.55 47.58 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -80.88 83.73 6.55 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.3 0.571 . . . . 0.0 109.78 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.46 127.68 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.944 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.82 162.6 41.1 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -156.71 128.91 7.41 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.804 0.335 . . . . 0.0 110.651 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -84.52 159.02 20.79 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.702 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -90.42 155.24 24.03 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.955 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -159.62 -150.09 5.73 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.322 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 0.518 HG13 ' H ' ' A' ' 352' ' ' LEU . 15.6 t -124.08 176.92 4.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.518 ' H ' HG13 ' A' ' 351' ' ' VAL . 82.8 mt -118.78 151.01 38.83 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . 0.557 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 35.2 t -58.66 142.99 82.76 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.488 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.557 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 56.3 Cg_endo -70.32 -8.94 24.81 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.149 2.566 . . . . 0.0 112.442 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.412 HE21 ' HB2' ' A' ' 355' ' ' GLN . 5.1 mt-30 -94.24 130.7 33.25 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.67 -23.75 63.14 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.264 2.643 . . . . 0.0 113.087 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -83.21 5.87 74.72 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.882 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.682 ' SG ' ' HE1' ' A' ' 360' ' ' MET . 26.5 t -119.2 -99.43 0.44 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 58.63 22.05 51.71 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.273 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' MET . . . . . 0.682 ' HE1' ' SG ' ' A' ' 358' ' ' CYS . 40.8 mtm -70.75 -58.95 3.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.917 0.389 . . . . 0.0 111.117 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 156.45 125.66 0.9 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.25 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 373' ' ' CYS . 4.6 mm? -115.35 126.87 54.95 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.076 0.465 . . . . 0.0 110.051 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -84.46 104.41 14.44 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.555 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.09 104.39 16.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.274 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.25 148.24 91.02 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.939 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.93 -47.09 22.61 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 123.774 2.983 . . . . 0.0 114.146 -176.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.59 -7.8 49.14 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.884 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 51.6 t -76.94 128.41 34.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . 0.495 ' HA ' ' HD3' ' A' ' 383' ' ' ARG . 0.0 OUTLIER -114.08 19.18 16.66 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -116.53 140.77 49.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.334 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.88 130.93 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.544 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 27.4 m -153.67 131.46 11.6 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.158 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.455 ' HA ' HD13 ' A' ' 362' ' ' LEU . 4.3 t -80.29 74.66 7.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.327 0.584 . . . . 0.0 109.73 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -81.15 -6.8 59.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.647 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -95.11 -16.89 22.29 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.07 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -153.88 -117.26 0.64 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.082 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.2 p -90.13 104.13 16.73 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.097 0.559 . . . . 0.0 111.33 -178.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 373' ' ' CYS . . . -69.95 109.9 3.08 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.97 -176.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -127.78 144.33 51.09 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.96 99.84 8.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.186 0.517 . . . . 0.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -127.76 -179.0 4.71 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 7.6 t -86.83 -176.2 5.68 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.495 ' HD3' ' HA ' ' A' ' 369' ' ' ARG . 17.9 ptt180 -94.24 -36.0 12.2 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.469 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.423 HD22 ' CB ' ' A' ' 394' ' ' CYS . 21.7 p-10 -104.7 -28.16 11.37 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.214 0.531 . . . . 0.0 110.759 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.459 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 23.1 p -130.73 -174.24 3.31 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.698 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 354' ' ' PRO . 10.5 mp -113.27 33.63 4.98 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.479 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . 0.459 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 12.8 mm100 -81.17 19.17 0.95 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.979 0.418 . . . . 0.0 112.029 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 71.36 31.46 65.92 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 114.35 0.5 . . . . 0.0 114.35 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 30.9 t80 67.66 110.39 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.045 0.538 . . . . 0.0 111.425 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.415 ' CD2' ' HB2' ' A' ' 387' ' ' GLN . 1.8 p80 -146.65 -53.45 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 16.7 tt -148.74 156.5 8.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.44 -47.73 48.93 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.64 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.51 110.16 21.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.142 0.496 . . . . 0.0 111.394 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.423 ' CB ' HD22 ' A' ' 384' ' ' ASN . 4.7 m -105.02 136.52 44.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.309 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 10.2 mp -118.7 133.58 23.59 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.141 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.66 173.22 14.83 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.697 2.264 . . . . 0.0 111.196 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -136.86 173.66 11.46 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.498 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 147.67 52.91 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.072 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 27.3 p -125.39 129.92 50.86 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -158.39 155.3 26.34 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.483 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -139.34 174.74 10.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.624 0.25 . . . . 0.0 110.359 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.8 m -144.88 155.96 43.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.49 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -139.83 146.14 39.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.634 0.254 . . . . 0.0 110.686 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 11.4 t -135.97 157.62 46.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.443 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -136.13 134.0 37.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.651 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.3 p -146.2 128.0 15.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.955 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 49.5 m -143.85 145.96 32.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.477 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -151.93 133.63 14.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.721 0.296 . . . . 0.0 110.963 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -143.96 133.77 23.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 12.0 p -122.63 139.39 53.98 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.653 0.263 . . . . 0.0 110.761 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.99 160.26 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.131 0.491 . . . . 0.0 111.494 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.64 149.24 39.62 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.478 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.6 -162.08 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.72 2.28 . . . . 0.0 111.419 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -145.17 158.04 43.93 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -146.4 120.69 9.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.846 0.355 . . . . 0.0 110.616 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -136.17 160.16 39.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.837 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -146.4 163.96 33.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.22 144.91 43.05 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -153.91 115.35 4.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.97 0.414 . . . . 0.0 111.946 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -133.16 161.04 35.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -152.93 167.76 28.05 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.878 0.37 . . . . 0.0 110.919 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -93.68 141.62 28.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -75.9 -70.22 0.45 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -168.75 -168.02 0.83 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 111.73 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 5.2 p -149.14 175.72 11.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.609 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -155.46 147.94 23.97 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.65 0.262 . . . . 0.0 111.158 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 9.2 p -159.4 144.52 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.456 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 10.1 t -149.28 147.21 28.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.671 0.272 . . . . 0.0 110.421 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.5 pp -136.24 175.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.106 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -118.55 -177.49 3.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.013 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.0 p -141.32 124.81 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.016 0.436 . . . . 0.0 111.203 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 50.2 m -124.9 2.52 8.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.067 0.461 . . . . 0.0 110.956 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.1 p -80.24 143.63 33.56 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.135 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 434' ' ' LYS . 11.5 mmpt? -105.68 131.73 21.5 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.9 126.87 13.71 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.274 1.983 . . . . 0.0 112.449 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 437' ' ' PRO . 36.0 t -63.13 136.61 96.77 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.501 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 12.4 Cg_exo -69.82 -17.0 37.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.479 2.119 . . . . 0.0 111.614 177.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 438' ' ' LYS . 0.5 OUTLIER -96.93 -60.37 1.6 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.3 p -107.67 -3.36 19.28 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 440' ' ' ARG . 15.5 tpp85 68.1 21.13 8.8 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.153 0.501 . . . . 0.0 111.892 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 17.9 p -77.49 152.28 80.97 Favored Pre-proline 0 C--N 1.308 -1.202 0 O-C-N 122.175 -0.328 . . . . 0.0 111.157 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.58 92.57 0.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.28 1.987 . . . . 0.0 111.05 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 25.1 m -93.3 114.01 26.35 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.127 0.489 . . . . 0.0 111.339 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -102.74 121.07 41.7 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -82.71 100.69 10.39 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.225 0.536 . . . . 0.0 111.373 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -89.88 107.23 18.99 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 123.21 129.55 3.51 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -67.84 96.21 0.36 Allowed Glycine 0 C--N 1.322 -0.211 0 C-N-CA 121.465 -0.398 . . . . 0.0 113.142 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 79.9 m -153.08 144.31 23.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 122.591 0.356 . . . . 0.0 110.168 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.723 ' SD ' HG22 ' A' ' 466' ' ' VAL . 46.5 tpp -84.89 -31.29 23.79 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -85.6 96.95 9.82 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -120.26 129.66 54.14 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.766 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 5.7 m -124.18 152.5 29.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.711 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.7 t -83.87 115.51 22.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 7.7 t -98.36 91.67 5.32 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 122.2 1.0 . . . . 0.0 109.942 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -129.81 132.06 46.38 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.47 98.37 0.09 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.898 0.38 . . . . 0.0 110.514 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 117.55 -4.13 17.54 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.945 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 47.7 t -108.67 -86.58 0.51 Allowed 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.713 0.292 . . . . 0.0 110.797 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 62.48 56.28 22.52 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -105.28 129.04 53.72 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.937 0.398 . . . . 0.0 111.045 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 471' ' ' TRP . 13.5 mp0 -95.85 140.02 31.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.871 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -161.62 167.25 25.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.476 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 3.9 m -86.71 148.8 25.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.047 0.451 . . . . 0.0 110.831 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -68.63 -50.49 50.96 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.612 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . 0.723 HG22 ' SD ' ' A' ' 450' ' ' MET . 94.7 t -70.72 -64.33 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 21.7 p -90.15 133.19 35.04 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.526 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -77.57 110.0 12.01 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 119.539 -0.864 . . . . 0.0 108.806 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.1 p -153.9 178.12 10.27 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.045 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -101.79 149.91 23.69 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . 0.41 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 44.3 t90 -62.43 98.17 0.11 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 474' ' ' ASP . 11.7 t -141.99 -168.73 2.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 120.927 0.394 . . . . 0.0 111.419 -175.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -69.54 -22.09 63.59 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.541 0.736 . . . . 0.0 112.755 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . 0.462 ' H ' HG22 ' A' ' 472' ' ' THR . 26.3 t70 -67.69 -58.54 4.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.906 0.384 . . . . 0.0 111.245 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 84.2 m -91.48 15.85 11.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.653 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 24.3 ptm -51.43 -32.26 26.07 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -150.6 33.51 0.98 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -88.64 -64.78 1.09 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -142.16 67.75 1.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -85.73 -7.83 58.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.548 0.689 . . . . 0.0 109.306 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -144.4 134.62 24.27 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.507 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.363 0 CA-C-O 118.772 -1.015 . . . . 0.0 110.999 -178.411 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 120.719 0.295 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -88.27 -18.2 29.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.084 0.469 . . . . 0.0 110.405 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -80.5 100.97 8.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.766 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 6.7 p -90.02 132.38 34.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.186 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.46 137.49 42.23 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.64 -173.9 4.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.925 0.393 . . . . 0.0 110.518 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -85.46 176.52 8.2 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.114 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -69.39 96.88 0.51 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.548 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -54.03 130.92 44.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.795 -0.241 . . . . 0.0 113.627 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 0.439 ' H ' ' HB ' ' A' ' 364' ' ' VAL . 9.4 p -75.61 168.21 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.456 ' HB3' ' HA2' ' A' ' 361' ' ' GLY . 1.0 OUTLIER -141.11 155.41 46.12 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 13.9 t -51.65 130.72 36.44 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.142 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.16 3.36 4.66 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.217 2.611 . . . . 0.0 112.934 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -101.39 122.82 46.74 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.08 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.96 -26.68 83.57 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.055 2.503 . . . . 0.0 113.191 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.24 -13.8 67.9 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.948 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.419 ' SG ' ' HE2' ' A' ' 360' ' ' MET . 42.0 t -92.62 -85.75 0.26 Allowed 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.628 0.252 . . . . 0.0 110.581 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.34 23.5 64.52 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.704 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' MET . . . . . 0.419 ' HE2' ' SG ' ' A' ' 358' ' ' CYS . 36.3 mtm -76.01 -48.51 20.73 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.562 -0.376 . . . . 0.0 111.302 -177.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 352' ' ' LEU . . . 109.46 129.51 5.81 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.832 -177.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.66 176.97 4.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.892 0.377 . . . . 0.0 110.751 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 364' ' ' VAL . 1.7 tt -101.8 148.8 24.86 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . 0.5 ' H ' HD23 ' A' ' 363' ' ' LEU . 4.7 p -130.95 8.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -57.58 151.18 41.74 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.917 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.86 -22.72 38.89 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.967 2.444 . . . . 0.0 112.475 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.58 -7.26 54.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.471 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.68 99.65 1.04 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -64.15 -42.41 96.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.753 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -156.32 125.3 6.02 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.485 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.8 p -90.32 124.31 42.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.21 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.6 m -150.47 141.99 23.47 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.235 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 16.1 t -74.73 70.96 1.92 Allowed 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.374 0.606 . . . . 0.0 109.891 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -84.71 -6.48 59.36 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.856 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -100.02 -4.8 29.22 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.828 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -153.5 -65.84 0.01 OUTLIER Glycine 0 C--O 1.234 0.154 0 C-N-CA 119.37 -1.395 . . . . 0.0 113.603 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 4.7 m -100.3 -131.39 0.24 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.202 0.525 . . . . 0.0 109.67 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -170.3 104.75 0.21 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -162.13 130.49 4.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 32.9 t -97.8 120.65 47.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -136.3 -175.54 4.03 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.234 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 42.4 t -85.64 168.29 14.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -97.98 -14.31 20.65 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.748 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.565 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 84.1 m-20 -103.33 -32.42 9.57 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.6 p -134.23 -171.12 2.67 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.873 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.57 28.03 8.7 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.857 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -85.56 11.08 11.4 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.86 29.47 15.58 Favored Glycine 0 C--N 1.319 -0.404 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.838 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 48.4 t80 72.86 135.1 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.518 0.727 . . . . 0.0 112.573 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -165.26 171.54 13.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.593 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.95 146.65 9.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 96.53 -162.48 22.45 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.698 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.64 173.52 7.57 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.959 0.409 . . . . 0.0 110.971 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.2 m -113.43 140.93 47.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.926 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 6.6 mp -131.37 127.92 21.85 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.85 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -60.07 151.93 69.0 Favored 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 123.014 2.476 . . . . 0.0 112.272 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -87.28 149.03 24.83 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.224 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -111.99 175.84 17.56 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.811 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 1.7 p -137.44 169.58 17.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.654 0.264 . . . . 0.0 111.541 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -171.19 -175.63 39.8 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.104 -0.569 . . . . 0.0 111.797 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -150.0 141.94 23.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.677 0.275 . . . . 0.0 110.537 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 48.0 t -140.7 124.15 16.85 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.456 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -136.32 90.9 2.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.961 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 19.7 p -126.12 124.68 41.09 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.582 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -124.52 -79.64 0.61 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.655 0.264 . . . . 0.0 111.172 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 9.4 p -162.14 170.0 19.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.581 0.229 . . . . 0.0 110.988 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 5.9 p -134.45 -65.49 0.64 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.528 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -83.95 143.44 29.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.089 0.471 . . . . 0.0 111.847 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 0.555 ' O ' HG21 ' A' ' 410' ' ' THR . 90.7 t80 -117.91 -27.73 6.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.394 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.555 HG21 ' O ' ' A' ' 409' ' ' TYR . 0.7 OUTLIER 62.14 169.55 0.12 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.622 1.169 . . . . 0.0 112.672 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 22.6 m -130.75 171.51 17.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.014 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -105.88 154.26 39.53 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.804 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.49 159.94 49.93 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.167 2.578 . . . . 0.0 112.846 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -110.02 179.32 4.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.359 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -144.41 157.11 44.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.726 0.298 . . . . 0.0 110.998 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -136.18 83.99 2.05 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.041 0.448 . . . . 0.0 110.531 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -160.88 144.45 13.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.13 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -144.17 167.55 22.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -79.06 157.53 28.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.287 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 69.77 104.17 0.06 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.659 0.783 . . . . 0.0 112.709 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -116.04 -19.24 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.818 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -137.87 154.22 49.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.1 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.05 -25.1 17.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 53.08 73.32 0.37 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.263 0.554 . . . . 0.0 111.745 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 54.4 m -149.99 103.44 3.2 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.382 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -88.39 124.19 33.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.816 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 27.6 m -74.96 132.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.311 0.577 . . . . 0.0 112.274 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 31.4 m -147.88 122.24 9.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.516 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 12.2 tt -113.79 136.29 50.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 0.0 111.383 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -105.5 131.81 52.44 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.405 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 9.2 p -67.85 125.79 26.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.34 0.59 . . . . 0.0 110.608 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 9.9 m -120.58 0.6 10.49 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.468 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 16.7 p -120.68 148.42 43.96 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.273 0.559 . . . . 0.0 112.106 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -112.64 131.89 22.48 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.36 118.9 5.95 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.083 1.855 . . . . 0.0 112.256 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 43.4 t -56.45 133.81 76.76 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.375 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.506 ' HG2' ' CE1' ' A' ' 461' ' ' PHE . 57.4 Cg_endo -72.24 -9.18 24.02 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.247 1.964 . . . . 0.0 111.445 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . 0.486 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 29.3 tptp -98.67 -70.92 0.71 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.147 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.8 p -92.62 -12.53 31.42 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 17.0 tpp180 69.17 29.54 4.63 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.554 0.742 . . . . 0.0 111.528 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 41.4 p -89.35 158.58 45.98 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.978 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -80.85 100.22 1.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.218 1.945 . . . . 0.0 112.367 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 11.4 m -84.59 118.53 24.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.855 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -64.51 121.06 13.52 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -93.51 146.67 23.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.569 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -125.49 120.04 29.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.536 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -67.11 124.18 22.54 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.932 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.9 -48.24 0.98 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.318 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 24.9 p -75.18 136.94 41.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.719 0.295 . . . . 0.0 110.591 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 59.8 mtt -97.66 -17.68 19.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.012 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -121.85 96.16 4.95 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.064 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 14.1 ptp -109.08 133.17 53.35 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.429 ' CB ' ' HB3' ' A' ' 462' ' ' GLU . 1.2 m -111.75 150.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.353 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.5 t -86.29 100.42 12.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.0 t -83.39 89.01 6.97 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.321 1.058 . . . . 0.0 109.276 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.515 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -131.22 114.26 14.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.598 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.414 ' HB3' HH21 ' A' ' 456' ' ' ARG . . . -56.52 107.37 0.37 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.33 13.17 19.93 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.123 -0.561 . . . . 0.0 111.843 -177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.515 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 43.8 t -123.64 -73.71 0.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 61.21 57.23 19.42 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . 0.506 ' CE1' ' HG2' ' A' ' 437' ' ' PRO . 50.0 t80 -136.45 129.39 31.05 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.908 0.385 . . . . 0.0 111.277 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 453' ' ' VAL . 0.0 OUTLIER -120.13 155.85 32.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 174.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -140.56 174.78 10.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 48.2 t -76.73 133.91 39.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.36 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -70.13 -56.73 6.11 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.4 -62.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.492 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 13.9 p -103.74 126.37 50.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -73.41 112.03 9.09 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 122.038 0.923 . . . . 0.0 109.549 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.0 p -150.1 177.74 9.61 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.321 -175.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -92.89 156.66 16.81 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -51.05 107.75 0.2 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.334 0.588 . . . . 0.0 110.472 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' THR . . . . . 0.436 HG21 ' H ' ' A' ' 474' ' ' ASP . 9.0 m -134.3 142.11 47.17 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.39 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . 0.484 ' O ' ' HD2' ' A' ' 473' ' ' ARG . 2.4 tmm_? -62.4 -21.32 65.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.406 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . 0.436 ' H ' HG21 ' A' ' 472' ' ' THR . 33.5 t70 -59.84 -58.79 7.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.762 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 480' ' ' TRP . 97.3 m -63.48 -26.46 68.73 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.594 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' MET . . . . . 0.465 ' HB3' ' O ' ' A' ' 473' ' ' ARG . 19.2 ttt -41.76 -46.53 3.87 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.08 0.863 . . . . 0.0 112.997 -177.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -136.89 17.63 3.63 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.19 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -86.81 -56.78 3.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.926 0.363 . . . . 0.0 111.167 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -132.56 10.01 4.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.603 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . 0.448 ' HB2' ' O ' ' A' ' 475' ' ' CYS . 61.1 t-105 -75.05 -41.31 59.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.954 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -73.88 100.79 3.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.119 0.485 . . . . 0.0 111.351 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.059 0 CA-C-O 118.934 -0.926 . . . . 0.0 111.533 179.256 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.987 0.423 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.62 173.9 13.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.285 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -144.08 54.49 1.29 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.294 0.569 . . . . 0.0 110.015 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.7 t -79.95 121.6 33.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.371 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 346' ' ' LEU . 3.6 pp -133.74 133.14 41.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.335 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -158.13 145.1 17.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.761 0.315 . . . . 0.0 110.374 -178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -105.97 110.28 22.5 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -80.23 124.17 6.37 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.926 -0.655 . . . . 0.0 112.167 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -101.76 -168.48 27.43 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 89.2 t -130.13 154.73 40.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 68.7 mt -114.92 148.05 39.18 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 38.6 t -60.75 128.86 89.32 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.02 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.512 ' HG2' ' CD2' ' A' ' 379' ' ' TYR . 43.1 Cg_endo -68.74 1.41 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.927 2.418 . . . . 0.0 112.705 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.44 ' HG3' ' SG ' ' A' ' 377' ' ' CYS . 14.7 mm-40 -73.84 120.63 82.25 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.98 105.66 0.25 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.634 2.223 . . . . 0.0 112.106 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 109.85 -2.99 30.32 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.724 -0.751 . . . . 0.0 113.024 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 52.2 t -81.24 -82.58 0.12 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.921 0.36 . . . . 0.0 110.258 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 57.31 25.36 54.42 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.567 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' MET . . . . . 0.404 ' HE2' ' HB3' ' A' ' 360' ' ' MET . 14.8 tmm? -59.17 -48.93 79.8 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.7 0.286 . . . . 0.0 111.18 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 122.62 108.96 1.98 Allowed Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.621 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.15 139.46 46.51 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.349 0.595 . . . . 0.0 111.049 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 64.3 tp -92.76 134.67 34.82 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.8 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 364' ' ' VAL . 12.4 p -127.84 100.49 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 122.032 0.92 . . . . 0.0 111.497 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -97.42 143.55 26.37 Favored Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.315 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.29 -31.41 76.58 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.39 2.06 . . . . 0.0 111.87 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -85.22 -16.51 40.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.038 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.8 t -93.05 101.27 13.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.092 0.472 . . . . 0.0 109.853 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . 0.551 ' NH2' ' HA3' ' A' ' 392' ' ' GLY . 17.7 ttt180 -92.31 -11.85 34.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.324 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -96.48 134.63 39.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.115 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.6 126.37 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.072 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 52.6 m -152.91 136.37 15.91 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.29 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.47 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 4.1 t -77.01 64.14 2.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.64 -6.38 40.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.893 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -116.3 9.32 14.47 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.363 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -150.84 -95.78 0.13 Allowed Glycine 0 C--O 1.238 0.351 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.601 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.47 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 6.6 p -135.88 111.89 9.6 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 122.717 0.407 . . . . 0.0 110.23 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.2 108.37 2.43 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.001 -174.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.512 ' CD2' ' HG2' ' A' ' 354' ' ' PRO . 89.8 t80 -120.16 151.33 39.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.443 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 11.0 m -89.03 114.63 27.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.312 0.577 . . . . 0.0 111.957 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -153.17 167.23 29.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.047 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 47.8 t -90.16 172.57 8.71 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -88.42 -23.68 23.25 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.336 0.588 . . . . 0.0 109.758 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.447 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 44.6 t30 -104.36 -37.57 7.17 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.889 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 12.5 p -129.44 -170.61 2.32 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.144 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.69 35.75 4.45 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.303 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . 0.485 ' HA ' ' OE1' ' A' ' 387' ' ' GLN . 12.7 mm-40 -79.91 13.41 2.21 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 80.66 23.76 59.59 Favored Glycine 0 N--CA 1.463 0.444 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.505 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 33.0 t80 68.23 117.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.603 0.761 . . . . 0.0 110.688 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -146.54 -162.49 1.54 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.991 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.458 ' H ' HD12 ' A' ' 391' ' ' ILE . 0.2 OUTLIER -65.84 166.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.551 ' HA3' ' NH2' ' A' ' 369' ' ' ARG . . . -76.54 47.73 2.46 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 121.012 -0.613 . . . . 0.0 114.066 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -141.42 96.66 3.02 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.201 0.524 . . . . 0.0 111.042 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 3.7 m -93.01 152.46 19.3 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.254 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 84.0 mt -109.08 110.23 60.72 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.74 -176.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.52 177.14 8.36 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.471 2.114 . . . . 0.0 110.564 175.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.42 114.37 17.43 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.033 0.444 . . . . 0.0 111.744 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -177.25 81.68 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.904 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 10.1 t -168.51 133.27 1.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.942 0.401 . . . . 0.0 110.811 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 157.12 99.34 0.16 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.439 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -136.41 109.03 7.45 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.674 0.273 . . . . 0.0 110.81 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 33.9 t -160.65 112.69 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.17 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -146.17 97.28 2.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 9.5 t -169.85 141.69 2.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.305 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -131.56 -50.24 0.99 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.012 0.434 . . . . 0.0 110.804 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.6 p -107.02 170.23 8.07 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.125 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 6.2 p -151.37 -64.83 0.18 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.804 0.335 . . . . 0.0 111.38 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -133.81 131.83 39.73 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.58 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -79.48 133.93 36.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 11.6 t -113.56 154.08 27.72 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.782 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 46.8 t 74.59 92.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.151 0.58 . . . . 0.0 111.293 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -98.38 148.53 34.65 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.908 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.77 150.55 87.78 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.58 2.187 . . . . 0.0 112.367 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -141.61 137.53 31.94 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.835 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -75.87 133.04 40.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.79 0.329 . . . . 0.0 110.691 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -116.37 132.31 56.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -95.69 165.28 12.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.905 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -144.62 173.38 11.87 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.466 0.174 . . . . 0.0 110.779 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -136.33 118.06 15.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.78 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -83.48 143.36 30.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.334 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -120.76 -175.83 3.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.935 0.398 . . . . 0.0 110.942 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -119.69 129.24 54.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.047 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -83.85 -43.44 15.35 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.855 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 55.75 35.37 25.2 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.002 0.429 . . . . 0.0 111.125 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 23.3 p -68.85 161.19 29.14 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.531 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -87.65 172.74 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.36 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.92 115.54 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.906 0.384 . . . . 0.0 111.133 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.3 t -83.36 137.65 33.86 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.23 174.44 3.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.55 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -115.89 179.68 3.91 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.677 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 8.1 p -156.48 132.22 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.93 0.395 . . . . 0.0 110.645 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.3 t -120.63 -10.24 9.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.916 0.389 . . . . 0.0 110.472 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 3.0 p -85.91 132.82 34.01 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.519 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 434' ' ' LYS . 0.3 OUTLIER -97.9 148.27 34.24 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.33 134.5 19.12 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.324 2.016 . . . . 0.0 113.156 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.572 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 15.5 t -67.44 141.64 95.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.945 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 3.6 Cg_exo -75.77 -13.99 19.68 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.296 1.997 . . . . 0.0 111.976 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -96.76 -64.0 1.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.056 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 1.5 p -109.87 3.45 20.66 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 15.9 ttm180 60.92 25.15 15.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.361 0.665 . . . . 0.0 112.403 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.455 ' H ' ' HB3' ' A' ' 436' ' ' CYS . 2.9 p -82.74 142.34 45.41 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.361 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -63.47 105.97 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.377 2.051 . . . . 0.0 112.225 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 17.7 m -78.25 125.73 29.77 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.049 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -92.24 131.25 37.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.569 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -85.2 94.95 9.02 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -109.99 123.86 50.39 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.17 -80.22 0.96 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.933 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.66 13.46 5.63 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.012 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.7 m -81.87 38.29 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.353 . . . . 0.0 110.813 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 479' ' ' HIS . 2.1 mpt? 64.11 16.92 10.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.377 0.671 . . . . 0.0 111.499 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -88.6 96.36 10.61 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 6.7 mmt -113.69 82.13 1.63 Allowed 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.43 171.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 2.2 m -126.8 142.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.05 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 52.6 t -96.04 108.15 20.53 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.92 0.39 . . . . 0.0 111.592 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 18.7 p -89.11 90.34 8.34 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.429 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 4.6 tmt_? -130.2 145.17 51.7 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.724 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.7 94.64 0.31 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 0.0 110.483 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 109.38 24.5 5.89 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.671 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.429 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 50.0 t -126.27 -95.4 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.735 0.303 . . . . 0.0 110.632 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 70.74 46.84 43.8 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.626 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -112.1 130.36 55.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 111.488 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -100.39 137.78 38.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.999 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -139.72 155.6 47.25 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 79.1 m -66.27 130.71 44.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -75.08 -46.44 34.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.268 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.61 -65.12 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.993 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 10.1 p -95.43 133.98 38.78 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -79.47 109.81 14.19 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.836 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.9 t -156.82 158.1 36.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.858 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -87.0 113.73 23.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.223 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 25.14 81.77 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.963 1.305 . . . . 0.0 113.158 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 14.8 m -117.21 110.13 17.76 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.949 0.404 . . . . 0.0 110.841 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -71.63 -22.46 61.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.49 -49.66 74.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.568 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . 0.401 ' HB2' ' CD2' ' A' ' 479' ' ' HIS . 2.5 p -91.79 -15.24 28.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.387 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' MET . . . . . 0.411 ' O ' ' HB3' ' A' ' 480' ' ' TRP . 25.0 ttt -54.75 -45.55 74.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.555 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -71.98 0.86 35.47 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.534 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.91 -60.08 1.84 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 117.164 0.482 . . . . 0.0 112.072 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . 0.52 ' O ' ' HG2' ' A' ' 450' ' ' MET . 17.6 p80 -94.89 -25.61 16.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . 0.411 ' HB3' ' O ' ' A' ' 476' ' ' MET . 31.3 t-105 -65.58 -41.91 92.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.938 0.399 . . . . 0.0 110.948 -176.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.47 95.65 8.56 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.235 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.883 0 CA-C-O 118.854 -0.97 . . . . 0.0 111.831 -178.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 120.899 0.381 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -91.68 92.16 8.32 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.091 0.472 . . . . 0.0 111.495 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -161.23 101.86 1.24 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.618 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.61 138.33 52.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.965 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -138.35 147.9 43.97 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -162.18 136.64 6.77 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.944 0.402 . . . . 0.0 110.689 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -99.98 -78.88 0.5 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 62.16 40.41 98.93 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.701 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -128.85 -148.85 6.76 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.223 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 0.442 HG21 ' H ' ' A' ' 352' ' ' LEU . 10.4 p -102.63 170.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.447 ' O ' HD13 ' A' ' 386' ' ' LEU . 5.4 mp -139.63 153.27 47.29 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 122.202 -0.311 . . . . 0.0 110.371 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 355' ' ' GLN . 52.5 t -57.48 135.67 81.96 Favored Pre-proline 0 N--CA 1.452 -0.372 0 O-C-N 123.502 0.501 . . . . 0.0 110.058 177.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.29 0.09 8.96 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.649 2.233 . . . . 0.0 112.083 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.497 ' HB3' ' SG ' ' A' ' 353' ' ' CYS . 7.6 tp-100 -86.41 122.64 72.0 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.016 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.56 -20.9 70.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.639 2.226 . . . . 0.0 112.169 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -76.89 -17.33 79.94 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.587 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 66.2 m -100.82 -176.54 3.21 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.062 0.458 . . . . 0.0 110.862 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 156.42 37.8 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' MET . . . . . 0.416 ' HE2' ' SG ' ' A' ' 373' ' ' CYS . 2.1 mpp? -82.76 -36.11 25.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 0.0 110.407 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.17 121.35 4.79 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.413 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.24 111.65 24.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.451 0.643 . . . . 0.0 110.081 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -83.6 109.17 17.21 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.076 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . 0.42 HG23 ' HB2' ' A' ' 383' ' ' ARG . 2.7 p -85.63 110.5 19.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.48 0.657 . . . . 0.0 111.658 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -97.58 150.85 37.22 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.298 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.64 -22.94 63.13 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.313 2.009 . . . . 0.0 110.995 175.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.52 -35.93 75.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.487 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.7 t -78.39 120.73 23.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.84 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -111.76 -8.85 14.13 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.251 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 108.38 11.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.548 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 381' ' ' PHE . 2.5 t -89.88 120.33 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 CA-C-N 116.366 -0.379 . . . . 0.0 109.98 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 86.2 m -152.24 139.61 19.49 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.52 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.416 ' SG ' ' HE2' ' A' ' 360' ' ' MET . 47.8 t -72.54 74.45 1.06 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.372 0.606 . . . . 0.0 110.292 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -85.13 -6.59 59.29 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.278 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -106.66 -11.37 15.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.176 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -117.45 -77.47 0.61 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.407 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 10.8 p -125.19 -102.12 0.37 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.038 0.447 . . . . 0.0 110.925 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -172.47 106.36 0.23 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -160.53 129.63 4.89 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 58.1 t -95.22 110.52 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.436 ' O ' ' HB ' ' A' ' 371' ' ' VAL . 34.3 p90 -127.32 -177.24 3.99 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.141 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 10.9 t -82.2 177.24 8.9 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.214 0.53 . . . . 0.0 110.782 -176.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.42 ' HB2' HG23 ' A' ' 364' ' ' VAL . 38.6 ptt180 -96.34 -27.81 14.78 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.889 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.437 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 6.7 t30 -104.43 -30.85 9.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.987 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.547 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 6.6 p -133.81 -172.96 3.11 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.255 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 352' ' ' LEU . 3.0 mm? -112.67 29.69 7.74 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.121 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . 0.547 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 9.3 mm100 -79.66 15.85 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 77.79 25.16 63.09 Favored Glycine 0 C--O 1.229 -0.209 0 C-N-CA 120.514 -0.851 . . . . 0.0 113.538 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 37.7 t80 72.1 134.52 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.397 0.679 . . . . 0.0 112.252 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -156.59 175.0 14.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.111 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 8.7 tp -93.13 144.95 8.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 102.13 -158.06 18.34 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.907 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -120.95 164.55 16.54 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 1.4 m -119.65 151.42 38.73 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.883 0.373 . . . . 0.0 111.631 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -136.24 148.47 64.53 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.21 155.51 50.9 Favored 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.599 2.199 . . . . 0.0 111.923 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.17 143.31 15.25 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.022 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 171.35 138.96 2.65 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.773 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 30.9 m -152.4 108.77 3.42 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -110.06 88.61 0.52 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.921 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -153.48 -175.41 5.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 19.5 t 63.65 91.47 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.982 0.513 . . . . 0.0 111.603 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -161.44 102.89 1.22 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 5.2 t -153.21 146.26 24.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -134.75 133.62 40.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.326 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 19.9 p -123.39 135.37 54.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.754 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 50.8 t -172.97 136.34 0.66 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.193 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -148.71 140.55 23.73 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -133.62 140.45 47.11 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 50.5 m -152.64 137.28 16.9 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.862 0.363 . . . . 0.0 111.371 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.78 155.38 41.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.576 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -109.12 132.5 21.18 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.212 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.41 -169.04 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.688 2.259 . . . . 0.0 110.879 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -151.55 158.78 44.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.99 0.424 . . . . 0.0 110.781 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -130.03 158.42 39.65 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -128.34 135.72 49.96 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.134 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -145.7 131.03 18.57 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.675 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.35 159.19 42.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.802 0.334 . . . . 0.0 111.181 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -160.33 96.4 1.18 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.528 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -76.22 124.6 27.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.088 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 49.4 p-90 -113.37 136.82 52.35 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.503 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -128.74 138.66 52.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.099 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.4 13.11 30.76 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -86.75 79.8 8.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.393 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.0 p 175.74 92.78 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.375 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -133.35 88.86 2.53 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.962 0.41 . . . . 0.0 110.53 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 56.2 t -117.34 119.57 62.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.996 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.4 t -97.56 159.15 15.1 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.868 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 32.9 pt -99.65 -179.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 120.691 0.281 . . . . 0.0 110.893 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -79.39 155.94 28.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.128 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 31.4 t -80.82 89.11 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.293 0.568 . . . . 0.0 111.173 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 13.4 p -112.87 4.61 16.99 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.982 0.896 . . . . 0.0 108.735 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.6 p -95.09 142.68 27.27 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.002 -177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.31 136.17 25.94 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.907 177.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.31 128.59 10.57 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.172 1.915 . . . . 0.0 112.238 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 35.6 t -57.98 142.08 80.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.08 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 4.8 Cg_exo -76.4 -6.2 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.441 2.094 . . . . 0.0 111.536 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -108.97 -65.25 1.16 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.395 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.4 p -99.62 -4.75 30.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.787 0.327 . . . . 0.0 111.772 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 0.0 OUTLIER 63.09 23.41 13.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.229 178.282 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 25.4 p -80.03 155.07 75.23 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-O 120.614 0.245 . . . . 0.0 111.062 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.8 107.48 2.48 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.659 2.239 . . . . 0.0 113.529 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 41.7 m -107.1 126.06 51.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.85 144.2 55.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.79 0.328 . . . . 0.0 110.419 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -99.79 169.76 9.02 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.435 0.636 . . . . 0.0 112.326 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.45 162.47 13.44 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.819 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -66.63 -57.4 10.08 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -144.2 42.8 1.02 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.234 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 46.7 t -109.84 135.99 49.86 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -78.89 -10.28 59.76 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -77.38 99.78 5.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.978 0.418 . . . . 0.0 110.919 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' MET . . . . . 0.499 ' CG ' ' HE3' ' A' ' 465' ' ' TRP . 27.4 mmt -120.86 95.45 4.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.435 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.461 ' CG1' ' HG3' ' A' ' 462' ' ' GLU . 3.6 m -128.99 144.6 37.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.021 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 7.5 t -73.7 135.25 43.66 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.138 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.9 t -113.34 87.72 2.67 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 122.254 1.026 . . . . 0.0 109.96 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -132.4 130.44 40.63 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.31 92.57 0.09 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.984 0.421 . . . . 0.0 110.726 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 128.69 -18.91 5.63 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.45 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 45.0 t -93.51 -83.38 0.32 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.665 0.269 . . . . 0.0 110.585 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.01 51.75 32.26 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.669 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -102.39 122.38 44.17 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.861 0.362 . . . . 0.0 111.425 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.461 ' HG3' ' CG1' ' A' ' 453' ' ' VAL . 13.4 mp0 -90.32 140.25 29.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.99 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -143.23 167.36 22.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.252 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 56.6 m -81.44 143.08 32.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.45 0.643 . . . . 0.0 112.168 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . 0.499 ' HE3' ' CG ' ' A' ' 452' ' ' MET . 15.0 t-105 -75.66 -41.3 54.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.237 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.61 -64.56 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.705 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 25.3 p -91.82 177.44 6.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 110.49 15.92 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.658 0.742 . . . . 0.0 110.438 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 15.1 t -157.76 178.16 10.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.443 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.15 135.81 33.52 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 36.3 t90 -60.45 106.53 0.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.161 0.505 . . . . 0.0 109.768 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.5 p -136.28 -176.86 4.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.707 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -73.45 -24.15 60.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.19 -56.49 14.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.45 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -99.61 16.96 21.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.722 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -56.12 -57.86 10.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.07 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -135.4 17.85 3.97 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.69 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.52 -28.54 69.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.931 0.396 . . . . 0.0 111.541 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -143.78 -6.59 0.77 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.439 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -59.91 99.63 0.07 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.776 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -150.26 127.97 11.66 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.462 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.501 0 CA-C-O 118.696 -1.058 . . . . 0.0 111.066 -179.894 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.728 0.299 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -89.02 108.01 19.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.774 0.321 . . . . 0.0 110.281 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -122.81 172.6 8.33 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.69 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 85.3 t -72.8 -37.15 54.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.548 . . . . 0.0 109.773 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -90.48 156.75 17.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.214 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -157.66 132.93 8.89 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -76.74 81.91 3.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.197 0.522 . . . . 0.0 111.514 -178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -106.06 -8.92 33.1 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -141.96 123.85 2.32 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 352' ' ' LEU . 10.6 p -98.39 168.09 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.405 ' H ' HG23 ' A' ' 351' ' ' VAL . 2.9 mm? -125.95 145.26 50.36 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 122.011 -0.431 . . . . 0.0 110.686 -176.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 354' ' ' PRO . 50.5 t -63.01 130.71 94.34 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 353' ' ' CYS . 9.5 Cg_exo -70.88 -12.1 30.29 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.829 2.353 . . . . 0.0 113.159 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -82.16 119.75 75.68 Favored Pre-proline 0 C--N 1.317 -0.828 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.21 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.79 129.28 33.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.567 2.178 . . . . 0.0 111.128 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 116.12 -21.97 11.7 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 35.4 m -90.97 -97.0 0.11 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.034 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 53.31 29.72 38.49 Favored Glycine 0 C--O 1.225 -0.466 0 O-C-N 123.404 0.44 . . . . 0.0 112.507 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' MET . . . . . 0.47 ' HE1' ' HA3' ' A' ' 376' ' ' GLY . 25.7 mtm -74.96 -67.19 0.67 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.935 0.398 . . . . 0.0 110.433 -178.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 147.14 120.02 1.18 Allowed Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.427 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.76 116.95 32.17 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.43 122.29 19.36 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.956 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.83 100.28 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.102 0.477 . . . . 0.0 110.863 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -89.4 135.71 30.8 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.236 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.07 -36.45 99.25 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.543 2.162 . . . . 0.0 111.303 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -77.98 -22.38 49.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 41.3 t -75.48 114.45 14.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.222 0.534 . . . . 0.0 110.98 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -114.81 -0.88 13.36 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.502 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -136.35 111.56 9.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.345 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 381' ' ' PHE . 0.8 OUTLIER -105.9 151.31 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.839 -176.69 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.2 m -154.09 143.21 21.25 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.637 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 41.5 t -72.67 71.98 1.02 Allowed 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.486 0.66 . . . . 0.0 109.927 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -85.18 -6.59 59.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.0 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -88.95 -17.74 28.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.852 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . 0.47 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -138.07 -88.13 0.19 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.048 -1.073 . . . . 0.0 113.169 -177.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' A' ' 378' ' ' GLY . 25.2 p -99.14 -109.34 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.198 0.523 . . . . 0.0 111.755 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' A' ' 377' ' ' CYS . . . -172.08 108.05 0.27 Allowed Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -160.03 145.7 15.41 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.18 113.45 44.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.492 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . 0.485 ' O ' HG22 ' A' ' 371' ' ' VAL . 13.5 p90 -129.84 -174.68 3.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.144 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . 0.554 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 29.3 t -81.2 172.09 14.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -97.42 -19.05 18.71 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.478 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 395' ' ' LEU . 28.6 t-20 -104.74 -31.74 9.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.296 0.57 . . . . 0.0 110.008 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 21.1 p -135.72 179.9 6.05 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.237 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.5 mp -108.62 31.49 5.58 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.482 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . 0.488 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 77.9 mm-40 -74.66 4.42 6.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.176 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 82.3 30.36 34.16 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.132 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 31.2 t80 72.17 128.03 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.828 0.451 . . . . 0.0 110.414 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -161.67 178.59 8.88 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.217 0.532 . . . . 0.0 111.756 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 47.4 mt -98.86 150.05 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.801 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 109.87 -164.03 12.39 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.089 -1.053 . . . . 0.0 112.736 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -116.42 149.62 39.14 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.786 0.326 . . . . 0.0 110.714 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 1.2 m -119.68 -72.63 0.68 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . 0.468 ' HB2' HD22 ' A' ' 384' ' ' ASN . 94.5 mt -140.01 89.36 11.27 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.72 -16.63 12.91 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 C-N-CA 122.701 2.267 . . . . 0.0 113.079 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 59.42 28.04 17.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.331 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 161.64 131.07 1.18 Allowed Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 9.5 t -119.05 2.37 11.46 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 117.295 0.547 . . . . 0.0 111.935 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.0 -74.86 2.35 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.585 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -69.4 117.97 11.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.952 0.406 . . . . 0.0 110.349 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 47.7 m -148.74 112.78 5.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.564 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -140.55 -172.51 3.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.201 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 11.9 t -125.47 148.51 48.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 120.984 0.421 . . . . 0.0 111.029 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -131.16 80.28 1.93 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.483 0.659 . . . . 0.0 109.518 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 7.8 p -131.23 128.2 39.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.648 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 60.7 m -136.08 91.0 2.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.974 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -157.56 127.57 6.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.209 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -177.31 119.19 0.11 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.159 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 8.3 t -144.72 132.33 21.01 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.031 0.443 . . . . 0.0 110.972 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 52.5 t -119.28 103.77 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.492 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -110.08 117.26 52.13 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.542 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.13 144.36 81.35 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.994 2.463 . . . . 0.0 112.638 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -86.01 -77.31 0.31 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.681 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -161.48 138.03 8.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.371 . . . . 0.0 111.362 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.29 98.34 1.7 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.79 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -163.35 103.77 0.96 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.635 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.03 137.23 6.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.115 175.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -157.88 124.94 5.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.675 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -113.13 170.21 8.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.929 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -162.45 144.05 10.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.775 0.321 . . . . 0.0 110.851 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -154.68 120.67 5.23 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.839 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.81 -22.68 20.01 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.405 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 53.3 70.28 0.61 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.525 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 13.7 p -78.27 125.54 29.5 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.499 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -149.82 114.91 5.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.76 148.79 15.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.914 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.7 t -153.19 173.07 16.0 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 13.4 tt -161.52 145.79 4.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . 0.427 ' HZ3' ' HB3' ' A' ' 430' ' ' LYS . 0.3 OUTLIER -152.55 131.96 12.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.016 0.436 . . . . 0.0 111.219 178.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.16 84.09 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 4.7 m -79.61 -38.82 33.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.007 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.1 174.18 11.82 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.288 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . 0.452 ' HD3' ' HD2' ' A' ' 435' ' ' PRO . 17.2 tppt? -116.6 115.96 39.13 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . 0.452 ' HD2' ' HD3' ' A' ' 434' ' ' LYS . 17.8 Cg_endo -61.28 123.36 12.67 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.925 1.75 . . . . 0.0 111.361 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 44.2 t -58.41 136.52 85.5 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.369 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.05 -3.7 14.11 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.46 2.106 . . . . 0.0 111.621 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -109.72 -68.44 0.92 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.916 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 7.6 p -95.09 -2.71 49.5 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 12.3 tpt180 62.17 23.7 14.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.009 0.524 . . . . 0.0 111.578 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.3 p -84.87 160.65 55.15 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.263 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.67 93.81 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.224 1.949 . . . . 0.0 111.809 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 4.7 m -83.7 126.02 32.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.186 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -104.63 151.74 23.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.447 ' HB3' ' HE3' ' A' ' 452' ' ' MET . 15.2 ptt180 -119.74 156.97 29.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.23 0.538 . . . . 0.0 111.458 -178.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -129.57 145.23 51.5 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.802 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 73.29 -141.6 30.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.208 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.15 72.39 0.25 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.675 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.2 p -123.71 175.71 6.69 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 47.4 mtt -97.83 -0.64 44.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.037 0.446 . . . . 0.0 110.328 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -80.03 99.41 7.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.972 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' MET . . . . . 0.447 ' HE3' ' HB3' ' A' ' 445' ' ' ARG . 96.5 mmm -112.94 97.36 6.48 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.908 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.4 t -109.42 113.93 45.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.24 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.64 111.16 14.43 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.531 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 11.9 p -93.55 90.78 6.8 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 121.411 0.624 . . . . 0.0 109.514 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.524 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 4.7 tmt_? -132.13 139.36 48.41 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.029 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.35 105.68 0.97 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.889 0.376 . . . . 0.0 110.668 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 101.33 7.14 49.86 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.249 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.524 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 53.4 t -104.51 -90.19 0.4 Allowed 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.721 -0.282 . . . . 0.0 110.592 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.29 46.2 80.65 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -113.27 130.18 56.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.908 0.385 . . . . 0.0 110.944 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -98.87 140.61 32.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.025 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 28.1 p-90 -151.35 149.95 29.92 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.413 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 53.4 m -74.24 149.66 40.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.412 0.625 . . . . 0.0 112.012 -178.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -74.71 -58.74 3.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.939 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.97 -47.29 76.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 8.1 p -104.21 125.25 50.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -75.34 110.6 9.83 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.7 p -153.51 177.85 10.47 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.476 -176.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -102.22 157.24 17.03 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -56.7 108.6 0.51 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.478 0.656 . . . . 0.0 111.189 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 476' ' ' MET . 61.1 p -123.74 175.73 6.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.532 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -85.21 -29.95 24.28 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.685 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . 0.411 ' O ' ' HB1' ' A' ' 478' ' ' ALA . 7.3 p-10 -67.54 -28.02 67.45 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.332 -178.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 47.1 m -93.36 -30.28 15.19 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 472' ' ' THR . 1.9 tmt? -51.08 -52.3 44.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.352 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -99.38 20.06 51.34 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.563 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 474' ' ' ASP . . . -111.17 -65.63 1.15 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -139.43 16.84 2.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -55.81 -38.62 70.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.253 0.549 . . . . 0.0 110.034 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -120.45 99.33 6.5 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.04 0 CA-C-O 118.434 -1.203 . . . . 0.0 111.803 -179.465 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . 0.418 ' H3 ' ' CD ' ' A' ' 342' ' ' GLU . 6.7 mp0 . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 60.95 90.03 0.07 Allowed 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.792 0.683 . . . . 0.0 111.577 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -123.43 137.09 54.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.047 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 74.6 t -88.22 99.6 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 121.273 0.558 . . . . 0.0 110.269 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 1.4 pp -105.33 6.37 32.65 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.148 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -92.13 138.41 31.55 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.143 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -156.83 -75.28 0.09 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.386 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -151.86 140.86 8.06 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.64 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -144.48 106.71 0.41 Allowed Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.01 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 24.4 m -107.91 178.5 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.009 0.433 . . . . 0.0 110.334 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 6.2 mp -134.08 152.37 51.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.567 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.4 t -52.55 134.82 44.25 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.001 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.0 -16.93 48.65 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.116 2.544 . . . . 0.0 113.025 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -87.73 117.94 69.13 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.8 -27.66 84.54 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.017 2.478 . . . . 0.0 112.426 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -72.22 -16.18 76.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.543 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.2 t -86.8 -77.71 0.31 Allowed 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.05 30.4 66.79 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.024 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 9.0 ttm -70.49 -76.72 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.009 0.433 . . . . 0.0 111.174 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 143.48 121.88 1.62 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.064 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.59 130.32 55.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.11 0.481 . . . . 0.0 110.772 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 364' ' ' VAL . 1.7 tm? -95.69 128.89 42.94 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.677 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . 0.402 ' N ' HD13 ' A' ' 363' ' ' LEU . 62.9 t -114.91 103.86 15.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.286 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -84.42 154.44 62.67 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.125 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.6 -9.85 26.8 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.052 1.835 . . . . 0.0 112.335 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -99.57 -14.43 19.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 52.8 t -125.07 136.85 54.06 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.936 0.398 . . . . 0.0 110.774 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.09 10.46 8.14 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.103 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -87.5 91.26 8.67 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.626 0.727 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . 0.504 HG21 ' C ' ' A' ' 382' ' ' CYS . 0.0 OUTLIER -85.0 113.77 24.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.509 178.285 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 91.4 m -153.19 139.87 18.9 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.245 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.443 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 4.7 t -76.44 67.48 2.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -66.45 -17.8 65.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.374 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -101.91 11.49 38.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -166.08 -126.09 0.81 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.164 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.443 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -83.2 91.08 7.18 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -69.06 108.88 2.64 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.693 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -114.09 143.62 44.48 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.448 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 14.0 m -83.58 102.02 9.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.445 0.64 . . . . 0.0 111.413 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -133.82 172.33 12.93 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . 0.504 ' C ' HG21 ' A' ' 371' ' ' VAL . 10.7 t -95.62 175.98 6.33 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.059 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . 0.435 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 5.7 ptp85 -78.06 -45.26 24.05 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.879 -175.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.589 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 20.3 m120 -105.33 -9.88 17.35 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.984 0.421 . . . . 0.0 111.197 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 26.4 p -140.21 176.07 9.06 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.919 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.81 32.64 5.7 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -72.63 -1.34 15.8 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 96.39 27.33 10.02 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.465 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 46.1 t80 66.42 103.99 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.23 0.612 . . . . 0.0 111.181 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -118.42 162.34 18.48 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.087 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 48.4 mm -91.69 120.93 41.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 132.96 -140.26 11.67 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -132.97 148.93 52.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.815 0.34 . . . . 0.0 110.635 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 1.3 m -89.35 -40.04 13.03 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.48 0.657 . . . . 0.0 109.905 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -74.78 125.79 89.13 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.656 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -90.31 -167.65 0.26 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.962 2.441 . . . . 0.0 111.076 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.0 -27.9 60.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.01 0.433 . . . . 0.0 110.896 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 153.35 -134.03 4.24 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 9.0 t -134.69 157.74 45.88 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.902 0.351 . . . . 0.0 110.27 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -157.68 63.95 0.31 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.288 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.0 116.43 32.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.99 0.424 . . . . 0.0 110.594 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 49.7 m -145.31 110.31 5.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.767 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -67.66 114.45 6.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.696 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 11.8 p -124.53 124.63 42.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.203 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -146.64 159.91 42.86 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 40.3 m -137.0 135.25 37.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.954 0.407 . . . . 0.0 111.401 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 55.7 m -87.37 169.29 12.39 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.749 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 72.25 152.19 0.12 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.585 0.553 . . . . 0.0 110.447 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 0.425 ' O ' ' HB ' ' A' ' 410' ' ' THR . 1.8 p90 -147.49 -53.27 0.21 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.644 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 409' ' ' TYR . 14.7 t 171.91 149.65 0.05 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.888 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.33 143.28 41.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.264 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -87.05 143.29 34.71 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.302 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.15 123.06 9.61 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.646 2.23 . . . . 0.0 113.299 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -103.72 126.59 50.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.136 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . 0.489 ' HD2' ' C ' ' A' ' 415' ' ' ARG . 0.0 OUTLIER -133.61 166.07 23.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.845 0.355 . . . . 0.0 111.293 -177.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -112.05 134.68 53.45 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.989 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -112.44 162.64 15.36 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -141.19 140.22 33.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.705 0.288 . . . . 0.0 111.084 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -147.89 111.95 5.16 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.241 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.67 156.97 22.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.422 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -92.75 -35.36 13.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.413 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -63.28 97.9 0.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.825 0.345 . . . . 0.0 111.327 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.409 ' H ' ' HG3' ' A' ' 423' ' ' GLU . 0.1 OUTLIER -105.91 -35.0 7.45 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.533 179.27 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -139.85 172.09 13.28 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.208 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 49.1 p -111.73 -26.37 9.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.849 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.45 46.18 7.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.118 0.967 . . . . 0.0 112.975 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 52.6 t -62.4 120.86 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.566 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 7.4 m -87.43 130.86 34.52 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.635 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 16.0 tt -95.82 139.09 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.79 0.329 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -88.41 154.9 20.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.425 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.485 HG22 ' H ' ' A' ' 433' ' ' THR . 14.9 p -75.53 139.35 19.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.291 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.1 p -96.47 -11.54 25.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.96 0.41 . . . . 0.0 111.788 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' THR . . . . . 0.485 ' H ' HG22 ' A' ' 431' ' ' VAL . 5.1 p -110.4 170.63 7.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.874 0.369 . . . . 0.0 111.005 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -131.51 125.43 20.65 Favored Pre-proline 0 N--CA 1.436 -1.135 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.77 136.41 57.57 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.753 2.302 . . . . 0.0 113.156 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 31.2 t -63.36 141.18 97.81 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.761 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 7.1 Cg_exo -73.77 -2.23 11.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.524 2.149 . . . . 0.0 111.78 176.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -117.4 -69.92 0.82 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.578 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 17.7 p -86.33 -10.61 54.1 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.63 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 71.5 mtt85 66.52 21.46 10.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.149 0.579 . . . . 0.0 112.17 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 42.2 p -82.01 149.7 63.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.462 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.28 99.81 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.3 2.0 . . . . 0.0 111.802 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 20.3 m -81.04 125.93 30.8 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.992 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -82.35 134.7 35.26 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.248 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -91.04 143.44 26.7 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.253 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -146.37 160.81 41.56 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.264 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -67.24 148.8 50.49 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.723 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 179.36 -154.75 14.37 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.078 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 450' ' ' MET . 61.1 m -108.45 49.87 0.8 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.924 0.392 . . . . 0.0 110.337 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.703 ' SD ' ' HA ' ' A' ' 480' ' ' TRP . 14.0 ptp 57.92 11.2 1.34 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.874 1.27 . . . . 0.0 112.925 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -94.48 94.78 8.42 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 49.0 tpp -108.07 128.3 54.56 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.025 0.44 . . . . 0.0 110.776 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.465 ' CG1' ' HG2' ' A' ' 462' ' ' GLU . 3.2 m -129.86 150.34 34.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 456' ' ' ARG . 12.9 t -69.36 111.7 5.42 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.477 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.3 t -83.7 87.43 7.05 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 122.5 1.143 . . . . 0.0 109.452 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.519 ' HB2' ' SG ' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -133.16 128.1 35.29 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 91.75 0.09 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.86 0.362 . . . . 0.0 110.565 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 124.93 -11.51 7.79 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.709 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . 0.506 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 23.6 t -98.1 -77.8 0.5 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.49 32.35 83.12 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.942 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . 0.425 ' HB2' ' SG ' ' A' ' 459' ' ' CYS . 29.8 t80 -75.58 120.02 20.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.465 ' HG2' ' CG1' ' A' ' 453' ' ' VAL . 45.0 mt-10 -91.48 138.43 31.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -156.48 160.23 39.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.961 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 44.8 t -69.99 138.05 51.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.427 0.632 . . . . 0.0 112.129 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -75.18 -41.63 57.55 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.614 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 41.9 t -77.06 -64.52 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.844 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.7 p -102.29 96.91 7.27 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -74.93 109.92 8.79 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.67 1.224 . . . . 0.0 112.56 -170.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.2 t -160.18 173.67 15.4 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.551 -1.659 . . . . 0.0 106.736 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.64 111.66 12.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.445 -0.902 . . . . 0.0 108.877 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . 0.438 ' CE3' ' HB3' ' A' ' 474' ' ' ASP . 1.3 m95 -158.24 145.05 17.66 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.752 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 476' ' ' MET . 10.5 p -134.45 -72.03 0.49 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . 0.479 ' NH1' ' HG2' ' A' ' 476' ' ' MET . 29.8 mmm180 -85.13 -29.2 25.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . 0.438 ' HB3' ' CE3' ' A' ' 471' ' ' TRP . 8.0 t70 -66.0 -51.75 55.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.118 0.485 . . . . 0.0 111.051 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.6 t -78.83 -10.7 59.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.824 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' MET . . . . . 0.521 ' HA ' ' HB3' ' A' ' 480' ' ' TRP . 47.7 tpp -57.61 -53.09 62.14 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.858 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -84.75 -10.54 78.95 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.325 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -71.12 -62.55 1.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.821 0.344 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -148.0 -12.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.836 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . 0.703 ' HA ' ' SD ' ' A' ' 450' ' ' MET . 2.3 t-105 -54.92 -41.3 70.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.354 0.597 . . . . 0.0 110.321 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -70.88 96.59 1.29 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.17 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.022 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.006 -179.292 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -96.85 105.48 17.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.138 0.495 . . . . 0.0 111.03 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -112.52 128.58 56.38 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.781 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.686 ' O ' HD21 ' A' ' 346' ' ' LEU . 57.8 t -95.4 -47.77 12.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.406 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.686 HD21 ' O ' ' A' ' 345' ' ' VAL . 0.5 OUTLIER 47.1 15.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.718 1.607 . . . . 0.0 114.351 178.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 345' ' ' VAL . 86.6 mm-40 -92.78 143.21 26.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.833 0.349 . . . . 0.0 110.753 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -106.66 -171.7 1.94 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.496 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 142.07 60.97 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.772 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -129.48 161.72 22.77 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.881 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' VAL . . . . . 0.508 HG22 ' H ' ' A' ' 352' ' ' LEU . 7.2 p -122.21 177.53 3.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.508 ' H ' HG22 ' A' ' 351' ' ' VAL . 98.4 mt -117.11 149.82 39.7 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 120.791 0.329 . . . . 0.0 110.963 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . 0.567 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 44.9 t -68.09 145.46 97.67 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.823 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' PRO . . . . . 0.567 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 27.6 Cg_endo -63.5 -14.85 44.94 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.812 2.342 . . . . 0.0 112.298 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -86.59 118.84 70.84 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.36 -30.55 91.55 Favored 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 123.159 2.573 . . . . 0.0 113.581 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -82.03 -10.22 84.2 Favored Glycine 0 C--O 1.236 0.247 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.27 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . 0.482 ' SG ' ' HE3' ' A' ' 360' ' ' MET . 47.1 t -74.24 -82.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.692 0.282 . . . . 0.0 110.289 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 60.32 22.12 58.06 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.441 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' MET . . . . . 0.482 ' HE3' ' SG ' ' A' ' 358' ' ' CYS . 34.9 mtm -74.2 -41.44 61.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.184 0.516 . . . . 0.0 110.785 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 106.51 115.02 3.97 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.569 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -99.37 144.91 27.94 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 122.528 0.331 . . . . 0.0 110.601 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.98 118.51 27.58 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . 0.432 ' O ' HG11 ' A' ' 364' ' ' VAL . 9.1 p -122.03 77.71 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 122.023 0.916 . . . . 0.0 112.339 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -97.98 154.5 37.74 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.13 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.81 -14.73 42.47 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.415 2.077 . . . . 0.0 111.331 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -85.46 -2.59 58.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.066 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 46.0 t -110.12 115.47 29.8 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.637 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.4 1.88 26.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.052 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -136.48 96.58 3.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.896 0.379 . . . . 0.0 111.175 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.8 120.38 40.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.423 0.63 . . . . 0.0 110.535 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 97.1 m -152.24 143.92 23.56 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.597 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' CYS . . . . . 0.444 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 3.7 t -76.51 67.02 2.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.474 0.654 . . . . 0.0 109.688 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -72.14 -6.12 40.4 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.501 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -106.41 -12.89 15.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.066 0.46 . . . . 0.0 110.793 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -144.64 -124.1 1.72 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.921 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.444 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -74.53 86.57 2.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.825 0.345 . . . . 0.0 110.553 178.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 373' ' ' CYS . . . -67.77 109.09 2.72 Favored Glycine 0 CA--C 1.495 -1.157 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.574 -172.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -147.85 134.77 20.18 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.3 p -83.64 133.16 29.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -142.03 166.62 24.22 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 11.3 t -79.87 160.13 26.16 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.236 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -92.79 -13.25 29.45 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.537 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -104.82 -30.62 9.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.277 0.56 . . . . 0.0 109.511 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 6.7 p -140.84 -165.88 2.03 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.241 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 65.1 mt -116.96 25.68 10.34 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.019 0.437 . . . . 0.0 110.942 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -75.97 20.36 0.19 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 78.89 16.85 78.32 Favored Glycine 0 N--CA 1.461 0.363 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.201 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' TYR . . . . . 0.406 ' CD1' ' HA ' ' A' ' 382' ' ' CYS . 0.3 OUTLIER 67.41 114.18 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.751 0.82 . . . . 0.0 111.477 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -141.06 -53.97 0.48 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.429 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ILE . . . . . 0.454 HG23 ' H ' ' A' ' 393' ' ' GLU . 40.8 mt -125.29 146.3 31.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -66.11 -23.75 71.5 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.292 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' GLU . . . . . 0.454 ' H ' HG23 ' A' ' 391' ' ' ILE . 31.6 mt-10 -135.36 134.76 40.11 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.45 0.3 . . . . 0.0 110.414 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 74.8 m -138.12 177.94 7.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.04 0.448 . . . . 0.0 111.498 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 27.2 tp -142.33 127.27 10.24 Favored Pre-proline 0 N--CA 1.435 -1.219 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.952 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -61.26 166.13 11.57 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 123.084 2.523 . . . . 0.0 112.333 177.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.85 115.49 15.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.179 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -152.46 48.15 0.55 Allowed Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 17.3 p -136.66 -178.76 5.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.616 0.246 . . . . 0.0 111.268 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.19 72.85 0.93 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.842 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -145.57 114.22 6.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.691 0.282 . . . . 0.0 110.697 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.7 p -153.76 148.05 25.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.576 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -142.54 165.81 26.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.604 0.24 . . . . 0.0 110.881 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 5.9 t -157.78 114.11 2.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.338 0.589 . . . . 0.0 110.913 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -112.93 144.68 42.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.381 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.8 p -157.05 130.48 7.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.007 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 41.9 t -161.51 102.29 1.2 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.605 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -136.44 115.75 12.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.789 0.328 . . . . 0.0 110.894 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -161.76 148.89 14.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.884 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 1.2 p -138.94 103.29 4.76 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.996 0.427 . . . . 0.0 110.796 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' VAL . . . . . 0.4 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 30.4 t -88.83 112.58 24.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -104.21 105.9 51.23 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.472 -177.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 411' ' ' VAL . 16.0 Cg_exo -70.21 140.58 41.29 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.542 2.162 . . . . 0.0 110.907 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -133.87 121.89 22.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.741 0.305 . . . . 0.0 111.036 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.97 160.95 40.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.704 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -156.06 93.38 1.43 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.582 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -164.37 124.23 2.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.12 152.64 37.67 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.725 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -167.62 156.52 9.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.268 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.46 138.74 5.39 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -164.99 151.22 10.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.065 0.459 . . . . 0.0 111.491 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -144.05 135.27 25.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.885 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.53 4.63 28.36 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.355 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -64.92 115.34 5.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.598 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.0 t -133.78 115.63 14.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.72 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -133.2 130.29 38.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.771 0.32 . . . . 0.0 110.814 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 23.0 t -107.85 135.56 46.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.88 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.5 t -96.97 153.28 18.0 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 48.0 mm -106.19 117.56 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 120.918 0.389 . . . . 0.0 110.64 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -128.48 162.15 27.87 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.695 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.33 92.15 2.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.109 0.481 . . . . 0.0 110.137 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.5 p -92.5 -15.63 26.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.551 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 1.1 p -102.49 163.47 12.21 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.807 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' LYS . . . . . 0.417 ' HD3' ' HD2' ' A' ' 435' ' ' PRO . 5.4 tppp? -115.66 118.52 38.94 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . 0.417 ' HD2' ' HD3' ' A' ' 434' ' ' LYS . 29.2 Cg_endo -63.58 134.16 43.07 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.249 1.966 . . . . 0.0 112.526 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 35.3 t -61.26 140.33 94.48 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.424 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.48 -11.52 31.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.341 2.027 . . . . 0.0 111.616 177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -102.45 -67.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.752 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 6.2 p -96.98 -1.25 45.97 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 440' ' ' ARG . 65.8 ttt180 61.69 23.73 13.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.284 0.564 . . . . 0.0 111.557 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 17.5 p -79.13 142.22 59.14 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.975 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 11.8 Cg_exo -67.41 102.28 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.295 1.997 . . . . 0.0 111.252 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 17.7 m -106.03 128.05 53.58 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.631 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -117.68 171.84 7.76 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 120.904 0.383 . . . . 0.0 110.892 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' ARG . . . . . 0.548 ' HD3' ' CZ2' ' A' ' 465' ' ' TRP . 33.8 ptt-85 -103.5 161.99 13.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.167 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.37 114.31 25.71 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 71.88 -115.89 5.74 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.468 -176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.69 38.82 1.64 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.914 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 61.2 m -71.68 141.94 49.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.824 0.345 . . . . 0.0 111.181 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 65.4 mtt -94.2 -21.36 19.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.875 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -75.33 95.74 3.26 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.155 0.502 . . . . 0.0 110.197 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 48.5 tpp -104.08 96.63 6.79 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.287 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . 0.425 ' HB ' ' HG3' ' A' ' 462' ' ' GLU . 3.8 p -112.97 129.5 68.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.197 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.22 116.84 6.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.376 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 7.9 p -100.81 92.39 5.05 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.495 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 458' ' ' GLY . 0.0 OUTLIER -130.43 148.15 52.21 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -71.28 14.74 0.15 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.097 0.475 . . . . 0.0 111.413 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 456' ' ' ARG . . . -160.61 34.63 0.42 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' CYS . . . . . . . . . . . . . 10.0 t -154.6 -152.09 0.39 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 136.16 74.12 0.07 OUTLIER Glycine 0 C--N 1.279 -2.638 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.762 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -137.48 130.41 30.36 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.628 0.251 . . . . 0.0 111.101 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.425 ' HG3' ' HB ' ' A' ' 453' ' ' VAL . 1.9 mp0 -87.78 127.42 35.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.941 177.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -134.2 161.56 34.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.61 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . 0.434 ' HA ' ' CZ3' ' A' ' 480' ' ' TRP . 8.2 t -68.41 133.39 48.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.264 0.554 . . . . 0.0 111.666 -175.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' TRP . . . . . 0.548 ' CZ2' ' HD3' ' A' ' 445' ' ' ARG . 23.5 t-105 -76.68 -55.35 5.58 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.463 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.68 -56.56 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 28.5 p -101.17 -161.06 0.83 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -131.32 110.11 10.84 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.795 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.6 p -155.5 151.44 27.7 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.646 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.48 156.76 38.95 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -50.02 109.01 0.25 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.309 0.576 . . . . 0.0 110.82 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 2.3 p -133.73 161.63 34.17 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.579 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' ARG . . . . . 0.496 ' HA ' ' HG2' ' A' ' 476' ' ' MET . 64.4 ttt180 -73.07 -22.06 60.67 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.742 178.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.4 -51.75 68.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.375 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 98.7 m -88.11 -23.41 23.69 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' MET . . . . . 0.496 ' HG2' ' HA ' ' A' ' 473' ' ' ARG . 5.4 ptp -49.48 -36.44 22.89 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -174.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -137.95 34.83 2.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.369 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.97 -65.85 1.12 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.809 0.338 . . . . 0.0 111.304 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -127.52 20.3 6.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 111.105 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' TRP . . . . . 0.434 ' CZ3' ' HA ' ' A' ' 464' ' ' CYS . 10.1 t-105 -79.88 -9.48 59.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.604 0.716 . . . . 0.0 109.407 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -104.99 133.42 49.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.77 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.546 -1.141 . . . . 0.0 111.943 -179.46 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.918 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.537 HG22 ' H ' ' A' ' 352' ' ' LEU . 9.8 p -166.39 174.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.537 ' H ' HG22 ' A' ' 351' ' ' VAL . 6.4 mp -125.85 151.74 46.43 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.1 t -63.26 126.39 89.13 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.4 ' HD3' ' CE2' ' A' ' 381' ' ' PHE . 73.0 Cg_endo -78.87 16.97 1.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.961 2.441 . . . . 0.0 113.623 -176.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 357' ' ' GLY . 32.3 tt0 -86.46 132.99 41.22 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.21 -20.56 62.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.729 2.286 . . . . 0.0 112.656 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' A' ' 355' ' ' GLN . . . -100.25 3.61 56.79 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.685 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 9.5 t -115.35 -147.93 0.42 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.362 0.601 . . . . 0.0 110.422 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.13 23.65 5.14 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.009 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.517 ' HE1' ' HA3' ' A' ' 376' ' ' GLY . 39.7 mtm -61.0 -44.93 96.7 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.975 0.417 . . . . 0.0 110.505 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.39 129.37 3.28 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.145 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.01 127.09 53.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.238 0.542 . . . . 0.0 110.384 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -100.85 114.29 27.99 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.467 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.25 119.4 50.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 120.97 0.414 . . . . 0.0 110.703 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 368' ' ' CYS . 8.6 mm-40 -81.07 149.72 67.04 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.032 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.72 -30.0 87.57 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.594 2.196 . . . . 0.0 112.243 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -101.11 15.18 29.57 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.463 0.649 . . . . 0.0 110.812 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 365' ' ' GLU . 51.6 t -104.09 134.63 47.02 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.09 -0.381 . . . . 0.0 110.046 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 29.63 5.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 370' ' ' LYS . 1.9 tpmt? -144.47 102.3 3.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.781 0.324 . . . . 0.0 110.423 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.48 124.38 51.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.239 0.542 . . . . 0.0 110.845 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.5 m -152.38 141.38 21.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.92 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 3.5 t -76.86 62.03 2.0 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.16 -22.7 67.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.134 0.492 . . . . 0.0 110.749 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -88.21 -13.3 41.42 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.041 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' GLY . . . . . 0.517 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -143.11 -124.31 1.86 Allowed Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.297 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -76.42 85.14 3.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.141 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -70.9 109.48 2.86 Favored Glycine 0 N--CA 1.435 -1.404 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -147.12 144.82 29.3 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' A' ' 389' ' ' TYR . 18.1 t -84.88 136.23 23.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.098 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.426 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 11.7 p90 -146.01 -175.67 4.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' CYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 19.4 t -94.81 162.56 13.71 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.884 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -86.25 -20.4 28.52 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.038 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.537 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 82.4 m-20 -105.47 -26.47 11.91 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.627 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 4.8 p -141.24 178.84 7.13 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.416 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.78 30.76 6.02 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -70.47 -2.74 14.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.312 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 82.94 27.4 41.4 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.537 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.412 ' HB2' HG12 ' A' ' 380' ' ' VAL . 53.1 t80 76.62 138.51 0.06 Allowed 'General case' 0 C--N 1.338 0.108 0 C-N-CA 124.402 1.081 . . . . 0.0 111.514 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -161.04 176.32 11.49 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 50.6 mm -114.6 132.15 64.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 129.66 -156.58 21.44 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.218 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -90.54 159.34 16.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.407 0.622 . . . . 0.0 111.801 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.7 p . . . . . 0 CA--C 1.501 -0.935 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.402 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 121.066 0.46 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.8 p -117.2 -2.25 11.68 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.19 0.519 . . . . 0.0 111.014 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 20.4 p -105.84 149.14 26.79 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -114.08 141.64 26.64 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.028 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.7 129.9 20.87 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.352 2.034 . . . . 0.0 112.738 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 24.3 t -59.1 140.32 87.34 Favored Pre-proline 0 C--N 1.333 -0.119 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.573 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.31 -16.71 39.64 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.127 1.885 . . . . 0.0 111.962 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -101.3 -66.64 0.9 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.542 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 15.6 p -93.57 -10.8 33.51 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 26.6 mmm180 70.03 20.57 6.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.074 0.55 . . . . 0.0 111.922 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 42.4 p -81.23 149.44 65.85 Favored Pre-proline 0 C--N 1.322 -0.622 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.703 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 16.2 Cg_exo -65.71 103.12 0.55 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.605 2.203 . . . . 0.0 112.403 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 89.8 m -95.87 122.69 38.93 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -95.75 156.77 16.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.61 156.4 18.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.724 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.78 107.58 16.26 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.182 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -57.95 124.9 37.71 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.003 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.87 -13.2 13.03 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.224 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 11.0 p -142.56 142.59 32.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.713 0.292 . . . . 0.0 110.96 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.686 ' O ' ' HB3' ' A' ' 465' ' ' TRP . 14.2 ptp -99.36 29.83 3.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.31 0.576 . . . . 0.0 111.338 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 451' ' ' HIS . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 480' ' ' TRP . 29.0 p-80 -123.38 138.25 54.64 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.433 174.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 3.7 ptp -143.06 124.54 14.79 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.18 0.514 . . . . 0.0 110.656 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 8.5 m -114.38 150.82 16.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.3 t -85.38 101.41 12.56 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.472 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 21.2 p -87.7 92.51 9.13 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.61 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.7 OUTLIER -128.83 146.98 50.77 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -177.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -50.74 -44.03 58.3 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.324 0.39 . . . . 0.0 111.809 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' GLY . . . . . 0.405 ' H ' ' HD3' ' A' ' 456' ' ' ARG . . . -124.6 61.37 0.6 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.612 178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 36.4 t -151.34 -90.61 0.06 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.605 0.241 . . . . 0.0 110.519 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 73.45 38.78 51.95 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.704 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -99.55 118.65 36.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.94 0.4 . . . . 0.0 111.016 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -90.33 139.94 30.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.738 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -148.72 154.44 39.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 49.2 t -73.09 139.49 46.52 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.008 0.432 . . . . 0.0 111.191 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' TRP . . . . . 0.686 ' HB3' ' O ' ' A' ' 450' ' ' MET . 11.3 t-105 -75.02 -51.58 13.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.602 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.45 -51.48 71.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.017 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.551 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.8 p -120.87 107.11 12.31 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -74.23 111.35 9.31 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.875 0.845 . . . . 0.0 111.246 -174.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.0 p -154.67 169.92 22.76 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.542 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.69 143.46 36.23 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.006 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -61.55 104.29 0.41 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.407 0.622 . . . . 0.0 110.46 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.5 p -134.43 -163.7 1.41 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.114 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 50.6 mmm-85 -80.75 -21.9 40.67 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.972 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.44 -59.27 4.89 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 13.2 t -120.57 83.65 2.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 46.1 ttp -88.2 5.68 40.34 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.752 0.787 . . . . 0.0 109.209 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' A' ' 480' ' ' TRP . . . 118.39 37.9 0.82 Allowed Glycine 0 N--CA 1.428 -1.852 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.83 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -57.34 -39.55 76.13 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.185 0.517 . . . . 0.0 110.743 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -118.59 37.28 4.11 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.061 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 480' ' ' TRP . . . . . 0.528 ' HB2' ' CA ' ' A' ' 477' ' ' GLY . 20.5 t-105 -82.41 45.45 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.306 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -146.51 124.78 12.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.478 . . . . 0.0 111.279 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.223 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.548 179.422 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.268 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.587 HG22 ' H ' ' A' ' 352' ' ' LEU . 9.3 p -142.92 177.37 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.587 ' H ' HG22 ' A' ' 351' ' ' VAL . 71.0 mt -130.37 145.72 51.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.647 0.261 . . . . 0.0 110.9 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.33 132.23 94.35 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.34 -7.93 22.32 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.035 2.49 . . . . 0.0 113.502 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -72.96 124.35 90.62 Favored Pre-proline 0 N--CA 1.447 -0.588 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.746 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.75 -30.78 77.58 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.934 2.423 . . . . 0.0 112.509 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -79.79 -17.19 75.71 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.875 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.514 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 33.8 t -89.03 -96.71 0.1 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.797 0.298 . . . . 0.0 110.679 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.09 19.36 59.12 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 35.7 ttp -65.7 -67.37 0.45 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.994 0.518 . . . . 0.0 111.544 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.452 ' HA2' HD23 ' A' ' 352' ' ' LEU . . . 147.12 122.5 1.36 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.109 -1.043 . . . . 0.0 112.346 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.45 135.85 54.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.954 0.406 . . . . 0.0 110.269 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -97.04 118.97 34.64 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.895 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 56.2 t -88.42 97.5 6.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.0 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.92 141.09 97.43 Favored Pre-proline 0 C--N 1.312 -1.027 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -51.9 -20.49 10.13 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.785 2.323 . . . . 0.0 112.639 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -114.97 24.11 12.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 45.8 t -71.16 110.87 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.42 . . . . 0.0 110.491 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -83.92 -39.9 19.23 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.025 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -140.26 108.28 5.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.108 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 12.8 p -83.08 128.47 38.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.386 0.612 . . . . 0.0 110.468 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 86.7 m -153.11 144.56 23.3 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.518 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 1.8 t -76.16 61.99 1.66 Allowed 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -69.96 -8.73 51.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.619 0.723 . . . . 0.0 109.888 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -102.73 0.17 32.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.871 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -155.93 -124.66 0.87 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 0.8 OUTLIER -85.42 98.84 10.81 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.567 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.9 111.12 3.74 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 114.434 0.534 . . . . 0.0 114.434 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -141.8 143.6 33.51 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.05 129.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.03 0.443 . . . . 0.0 110.969 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.415 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 20.0 p90 -143.93 -175.84 4.76 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 17.2 t -80.75 168.61 18.62 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.85 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -101.64 -13.86 17.64 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.506 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.58 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 4.3 m-20 -104.23 -26.32 12.55 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 21.1 p -145.5 -164.46 1.95 Allowed 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.384 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.05 27.07 9.5 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.614 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -87.25 32.75 0.69 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 70.37 18.31 75.11 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 121.073 -0.584 . . . . 0.0 114.286 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 69.19 121.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.632 0.773 . . . . 0.0 110.382 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -145.89 -176.25 5.07 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.4 tt -112.67 153.15 14.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 99.24 -146.76 18.17 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.139 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -102.13 154.01 19.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.895 0.379 . . . . 0.0 110.99 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 35.0 m . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.537 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.414 0.626 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.502 ' O ' ' HE3' ' A' ' 434' ' ' LYS . 18.1 m -82.27 -29.07 31.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.237 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' THR . . . . . 0.623 ' HA ' ' HB2' ' A' ' 444' ' ' GLU . 5.8 p -78.8 150.2 32.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.346 0.593 . . . . 0.0 112.036 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.502 ' HE3' ' O ' ' A' ' 432' ' ' SER . 15.8 mmtp -99.93 147.52 33.57 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.694 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -82.62 129.78 5.78 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.03 1.82 . . . . 0.0 112.073 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 42.0 t -66.88 140.95 96.45 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.43 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.407 ' HD2' ' SG ' ' A' ' 436' ' ' CYS . 36.6 Cg_endo -67.51 -19.28 48.93 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.25 1.967 . . . . 0.0 112.241 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -103.24 -73.56 0.66 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 10.0 p -79.15 -17.71 54.51 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 44.5 mtt180 62.18 33.71 16.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.416 0.627 . . . . 0.0 111.126 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.2 p -90.44 154.34 46.4 Favored Pre-proline 0 N--CA 1.434 -1.24 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.782 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.78 110.53 1.7 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.73 2.287 . . . . 0.0 111.787 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 88.7 m -129.49 123.14 30.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.339 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' GLU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 433' ' ' THR . 4.7 tp10 -134.6 142.67 46.99 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.431 ' NH1' ' HE2' ' A' ' 451' ' ' HIS . 9.7 tpt180 -111.92 106.61 15.36 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.107 0.48 . . . . 0.0 110.677 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -90.81 102.4 15.16 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.997 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 81.61 149.19 6.91 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.306 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 123.87 -165.58 16.66 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.285 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 8.2 t -82.99 -175.77 6.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.031 0.443 . . . . 0.0 110.787 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -80.14 50.04 1.18 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.075 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' HIS . . . . . 0.431 ' HE2' ' NH1' ' A' ' 445' ' ' ARG . 50.8 p-80 -119.48 139.34 52.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.346 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 1.1 mmt -119.78 80.25 1.56 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 36.4 t -94.87 117.51 38.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.257 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 48.0 t -80.86 99.7 8.46 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.46 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 2.1 p -82.2 89.14 6.48 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.611 0.719 . . . . 0.0 109.136 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.587 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 1.4 tmt_? -132.16 135.82 46.64 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.826 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.459 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -65.07 105.73 1.12 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.913 0.387 . . . . 0.0 110.2 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 106.54 -1.02 36.85 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.365 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 47.6 t -110.22 -90.89 0.47 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.34 . . . . 0.0 110.236 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 73.77 28.27 65.38 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.113 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -96.73 131.13 43.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.97 0.414 . . . . 0.0 110.083 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -117.27 136.87 52.78 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.117 0.484 . . . . 0.0 111.073 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -131.63 177.7 7.31 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.551 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 464' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 60.6 m -81.3 142.04 33.48 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -175.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -76.32 -56.62 4.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.566 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' VAL . . . . . 0.473 HG23 ' H ' ' A' ' 467' ' ' CYS . 3.2 m -71.26 -60.23 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.473 ' H ' HG23 ' A' ' 466' ' ' VAL . 16.1 p -93.73 170.15 9.78 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -111.63 109.22 19.0 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.245 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.52 160.12 40.28 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.586 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.15 149.89 25.88 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -56.41 108.12 0.45 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.627 0.727 . . . . 0.0 110.942 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 p -132.97 -179.17 5.32 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.121 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -70.21 -22.69 62.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.244 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.17 -54.07 7.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.186 0.517 . . . . 0.0 110.771 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 480' ' ' TRP . 85.1 m -85.01 8.25 18.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.933 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.5 ttt -53.95 -53.47 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.78 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -137.59 -0.47 2.61 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.031 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -58.84 -64.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.463 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -113.56 -4.88 13.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.88 0.372 . . . . 0.0 110.709 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 480' ' ' TRP . . . . . 0.414 ' HB2' ' O ' ' A' ' 475' ' ' CYS . 35.0 t-105 -68.19 -28.73 67.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.369 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -97.45 106.39 18.7 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.525 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 CA-C-O 118.886 -0.952 . . . . 0.0 111.887 -179.58 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 350' ' ' GLY . . . . . 0.482 ' HA2' HG12 ' A' ' 364' ' ' VAL . . . . . . . . 0 N--CA 1.434 -1.451 0 CA-C-O 121.307 0.393 . . . . 0.0 113.424 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 352' ' ' LEU . 10.5 p -129.63 175.06 11.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.517 ' H ' HG22 ' A' ' 351' ' ' VAL . 6.5 mp -130.79 151.7 50.94 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.796 -0.565 . . . . 0.0 111.865 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' CYS . . . . . 0.507 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 34.3 t -57.12 141.01 77.47 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.398 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.507 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 28.2 Cg_endo -61.75 -10.81 18.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.417 2.745 . . . . 0.0 114.515 -176.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -111.02 136.46 20.8 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.129 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.76 -19.83 30.88 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.053 2.502 . . . . 0.0 112.437 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -70.26 -17.44 74.13 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.253 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 41.1 t -86.55 -82.79 0.2 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.42 -0.39 . . . . 0.0 110.467 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 61.28 27.48 67.67 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.182 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -75.45 -40.09 57.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.653 0.263 . . . . 0.0 111.26 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.7 121.37 4.25 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.974 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -111.11 109.93 20.22 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.267 0.556 . . . . 0.0 110.411 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -88.01 112.48 22.65 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.65 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.482 HG12 ' HA2' ' A' ' 350' ' ' GLY . 7.7 p -83.63 104.73 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 121.865 0.84 . . . . 0.0 110.661 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 368' ' ' CYS . 8.6 pt-20 -90.26 159.79 41.22 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.667 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.81 -20.78 72.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.464 2.109 . . . . 0.0 111.305 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -99.37 3.67 46.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.418 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.53 ' N ' ' HG3' ' A' ' 365' ' ' GLU . 53.5 t -63.38 106.05 0.85 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 111.044 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' ARG . . . . . 0.685 ' NE ' ' H ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -80.11 -37.92 32.65 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.069 0.462 . . . . 0.0 110.562 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -145.12 143.86 30.6 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.521 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.61 119.95 50.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.294 0.569 . . . . 0.0 110.137 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 50.5 m -152.26 139.69 19.56 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.646 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 12.6 t -77.81 47.47 0.63 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 121.14 0.495 . . . . 0.0 110.266 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -65.19 -11.9 45.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.925 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -96.23 -10.67 27.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.028 0.442 . . . . 0.0 110.739 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -133.42 -79.79 0.15 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.441 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 3.4 m -100.4 -131.28 0.24 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -168.87 104.11 0.2 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 173.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -162.66 145.98 11.22 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 17.8 m -108.28 127.58 64.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -141.39 -177.7 5.27 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.097 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 44.5 t -80.99 159.97 24.72 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.611 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.463 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 29.0 ptt180 -88.41 -15.42 35.53 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.215 0.531 . . . . 0.0 109.628 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.463 ' OD1' ' HG3' ' A' ' 383' ' ' ARG . 4.6 m-20 -106.03 -29.62 9.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.112 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 31.4 p -143.02 -159.66 1.0 Allowed 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.159 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.13 18.48 14.56 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.064 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -76.18 25.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 72.76 31.34 62.58 Favored Glycine 0 N--CA 1.463 0.485 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.53 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.4 100.49 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.407 0.622 . . . . 0.0 111.252 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -126.61 161.12 28.78 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.223 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 391' ' ' ILE . 1.9 pp -85.29 160.43 3.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.478 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.61 -146.29 25.75 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.88 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -124.11 162.28 23.88 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.739 0.304 . . . . 0.0 110.804 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.32 -0.717 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.066 -179.901 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 121.509 0.671 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.8 p -96.51 2.09 52.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.696 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 8.6 p -117.04 -177.0 3.1 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.135 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -122.83 110.77 31.39 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -63.69 125.84 16.29 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.968 1.778 . . . . 0.0 111.84 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 38.9 t -56.03 139.13 71.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.787 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.39 -1.83 11.82 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.205 1.937 . . . . 0.0 111.729 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' LYS . . . . . 0.419 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 1.7 tppm? -109.87 -61.25 1.68 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.557 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 23.9 p -101.46 -10.94 19.73 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.794 0.331 . . . . 0.0 111.375 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 69.0 mtt180 67.4 28.53 7.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.621 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 25.2 p -85.96 147.95 46.86 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.484 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.64 98.26 0.57 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.494 2.129 . . . . 0.0 112.355 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 16.9 m -85.96 124.34 32.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.027 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.35 131.05 35.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.394 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -95.7 98.76 10.71 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.271 0.558 . . . . 0.0 111.271 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -107.49 155.3 20.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.132 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 80.85 -82.71 1.5 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.241 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 127.65 3.29 6.05 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.168 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 7.0 p -68.56 161.18 28.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.564 0.221 . . . . 0.0 110.426 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.58 ' SD ' ' HA3' ' A' ' 482' ' ' GLY . 67.3 mtt -78.01 -10.29 59.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.143 0.497 . . . . 0.0 110.77 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -96.72 105.6 17.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.46 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 5.9 ptp -147.1 135.88 22.15 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.549 173.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.06 140.74 44.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.159 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 35.0 t -59.54 103.16 0.18 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.993 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 6.3 t -85.61 90.81 8.09 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 122.408 1.099 . . . . 0.0 109.559 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -129.45 138.22 51.31 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.414 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -52.67 -47.12 67.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.809 0.337 . . . . 0.0 111.183 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -104.0 49.43 0.93 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.97 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 21.5 t -152.09 -90.33 0.06 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.941 0.371 . . . . 0.0 111.508 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.14 38.16 63.54 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -90.85 118.3 30.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.747 0.308 . . . . 0.0 110.905 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -87.35 122.52 31.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.226 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -129.62 156.46 44.18 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 42.4 t -67.34 136.58 55.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.622 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -75.07 -36.96 61.76 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.543 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.19 -64.04 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.873 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.9 p -109.48 155.51 21.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.36 107.8 8.87 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 118.687 -1.205 . . . . 0.0 108.256 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.12 151.77 23.62 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.337 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.33 158.37 24.75 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -48.35 110.56 0.35 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.627 0.727 . . . . 0.0 111.382 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.6 m -138.87 154.7 48.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.639 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 476' ' ' MET . 46.7 mtp180 -61.99 -36.58 81.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.05 -32.1 72.58 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.222 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 88.0 m -87.72 -37.21 16.87 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' MET . . . . . 0.412 ' HB3' ' HA ' ' A' ' 473' ' ' ARG . 43.9 tpp -50.72 -54.65 21.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.272 -177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -90.56 7.47 81.32 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.169 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -111.13 -64.77 1.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -137.62 31.22 2.55 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -91.36 -34.04 15.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.03 0.443 . . . . 0.0 110.873 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -96.28 100.16 11.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.002 0.43 . . . . 0.0 110.978 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 482' ' ' GLY . . . . . 0.58 ' HA3' ' SD ' ' A' ' 450' ' ' MET . . . . . . . . 0 N--CA 1.437 -1.239 0 CA-C-O 118.425 -1.208 . . . . 0.0 112.072 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.558 0 N-CA-C 112.329 -0.308 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 352' ' ' LEU . 10.0 p -124.81 177.64 4.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.617 ' H ' HG22 ' A' ' 351' ' ' VAL . 85.9 mt -126.77 149.45 49.63 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 122.126 -0.359 . . . . 0.0 111.026 -177.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 355' ' ' GLN . 51.0 t -65.19 138.07 97.13 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.692 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.83 -14.25 40.95 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.924 2.416 . . . . 0.0 112.279 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.495 ' HB2' ' SG ' ' A' ' 353' ' ' CYS . 1.4 mp0 -75.48 123.68 88.66 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-O 120.92 0.39 . . . . 0.0 110.766 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.3 -22.21 46.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.097 2.532 . . . . 0.0 112.959 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -88.64 1.85 84.11 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.697 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.468 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 48.3 t -104.47 -93.56 0.35 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.921 0.391 . . . . 0.0 110.585 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.15 23.51 64.13 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.307 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.448 ' HB2' ' HE3' ' A' ' 360' ' ' MET . 47.4 mtm -61.74 -72.49 0.12 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.859 0.361 . . . . 0.0 110.844 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.447 ' HA2' HD23 ' A' ' 352' ' ' LEU . . . 145.9 109.92 0.63 Allowed Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.117 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -101.75 109.98 21.87 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 364' ' ' VAL . 3.0 tt -82.91 135.67 34.84 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.017 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.509 ' N ' HD23 ' A' ' 363' ' ' LEU . 39.2 t -90.96 86.6 2.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.263 0.554 . . . . 0.0 109.986 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 366' ' ' PRO . 6.9 mm-40 -80.97 139.56 49.71 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.634 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 365' ' ' GLU . 31.2 Cg_exo -60.62 -21.76 70.18 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.514 2.143 . . . . 0.0 111.308 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -88.58 -7.47 56.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.46 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 7.5 t -107.82 105.0 14.61 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.715 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -93.76 15.18 17.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -155.76 144.34 20.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.017 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.22 120.96 64.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.434 0.635 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' THR . . . . . 0.483 ' OG1' HG12 ' A' ' 380' ' ' VAL . 62.1 m -147.47 136.96 22.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.916 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.6 t -78.2 67.16 3.96 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.171 0.51 . . . . 0.0 109.969 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -85.43 -7.01 59.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.381 0.61 . . . . 0.0 109.816 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -90.44 -17.11 27.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.441 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -140.17 -78.65 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.49 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 3.2 m -89.03 -127.2 0.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -171.21 104.55 0.2 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 381' ' ' PHE . 55.1 t80 -163.24 137.43 6.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.484 0.142 . . . . 0.0 111.115 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.483 HG12 ' OG1' ' A' ' 372' ' ' THR . 35.1 m -100.29 128.82 51.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.436 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 7.4 p90 -142.56 -176.68 4.95 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.326 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' CYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 31.6 t -86.85 171.71 10.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.405 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 16.2 ptt180 -97.33 -16.37 20.31 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.486 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.481 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 4.6 m-20 -105.01 -28.31 11.14 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.753 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 24.5 p -143.21 -170.79 3.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.159 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.9 mp -110.62 24.06 13.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.912 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -75.58 15.58 0.47 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 76.33 29.1 58.8 Favored Glycine 0 N--CA 1.46 0.282 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.579 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 19.1 t80 63.2 101.05 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.335 0.654 . . . . 0.0 110.756 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -127.11 179.75 5.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.579 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.85 166.21 5.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.106 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.65 -132.19 11.1 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.618 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.33 149.65 49.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.781 0.324 . . . . 0.0 110.379 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 6.6 m . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.698 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 121.145 0.497 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.6 m -104.56 -15.07 15.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.573 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.5 p -94.12 138.91 31.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.552 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -108.76 140.24 21.65 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.31 125.29 11.19 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.228 1.952 . . . . 0.0 112.708 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 42.0 t -58.13 139.68 83.45 Favored Pre-proline 0 N--CA 1.456 -0.126 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.278 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 4.5 Cg_exo -70.39 -20.91 31.27 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.942 1.762 . . . . 0.0 111.335 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 438' ' ' LYS . 0.1 OUTLIER -96.29 -67.49 0.85 Allowed 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.08 -177.027 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 439' ' ' CYS . . . . . 0.532 ' SG ' ' HG3' ' A' ' 456' ' ' ARG . 21.3 p -93.09 -8.33 43.03 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.704 ' HD3' ' O ' ' A' ' 440' ' ' ARG . 1.0 OUTLIER 65.23 23.05 12.21 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.586 0.754 . . . . 0.0 111.435 177.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 39.2 p -82.56 162.74 54.83 Favored Pre-proline 0 C--N 1.31 -1.122 0 O-C-N 121.967 -0.458 . . . . 0.0 110.359 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -79.21 100.7 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.243 1.962 . . . . 0.0 112.53 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 12.1 m -92.42 128.21 38.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.193 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -86.55 160.03 19.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.607 0.242 . . . . 0.0 110.97 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.422 ' C ' ' HD2' ' A' ' 445' ' ' ARG . 7.0 tmm_? -118.06 108.69 15.54 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.61 141.95 33.69 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.315 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 71.92 -143.52 35.04 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.568 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -139.53 26.64 2.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.685 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 8.8 p -87.21 155.76 19.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.853 0.358 . . . . 0.0 111.088 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -82.79 -16.31 48.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.096 0.474 . . . . 0.0 109.932 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -86.38 96.89 10.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.199 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 3.7 ptp -117.59 111.07 18.71 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.06 129.15 41.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.177 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 43.0 t -70.39 105.2 2.95 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.645 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 5.1 t -87.01 90.27 8.29 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 122.073 0.939 . . . . 0.0 108.948 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.57 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -130.97 139.18 49.99 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.406 -177.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.65 87.31 0.13 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.872 0.368 . . . . 0.0 110.247 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.45 39.69 1.45 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.088 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 461' ' ' PHE . 19.5 t -145.78 -91.9 0.09 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.624 -0.339 . . . . 0.0 110.921 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.57 27.19 69.9 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' PHE . . . . . 0.627 ' HB2' ' SG ' ' A' ' 459' ' ' CYS . 9.8 t80 -72.6 128.2 34.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.06 0.457 . . . . 0.0 110.887 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.53 134.75 49.18 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -150.5 159.12 44.71 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.875 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 76.4 m -70.3 140.99 52.39 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.215 0.531 . . . . 0.0 110.951 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -74.31 -40.22 62.38 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.221 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 23.1 t -85.53 -58.87 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.202 -174.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 6.9 p -91.81 152.87 19.92 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -93.45 110.05 21.62 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.345 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' THR . . . . . 0.509 HG21 ' SG ' ' A' ' 475' ' ' CYS . 13.0 t -157.65 178.48 10.22 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.609 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.22 156.89 22.47 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 32.2 p-90 -51.89 117.74 2.94 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.332 0.587 . . . . 0.0 110.362 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 10.8 t -156.99 179.15 9.58 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.53 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -71.5 -23.38 61.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.978 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -62.64 -54.19 43.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.819 0.342 . . . . 0.0 111.3 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' CYS . . . . . 0.509 ' SG ' HG21 ' A' ' 469' ' ' THR . 70.8 m -98.94 24.56 7.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.631 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -61.26 -36.92 81.33 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.896 0.379 . . . . 0.0 111.271 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -167.9 26.15 0.13 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.773 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -78.32 -62.12 1.78 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.195 0.521 . . . . 0.0 110.681 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -110.77 -4.82 15.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.788 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -73.86 86.18 1.73 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.76 95.64 2.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.653 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.225 0 CA-C-O 118.321 -1.266 . . . . 0.0 111.042 -178.611 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 350' ' ' GLY . . . . . 0.437 ' HA2' HG23 ' A' ' 364' ' ' VAL . . . . . . . . 0 N--CA 1.436 -1.361 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 352' ' ' LEU . 7.8 p -155.81 175.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.495 ' H ' HG22 ' A' ' 351' ' ' VAL . 6.7 mp -129.14 150.85 50.36 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.784 -0.572 . . . . 0.0 111.337 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' CYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 354' ' ' PRO . 43.3 t -63.75 128.33 92.67 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.446 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 353' ' ' CYS . 17.8 Cg_exo -67.38 -9.38 25.08 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.19 2.593 . . . . 0.0 113.129 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 358' ' ' CYS . 10.3 tm0? -65.0 122.53 80.06 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.1 -28.6 51.7 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 123.765 2.977 . . . . 0.0 114.964 -174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -108.19 16.97 35.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.702 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.751 ' SG ' ' HG3' ' A' ' 360' ' ' MET . 12.2 t -106.04 -97.27 0.34 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.27 32.38 71.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.078 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.751 ' HG3' ' SG ' ' A' ' 358' ' ' CYS . 0.6 OUTLIER -65.86 -32.98 74.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.83 107.63 2.94 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.955 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.41 HD22 ' SD ' ' A' ' 360' ' ' MET . 3.9 mm? -99.45 135.46 40.83 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.82 128.68 55.11 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.437 HG23 ' HA2' ' A' ' 350' ' ' GLY . 79.7 t -77.9 91.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.409 0.623 . . . . 0.0 109.781 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 368' ' ' CYS . 16.2 mm-40 -90.07 148.29 39.11 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.368 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.67 -22.75 74.26 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.478 2.119 . . . . 0.0 111.62 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -99.52 9.85 42.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.419 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 365' ' ' GLU . 37.2 t -89.7 78.95 6.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.445 0.64 . . . . 0.0 109.698 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' ARG . . . . . 0.478 ' H ' ' HD2' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -72.76 -22.59 60.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.758 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 370' ' ' LYS . 3.7 mmmp? -135.26 113.63 11.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.169 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.84 112.66 23.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.566 0.698 . . . . 0.0 110.041 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 94.9 m -147.44 138.86 23.86 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.92 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.422 ' SG ' ' HA3' ' A' ' 376' ' ' GLY . 21.6 t -74.86 76.8 2.13 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.225 0.536 . . . . 0.0 109.69 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -86.08 -38.7 17.53 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.048 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.53 -18.35 54.86 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.098 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' GLY . . . . . 0.422 ' HA3' ' SG ' ' A' ' 373' ' ' CYS . . . -101.32 -89.98 2.08 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.925 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.2 p -124.7 -91.52 0.54 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.013 0.435 . . . . 0.0 110.567 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -172.52 107.23 0.25 Allowed Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -161.02 131.81 5.31 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.872 0.336 . . . . 0.0 110.308 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.88 124.38 65.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.42 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 6.2 p90 -152.66 179.49 8.56 Favored 'General case' 0 C--O 1.21 -0.999 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.253 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 24.5 t -84.43 167.78 16.12 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -95.4 -16.6 22.19 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.323 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -104.31 -32.8 8.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.872 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 27.8 p -137.59 -166.38 1.93 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.101 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.401 ' HG ' ' HG3' ' A' ' 354' ' ' PRO . 10.9 mp -115.06 27.51 9.35 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.774 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -78.16 16.03 0.83 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 79.18 17.47 76.51 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.609 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 73.45 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.512 0.725 . . . . 0.0 111.244 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -148.23 -46.81 0.16 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.045 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.9 tt -150.3 158.04 5.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -87.91 6.24 83.75 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.767 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -136.03 115.59 12.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.136 0.468 . . . . 0.0 111.327 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 59.2 m . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.949 -179.053 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 121.264 0.554 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.1 m -107.63 -31.22 8.18 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.693 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.2 p -80.12 -178.58 6.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.234 0.54 . . . . 0.0 111.413 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.541 ' HG2' ' CH2' ' A' ' 463' ' ' TRP . 1.6 tpmt? -112.84 108.82 53.27 Favored Pre-proline 0 C--N 1.312 -1.047 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 434' ' ' LYS . 24.9 Cg_endo -63.05 130.69 29.81 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.117 1.878 . . . . 0.0 111.739 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 45.5 t -57.36 134.93 81.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.358 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.36 -7.64 21.47 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.365 2.043 . . . . 0.0 111.746 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -107.59 -63.99 1.25 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.83 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 6.2 p -95.47 -3.11 47.41 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 60.7 26.05 15.82 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 21.4 p -87.22 143.11 34.13 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.73 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -63.75 104.73 0.48 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.345 2.03 . . . . 0.0 111.449 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 37.9 m -96.4 133.6 40.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.939 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.21 163.98 23.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.761 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -120.58 162.43 19.64 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.122 0.487 . . . . 0.0 111.647 -176.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -99.79 162.57 12.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.059 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -63.04 -50.87 59.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.854 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -151.3 52.8 0.49 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.351 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 61.6 m -118.91 137.35 53.52 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -17.45 27.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.85 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.32 96.95 10.53 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 70.0 mmm -106.51 112.53 25.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 462' ' ' GLU . 21.3 t -115.6 141.37 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.996 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 28.8 t -83.03 125.66 31.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.06 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 19.9 p -101.54 89.96 3.9 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 121.833 0.825 . . . . 0.0 110.338 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.531 ' HB3' ' HB2' ' A' ' 459' ' ' CYS . 2.7 tmt_? -131.97 135.39 46.54 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.41 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -62.33 97.65 0.1 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.695 0.284 . . . . 0.0 110.954 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.06 22.24 8.44 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.581 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 456' ' ' ARG . 51.4 t -114.36 -80.93 0.6 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.429 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.72 24.12 76.45 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.25 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -93.91 139.25 31.13 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.421 ' HB3' HG13 ' A' ' 453' ' ' VAL . 7.3 pt-20 -126.55 157.71 38.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.301 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' TRP . . . . . 0.541 ' CH2' ' HG2' ' A' ' 434' ' ' LYS . 7.4 p-90 -147.4 163.43 36.51 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.12 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 464' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 43.9 t -70.49 143.24 51.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.682 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -75.75 -42.09 51.44 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.609 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.79 -48.05 24.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 27.4 p -118.96 143.79 46.83 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.52 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -77.09 111.65 12.91 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.378 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 3.7 p -152.85 174.99 13.39 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.995 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -96.48 152.44 18.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' TRP . . . . . 0.4 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 35.4 t-105 -54.1 122.9 11.17 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.02 0.438 . . . . 0.0 111.748 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.8 t -160.43 153.62 21.78 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.592 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -66.67 -25.42 66.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.3 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.83 -34.71 69.98 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.472 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.65 -27.59 14.72 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.7 ttt -53.81 -44.6 70.34 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.452 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -100.85 20.25 48.73 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.669 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -105.71 -64.94 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.681 -0.306 . . . . 0.0 111.44 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -148.68 28.76 0.85 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.275 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -69.45 -29.86 67.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.176 0.512 . . . . 0.0 109.884 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -92.9 111.67 23.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.445 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.038 0 CA-C-O 118.461 -1.188 . . . . 0.0 112.058 -179.161 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.914 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 362' ' ' LEU . 9.9 p -126.72 167.68 21.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.407 ' H ' HG22 ' A' ' 351' ' ' VAL . 5.8 mp -137.41 152.28 49.45 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.914 0.388 . . . . 0.0 111.716 -177.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 18.5 t -59.41 135.68 88.77 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.698 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 379' ' ' TYR . 42.7 Cg_endo -66.73 -15.57 47.77 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.913 2.409 . . . . 0.0 113.785 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -99.0 134.45 21.42 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 120.822 0.344 . . . . 0.0 111.788 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.81 -15.65 44.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.216 2.611 . . . . 0.0 112.729 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -79.71 16.12 12.25 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.831 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.7 t -126.68 -87.3 0.59 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 64.43 21.13 66.32 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.827 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 37.5 ttp -67.59 -43.65 80.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.832 0.348 . . . . 0.0 111.172 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.72 118.92 4.44 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.007 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.458 ' HB2' HG13 ' A' ' 351' ' ' VAL . 4.0 mm? -112.8 155.62 24.29 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.796 0.332 . . . . 0.0 110.456 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.409 ' HG ' ' N ' ' A' ' 364' ' ' VAL . 26.7 tp -102.61 157.06 17.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.66 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.409 ' N ' ' HG ' ' A' ' 363' ' ' LEU . 48.8 t -121.85 90.88 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 120.954 0.407 . . . . 0.0 110.563 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.33 152.22 96.6 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.41 -30.15 86.63 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.073 1.849 . . . . 0.0 111.139 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.57 15.0 28.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.115 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.35 101.77 3.54 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -111.7 -3.32 15.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 370' ' ' LYS . 5.5 mmpt? -144.95 91.53 2.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.835 177.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.78 129.06 46.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.5 0.667 . . . . 0.0 110.513 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.6 m -152.45 145.11 24.23 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.296 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 8.7 t -76.12 45.99 0.38 Allowed 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 121.326 0.584 . . . . 0.0 109.786 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -63.75 -12.38 34.49 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -98.62 -2.64 37.99 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -143.13 -75.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.101 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.1 m -99.72 -132.64 0.25 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -170.83 103.97 0.2 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.422 ' CD2' ' HG3' ' A' ' 354' ' ' PRO . 54.7 t80 -162.14 139.56 8.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 26.2 m -95.04 126.11 47.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.438 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 16.7 p90 -138.51 -176.57 4.51 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' CYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 16.4 t -82.27 164.05 21.42 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.706 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -92.28 -18.9 22.75 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.097 0.475 . . . . 0.0 110.352 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.577 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 1.6 t-20 -106.57 -29.22 9.78 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.174 0.511 . . . . 0.0 109.927 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 29.3 p -136.39 -165.2 1.68 Allowed 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.739 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 62.8 mt -117.51 25.71 10.23 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.878 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -86.55 30.41 0.72 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 70.26 23.16 77.52 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.573 175.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.92 113.03 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.762 0.825 . . . . 0.0 112.14 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -131.91 168.44 17.87 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.841 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.71 147.87 6.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.273 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 100.02 173.97 30.35 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.445 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -100.44 128.97 46.36 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.803 0.335 . . . . 0.0 110.214 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 1.3 m . . . . . 0 C--N 1.316 -0.879 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.386 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 121.048 0.451 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 22.2 m -91.32 -13.38 32.69 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.844 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 4.0 p -82.92 138.72 33.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.591 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.441 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 1.7 tpmt? -90.91 124.67 61.35 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 5.8 Cg_exo -73.54 122.71 8.08 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.097 1.865 . . . . 0.0 111.764 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 440' ' ' ARG . 35.1 t -53.25 136.66 49.81 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.103 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.85 -14.69 46.42 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.712 2.275 . . . . 0.0 112.4 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.69 -67.86 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 7.8 p -86.45 -8.5 57.56 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 436' ' ' CYS . 18.7 mmm180 64.14 26.01 13.81 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.643 0.377 . . . . 0.0 111.628 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 29.3 p -87.29 141.82 32.95 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.632 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 11.9 Cg_exo -69.49 104.36 1.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.597 2.198 . . . . 0.0 112.094 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 18.0 m -81.16 119.69 23.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.335 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.64 95.44 4.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.362 0.601 . . . . 0.0 109.711 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 445' ' ' ARG . 20.7 mtp180 -137.07 156.58 48.22 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.741 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.18 151.39 22.72 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -81.95 59.04 4.9 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.34 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -72.38 -35.61 59.89 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 27.1 p -140.34 175.46 9.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.498 ' HA ' ' HB3' ' A' ' 465' ' ' TRP . 1.0 OUTLIER -83.72 0.89 45.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.781 0.324 . . . . 0.0 111.271 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -93.2 100.48 12.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.774 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' MET . . . . . 0.416 ' HG2' ' HB2' ' A' ' 465' ' ' TRP . 10.3 mmt -100.1 107.01 18.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.345 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' A' ' 462' ' ' GLU . 21.7 t -105.73 124.8 61.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.044 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 52.4 t -78.83 99.7 6.85 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.994 0.426 . . . . 0.0 109.954 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 13.0 p -83.49 90.25 7.19 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 121.623 0.725 . . . . 0.0 110.111 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.484 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 4.0 tmm_? -130.76 145.61 52.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.462 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -69.61 93.26 0.69 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.769 0.318 . . . . 0.0 110.683 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 111.66 13.22 13.11 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.748 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.484 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 49.6 t -114.12 -88.4 0.56 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 122.788 -0.242 . . . . 0.0 110.566 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.16 27.17 70.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.145 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -88.28 142.91 27.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.918 0.39 . . . . 0.0 110.451 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.474 ' HG2' HG22 ' A' ' 453' ' ' VAL . 51.7 mt-10 -114.85 133.24 56.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.296 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -133.74 164.75 26.54 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.976 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 13.8 t -77.97 136.01 37.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.316 0.579 . . . . 0.0 111.962 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 465' ' ' TRP . . . . . 0.498 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 21.4 t-105 -77.51 -44.1 29.88 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.274 177.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 22.7 m -78.57 -17.18 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -173.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 18.5 p -145.19 148.99 34.15 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -82.52 108.67 16.1 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.718 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.3 p -155.82 178.1 10.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.246 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.04 157.62 17.39 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' TRP . . . . . 0.467 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 45.6 t90 -53.04 104.45 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 109.897 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 p -134.07 152.82 52.01 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.07 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' ARG . . . . . 0.592 ' HG3' ' SD ' ' A' ' 476' ' ' MET . 14.9 ttm180 -70.12 -23.0 62.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.102 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.0 -28.46 68.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.23 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 2.8 t -100.47 -27.34 13.49 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' MET . . . . . 0.592 ' SD ' ' HG3' ' A' ' 473' ' ' ARG . 14.2 ptm -55.74 -29.49 59.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.858 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -111.04 12.1 29.19 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.216 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -100.16 -65.91 0.94 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.805 0.336 . . . . 0.0 110.841 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -146.27 21.42 1.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.662 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -72.87 -11.75 60.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.776 0.798 . . . . 0.0 108.878 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -119.56 151.82 38.02 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.767 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.476 -1.18 . . . . 0.0 112.131 -179.548 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.358 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 6.2 p -101.32 166.01 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.86 141.5 47.82 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 30.0 t -66.6 118.58 55.54 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.925 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.563 ' CG ' HD11 ' A' ' 386' ' ' LEU . 92.3 Cg_endo -81.9 4.98 6.62 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.518 2.812 . . . . 0.0 112.195 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -87.12 121.2 71.6 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.79 111.9 0.98 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.928 2.419 . . . . 0.0 112.816 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 126.39 3.07 6.8 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.343 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.702 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 36.6 t -113.08 -90.22 0.52 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 120.768 0.318 . . . . 0.0 111.089 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 60.55 22.85 59.8 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 43.5 ttp -72.37 -73.1 0.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.489 0.316 . . . . 0.0 111.36 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 148.36 121.63 1.2 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.737 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.5 129.11 56.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.973 0.416 . . . . 0.0 110.201 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 51.9 tp -86.51 129.82 34.72 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.676 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.22 87.43 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.485 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.61 166.58 44.09 Favored Pre-proline 0 C--N 1.313 -0.989 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.781 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.26 -23.88 64.65 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.236 1.957 . . . . 0.0 111.75 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.24 2.5 42.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.128 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.76 86.84 7.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -104.69 21.7 16.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.1 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -156.0 110.89 2.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.382 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.8 128.07 60.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.609 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 48.9 m -152.64 137.24 16.87 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.218 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 2.4 t -79.82 61.23 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.193 0.52 . . . . 0.0 110.17 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -70.71 -6.39 36.93 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.296 0.57 . . . . 0.0 110.187 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -99.67 -3.83 32.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.519 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -158.67 -115.79 0.44 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.964 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.3 p -86.66 94.89 9.61 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.84 113.77 5.45 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.922 -0.581 . . . . 0.0 114.495 -172.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -150.92 133.76 15.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.79 133.51 29.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 120.828 0.347 . . . . 0.0 110.08 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 389' ' ' TYR . 30.8 p90 -148.38 176.04 10.61 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 29.8 t -85.98 151.7 23.52 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -80.76 -11.59 59.59 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.028 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.466 ' CG ' ' H ' ' A' ' 394' ' ' CYS . 13.5 m-80 -105.47 -37.91 6.64 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.888 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.41 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 27.0 p -140.52 -159.21 0.93 Allowed 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.93 -176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.563 HD11 ' CG ' ' A' ' 354' ' ' PRO . 3.9 mm? -116.33 23.6 11.99 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' GLN . . . . . 0.538 ' HB2' ' CD2' ' A' ' 390' ' ' HIS . 75.2 mm-40 -83.07 28.0 0.53 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 69.5 25.5 75.44 Favored Glycine 0 N--CA 1.469 0.891 0 C-N-CA 121.478 -0.391 . . . . 0.0 114.05 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 381' ' ' PHE . 13.7 t80 63.31 105.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.409 0.684 . . . . 0.0 110.92 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.547 ' CG ' ' H ' ' A' ' 391' ' ' ILE . 2.3 p80 -132.63 -72.97 0.51 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.529 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.547 ' H ' ' CG ' ' A' ' 390' ' ' HIS . 50.7 mm -88.49 149.4 4.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -57.78 -54.23 38.97 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.81 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -130.72 122.41 27.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.877 0.37 . . . . 0.0 110.661 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.466 ' H ' ' CG ' ' A' ' 384' ' ' ASN . 62.3 m . . . . . 0 C--N 1.313 -0.992 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.069 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.651 0.262 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 19.9 m -72.46 -28.64 63.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.873 0.368 . . . . 0.0 110.6 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 11.8 p -78.73 115.33 18.35 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.197 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -92.39 143.89 28.04 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.304 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.58 127.25 15.25 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.461 2.107 . . . . 0.0 111.87 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 30.3 t -57.08 139.29 79.21 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.949 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.2 -15.74 46.92 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.134 1.889 . . . . 0.0 112.055 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -103.2 -60.17 1.6 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.0 p -99.68 -8.04 24.88 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 440' ' ' ARG . 3.1 mpt_? 63.4 24.77 14.3 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 34.3 p -82.95 157.68 65.98 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.84 103.85 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.121 1.881 . . . . 0.0 111.22 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 26.9 m -77.27 112.47 14.01 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.571 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.15 108.93 14.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.975 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -111.25 125.81 54.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.176 0.512 . . . . 0.0 110.73 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -141.87 104.05 4.44 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 78.4 52.48 5.15 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -53.03 126.35 33.04 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.357 -0.422 . . . . 0.0 112.895 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 13.1 t -93.83 24.57 4.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.73 0.3 . . . . 0.0 110.365 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 43.1 ttm 72.82 -40.19 0.47 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.851 0.86 . . . . 0.0 111.271 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -84.32 105.0 14.82 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 87.2 mmm -98.73 120.51 39.29 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.725 0.298 . . . . 0.0 111.169 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.57 128.41 76.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.348 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.5 t -92.73 106.21 18.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.994 0.426 . . . . 0.0 110.403 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.0 p -87.87 90.77 8.51 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.296 0.57 . . . . 0.0 110.129 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.556 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 2.5 tmm_? -130.74 138.94 50.21 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -62.36 98.43 0.11 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.719 0.295 . . . . 0.0 110.59 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.71 9.11 29.25 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.086 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.556 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 45.2 t -113.86 -91.8 0.5 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 122.431 -0.452 . . . . 0.0 110.758 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.71 23.95 77.35 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' PHE . . . . . 0.41 ' CD2' ' HZ3' ' A' ' 471' ' ' TRP . 27.5 t80 -84.2 108.77 17.28 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.158 0.504 . . . . 0.0 110.372 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 471' ' ' TRP . 6.3 pt-20 -97.98 126.24 43.3 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.731 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -128.86 166.44 19.07 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.791 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' CYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 27.2 t -78.77 144.04 35.54 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.311 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -76.5 -39.21 53.73 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.165 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.71 -8.18 9.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 17.9 p -148.95 155.87 41.46 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -91.38 107.74 19.41 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.104 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 5.0 p -155.6 169.98 23.04 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.223 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -96.14 157.05 16.08 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' TRP . . . . . 0.479 ' HB3' ' HG3' ' A' ' 462' ' ' GLU . 20.3 p90 -48.92 111.97 0.55 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.595 0.712 . . . . 0.0 111.333 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 5.4 p -134.35 148.9 50.8 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.107 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 473' ' ' ARG . 14.5 mmt180 -74.95 -22.14 58.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.129 0.49 . . . . 0.0 110.055 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.82 -50.51 70.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.913 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 18.7 t -74.68 -30.19 61.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.628 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' MET . . . . . 0.552 ' HA ' ' CB ' ' A' ' 480' ' ' TRP . 28.1 ttt -52.76 -38.04 60.42 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.729 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -100.83 13.05 59.33 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.159 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.41 -66.17 1.08 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.818 -0.225 . . . . 0.0 111.346 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -153.79 12.45 0.45 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.892 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 480' ' ' TRP . . . . . 0.552 ' CB ' ' HA ' ' A' ' 476' ' ' MET . 76.6 t-105 -56.64 -43.24 80.08 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.273 0.559 . . . . 0.0 110.497 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -147.44 89.4 1.78 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.019 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.115 0 CA-C-O 118.573 -1.126 . . . . 0.0 111.449 -178.319 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.562 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.572 HG22 ' H ' ' A' ' 352' ' ' LEU . 5.8 p -122.66 176.19 4.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.572 ' H ' HG22 ' A' ' 351' ' ' VAL . 3.6 mm? -112.88 146.7 38.46 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.3 t -62.49 138.97 96.64 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.23 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.64 -4.21 14.93 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.856 2.371 . . . . 0.0 112.304 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -86.46 124.76 69.27 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.239 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.45 112.99 3.48 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.563 2.176 . . . . 0.0 112.012 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 120.29 -6.39 11.84 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.831 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.403 ' SG ' ' HG3' ' A' ' 360' ' ' MET . 47.5 t -84.5 -79.92 0.21 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.43 20.88 52.77 Favored Glycine 0 C--O 1.228 -0.236 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.648 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.569 ' HE1' ' HA3' ' A' ' 376' ' ' GLY . 34.2 mtm -68.01 -56.95 7.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.012 0.406 . . . . 0.0 111.024 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 124.67 114.16 2.03 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.71 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.3 mm? -98.45 134.77 40.97 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.058 0.456 . . . . 0.0 111.355 -177.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -93.03 124.08 36.75 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.35 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.28 116.97 48.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.975 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.31 155.5 66.51 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -42.91 -51.12 5.67 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.36 2.707 . . . . 0.0 113.656 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -106.86 28.8 7.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.852 0.358 . . . . 0.0 111.85 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 37.1 t -67.31 -52.79 36.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.613 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 67.03 -59.42 0.38 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.672 0.789 . . . . 0.0 111.98 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -72.98 116.73 13.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.44 0.638 . . . . 0.0 111.126 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 381' ' ' PHE . 0.0 OUTLIER -116.79 125.19 73.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.819 176.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 81.6 m -153.07 142.22 21.42 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.279 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.492 ' HA ' HD11 ' A' ' 362' ' ' LEU . 5.2 t -73.22 74.52 1.29 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.34 -18.8 61.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.393 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -99.3 -11.04 21.6 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.131 0.491 . . . . 0.0 110.807 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' GLY . . . . . 0.569 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -141.79 -129.6 2.45 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.759 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.41 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.9 OUTLIER -74.98 91.18 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.829 0.452 . . . . 0.0 111.017 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.72 119.23 9.75 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.9 -174.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -142.2 139.82 32.16 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.516 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 14.5 m -83.09 124.65 39.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.204 0.526 . . . . 0.0 111.186 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 371' ' ' VAL . 5.4 p90 -141.36 -176.9 4.89 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.469 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' CYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 36.4 t -105.46 169.96 8.16 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.46 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 7.1 ptt180 -87.93 -27.02 22.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.285 0.564 . . . . 0.0 109.805 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.46 ' OD1' ' HG3' ' A' ' 383' ' ' ARG . 5.6 m-20 -103.55 -19.73 14.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.431 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 394' ' ' CYS . 1.4 m -138.02 165.86 25.54 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.378 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.3 mp -111.89 34.83 3.98 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -86.97 2.13 50.49 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 100.67 27.75 7.38 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 119.565 -1.303 . . . . 0.0 114.04 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 47.2 t80 72.73 121.35 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.291 0.636 . . . . 0.0 111.921 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -167.92 176.86 5.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.932 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 391' ' ' ILE . 2.4 pp -139.51 148.93 22.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.757 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.95 -33.62 2.63 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.657 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -70.97 -20.26 62.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.567 0.698 . . . . 0.0 111.346 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.551 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 2.7 p . . . . . 0 C--N 1.291 -1.938 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.977 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.984 0.421 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 47.9 m -113.55 -0.49 14.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.379 0.609 . . . . 0.0 110.541 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 7.4 p -101.97 172.43 6.93 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.696 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -122.1 127.58 25.87 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.367 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.18 122.88 10.75 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.161 1.907 . . . . 0.0 111.77 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.61 ' O ' ' HD3' ' A' ' 440' ' ' ARG . 41.6 t -56.41 137.26 76.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.465 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.22 -14.8 41.43 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.212 1.941 . . . . 0.0 111.605 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -99.79 -78.04 0.51 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.667 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.0 p -81.41 -9.37 59.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.61 ' HD3' ' O ' ' A' ' 436' ' ' CYS . 38.4 mmt180 64.98 25.59 12.69 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.777 0.431 . . . . 0.0 111.875 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 39.3 p -88.76 151.88 48.18 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.44 102.12 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.525 2.15 . . . . 0.0 111.944 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 51.7 m -94.11 130.23 40.38 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.396 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -74.75 146.32 42.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.014 0.435 . . . . 0.0 111.051 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -95.71 162.13 13.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.134 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -117.9 141.77 48.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -97.82 4.12 61.11 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.118 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -127.17 -49.23 0.17 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.656 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.7 t -96.16 136.43 36.64 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.856 0.36 . . . . 0.0 110.548 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.76 19.81 3.3 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.574 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -104.01 111.97 24.75 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' MET . . . . . 0.494 ' HG2' ' HB2' ' A' ' 465' ' ' TRP . 79.2 mmm -99.83 111.83 24.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 0.0 110.923 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.84 130.07 60.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.823 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.1 t -91.38 130.39 37.24 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 3.4 p -109.62 88.85 2.84 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 121.561 0.696 . . . . 0.0 110.084 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.46 135.78 44.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.52 95.25 0.32 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.961 0.41 . . . . 0.0 110.086 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 123.94 -9.99 8.44 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.527 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' CYS . . . . . . . . . . . . . 48.1 t -97.22 -88.34 0.3 Allowed 'General case' 0 C--O 1.239 0.503 0 O-C-N 122.673 -0.31 . . . . 0.0 111.009 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.27 31.43 63.69 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.821 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -95.18 142.12 28.0 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.973 0.416 . . . . 0.0 110.514 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.01 135.97 55.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.583 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -143.45 165.92 26.21 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.523 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 61.2 m -73.59 144.72 45.89 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.312 0.577 . . . . 0.0 112.018 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' TRP . . . . . 0.494 ' HB2' ' HG2' ' A' ' 452' ' ' MET . 26.1 t-105 -76.7 -51.33 11.67 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.046 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.36 -35.7 63.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 26.3 p -116.74 -161.65 0.81 Allowed 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -142.62 109.55 5.51 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' THR . . . . . 0.458 HG21 ' SG ' ' A' ' 475' ' ' CYS . 13.4 t -158.02 177.88 10.83 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.386 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -87.74 150.43 23.6 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -52.74 101.73 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.584 0.707 . . . . 0.0 110.14 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.8 p -130.57 171.9 12.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.621 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -73.93 -21.73 59.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.144 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.96 -52.76 63.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.495 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' CYS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 478' ' ' ALA . 72.5 m -84.0 -18.7 36.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.112 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 24.2 ttt -46.68 -54.13 10.24 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.728 0.643 . . . . 0.0 111.632 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -97.98 17.77 58.22 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.356 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 475' ' ' CYS . . . -110.01 -66.28 1.08 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.695 0.283 . . . . 0.0 111.4 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -144.67 12.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -68.09 -28.17 67.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.484 0.659 . . . . 0.0 109.812 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -132.14 105.73 7.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.386 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-O 118.712 -1.049 . . . . 0.0 112.502 -178.173 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.085 0 CA-C-O 120.958 0.199 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 362' ' ' LEU . 29.6 m -120.58 -178.25 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 C-N-CA 123.339 0.656 . . . . 0.0 109.879 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 22.4 mt -126.6 150.45 48.87 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 54.0 t -57.98 137.37 83.79 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.436 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.02 -17.16 51.0 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.984 2.456 . . . . 0.0 112.299 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 358' ' ' CYS . 34.7 tt0 -72.45 121.29 84.44 Favored Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.3 -39.46 91.14 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.094 2.53 . . . . 0.0 112.599 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -78.69 -10.75 85.92 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.348 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 355' ' ' GLN . 7.1 t -88.58 -76.65 0.39 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.971 0.415 . . . . 0.0 110.03 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 68.72 27.23 74.0 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.645 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.432 ' HE2' ' HB3' ' A' ' 360' ' ' MET . 35.2 ttp -88.62 153.09 21.39 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -88.6 115.16 4.37 Favored Glycine 0 C--N 1.284 -2.335 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.534 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.495 ' HB2' HG23 ' A' ' 351' ' ' VAL . 4.5 mm? -94.59 134.22 37.39 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.511 HD13 ' N ' ' A' ' 364' ' ' VAL . 1.1 tm? -92.68 139.63 30.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.511 ' N ' HD13 ' A' ' 363' ' ' LEU . 43.7 t -108.89 91.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 120.851 0.357 . . . . 0.0 110.262 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -71.38 145.92 91.17 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.57 -22.47 58.33 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 121.948 1.765 . . . . 0.0 110.341 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -108.38 23.05 15.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.066 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 51.5 t -56.51 124.07 16.93 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.461 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -83.19 -48.63 10.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.692 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -148.72 118.19 6.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.633 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 381' ' ' PHE . 2.0 p -84.6 111.8 20.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.483 0.659 . . . . 0.0 109.539 176.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 91.4 m -152.78 144.22 23.33 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.98 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 19.9 t -75.57 69.66 2.33 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.345 0.593 . . . . 0.0 110.064 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -83.8 -6.55 59.45 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.567 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -111.25 5.77 20.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.934 -177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -133.79 -75.87 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.566 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.5 p -124.6 -102.72 0.37 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.873 0.368 . . . . 0.0 110.37 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -173.0 106.07 0.22 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -163.39 123.36 2.19 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.97 129.26 49.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.467 ' O ' HG13 ' A' ' 371' ' ' VAL . 8.1 p90 -140.0 -177.34 4.95 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.887 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 27.9 t -83.44 172.78 12.11 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -100.42 -14.66 18.23 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.639 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.537 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 8.6 t30 -105.21 -26.86 11.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.434 0.635 . . . . 0.0 109.483 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 28.8 p -143.31 -169.84 3.14 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.724 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 11.1 mp -116.47 26.4 9.91 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.561 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -76.56 11.54 1.6 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 86.62 21.07 52.52 Favored Glycine 0 N--CA 1.459 0.205 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.398 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 72.95 120.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.696 0.798 . . . . 0.0 111.631 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -150.6 166.6 29.81 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.791 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.71 143.09 24.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 111.41 23.08 5.86 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.087 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 61.64 -178.88 0.12 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.5 0.72 . . . . 0.0 111.827 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 2.5 m . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.196 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 121.35 0.595 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.434 ' O ' ' HD2' ' A' ' 445' ' ' ARG . 3.2 p -115.26 3.63 14.31 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.45 0.643 . . . . 0.0 110.489 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.68 152.14 20.96 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.097 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 434' ' ' LYS . 0.0 OUTLIER -118.93 119.15 32.51 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 435' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 10.7 Cg_exo -68.52 126.18 13.8 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 122.006 1.804 . . . . 0.0 112.206 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 438' ' ' LYS . 43.6 t -57.91 131.26 83.08 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.431 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.497 ' HG2' ' CE2' ' A' ' 461' ' ' PHE . 64.6 Cg_endo -74.64 -1.24 10.83 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.322 2.014 . . . . 0.0 111.391 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' LYS . . . . . 0.572 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 27.7 tptp -102.81 -64.7 1.05 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.971 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 11.0 p -103.59 -3.46 25.17 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 22.0 mmm180 68.58 29.16 5.6 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 34.7 p -90.27 141.38 27.56 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 2.4 Cg_endo -75.63 94.52 0.99 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.916 1.744 . . . . 0.0 111.398 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 30.4 m -89.64 128.21 36.02 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.016 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.62 151.11 44.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.904 0.383 . . . . 0.0 111.338 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.516 ' HD3' ' H ' ' A' ' 445' ' ' ARG . 0.3 OUTLIER -82.57 146.14 29.34 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.574 177.758 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -117.43 89.45 3.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.88 0.371 . . . . 0.0 110.955 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 60.03 -134.88 50.68 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.623 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -112.99 18.24 21.79 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.681 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 43.3 t -63.95 129.46 40.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.418 ' HA ' ' HB3' ' A' ' 465' ' ' TRP . 60.6 mtt -75.99 -25.68 56.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.977 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -79.22 96.2 5.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 40.6 mmm -118.43 109.68 16.53 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.68 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.413 ' CG1' ' HG2' ' A' ' 462' ' ' GLU . 4.0 m -121.66 150.87 24.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 120.952 0.406 . . . . 0.0 110.275 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 456' ' ' ARG . 42.8 t -83.68 100.65 11.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.499 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 5.9 p -81.45 92.15 6.42 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -128.9 139.64 52.04 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -177.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -45.71 -45.57 14.38 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.486 0.491 . . . . 0.0 112.231 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -122.56 59.34 0.59 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.749 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 45.4 t -146.38 -83.54 0.13 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.83 0.315 . . . . 0.0 110.793 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.88 49.52 41.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.375 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' PHE . . . . . 0.497 ' CE2' ' HG2' ' A' ' 437' ' ' PRO . 65.1 t80 -99.8 120.53 39.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.825 0.345 . . . . 0.0 111.097 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.413 ' HG2' ' CG1' ' A' ' 453' ' ' VAL . 41.1 mt-10 -94.22 134.17 36.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.842 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -144.29 161.28 39.33 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.889 0.376 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' CYS . . . . . 0.792 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 19.8 m -76.61 137.35 39.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.313 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' TRP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 15.9 t-105 -68.45 -45.55 72.19 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.689 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.39 -63.92 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.237 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.792 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 17.1 p -98.79 126.34 44.39 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.55 109.37 7.97 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.579 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.5 156.21 36.28 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.046 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -85.97 135.84 33.5 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -55.76 106.97 0.29 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.2 p -140.52 -164.96 1.83 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.589 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -73.58 -29.31 62.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 109.817 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -72.06 -58.45 3.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.158 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 34.3 m -97.54 70.05 2.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.497 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.58 4.15 53.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.46 0.648 . . . . 0.0 109.453 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 477' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 480' ' ' TRP . . . 121.38 12.68 5.58 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.271 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -61.93 -19.42 62.71 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -121.91 9.46 10.02 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.178 0.513 . . . . 0.0 109.911 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 480' ' ' TRP . . . . . 0.407 ' HB2' ' HA2' ' A' ' 477' ' ' GLY . 9.3 t-105 -86.43 86.24 7.33 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.166 -175.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -149.9 121.19 7.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.385 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.101 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.227 179.09 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.972 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.01 165.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.74 148.26 33.87 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 122.207 -0.308 . . . . 0.0 110.965 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 34.2 t -68.53 122.04 83.09 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.499 ' CG ' HD11 ' A' ' 386' ' ' LEU . 92.4 Cg_endo -79.5 0.03 10.34 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.936 2.424 . . . . 0.0 112.748 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 52.8 tt0 -81.06 120.2 78.04 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 355' ' ' GLN . 39.1 Cg_exo -58.0 106.52 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.796 2.331 . . . . 0.0 112.325 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 128.39 -6.54 6.69 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.768 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.3 t -94.42 -94.04 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.898 0.349 . . . . 0.0 110.557 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 71.07 16.21 74.83 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.006 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.404 ' HE2' ' HB3' ' A' ' 360' ' ' MET . 41.6 ttp -67.06 -54.88 17.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.98 0.419 . . . . 0.0 111.198 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.63 122.49 2.56 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.653 -0.785 . . . . 0.0 111.695 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.608 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.3 mm? -109.03 132.61 53.95 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.515 0.674 . . . . 0.0 111.325 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.81 106.22 18.22 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.778 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 11.4 p -116.41 127.42 74.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.289 0.566 . . . . 0.0 110.25 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -94.49 162.61 25.37 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.992 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.04 -26.32 81.21 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.472 2.115 . . . . 0.0 111.645 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.18 5.63 40.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.305 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 46.6 t -88.18 108.04 19.08 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.954 0.407 . . . . 0.0 110.693 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' ARG . . . . . 0.437 ' O ' ' HE1' ' A' ' 389' ' ' TYR . 0.7 OUTLIER -94.08 -33.13 13.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.656 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -85.75 104.6 15.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.207 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 14.4 p -103.7 122.81 56.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.267 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 96.7 m -153.27 139.49 18.43 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.075 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.608 ' HA ' HD11 ' A' ' 362' ' ' LEU . 2.5 t -74.83 69.89 1.88 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -68.7 -13.26 62.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.559 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -103.9 -3.72 24.41 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.96 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -154.63 -124.63 0.93 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.87 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 373' ' ' CYS . 1.7 p -74.85 91.68 2.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.885 0.374 . . . . 0.0 111.12 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.99 124.09 19.56 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.827 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -151.9 132.8 14.18 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 26.6 m -90.36 124.81 43.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.953 0.406 . . . . 0.0 110.67 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.402 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 27.8 p90 -145.6 -175.77 4.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.169 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' CYS . . . . . 0.558 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 42.8 t -88.47 141.23 28.71 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -66.47 -22.13 66.2 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.616 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -105.93 -28.63 10.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.836 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 5.4 m -134.11 178.73 6.74 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 121.286 0.565 . . . . 0.0 111.779 -174.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.499 HD11 ' CG ' ' A' ' 354' ' ' PRO . 4.2 mm? -110.04 30.2 6.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -77.27 3.05 13.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.716 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 76.33 40.26 28.99 Favored Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.54 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.437 ' HE1' ' O ' ' A' ' 369' ' ' ARG . 37.0 t80 69.76 110.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.787 0.835 . . . . 0.0 111.638 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -134.68 -169.13 2.28 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.456 HG12 ' H ' ' A' ' 393' ' ' GLU . 0.2 OUTLIER -57.52 159.91 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.824 178.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.69 9.6 2.58 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-N 116.277 -0.42 . . . . 0.0 114.048 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' GLU . . . . . 0.456 ' H ' HG12 ' A' ' 391' ' ' ILE . 46.1 mt-10 -115.59 111.81 21.22 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.168 0.508 . . . . 0.0 111.093 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.548 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 1.9 m . . . . . 0 C--N 1.314 -0.951 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.597 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 121.417 0.627 . . . . 0.0 111.683 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 31.3 m -96.77 4.96 51.48 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.3 p -115.57 155.05 28.3 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.913 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 30.3 mmmt -121.52 134.43 24.55 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 5.1 Cg_exo -74.34 118.14 5.25 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.802 1.668 . . . . 0.0 111.938 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 37.2 t -55.32 138.72 67.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.528 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.31 -1.17 10.95 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.577 2.185 . . . . 0.0 112.031 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -111.68 -60.21 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' CYS . . . . . 0.405 ' SG ' ' HG3' ' A' ' 456' ' ' ARG . 5.3 p -100.58 -3.31 30.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.78 33.7 23.53 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.072 0.463 . . . . 0.0 111.166 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 36.4 p -97.81 154.89 37.67 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.16 99.34 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.181 1.921 . . . . 0.0 112.302 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 5.8 m -85.96 121.05 28.04 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -76.21 124.35 27.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.965 0.412 . . . . 0.0 110.357 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.431 ' HD3' ' O ' ' A' ' 445' ' ' ARG . 0.0 OUTLIER -96.19 155.4 16.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.015 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -140.7 148.86 41.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -85.43 115.1 4.09 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.791 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 136.46 -12.59 4.03 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.793 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 57.9 m -112.94 110.24 20.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.417 ' HA ' ' CD1' ' A' ' 465' ' ' TRP . 0.7 OUTLIER -82.54 -12.73 57.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.195 0.521 . . . . 0.0 110.224 176.509 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -101.0 96.4 7.22 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 46.3 tpp -104.13 129.77 51.84 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 120.942 0.401 . . . . 0.0 111.05 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 18.6 t -134.37 137.27 51.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 48.1 t -86.52 95.04 9.59 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 20.6 p -81.96 90.23 6.46 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.515 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 0.1 OUTLIER -131.27 141.97 50.06 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.791 -176.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.451 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -64.42 106.06 1.05 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.808 0.337 . . . . 0.0 110.141 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 101.69 4.69 51.97 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.414 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.515 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 44.2 t -113.21 -90.19 0.52 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.743 0.271 . . . . 0.0 110.599 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 70.4 34.25 68.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.567 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -94.76 134.23 37.59 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.951 0.405 . . . . 0.0 111.07 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.37 128.85 52.28 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -138.58 157.98 45.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.048 0.451 . . . . 0.0 111.752 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' CYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 28.5 m -65.92 136.07 55.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.044 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' TRP . . . . . 0.417 ' CD1' ' HA ' ' A' ' 450' ' ' MET . 23.9 t-105 -74.33 -49.44 22.86 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.265 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 13.4 t -73.24 -64.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.822 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.672 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 13.9 p -93.32 133.81 36.18 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -76.8 107.64 9.27 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.798 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -155.76 176.53 12.51 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.956 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -113.9 140.84 48.04 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 63.9 t90 -59.75 103.97 0.25 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.799 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 473' ' ' ARG . 0.7 OUTLIER -142.41 -152.47 0.41 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 473' ' ' ARG . . . . . 0.484 ' H ' HG22 ' A' ' 472' ' ' THR . 33.4 ptt180 -82.94 -23.98 33.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.058 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.85 -50.39 56.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.901 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 66.1 m -110.89 81.17 1.39 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.116 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 92.4 mtp -89.46 -35.53 15.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.818 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . 159.26 40.45 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.555 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -90.83 -3.0 57.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.098 0.475 . . . . 0.0 110.973 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 479' ' ' HIS . . . . . 0.414 ' CE1' ' SG ' ' A' ' 464' ' ' CYS . 19.2 p80 -143.88 19.5 1.8 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.135 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 480' ' ' TRP . . . . . 0.461 ' CZ3' ' HA ' ' A' ' 464' ' ' CYS . 9.5 t-105 -87.85 3.36 48.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.299 0.571 . . . . 0.0 110.093 -176.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -64.81 115.77 5.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.091 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-O 118.677 -1.068 . . . . 0.0 111.469 179.744 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-O 121.035 0.241 . . . . 0.0 112.622 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 352' ' ' LEU . 30.0 t -100.38 163.76 2.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.423 ' N ' HG12 ' A' ' 351' ' ' VAL . 4.2 mm? -113.76 143.89 43.89 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 353' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 354' ' ' PRO . 44.5 t -64.95 139.68 97.87 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.779 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 353' ' ' CYS . 7.8 Cg_exo -74.66 -10.83 22.0 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.557 2.171 . . . . 0.0 112.402 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -71.42 136.13 83.94 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 110.857 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.1 -43.13 16.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.986 2.457 . . . . 0.0 113.223 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -82.27 7.14 65.04 Favored Glycine 0 CA--C 1.51 -0.279 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.3 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.586 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 43.9 t -92.4 -103.42 0.12 Allowed 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 122.667 -0.314 . . . . 0.0 110.866 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 70.03 27.91 72.4 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 37.5 ttp -79.44 -69.7 0.56 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.913 0.387 . . . . 0.0 110.643 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 139.92 131.38 2.77 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.957 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.36 140.79 48.81 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.952 0.406 . . . . 0.0 110.661 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -105.86 123.37 47.85 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.619 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 59.6 t -118.89 114.47 44.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.873 0.368 . . . . 0.0 110.629 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.67 142.64 70.47 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -46.32 -42.75 22.15 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.345 2.697 . . . . 0.0 114.014 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -80.21 -3.62 49.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 43.6 t -123.58 158.38 31.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.102 0.477 . . . . 0.0 111.131 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -134.74 9.23 3.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.064 0.459 . . . . 0.0 109.779 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -71.95 108.09 5.03 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.525 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.487 HG21 ' C ' ' A' ' 382' ' ' CYS . 0.0 OUTLIER -115.36 112.15 38.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.175 177.27 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.3 m -153.71 135.15 14.24 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.438 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.447 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 3.4 t -74.76 69.57 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.465 0.65 . . . . 0.0 109.738 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -76.03 -9.8 58.9 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.395 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -104.99 5.97 33.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.497 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -161.11 -123.0 0.65 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.583 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.1 p -84.58 92.6 8.17 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.676 0.39 . . . . 0.0 110.67 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -69.52 108.95 2.66 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.896 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -128.08 141.88 51.37 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.75 122.8 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.259 0.552 . . . . 0.0 111.88 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -151.94 -177.5 6.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.824 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' CYS . . . . . 0.487 ' C ' HG21 ' A' ' 371' ' ' VAL . 19.5 t -108.57 175.46 5.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -82.54 -39.0 22.94 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.935 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.624 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 5.2 m-20 -104.44 -5.33 21.74 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -177.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 21.3 p -151.84 173.2 15.06 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.243 0.544 . . . . 0.0 111.397 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 8.9 mp -110.36 35.38 3.46 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.992 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -79.08 3.84 16.3 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.327 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 83.79 27.58 37.8 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.941 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 25.7 t80 70.08 125.89 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.468 0.707 . . . . 0.0 111.036 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -143.96 -175.72 4.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 43.6 mm -105.52 145.49 13.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.8 -163.41 27.03 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.775 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -91.24 166.53 12.89 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.889 0.376 . . . . 0.0 110.365 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.0 m . . . . . 0 C--N 1.308 -1.213 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.768 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.451 -0.41 0 CA-C-O 121.433 0.635 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.0 m -114.82 2.04 14.26 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.675 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.1 p -105.83 126.04 51.7 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.877 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 5.2 mptp? -90.48 144.97 31.52 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 1.1 Cg_endo -80.46 121.14 4.17 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.013 1.809 . . . . 0.0 111.822 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 440' ' ' ARG . 37.1 t -54.99 135.2 67.27 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.609 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.53 -15.62 38.06 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.159 1.906 . . . . 0.0 111.651 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' LYS . . . . . 0.499 ' HA ' ' HE3' ' A' ' 438' ' ' LYS . 0.9 OUTLIER -91.85 -70.49 0.69 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.493 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.1 p -97.6 -6.09 34.12 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 436' ' ' CYS . 23.9 mmt180 67.11 26.1 8.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.771 0.429 . . . . 0.0 111.664 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 26.9 p -86.19 158.81 54.89 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.902 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.02 101.53 1.34 Allowed 'Trans proline' 0 C--O 1.239 0.53 0 C-N-CA 122.428 2.085 . . . . 0.0 112.224 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 7.3 m -90.32 113.16 24.96 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -104.09 141.1 36.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 445' ' ' ARG . 6.6 ptm180 -85.74 95.04 9.27 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.633 0.73 . . . . 0.0 110.057 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -135.47 115.3 12.98 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.892 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 84.16 20.34 59.24 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.78 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -149.89 129.2 2.91 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 76.5 m -81.84 -73.1 0.4 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.754 0.311 . . . . 0.0 110.893 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -112.3 -6.52 14.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.502 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -96.65 96.5 8.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.959 0.409 . . . . 0.0 110.546 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 80.0 mmm -89.51 91.85 8.87 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 23.7 t -99.95 116.76 43.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.89 99.55 12.48 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 1.3 t -87.24 92.78 9.18 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.604 0.716 . . . . 0.0 110.471 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.589 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -130.3 148.22 52.1 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.427 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -46.41 -64.76 0.68 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -93.78 37.5 3.39 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.773 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 51.1 t -130.97 -100.36 0.3 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.851 0.357 . . . . 0.0 111.073 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 78.81 22.53 66.2 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -89.28 114.88 26.3 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.361 0.601 . . . . 0.0 111.076 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.482 ' HG3' ' HB3' ' A' ' 471' ' ' TRP . 4.1 pt-20 -105.58 146.19 29.97 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.62 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -146.45 159.38 43.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.941 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 41.8 m -62.51 146.95 50.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.472 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -74.87 -54.54 7.08 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.468 176.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.01 -63.83 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.626 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.521 ' HG ' ' CE1' ' A' ' 479' ' ' HIS . 28.0 p -98.67 165.96 11.55 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -106.6 111.42 23.96 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.729 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.4 p -150.64 154.75 38.06 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.387 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -73.85 154.36 39.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' TRP . . . . . 0.482 ' HB3' ' HG3' ' A' ' 462' ' ' GLU . 5.3 p-90 -60.7 91.87 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.887 0.851 . . . . 0.0 111.981 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.2 t -134.77 141.08 46.36 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.761 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' ARG . . . . . 0.499 ' HA ' ' HB3' ' A' ' 476' ' ' MET . 36.3 mtp180 -63.48 -29.38 70.67 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -174.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 474' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 4.9 p-10 -65.51 -18.32 65.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.293 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 8.2 t -110.61 -40.6 4.54 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' MET . . . . . 0.499 ' HB3' ' HA ' ' A' ' 473' ' ' ARG . 10.8 tpt -52.99 -41.02 64.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.26 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -106.03 16.8 42.3 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.169 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 474' ' ' ASP . . . -92.78 -65.54 0.99 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.75 0.309 . . . . 0.0 110.828 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 479' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 480' ' ' TRP . 9.5 p80 -108.32 -69.62 0.84 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.031 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 480' ' ' TRP . . . . . 0.593 ' H ' ' CG ' ' A' ' 479' ' ' HIS . 22.0 t-105 63.51 -71.81 0.06 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.332 1.053 . . . . 0.0 111.734 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -70.23 137.07 50.54 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.416 0.286 . . . . 0.0 110.395 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.295 0 CA-C-O 118.435 -1.203 . . . . 0.0 111.876 -179.658 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.393 0 CA-C-O 120.896 0.164 . . . . 0.0 112.846 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.34 -179.03 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 C-N-CA 123.094 0.558 . . . . 0.0 110.3 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 7.5 mp -124.35 151.53 44.24 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.872 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.9 t -54.61 138.67 60.91 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.694 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.501 ' HG3' ' CD1' ' A' ' 379' ' ' TYR . 18.6 Cg_endo -59.56 -19.69 53.63 Favored 'Trans proline' 0 N--CA 1.473 0.281 0 C-N-CA 123.195 2.597 . . . . 0.0 112.396 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -84.93 113.09 47.76 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.03 -28.22 74.44 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.46 2.106 . . . . 0.0 111.842 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -67.86 -25.3 74.24 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 40.0 t -73.95 -73.08 0.24 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 53.24 31.53 42.11 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.249 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 47.9 ttp -70.96 -62.55 1.35 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.168 0.508 . . . . 0.0 110.8 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 125.8 123.62 2.7 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.75 130.11 56.52 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.237 0.542 . . . . 0.0 110.478 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.521 HD12 ' HG2' ' A' ' 365' ' ' GLU . 0.8 OUTLIER -89.62 124.66 34.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.859 -178.204 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.405 ' N ' HD13 ' A' ' 363' ' ' LEU . 100.0 t -93.75 100.99 12.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.102 0.477 . . . . 0.0 110.673 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.521 ' HG2' HD12 ' A' ' 363' ' ' LEU . 6.0 mm-40 -94.89 153.73 39.91 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.369 177.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.82 -11.34 31.76 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 121.785 1.657 . . . . 0.0 109.821 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -102.98 24.99 9.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.182 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' CYS . . . . . 0.403 ' SG ' ' HD2' ' A' ' 383' ' ' ARG . 27.1 p -71.83 74.67 0.87 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.556 0.693 . . . . 0.0 110.823 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 369' ' ' ARG . . . . . 0.633 ' HD3' ' H ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -64.88 -23.07 67.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.196 179.411 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -162.11 109.47 1.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.168 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 381' ' ' PHE . 0.6 OUTLIER -92.64 113.67 28.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.659 0.742 . . . . 0.0 110.326 176.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 372' ' ' THR . . . . . 0.43 ' OG1' HG12 ' A' ' 380' ' ' VAL . 92.2 m -152.54 144.93 24.03 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.443 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 9.3 t -74.62 73.24 1.98 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.444 0.64 . . . . 0.0 109.335 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -84.87 -19.48 32.3 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.988 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -96.81 -16.88 20.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.044 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -108.91 -101.26 2.68 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.918 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 4.0 p -100.2 -100.91 0.24 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.774 0.321 . . . . 0.0 110.618 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -173.32 107.06 0.24 Allowed Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.214 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.501 ' CD1' ' HG3' ' A' ' 354' ' ' PRO . 23.8 t80 -161.89 135.55 6.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.833 0.316 . . . . 0.0 110.648 177.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.43 HG12 ' OG1' ' A' ' 372' ' ' THR . 29.1 m -101.01 125.95 54.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.568 ' O ' HG13 ' A' ' 371' ' ' VAL . 23.6 p90 -146.94 -175.12 4.69 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.537 -177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 34.2 t -77.2 -178.07 4.88 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.403 ' HD2' ' SG ' ' A' ' 368' ' ' CYS . 11.3 ptm180 -95.94 -32.71 12.48 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.837 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -105.57 -7.78 18.38 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.505 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.04 -170.58 3.68 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.451 0.643 . . . . 0.0 111.462 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.81 28.59 8.66 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.145 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -81.09 18.37 1.07 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 72.07 45.43 41.04 Favored Glycine 0 C--O 1.227 -0.282 0 C-N-CA 120.843 -0.694 . . . . 0.0 114.603 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 5.2 t80 59.71 94.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -133.96 -163.12 1.32 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.43 157.31 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -75.33 46.93 1.95 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.5 -0.381 . . . . 0.0 113.77 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.61 107.68 7.18 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.311 -1.068 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.643 -176.677 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 121.828 0.823 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.7 p -100.63 4.43 43.3 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.359 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.5 p -95.56 154.35 17.25 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.665 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.48 ' HA ' ' HE3' ' A' ' 434' ' ' LYS . 0.0 OUTLIER -117.15 140.45 27.15 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.308 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.24 124.59 4.88 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.969 1.779 . . . . 0.0 112.499 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 438' ' ' LYS . 41.2 t -64.3 134.93 96.13 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.075 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.16 -4.87 16.01 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.108 1.872 . . . . 0.0 111.492 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' LYS . . . . . 0.646 ' HB2' ' SG ' ' A' ' 436' ' ' CYS . 6.0 mmmm -100.68 -74.46 0.61 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.101 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 3.6 p -94.99 -7.67 39.13 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.163 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 52.2 mtt180 61.57 31.93 18.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.278 0.561 . . . . 0.0 111.479 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 20.7 p -84.96 154.2 60.71 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.102 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.75 93.66 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.32 2.013 . . . . 0.0 112.855 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 14.8 m -82.92 122.55 28.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.583 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.54 155.93 39.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.584 0.231 . . . . 0.0 110.877 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -116.32 157.79 24.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.025 0.44 . . . . 0.0 111.476 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -143.06 138.04 29.65 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -88.74 51.51 3.86 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.139 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -137.88 -56.09 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.102 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.4 p -83.36 -178.97 7.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.083 0.468 . . . . 0.0 110.483 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.479 ' HE3' ' HB2' ' A' ' 450' ' ' MET . 35.8 ttm -135.57 -14.89 1.9 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.295 0.569 . . . . 0.0 110.062 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -88.56 95.18 10.14 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' MET . . . . . 0.401 ' CG ' ' HB2' ' A' ' 465' ' ' TRP . 70.7 mmm -100.0 115.96 30.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.476 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.84 144.84 33.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.369 0.604 . . . . 0.0 110.939 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 42.5 t -84.41 108.87 17.46 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.774 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 15.3 p -91.64 88.64 6.81 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.624 0.726 . . . . 0.0 109.351 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -132.06 126.96 35.1 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.413 ' HB3' ' NH2' ' A' ' 456' ' ' ARG . . . -49.6 -31.88 11.59 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -109.29 25.04 19.24 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.178 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 31.8 t -133.56 -81.18 0.47 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.148 0.474 . . . . 0.0 111.215 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.13 65.63 3.0 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -124.27 121.61 35.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.889 0.376 . . . . 0.0 111.692 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.51 157.37 18.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.577 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -166.62 158.99 13.73 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.761 0.315 . . . . 0.0 111.291 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 52.2 t -71.89 134.78 46.25 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.851 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' TRP . . . . . 0.401 ' HB2' ' CG ' ' A' ' 452' ' ' MET . 14.0 t-105 -69.37 -43.77 72.9 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.005 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 43.1 t -69.85 -63.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 5.6 p -105.74 143.86 33.29 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.359 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -75.22 113.91 13.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.638 0.732 . . . . 0.0 110.58 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.6 p -142.85 178.03 7.93 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.682 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.31 117.88 35.28 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 65.3 m95 63.76 -168.6 0.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.593 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 476' ' ' MET . 7.0 m -109.83 30.93 6.24 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.659 0.742 . . . . 0.0 109.3 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -85.57 -57.61 2.99 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -70.28 -24.73 63.1 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.372 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' CYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 478' ' ' ALA . 93.8 m -89.0 -8.82 53.35 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.893 176.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 476' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 472' ' ' THR . 25.8 ttt -50.59 -57.85 7.21 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.754 0.659 . . . . 0.0 111.491 -176.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -109.73 12.9 32.52 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.371 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 478' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 475' ' ' CYS . . . -88.31 -64.94 1.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.921 0.391 . . . . 0.0 110.585 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 479' ' ' HIS . . . . . 0.456 ' CG ' ' H ' ' A' ' 480' ' ' TRP . 6.6 p80 -137.74 -65.39 0.52 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.104 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 480' ' ' TRP . . . . . 0.456 ' H ' ' CG ' ' A' ' 479' ' ' HIS . 21.4 t-105 54.53 31.27 14.57 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.984 0.897 . . . . 0.0 110.114 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -142.05 151.18 42.15 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.351 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.273 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.988 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.834 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 352' ' ' LEU . 4.2 t -110.03 175.41 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.598 ' H ' HG12 ' A' ' 351' ' ' VAL . 5.8 mp -137.53 152.37 49.4 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.5 t -56.01 130.64 73.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.74 9.99 1.77 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.99 2.46 . . . . 0.0 113.312 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -98.56 145.56 30.1 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.638 0.256 . . . . 0.0 110.875 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.22 -26.3 30.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.833 2.355 . . . . 0.0 112.789 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.15 -28.34 64.46 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.962 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 86.7 m -95.08 -151.9 0.34 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 120.929 0.395 . . . . 0.0 110.667 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 118.96 19.48 4.37 Favored Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -65.9 -66.14 0.59 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 110.32 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 151.31 130.56 1.69 Allowed Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.164 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.06 109.94 17.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.432 0.634 . . . . 0.0 109.909 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -88.31 106.86 18.51 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.433 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 48.6 t -82.45 105.55 12.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.947 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.49 152.66 95.37 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.468 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.07 -20.53 70.05 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.002 1.801 . . . . 0.0 111.175 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.45 12.09 33.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.758 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 47.4 t -70.73 101.28 2.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.258 0.552 . . . . 0.0 110.243 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' ARG . . . . . 0.693 ' HD3' ' H ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -91.3 0.61 57.49 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.772 -178.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -162.35 110.36 1.36 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 381' ' ' PHE . 2.7 p -101.09 124.96 55.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.226 0.536 . . . . 0.0 110.348 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.3 m -152.2 147.88 26.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.452 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 29.6 t -69.73 74.99 0.43 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-O 121.563 0.697 . . . . 0.0 109.154 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.52 -20.42 29.68 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.863 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -98.36 13.07 32.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.647 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -142.41 -104.8 0.53 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.158 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 378' ' ' GLY . 20.6 p -97.49 -102.45 0.19 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.233 0.539 . . . . 0.0 110.735 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.462 ' N ' ' SG ' ' A' ' 377' ' ' CYS . . . -171.85 106.55 0.24 Allowed Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -160.21 117.88 2.56 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.95 132.76 38.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 389' ' ' TYR . 30.0 p90 -140.66 176.26 8.94 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.153 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' CYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 46.9 t -88.66 165.65 14.63 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 383' ' ' ARG . 11.5 ptt180 -88.55 -30.51 19.25 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.25 0.548 . . . . 0.0 110.127 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.509 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 8.1 m-20 -105.79 -11.05 16.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.196 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 394' ' ' CYS . 5.6 m -145.29 -179.13 6.44 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -174.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 386' ' ' LEU . 8.0 tp -118.23 22.46 12.15 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.986 177.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -81.27 28.97 0.36 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 71.97 32.48 63.42 Favored Glycine 0 N--CA 1.465 0.576 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.596 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 381' ' ' PHE . 20.8 t80 57.95 73.5 0.47 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.334 0.588 . . . . 0.0 111.061 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.46 ' CD2' ' H ' ' A' ' 390' ' ' HIS . 0.3 OUTLIER -77.13 145.2 37.93 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.092 179.034 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 6.7 tp -77.2 131.01 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.798 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 104.95 -158.98 15.93 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.344 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -87.34 146.66 25.82 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.117 0.484 . . . . 0.0 111.162 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 3.7 m . . . . . 0 C--N 1.314 -0.953 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.168 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.442 -0.86 0 CA-C-O 121.403 0.62 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 23.6 m -86.28 -21.11 27.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.744 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.19 132.58 35.24 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.325 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -99.92 111.39 61.88 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.08 127.39 24.78 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.238 1.959 . . . . 0.0 111.94 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 44.5 t -50.96 138.12 25.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.07 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.61 -2.44 12.44 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.264 1.976 . . . . 0.0 111.476 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' LYS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 29.4 tptp -109.71 -61.16 1.68 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.413 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 11.8 p -102.69 -3.88 25.9 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 29.5 ttp180 65.19 21.19 12.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.66 0.784 . . . . 0.0 112.33 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.3 p -82.76 140.41 43.82 Favored Pre-proline 0 C--N 1.314 -0.963 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.082 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.4 101.97 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.467 2.111 . . . . 0.0 112.213 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 45.0 m -77.55 123.48 26.66 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.74 114.46 5.04 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.598 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -96.58 105.87 18.03 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.306 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.58 128.29 55.85 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.207 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 66.43 -116.24 8.16 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.371 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -155.81 42.99 0.56 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.945 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 47.7 t -71.67 123.77 23.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.784 0.326 . . . . 0.0 110.254 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.652 ' SD ' ' HA ' ' A' ' 480' ' ' TRP . 43.3 ttm -75.31 -20.43 59.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.781 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -86.02 96.4 9.83 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 21.5 mmt -97.34 113.44 25.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.081 0.467 . . . . 0.0 110.684 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.26 117.44 55.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.648 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 40.7 t -78.92 99.8 6.96 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.545 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 30.8 p -83.7 90.55 7.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.597 0.713 . . . . 0.0 109.35 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.571 ' HD2' ' N ' ' A' ' 457' ' ' ALA . 3.1 tmm_? -130.46 137.54 49.84 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.571 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -63.91 95.66 0.12 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.152 0.501 . . . . 0.0 110.602 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 106.39 24.14 6.93 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.383 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 29.7 t -131.02 -85.06 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.967 0.384 . . . . 0.0 110.51 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.58 35.42 91.91 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -84.92 124.68 31.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.907 0.384 . . . . 0.0 110.529 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.74 133.72 46.03 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.056 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -143.69 147.22 33.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.748 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' CYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 52.5 t -70.65 141.9 51.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.089 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' TRP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 26.9 t-105 -68.31 -45.22 73.57 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.644 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 51.0 t -75.93 -59.47 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.078 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 7.4 p -101.89 99.06 9.22 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -74.14 110.94 8.83 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.448 0.642 . . . . 0.0 109.96 -175.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.77 175.45 13.71 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.544 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -74.71 139.32 43.37 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -52.7 109.9 0.46 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.074 0.464 . . . . 0.0 110.184 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 13.9 p -146.8 -163.46 1.76 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.244 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -74.92 -21.73 59.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.395 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -46.66 -58.64 3.65 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.762 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 2.1 t -123.38 56.75 1.18 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.268 0.556 . . . . 0.0 109.903 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 60.2 ttp -70.12 -27.82 64.89 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -177.66 40.49 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.693 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -72.38 -64.31 0.97 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.093 0.473 . . . . 0.0 110.996 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -126.83 17.06 7.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.832 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 480' ' ' TRP . . . . . 0.652 ' HA ' ' SD ' ' A' ' 450' ' ' MET . 35.6 t-105 -62.73 -27.08 69.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.316 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -76.23 104.81 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.256 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.041 0 CA-C-O 118.855 -0.969 . . . . 0.0 111.838 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.212 0 N-CA-C 112.322 -0.311 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 352' ' ' LEU . 15.6 t -124.08 176.92 4.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.595 ' H ' HG12 ' A' ' 351' ' ' VAL . 82.8 mt -118.78 151.01 38.83 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' CYS . . . . . 0.556 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 35.2 t -58.66 142.99 82.76 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.488 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.556 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 56.3 Cg_endo -70.32 -8.94 24.81 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.149 2.566 . . . . 0.0 112.442 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -94.24 130.7 33.25 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.67 -23.75 63.14 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.264 2.643 . . . . 0.0 113.087 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -83.21 5.87 74.72 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.882 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 26.5 t -119.2 -99.43 0.44 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 58.63 22.05 51.71 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.273 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.663 ' HE1' ' HA3' ' A' ' 376' ' ' GLY . 40.8 mtm -70.75 -58.95 3.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.917 0.389 . . . . 0.0 111.117 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.405 ' HA2' HD23 ' A' ' 352' ' ' LEU . . . 156.45 125.66 0.9 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.25 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.6 mm? -115.35 126.87 54.95 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.076 0.465 . . . . 0.0 110.051 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -84.46 104.41 14.44 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.555 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.09 104.39 16.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.274 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.25 148.24 91.02 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.939 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.93 -47.09 22.61 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 123.774 2.983 . . . . 0.0 114.146 -176.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.59 -7.8 49.14 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.884 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 51.6 t -76.94 128.41 34.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' ARG . . . . . 0.558 ' HA ' ' HD3' ' A' ' 383' ' ' ARG . 0.0 OUTLIER -114.08 19.18 16.66 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -116.53 140.77 49.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.334 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 383' ' ' ARG . 0.0 OUTLIER -135.88 130.93 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.544 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 27.4 m -153.67 131.46 11.6 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.158 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.502 ' HA ' HD11 ' A' ' 362' ' ' LEU . 4.3 t -80.29 74.66 7.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.327 0.584 . . . . 0.0 109.73 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -81.15 -6.8 59.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.647 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -95.11 -16.89 22.29 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.07 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' GLY . . . . . 0.663 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -153.88 -117.26 0.64 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.082 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.2 p -90.13 104.13 16.73 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.097 0.559 . . . . 0.0 111.33 -178.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 373' ' ' CYS . . . -69.95 109.9 3.08 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.97 -176.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -127.78 144.33 51.09 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.96 99.84 8.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.186 0.517 . . . . 0.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -127.76 -179.0 4.71 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 7.6 t -86.83 -176.2 5.68 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.558 ' HD3' ' HA ' ' A' ' 369' ' ' ARG . 17.9 ptt180 -94.24 -36.0 12.2 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.469 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.467 HD21 ' CB ' ' A' ' 394' ' ' CYS . 21.7 p-10 -104.7 -28.16 11.37 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.214 0.531 . . . . 0.0 110.759 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.48 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 23.1 p -130.73 -174.24 3.31 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.698 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.416 ' HG ' ' HB3' ' A' ' 354' ' ' PRO . 10.5 mp -113.27 33.63 4.98 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.479 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 387' ' ' GLN . . . . . 0.48 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 12.8 mm100 -81.17 19.17 0.95 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.979 0.418 . . . . 0.0 112.029 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 71.36 31.46 65.92 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 114.35 0.5 . . . . 0.0 114.35 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 30.9 t80 67.66 110.39 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.045 0.538 . . . . 0.0 111.425 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.458 ' HE2' ' HG ' ' A' ' 394' ' ' CYS . 1.8 p80 -146.65 -53.45 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 16.7 tt -148.74 156.5 8.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.44 -47.73 48.93 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.64 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.51 110.16 21.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.142 0.496 . . . . 0.0 111.394 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.467 ' CB ' HD21 ' A' ' 384' ' ' ASN . 4.7 m . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.309 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.016 0.436 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 50.2 m -124.9 2.52 8.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.067 0.461 . . . . 0.0 110.956 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 444' ' ' GLU . 2.1 p -80.24 143.63 33.56 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.135 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 434' ' ' LYS . 11.5 mmpt? -105.68 131.73 21.5 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.9 126.87 13.71 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.274 1.983 . . . . 0.0 112.449 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 437' ' ' PRO . 36.0 t -63.13 136.61 96.77 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.501 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 12.4 Cg_exo -69.82 -17.0 37.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.479 2.119 . . . . 0.0 111.614 177.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 438' ' ' LYS . 0.5 OUTLIER -96.93 -60.37 1.6 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.698 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.3 p -107.67 -3.36 19.28 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 440' ' ' ARG . 15.5 tpp85 68.1 21.13 8.8 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.153 0.501 . . . . 0.0 111.892 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 17.9 p -77.49 152.28 80.97 Favored Pre-proline 0 C--N 1.308 -1.202 0 O-C-N 122.175 -0.328 . . . . 0.0 111.157 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.58 92.57 0.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.28 1.987 . . . . 0.0 111.05 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 25.1 m -93.3 114.01 26.35 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.127 0.489 . . . . 0.0 111.339 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' GLU . . . . . 0.453 ' HB2' HG22 ' A' ' 433' ' ' THR . 2.5 tm-20 -102.74 121.07 41.7 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -82.71 100.69 10.39 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.225 0.536 . . . . 0.0 111.373 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -89.88 107.23 18.99 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 123.21 129.55 3.51 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -67.84 96.21 0.36 Allowed Glycine 0 C--N 1.322 -0.211 0 C-N-CA 121.465 -0.398 . . . . 0.0 113.142 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 79.9 m -153.08 144.31 23.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 122.591 0.356 . . . . 0.0 110.168 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.703 ' SD ' HG23 ' A' ' 466' ' ' VAL . 46.5 tpp -84.89 -31.29 23.79 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -85.6 96.95 9.82 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -120.26 129.66 54.14 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.766 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.492 HG11 ' HG3' ' A' ' 462' ' ' GLU . 5.7 m -124.18 152.5 29.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.711 -175.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.7 t -83.87 115.51 22.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 7.7 t -98.36 91.67 5.32 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 122.2 1.0 . . . . 0.0 109.942 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -129.81 132.06 46.38 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.47 98.37 0.09 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.898 0.38 . . . . 0.0 110.514 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 117.55 -4.13 17.54 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.945 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 47.7 t -108.67 -86.58 0.51 Allowed 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.713 0.292 . . . . 0.0 110.797 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 62.48 56.28 22.52 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -105.28 129.04 53.72 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.937 0.398 . . . . 0.0 111.045 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.492 ' HG3' HG11 ' A' ' 453' ' ' VAL . 13.5 mp0 -95.85 140.02 31.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.871 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -161.62 167.25 25.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.476 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 3.9 m -86.71 148.8 25.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.047 0.451 . . . . 0.0 110.831 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -68.63 -50.49 50.96 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.612 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' VAL . . . . . 0.703 HG23 ' SD ' ' A' ' 450' ' ' MET . 94.7 t -70.72 -64.33 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 21.7 p -90.15 133.19 35.04 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.526 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -77.57 110.0 12.01 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 119.539 -0.864 . . . . 0.0 108.806 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.1 p -153.9 178.12 10.27 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.045 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -101.79 149.91 23.69 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' TRP . . . . . 0.432 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 44.3 t90 -62.43 98.17 0.11 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 474' ' ' ASP . 11.7 t -141.99 -168.73 2.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 120.927 0.394 . . . . 0.0 111.419 -175.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -69.54 -22.09 63.59 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.541 0.736 . . . . 0.0 112.755 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' ASP . . . . . 0.528 ' H ' HG23 ' A' ' 472' ' ' THR . 26.3 t70 -67.69 -58.54 4.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.906 0.384 . . . . 0.0 111.245 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 84.2 m -91.48 15.85 11.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.653 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 24.3 ptm -51.43 -32.26 26.07 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -150.6 33.51 0.98 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -88.64 -64.78 1.09 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -142.16 67.75 1.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -85.73 -7.83 58.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.548 0.689 . . . . 0.0 109.306 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -144.4 134.62 24.27 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.507 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.363 0 CA-C-O 118.772 -1.015 . . . . 0.0 110.999 -178.411 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 113.627 0.211 . . . . 0.0 113.627 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.47 ' H ' ' HB ' ' A' ' 364' ' ' VAL . 9.4 p -75.61 168.21 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.48 ' HB3' ' HA2' ' A' ' 361' ' ' GLY . 1.0 OUTLIER -141.11 155.41 46.12 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.176 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 13.9 t -51.65 130.72 36.44 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.142 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.16 3.36 4.66 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.217 2.611 . . . . 0.0 112.934 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -101.39 122.82 46.74 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.08 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.96 -26.68 83.57 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.055 2.503 . . . . 0.0 113.191 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.24 -13.8 67.9 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.948 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.406 ' SG ' ' HG3' ' A' ' 360' ' ' MET . 42.0 t -92.62 -85.75 0.26 Allowed 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.628 0.252 . . . . 0.0 110.581 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.34 23.5 64.52 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.704 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.474 ' HE1' ' HA3' ' A' ' 376' ' ' GLY . 36.3 mtm -76.01 -48.51 20.73 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.562 -0.376 . . . . 0.0 111.302 -177.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 352' ' ' LEU . . . 109.46 129.51 5.81 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.832 -177.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.66 176.97 4.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.892 0.377 . . . . 0.0 110.751 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 364' ' ' VAL . 1.7 tt -101.8 148.8 24.86 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.534 ' H ' HD23 ' A' ' 363' ' ' LEU . 4.7 p -130.95 8.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.461 ' H ' ' CD2' ' A' ' 363' ' ' LEU . 43.3 mm-40 -57.58 151.18 41.74 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.917 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.86 -22.72 38.89 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.967 2.444 . . . . 0.0 112.475 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.58 -7.26 54.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.471 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.68 99.65 1.04 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -64.15 -42.41 96.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.753 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -156.32 125.3 6.02 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.485 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.8 p -90.32 124.31 42.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.21 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.6 m -150.47 141.99 23.47 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.235 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 16.1 t -74.73 70.96 1.92 Allowed 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.374 0.606 . . . . 0.0 109.891 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -84.71 -6.48 59.36 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.856 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -100.02 -4.8 29.22 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.828 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' GLY . . . . . 0.474 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -153.5 -65.84 0.01 OUTLIER Glycine 0 C--O 1.234 0.154 0 C-N-CA 119.37 -1.395 . . . . 0.0 113.603 -178.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 4.7 m -100.3 -131.39 0.24 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.202 0.525 . . . . 0.0 109.67 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -170.3 104.75 0.21 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 381' ' ' PHE . 50.6 t80 -162.13 130.49 4.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 32.9 t -97.8 120.65 47.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.409 ' HB3' ' CE2' ' A' ' 379' ' ' TYR . 9.2 p90 -136.3 -175.54 4.03 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.234 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 42.4 t -85.64 168.29 14.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.496 ' HB2' HG23 ' A' ' 364' ' ' VAL . 16.8 ptt180 -97.98 -14.31 20.65 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.748 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.585 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 84.1 m-20 -103.33 -32.42 9.57 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.6 p -134.23 -171.12 2.67 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.873 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.57 28.03 8.7 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.857 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -85.56 11.08 11.4 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.86 29.47 15.58 Favored Glycine 0 C--N 1.319 -0.404 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.838 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 48.4 t80 72.86 135.1 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.518 0.727 . . . . 0.0 112.573 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -165.26 171.54 13.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.593 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.95 146.65 9.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 96.53 -162.48 22.45 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.698 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.64 173.52 7.57 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.959 0.409 . . . . 0.0 110.971 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.2 m . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.926 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.237 0.424 0 CA-C-O 121.34 0.59 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 445' ' ' ARG . 9.9 m -120.58 0.6 10.49 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.468 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 16.7 p -120.68 148.42 43.96 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.273 0.559 . . . . 0.0 112.106 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -112.64 131.89 22.48 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.36 118.9 5.95 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.083 1.855 . . . . 0.0 112.256 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 43.4 t -56.45 133.81 76.76 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.375 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.539 ' HG2' ' CE1' ' A' ' 461' ' ' PHE . 57.4 Cg_endo -72.24 -9.18 24.02 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.247 1.964 . . . . 0.0 111.445 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 438' ' ' LYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 29.3 tptp -98.67 -70.92 0.71 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.147 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.8 p -92.62 -12.53 31.42 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 17.0 tpp180 69.17 29.54 4.63 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.554 0.742 . . . . 0.0 111.528 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 41.4 p -89.35 158.58 45.98 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.978 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -80.85 100.22 1.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.218 1.945 . . . . 0.0 112.367 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 11.4 m -84.59 118.53 24.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.855 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -64.51 121.06 13.52 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 432' ' ' SER . 36.7 ptt180 -93.51 146.67 23.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.569 -176.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -125.49 120.04 29.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.536 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -67.11 124.18 22.54 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.932 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.9 -48.24 0.98 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.318 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 24.9 p -75.18 136.94 41.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.719 0.295 . . . . 0.0 110.591 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 59.8 mtt -97.66 -17.68 19.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.012 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -121.85 96.16 4.95 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.064 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 14.1 ptp -109.08 133.17 53.35 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.44 ' CB ' ' HB3' ' A' ' 462' ' ' GLU . 1.2 m -111.75 150.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.353 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.5 t -86.29 100.42 12.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.0 t -83.39 89.01 6.97 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.321 1.058 . . . . 0.0 109.276 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.53 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -131.22 114.26 14.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.598 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.465 ' HB3' HH21 ' A' ' 456' ' ' ARG . . . -56.52 107.37 0.37 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.33 13.17 19.93 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.123 -0.561 . . . . 0.0 111.843 -177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.53 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 43.8 t -123.64 -73.71 0.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 61.21 57.23 19.42 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' PHE . . . . . 0.539 ' CE1' ' HG2' ' A' ' 437' ' ' PRO . 50.0 t80 -136.45 129.39 31.05 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.908 0.385 . . . . 0.0 111.277 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.44 ' HB3' ' CB ' ' A' ' 453' ' ' VAL . 0.0 OUTLIER -120.13 155.85 32.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 174.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -140.56 174.78 10.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 48.2 t -76.73 133.91 39.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.36 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -70.13 -56.73 6.11 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.4 -62.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.492 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 13.9 p -103.74 126.37 50.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -73.41 112.03 9.09 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 122.038 0.923 . . . . 0.0 109.549 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.0 p -150.1 177.74 9.61 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.321 -175.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' GLU . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 461' ' ' PHE . 39.2 tt0 -92.89 156.66 16.81 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -51.05 107.75 0.2 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.334 0.588 . . . . 0.0 110.472 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 474' ' ' ASP . 9.0 m -134.3 142.11 47.17 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.39 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 473' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 476' ' ' MET . 2.4 tmm_? -62.4 -21.32 65.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.406 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 474' ' ' ASP . . . . . 0.505 ' H ' HG22 ' A' ' 472' ' ' THR . 33.5 t70 -59.84 -58.79 7.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.762 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 475' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 480' ' ' TRP . 97.3 m -63.48 -26.46 68.73 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.594 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 476' ' ' MET . . . . . 0.482 ' HB3' ' O ' ' A' ' 473' ' ' ARG . 19.2 ttt -41.76 -46.53 3.87 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.08 0.863 . . . . 0.0 112.997 -177.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -136.89 17.63 3.63 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.19 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -86.81 -56.78 3.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.926 0.363 . . . . 0.0 111.167 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -132.56 10.01 4.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.603 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 480' ' ' TRP . . . . . 0.472 ' HB2' ' O ' ' A' ' 475' ' ' CYS . 61.1 t-105 -75.05 -41.31 59.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.954 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -73.88 100.79 3.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.119 0.485 . . . . 0.0 111.351 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.059 0 CA-C-O 118.934 -0.926 . . . . 0.0 111.533 179.256 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.984 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.412 HG23 ' CG1' ' A' ' 364' ' ' VAL . 89.2 t -130.13 154.73 40.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 68.7 mt -114.92 148.05 39.18 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 38.6 t -60.75 128.86 89.32 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.02 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.541 ' HG2' ' CD2' ' A' ' 379' ' ' TYR . 43.1 Cg_endo -68.74 1.41 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.927 2.418 . . . . 0.0 112.705 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.445 ' HG3' ' SG ' ' A' ' 377' ' ' CYS . 14.7 mm-40 -73.84 120.63 82.25 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.98 105.66 0.25 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.634 2.223 . . . . 0.0 112.106 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 109.85 -2.99 30.32 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.724 -0.751 . . . . 0.0 113.024 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 52.2 t -81.24 -82.58 0.12 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.921 0.36 . . . . 0.0 110.258 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 57.31 25.36 54.42 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.567 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -59.17 -48.93 79.8 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.7 0.286 . . . . 0.0 111.18 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 122.62 108.96 1.98 Allowed Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.621 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.15 139.46 46.51 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.349 0.595 . . . . 0.0 111.049 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 64.3 tp -92.76 134.67 34.82 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.8 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 364' ' ' VAL . 12.4 p -127.84 100.49 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 122.032 0.92 . . . . 0.0 111.497 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -97.42 143.55 26.37 Favored Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.315 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.29 -31.41 76.58 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.39 2.06 . . . . 0.0 111.87 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -85.22 -16.51 40.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.038 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.8 t -93.05 101.27 13.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.092 0.472 . . . . 0.0 109.853 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' ARG . . . . . 0.563 ' NH2' ' HA3' ' A' ' 392' ' ' GLY . 17.7 ttt180 -92.31 -11.85 34.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.324 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -96.48 134.63 39.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.115 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.6 126.37 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.072 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 52.6 m -152.91 136.37 15.91 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.29 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.485 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 4.1 t -77.01 64.14 2.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.64 -6.38 40.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.893 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -116.3 9.32 14.47 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.363 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -150.84 -95.78 0.13 Allowed Glycine 0 C--O 1.238 0.351 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.601 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.485 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 6.6 p -135.88 111.89 9.6 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 122.717 0.407 . . . . 0.0 110.23 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.2 108.37 2.43 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.001 -174.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' TYR . . . . . 0.541 ' CD2' ' HG2' ' A' ' 354' ' ' PRO . 89.8 t80 -120.16 151.33 39.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.455 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 11.0 m -89.03 114.63 27.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.312 0.577 . . . . 0.0 111.957 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -153.17 167.23 29.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.047 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' CYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 47.8 t -90.16 172.57 8.71 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -88.42 -23.68 23.25 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.336 0.588 . . . . 0.0 109.758 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.456 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 44.6 t30 -104.36 -37.57 7.17 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.889 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 12.5 p -129.44 -170.61 2.32 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.144 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.69 35.75 4.45 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.303 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' GLN . . . . . 0.467 ' HA ' ' OE1' ' A' ' 387' ' ' GLN . 12.7 mm-40 -79.91 13.41 2.21 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 80.66 23.76 59.59 Favored Glycine 0 N--CA 1.463 0.444 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.505 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 33.0 t80 68.23 117.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.603 0.761 . . . . 0.0 110.688 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -146.54 -162.49 1.54 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.991 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.577 ' H ' HD13 ' A' ' 391' ' ' ILE . 0.2 OUTLIER -65.84 166.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 392' ' ' GLY . . . . . 0.563 ' HA3' ' NH2' ' A' ' 369' ' ' ARG . . . -76.54 47.73 2.46 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 121.012 -0.613 . . . . 0.0 114.066 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -141.42 96.66 3.02 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.201 0.524 . . . . 0.0 111.042 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 3.7 m . . . . . 0 C--N 1.302 -1.459 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.254 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 120.93 0.395 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.3 t -120.63 -10.24 9.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.916 0.389 . . . . 0.0 110.472 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 3.0 p -85.91 132.82 34.01 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.519 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.437 ' N ' ' HD2' ' A' ' 434' ' ' LYS . 0.3 OUTLIER -97.9 148.27 34.24 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.679 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.33 134.5 19.12 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.324 2.016 . . . . 0.0 113.156 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 15.5 t -67.44 141.64 95.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.945 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 3.6 Cg_exo -75.77 -13.99 19.68 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.296 1.997 . . . . 0.0 111.976 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -96.76 -64.0 1.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.056 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 1.5 p -109.87 3.45 20.66 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 15.9 ttm180 60.92 25.15 15.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.361 0.665 . . . . 0.0 112.403 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.467 ' H ' ' HB3' ' A' ' 436' ' ' CYS . 2.9 p -82.74 142.34 45.41 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.361 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 21.1 Cg_exo -63.47 105.97 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.377 2.051 . . . . 0.0 112.225 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 17.7 m -78.25 125.73 29.77 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.049 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -92.24 131.25 37.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.569 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -85.2 94.95 9.02 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -109.99 123.86 50.39 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.17 -80.22 0.96 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.933 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.66 13.46 5.63 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.012 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.7 m -81.87 38.29 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.353 . . . . 0.0 110.813 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.532 ' HG2' ' O ' ' A' ' 479' ' ' HIS . 2.1 mpt? 64.11 16.92 10.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.377 0.671 . . . . 0.0 111.499 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -88.6 96.36 10.61 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 6.7 mmt -113.69 82.13 1.63 Allowed 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.43 171.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 2.2 m -126.8 142.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.05 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 52.6 t -96.04 108.15 20.53 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.92 0.39 . . . . 0.0 111.592 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 18.7 p -89.11 90.34 8.34 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.44 ' HG3' HG21 ' A' ' 441' ' ' THR . 4.6 tmt_? -130.2 145.17 51.7 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.724 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.7 94.64 0.31 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 0.0 110.483 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 109.38 24.5 5.89 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.671 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.44 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 50.0 t -126.27 -95.4 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.735 0.303 . . . . 0.0 110.632 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 70.74 46.84 43.8 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.626 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -112.1 130.36 55.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 111.488 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -100.39 137.78 38.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.999 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -139.72 155.6 47.25 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 79.1 m -66.27 130.71 44.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -75.08 -46.44 34.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.268 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 479' ' ' HIS . 21.3 t -69.61 -65.12 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.993 -176.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 10.1 p -95.43 133.98 38.78 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -79.47 109.81 14.19 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.836 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.9 t -156.82 158.1 36.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.858 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -87.0 113.73 23.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.223 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 25.14 81.77 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.963 1.305 . . . . 0.0 113.158 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 14.8 m -117.21 110.13 17.76 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.949 0.404 . . . . 0.0 110.841 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -71.63 -22.46 61.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.49 -49.66 74.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.568 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' CYS . . . . . 0.403 ' HB2' ' CD2' ' A' ' 479' ' ' HIS . 2.5 p -91.79 -15.24 28.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.387 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 476' ' ' MET . . . . . 0.429 ' O ' ' HB3' ' A' ' 480' ' ' TRP . 25.0 ttt -54.75 -45.55 74.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.555 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -71.98 0.86 35.47 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.534 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.91 -60.08 1.84 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 117.164 0.482 . . . . 0.0 112.072 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 479' ' ' HIS . . . . . 0.532 ' O ' ' HG2' ' A' ' 450' ' ' MET . 17.6 p80 -94.89 -25.61 16.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 480' ' ' TRP . . . . . 0.429 ' HB3' ' O ' ' A' ' 476' ' ' MET . 31.3 t-105 -65.58 -41.91 92.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.938 0.399 . . . . 0.0 110.948 -176.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.47 95.65 8.56 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.235 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.883 0 CA-C-O 118.854 -0.97 . . . . 0.0 111.831 -178.942 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.95 0 N-CA-C 112.223 -0.351 . . . . 0.0 112.223 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 352' ' ' LEU . 10.4 p -102.63 170.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.449 ' H ' HG22 ' A' ' 351' ' ' VAL . 5.4 mp -139.63 153.27 47.29 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 122.202 -0.311 . . . . 0.0 110.371 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 355' ' ' GLN . 52.5 t -57.48 135.67 81.96 Favored Pre-proline 0 N--CA 1.452 -0.372 0 O-C-N 123.502 0.501 . . . . 0.0 110.058 177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.29 0.09 8.96 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.649 2.233 . . . . 0.0 112.083 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.512 ' HB3' ' SG ' ' A' ' 353' ' ' CYS . 56.8 tp60 -86.41 122.64 72.0 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.016 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.56 -20.9 70.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.639 2.226 . . . . 0.0 112.169 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' GLY . . . . . 0.406 ' H ' ' HG3' ' A' ' 355' ' ' GLN . . . -76.89 -17.33 79.94 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.587 177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 66.2 m -100.82 -176.54 3.21 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.062 0.458 . . . . 0.0 110.862 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 156.42 37.8 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.423 ' HB2' ' HE2' ' A' ' 360' ' ' MET . 2.1 mpp? -82.76 -36.11 25.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 0.0 110.407 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.403 ' HA2' ' HG ' ' A' ' 352' ' ' LEU . . . 101.17 121.35 4.79 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.413 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.24 111.65 24.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.451 0.643 . . . . 0.0 110.081 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -83.6 109.17 17.21 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.076 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.56 HG21 ' HB2' ' A' ' 383' ' ' ARG . 2.7 p -85.63 110.5 19.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.48 0.657 . . . . 0.0 111.658 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -97.58 150.85 37.22 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.298 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.64 -22.94 63.13 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.313 2.009 . . . . 0.0 110.995 175.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.52 -35.93 75.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.487 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.7 t -78.39 120.73 23.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.84 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -111.76 -8.85 14.13 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.251 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 108.38 11.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.548 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 381' ' ' PHE . 2.5 t -89.88 120.33 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 CA-C-N 116.366 -0.379 . . . . 0.0 109.98 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 86.2 m -152.24 139.61 19.49 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.52 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 47.8 t -72.54 74.45 1.06 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.372 0.606 . . . . 0.0 110.292 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -85.13 -6.59 59.29 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.278 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -106.66 -11.37 15.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.176 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -117.45 -77.47 0.61 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.407 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 10.8 p -125.19 -102.12 0.37 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.038 0.447 . . . . 0.0 110.925 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -172.47 106.36 0.23 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -160.53 129.63 4.89 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 58.1 t -95.22 110.52 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.447 ' O ' ' HB ' ' A' ' 371' ' ' VAL . 34.3 p90 -127.32 -177.24 3.99 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.141 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 10.9 t -82.2 177.24 8.9 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.214 0.53 . . . . 0.0 110.782 -176.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.56 ' HB2' HG21 ' A' ' 364' ' ' VAL . 38.6 ptt180 -96.34 -27.81 14.78 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.889 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.45 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 25.9 t-20 -104.43 -30.85 9.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.987 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.568 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 6.6 p -133.81 -172.96 3.11 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.255 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 352' ' ' LEU . 3.0 mm? -112.67 29.69 7.74 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.121 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' GLN . . . . . 0.568 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 9.3 mm100 -79.66 15.85 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 77.79 25.16 63.09 Favored Glycine 0 C--O 1.229 -0.209 0 C-N-CA 120.514 -0.851 . . . . 0.0 113.538 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 37.7 t80 72.1 134.52 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.397 0.679 . . . . 0.0 112.252 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -156.59 175.0 14.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.111 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 8.7 tp -93.13 144.95 8.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 102.13 -158.06 18.34 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.907 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -120.95 164.55 16.54 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 1.4 m . . . . . 0 C--N 1.319 -0.752 0 CA-C-O 120.883 0.373 . . . . 0.0 111.631 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 31.4 t . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.293 0.568 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 13.4 p -112.87 4.61 16.99 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.982 0.896 . . . . 0.0 108.735 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.6 p -95.09 142.68 27.27 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.002 -177.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.31 136.17 25.94 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.907 177.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.31 128.59 10.57 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.172 1.915 . . . . 0.0 112.238 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 35.6 t -57.98 142.08 80.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.08 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 4.8 Cg_exo -76.4 -6.2 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.441 2.094 . . . . 0.0 111.536 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -108.97 -65.25 1.16 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.395 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.4 p -99.62 -4.75 30.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.787 0.327 . . . . 0.0 111.772 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 0.0 OUTLIER 63.09 23.41 13.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.229 178.282 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 25.4 p -80.03 155.07 75.23 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-O 120.614 0.245 . . . . 0.0 111.062 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.8 107.48 2.48 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.659 2.239 . . . . 0.0 113.529 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 41.7 m -107.1 126.06 51.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.85 144.2 55.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.79 0.328 . . . . 0.0 110.419 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -99.79 169.76 9.02 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.435 0.636 . . . . 0.0 112.326 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.45 162.47 13.44 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.819 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -66.63 -57.4 10.08 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -144.2 42.8 1.02 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.234 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 46.7 t -109.84 135.99 49.86 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -78.89 -10.28 59.76 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -77.38 99.78 5.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.978 0.418 . . . . 0.0 110.919 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' MET . . . . . 0.503 ' CG ' ' HE3' ' A' ' 465' ' ' TRP . 27.4 mmt -120.86 95.45 4.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.435 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.474 ' CG1' ' HG3' ' A' ' 462' ' ' GLU . 3.6 m -128.99 144.6 37.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.021 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 7.5 t -73.7 135.25 43.66 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.138 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.9 t -113.34 87.72 2.67 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 122.254 1.026 . . . . 0.0 109.96 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.453 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -132.4 130.44 40.63 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.31 92.57 0.09 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.984 0.421 . . . . 0.0 110.726 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 128.69 -18.91 5.63 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.45 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 45.0 t -93.51 -83.38 0.32 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.665 0.269 . . . . 0.0 110.585 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.01 51.75 32.26 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.669 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -102.39 122.38 44.17 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.861 0.362 . . . . 0.0 111.425 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.474 ' HG3' ' CG1' ' A' ' 453' ' ' VAL . 13.4 mp0 -90.32 140.25 29.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.99 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -143.23 167.36 22.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.252 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 56.6 m -81.44 143.08 32.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.45 0.643 . . . . 0.0 112.168 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 465' ' ' TRP . . . . . 0.503 ' HE3' ' CG ' ' A' ' 452' ' ' MET . 15.0 t-105 -75.66 -41.3 54.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.237 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.61 -64.56 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.705 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 25.3 p -91.82 177.44 6.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 110.49 15.92 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.658 0.742 . . . . 0.0 110.438 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 15.1 t -157.76 178.16 10.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.443 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.15 135.81 33.52 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 471' ' ' TRP . . . . . 0.417 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 36.3 t90 -60.45 106.53 0.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.161 0.505 . . . . 0.0 109.768 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.5 p -136.28 -176.86 4.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.707 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -73.45 -24.15 60.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.19 -56.49 14.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.45 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -99.61 16.96 21.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.722 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -56.12 -57.86 10.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.07 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 480' ' ' TRP . . . -135.4 17.85 3.97 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.69 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.52 -28.54 69.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.931 0.396 . . . . 0.0 111.541 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -143.78 -6.59 0.77 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.439 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 480' ' ' TRP . . . . . 0.401 ' HB3' ' HA2' ' A' ' 477' ' ' GLY . 65.5 t-105 -59.91 99.63 0.07 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.776 -175.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -150.26 127.97 11.66 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.462 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.501 0 CA-C-O 118.696 -1.058 . . . . 0.0 111.066 -179.894 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.519 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 362' ' ' LEU . 10.6 p -98.39 168.09 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.411 ' H ' HG22 ' A' ' 351' ' ' VAL . 2.9 mm? -125.95 145.26 50.36 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 122.011 -0.431 . . . . 0.0 110.686 -176.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 353' ' ' CYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 354' ' ' PRO . 50.5 t -63.01 130.71 94.34 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 353' ' ' CYS . 9.5 Cg_exo -70.88 -12.1 30.29 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.829 2.353 . . . . 0.0 113.159 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -82.16 119.75 75.68 Favored Pre-proline 0 C--N 1.317 -0.828 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.21 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.79 129.28 33.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.567 2.178 . . . . 0.0 111.128 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 116.12 -21.97 11.7 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 35.4 m -90.97 -97.0 0.11 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.034 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 53.31 29.72 38.49 Favored Glycine 0 C--O 1.225 -0.466 0 O-C-N 123.404 0.44 . . . . 0.0 112.507 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 25.7 mtm -74.96 -67.19 0.67 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.935 0.398 . . . . 0.0 110.433 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' GLY . . . . . 0.4 ' HA2' HD13 ' A' ' 352' ' ' LEU . . . 147.14 120.02 1.18 Allowed Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.427 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.421 ' HB2' HG13 ' A' ' 351' ' ' VAL . 4.2 mm? -110.76 116.95 32.17 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.43 122.29 19.36 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.956 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.83 100.28 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.102 0.477 . . . . 0.0 110.863 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -89.4 135.71 30.8 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.236 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.07 -36.45 99.25 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.543 2.162 . . . . 0.0 111.303 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -77.98 -22.38 49.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 41.3 t -75.48 114.45 14.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.222 0.534 . . . . 0.0 110.98 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -114.81 -0.88 13.36 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.502 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -136.35 111.56 9.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.345 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 381' ' ' PHE . 0.8 OUTLIER -105.9 151.31 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.839 -176.69 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.2 m -154.09 143.21 21.25 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.637 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 41.5 t -72.67 71.98 1.02 Allowed 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.486 0.66 . . . . 0.0 109.927 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -85.18 -6.59 59.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.0 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -88.95 -17.74 28.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.852 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -138.07 -88.13 0.19 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.048 -1.073 . . . . 0.0 113.169 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' A' ' 378' ' ' GLY . 25.2 p -99.14 -109.34 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.198 0.523 . . . . 0.0 111.755 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' A' ' 377' ' ' CYS . . . -172.08 108.05 0.27 Allowed Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -160.03 145.7 15.41 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.18 113.45 44.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.492 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' PHE . . . . . 0.486 ' O ' HG22 ' A' ' 371' ' ' VAL . 13.5 p90 -129.84 -174.68 3.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.144 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' CYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 29.3 t -81.2 172.09 14.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -97.42 -19.05 18.71 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.478 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -104.74 -31.74 9.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.296 0.57 . . . . 0.0 110.008 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.562 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 21.1 p -135.72 179.9 6.05 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.237 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.5 mp -108.62 31.49 5.58 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.482 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' GLN . . . . . 0.509 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 77.9 mm-40 -74.66 4.42 6.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.176 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 82.3 30.36 34.16 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.132 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 31.2 t80 72.17 128.03 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.828 0.451 . . . . 0.0 110.414 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -161.67 178.59 8.88 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.217 0.532 . . . . 0.0 111.756 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 47.4 mt -98.86 150.05 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.801 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 109.87 -164.03 12.39 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.089 -1.053 . . . . 0.0 112.736 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -116.42 149.62 39.14 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.786 0.326 . . . . 0.0 110.714 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.318 -0.77 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.969 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 4.7 m -79.61 -38.82 33.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.007 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.1 174.18 11.82 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.288 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.467 ' HD3' ' HD2' ' A' ' 435' ' ' PRO . 17.2 tppt? -116.6 115.96 39.13 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' PRO . . . . . 0.467 ' HD2' ' HD3' ' A' ' 434' ' ' LYS . 17.8 Cg_endo -61.28 123.36 12.67 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.925 1.75 . . . . 0.0 111.361 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 44.2 t -58.41 136.52 85.5 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.369 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.05 -3.7 14.11 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.46 2.106 . . . . 0.0 111.621 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -109.72 -68.44 0.92 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.916 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 7.6 p -95.09 -2.71 49.5 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 12.3 tpt180 62.17 23.7 14.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.009 0.524 . . . . 0.0 111.578 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.3 p -84.87 160.65 55.15 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.263 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.67 93.81 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.224 1.949 . . . . 0.0 111.809 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 4.7 m -83.7 126.02 32.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.186 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -104.63 151.74 23.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.504 ' HB3' ' HE1' ' A' ' 452' ' ' MET . 15.2 ptt180 -119.74 156.97 29.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.23 0.538 . . . . 0.0 111.458 -178.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -129.57 145.23 51.5 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.802 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 73.29 -141.6 30.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.208 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.15 72.39 0.25 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.675 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.2 p -123.71 175.71 6.69 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.41 ' HA ' ' HB3' ' A' ' 465' ' ' TRP . 47.4 mtt -97.83 -0.64 44.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.037 0.446 . . . . 0.0 110.328 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -80.03 99.41 7.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.972 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' MET . . . . . 0.504 ' HE1' ' HB3' ' A' ' 445' ' ' ARG . 96.5 mmm -112.94 97.36 6.48 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.908 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.4 t -109.42 113.93 45.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.24 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.64 111.16 14.43 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.531 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 11.9 p -93.55 90.78 6.8 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 121.411 0.624 . . . . 0.0 109.514 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.535 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 4.7 tmt_? -132.13 139.36 48.41 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.029 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.35 105.68 0.97 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.889 0.376 . . . . 0.0 110.668 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 101.33 7.14 49.86 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.249 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 53.4 t -104.51 -90.19 0.4 Allowed 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.721 -0.282 . . . . 0.0 110.592 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.29 46.2 80.65 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -113.27 130.18 56.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.908 0.385 . . . . 0.0 110.944 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -98.87 140.61 32.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.025 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 28.1 p-90 -151.35 149.95 29.92 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.413 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 53.4 m -74.24 149.66 40.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.412 0.625 . . . . 0.0 112.012 -178.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' TRP . . . . . 0.41 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 32.6 t-105 -74.71 -58.74 3.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.939 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.97 -47.29 76.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 8.1 p -104.21 125.25 50.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -75.34 110.6 9.83 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.7 p -153.51 177.85 10.47 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.476 -176.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -102.22 157.24 17.03 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -56.7 108.6 0.51 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.478 0.656 . . . . 0.0 111.189 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 476' ' ' MET . 61.1 p -123.74 175.73 6.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.532 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -85.21 -29.95 24.28 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.685 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -67.54 -28.02 67.45 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.332 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 47.1 m -93.36 -30.28 15.19 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 472' ' ' THR . 1.9 tmt? -51.08 -52.3 44.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.352 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -99.38 20.06 51.34 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.563 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -111.17 -65.63 1.15 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -139.43 16.84 2.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -55.81 -38.62 70.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.253 0.549 . . . . 0.0 110.034 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -120.45 99.33 6.5 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.04 0 CA-C-O 118.434 -1.203 . . . . 0.0 111.803 -179.465 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.118 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 24.4 m -107.91 178.5 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.009 0.433 . . . . 0.0 110.334 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 6.2 mp -134.08 152.37 51.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.567 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.4 t -52.55 134.82 44.25 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.001 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.0 -16.93 48.65 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.116 2.544 . . . . 0.0 113.025 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -87.73 117.94 69.13 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.8 -27.66 84.54 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.017 2.478 . . . . 0.0 112.426 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -72.22 -16.18 76.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.543 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.2 t -86.8 -77.71 0.31 Allowed 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.05 30.4 66.79 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.024 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 9.0 ttm -70.49 -76.72 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.009 0.433 . . . . 0.0 111.174 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 143.48 121.88 1.62 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.064 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.59 130.32 55.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.11 0.481 . . . . 0.0 110.772 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.406 HD13 ' N ' ' A' ' 364' ' ' VAL . 1.7 tm? -95.69 128.89 42.94 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.677 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.406 ' N ' HD13 ' A' ' 363' ' ' LEU . 62.9 t -114.91 103.86 15.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.286 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -84.42 154.44 62.67 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.125 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.6 -9.85 26.8 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.052 1.835 . . . . 0.0 112.335 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -99.57 -14.43 19.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 52.8 t -125.07 136.85 54.06 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.936 0.398 . . . . 0.0 110.774 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.09 10.46 8.14 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.103 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -87.5 91.26 8.67 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.626 0.727 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' VAL . . . . . 0.518 HG21 ' C ' ' A' ' 382' ' ' CYS . 0.0 OUTLIER -85.0 113.77 24.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.509 178.285 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 91.4 m -153.19 139.87 18.9 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.245 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.453 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 4.7 t -76.44 67.48 2.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -66.45 -17.8 65.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.374 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -101.91 11.49 38.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -166.08 -126.09 0.81 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.164 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.453 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -83.2 91.08 7.18 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -69.06 108.88 2.64 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.693 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -114.09 143.62 44.48 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.457 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 14.0 m -83.58 102.02 9.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.445 0.64 . . . . 0.0 111.413 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -133.82 172.33 12.93 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' CYS . . . . . 0.518 ' C ' HG21 ' A' ' 371' ' ' VAL . 10.7 t -95.62 175.98 6.33 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.059 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 383' ' ' ARG . . . . . 0.452 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 5.7 ptp85 -78.06 -45.26 24.05 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.879 -175.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.596 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 20.3 m120 -105.33 -9.88 17.35 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.984 0.421 . . . . 0.0 111.197 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 26.4 p -140.21 176.07 9.06 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.919 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.81 32.64 5.7 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -72.63 -1.34 15.8 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 96.39 27.33 10.02 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.465 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 46.1 t80 66.42 103.99 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.23 0.612 . . . . 0.0 111.181 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -118.42 162.34 18.48 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.087 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 48.4 mm -91.69 120.93 41.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 132.96 -140.26 11.67 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -132.97 148.93 52.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.815 0.34 . . . . 0.0 110.635 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 1.3 m . . . . . 0 C--N 1.319 -0.722 0 CA-C-O 121.48 0.657 . . . . 0.0 109.905 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.569 HG22 ' H ' ' A' ' 433' ' ' THR . 14.9 p . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.81 0.338 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.1 p -96.47 -11.54 25.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.96 0.41 . . . . 0.0 111.788 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' THR . . . . . 0.569 ' H ' HG22 ' A' ' 431' ' ' VAL . 5.1 p -110.4 170.63 7.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.874 0.369 . . . . 0.0 111.005 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 434' ' ' LYS . 33.1 ttmt -131.51 125.43 20.65 Favored Pre-proline 0 N--CA 1.436 -1.135 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.77 136.41 57.57 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.753 2.302 . . . . 0.0 113.156 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 31.2 t -63.36 141.18 97.81 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.761 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 7.1 Cg_exo -73.77 -2.23 11.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.524 2.149 . . . . 0.0 111.78 176.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -117.4 -69.92 0.82 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.578 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 17.7 p -86.33 -10.61 54.1 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.63 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 71.5 mtt85 66.52 21.46 10.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.149 0.579 . . . . 0.0 112.17 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 42.2 p -82.01 149.7 63.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.462 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.28 99.81 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.3 2.0 . . . . 0.0 111.802 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 20.3 m -81.04 125.93 30.8 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.992 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -82.35 134.7 35.26 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.248 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -91.04 143.44 26.7 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.253 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -146.37 160.81 41.56 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.264 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -67.24 148.8 50.49 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.723 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 179.36 -154.75 14.37 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.078 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' CYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 450' ' ' MET . 61.1 m -108.45 49.87 0.8 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.924 0.392 . . . . 0.0 110.337 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.719 ' SD ' ' HA ' ' A' ' 480' ' ' TRP . 14.0 ptp 57.92 11.2 1.34 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.874 1.27 . . . . 0.0 112.925 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 451' ' ' HIS . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 480' ' ' TRP . 2.9 t60 -94.48 94.78 8.42 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 49.0 tpp -108.07 128.3 54.56 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.025 0.44 . . . . 0.0 110.776 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 462' ' ' GLU . 3.2 m -129.86 150.34 34.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 454' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 456' ' ' ARG . 12.9 t -69.36 111.7 5.42 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.477 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.3 t -83.7 87.43 7.05 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 122.5 1.143 . . . . 0.0 109.452 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.531 ' HB2' ' SG ' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -133.16 128.1 35.29 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.367 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 91.75 0.09 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.86 0.362 . . . . 0.0 110.565 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 124.93 -11.51 7.79 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.709 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 459' ' ' CYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 23.6 t -98.1 -77.8 0.5 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.49 32.35 83.12 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.942 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' PHE . . . . . 0.449 ' HB2' ' SG ' ' A' ' 459' ' ' CYS . 29.8 t80 -75.58 120.02 20.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.475 ' HG2' ' CG1' ' A' ' 453' ' ' VAL . 45.0 mt-10 -91.48 138.43 31.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -156.48 160.23 39.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.961 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' CYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 44.8 t -69.99 138.05 51.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.427 0.632 . . . . 0.0 112.129 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -75.18 -41.63 57.55 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.614 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 41.9 t -77.06 -64.52 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.844 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.7 p -102.29 96.91 7.27 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -74.93 109.92 8.79 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.67 1.224 . . . . 0.0 112.56 -170.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.2 t -160.18 173.67 15.4 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.551 -1.659 . . . . 0.0 106.736 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.64 111.66 12.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.445 -0.902 . . . . 0.0 108.877 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 471' ' ' TRP . . . . . 0.457 ' CE3' ' HB3' ' A' ' 474' ' ' ASP . 1.3 m95 -158.24 145.05 17.66 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.752 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 476' ' ' MET . 10.5 p -134.45 -72.03 0.49 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 473' ' ' ARG . . . . . 0.495 ' NH1' ' HG2' ' A' ' 476' ' ' MET . 29.8 mmm180 -85.13 -29.2 25.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 474' ' ' ASP . . . . . 0.457 ' HB3' ' CE3' ' A' ' 471' ' ' TRP . 8.0 t70 -66.0 -51.75 55.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.118 0.485 . . . . 0.0 111.051 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.6 t -78.83 -10.7 59.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.824 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' MET . . . . . 0.584 ' HA ' ' HB3' ' A' ' 480' ' ' TRP . 47.7 tpp -57.61 -53.09 62.14 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.858 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -84.75 -10.54 78.95 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.325 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -71.12 -62.55 1.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.821 0.344 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -148.0 -12.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.836 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 480' ' ' TRP . . . . . 0.719 ' HA ' ' SD ' ' A' ' 450' ' ' MET . 2.3 t-105 -54.92 -41.3 70.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.354 0.597 . . . . 0.0 110.321 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -70.88 96.59 1.29 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.17 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.022 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.006 -179.292 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.561 0 CA-C-O 121.012 0.229 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 351' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 352' ' ' LEU . 7.2 p -122.21 177.53 3.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.607 ' H ' HG22 ' A' ' 351' ' ' VAL . 98.4 mt -117.11 149.82 39.7 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 120.791 0.329 . . . . 0.0 110.963 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 353' ' ' CYS . . . . . 0.557 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 44.9 t -68.09 145.46 97.67 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.823 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 354' ' ' PRO . . . . . 0.557 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 27.6 Cg_endo -63.5 -14.85 44.94 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.812 2.342 . . . . 0.0 112.298 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -86.59 118.84 70.84 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.36 -30.55 91.55 Favored 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 123.159 2.573 . . . . 0.0 113.581 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -82.03 -10.22 84.2 Favored Glycine 0 C--O 1.236 0.247 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.27 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 358' ' ' CYS . . . . . 0.468 ' SG ' ' HE2' ' A' ' 360' ' ' MET . 47.1 t -74.24 -82.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.692 0.282 . . . . 0.0 110.289 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 60.32 22.12 58.06 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.441 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' MET . . . . . 0.468 ' HE2' ' SG ' ' A' ' 358' ' ' CYS . 34.9 mtm -74.2 -41.44 61.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.184 0.516 . . . . 0.0 110.785 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 106.51 115.02 3.97 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.569 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' LEU . . . . . 0.42 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.5 mm? -99.37 144.91 27.94 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 122.528 0.331 . . . . 0.0 110.601 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.98 118.51 27.58 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 364' ' ' VAL . 9.1 p -122.03 77.71 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 122.023 0.916 . . . . 0.0 112.339 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -97.98 154.5 37.74 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.13 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.81 -14.73 42.47 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.415 2.077 . . . . 0.0 111.331 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -85.46 -2.59 58.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.066 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 46.0 t -110.12 115.47 29.8 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.637 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.4 1.88 26.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.052 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -136.48 96.58 3.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.896 0.379 . . . . 0.0 111.175 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.8 120.38 40.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.423 0.63 . . . . 0.0 110.535 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 97.1 m -152.24 143.92 23.56 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.597 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' CYS . . . . . 0.46 ' HB3' ' HA2' ' A' ' 378' ' ' GLY . 3.7 t -76.51 67.02 2.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.474 0.654 . . . . 0.0 109.688 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -72.14 -6.12 40.4 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.501 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -106.41 -12.89 15.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.066 0.46 . . . . 0.0 110.793 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -144.64 -124.1 1.72 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.921 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' CYS . . . . . 0.453 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -74.53 86.57 2.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.825 0.345 . . . . 0.0 110.553 178.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 378' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 373' ' ' CYS . . . -67.77 109.09 2.72 Favored Glycine 0 CA--C 1.495 -1.157 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.574 -172.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -147.85 134.77 20.18 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.3 p -83.64 133.16 29.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -142.03 166.62 24.22 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 11.3 t -79.87 160.13 26.16 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.236 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -92.79 -13.25 29.45 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.537 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -104.82 -30.62 9.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.277 0.56 . . . . 0.0 109.511 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 6.7 p -140.84 -165.88 2.03 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.241 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 65.1 mt -116.96 25.68 10.34 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.019 0.437 . . . . 0.0 110.942 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -75.97 20.36 0.19 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 78.89 16.85 78.32 Favored Glycine 0 N--CA 1.461 0.363 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.201 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 382' ' ' CYS . 0.3 OUTLIER 67.41 114.18 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.751 0.82 . . . . 0.0 111.477 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.409 ' HE2' ' HG ' ' A' ' 394' ' ' CYS . 1.4 p80 -141.06 -53.97 0.48 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.429 -177.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 393' ' ' GLU . 40.8 mt -125.29 146.3 31.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -66.11 -23.75 71.5 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.292 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' GLU . . . . . 0.51 ' H ' HG22 ' A' ' 391' ' ' ILE . 31.6 mt-10 -135.36 134.76 40.11 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.45 0.3 . . . . 0.0 110.414 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' CYS . . . . . 0.409 ' HG ' ' HE2' ' A' ' 390' ' ' HIS . 74.8 m . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 121.04 0.448 . . . . 0.0 111.498 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.109 0.481 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.5 p -92.5 -15.63 26.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.551 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 444' ' ' GLU . 1.1 p -102.49 163.47 12.21 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.807 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' LYS . . . . . 0.451 ' HD3' ' HD2' ' A' ' 435' ' ' PRO . 5.4 tppp? -115.66 118.52 38.94 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' PRO . . . . . 0.451 ' HD2' ' HD3' ' A' ' 434' ' ' LYS . 29.2 Cg_endo -63.58 134.16 43.07 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.249 1.966 . . . . 0.0 112.526 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 436' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 35.3 t -61.26 140.33 94.48 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.424 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.48 -11.52 31.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.341 2.027 . . . . 0.0 111.616 177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -102.45 -67.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.752 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 6.2 p -96.98 -1.25 45.97 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 440' ' ' ARG . 65.8 ttt180 61.69 23.73 13.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.284 0.564 . . . . 0.0 111.557 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 17.5 p -79.13 142.22 59.14 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.975 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 11.8 Cg_exo -67.41 102.28 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.295 1.997 . . . . 0.0 111.252 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 17.7 m -106.03 128.05 53.58 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.631 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' GLU . . . . . 0.479 ' HB3' HG22 ' A' ' 433' ' ' THR . 10.2 pt-20 -117.68 171.84 7.76 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 120.904 0.383 . . . . 0.0 110.892 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' ARG . . . . . 0.564 ' HD3' ' CZ2' ' A' ' 465' ' ' TRP . 33.8 ptt-85 -103.5 161.99 13.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.167 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.37 114.31 25.71 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 71.88 -115.89 5.74 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.468 -176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.69 38.82 1.64 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.914 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 61.2 m -71.68 141.94 49.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.824 0.345 . . . . 0.0 111.181 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 65.4 mtt -94.2 -21.36 19.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.875 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -75.33 95.74 3.26 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.155 0.502 . . . . 0.0 110.197 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 48.5 tpp -104.08 96.63 6.79 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.287 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' VAL . . . . . 0.452 ' HB ' ' HG3' ' A' ' 462' ' ' GLU . 3.8 p -112.97 129.5 68.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.197 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.22 116.84 6.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.376 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 7.9 p -100.81 92.39 5.05 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.495 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' ARG . . . . . 0.449 ' C ' ' H ' ' A' ' 458' ' ' GLY . 0.0 OUTLIER -130.43 148.15 52.21 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -71.28 14.74 0.15 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.097 0.475 . . . . 0.0 111.413 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 456' ' ' ARG . . . -160.61 34.63 0.42 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 459' ' ' CYS . . . . . . . . . . . . . 10.0 t -154.6 -152.09 0.39 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 136.16 74.12 0.07 OUTLIER Glycine 0 C--N 1.279 -2.638 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.762 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -137.48 130.41 30.36 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.628 0.251 . . . . 0.0 111.101 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 453' ' ' VAL . 1.9 mp0 -87.78 127.42 35.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.941 177.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -134.2 161.56 34.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.61 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' CYS . . . . . 0.43 ' HA ' ' CZ3' ' A' ' 480' ' ' TRP . 8.2 t -68.41 133.39 48.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.264 0.554 . . . . 0.0 111.666 -175.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' TRP . . . . . 0.564 ' CZ2' ' HD3' ' A' ' 445' ' ' ARG . 23.5 t-105 -76.68 -55.35 5.58 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.463 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.68 -56.56 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 28.5 p -101.17 -161.06 0.83 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -131.32 110.11 10.84 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.795 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.6 p -155.5 151.44 27.7 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.646 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.48 156.76 38.95 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -50.02 109.01 0.25 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.309 0.576 . . . . 0.0 110.82 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 2.3 p -133.73 161.63 34.17 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.579 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' ARG . . . . . 0.536 ' HA ' ' HG2' ' A' ' 476' ' ' MET . 64.4 ttt180 -73.07 -22.06 60.67 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.742 178.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.4 -51.75 68.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.375 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 98.7 m -88.11 -23.41 23.69 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' MET . . . . . 0.536 ' HG2' ' HA ' ' A' ' 473' ' ' ARG . 5.4 ptp -49.48 -36.44 22.89 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -174.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -137.95 34.83 2.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.369 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.97 -65.85 1.12 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.809 0.338 . . . . 0.0 111.304 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -127.52 20.3 6.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 111.105 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 480' ' ' TRP . . . . . 0.43 ' CZ3' ' HA ' ' A' ' 464' ' ' CYS . 10.1 t-105 -79.88 -9.48 59.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.604 0.716 . . . . 0.0 109.407 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -104.99 133.42 49.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.77 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.546 -1.141 . . . . 0.0 111.943 -179.46 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 121.02 0.438 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -142.14 80.5 1.71 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.624 0.726 . . . . 0.0 110.082 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -145.06 125.38 13.86 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.289 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.68 120.12 34.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.393 0.616 . . . . 0.0 111.046 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.2 pp -137.58 -176.85 4.55 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.516 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -145.67 147.29 31.83 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.807 0.337 . . . . 0.0 110.196 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -109.02 -174.76 2.59 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.146 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -79.09 127.49 8.03 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.906 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -93.2 -158.42 34.15 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.812 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.537 HG22 ' H ' ' A' ' 352' ' ' LEU . 9.8 p -166.39 174.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.537 ' H ' HG22 ' A' ' 351' ' ' VAL . 6.4 mp -125.85 151.74 46.43 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.1 t -63.26 126.39 89.13 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.4 ' HD3' ' CE2' ' A' ' 381' ' ' PHE . 73.0 Cg_endo -78.87 16.97 1.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.961 2.441 . . . . 0.0 113.623 -176.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 357' ' ' GLY . 32.3 tt0 -86.46 132.99 41.22 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.21 -20.56 62.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.729 2.286 . . . . 0.0 112.656 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' A' ' 355' ' ' GLN . . . -100.25 3.61 56.79 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.685 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 9.5 t -115.35 -147.93 0.42 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.362 0.601 . . . . 0.0 110.422 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.13 23.65 5.14 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.009 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.479 ' HE1' ' HA3' ' A' ' 376' ' ' GLY . 39.7 mtm -61.0 -44.93 96.7 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.975 0.417 . . . . 0.0 110.505 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.39 129.37 3.28 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.145 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.01 127.09 53.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.238 0.542 . . . . 0.0 110.384 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -100.85 114.29 27.99 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.467 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.25 119.4 50.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 120.97 0.414 . . . . 0.0 110.703 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 368' ' ' CYS . 8.6 mm-40 -81.07 149.72 67.04 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.032 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.72 -30.0 87.57 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.594 2.196 . . . . 0.0 112.243 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -101.11 15.18 29.57 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.463 0.649 . . . . 0.0 110.812 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 365' ' ' GLU . 51.6 t -104.09 134.63 47.02 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.09 -0.381 . . . . 0.0 110.046 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 29.63 5.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 370' ' ' LYS . 1.9 tpmt? -144.47 102.3 3.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.781 0.324 . . . . 0.0 110.423 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.48 124.38 51.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.239 0.542 . . . . 0.0 110.845 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.5 m -152.38 141.38 21.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.92 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 3.5 t -76.86 62.03 2.0 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.16 -22.7 67.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.134 0.492 . . . . 0.0 110.749 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -88.21 -13.3 41.42 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.041 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' GLY . . . . . 0.479 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -143.11 -124.31 1.86 Allowed Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.297 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -76.42 85.14 3.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.141 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -70.9 109.48 2.86 Favored Glycine 0 N--CA 1.435 -1.404 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -147.12 144.82 29.3 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' A' ' 389' ' ' TYR . 18.1 t -84.88 136.23 23.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.098 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.426 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 11.7 p90 -146.01 -175.67 4.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' CYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 19.4 t -94.81 162.56 13.71 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.884 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -86.25 -20.4 28.52 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.038 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.537 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 82.4 m-20 -105.47 -26.47 11.91 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.627 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 4.8 p -141.24 178.84 7.13 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.416 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.78 30.76 6.02 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -70.47 -2.74 14.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.312 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 82.94 27.4 41.4 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.537 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.412 ' HB2' HG12 ' A' ' 380' ' ' VAL . 53.1 t80 76.62 138.51 0.06 Allowed 'General case' 0 C--N 1.338 0.108 0 C-N-CA 124.402 1.081 . . . . 0.0 111.514 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -161.04 176.32 11.49 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 50.6 mm -114.6 132.15 64.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 129.66 -156.58 21.44 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.218 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -90.54 159.34 16.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.407 0.622 . . . . 0.0 111.801 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.7 p -174.99 145.61 0.83 Allowed 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.402 177.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 3.2 tt -142.66 130.41 11.26 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.14 154.17 70.6 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.389 2.059 . . . . 0.0 111.507 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.77 21.02 12.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.75 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 97.01 143.96 16.12 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.233 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 25.7 p -78.49 -24.84 45.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.889 0.375 . . . . 0.0 111.257 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 76.57 32.14 51.85 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.859 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -122.65 107.36 11.87 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.74 0.305 . . . . 0.0 110.422 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 35.9 t -99.75 -35.38 9.81 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.295 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -153.82 176.0 12.66 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.477 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 22.2 m -148.88 -88.59 0.08 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.894 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -146.57 136.77 23.63 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 120.736 0.303 . . . . 0.0 111.119 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.2 t -166.56 97.27 0.57 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.807 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 13.2 p -159.72 123.18 3.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.22 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.02 113.31 7.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.144 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -163.56 131.05 3.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.756 0.313 . . . . 0.0 110.563 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 5.5 t -126.18 146.19 50.07 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.298 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 12.8 m -121.05 157.65 24.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.504 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -103.39 145.07 29.91 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.44 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.75 -167.79 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.732 2.288 . . . . 0.0 111.784 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -117.16 -70.77 0.77 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.646 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 60.72 28.04 17.77 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.955 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -123.54 117.71 25.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.86 0.362 . . . . 0.0 111.059 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -146.51 167.46 23.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.25 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.95 155.33 36.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.536 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -147.16 133.31 19.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.669 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -150.17 165.98 31.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.153 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -169.13 131.3 1.22 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.887 0.375 . . . . 0.0 111.075 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -105.53 130.8 53.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.625 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.91 -69.82 0.28 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -169.95 177.08 4.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.698 0.285 . . . . 0.0 111.133 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 13.4 t -149.13 146.04 27.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.124 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.3 t30 72.02 117.67 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.715 0.806 . . . . 0.0 112.226 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.79 106.48 13.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.064 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 21.2 m -101.26 118.87 37.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 55.8 mt -110.75 138.97 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.761 0.315 . . . . 0.0 110.405 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -120.13 160.03 23.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.742 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.19 123.86 72.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.191 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.8 p -117.2 -2.25 11.68 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.19 0.519 . . . . 0.0 111.014 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 20.4 p -105.84 149.14 26.79 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -114.08 141.64 26.64 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.028 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.7 129.9 20.87 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.352 2.034 . . . . 0.0 112.738 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 24.3 t -59.1 140.32 87.34 Favored Pre-proline 0 C--N 1.333 -0.119 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.573 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.31 -16.71 39.64 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.127 1.885 . . . . 0.0 111.962 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -101.3 -66.64 0.9 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.542 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 15.6 p -93.57 -10.8 33.51 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 26.6 mmm180 70.03 20.57 6.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.074 0.55 . . . . 0.0 111.922 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 42.4 p -81.23 149.44 65.85 Favored Pre-proline 0 C--N 1.322 -0.622 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.703 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 16.2 Cg_exo -65.71 103.12 0.55 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.605 2.203 . . . . 0.0 112.403 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 89.8 m -95.87 122.69 38.93 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -95.75 156.77 16.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.61 156.4 18.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.724 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.78 107.58 16.26 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.182 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -57.95 124.9 37.71 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.003 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.87 -13.2 13.03 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.224 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 11.0 p -142.56 142.59 32.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.713 0.292 . . . . 0.0 110.96 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.686 ' O ' ' HB3' ' A' ' 465' ' ' TRP . 14.2 ptp -99.36 29.83 3.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.31 0.576 . . . . 0.0 111.338 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 451' ' ' HIS . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 480' ' ' TRP . 29.0 p-80 -123.38 138.25 54.64 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.433 174.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 3.7 ptp -143.06 124.54 14.79 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.18 0.514 . . . . 0.0 110.656 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 8.5 m -114.38 150.82 16.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.3 t -85.38 101.41 12.56 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.472 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 21.2 p -87.7 92.51 9.13 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.61 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.7 OUTLIER -128.83 146.98 50.77 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -177.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -50.74 -44.03 58.3 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.324 0.39 . . . . 0.0 111.809 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' GLY . . . . . 0.405 ' H ' ' HD3' ' A' ' 456' ' ' ARG . . . -124.6 61.37 0.6 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.612 178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 36.4 t -151.34 -90.61 0.06 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.605 0.241 . . . . 0.0 110.519 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 73.45 38.78 51.95 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.704 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -99.55 118.65 36.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.94 0.4 . . . . 0.0 111.016 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -90.33 139.94 30.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.738 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -148.72 154.44 39.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 49.2 t -73.09 139.49 46.52 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.008 0.432 . . . . 0.0 111.191 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' TRP . . . . . 0.686 ' HB3' ' O ' ' A' ' 450' ' ' MET . 11.3 t-105 -75.02 -51.58 13.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.602 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.45 -51.48 71.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.017 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.551 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.8 p -120.87 107.11 12.31 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -74.23 111.35 9.31 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.875 0.845 . . . . 0.0 111.246 -174.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.0 p -154.67 169.92 22.76 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.542 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.69 143.46 36.23 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.006 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -61.55 104.29 0.41 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.407 0.622 . . . . 0.0 110.46 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.5 p -134.43 -163.7 1.41 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.114 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 50.6 mmm-85 -80.75 -21.9 40.67 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.972 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.44 -59.27 4.89 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 13.2 t -120.57 83.65 2.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 46.1 ttp -88.2 5.68 40.34 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.752 0.787 . . . . 0.0 109.209 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' A' ' 480' ' ' TRP . . . 118.39 37.9 0.82 Allowed Glycine 0 N--CA 1.428 -1.852 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.83 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -57.34 -39.55 76.13 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.185 0.517 . . . . 0.0 110.743 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -118.59 37.28 4.11 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.061 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' TRP . . . . . 0.528 ' HB2' ' CA ' ' A' ' 477' ' ' GLY . 20.5 t-105 -82.41 45.45 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.306 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -146.51 124.78 12.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.478 . . . . 0.0 111.279 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.223 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.548 179.422 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 120.781 0.324 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -82.19 144.64 30.56 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.65 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -72.73 166.98 21.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.195 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.5 p -150.79 137.16 12.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.601 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.77 147.26 11.68 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.179 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -113.36 104.56 12.43 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -124.62 70.4 1.12 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.986 0.422 . . . . 0.0 110.112 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -89.06 -25.24 29.64 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.706 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -160.5 -162.66 12.7 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.313 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.587 HG22 ' H ' ' A' ' 352' ' ' LEU . 9.3 p -142.92 177.37 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.587 ' H ' HG22 ' A' ' 351' ' ' VAL . 71.0 mt -130.37 145.72 51.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.647 0.261 . . . . 0.0 110.9 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.33 132.23 94.35 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.34 -7.93 22.32 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.035 2.49 . . . . 0.0 113.502 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -72.96 124.35 90.62 Favored Pre-proline 0 N--CA 1.447 -0.588 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.746 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.75 -30.78 77.58 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.934 2.423 . . . . 0.0 112.509 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -79.79 -17.19 75.71 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.875 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.514 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 33.8 t -89.03 -96.71 0.1 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.797 0.298 . . . . 0.0 110.679 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.09 19.36 59.12 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 35.7 ttp -65.7 -67.37 0.45 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.994 0.518 . . . . 0.0 111.544 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.452 ' HA2' HD23 ' A' ' 352' ' ' LEU . . . 147.12 122.5 1.36 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.109 -1.043 . . . . 0.0 112.346 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.45 135.85 54.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.954 0.406 . . . . 0.0 110.269 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -97.04 118.97 34.64 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.895 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 56.2 t -88.42 97.5 6.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.0 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.92 141.09 97.43 Favored Pre-proline 0 C--N 1.312 -1.027 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -51.9 -20.49 10.13 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.785 2.323 . . . . 0.0 112.639 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -114.97 24.11 12.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 45.8 t -71.16 110.87 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.42 . . . . 0.0 110.491 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -83.92 -39.9 19.23 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.025 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -140.26 108.28 5.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.108 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 12.8 p -83.08 128.47 38.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.386 0.612 . . . . 0.0 110.468 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 86.7 m -153.11 144.56 23.3 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.518 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 1.8 t -76.16 61.99 1.66 Allowed 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -69.96 -8.73 51.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.619 0.723 . . . . 0.0 109.888 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -102.73 0.17 32.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.871 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -155.93 -124.66 0.87 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 0.8 OUTLIER -85.42 98.84 10.81 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.9 111.12 3.74 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 114.434 0.534 . . . . 0.0 114.434 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -141.8 143.6 33.51 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.05 129.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.03 0.443 . . . . 0.0 110.969 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.415 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 20.0 p90 -143.93 -175.84 4.76 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 17.2 t -80.75 168.61 18.62 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.85 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -101.64 -13.86 17.64 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.506 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.58 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 4.3 m-20 -104.23 -26.32 12.55 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 21.1 p -145.5 -164.46 1.95 Allowed 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.384 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.05 27.07 9.5 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.614 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -87.25 32.75 0.69 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 70.37 18.31 75.11 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 121.073 -0.584 . . . . 0.0 114.286 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 69.19 121.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.632 0.773 . . . . 0.0 110.382 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -145.89 -176.25 5.07 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.4 tt -112.67 153.15 14.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 99.24 -146.76 18.17 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.139 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -102.13 154.01 19.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.895 0.379 . . . . 0.0 110.99 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 35.0 m -103.1 163.18 12.38 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.537 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 395' ' ' LEU . 2.6 pt? -115.91 146.17 36.37 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -88.02 162.03 7.32 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.538 2.159 . . . . 0.0 112.119 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -97.54 -47.14 5.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.484 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 139.81 -129.34 4.26 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.342 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 24.2 p -113.98 168.21 10.0 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -134.05 -72.02 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.16 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . 59.53 80.16 0.21 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.22 0.533 . . . . 0.0 111.522 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.4 t -84.32 158.27 21.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.037 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -133.62 175.25 9.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.818 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 12.1 t -130.73 147.53 52.41 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.914 0.388 . . . . 0.0 110.467 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -101.96 126.52 48.9 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.9 t -149.08 139.04 22.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.535 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 45.0 t -154.59 158.22 39.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 408' ' ' GLU . 0.6 OUTLIER -89.33 -175.79 4.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.038 0.447 . . . . 0.0 111.102 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -132.23 133.82 44.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.942 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 9.0 t -97.68 139.52 33.44 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.752 0.31 . . . . 0.0 110.311 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 22.3 m -107.47 149.82 10.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.135 0.493 . . . . 0.0 111.841 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -110.92 145.6 32.74 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.389 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.22 162.26 41.06 Favored 'Trans proline' 0 C--O 1.238 0.51 0 C-N-CA 122.217 1.945 . . . . 0.0 110.335 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -74.61 -83.53 0.05 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.591 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -172.61 178.97 2.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.67 0.271 . . . . 0.0 111.172 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -107.02 165.54 11.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.98 0.419 . . . . 0.0 110.911 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -128.66 127.2 41.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.221 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.06 159.53 34.03 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.236 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -107.51 149.44 27.97 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.394 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -136.49 168.05 20.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.269 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -130.56 171.59 12.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.712 0.291 . . . . 0.0 110.599 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.4 117.75 15.53 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.066 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -100.99 -14.1 17.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.747 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -86.94 148.42 25.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.814 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 14.0 t -152.29 145.59 24.73 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -63.33 118.62 8.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.198 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.83 134.82 37.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 11.2 m -73.93 111.59 9.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.183 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.6 pp -110.01 173.91 2.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.055 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' LYS . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 430' ' ' LYS . 2.5 mmmp? -122.66 144.3 49.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.456 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.6 109.0 18.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.414 0.626 . . . . 0.0 110.763 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.502 ' O ' ' HE3' ' A' ' 434' ' ' LYS . 18.1 m -82.27 -29.07 31.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.237 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' THR . . . . . 0.623 ' HA ' ' HB2' ' A' ' 444' ' ' GLU . 5.8 p -78.8 150.2 32.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.346 0.593 . . . . 0.0 112.036 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.502 ' HE3' ' O ' ' A' ' 432' ' ' SER . 15.8 mmtp -99.93 147.52 33.57 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.694 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -82.62 129.78 5.78 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.03 1.82 . . . . 0.0 112.073 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 42.0 t -66.88 140.95 96.45 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.43 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.407 ' HD2' ' SG ' ' A' ' 436' ' ' CYS . 36.6 Cg_endo -67.51 -19.28 48.93 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.25 1.967 . . . . 0.0 112.241 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -103.24 -73.56 0.66 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 10.0 p -79.15 -17.71 54.51 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 44.5 mtt180 62.18 33.71 16.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.416 0.627 . . . . 0.0 111.126 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.2 p -90.44 154.34 46.4 Favored Pre-proline 0 N--CA 1.434 -1.24 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.782 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.78 110.53 1.7 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.73 2.287 . . . . 0.0 111.787 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 88.7 m -129.49 123.14 30.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.339 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' GLU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 433' ' ' THR . 4.7 tp10 -134.6 142.67 46.99 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.431 ' NH1' ' HE2' ' A' ' 451' ' ' HIS . 9.7 tpt180 -111.92 106.61 15.36 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.107 0.48 . . . . 0.0 110.677 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -90.81 102.4 15.16 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.997 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 81.61 149.19 6.91 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.306 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 123.87 -165.58 16.66 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.285 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 8.2 t -82.99 -175.77 6.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.031 0.443 . . . . 0.0 110.787 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -80.14 50.04 1.18 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.075 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' HIS . . . . . 0.431 ' HE2' ' NH1' ' A' ' 445' ' ' ARG . 50.8 p-80 -119.48 139.34 52.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.346 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 1.1 mmt -119.78 80.25 1.56 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 36.4 t -94.87 117.51 38.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.257 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 48.0 t -80.86 99.7 8.46 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.46 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 2.1 p -82.2 89.14 6.48 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.611 0.719 . . . . 0.0 109.136 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.587 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 1.4 tmt_? -132.16 135.82 46.64 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.826 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.459 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -65.07 105.73 1.12 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.913 0.387 . . . . 0.0 110.2 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 106.54 -1.02 36.85 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.365 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 47.6 t -110.22 -90.89 0.47 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.34 . . . . 0.0 110.236 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 73.77 28.27 65.38 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.113 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -96.73 131.13 43.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.97 0.414 . . . . 0.0 110.083 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -117.27 136.87 52.78 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.117 0.484 . . . . 0.0 111.073 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -131.63 177.7 7.31 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.551 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 464' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 60.6 m -81.3 142.04 33.48 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -175.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -76.32 -56.62 4.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.566 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' VAL . . . . . 0.473 HG23 ' H ' ' A' ' 467' ' ' CYS . 3.2 m -71.26 -60.23 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.473 ' H ' HG23 ' A' ' 466' ' ' VAL . 16.1 p -93.73 170.15 9.78 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -111.63 109.22 19.0 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.245 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.52 160.12 40.28 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.586 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.15 149.89 25.88 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -56.41 108.12 0.45 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.627 0.727 . . . . 0.0 110.942 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 p -132.97 -179.17 5.32 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.121 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -70.21 -22.69 62.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.244 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.17 -54.07 7.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.186 0.517 . . . . 0.0 110.771 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 480' ' ' TRP . 85.1 m -85.01 8.25 18.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.933 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.5 ttt -53.95 -53.47 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.78 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -137.59 -0.47 2.61 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.031 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -58.84 -64.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.463 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -113.56 -4.88 13.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.88 0.372 . . . . 0.0 110.709 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' TRP . . . . . 0.414 ' HB2' ' O ' ' A' ' 475' ' ' CYS . 35.0 t-105 -68.19 -28.73 67.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.369 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -97.45 106.39 18.7 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.525 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 CA-C-O 118.886 -0.952 . . . . 0.0 111.887 -179.58 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.695 0.283 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.27 141.39 55.89 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.782 0.325 . . . . 0.0 110.247 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -88.19 97.22 10.89 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.277 0.561 . . . . 0.0 111.544 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 31.2 t -111.35 97.37 5.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.689 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.61 174.9 11.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.06 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' GLN . . . . . 0.422 HE22 HD11 ' A' ' 363' ' ' LEU . 4.4 pp0? -134.19 151.28 51.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.744 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -115.54 34.05 5.13 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -82.03 113.99 3.75 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.494 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' GLY . . . . . 0.482 ' HA2' HG12 ' A' ' 364' ' ' VAL . . . -153.57 -174.31 23.69 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.424 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 352' ' ' LEU . 10.5 p -129.63 175.06 11.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.517 ' H ' HG22 ' A' ' 351' ' ' VAL . 6.5 mp -130.79 151.7 50.94 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.796 -0.565 . . . . 0.0 111.865 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' CYS . . . . . 0.507 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 34.3 t -57.12 141.01 77.47 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.398 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.507 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 28.2 Cg_endo -61.75 -10.81 18.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.417 2.745 . . . . 0.0 114.515 -176.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -111.02 136.46 20.8 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.129 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.76 -19.83 30.88 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.053 2.502 . . . . 0.0 112.437 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -70.26 -17.44 74.13 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.253 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 41.1 t -86.55 -82.79 0.2 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.42 -0.39 . . . . 0.0 110.467 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 61.28 27.48 67.67 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.182 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -75.45 -40.09 57.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.653 0.263 . . . . 0.0 111.26 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.7 121.37 4.25 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.974 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -111.11 109.93 20.22 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.267 0.556 . . . . 0.0 110.411 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.422 HD11 HE22 ' A' ' 347' ' ' GLN . 1.9 tm? -88.01 112.48 22.65 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.65 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.482 HG12 ' HA2' ' A' ' 350' ' ' GLY . 7.7 p -83.63 104.73 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 121.865 0.84 . . . . 0.0 110.661 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 368' ' ' CYS . 8.6 pt-20 -90.26 159.79 41.22 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.667 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.81 -20.78 72.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.464 2.109 . . . . 0.0 111.305 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -99.37 3.67 46.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.418 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.53 ' N ' ' HG3' ' A' ' 365' ' ' GLU . 53.5 t -63.38 106.05 0.85 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 111.044 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ARG . . . . . 0.685 ' NE ' ' H ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -80.11 -37.92 32.65 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.069 0.462 . . . . 0.0 110.562 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -145.12 143.86 30.6 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.521 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.61 119.95 50.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.294 0.569 . . . . 0.0 110.137 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 50.5 m -152.26 139.69 19.56 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.646 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 12.6 t -77.81 47.47 0.63 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 121.14 0.495 . . . . 0.0 110.266 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -65.19 -11.9 45.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.925 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -96.23 -10.67 27.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.028 0.442 . . . . 0.0 110.739 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -133.42 -79.79 0.15 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.441 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 3.4 m -100.4 -131.28 0.24 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -168.87 104.11 0.2 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 173.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -162.66 145.98 11.22 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 17.8 m -108.28 127.58 64.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -141.39 -177.7 5.27 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.097 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 44.5 t -80.99 159.97 24.72 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.611 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.463 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 29.0 ptt180 -88.41 -15.42 35.53 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.215 0.531 . . . . 0.0 109.628 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.463 ' OD1' ' HG3' ' A' ' 383' ' ' ARG . 4.6 m-20 -106.03 -29.62 9.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.112 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 31.4 p -143.02 -159.66 1.0 Allowed 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.159 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.13 18.48 14.56 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.064 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -76.18 25.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 72.76 31.34 62.58 Favored Glycine 0 N--CA 1.463 0.485 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.53 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.4 100.49 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.407 0.622 . . . . 0.0 111.252 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -126.61 161.12 28.78 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.223 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 391' ' ' ILE . 1.9 pp -85.29 160.43 3.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.478 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.61 -146.29 25.75 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.88 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -124.11 162.28 23.88 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.739 0.304 . . . . 0.0 110.804 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 3.1 m -85.66 143.19 28.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.066 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.26 153.41 68.85 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.19 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.05 179.12 6.2 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.755 2.303 . . . . 0.0 112.999 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -135.42 123.69 23.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.284 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -172.23 124.82 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.174 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 4.9 p -136.36 169.95 16.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.564 0.221 . . . . 0.0 110.932 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 143.99 128.72 2.17 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.157 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -158.21 143.79 16.86 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.346 0.258 . . . . 0.0 110.452 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.8 t -155.81 133.34 11.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.782 0.325 . . . . 0.0 110.673 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -128.09 153.98 46.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.911 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 63.0 m -153.78 130.23 10.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.834 0.349 . . . . 0.0 111.276 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -127.57 105.03 8.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.986 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 2.5 p -86.38 127.97 34.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.776 0.322 . . . . 0.0 111.132 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 9.6 p -137.62 152.61 49.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.029 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -146.2 174.13 11.6 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.276 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -151.31 141.15 21.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.434 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 7.9 p -107.76 154.12 21.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.975 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.43 130.15 74.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.63 120.21 69.53 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-O 121.14 0.495 . . . . 0.0 110.732 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.1 132.48 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.715 2.277 . . . . 0.0 111.428 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -127.44 144.17 51.1 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -166.05 109.24 0.78 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.357 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -147.75 118.4 7.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.806 0.336 . . . . 0.0 110.878 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -151.19 106.26 3.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.335 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -96.17 161.25 14.04 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.417 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.33 145.38 22.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.18 118.19 2.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -131.9 156.4 46.18 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.734 0.302 . . . . 0.0 110.918 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -159.27 117.91 2.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.015 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -104.86 -39.34 6.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.48 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 58.41 34.43 23.98 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.026 0.53 . . . . 0.0 111.858 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 23.7 m -67.49 123.71 21.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.678 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -165.63 152.73 10.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.093 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 16.6 m -134.72 171.79 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.903 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.6 t -138.61 133.43 32.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.695 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 46.4 pt -122.49 -172.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.924 0.392 . . . . 0.0 111.181 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -137.06 156.57 48.23 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.37 109.19 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.509 0.671 . . . . 0.0 111.23 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.8 p -96.51 2.09 52.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.696 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 8.6 p -117.04 -177.0 3.1 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.135 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -122.83 110.77 31.39 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -63.69 125.84 16.29 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.968 1.778 . . . . 0.0 111.84 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 38.9 t -56.03 139.13 71.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.787 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.39 -1.83 11.82 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.205 1.937 . . . . 0.0 111.729 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' LYS . . . . . 0.419 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 1.7 tppm? -109.87 -61.25 1.68 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.557 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 23.9 p -101.46 -10.94 19.73 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.794 0.331 . . . . 0.0 111.375 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 69.0 mtt180 67.4 28.53 7.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.621 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 25.2 p -85.96 147.95 46.86 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.484 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.64 98.26 0.57 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.494 2.129 . . . . 0.0 112.355 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 16.9 m -85.96 124.34 32.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.027 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.35 131.05 35.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.394 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -95.7 98.76 10.71 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.271 0.558 . . . . 0.0 111.271 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -107.49 155.3 20.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.132 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 80.85 -82.71 1.5 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.241 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 127.65 3.29 6.05 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.168 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 7.0 p -68.56 161.18 28.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.564 0.221 . . . . 0.0 110.426 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.58 ' SD ' ' HA3' ' A' ' 482' ' ' GLY . 67.3 mtt -78.01 -10.29 59.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.143 0.497 . . . . 0.0 110.77 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -96.72 105.6 17.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.46 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 5.9 ptp -147.1 135.88 22.15 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.549 173.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.06 140.74 44.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.159 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 35.0 t -59.54 103.16 0.18 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.993 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 6.3 t -85.61 90.81 8.09 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 122.408 1.099 . . . . 0.0 109.559 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -129.45 138.22 51.31 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.414 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -52.67 -47.12 67.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.809 0.337 . . . . 0.0 111.183 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -104.0 49.43 0.93 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.97 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 21.5 t -152.09 -90.33 0.06 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.941 0.371 . . . . 0.0 111.508 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.14 38.16 63.54 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -90.85 118.3 30.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.747 0.308 . . . . 0.0 110.905 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -87.35 122.52 31.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.226 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -129.62 156.46 44.18 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 42.4 t -67.34 136.58 55.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.622 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -75.07 -36.96 61.76 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.543 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.19 -64.04 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.873 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.9 p -109.48 155.51 21.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.36 107.8 8.87 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 118.687 -1.205 . . . . 0.0 108.256 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.12 151.77 23.62 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.337 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.33 158.37 24.75 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -48.35 110.56 0.35 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.627 0.727 . . . . 0.0 111.382 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.6 m -138.87 154.7 48.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.639 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 476' ' ' MET . 46.7 mtp180 -61.99 -36.58 81.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.05 -32.1 72.58 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.222 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 88.0 m -87.72 -37.21 16.87 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' MET . . . . . 0.412 ' HB3' ' HA ' ' A' ' 473' ' ' ARG . 43.9 tpp -50.72 -54.65 21.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.272 -177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -90.56 7.47 81.32 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.169 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -111.13 -64.77 1.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -137.62 31.22 2.55 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -91.36 -34.04 15.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.03 0.443 . . . . 0.0 110.873 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -96.28 100.16 11.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.002 0.43 . . . . 0.0 110.978 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' GLY . . . . . 0.58 ' HA3' ' SD ' ' A' ' 450' ' ' MET . . . . . . . . 0 N--CA 1.437 -1.239 0 CA-C-O 118.425 -1.208 . . . . 0.0 112.072 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 120.905 0.384 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.04 -174.54 3.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.715 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -115.98 17.31 15.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 9.0 p 46.58 26.04 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 124.116 0.966 . . . . 0.0 111.739 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 52.2 tp -112.23 116.99 31.32 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.271 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -117.22 -54.25 2.41 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -110.5 124.2 51.36 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.998 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -161.28 31.44 0.34 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -143.92 155.42 26.19 Favored Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.329 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 352' ' ' LEU . 10.0 p -124.81 177.64 4.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.617 ' H ' HG22 ' A' ' 351' ' ' VAL . 85.9 mt -126.77 149.45 49.63 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 122.126 -0.359 . . . . 0.0 111.026 -177.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 355' ' ' GLN . 51.0 t -65.19 138.07 97.13 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.692 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.83 -14.25 40.95 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.924 2.416 . . . . 0.0 112.279 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.495 ' HB2' ' SG ' ' A' ' 353' ' ' CYS . 1.4 mp0 -75.48 123.68 88.66 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-O 120.92 0.39 . . . . 0.0 110.766 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.3 -22.21 46.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.097 2.532 . . . . 0.0 112.959 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -88.64 1.85 84.11 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.697 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.465 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 48.3 t -104.47 -93.56 0.35 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.921 0.391 . . . . 0.0 110.585 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.15 23.51 64.13 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.307 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.422 ' HG3' ' SG ' ' A' ' 358' ' ' CYS . 47.4 mtm -61.74 -72.49 0.12 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.859 0.361 . . . . 0.0 110.844 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.447 ' HA2' HD23 ' A' ' 352' ' ' LEU . . . 145.9 109.92 0.63 Allowed Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.117 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -101.75 109.98 21.87 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 364' ' ' VAL . 3.0 tt -82.91 135.67 34.84 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.017 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.509 ' N ' HD23 ' A' ' 363' ' ' LEU . 39.2 t -90.96 86.6 2.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.263 0.554 . . . . 0.0 109.986 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 366' ' ' PRO . 6.9 mm-40 -80.97 139.56 49.71 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.634 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 365' ' ' GLU . 31.2 Cg_exo -60.62 -21.76 70.18 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.514 2.143 . . . . 0.0 111.308 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -88.58 -7.47 56.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.46 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 7.5 t -107.82 105.0 14.61 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.715 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -93.76 15.18 17.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -155.76 144.34 20.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.017 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.22 120.96 64.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.434 0.635 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' THR . . . . . 0.483 ' OG1' HG12 ' A' ' 380' ' ' VAL . 62.1 m -147.47 136.96 22.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.916 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.6 t -78.2 67.16 3.96 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.171 0.51 . . . . 0.0 109.969 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -85.43 -7.01 59.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.381 0.61 . . . . 0.0 109.816 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -90.44 -17.11 27.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.441 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -140.17 -78.65 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.49 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 3.2 m -89.03 -127.2 0.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -171.21 104.55 0.2 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 381' ' ' PHE . 55.1 t80 -163.24 137.43 6.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.484 0.142 . . . . 0.0 111.115 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.483 HG12 ' OG1' ' A' ' 372' ' ' THR . 35.1 m -100.29 128.82 51.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.436 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 7.4 p90 -142.56 -176.68 4.95 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.326 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' CYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 31.6 t -86.85 171.71 10.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.405 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 16.2 ptt180 -97.33 -16.37 20.31 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.486 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.481 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 4.6 m-20 -105.01 -28.31 11.14 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.753 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 24.5 p -143.21 -170.79 3.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.159 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.9 mp -110.62 24.06 13.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.912 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -75.58 15.58 0.47 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 76.33 29.1 58.8 Favored Glycine 0 N--CA 1.46 0.282 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.579 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 19.1 t80 63.2 101.05 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.335 0.654 . . . . 0.0 110.756 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -127.11 179.75 5.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.579 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.85 166.21 5.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.106 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.65 -132.19 11.1 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.618 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.33 149.65 49.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.781 0.324 . . . . 0.0 110.379 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 6.6 m -88.77 -63.06 1.35 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.698 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.53 126.08 69.9 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.1 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -90.79 -174.16 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.8 2.333 . . . . 0.0 112.197 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -145.8 140.79 27.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -98.41 -173.64 32.52 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.817 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 12.6 t -177.63 -177.06 0.64 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 167.09 167.97 28.58 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -160.16 174.45 14.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.0 p -152.13 153.12 33.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.702 0.287 . . . . 0.0 110.961 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -128.92 174.64 9.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.525 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 10.0 t -171.83 133.15 0.73 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.96 0.41 . . . . 0.0 110.994 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -110.34 153.76 24.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 19.3 p -138.56 130.23 27.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.794 0.331 . . . . 0.0 111.176 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 43.3 t -162.96 141.47 8.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.59 176.85 8.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.021 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -158.03 176.16 12.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.501 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 14.7 t -154.38 160.3 41.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.617 0.246 . . . . 0.0 110.473 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.98 171.08 2.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.73 0.3 . . . . 0.0 110.626 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -109.15 148.26 37.6 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.011 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.14 148.55 27.5 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.614 2.209 . . . . 0.0 112.174 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -102.47 178.16 4.66 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -140.74 144.69 35.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.995 0.426 . . . . 0.0 111.576 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -155.49 129.07 8.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.009 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -143.54 84.23 1.8 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.193 0.52 . . . . 0.0 110.606 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -92.71 150.46 20.65 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -159.07 124.27 4.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.838 0.352 . . . . 0.0 110.845 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -125.24 144.24 50.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.57 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 30.7 m-90 -116.31 150.4 37.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.769 0.318 . . . . 0.0 110.815 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.85 125.74 41.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.542 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -106.18 -21.38 13.13 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.045 0.45 . . . . 0.0 110.31 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -61.04 119.85 9.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.827 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 25.6 t -147.92 142.55 26.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.21 128.68 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.933 0.397 . . . . 0.0 110.497 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.72 105.37 7.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.495 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.7 t -102.57 154.81 18.76 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 6.1 tp -82.31 117.54 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 121.664 0.745 . . . . 0.0 111.47 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -131.73 121.57 24.43 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.01 127.49 73.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.145 0.497 . . . . 0.0 111.734 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.6 m -104.56 -15.07 15.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.573 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.5 p -94.12 138.91 31.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.552 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -108.76 140.24 21.65 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.31 125.29 11.19 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.228 1.952 . . . . 0.0 112.708 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 42.0 t -58.13 139.68 83.45 Favored Pre-proline 0 N--CA 1.456 -0.126 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.278 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 4.5 Cg_exo -70.39 -20.91 31.27 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.942 1.762 . . . . 0.0 111.335 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 438' ' ' LYS . 0.1 OUTLIER -96.29 -67.49 0.85 Allowed 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.08 -177.027 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 439' ' ' CYS . . . . . 0.532 ' SG ' ' HG3' ' A' ' 456' ' ' ARG . 21.3 p -93.09 -8.33 43.03 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.704 ' HD3' ' O ' ' A' ' 440' ' ' ARG . 1.0 OUTLIER 65.23 23.05 12.21 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.586 0.754 . . . . 0.0 111.435 177.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 39.2 p -82.56 162.74 54.83 Favored Pre-proline 0 C--N 1.31 -1.122 0 O-C-N 121.967 -0.458 . . . . 0.0 110.359 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -79.21 100.7 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.243 1.962 . . . . 0.0 112.53 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 12.1 m -92.42 128.21 38.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.193 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -86.55 160.03 19.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.607 0.242 . . . . 0.0 110.97 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.422 ' C ' ' HD2' ' A' ' 445' ' ' ARG . 7.0 tmm_? -118.06 108.69 15.54 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.61 141.95 33.69 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.315 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 71.92 -143.52 35.04 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.568 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -139.53 26.64 2.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.685 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 8.8 p -87.21 155.76 19.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.853 0.358 . . . . 0.0 111.088 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -82.79 -16.31 48.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.096 0.474 . . . . 0.0 109.932 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -86.38 96.89 10.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.199 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 3.7 ptp -117.59 111.07 18.71 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.06 129.15 41.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.177 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 43.0 t -70.39 105.2 2.95 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.645 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 5.1 t -87.01 90.27 8.29 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 122.073 0.939 . . . . 0.0 108.948 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.57 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -130.97 139.18 49.99 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.406 -177.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.65 87.31 0.13 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.872 0.368 . . . . 0.0 110.247 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.45 39.69 1.45 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.088 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 461' ' ' PHE . 19.5 t -145.78 -91.9 0.09 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.624 -0.339 . . . . 0.0 110.921 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.57 27.19 69.9 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' PHE . . . . . 0.627 ' HB2' ' SG ' ' A' ' 459' ' ' CYS . 9.8 t80 -72.6 128.2 34.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.06 0.457 . . . . 0.0 110.887 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.53 134.75 49.18 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -150.5 159.12 44.71 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.875 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 76.4 m -70.3 140.99 52.39 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.215 0.531 . . . . 0.0 110.951 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -74.31 -40.22 62.38 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.221 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 23.1 t -85.53 -58.87 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.202 -174.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 6.9 p -91.81 152.87 19.92 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -93.45 110.05 21.62 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.345 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' THR . . . . . 0.509 HG21 ' SG ' ' A' ' 475' ' ' CYS . 13.0 t -157.65 178.48 10.22 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.609 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.22 156.89 22.47 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 32.2 p-90 -51.89 117.74 2.94 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.332 0.587 . . . . 0.0 110.362 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 10.8 t -156.99 179.15 9.58 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.53 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -71.5 -23.38 61.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.978 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -62.64 -54.19 43.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.819 0.342 . . . . 0.0 111.3 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' CYS . . . . . 0.509 ' SG ' HG21 ' A' ' 469' ' ' THR . 70.8 m -98.94 24.56 7.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.631 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -61.26 -36.92 81.33 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.896 0.379 . . . . 0.0 111.271 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -167.9 26.15 0.13 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.773 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -78.32 -62.12 1.78 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.195 0.521 . . . . 0.0 110.681 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -110.77 -4.82 15.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.788 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -73.86 86.18 1.73 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.76 95.64 2.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.653 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.225 0 CA-C-O 118.321 -1.266 . . . . 0.0 111.042 -178.611 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 121.047 0.451 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -155.05 79.13 1.05 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.336 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -86.25 109.0 18.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.378 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 52.6 t -118.36 111.09 32.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.395 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.74 106.05 17.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -84.26 112.71 20.54 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.607 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -113.67 -168.52 1.36 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.142 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 150.24 -125.47 1.95 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.356 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' GLY . . . . . 0.437 ' HA2' HG23 ' A' ' 364' ' ' VAL . . . -158.82 -149.76 5.6 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.556 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 352' ' ' LEU . 7.8 p -155.81 175.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.495 ' H ' HG22 ' A' ' 351' ' ' VAL . 6.7 mp -129.14 150.85 50.36 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.784 -0.572 . . . . 0.0 111.337 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' CYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 354' ' ' PRO . 43.3 t -63.75 128.33 92.67 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.446 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 353' ' ' CYS . 17.8 Cg_exo -67.38 -9.38 25.08 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.19 2.593 . . . . 0.0 113.129 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 358' ' ' CYS . 10.3 tm0? -65.0 122.53 80.06 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.1 -28.6 51.7 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 123.765 2.977 . . . . 0.0 114.964 -174.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -108.19 16.97 35.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.702 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.751 ' SG ' ' HG3' ' A' ' 360' ' ' MET . 12.2 t -106.04 -97.27 0.34 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.27 32.38 71.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.078 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.751 ' HG3' ' SG ' ' A' ' 358' ' ' CYS . 0.6 OUTLIER -65.86 -32.98 74.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.83 107.63 2.94 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.955 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.41 HD22 ' SD ' ' A' ' 360' ' ' MET . 3.9 mm? -99.45 135.46 40.83 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.82 128.68 55.11 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.437 HG23 ' HA2' ' A' ' 350' ' ' GLY . 79.7 t -77.9 91.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.409 0.623 . . . . 0.0 109.781 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 368' ' ' CYS . 16.2 mm-40 -90.07 148.29 39.11 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.368 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.67 -22.75 74.26 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.478 2.119 . . . . 0.0 111.62 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -99.52 9.85 42.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.419 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 365' ' ' GLU . 37.2 t -89.7 78.95 6.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.445 0.64 . . . . 0.0 109.698 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ARG . . . . . 0.478 ' H ' ' HD2' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -72.76 -22.59 60.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.758 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 370' ' ' LYS . 3.7 mmmp? -135.26 113.63 11.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.169 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.84 112.66 23.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.566 0.698 . . . . 0.0 110.041 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 94.9 m -147.44 138.86 23.86 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.92 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.422 ' SG ' ' HA3' ' A' ' 376' ' ' GLY . 21.6 t -74.86 76.8 2.13 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.225 0.536 . . . . 0.0 109.69 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -86.08 -38.7 17.53 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.048 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.53 -18.35 54.86 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.098 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' GLY . . . . . 0.422 ' HA3' ' SG ' ' A' ' 373' ' ' CYS . . . -101.32 -89.98 2.08 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.925 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.2 p -124.7 -91.52 0.54 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.013 0.435 . . . . 0.0 110.567 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -172.52 107.23 0.25 Allowed Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -161.02 131.81 5.31 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.872 0.336 . . . . 0.0 110.308 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.88 124.38 65.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.42 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 6.2 p90 -152.66 179.49 8.56 Favored 'General case' 0 C--O 1.21 -0.999 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.253 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 24.5 t -84.43 167.78 16.12 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -95.4 -16.6 22.19 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.323 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -104.31 -32.8 8.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.872 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 27.8 p -137.59 -166.38 1.93 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.101 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.401 ' HG ' ' HG3' ' A' ' 354' ' ' PRO . 10.9 mp -115.06 27.51 9.35 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.774 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -78.16 16.03 0.83 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 79.18 17.47 76.51 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.609 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 73.45 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.512 0.725 . . . . 0.0 111.244 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -148.23 -46.81 0.16 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.045 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.9 tt -150.3 158.04 5.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -87.91 6.24 83.75 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.767 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -136.03 115.59 12.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.136 0.468 . . . . 0.0 111.327 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 59.2 m -129.43 165.76 20.92 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.949 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.47 152.04 87.55 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.526 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.49 176.07 3.02 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 122.673 2.248 . . . . 0.0 112.392 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.96 100.76 5.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.466 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -113.81 -59.33 0.39 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.096 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 8.4 m -93.32 91.93 7.44 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.954 0.407 . . . . 0.0 110.568 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -136.52 10.56 4.04 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -90.3 141.6 28.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 47.8 m -82.06 92.64 6.85 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.195 0.522 . . . . 0.0 111.191 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -88.07 -36.35 17.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.186 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.5 m -76.58 102.99 6.33 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.541 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -79.23 -43.36 23.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.639 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.9 m -74.24 164.24 26.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.19 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 8.9 p -158.24 153.31 25.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.723 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -86.18 143.12 28.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.203 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -121.79 154.51 36.89 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.531 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 11.9 t -138.43 166.97 22.92 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 32.6 m -81.59 168.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 120.847 0.356 . . . . 0.0 110.268 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -93.83 125.32 53.69 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.32 108.07 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.694 2.263 . . . . 0.0 111.395 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -79.08 177.49 8.76 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.157 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -106.84 124.34 49.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.03 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -80.94 -44.86 17.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.23 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . 62.76 100.9 0.03 OUTLIER 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.626 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.25 148.54 32.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.419 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -145.22 130.88 18.93 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.048 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -98.41 144.95 27.23 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.772 0.32 . . . . 0.0 110.391 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -123.19 38.29 4.22 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.291 0.567 . . . . 0.0 109.845 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -85.95 122.04 29.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.191 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.79 -13.15 15.62 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 60.76 32.4 20.19 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.455 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 18.7 p -83.73 112.65 20.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.868 0.366 . . . . 0.0 110.323 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -102.92 118.83 37.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.128 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.49 154.26 22.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.882 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 8.8 t -86.45 129.07 34.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.084 0.468 . . . . 0.0 110.285 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 429' ' ' ILE . 3.0 mp -77.72 122.51 32.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.661 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -96.53 135.0 39.02 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p -67.21 123.98 21.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.264 0.554 . . . . 0.0 110.689 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.1 m -107.63 -31.22 8.18 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.693 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.2 p -80.12 -178.58 6.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.234 0.54 . . . . 0.0 111.413 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.541 ' HG2' ' CH2' ' A' ' 463' ' ' TRP . 1.6 tpmt? -112.84 108.82 53.27 Favored Pre-proline 0 C--N 1.312 -1.047 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 434' ' ' LYS . 24.9 Cg_endo -63.05 130.69 29.81 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.117 1.878 . . . . 0.0 111.739 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 45.5 t -57.36 134.93 81.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.358 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.36 -7.64 21.47 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.365 2.043 . . . . 0.0 111.746 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -107.59 -63.99 1.25 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.83 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 6.2 p -95.47 -3.11 47.41 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 60.7 26.05 15.82 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 21.4 p -87.22 143.11 34.13 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.73 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -63.75 104.73 0.48 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.345 2.03 . . . . 0.0 111.449 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 37.9 m -96.4 133.6 40.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.939 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.21 163.98 23.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.761 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -120.58 162.43 19.64 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.122 0.487 . . . . 0.0 111.647 -176.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -99.79 162.57 12.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.059 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -63.04 -50.87 59.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.854 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -151.3 52.8 0.49 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.351 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 61.6 m -118.91 137.35 53.52 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -17.45 27.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.85 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.32 96.95 10.53 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 70.0 mmm -106.51 112.53 25.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 462' ' ' GLU . 21.3 t -115.6 141.37 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.996 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 28.8 t -83.03 125.66 31.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.06 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 19.9 p -101.54 89.96 3.9 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 121.833 0.825 . . . . 0.0 110.338 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.531 ' HB3' ' HB2' ' A' ' 459' ' ' CYS . 2.7 tmt_? -131.97 135.39 46.54 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.41 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -62.33 97.65 0.1 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.695 0.284 . . . . 0.0 110.954 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.06 22.24 8.44 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.581 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 456' ' ' ARG . 51.4 t -114.36 -80.93 0.6 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.429 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.72 24.12 76.45 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.25 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -93.91 139.25 31.13 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.421 ' HB3' HG13 ' A' ' 453' ' ' VAL . 7.3 pt-20 -126.55 157.71 38.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.301 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' TRP . . . . . 0.541 ' CH2' ' HG2' ' A' ' 434' ' ' LYS . 7.4 p-90 -147.4 163.43 36.51 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.12 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 43.9 t -70.49 143.24 51.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.682 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -75.75 -42.09 51.44 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.609 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.79 -48.05 24.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 27.4 p -118.96 143.79 46.83 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.52 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -77.09 111.65 12.91 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.378 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 3.7 p -152.85 174.99 13.39 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.995 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -96.48 152.44 18.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' TRP . . . . . 0.4 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 35.4 t-105 -54.1 122.9 11.17 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.02 0.438 . . . . 0.0 111.748 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.8 t -160.43 153.62 21.78 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.592 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -66.67 -25.42 66.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.3 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.83 -34.71 69.98 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.472 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.65 -27.59 14.72 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.7 ttt -53.81 -44.6 70.34 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.452 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -100.85 20.25 48.73 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.669 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -105.71 -64.94 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.681 -0.306 . . . . 0.0 111.44 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -148.68 28.76 0.85 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.275 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -69.45 -29.86 67.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.176 0.512 . . . . 0.0 109.884 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -92.9 111.67 23.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.445 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.038 0 CA-C-O 118.461 -1.188 . . . . 0.0 112.058 -179.161 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -171.24 134.18 0.89 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -81.07 73.56 8.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.187 0.518 . . . . 0.0 111.4 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.1 p -121.25 98.38 5.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.558 0.694 . . . . 0.0 110.725 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 346' ' ' LEU . 3.7 mm? -105.29 104.78 14.58 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -154.85 148.52 25.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.711 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -155.43 167.61 29.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.048 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 130.72 -18.12 5.16 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.761 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -173.86 174.23 46.17 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.634 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 362' ' ' LEU . 9.9 p -126.72 167.68 21.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.407 ' H ' HG22 ' A' ' 351' ' ' VAL . 5.8 mp -137.41 152.28 49.45 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.914 0.388 . . . . 0.0 111.716 -177.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 18.5 t -59.41 135.68 88.77 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.698 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 379' ' ' TYR . 42.7 Cg_endo -66.73 -15.57 47.77 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.913 2.409 . . . . 0.0 113.785 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -99.0 134.45 21.42 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 120.822 0.344 . . . . 0.0 111.788 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.81 -15.65 44.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.216 2.611 . . . . 0.0 112.729 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -79.71 16.12 12.25 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.831 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.7 t -126.68 -87.3 0.59 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 64.43 21.13 66.32 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.827 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 37.5 ttp -67.59 -43.65 80.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.832 0.348 . . . . 0.0 111.172 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.72 118.92 4.44 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.007 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.458 ' HB2' HG13 ' A' ' 351' ' ' VAL . 4.0 mm? -112.8 155.62 24.29 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.796 0.332 . . . . 0.0 110.456 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.409 ' HG ' ' N ' ' A' ' 364' ' ' VAL . 26.7 tp -102.61 157.06 17.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.66 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.409 ' N ' ' HG ' ' A' ' 363' ' ' LEU . 48.8 t -121.85 90.88 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 120.954 0.407 . . . . 0.0 110.563 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.33 152.22 96.6 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.41 -30.15 86.63 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.073 1.849 . . . . 0.0 111.139 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.57 15.0 28.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.115 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.35 101.77 3.54 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -111.7 -3.32 15.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 370' ' ' LYS . 5.5 mmpt? -144.95 91.53 2.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.835 177.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.78 129.06 46.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.5 0.667 . . . . 0.0 110.513 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.6 m -152.45 145.11 24.23 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.296 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 8.7 t -76.12 45.99 0.38 Allowed 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 121.326 0.584 . . . . 0.0 109.786 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -63.75 -12.38 34.49 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -98.62 -2.64 37.99 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -143.13 -75.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.101 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.1 m -99.72 -132.64 0.25 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -170.83 103.97 0.2 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.422 ' CD2' ' HG3' ' A' ' 354' ' ' PRO . 54.7 t80 -162.14 139.56 8.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 26.2 m -95.04 126.11 47.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.438 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 16.7 p90 -138.51 -176.57 4.51 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' CYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 16.4 t -82.27 164.05 21.42 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.706 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -92.28 -18.9 22.75 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.097 0.475 . . . . 0.0 110.352 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.577 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 1.6 t-20 -106.57 -29.22 9.78 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.174 0.511 . . . . 0.0 109.927 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 29.3 p -136.39 -165.2 1.68 Allowed 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.739 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 62.8 mt -117.51 25.71 10.23 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.878 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -86.55 30.41 0.72 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 70.26 23.16 77.52 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.573 175.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.92 113.03 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.762 0.825 . . . . 0.0 112.14 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -131.91 168.44 17.87 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.841 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.71 147.87 6.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.273 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 100.02 173.97 30.35 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.445 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -100.44 128.97 46.36 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.803 0.335 . . . . 0.0 110.214 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 1.3 m -83.52 154.73 23.7 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.386 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.9 145.0 31.63 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.582 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -92.51 -160.05 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.908 2.405 . . . . 0.0 111.11 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.04 95.76 5.6 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -116.92 64.16 0.36 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.678 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 17.3 p -82.72 149.04 27.52 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.819 0.342 . . . . 0.0 111.021 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -142.31 143.92 13.44 Favored Glycine 0 C--O 1.24 0.488 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -168.38 -178.39 3.55 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.726 0.263 . . . . 0.0 111.024 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 31.6 t 72.99 115.94 0.05 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.044 0.937 . . . . 0.0 112.215 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -147.91 137.29 22.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.162 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 14.1 t -100.48 154.84 18.21 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.009 0.433 . . . . 0.0 111.324 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -131.68 160.63 34.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.763 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 19.5 m -149.01 165.71 30.84 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.635 0.255 . . . . 0.0 111.312 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 24.3 p -166.6 150.09 7.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.849 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.08 164.5 37.13 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.567 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -149.62 169.2 21.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 33.7 m -156.89 122.31 4.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 21.4 m -112.2 142.49 24.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.886 0.374 . . . . 0.0 110.999 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -100.86 152.93 37.97 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.417 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -84.39 150.26 11.81 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.8 2.334 . . . . 0.0 111.931 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.67 157.32 17.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.961 0.41 . . . . 0.0 111.194 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 30.7 mmm-85 -132.17 173.12 11.57 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.19 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.0 116.7 3.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.304 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -127.3 141.22 51.77 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.49 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.24 175.39 10.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.053 0.454 . . . . 0.0 111.147 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.79 120.09 4.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.452 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -128.56 145.01 51.25 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.848 0.356 . . . . 0.0 111.234 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -148.38 162.39 39.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.658 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -101.56 149.42 24.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.222 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -104.9 13.01 31.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.397 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.12 122.61 17.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.224 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 5.6 t -165.49 145.57 6.78 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.561 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -152.64 101.14 2.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.188 0.518 . . . . 0.0 110.783 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.84 175.84 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.69 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 7.6 t -154.67 125.07 6.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.341 0.591 . . . . 0.0 111.074 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.45 ' O ' HD12 ' A' ' 429' ' ' ILE . 2.2 pp -119.37 149.48 21.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -137.18 148.41 46.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.554 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.19 104.36 15.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.819 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 22.2 m -91.32 -13.38 32.69 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.844 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 4.0 p -82.92 138.72 33.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.591 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.441 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 1.7 tpmt? -90.91 124.67 61.35 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 5.8 Cg_exo -73.54 122.71 8.08 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.097 1.865 . . . . 0.0 111.764 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 440' ' ' ARG . 35.1 t -53.25 136.66 49.81 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.103 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.85 -14.69 46.42 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.712 2.275 . . . . 0.0 112.4 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.69 -67.86 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 7.8 p -86.45 -8.5 57.56 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 436' ' ' CYS . 18.7 mmm180 64.14 26.01 13.81 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.643 0.377 . . . . 0.0 111.628 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 29.3 p -87.29 141.82 32.95 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.632 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 11.9 Cg_exo -69.49 104.36 1.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.597 2.198 . . . . 0.0 112.094 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 18.0 m -81.16 119.69 23.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.335 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.64 95.44 4.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.362 0.601 . . . . 0.0 109.711 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 445' ' ' ARG . 20.7 mtp180 -137.07 156.58 48.22 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.741 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.18 151.39 22.72 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -81.95 59.04 4.9 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.34 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -72.38 -35.61 59.89 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 27.1 p -140.34 175.46 9.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.498 ' HA ' ' HB3' ' A' ' 465' ' ' TRP . 1.0 OUTLIER -83.72 0.89 45.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.781 0.324 . . . . 0.0 111.271 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -93.2 100.48 12.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.774 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' MET . . . . . 0.416 ' HG2' ' HB2' ' A' ' 465' ' ' TRP . 10.3 mmt -100.1 107.01 18.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.345 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' A' ' 462' ' ' GLU . 21.7 t -105.73 124.8 61.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.044 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 52.4 t -78.83 99.7 6.85 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.994 0.426 . . . . 0.0 109.954 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 13.0 p -83.49 90.25 7.19 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 121.623 0.725 . . . . 0.0 110.111 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.484 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 4.0 tmm_? -130.76 145.61 52.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.462 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -69.61 93.26 0.69 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.769 0.318 . . . . 0.0 110.683 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 111.66 13.22 13.11 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.748 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.484 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 49.6 t -114.12 -88.4 0.56 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 122.788 -0.242 . . . . 0.0 110.566 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.16 27.17 70.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.145 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -88.28 142.91 27.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.918 0.39 . . . . 0.0 110.451 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.474 ' HG2' HG22 ' A' ' 453' ' ' VAL . 51.7 mt-10 -114.85 133.24 56.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.296 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -133.74 164.75 26.54 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.976 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 13.8 t -77.97 136.01 37.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.316 0.579 . . . . 0.0 111.962 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' TRP . . . . . 0.498 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 21.4 t-105 -77.51 -44.1 29.88 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.274 177.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 22.7 m -78.57 -17.18 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -173.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 18.5 p -145.19 148.99 34.15 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -82.52 108.67 16.1 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.718 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.3 p -155.82 178.1 10.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.246 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.04 157.62 17.39 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' TRP . . . . . 0.467 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 45.6 t90 -53.04 104.45 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 109.897 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 p -134.07 152.82 52.01 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.07 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' ARG . . . . . 0.592 ' HG3' ' SD ' ' A' ' 476' ' ' MET . 14.9 ttm180 -70.12 -23.0 62.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.102 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.0 -28.46 68.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.23 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 2.8 t -100.47 -27.34 13.49 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' MET . . . . . 0.592 ' SD ' ' HG3' ' A' ' 473' ' ' ARG . 14.2 ptm -55.74 -29.49 59.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.858 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -111.04 12.1 29.19 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.216 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -100.16 -65.91 0.94 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.805 0.336 . . . . 0.0 110.841 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -146.27 21.42 1.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.662 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -72.87 -11.75 60.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.776 0.798 . . . . 0.0 108.878 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -119.56 151.82 38.02 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.767 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.476 -1.18 . . . . 0.0 112.131 -179.548 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.824 0.345 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -69.31 99.29 1.16 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.109 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -89.21 80.74 6.84 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.328 0.585 . . . . 0.0 109.688 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.88 114.08 30.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.963 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.445 ' H ' HD23 ' A' ' 346' ' ' LEU . 2.5 pt? -138.99 -4.85 1.51 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.933 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -108.57 152.68 24.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.409 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -93.43 -3.92 52.26 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.441 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 76.91 -124.41 6.99 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.734 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -146.03 142.3 10.44 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.662 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 6.2 p -101.32 166.01 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.86 141.5 47.82 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 30.0 t -66.6 118.58 55.54 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.925 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.563 ' CG ' HD11 ' A' ' 386' ' ' LEU . 92.3 Cg_endo -81.9 4.98 6.62 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.518 2.812 . . . . 0.0 112.195 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -87.12 121.2 71.6 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.79 111.9 0.98 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.928 2.419 . . . . 0.0 112.816 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 126.39 3.07 6.8 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.343 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.697 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 36.6 t -113.08 -90.22 0.52 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 120.768 0.318 . . . . 0.0 111.089 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 60.55 22.85 59.8 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 43.5 ttp -72.37 -73.1 0.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.489 0.316 . . . . 0.0 111.36 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 148.36 121.63 1.2 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.737 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.5 129.11 56.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.973 0.416 . . . . 0.0 110.201 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 51.9 tp -86.51 129.82 34.72 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.676 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.22 87.43 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.485 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.61 166.58 44.09 Favored Pre-proline 0 C--N 1.313 -0.989 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.781 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.26 -23.88 64.65 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.236 1.957 . . . . 0.0 111.75 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.24 2.5 42.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.128 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.76 86.84 7.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -104.69 21.7 16.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.1 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -156.0 110.89 2.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.382 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.8 128.07 60.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.609 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 48.9 m -152.64 137.24 16.87 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.218 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 2.4 t -79.82 61.23 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.193 0.52 . . . . 0.0 110.17 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -70.71 -6.39 36.93 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.296 0.57 . . . . 0.0 110.187 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -99.67 -3.83 32.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.519 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -158.67 -115.79 0.44 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.964 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.3 p -86.66 94.89 9.61 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.84 113.77 5.45 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.922 -0.581 . . . . 0.0 114.495 -172.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -150.92 133.76 15.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.79 133.51 29.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 120.828 0.347 . . . . 0.0 110.08 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 389' ' ' TYR . 30.8 p90 -148.38 176.04 10.61 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 29.8 t -85.98 151.7 23.52 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -80.76 -11.59 59.59 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.028 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.466 ' CG ' ' H ' ' A' ' 394' ' ' CYS . 13.5 m-80 -105.47 -37.91 6.64 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.888 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.41 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 27.0 p -140.52 -159.21 0.93 Allowed 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.93 -176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.563 HD11 ' CG ' ' A' ' 354' ' ' PRO . 3.9 mm? -116.33 23.6 11.99 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' GLN . . . . . 0.538 ' HB2' ' CD2' ' A' ' 390' ' ' HIS . 75.2 mm-40 -83.07 28.0 0.53 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 69.5 25.5 75.44 Favored Glycine 0 N--CA 1.469 0.891 0 C-N-CA 121.478 -0.391 . . . . 0.0 114.05 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 381' ' ' PHE . 13.7 t80 63.31 105.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.409 0.684 . . . . 0.0 110.92 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.547 ' CG ' ' H ' ' A' ' 391' ' ' ILE . 2.3 p80 -132.63 -72.97 0.51 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.529 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.547 ' H ' ' CG ' ' A' ' 390' ' ' HIS . 50.7 mm -88.49 149.4 4.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -57.78 -54.23 38.97 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.81 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -130.72 122.41 27.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.877 0.37 . . . . 0.0 110.661 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.466 ' H ' ' CG ' ' A' ' 384' ' ' ASN . 62.3 m -104.0 -176.69 3.15 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.069 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 79.7 mt -89.07 150.55 45.41 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.106 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.63 -170.06 0.82 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.376 2.051 . . . . 0.0 111.666 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.96 -50.36 72.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.015 0.436 . . . . 0.0 110.378 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 70.21 -96.24 0.54 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 14.8 t -124.55 0.99 8.25 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.058 0.456 . . . . 0.0 110.07 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 77.35 33.77 42.91 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.261 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -85.92 94.82 9.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.065 0.46 . . . . 0.0 110.291 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 10.0 t -78.5 89.41 4.46 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.385 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -164.76 110.86 0.98 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.697 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 20.9 p -129.87 145.35 51.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.138 0.494 . . . . 0.0 112.303 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -129.76 152.34 49.36 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 37.9 t -141.41 -48.67 0.4 Allowed 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.71 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 34.4 m -92.44 20.14 6.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.954 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -89.46 96.85 10.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.875 0.369 . . . . 0.0 110.088 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -160.53 126.01 3.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.925 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 50.2 m -153.68 96.8 2.04 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.914 0.388 . . . . 0.0 110.489 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 8.4 p -108.02 -6.82 10.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.56 0.695 . . . . 0.0 109.936 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.1 149.7 53.47 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.969 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.25 111.99 1.09 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.01 2.473 . . . . 0.0 113.447 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -93.27 112.24 24.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.679 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.77 160.97 43.12 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.431 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -152.91 106.08 3.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.749 0.309 . . . . 0.0 110.617 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -134.79 111.14 9.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.487 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -167.17 133.1 2.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.896 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -171.28 140.23 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.266 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -135.61 172.25 13.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -157.12 109.49 2.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -129.92 114.03 15.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.662 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -105.65 2.13 27.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.4 0.619 . . . . 0.0 110.262 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -92.47 -173.08 3.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.428 -177.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 40.4 t -149.23 153.04 37.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.93 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.89 153.03 26.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.47 141.56 15.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.114 0.483 . . . . 0.0 110.63 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 31.4 m -124.78 127.97 48.01 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.754 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 51.1 mt -91.46 -35.13 6.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.178 0.513 . . . . 0.0 110.175 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -84.32 43.76 0.98 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.384 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 12.1 m -76.28 160.13 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.411 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 19.9 m -72.46 -28.64 63.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.873 0.368 . . . . 0.0 110.6 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 11.8 p -78.73 115.33 18.35 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.197 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -92.39 143.89 28.04 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.304 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.58 127.25 15.25 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.461 2.107 . . . . 0.0 111.87 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 30.3 t -57.08 139.29 79.21 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.949 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.2 -15.74 46.92 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.134 1.889 . . . . 0.0 112.055 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -103.2 -60.17 1.6 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.0 p -99.68 -8.04 24.88 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 440' ' ' ARG . 3.1 mpt_? 63.4 24.77 14.3 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 34.3 p -82.95 157.68 65.98 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.84 103.85 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.121 1.881 . . . . 0.0 111.22 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 26.9 m -77.27 112.47 14.01 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.571 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.15 108.93 14.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.975 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -111.25 125.81 54.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.176 0.512 . . . . 0.0 110.73 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -141.87 104.05 4.44 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 78.4 52.48 5.15 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -53.03 126.35 33.04 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.357 -0.422 . . . . 0.0 112.895 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 13.1 t -93.83 24.57 4.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.73 0.3 . . . . 0.0 110.365 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 43.1 ttm 72.82 -40.19 0.47 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.851 0.86 . . . . 0.0 111.271 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -84.32 105.0 14.82 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 87.2 mmm -98.73 120.51 39.29 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.725 0.298 . . . . 0.0 111.169 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.57 128.41 76.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.348 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.5 t -92.73 106.21 18.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.994 0.426 . . . . 0.0 110.403 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.0 p -87.87 90.77 8.51 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.296 0.57 . . . . 0.0 110.129 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.556 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 2.5 tmm_? -130.74 138.94 50.21 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -62.36 98.43 0.11 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.719 0.295 . . . . 0.0 110.59 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.71 9.11 29.25 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.086 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.556 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 45.2 t -113.86 -91.8 0.5 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 122.431 -0.452 . . . . 0.0 110.758 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.71 23.95 77.35 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' PHE . . . . . 0.41 ' CD2' ' HZ3' ' A' ' 471' ' ' TRP . 27.5 t80 -84.2 108.77 17.28 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.158 0.504 . . . . 0.0 110.372 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 471' ' ' TRP . 6.3 pt-20 -97.98 126.24 43.3 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.731 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -128.86 166.44 19.07 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.791 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' CYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 27.2 t -78.77 144.04 35.54 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.311 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -76.5 -39.21 53.73 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.165 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.71 -8.18 9.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 17.9 p -148.95 155.87 41.46 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -91.38 107.74 19.41 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.104 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 5.0 p -155.6 169.98 23.04 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.223 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -96.14 157.05 16.08 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' TRP . . . . . 0.479 ' HB3' ' HG3' ' A' ' 462' ' ' GLU . 20.3 p90 -48.92 111.97 0.55 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.595 0.712 . . . . 0.0 111.333 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 5.4 p -134.35 148.9 50.8 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.107 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 473' ' ' ARG . 14.5 mmt180 -74.95 -22.14 58.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.129 0.49 . . . . 0.0 110.055 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.82 -50.51 70.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.913 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 18.7 t -74.68 -30.19 61.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.628 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' MET . . . . . 0.552 ' HA ' ' CB ' ' A' ' 480' ' ' TRP . 28.1 ttt -52.76 -38.04 60.42 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.729 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -100.83 13.05 59.33 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.159 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.41 -66.17 1.08 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.818 -0.225 . . . . 0.0 111.346 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -153.79 12.45 0.45 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.892 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' TRP . . . . . 0.552 ' CB ' ' HA ' ' A' ' 476' ' ' MET . 76.6 t-105 -56.64 -43.24 80.08 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.273 0.559 . . . . 0.0 110.497 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -147.44 89.4 1.78 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.019 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.115 0 CA-C-O 118.573 -1.126 . . . . 0.0 111.449 -178.319 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.604 0.24 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -74.6 108.39 7.32 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 120.864 0.364 . . . . 0.0 110.439 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -134.08 135.25 43.13 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.196 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.81 125.1 54.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.286 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 346' ' ' LEU . 1.5 pp -154.76 146.46 23.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.009 0.433 . . . . 0.0 111.783 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -156.66 138.44 14.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.711 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -118.1 98.98 6.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.162 0.506 . . . . 0.0 110.82 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 177.86 38.72 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.706 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -100.87 -178.78 29.28 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.113 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.572 HG22 ' H ' ' A' ' 352' ' ' LEU . 5.8 p -122.66 176.19 4.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.572 ' H ' HG22 ' A' ' 351' ' ' VAL . 3.6 mm? -112.88 146.7 38.46 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.3 t -62.49 138.97 96.64 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.23 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.64 -4.21 14.93 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.856 2.371 . . . . 0.0 112.304 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -86.46 124.76 69.27 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.239 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.45 112.99 3.48 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.563 2.176 . . . . 0.0 112.012 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 120.29 -6.39 11.84 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.831 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.456 ' SG ' ' HE2' ' A' ' 360' ' ' MET . 47.5 t -84.5 -79.92 0.21 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.43 20.88 52.77 Favored Glycine 0 C--O 1.228 -0.236 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.648 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.456 ' HE2' ' SG ' ' A' ' 358' ' ' CYS . 34.2 mtm -68.01 -56.95 7.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.012 0.406 . . . . 0.0 111.024 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 124.67 114.16 2.03 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.71 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.3 mm? -98.45 134.77 40.97 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.058 0.456 . . . . 0.0 111.355 -177.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -93.03 124.08 36.75 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.35 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.28 116.97 48.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.975 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.31 155.5 66.51 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -42.91 -51.12 5.67 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.36 2.707 . . . . 0.0 113.656 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -106.86 28.8 7.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.852 0.358 . . . . 0.0 111.85 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 37.1 t -67.31 -52.79 36.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.613 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 67.03 -59.42 0.38 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.672 0.789 . . . . 0.0 111.98 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -72.98 116.73 13.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.44 0.638 . . . . 0.0 111.126 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 381' ' ' PHE . 0.0 OUTLIER -116.79 125.19 73.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.819 176.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 81.6 m -153.07 142.22 21.42 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.279 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.492 ' HA ' HD11 ' A' ' 362' ' ' LEU . 5.2 t -73.22 74.52 1.29 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.34 -18.8 61.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.393 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -99.3 -11.04 21.6 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.131 0.491 . . . . 0.0 110.807 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -141.79 -129.6 2.45 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.759 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.41 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.9 OUTLIER -74.98 91.18 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.829 0.452 . . . . 0.0 111.017 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.72 119.23 9.75 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.9 -174.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -142.2 139.82 32.16 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.516 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 14.5 m -83.09 124.65 39.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.204 0.526 . . . . 0.0 111.186 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 371' ' ' VAL . 5.4 p90 -141.36 -176.9 4.89 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.469 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' CYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 36.4 t -105.46 169.96 8.16 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.46 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 7.1 ptt180 -87.93 -27.02 22.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.285 0.564 . . . . 0.0 109.805 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.46 ' OD1' ' HG3' ' A' ' 383' ' ' ARG . 5.6 m-20 -103.55 -19.73 14.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.431 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' ' 394' ' ' CYS . 1.4 m -138.02 165.86 25.54 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.378 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.3 mp -111.89 34.83 3.98 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -86.97 2.13 50.49 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 100.67 27.75 7.38 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 119.565 -1.303 . . . . 0.0 114.04 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 47.2 t80 72.73 121.35 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.291 0.636 . . . . 0.0 111.921 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -167.92 176.86 5.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.932 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 391' ' ' ILE . 2.4 pp -139.51 148.93 22.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.757 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.95 -33.62 2.63 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.657 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -70.97 -20.26 62.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.567 0.698 . . . . 0.0 111.346 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.546 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 2.7 p -121.21 152.95 38.23 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.977 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.3 158.58 48.29 Favored Pre-proline 0 C--N 1.311 -1.073 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.967 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.87 -167.58 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.643 2.228 . . . . 0.0 111.124 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 397' ' ' GLU . 1.6 mp0 -58.34 132.79 54.68 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.111 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -108.5 144.93 16.34 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.055 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 28.1 m -99.83 -43.0 6.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.7 0.286 . . . . 0.0 110.847 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.89 159.75 31.27 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.026 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -148.58 156.17 42.07 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.691 0.246 . . . . 0.0 110.498 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.4 t -168.93 139.24 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -138.93 166.74 23.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.8 0.334 . . . . 0.0 111.118 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.6 p -125.36 165.99 17.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.587 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -160.7 120.62 2.76 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.2 t -126.19 136.2 52.54 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.299 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 56.8 m -125.63 122.23 35.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.625 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -124.47 134.15 53.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.131 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -156.91 103.54 2.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.009 0.433 . . . . 0.0 111.201 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 8.6 t -144.2 138.99 28.45 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.374 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 30.7 m -132.61 179.49 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.817 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -107.49 147.65 35.71 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.349 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.69 -175.23 2.62 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.732 2.288 . . . . 0.0 111.524 177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -153.18 142.22 21.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.568 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.77 164.26 22.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.209 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -85.3 177.03 7.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.088 0.471 . . . . 0.0 111.591 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -135.26 166.79 22.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.04 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -79.39 161.74 25.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.99 0.424 . . . . 0.0 111.172 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -141.48 134.33 28.83 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.799 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -122.52 110.54 15.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.003 0.43 . . . . 0.0 111.984 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -129.54 74.23 1.57 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.324 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.56 134.69 27.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.966 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -106.54 -43.07 4.83 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.447 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 49.77 55.6 9.15 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.553 0.533 . . . . 0.0 111.586 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.7 p -153.43 147.01 25.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.05 0.452 . . . . 0.0 111.898 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -149.79 130.26 13.89 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 40.9 t -101.09 146.27 9.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.1 t -74.54 166.58 23.3 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.764 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 47.6 pt -106.22 -3.05 9.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.443 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -71.55 145.21 49.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.944 0.402 . . . . 0.0 111.19 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.21 130.93 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.647 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 47.9 m -113.55 -0.49 14.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.379 0.609 . . . . 0.0 110.541 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 7.4 p -101.97 172.43 6.93 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.696 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -122.1 127.58 25.87 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.367 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.18 122.88 10.75 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.161 1.907 . . . . 0.0 111.77 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.61 ' O ' ' HD3' ' A' ' 440' ' ' ARG . 41.6 t -56.41 137.26 76.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.465 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.22 -14.8 41.43 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.212 1.941 . . . . 0.0 111.605 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -99.79 -78.04 0.51 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.667 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.0 p -81.41 -9.37 59.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.61 ' HD3' ' O ' ' A' ' 436' ' ' CYS . 38.4 mmt180 64.98 25.59 12.69 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.777 0.431 . . . . 0.0 111.875 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 39.3 p -88.76 151.88 48.18 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.44 102.12 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.525 2.15 . . . . 0.0 111.944 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 51.7 m -94.11 130.23 40.38 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.396 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -74.75 146.32 42.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.014 0.435 . . . . 0.0 111.051 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -95.71 162.13 13.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.134 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -117.9 141.77 48.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -97.82 4.12 61.11 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.118 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -127.17 -49.23 0.17 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.656 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.7 t -96.16 136.43 36.64 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.856 0.36 . . . . 0.0 110.548 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.76 19.81 3.3 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.574 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -104.01 111.97 24.75 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' MET . . . . . 0.494 ' HG2' ' HB2' ' A' ' 465' ' ' TRP . 79.2 mmm -99.83 111.83 24.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 0.0 110.923 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.84 130.07 60.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.823 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.1 t -91.38 130.39 37.24 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 3.4 p -109.62 88.85 2.84 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 121.561 0.696 . . . . 0.0 110.084 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.46 135.78 44.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.52 95.25 0.32 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.961 0.41 . . . . 0.0 110.086 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 123.94 -9.99 8.44 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.527 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' CYS . . . . . . . . . . . . . 48.1 t -97.22 -88.34 0.3 Allowed 'General case' 0 C--O 1.239 0.503 0 O-C-N 122.673 -0.31 . . . . 0.0 111.009 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.27 31.43 63.69 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.821 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -95.18 142.12 28.0 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.973 0.416 . . . . 0.0 110.514 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.01 135.97 55.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.583 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -143.45 165.92 26.21 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.523 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 61.2 m -73.59 144.72 45.89 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.312 0.577 . . . . 0.0 112.018 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' TRP . . . . . 0.494 ' HB2' ' HG2' ' A' ' 452' ' ' MET . 26.1 t-105 -76.7 -51.33 11.67 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.046 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.36 -35.7 63.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 26.3 p -116.74 -161.65 0.81 Allowed 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -142.62 109.55 5.51 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' THR . . . . . 0.458 HG21 ' SG ' ' A' ' 475' ' ' CYS . 13.4 t -158.02 177.88 10.83 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.386 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -87.74 150.43 23.6 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -52.74 101.73 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.584 0.707 . . . . 0.0 110.14 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.8 p -130.57 171.9 12.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.621 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -73.93 -21.73 59.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.144 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.96 -52.76 63.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.495 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' CYS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 478' ' ' ALA . 72.5 m -84.0 -18.7 36.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.112 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 24.2 ttt -46.68 -54.13 10.24 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.728 0.643 . . . . 0.0 111.632 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -97.98 17.77 58.22 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.356 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 475' ' ' CYS . . . -110.01 -66.28 1.08 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.695 0.283 . . . . 0.0 111.4 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -144.67 12.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -68.09 -28.17 67.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.484 0.659 . . . . 0.0 109.812 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -132.14 105.73 7.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.386 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-O 118.712 -1.049 . . . . 0.0 112.502 -178.173 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.813 0.34 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.8 178.28 4.67 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.461 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -106.34 160.15 15.59 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.451 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 51.0 t -68.45 -54.15 23.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -173.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 346' ' ' LEU . 2.4 pt? -135.44 -174.79 3.73 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.395 0.617 . . . . 0.0 112.117 -175.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -132.79 141.19 48.37 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.067 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -61.11 135.23 57.7 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.358 0.411 . . . . 0.0 111.57 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 147.77 -95.45 0.17 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.931 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -151.77 162.17 29.56 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.755 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 362' ' ' LEU . 29.6 m -120.58 -178.25 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 C-N-CA 123.339 0.656 . . . . 0.0 109.879 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 22.4 mt -126.6 150.45 48.87 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 54.0 t -57.98 137.37 83.79 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.436 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.02 -17.16 51.0 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.984 2.456 . . . . 0.0 112.299 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 358' ' ' CYS . 34.7 tt0 -72.45 121.29 84.44 Favored Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.3 -39.46 91.14 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.094 2.53 . . . . 0.0 112.599 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -78.69 -10.75 85.92 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.348 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 355' ' ' GLN . 7.1 t -88.58 -76.65 0.39 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.971 0.415 . . . . 0.0 110.03 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 68.72 27.23 74.0 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.645 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.416 ' HE2' ' HB3' ' A' ' 360' ' ' MET . 35.2 ttp -88.62 153.09 21.39 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -88.6 115.16 4.37 Favored Glycine 0 C--N 1.284 -2.335 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.534 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.495 ' HB2' HG23 ' A' ' 351' ' ' VAL . 4.5 mm? -94.59 134.22 37.39 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.511 HD13 ' N ' ' A' ' 364' ' ' VAL . 1.1 tm? -92.68 139.63 30.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.511 ' N ' HD13 ' A' ' 363' ' ' LEU . 43.7 t -108.89 91.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 120.851 0.357 . . . . 0.0 110.262 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -71.38 145.92 91.17 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.57 -22.47 58.33 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 121.948 1.765 . . . . 0.0 110.341 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -108.38 23.05 15.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.066 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 51.5 t -56.51 124.07 16.93 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.461 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -83.19 -48.63 10.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.692 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -148.72 118.19 6.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.633 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 381' ' ' PHE . 2.0 p -84.6 111.8 20.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.483 0.659 . . . . 0.0 109.539 176.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 91.4 m -152.78 144.22 23.33 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.98 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 19.9 t -75.57 69.66 2.33 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.345 0.593 . . . . 0.0 110.064 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -83.8 -6.55 59.45 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.567 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -111.25 5.77 20.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.934 -177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -133.79 -75.87 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.566 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.5 p -124.6 -102.72 0.37 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.873 0.368 . . . . 0.0 110.37 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -173.0 106.07 0.22 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -163.39 123.36 2.19 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.97 129.26 49.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.467 ' O ' HG13 ' A' ' 371' ' ' VAL . 8.1 p90 -140.0 -177.34 4.95 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.887 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 27.9 t -83.44 172.78 12.11 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -100.42 -14.66 18.23 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.639 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.537 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 28.7 t-20 -105.21 -26.86 11.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.434 0.635 . . . . 0.0 109.483 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 28.8 p -143.31 -169.84 3.14 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.724 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 11.1 mp -116.47 26.4 9.91 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.561 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -76.56 11.54 1.6 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 86.62 21.07 52.52 Favored Glycine 0 N--CA 1.459 0.205 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.398 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 72.95 120.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.696 0.798 . . . . 0.0 111.631 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -150.6 166.6 29.81 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.791 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.71 143.09 24.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 111.41 23.08 5.86 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.087 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 61.64 -178.88 0.12 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.5 0.72 . . . . 0.0 111.827 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 2.5 m -125.06 -59.18 1.42 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.196 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 395' ' ' LEU . 2.7 pt? -62.89 146.56 95.12 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.941 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.16 176.17 6.03 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.691 2.26 . . . . 0.0 112.143 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -105.93 -49.74 3.33 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.744 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.56 176.72 45.72 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.598 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 14.0 t -160.57 158.93 29.93 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -147.49 126.5 2.4 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -123.15 134.62 54.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.882 0.372 . . . . 0.0 111.346 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.4 p -103.82 132.45 50.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.341 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -149.3 130.25 14.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.858 0.361 . . . . 0.0 110.669 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.4 t -159.34 147.25 17.5 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.525 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -140.35 132.79 28.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.818 0.342 . . . . 0.0 110.86 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 9.5 m -134.14 113.79 12.43 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.013 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 73.2 m -111.2 131.44 55.11 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.832 0.348 . . . . 0.0 110.746 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -91.96 156.84 17.16 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.314 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -141.9 134.51 28.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 11.4 p -118.24 159.49 23.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.55 161.87 29.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.461 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.94 115.62 56.86 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -98.12 -176.42 0.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.281 2.654 . . . . 0.0 111.564 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -112.36 -178.38 3.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.233 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -131.02 -75.11 0.53 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.3 170.82 21.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.616 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.75 -171.32 1.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.842 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -89.36 166.12 13.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.458 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -164.21 120.91 1.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.899 0.38 . . . . 0.0 111.236 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -131.33 117.31 18.75 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -112.99 157.72 21.16 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.14 0.495 . . . . 0.0 111.64 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -130.7 128.52 41.03 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.06 -71.62 0.45 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.57 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -173.53 -174.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.055 0.455 . . . . 0.0 111.216 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 9.1 m -138.33 149.84 46.02 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.585 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -141.8 107.13 5.0 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.065 0.46 . . . . 0.0 110.665 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.37 87.68 2.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.719 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.1 t -101.78 119.23 38.46 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.88 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 39.3 pt -129.63 164.8 31.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.471 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -154.93 114.45 3.71 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.57 113.03 22.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.35 0.595 . . . . 0.0 111.456 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.434 ' O ' ' HD2' ' A' ' 445' ' ' ARG . 3.2 p -115.26 3.63 14.31 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.45 0.643 . . . . 0.0 110.489 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.68 152.14 20.96 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.097 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 434' ' ' LYS . 0.0 OUTLIER -118.93 119.15 32.51 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 435' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 10.7 Cg_exo -68.52 126.18 13.8 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 122.006 1.804 . . . . 0.0 112.206 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 438' ' ' LYS . 43.6 t -57.91 131.26 83.08 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.431 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.497 ' HG2' ' CE2' ' A' ' 461' ' ' PHE . 64.6 Cg_endo -74.64 -1.24 10.83 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.322 2.014 . . . . 0.0 111.391 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' LYS . . . . . 0.572 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 27.7 tptp -102.81 -64.7 1.05 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.971 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 11.0 p -103.59 -3.46 25.17 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 22.0 mmm180 68.58 29.16 5.6 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 34.7 p -90.27 141.38 27.56 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 2.4 Cg_endo -75.63 94.52 0.99 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.916 1.744 . . . . 0.0 111.398 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 30.4 m -89.64 128.21 36.02 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.016 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.62 151.11 44.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.904 0.383 . . . . 0.0 111.338 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.516 ' HD3' ' H ' ' A' ' 445' ' ' ARG . 0.3 OUTLIER -82.57 146.14 29.34 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.574 177.758 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -117.43 89.45 3.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.88 0.371 . . . . 0.0 110.955 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 60.03 -134.88 50.68 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.623 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -112.99 18.24 21.79 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.681 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 43.3 t -63.95 129.46 40.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.418 ' HA ' ' HB3' ' A' ' 465' ' ' TRP . 60.6 mtt -75.99 -25.68 56.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.977 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -79.22 96.2 5.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 40.6 mmm -118.43 109.68 16.53 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.68 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.413 ' CG1' ' HG2' ' A' ' 462' ' ' GLU . 4.0 m -121.66 150.87 24.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 120.952 0.406 . . . . 0.0 110.275 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 456' ' ' ARG . 42.8 t -83.68 100.65 11.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.499 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 5.9 p -81.45 92.15 6.42 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -128.9 139.64 52.04 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -177.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -45.71 -45.57 14.38 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.486 0.491 . . . . 0.0 112.231 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -122.56 59.34 0.59 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.749 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 45.4 t -146.38 -83.54 0.13 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.83 0.315 . . . . 0.0 110.793 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.88 49.52 41.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.375 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' PHE . . . . . 0.497 ' CE2' ' HG2' ' A' ' 437' ' ' PRO . 65.1 t80 -99.8 120.53 39.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.825 0.345 . . . . 0.0 111.097 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.413 ' HG2' ' CG1' ' A' ' 453' ' ' VAL . 41.1 mt-10 -94.22 134.17 36.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.842 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -144.29 161.28 39.33 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.889 0.376 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' CYS . . . . . 0.792 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 19.8 m -76.61 137.35 39.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.313 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' TRP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 15.9 t-105 -68.45 -45.55 72.19 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.689 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.39 -63.92 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.237 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.792 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 17.1 p -98.79 126.34 44.39 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.55 109.37 7.97 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.579 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.5 156.21 36.28 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.046 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -85.97 135.84 33.5 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -55.76 106.97 0.29 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.2 p -140.52 -164.96 1.83 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.589 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -73.58 -29.31 62.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 109.817 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -72.06 -58.45 3.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.158 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 34.3 m -97.54 70.05 2.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.497 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.58 4.15 53.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.46 0.648 . . . . 0.0 109.453 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 477' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 480' ' ' TRP . . . 121.38 12.68 5.58 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.271 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -61.93 -19.42 62.71 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -121.91 9.46 10.02 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.178 0.513 . . . . 0.0 109.911 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' TRP . . . . . 0.407 ' HB2' ' HA2' ' A' ' 477' ' ' GLY . 9.3 t-105 -86.43 86.24 7.33 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.166 -175.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -149.9 121.19 7.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.385 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.101 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.227 179.09 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.98 139.75 51.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.006 0.432 . . . . 0.0 110.984 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -129.47 94.93 3.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.357 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.554 HG13 ' H ' ' A' ' 346' ' ' LEU . 3.5 p -59.6 -60.8 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.28 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.554 ' H ' HG13 ' A' ' 345' ' ' VAL . 0.6 OUTLIER 174.16 129.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.487 0.492 . . . . 0.0 110.64 176.529 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 347' ' ' GLN . . . . . 0.438 ' N ' HD13 ' A' ' 346' ' ' LEU . 28.0 tt0 -165.91 116.08 1.01 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -160.9 161.92 31.92 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.688 0.28 . . . . 0.0 110.926 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -82.74 61.61 4.73 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.599 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -98.03 -149.49 25.12 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.434 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.01 165.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.74 148.26 33.87 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 122.207 -0.308 . . . . 0.0 110.965 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 34.2 t -68.53 122.04 83.09 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.499 ' CG ' HD11 ' A' ' 386' ' ' LEU . 92.4 Cg_endo -79.5 0.03 10.34 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.936 2.424 . . . . 0.0 112.748 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 52.8 tt0 -81.06 120.2 78.04 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 355' ' ' GLN . 39.1 Cg_exo -58.0 106.52 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.796 2.331 . . . . 0.0 112.325 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 128.39 -6.54 6.69 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.768 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.3 t -94.42 -94.04 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.898 0.349 . . . . 0.0 110.557 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 71.07 16.21 74.83 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.006 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.404 ' HE2' ' HB3' ' A' ' 360' ' ' MET . 41.6 ttp -67.06 -54.88 17.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.98 0.419 . . . . 0.0 111.198 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.63 122.49 2.56 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.653 -0.785 . . . . 0.0 111.695 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.608 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.3 mm? -109.03 132.61 53.95 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.515 0.674 . . . . 0.0 111.325 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.81 106.22 18.22 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.778 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 11.4 p -116.41 127.42 74.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.289 0.566 . . . . 0.0 110.25 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -94.49 162.61 25.37 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.992 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.04 -26.32 81.21 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.472 2.115 . . . . 0.0 111.645 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.18 5.63 40.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.305 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 46.6 t -88.18 108.04 19.08 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.954 0.407 . . . . 0.0 110.693 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ARG . . . . . 0.437 ' O ' ' HE1' ' A' ' 389' ' ' TYR . 0.7 OUTLIER -94.08 -33.13 13.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.656 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -85.75 104.6 15.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.207 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 14.4 p -103.7 122.81 56.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.267 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 96.7 m -153.27 139.49 18.43 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.075 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.608 ' HA ' HD11 ' A' ' 362' ' ' LEU . 2.5 t -74.83 69.89 1.88 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -68.7 -13.26 62.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.559 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -103.9 -3.72 24.41 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.96 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -154.63 -124.63 0.93 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.87 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 373' ' ' CYS . 1.7 p -74.85 91.68 2.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.885 0.374 . . . . 0.0 111.12 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.99 124.09 19.56 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.827 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -151.9 132.8 14.18 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 26.6 m -90.36 124.81 43.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.953 0.406 . . . . 0.0 110.67 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.402 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 27.8 p90 -145.6 -175.77 4.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.169 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' CYS . . . . . 0.558 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 42.8 t -88.47 141.23 28.71 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -66.47 -22.13 66.2 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.616 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -105.93 -28.63 10.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.836 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 5.4 m -134.11 178.73 6.74 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 121.286 0.565 . . . . 0.0 111.779 -174.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.499 HD11 ' CG ' ' A' ' 354' ' ' PRO . 4.2 mm? -110.04 30.2 6.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -77.27 3.05 13.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.716 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 76.33 40.26 28.99 Favored Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.54 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.437 ' HE1' ' O ' ' A' ' 369' ' ' ARG . 37.0 t80 69.76 110.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.787 0.835 . . . . 0.0 111.638 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -134.68 -169.13 2.28 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.456 HG12 ' H ' ' A' ' 393' ' ' GLU . 0.2 OUTLIER -57.52 159.91 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.824 178.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.69 9.6 2.58 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-N 116.277 -0.42 . . . . 0.0 114.048 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' GLU . . . . . 0.456 ' H ' HG12 ' A' ' 391' ' ' ILE . 46.1 mt-10 -115.59 111.81 21.22 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.168 0.508 . . . . 0.0 111.093 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.542 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 1.9 m -113.07 147.04 38.08 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.597 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.2 152.41 60.39 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.032 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.18 175.95 7.74 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.735 2.29 . . . . 0.0 112.022 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -115.72 137.66 51.86 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.702 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 126.16 117.39 2.14 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.494 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 8.8 t -148.87 162.66 39.4 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 172.92 139.84 2.97 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.444 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -151.84 143.22 23.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.743 0.306 . . . . 0.0 110.381 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.1 p -120.55 153.81 36.22 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.103 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -160.3 137.24 9.16 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.984 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 26.2 m -157.92 143.36 16.94 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.216 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -155.4 148.08 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 t -150.15 157.43 43.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 58.5 m -140.39 116.07 10.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.879 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -130.65 138.64 50.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.367 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -164.83 138.97 5.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.509 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 9.3 t -132.08 155.26 48.41 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.856 0.36 . . . . 0.0 110.552 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.62 126.97 74.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.019 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -87.3 148.31 44.39 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.669 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.12 -178.47 2.49 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.068 2.512 . . . . 0.0 113.106 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -119.36 173.76 6.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.512 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -133.51 135.02 44.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.528 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -125.04 144.14 50.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.912 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -129.95 141.97 50.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.707 0.289 . . . . 0.0 111.248 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -99.51 -175.37 2.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.311 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -138.37 170.11 16.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.692 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -118.54 155.83 30.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.209 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -119.85 159.47 24.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.959 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -113.59 133.1 55.47 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.1 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.514 ' H ' ' CD ' ' A' ' 423' ' ' GLU . 0.1 OUTLIER -92.47 -32.93 14.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.864 178.044 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 56.55 77.59 0.25 Allowed 'General case' 0 C--N 1.341 0.218 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.766 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 30.1 t -88.87 113.09 24.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.205 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -85.49 179.41 7.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.608 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.64 151.83 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.7 t -89.93 152.82 21.04 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.642 ' H ' HD13 ' A' ' 429' ' ' ILE . 0.2 OUTLIER -115.79 167.42 8.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.639 0.257 . . . . 0.0 111.001 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 430' ' ' LYS . . . . . 0.451 ' HD3' ' N ' ' A' ' 430' ' ' LYS . 0.0 OUTLIER -86.62 159.52 19.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.955 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 33.1 m -82.36 132.39 31.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.417 0.627 . . . . 0.0 111.683 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 31.3 m -96.77 4.96 51.48 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.3 p -115.57 155.05 28.3 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.913 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 30.3 mmmt -121.52 134.43 24.55 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 5.1 Cg_exo -74.34 118.14 5.25 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.802 1.668 . . . . 0.0 111.938 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 37.2 t -55.32 138.72 67.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.528 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.31 -1.17 10.95 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.577 2.185 . . . . 0.0 112.031 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -111.68 -60.21 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' CYS . . . . . 0.405 ' SG ' ' HG3' ' A' ' 456' ' ' ARG . 5.3 p -100.58 -3.31 30.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.78 33.7 23.53 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.072 0.463 . . . . 0.0 111.166 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 36.4 p -97.81 154.89 37.67 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.16 99.34 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.181 1.921 . . . . 0.0 112.302 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 5.8 m -85.96 121.05 28.04 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -76.21 124.35 27.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.965 0.412 . . . . 0.0 110.357 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.431 ' HD3' ' O ' ' A' ' 445' ' ' ARG . 0.0 OUTLIER -96.19 155.4 16.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.015 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -140.7 148.86 41.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -85.43 115.1 4.09 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.791 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 136.46 -12.59 4.03 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.793 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 57.9 m -112.94 110.24 20.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.417 ' HA ' ' CD1' ' A' ' 465' ' ' TRP . 0.7 OUTLIER -82.54 -12.73 57.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.195 0.521 . . . . 0.0 110.224 176.509 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -101.0 96.4 7.22 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 46.3 tpp -104.13 129.77 51.84 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 120.942 0.401 . . . . 0.0 111.05 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 18.6 t -134.37 137.27 51.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 48.1 t -86.52 95.04 9.59 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 20.6 p -81.96 90.23 6.46 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.515 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 0.1 OUTLIER -131.27 141.97 50.06 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.791 -176.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.451 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -64.42 106.06 1.05 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.808 0.337 . . . . 0.0 110.141 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 101.69 4.69 51.97 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.414 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.515 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 44.2 t -113.21 -90.19 0.52 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.743 0.271 . . . . 0.0 110.599 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 70.4 34.25 68.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.567 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -94.76 134.23 37.59 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.951 0.405 . . . . 0.0 111.07 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.37 128.85 52.28 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -138.58 157.98 45.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.048 0.451 . . . . 0.0 111.752 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' CYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 28.5 m -65.92 136.07 55.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.044 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' TRP . . . . . 0.417 ' CD1' ' HA ' ' A' ' 450' ' ' MET . 23.9 t-105 -74.33 -49.44 22.86 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.265 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 13.4 t -73.24 -64.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.822 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.672 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 13.9 p -93.32 133.81 36.18 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -76.8 107.64 9.27 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.798 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -155.76 176.53 12.51 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.956 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -113.9 140.84 48.04 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 63.9 t90 -59.75 103.97 0.25 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.799 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 473' ' ' ARG . 0.7 OUTLIER -142.41 -152.47 0.41 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 473' ' ' ARG . . . . . 0.484 ' H ' HG22 ' A' ' 472' ' ' THR . 33.4 ptt180 -82.94 -23.98 33.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.058 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.85 -50.39 56.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.901 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 66.1 m -110.89 81.17 1.39 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.116 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 92.4 mtp -89.46 -35.53 15.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.818 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . 159.26 40.45 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.555 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -90.83 -3.0 57.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.098 0.475 . . . . 0.0 110.973 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' HIS . . . . . 0.414 ' CE1' ' SG ' ' A' ' 464' ' ' CYS . 19.2 p80 -143.88 19.5 1.8 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.135 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 480' ' ' TRP . . . . . 0.461 ' CZ3' ' HA ' ' A' ' 464' ' ' CYS . 9.5 t-105 -87.85 3.36 48.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.299 0.571 . . . . 0.0 110.093 -176.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -64.81 115.77 5.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.091 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-O 118.677 -1.068 . . . . 0.0 111.469 179.744 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 N--CA 1.468 0.47 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -104.86 128.91 53.25 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.963 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -102.69 127.03 49.99 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.8 p -94.65 113.05 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.771 HD13 ' H ' ' A' ' 346' ' ' LEU . 0.0 OUTLIER -107.84 153.56 22.83 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.214 0.53 . . . . 0.0 112.297 -176.107 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -159.9 172.09 18.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.227 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -157.08 -171.46 3.65 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -77.86 74.71 1.95 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -83.83 -150.01 10.14 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.622 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 352' ' ' LEU . 30.0 t -100.38 163.76 2.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.423 ' N ' HG12 ' A' ' 351' ' ' VAL . 4.2 mm? -113.76 143.89 43.89 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 354' ' ' PRO . 44.5 t -64.95 139.68 97.87 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.779 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 353' ' ' CYS . 7.8 Cg_exo -74.66 -10.83 22.0 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.557 2.171 . . . . 0.0 112.402 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -71.42 136.13 83.94 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 110.857 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.1 -43.13 16.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.986 2.457 . . . . 0.0 113.223 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -82.27 7.14 65.04 Favored Glycine 0 CA--C 1.51 -0.279 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.3 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.586 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 43.9 t -92.4 -103.42 0.12 Allowed 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 122.667 -0.314 . . . . 0.0 110.866 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 70.03 27.91 72.4 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 37.5 ttp -79.44 -69.7 0.56 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.913 0.387 . . . . 0.0 110.643 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 139.92 131.38 2.77 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.957 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.36 140.79 48.81 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.952 0.406 . . . . 0.0 110.661 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -105.86 123.37 47.85 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.619 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 59.6 t -118.89 114.47 44.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.873 0.368 . . . . 0.0 110.629 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.67 142.64 70.47 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -46.32 -42.75 22.15 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.345 2.697 . . . . 0.0 114.014 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -80.21 -3.62 49.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 43.6 t -123.58 158.38 31.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.102 0.477 . . . . 0.0 111.131 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -134.74 9.23 3.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.064 0.459 . . . . 0.0 109.779 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -71.95 108.09 5.03 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.525 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.487 HG21 ' C ' ' A' ' 382' ' ' CYS . 0.0 OUTLIER -115.36 112.15 38.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.175 177.27 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.3 m -153.71 135.15 14.24 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.438 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.447 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 3.4 t -74.76 69.57 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.465 0.65 . . . . 0.0 109.738 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -76.03 -9.8 58.9 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.395 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -104.99 5.97 33.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.497 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -161.11 -123.0 0.65 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.583 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.1 p -84.58 92.6 8.17 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.676 0.39 . . . . 0.0 110.67 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -69.52 108.95 2.66 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.896 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -128.08 141.88 51.37 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.75 122.8 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.259 0.552 . . . . 0.0 111.88 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -151.94 -177.5 6.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.824 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' CYS . . . . . 0.487 ' C ' HG21 ' A' ' 371' ' ' VAL . 19.5 t -108.57 175.46 5.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -82.54 -39.0 22.94 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.935 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.624 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 5.2 m-20 -104.44 -5.33 21.74 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -177.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 21.3 p -151.84 173.2 15.06 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.243 0.544 . . . . 0.0 111.397 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 8.9 mp -110.36 35.38 3.46 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.992 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -79.08 3.84 16.3 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.327 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 83.79 27.58 37.8 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.941 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 25.7 t80 70.08 125.89 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.468 0.707 . . . . 0.0 111.036 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -143.96 -175.72 4.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 43.6 mm -105.52 145.49 13.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.8 -163.41 27.03 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.775 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -91.24 166.53 12.89 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.889 0.376 . . . . 0.0 110.365 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.0 m -96.58 -58.24 2.1 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.768 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.33 124.57 82.4 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.21 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.82 -171.15 1.17 Allowed 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.687 2.258 . . . . 0.0 111.555 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.44 -64.51 1.04 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.722 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 68.1 66.73 2.21 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.48 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 45.5 m -106.75 119.0 38.16 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.945 0.403 . . . . 0.0 110.936 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -125.53 117.81 3.04 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.936 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.84 -55.39 3.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.597 0.237 . . . . 0.0 110.607 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 45.9 p 50.15 84.87 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.776 0.83 . . . . 0.0 111.998 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.78 119.29 6.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.681 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.0 t -165.84 135.75 3.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.994 0.425 . . . . 0.0 111.206 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -147.86 167.59 24.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.911 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.5 p -134.88 -70.13 0.5 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.728 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 18.4 t 54.36 85.9 0.05 Allowed 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.795 0.684 . . . . 0.0 111.085 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -136.22 132.6 36.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.239 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -175.51 132.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.711 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 15.3 t -138.29 155.22 48.8 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.753 0.311 . . . . 0.0 110.743 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.38 150.42 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.129 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -109.49 150.6 41.39 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.384 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.44 171.61 3.58 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.882 2.388 . . . . 0.0 112.594 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -148.04 145.28 28.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.556 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -154.61 130.55 10.16 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.226 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.26 134.51 10.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.443 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -164.94 119.45 1.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.479 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.4 145.46 29.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.751 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -147.19 139.95 24.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.713 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -142.68 137.26 29.78 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -135.27 156.7 48.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.764 0.316 . . . . 0.0 111.404 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -108.87 122.72 47.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.184 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -104.7 -26.53 12.26 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.212 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -62.35 120.18 10.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.984 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.5 t -163.04 146.61 10.9 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -162.27 132.74 4.82 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.118 0.485 . . . . 0.0 110.861 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.44 124.64 57.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 40.6 m -142.25 125.85 16.85 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.962 0.411 . . . . 0.0 111.02 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.14 162.51 23.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.374 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -104.96 132.99 50.5 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.311 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.1 p -56.93 110.97 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.433 0.635 . . . . 0.0 111.184 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.0 m -114.82 2.04 14.26 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.675 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.1 p -105.83 126.04 51.7 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.877 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 5.2 mptp? -90.48 144.97 31.52 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 1.1 Cg_endo -80.46 121.14 4.17 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.013 1.809 . . . . 0.0 111.822 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 440' ' ' ARG . 37.1 t -54.99 135.2 67.27 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.609 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.53 -15.62 38.06 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.159 1.906 . . . . 0.0 111.651 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' LYS . . . . . 0.499 ' HA ' ' HE3' ' A' ' 438' ' ' LYS . 0.9 OUTLIER -91.85 -70.49 0.69 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.493 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.1 p -97.6 -6.09 34.12 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 436' ' ' CYS . 23.9 mmt180 67.11 26.1 8.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.771 0.429 . . . . 0.0 111.664 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 26.9 p -86.19 158.81 54.89 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.902 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.02 101.53 1.34 Allowed 'Trans proline' 0 C--O 1.239 0.53 0 C-N-CA 122.428 2.085 . . . . 0.0 112.224 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 7.3 m -90.32 113.16 24.96 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -104.09 141.1 36.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 445' ' ' ARG . 6.6 ptm180 -85.74 95.04 9.27 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.633 0.73 . . . . 0.0 110.057 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -135.47 115.3 12.98 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.892 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 84.16 20.34 59.24 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.78 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -149.89 129.2 2.91 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 76.5 m -81.84 -73.1 0.4 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.754 0.311 . . . . 0.0 110.893 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -112.3 -6.52 14.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.502 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -96.65 96.5 8.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.959 0.409 . . . . 0.0 110.546 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 80.0 mmm -89.51 91.85 8.87 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 23.7 t -99.95 116.76 43.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.89 99.55 12.48 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 1.3 t -87.24 92.78 9.18 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.604 0.716 . . . . 0.0 110.471 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.589 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -130.3 148.22 52.1 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.427 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -46.41 -64.76 0.68 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -93.78 37.5 3.39 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.773 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 51.1 t -130.97 -100.36 0.3 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.851 0.357 . . . . 0.0 111.073 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 78.81 22.53 66.2 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -89.28 114.88 26.3 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.361 0.601 . . . . 0.0 111.076 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.482 ' HG3' ' HB3' ' A' ' 471' ' ' TRP . 4.1 pt-20 -105.58 146.19 29.97 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.62 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -146.45 159.38 43.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.941 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 41.8 m -62.51 146.95 50.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.472 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -74.87 -54.54 7.08 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.468 176.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.01 -63.83 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.626 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 28.0 p -98.67 165.96 11.55 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -106.6 111.42 23.96 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.729 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.4 p -150.64 154.75 38.06 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.387 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -73.85 154.36 39.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' TRP . . . . . 0.482 ' HB3' ' HG3' ' A' ' 462' ' ' GLU . 5.3 p-90 -60.7 91.87 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.887 0.851 . . . . 0.0 111.981 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.2 t -134.77 141.08 46.36 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.761 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' ARG . . . . . 0.499 ' HA ' ' HB3' ' A' ' 476' ' ' MET . 36.3 mtp180 -63.48 -29.38 70.67 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -174.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 474' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 4.9 p-10 -65.51 -18.32 65.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.293 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 8.2 t -110.61 -40.6 4.54 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' MET . . . . . 0.499 ' HB3' ' HA ' ' A' ' 473' ' ' ARG . 10.8 tpt -52.99 -41.02 64.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.26 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -106.03 16.8 42.3 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.169 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 474' ' ' ASP . . . -92.78 -65.54 0.99 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.75 0.309 . . . . 0.0 110.828 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 479' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 480' ' ' TRP . 9.5 p80 -108.32 -69.62 0.84 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.031 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 480' ' ' TRP . . . . . 0.593 ' H ' ' CG ' ' A' ' 479' ' ' HIS . 22.0 t-105 63.51 -71.81 0.06 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.332 1.053 . . . . 0.0 111.734 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -70.23 137.07 50.54 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.416 0.286 . . . . 0.0 110.395 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.295 0 CA-C-O 118.435 -1.203 . . . . 0.0 111.876 -179.658 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.595 0.236 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.73 143.92 49.99 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -97.03 83.3 3.34 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.286 0.565 . . . . 0.0 109.94 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.43 ' O ' HD22 ' A' ' 346' ' ' LEU . 3.3 p -127.07 98.38 4.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.508 0.67 . . . . 0.0 111.192 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.467 ' HA ' HD13 ' A' ' 346' ' ' LEU . 3.3 mm? -125.46 164.87 19.52 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.17 175.79 10.23 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.715 177.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -134.63 155.46 50.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.394 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 79.81 -68.97 3.13 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.259 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -173.28 -150.25 7.35 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.846 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.34 -179.03 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 C-N-CA 123.094 0.558 . . . . 0.0 110.3 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 7.5 mp -124.35 151.53 44.24 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.872 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.9 t -54.61 138.67 60.91 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.694 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.501 ' HG3' ' CD1' ' A' ' 379' ' ' TYR . 18.6 Cg_endo -59.56 -19.69 53.63 Favored 'Trans proline' 0 N--CA 1.473 0.281 0 C-N-CA 123.195 2.597 . . . . 0.0 112.396 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -84.93 113.09 47.76 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.03 -28.22 74.44 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.46 2.106 . . . . 0.0 111.842 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -67.86 -25.3 74.24 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 40.0 t -73.95 -73.08 0.24 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 53.24 31.53 42.11 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.249 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 47.9 ttp -70.96 -62.55 1.35 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.168 0.508 . . . . 0.0 110.8 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 125.8 123.62 2.7 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.75 130.11 56.52 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.237 0.542 . . . . 0.0 110.478 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.521 HD12 ' HG2' ' A' ' 365' ' ' GLU . 0.8 OUTLIER -89.62 124.66 34.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.859 -178.204 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.405 ' N ' HD13 ' A' ' 363' ' ' LEU . 100.0 t -93.75 100.99 12.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.102 0.477 . . . . 0.0 110.673 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.521 ' HG2' HD12 ' A' ' 363' ' ' LEU . 6.0 mm-40 -94.89 153.73 39.91 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.369 177.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.82 -11.34 31.76 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 121.785 1.657 . . . . 0.0 109.821 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -102.98 24.99 9.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.182 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' CYS . . . . . 0.403 ' SG ' ' HD2' ' A' ' 383' ' ' ARG . 27.1 p -71.83 74.67 0.87 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.556 0.693 . . . . 0.0 110.823 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ARG . . . . . 0.633 ' HD3' ' H ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -64.88 -23.07 67.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.196 179.411 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -162.11 109.47 1.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.168 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 381' ' ' PHE . 0.6 OUTLIER -92.64 113.67 28.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.659 0.742 . . . . 0.0 110.326 176.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 372' ' ' THR . . . . . 0.43 ' OG1' HG12 ' A' ' 380' ' ' VAL . 92.2 m -152.54 144.93 24.03 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.443 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 9.3 t -74.62 73.24 1.98 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.444 0.64 . . . . 0.0 109.335 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -84.87 -19.48 32.3 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.988 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -96.81 -16.88 20.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.044 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -108.91 -101.26 2.68 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.918 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 4.0 p -100.2 -100.91 0.24 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.774 0.321 . . . . 0.0 110.618 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -173.32 107.06 0.24 Allowed Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.214 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.501 ' CD1' ' HG3' ' A' ' 354' ' ' PRO . 23.8 t80 -161.89 135.55 6.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.833 0.316 . . . . 0.0 110.648 177.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.43 HG12 ' OG1' ' A' ' 372' ' ' THR . 29.1 m -101.01 125.95 54.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.568 ' O ' HG13 ' A' ' 371' ' ' VAL . 23.6 p90 -146.94 -175.12 4.69 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.537 -177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 34.2 t -77.2 -178.07 4.88 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.403 ' HD2' ' SG ' ' A' ' 368' ' ' CYS . 11.3 ptm180 -95.94 -32.71 12.48 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.837 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -105.57 -7.78 18.38 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.505 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.04 -170.58 3.68 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.451 0.643 . . . . 0.0 111.462 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.81 28.59 8.66 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.145 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -81.09 18.37 1.07 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 72.07 45.43 41.04 Favored Glycine 0 C--O 1.227 -0.282 0 C-N-CA 120.843 -0.694 . . . . 0.0 114.603 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 5.2 t80 59.71 94.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -133.96 -163.12 1.32 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.43 157.31 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -75.33 46.93 1.95 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.5 -0.381 . . . . 0.0 113.77 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.61 107.68 7.18 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 1.6 m -136.33 -67.6 0.51 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.643 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 98.8 mt -114.13 132.32 22.78 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.822 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.78 -164.22 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.674 2.249 . . . . 0.0 111.56 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -80.56 142.66 33.89 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.187 0.518 . . . . 0.0 111.406 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -123.29 97.05 0.56 Allowed Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.226 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 78.4 m -115.49 116.22 27.83 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -119.98 178.3 16.49 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.834 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -157.31 155.84 31.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.738 0.304 . . . . 0.0 110.491 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 17.1 p -81.85 156.44 24.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.471 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -71.55 163.57 27.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.803 0.335 . . . . 0.0 110.762 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.3 m -85.44 103.48 14.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.422 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -73.59 121.26 20.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.531 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.0 t -86.7 144.46 27.1 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.777 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 19.0 p -123.54 134.92 53.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.747 0.308 . . . . 0.0 110.735 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -122.9 169.11 11.47 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.224 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -139.17 164.58 29.42 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.948 0.404 . . . . 0.0 111.175 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 14.8 m -134.12 98.22 4.07 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 10.8 p -107.71 142.84 19.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.766 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.54 136.44 67.83 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.406 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.45 110.19 2.43 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.52 2.147 . . . . 0.0 111.093 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -77.92 126.14 30.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.084 0.469 . . . . 0.0 111.529 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -95.32 114.77 26.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.579 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -137.2 137.21 38.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.892 0.377 . . . . 0.0 111.086 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -126.92 145.02 50.83 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.343 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -96.45 -178.34 4.25 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.175 0.512 . . . . 0.0 111.674 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -141.39 137.92 32.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.805 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -158.14 133.45 8.76 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 32.9 m-90 -113.13 -25.06 9.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.449 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.2 171.46 19.16 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -95.26 -71.21 0.68 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 179.21 149.1 0.25 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.388 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 22.7 t -123.47 155.67 37.05 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -138.65 174.27 10.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.034 0.445 . . . . 0.0 111.569 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.25 -51.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.453 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.9 t -164.46 151.68 11.58 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.751 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 9.5 tp -103.59 136.64 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.005 0.431 . . . . 0.0 110.87 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -83.48 138.9 33.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.067 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.91 97.71 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.828 0.823 . . . . 0.0 110.951 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.7 p -100.63 4.43 43.3 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.359 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.5 p -95.56 154.35 17.25 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.665 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.48 ' HA ' ' HE3' ' A' ' 434' ' ' LYS . 0.0 OUTLIER -117.15 140.45 27.15 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.308 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.24 124.59 4.88 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.969 1.779 . . . . 0.0 112.499 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 438' ' ' LYS . 41.2 t -64.3 134.93 96.13 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.075 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.16 -4.87 16.01 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.108 1.872 . . . . 0.0 111.492 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' LYS . . . . . 0.646 ' HB2' ' SG ' ' A' ' 436' ' ' CYS . 6.0 mmmm -100.68 -74.46 0.61 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.101 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 3.6 p -94.99 -7.67 39.13 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.163 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 52.2 mtt180 61.57 31.93 18.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.278 0.561 . . . . 0.0 111.479 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 20.7 p -84.96 154.2 60.71 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.102 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.75 93.66 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.32 2.013 . . . . 0.0 112.855 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 14.8 m -82.92 122.55 28.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.583 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.54 155.93 39.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.584 0.231 . . . . 0.0 110.877 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -116.32 157.79 24.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.025 0.44 . . . . 0.0 111.476 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -143.06 138.04 29.65 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -88.74 51.51 3.86 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.139 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -137.88 -56.09 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.102 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.4 p -83.36 -178.97 7.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.083 0.468 . . . . 0.0 110.483 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.479 ' HE3' ' HB2' ' A' ' 450' ' ' MET . 35.8 ttm -135.57 -14.89 1.9 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.295 0.569 . . . . 0.0 110.062 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -88.56 95.18 10.14 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' MET . . . . . 0.401 ' CG ' ' HB2' ' A' ' 465' ' ' TRP . 70.7 mmm -100.0 115.96 30.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.476 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.84 144.84 33.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.369 0.604 . . . . 0.0 110.939 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 42.5 t -84.41 108.87 17.46 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.774 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 15.3 p -91.64 88.64 6.81 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.624 0.726 . . . . 0.0 109.351 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -132.06 126.96 35.1 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.413 ' HB3' ' NH2' ' A' ' 456' ' ' ARG . . . -49.6 -31.88 11.59 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -109.29 25.04 19.24 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.178 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 31.8 t -133.56 -81.18 0.47 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.148 0.474 . . . . 0.0 111.215 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.13 65.63 3.0 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -124.27 121.61 35.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.889 0.376 . . . . 0.0 111.692 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.51 157.37 18.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.577 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -166.62 158.99 13.73 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.761 0.315 . . . . 0.0 111.291 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 52.2 t -71.89 134.78 46.25 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.851 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' TRP . . . . . 0.401 ' HB2' ' CG ' ' A' ' 452' ' ' MET . 14.0 t-105 -69.37 -43.77 72.9 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.005 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 43.1 t -69.85 -63.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 5.6 p -105.74 143.86 33.29 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.359 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -75.22 113.91 13.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.638 0.732 . . . . 0.0 110.58 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.6 p -142.85 178.03 7.93 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.682 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.31 117.88 35.28 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 65.3 m95 63.76 -168.6 0.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.593 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 476' ' ' MET . 7.0 m -109.83 30.93 6.24 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.659 0.742 . . . . 0.0 109.3 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -85.57 -57.61 2.99 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -70.28 -24.73 63.1 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.372 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' CYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 478' ' ' ALA . 93.8 m -89.0 -8.82 53.35 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.893 176.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 476' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 472' ' ' THR . 25.8 ttt -50.59 -57.85 7.21 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.754 0.659 . . . . 0.0 111.491 -176.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -109.73 12.9 32.52 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.371 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 475' ' ' CYS . . . -88.31 -64.94 1.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.921 0.391 . . . . 0.0 110.585 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 479' ' ' HIS . . . . . 0.456 ' CG ' ' H ' ' A' ' 480' ' ' TRP . 6.6 p80 -137.74 -65.39 0.52 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.104 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 480' ' ' TRP . . . . . 0.456 ' H ' ' CG ' ' A' ' 479' ' ' HIS . 21.4 t-105 54.53 31.27 14.57 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.984 0.897 . . . . 0.0 110.114 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -142.05 151.18 42.15 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.351 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.273 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.988 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -100.03 150.35 22.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.906 0.384 . . . . 0.0 111.445 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -143.21 100.31 3.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.084 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.66 115.15 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.072 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 346' ' ' LEU . 0.6 OUTLIER -112.34 107.81 16.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.637 0.732 . . . . 0.0 111.323 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -151.36 129.33 11.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.063 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -171.48 -177.74 2.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.811 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -86.37 42.16 3.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.274 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -90.15 -173.17 44.95 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.12 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 352' ' ' LEU . 4.2 t -110.03 175.41 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.598 ' H ' HG12 ' A' ' 351' ' ' VAL . 5.8 mp -137.53 152.37 49.4 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.5 t -56.01 130.64 73.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.74 9.99 1.77 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.99 2.46 . . . . 0.0 113.312 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -98.56 145.56 30.1 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.638 0.256 . . . . 0.0 110.875 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.22 -26.3 30.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.833 2.355 . . . . 0.0 112.789 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.15 -28.34 64.46 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.962 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 86.7 m -95.08 -151.9 0.34 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 120.929 0.395 . . . . 0.0 110.667 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 118.96 19.48 4.37 Favored Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -65.9 -66.14 0.59 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 110.32 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 151.31 130.56 1.69 Allowed Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.164 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.06 109.94 17.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.432 0.634 . . . . 0.0 109.909 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -88.31 106.86 18.51 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.433 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 48.6 t -82.45 105.55 12.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.947 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.49 152.66 95.37 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.468 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.07 -20.53 70.05 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.002 1.801 . . . . 0.0 111.175 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.45 12.09 33.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.758 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 47.4 t -70.73 101.28 2.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.258 0.552 . . . . 0.0 110.243 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ARG . . . . . 0.693 ' HD3' ' H ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -91.3 0.61 57.49 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.772 -178.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -162.35 110.36 1.36 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 381' ' ' PHE . 2.7 p -101.09 124.96 55.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.226 0.536 . . . . 0.0 110.348 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.3 m -152.2 147.88 26.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.452 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 29.6 t -69.73 74.99 0.43 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-O 121.563 0.697 . . . . 0.0 109.154 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.52 -20.42 29.68 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.863 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -98.36 13.07 32.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.647 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -142.41 -104.8 0.53 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.158 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 378' ' ' GLY . 20.6 p -97.49 -102.45 0.19 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.233 0.539 . . . . 0.0 110.735 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.462 ' N ' ' SG ' ' A' ' 377' ' ' CYS . . . -171.85 106.55 0.24 Allowed Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -160.21 117.88 2.56 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.95 132.76 38.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 389' ' ' TYR . 30.0 p90 -140.66 176.26 8.94 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.153 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' CYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 46.9 t -88.66 165.65 14.63 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 383' ' ' ARG . 11.5 ptt180 -88.55 -30.51 19.25 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.25 0.548 . . . . 0.0 110.127 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.509 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 8.1 m-20 -105.79 -11.05 16.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.196 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 394' ' ' CYS . 5.6 m -145.29 -179.13 6.44 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -174.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 386' ' ' LEU . 8.0 tp -118.23 22.46 12.15 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.986 177.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -81.27 28.97 0.36 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 71.97 32.48 63.42 Favored Glycine 0 N--CA 1.465 0.576 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.596 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 381' ' ' PHE . 20.8 t80 57.95 73.5 0.47 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.334 0.588 . . . . 0.0 111.061 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.46 ' CD2' ' H ' ' A' ' 390' ' ' HIS . 0.3 OUTLIER -77.13 145.2 37.93 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.092 179.034 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 6.7 tp -77.2 131.01 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.798 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 104.95 -158.98 15.93 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.344 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -87.34 146.66 25.82 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.117 0.484 . . . . 0.0 111.162 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 3.7 m -79.48 -44.23 21.67 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.168 -177.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.57 131.72 82.04 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.452 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.21 175.32 10.96 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.989 2.46 . . . . 0.0 112.694 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -118.37 175.02 5.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.18 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -142.04 96.93 0.2 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.48 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 9.0 t -147.18 163.96 34.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 163.13 70.77 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.255 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -131.63 100.72 5.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 56.8 m -155.2 139.88 17.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.39 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -158.19 107.48 2.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.789 0.328 . . . . 0.0 110.766 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 50.7 m -87.19 131.44 34.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.695 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -113.3 152.75 29.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.274 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 35.5 t -119.84 154.83 33.73 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.269 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 71.1 m -84.8 124.72 31.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.963 0.411 . . . . 0.0 110.366 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -83.63 116.63 22.71 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -114.89 115.13 26.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.971 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 11.0 t -96.71 151.95 19.14 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.097 0.475 . . . . 0.0 110.987 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 33.0 m -81.39 170.55 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.517 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.16 121.92 86.33 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.408 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.16 -164.51 0.22 Allowed 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 123.155 2.57 . . . . 0.0 112.872 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 52.0 t30 69.68 104.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.345 0.658 . . . . 0.0 110.58 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -151.71 151.06 30.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.038 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -86.39 93.02 9.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.964 0.411 . . . . 0.0 110.06 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -155.56 144.75 20.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.725 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -108.3 119.32 39.15 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.108 0.48 . . . . 0.0 110.972 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -142.9 174.13 10.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.357 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -93.6 102.38 14.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.984 0.421 . . . . 0.0 110.514 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 42.9 p-90 -161.28 156.0 23.4 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.932 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -148.55 160.17 43.35 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.028 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -102.17 -50.87 3.52 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.252 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 63.91 17.21 10.4 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.235 0.614 . . . . 0.0 112.435 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 38.6 m -104.3 132.05 50.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.555 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -151.22 95.64 2.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.331 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 31.9 m -100.14 158.91 3.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.008 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.7 m -104.97 83.92 2.06 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.132 0.491 . . . . 0.0 110.247 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 45.0 mm -129.51 113.87 29.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.132 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt 61.38 45.15 8.84 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.087 0.47 . . . . 0.0 110.768 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.08 110.68 8.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.37 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 23.6 m -86.28 -21.11 27.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.744 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.19 132.58 35.24 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.325 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -99.92 111.39 61.88 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.08 127.39 24.78 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.238 1.959 . . . . 0.0 111.94 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 44.5 t -50.96 138.12 25.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.07 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.61 -2.44 12.44 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.264 1.976 . . . . 0.0 111.476 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' LYS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 29.4 tptp -109.71 -61.16 1.68 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.413 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 11.8 p -102.69 -3.88 25.9 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 29.5 ttp180 65.19 21.19 12.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.66 0.784 . . . . 0.0 112.33 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.3 p -82.76 140.41 43.82 Favored Pre-proline 0 C--N 1.314 -0.963 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.082 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.4 101.97 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.467 2.111 . . . . 0.0 112.213 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 45.0 m -77.55 123.48 26.66 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.74 114.46 5.04 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.598 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -96.58 105.87 18.03 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.306 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.58 128.29 55.85 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.207 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 66.43 -116.24 8.16 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.371 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -155.81 42.99 0.56 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.945 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 47.7 t -71.67 123.77 23.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.784 0.326 . . . . 0.0 110.254 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.652 ' SD ' ' HA ' ' A' ' 480' ' ' TRP . 43.3 ttm -75.31 -20.43 59.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.781 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -86.02 96.4 9.83 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 21.5 mmt -97.34 113.44 25.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.081 0.467 . . . . 0.0 110.684 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.26 117.44 55.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.648 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 40.7 t -78.92 99.8 6.96 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.545 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 30.8 p -83.7 90.55 7.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.597 0.713 . . . . 0.0 109.35 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.571 ' HD2' ' N ' ' A' ' 457' ' ' ALA . 3.1 tmm_? -130.46 137.54 49.84 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.571 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -63.91 95.66 0.12 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.152 0.501 . . . . 0.0 110.602 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 106.39 24.14 6.93 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.383 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 29.7 t -131.02 -85.06 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.967 0.384 . . . . 0.0 110.51 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.58 35.42 91.91 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -84.92 124.68 31.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.907 0.384 . . . . 0.0 110.529 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.74 133.72 46.03 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.056 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -143.69 147.22 33.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.748 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' CYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 52.5 t -70.65 141.9 51.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.089 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' TRP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 26.9 t-105 -68.31 -45.22 73.57 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.644 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 51.0 t -75.93 -59.47 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.078 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 7.4 p -101.89 99.06 9.22 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -74.14 110.94 8.83 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.448 0.642 . . . . 0.0 109.96 -175.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.77 175.45 13.71 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.544 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -74.71 139.32 43.37 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -52.7 109.9 0.46 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.074 0.464 . . . . 0.0 110.184 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 13.9 p -146.8 -163.46 1.76 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.244 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -74.92 -21.73 59.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.395 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -46.66 -58.64 3.65 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.762 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 2.1 t -123.38 56.75 1.18 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.268 0.556 . . . . 0.0 109.903 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 60.2 ttp -70.12 -27.82 64.89 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -177.66 40.49 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.693 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -72.38 -64.31 0.97 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.093 0.473 . . . . 0.0 110.996 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -126.83 17.06 7.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.832 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' TRP . . . . . 0.652 ' HA ' ' SD ' ' A' ' 450' ' ' MET . 35.6 t-105 -62.73 -27.08 69.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.316 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -76.23 104.81 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.256 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.041 0 CA-C-O 118.855 -0.969 . . . . 0.0 111.838 179.924 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 120.729 0.3 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.05 146.55 47.58 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -80.88 83.73 6.55 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.3 0.571 . . . . 0.0 109.78 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.46 127.68 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.944 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.82 162.6 41.1 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -156.71 128.91 7.41 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.804 0.335 . . . . 0.0 110.651 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -84.52 159.02 20.79 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.702 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -90.42 155.24 24.03 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.955 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -159.62 -150.09 5.73 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.322 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 352' ' ' LEU . 15.6 t -124.08 176.92 4.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.595 ' H ' HG12 ' A' ' 351' ' ' VAL . 82.8 mt -118.78 151.01 38.83 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' CYS . . . . . 0.556 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 35.2 t -58.66 142.99 82.76 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.488 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.556 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 56.3 Cg_endo -70.32 -8.94 24.81 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.149 2.566 . . . . 0.0 112.442 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -94.24 130.7 33.25 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.67 -23.75 63.14 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.264 2.643 . . . . 0.0 113.087 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -83.21 5.87 74.72 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.882 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.529 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 26.5 t -119.2 -99.43 0.44 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 58.63 22.05 51.71 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.273 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.694 ' HE1' ' HA3' ' A' ' 376' ' ' GLY . 40.8 mtm -70.75 -58.95 3.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.917 0.389 . . . . 0.0 111.117 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.405 ' HA2' HD23 ' A' ' 352' ' ' LEU . . . 156.45 125.66 0.9 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.25 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.6 mm? -115.35 126.87 54.95 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.076 0.465 . . . . 0.0 110.051 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -84.46 104.41 14.44 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.555 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.09 104.39 16.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.274 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.25 148.24 91.02 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.939 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.93 -47.09 22.61 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 123.774 2.983 . . . . 0.0 114.146 -176.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.59 -7.8 49.14 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.884 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 51.6 t -76.94 128.41 34.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ARG . . . . . 0.558 ' HA ' ' HD3' ' A' ' 383' ' ' ARG . 0.0 OUTLIER -114.08 19.18 16.66 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -116.53 140.77 49.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.334 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 383' ' ' ARG . 0.0 OUTLIER -135.88 130.93 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.544 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 27.4 m -153.67 131.46 11.6 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.158 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.502 ' HA ' HD11 ' A' ' 362' ' ' LEU . 4.3 t -80.29 74.66 7.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.327 0.584 . . . . 0.0 109.73 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -81.15 -6.8 59.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.647 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -95.11 -16.89 22.29 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.07 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' GLY . . . . . 0.694 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -153.88 -117.26 0.64 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.082 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.2 p -90.13 104.13 16.73 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.097 0.559 . . . . 0.0 111.33 -178.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 373' ' ' CYS . . . -69.95 109.9 3.08 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.97 -176.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -127.78 144.33 51.09 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.96 99.84 8.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.186 0.517 . . . . 0.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -127.76 -179.0 4.71 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 7.6 t -86.83 -176.2 5.68 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.558 ' HD3' ' HA ' ' A' ' 369' ' ' ARG . 17.9 ptt180 -94.24 -36.0 12.2 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.469 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.467 HD21 ' CB ' ' A' ' 394' ' ' CYS . 21.7 p-10 -104.7 -28.16 11.37 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.214 0.531 . . . . 0.0 110.759 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.48 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 23.1 p -130.73 -174.24 3.31 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.698 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.416 ' HG ' ' HB3' ' A' ' 354' ' ' PRO . 10.5 mp -113.27 33.63 4.98 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.479 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' GLN . . . . . 0.48 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 12.8 mm100 -81.17 19.17 0.95 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.979 0.418 . . . . 0.0 112.029 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 71.36 31.46 65.92 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 114.35 0.5 . . . . 0.0 114.35 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 30.9 t80 67.66 110.39 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.045 0.538 . . . . 0.0 111.425 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.432 ' CD2' ' HB2' ' A' ' 387' ' ' GLN . 1.8 p80 -146.65 -53.45 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 16.7 tt -148.74 156.5 8.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.44 -47.73 48.93 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.64 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.51 110.16 21.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.142 0.496 . . . . 0.0 111.394 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.467 ' CB ' HD21 ' A' ' 384' ' ' ASN . 4.7 m -105.02 136.52 44.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.309 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 10.2 mp -118.7 133.58 23.59 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.141 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.66 173.22 14.83 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.697 2.264 . . . . 0.0 111.196 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -136.86 173.66 11.46 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.498 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 147.67 52.91 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.072 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 27.3 p -125.39 129.92 50.86 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -158.39 155.3 26.34 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.483 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -139.34 174.74 10.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.624 0.25 . . . . 0.0 110.359 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.8 m -144.88 155.96 43.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.49 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -139.83 146.14 39.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.634 0.254 . . . . 0.0 110.686 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 11.4 t -135.97 157.62 46.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.443 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -136.13 134.0 37.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.651 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.3 p -146.2 128.0 15.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.955 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 49.5 m -143.85 145.96 32.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.477 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -151.93 133.63 14.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.721 0.296 . . . . 0.0 110.963 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -143.96 133.77 23.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 12.0 p -122.63 139.39 53.98 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.653 0.263 . . . . 0.0 110.761 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.99 160.26 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.131 0.491 . . . . 0.0 111.494 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.64 149.24 39.62 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.478 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.6 -162.08 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.72 2.28 . . . . 0.0 111.419 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -145.17 158.04 43.93 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -146.4 120.69 9.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.846 0.355 . . . . 0.0 110.616 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -136.17 160.16 39.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.837 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -146.4 163.96 33.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.22 144.91 43.05 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -153.91 115.35 4.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.97 0.414 . . . . 0.0 111.946 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -133.16 161.04 35.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -152.93 167.76 28.05 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.878 0.37 . . . . 0.0 110.919 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -93.68 141.62 28.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -75.9 -70.22 0.45 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -168.75 -168.02 0.83 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 111.73 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 5.2 p -149.14 175.72 11.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.609 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -155.46 147.94 23.97 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.65 0.262 . . . . 0.0 111.158 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 9.2 p -159.4 144.52 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.456 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 10.1 t -149.28 147.21 28.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.671 0.272 . . . . 0.0 110.421 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.5 pp -136.24 175.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.106 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -118.55 -177.49 3.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.013 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.0 p -141.32 124.81 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.016 0.436 . . . . 0.0 111.203 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 50.2 m -124.9 2.52 8.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.067 0.461 . . . . 0.0 110.956 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 444' ' ' GLU . 2.1 p -80.24 143.63 33.56 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.135 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 434' ' ' LYS . 11.5 mmpt? -105.68 131.73 21.5 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.9 126.87 13.71 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.274 1.983 . . . . 0.0 112.449 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 437' ' ' PRO . 36.0 t -63.13 136.61 96.77 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.501 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 12.4 Cg_exo -69.82 -17.0 37.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.479 2.119 . . . . 0.0 111.614 177.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 438' ' ' LYS . 0.5 OUTLIER -96.93 -60.37 1.6 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.3 p -107.67 -3.36 19.28 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 440' ' ' ARG . 15.5 tpp85 68.1 21.13 8.8 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.153 0.501 . . . . 0.0 111.892 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 17.9 p -77.49 152.28 80.97 Favored Pre-proline 0 C--N 1.308 -1.202 0 O-C-N 122.175 -0.328 . . . . 0.0 111.157 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.58 92.57 0.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.28 1.987 . . . . 0.0 111.05 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 25.1 m -93.3 114.01 26.35 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.127 0.489 . . . . 0.0 111.339 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' GLU . . . . . 0.453 ' HB2' HG22 ' A' ' 433' ' ' THR . 2.5 tm-20 -102.74 121.07 41.7 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -82.71 100.69 10.39 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.225 0.536 . . . . 0.0 111.373 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -89.88 107.23 18.99 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 123.21 129.55 3.51 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -67.84 96.21 0.36 Allowed Glycine 0 C--N 1.322 -0.211 0 C-N-CA 121.465 -0.398 . . . . 0.0 113.142 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 79.9 m -153.08 144.31 23.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 122.591 0.356 . . . . 0.0 110.168 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.703 ' SD ' HG23 ' A' ' 466' ' ' VAL . 46.5 tpp -84.89 -31.29 23.79 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -85.6 96.95 9.82 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -120.26 129.66 54.14 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.766 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.492 HG11 ' HG3' ' A' ' 462' ' ' GLU . 5.7 m -124.18 152.5 29.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.711 -175.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.7 t -83.87 115.51 22.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 7.7 t -98.36 91.67 5.32 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 122.2 1.0 . . . . 0.0 109.942 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -129.81 132.06 46.38 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.47 98.37 0.09 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.898 0.38 . . . . 0.0 110.514 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 117.55 -4.13 17.54 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.945 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 47.7 t -108.67 -86.58 0.51 Allowed 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.713 0.292 . . . . 0.0 110.797 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 62.48 56.28 22.52 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -105.28 129.04 53.72 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.937 0.398 . . . . 0.0 111.045 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.492 ' HG3' HG11 ' A' ' 453' ' ' VAL . 13.5 mp0 -95.85 140.02 31.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.871 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -161.62 167.25 25.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.476 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 3.9 m -86.71 148.8 25.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.047 0.451 . . . . 0.0 110.831 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -68.63 -50.49 50.96 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.612 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' VAL . . . . . 0.703 HG23 ' SD ' ' A' ' 450' ' ' MET . 94.7 t -70.72 -64.33 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 21.7 p -90.15 133.19 35.04 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.526 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -77.57 110.0 12.01 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 119.539 -0.864 . . . . 0.0 108.806 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.1 p -153.9 178.12 10.27 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.045 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -101.79 149.91 23.69 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' TRP . . . . . 0.432 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 44.3 t90 -62.43 98.17 0.11 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 474' ' ' ASP . 11.7 t -141.99 -168.73 2.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 120.927 0.394 . . . . 0.0 111.419 -175.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -69.54 -22.09 63.59 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.541 0.736 . . . . 0.0 112.755 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' ASP . . . . . 0.528 ' H ' HG23 ' A' ' 472' ' ' THR . 26.3 t70 -67.69 -58.54 4.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.906 0.384 . . . . 0.0 111.245 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 84.2 m -91.48 15.85 11.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.653 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 24.3 ptm -51.43 -32.26 26.07 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -150.6 33.51 0.98 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -88.64 -64.78 1.09 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -142.16 67.75 1.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -85.73 -7.83 58.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.548 0.689 . . . . 0.0 109.306 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -144.4 134.62 24.27 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.507 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.363 0 CA-C-O 118.772 -1.015 . . . . 0.0 110.999 -178.411 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 120.719 0.295 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -88.27 -18.2 29.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.084 0.469 . . . . 0.0 110.405 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -80.5 100.97 8.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.766 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 6.7 p -90.02 132.38 34.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.186 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.46 137.49 42.23 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.64 -173.9 4.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.925 0.393 . . . . 0.0 110.518 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -85.46 176.52 8.2 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.114 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -69.39 96.88 0.51 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.548 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -54.03 130.92 44.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.795 -0.241 . . . . 0.0 113.627 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.47 ' H ' ' HB ' ' A' ' 364' ' ' VAL . 9.4 p -75.61 168.21 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.48 ' HB3' ' HA2' ' A' ' 361' ' ' GLY . 1.0 OUTLIER -141.11 155.41 46.12 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.176 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 13.9 t -51.65 130.72 36.44 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.142 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.16 3.36 4.66 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.217 2.611 . . . . 0.0 112.934 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -101.39 122.82 46.74 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.08 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.96 -26.68 83.57 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.055 2.503 . . . . 0.0 113.191 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.24 -13.8 67.9 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.948 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.454 ' SG ' ' HE2' ' A' ' 360' ' ' MET . 42.0 t -92.62 -85.75 0.26 Allowed 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.628 0.252 . . . . 0.0 110.581 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.34 23.5 64.52 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.704 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.454 ' HE2' ' SG ' ' A' ' 358' ' ' CYS . 36.3 mtm -76.01 -48.51 20.73 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.562 -0.376 . . . . 0.0 111.302 -177.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 352' ' ' LEU . . . 109.46 129.51 5.81 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.832 -177.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.66 176.97 4.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.892 0.377 . . . . 0.0 110.751 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 364' ' ' VAL . 1.7 tt -101.8 148.8 24.86 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.534 ' H ' HD23 ' A' ' 363' ' ' LEU . 4.7 p -130.95 8.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.461 ' H ' ' CD2' ' A' ' 363' ' ' LEU . 43.3 mm-40 -57.58 151.18 41.74 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.917 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.86 -22.72 38.89 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.967 2.444 . . . . 0.0 112.475 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.58 -7.26 54.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.471 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.68 99.65 1.04 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -64.15 -42.41 96.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.753 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -156.32 125.3 6.02 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.485 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.8 p -90.32 124.31 42.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.21 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.6 m -150.47 141.99 23.47 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.235 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 16.1 t -74.73 70.96 1.92 Allowed 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.374 0.606 . . . . 0.0 109.891 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -84.71 -6.48 59.36 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.856 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -100.02 -4.8 29.22 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.828 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' GLY . . . . . 0.418 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -153.5 -65.84 0.01 OUTLIER Glycine 0 C--O 1.234 0.154 0 C-N-CA 119.37 -1.395 . . . . 0.0 113.603 -178.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 4.7 m -100.3 -131.39 0.24 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.202 0.525 . . . . 0.0 109.67 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -170.3 104.75 0.21 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 381' ' ' PHE . 50.6 t80 -162.13 130.49 4.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 32.9 t -97.8 120.65 47.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.409 ' HB3' ' CE2' ' A' ' 379' ' ' TYR . 9.2 p90 -136.3 -175.54 4.03 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.234 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 42.4 t -85.64 168.29 14.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.496 ' HB2' HG23 ' A' ' 364' ' ' VAL . 16.8 ptt180 -97.98 -14.31 20.65 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.748 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.585 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 84.1 m-20 -103.33 -32.42 9.57 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.6 p -134.23 -171.12 2.67 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.873 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.57 28.03 8.7 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.857 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -85.56 11.08 11.4 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.86 29.47 15.58 Favored Glycine 0 C--N 1.319 -0.404 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.838 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 48.4 t80 72.86 135.1 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.518 0.727 . . . . 0.0 112.573 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -165.26 171.54 13.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.593 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.95 146.65 9.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 96.53 -162.48 22.45 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.698 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.64 173.52 7.57 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.959 0.409 . . . . 0.0 110.971 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.2 m -113.43 140.93 47.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.926 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 6.6 mp -131.37 127.92 21.85 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.85 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 395' ' ' LEU . 50.2 Cg_exo -60.07 151.93 69.0 Favored 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 123.014 2.476 . . . . 0.0 112.272 177.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -87.28 149.03 24.83 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.224 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -111.99 175.84 17.56 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.811 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 1.7 p -137.44 169.58 17.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.654 0.264 . . . . 0.0 111.541 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -171.19 -175.63 39.8 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.104 -0.569 . . . . 0.0 111.797 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -150.0 141.94 23.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.677 0.275 . . . . 0.0 110.537 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 48.0 t -140.7 124.15 16.85 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.456 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -136.32 90.9 2.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.961 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 19.7 p -126.12 124.68 41.09 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.582 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -124.52 -79.64 0.61 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.655 0.264 . . . . 0.0 111.172 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 9.4 p -162.14 170.0 19.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.581 0.229 . . . . 0.0 110.988 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 5.9 p -134.45 -65.49 0.64 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.528 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -83.95 143.44 29.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.089 0.471 . . . . 0.0 111.847 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.557 ' O ' HG22 ' A' ' 410' ' ' THR . 90.7 t80 -117.91 -27.73 6.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.394 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 409' ' ' TYR . 0.7 OUTLIER 62.14 169.55 0.12 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.622 1.169 . . . . 0.0 112.672 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 22.6 m -130.75 171.51 17.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.014 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -105.88 154.26 39.53 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.804 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.49 159.94 49.93 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.167 2.578 . . . . 0.0 112.846 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -110.02 179.32 4.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.359 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -144.41 157.11 44.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.726 0.298 . . . . 0.0 110.998 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -136.18 83.99 2.05 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.041 0.448 . . . . 0.0 110.531 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -160.88 144.45 13.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.13 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -144.17 167.55 22.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -79.06 157.53 28.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.287 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 69.77 104.17 0.06 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.659 0.783 . . . . 0.0 112.709 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -116.04 -19.24 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.818 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -137.87 154.22 49.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.1 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.05 -25.1 17.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 53.08 73.32 0.37 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.263 0.554 . . . . 0.0 111.745 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 54.4 m -149.99 103.44 3.2 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.382 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -88.39 124.19 33.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.816 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 27.6 m -74.96 132.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.311 0.577 . . . . 0.0 112.274 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 31.4 m -147.88 122.24 9.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.516 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 12.2 tt -113.79 136.29 50.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 0.0 111.383 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -105.5 131.81 52.44 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.405 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 9.2 p -67.85 125.79 26.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.34 0.59 . . . . 0.0 110.608 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 445' ' ' ARG . 9.9 m -120.58 0.6 10.49 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.468 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 16.7 p -120.68 148.42 43.96 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.273 0.559 . . . . 0.0 112.106 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -112.64 131.89 22.48 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.36 118.9 5.95 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.083 1.855 . . . . 0.0 112.256 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 43.4 t -56.45 133.81 76.76 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.375 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.539 ' HG2' ' CE1' ' A' ' 461' ' ' PHE . 57.4 Cg_endo -72.24 -9.18 24.02 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.247 1.964 . . . . 0.0 111.445 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' LYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 29.3 tptp -98.67 -70.92 0.71 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.147 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.8 p -92.62 -12.53 31.42 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 17.0 tpp180 69.17 29.54 4.63 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.554 0.742 . . . . 0.0 111.528 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 41.4 p -89.35 158.58 45.98 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.978 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -80.85 100.22 1.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.218 1.945 . . . . 0.0 112.367 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 11.4 m -84.59 118.53 24.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.855 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -64.51 121.06 13.52 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 432' ' ' SER . 36.7 ptt180 -93.51 146.67 23.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.569 -176.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -125.49 120.04 29.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.536 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -67.11 124.18 22.54 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.932 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.9 -48.24 0.98 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.318 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 24.9 p -75.18 136.94 41.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.719 0.295 . . . . 0.0 110.591 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 59.8 mtt -97.66 -17.68 19.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.012 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -121.85 96.16 4.95 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.064 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 14.1 ptp -109.08 133.17 53.35 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.44 ' CB ' ' HB3' ' A' ' 462' ' ' GLU . 1.2 m -111.75 150.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.353 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.5 t -86.29 100.42 12.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.0 t -83.39 89.01 6.97 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.321 1.058 . . . . 0.0 109.276 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.53 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -131.22 114.26 14.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.598 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.465 ' HB3' HH21 ' A' ' 456' ' ' ARG . . . -56.52 107.37 0.37 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.33 13.17 19.93 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.123 -0.561 . . . . 0.0 111.843 -177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.53 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 43.8 t -123.64 -73.71 0.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 61.21 57.23 19.42 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' PHE . . . . . 0.539 ' CE1' ' HG2' ' A' ' 437' ' ' PRO . 50.0 t80 -136.45 129.39 31.05 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.908 0.385 . . . . 0.0 111.277 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.44 ' HB3' ' CB ' ' A' ' 453' ' ' VAL . 0.0 OUTLIER -120.13 155.85 32.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 174.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -140.56 174.78 10.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 48.2 t -76.73 133.91 39.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.36 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -70.13 -56.73 6.11 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.4 -62.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.492 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 13.9 p -103.74 126.37 50.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -73.41 112.03 9.09 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 122.038 0.923 . . . . 0.0 109.549 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.0 p -150.1 177.74 9.61 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.321 -175.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' GLU . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 461' ' ' PHE . 39.2 tt0 -92.89 156.66 16.81 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -51.05 107.75 0.2 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.334 0.588 . . . . 0.0 110.472 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 474' ' ' ASP . 9.0 m -134.3 142.11 47.17 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.39 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 473' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 476' ' ' MET . 2.4 tmm_? -62.4 -21.32 65.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.406 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 474' ' ' ASP . . . . . 0.505 ' H ' HG22 ' A' ' 472' ' ' THR . 33.5 t70 -59.84 -58.79 7.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.762 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 475' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 480' ' ' TRP . 97.3 m -63.48 -26.46 68.73 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.594 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 476' ' ' MET . . . . . 0.482 ' HB3' ' O ' ' A' ' 473' ' ' ARG . 19.2 ttt -41.76 -46.53 3.87 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.08 0.863 . . . . 0.0 112.997 -177.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -136.89 17.63 3.63 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.19 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -86.81 -56.78 3.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.926 0.363 . . . . 0.0 111.167 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -132.56 10.01 4.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.603 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' TRP . . . . . 0.472 ' HB2' ' O ' ' A' ' 475' ' ' CYS . 61.1 t-105 -75.05 -41.31 59.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.954 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -73.88 100.79 3.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.119 0.485 . . . . 0.0 111.351 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.059 0 CA-C-O 118.934 -0.926 . . . . 0.0 111.533 179.256 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.987 0.423 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.62 173.9 13.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.285 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -144.08 54.49 1.29 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.294 0.569 . . . . 0.0 110.015 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.7 t -79.95 121.6 33.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.371 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 346' ' ' LEU . 3.6 pp -133.74 133.14 41.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.335 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -158.13 145.1 17.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.761 0.315 . . . . 0.0 110.374 -178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -105.97 110.28 22.5 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -80.23 124.17 6.37 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.926 -0.655 . . . . 0.0 112.167 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -101.76 -168.48 27.43 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.412 HG23 ' CG1' ' A' ' 364' ' ' VAL . 89.2 t -130.13 154.73 40.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 68.7 mt -114.92 148.05 39.18 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 38.6 t -60.75 128.86 89.32 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.02 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.541 ' HG2' ' CD2' ' A' ' 379' ' ' TYR . 43.1 Cg_endo -68.74 1.41 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.927 2.418 . . . . 0.0 112.705 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.445 ' HG3' ' SG ' ' A' ' 377' ' ' CYS . 14.7 mm-40 -73.84 120.63 82.25 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.98 105.66 0.25 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.634 2.223 . . . . 0.0 112.106 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 109.85 -2.99 30.32 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.724 -0.751 . . . . 0.0 113.024 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 52.2 t -81.24 -82.58 0.12 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.921 0.36 . . . . 0.0 110.258 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 57.31 25.36 54.42 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.567 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -59.17 -48.93 79.8 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.7 0.286 . . . . 0.0 111.18 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 122.62 108.96 1.98 Allowed Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.621 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.15 139.46 46.51 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.349 0.595 . . . . 0.0 111.049 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 64.3 tp -92.76 134.67 34.82 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.8 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 364' ' ' VAL . 12.4 p -127.84 100.49 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 122.032 0.92 . . . . 0.0 111.497 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -97.42 143.55 26.37 Favored Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.315 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.29 -31.41 76.58 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.39 2.06 . . . . 0.0 111.87 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -85.22 -16.51 40.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.038 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.8 t -93.05 101.27 13.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.092 0.472 . . . . 0.0 109.853 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ARG . . . . . 0.563 ' NH2' ' HA3' ' A' ' 392' ' ' GLY . 17.7 ttt180 -92.31 -11.85 34.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.324 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -96.48 134.63 39.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.115 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.6 126.37 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.072 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 52.6 m -152.91 136.37 15.91 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.29 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.485 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 4.1 t -77.01 64.14 2.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.64 -6.38 40.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.893 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -116.3 9.32 14.47 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.363 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -150.84 -95.78 0.13 Allowed Glycine 0 C--O 1.238 0.351 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.601 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.485 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 6.6 p -135.88 111.89 9.6 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 122.717 0.407 . . . . 0.0 110.23 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.2 108.37 2.43 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.001 -174.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.541 ' CD2' ' HG2' ' A' ' 354' ' ' PRO . 89.8 t80 -120.16 151.33 39.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.455 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 11.0 m -89.03 114.63 27.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.312 0.577 . . . . 0.0 111.957 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -153.17 167.23 29.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.047 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' CYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 47.8 t -90.16 172.57 8.71 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -88.42 -23.68 23.25 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.336 0.588 . . . . 0.0 109.758 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.456 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 44.6 t30 -104.36 -37.57 7.17 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.889 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 12.5 p -129.44 -170.61 2.32 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.144 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.69 35.75 4.45 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.303 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' GLN . . . . . 0.467 ' HA ' ' OE1' ' A' ' 387' ' ' GLN . 12.7 mm-40 -79.91 13.41 2.21 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 80.66 23.76 59.59 Favored Glycine 0 N--CA 1.463 0.444 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.505 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 33.0 t80 68.23 117.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.603 0.761 . . . . 0.0 110.688 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -146.54 -162.49 1.54 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.991 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.577 ' H ' HD13 ' A' ' 391' ' ' ILE . 0.2 OUTLIER -65.84 166.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.563 ' HA3' ' NH2' ' A' ' 369' ' ' ARG . . . -76.54 47.73 2.46 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 121.012 -0.613 . . . . 0.0 114.066 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -141.42 96.66 3.02 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.201 0.524 . . . . 0.0 111.042 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 3.7 m -93.01 152.46 19.3 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.254 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 84.0 mt -109.08 110.23 60.72 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.74 -176.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.52 177.14 8.36 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.471 2.114 . . . . 0.0 110.564 175.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.42 114.37 17.43 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.033 0.444 . . . . 0.0 111.744 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -177.25 81.68 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.904 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 10.1 t -168.51 133.27 1.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.942 0.401 . . . . 0.0 110.811 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 157.12 99.34 0.16 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.439 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -136.41 109.03 7.45 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.674 0.273 . . . . 0.0 110.81 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 33.9 t -160.65 112.69 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.17 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -146.17 97.28 2.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 9.5 t -169.85 141.69 2.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.305 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -131.56 -50.24 0.99 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.012 0.434 . . . . 0.0 110.804 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.6 p -107.02 170.23 8.07 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.125 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 6.2 p -151.37 -64.83 0.18 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.804 0.335 . . . . 0.0 111.38 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -133.81 131.83 39.73 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.58 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -79.48 133.93 36.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 11.6 t -113.56 154.08 27.72 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.782 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 46.8 t 74.59 92.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.151 0.58 . . . . 0.0 111.293 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -98.38 148.53 34.65 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.908 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.77 150.55 87.78 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.58 2.187 . . . . 0.0 112.367 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -141.61 137.53 31.94 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.835 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -75.87 133.04 40.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.79 0.329 . . . . 0.0 110.691 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -116.37 132.31 56.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -95.69 165.28 12.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.905 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -144.62 173.38 11.87 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.466 0.174 . . . . 0.0 110.779 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -136.33 118.06 15.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.78 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -83.48 143.36 30.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.334 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -120.76 -175.83 3.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.935 0.398 . . . . 0.0 110.942 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -119.69 129.24 54.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.047 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -83.85 -43.44 15.35 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.855 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 55.75 35.37 25.2 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.002 0.429 . . . . 0.0 111.125 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 23.3 p -68.85 161.19 29.14 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.531 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -87.65 172.74 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.36 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.92 115.54 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.906 0.384 . . . . 0.0 111.133 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.3 t -83.36 137.65 33.86 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.23 174.44 3.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.55 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -115.89 179.68 3.91 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.677 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 8.1 p -156.48 132.22 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.93 0.395 . . . . 0.0 110.645 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.3 t -120.63 -10.24 9.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.916 0.389 . . . . 0.0 110.472 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 3.0 p -85.91 132.82 34.01 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.519 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.437 ' N ' ' HD2' ' A' ' 434' ' ' LYS . 0.3 OUTLIER -97.9 148.27 34.24 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.679 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.33 134.5 19.12 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.324 2.016 . . . . 0.0 113.156 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 15.5 t -67.44 141.64 95.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.945 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 3.6 Cg_exo -75.77 -13.99 19.68 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.296 1.997 . . . . 0.0 111.976 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -96.76 -64.0 1.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.056 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 1.5 p -109.87 3.45 20.66 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 15.9 ttm180 60.92 25.15 15.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.361 0.665 . . . . 0.0 112.403 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.467 ' H ' ' HB3' ' A' ' 436' ' ' CYS . 2.9 p -82.74 142.34 45.41 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.361 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 21.1 Cg_exo -63.47 105.97 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.377 2.051 . . . . 0.0 112.225 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 17.7 m -78.25 125.73 29.77 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.049 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -92.24 131.25 37.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.569 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -85.2 94.95 9.02 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -109.99 123.86 50.39 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.17 -80.22 0.96 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.933 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.66 13.46 5.63 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.012 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.7 m -81.87 38.29 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.353 . . . . 0.0 110.813 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.532 ' HG2' ' O ' ' A' ' 479' ' ' HIS . 2.1 mpt? 64.11 16.92 10.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.377 0.671 . . . . 0.0 111.499 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -88.6 96.36 10.61 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 6.7 mmt -113.69 82.13 1.63 Allowed 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.43 171.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 2.2 m -126.8 142.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.05 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 52.6 t -96.04 108.15 20.53 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.92 0.39 . . . . 0.0 111.592 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 18.7 p -89.11 90.34 8.34 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.44 ' HG3' HG21 ' A' ' 441' ' ' THR . 4.6 tmt_? -130.2 145.17 51.7 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.724 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.7 94.64 0.31 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 0.0 110.483 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 109.38 24.5 5.89 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.671 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.44 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 50.0 t -126.27 -95.4 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.735 0.303 . . . . 0.0 110.632 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 70.74 46.84 43.8 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.626 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -112.1 130.36 55.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 111.488 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -100.39 137.78 38.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.999 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -139.72 155.6 47.25 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 79.1 m -66.27 130.71 44.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -75.08 -46.44 34.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.268 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 479' ' ' HIS . 21.3 t -69.61 -65.12 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.993 -176.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 10.1 p -95.43 133.98 38.78 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -79.47 109.81 14.19 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.836 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.9 t -156.82 158.1 36.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.858 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -87.0 113.73 23.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.223 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 25.14 81.77 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.963 1.305 . . . . 0.0 113.158 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 14.8 m -117.21 110.13 17.76 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.949 0.404 . . . . 0.0 110.841 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -71.63 -22.46 61.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.49 -49.66 74.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.568 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' CYS . . . . . 0.403 ' HB2' ' CD2' ' A' ' 479' ' ' HIS . 2.5 p -91.79 -15.24 28.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.387 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 476' ' ' MET . . . . . 0.429 ' O ' ' HB3' ' A' ' 480' ' ' TRP . 25.0 ttt -54.75 -45.55 74.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.555 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -71.98 0.86 35.47 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.534 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.91 -60.08 1.84 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 117.164 0.482 . . . . 0.0 112.072 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' HIS . . . . . 0.532 ' O ' ' HG2' ' A' ' 450' ' ' MET . 17.6 p80 -94.89 -25.61 16.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 480' ' ' TRP . . . . . 0.429 ' HB3' ' O ' ' A' ' 476' ' ' MET . 31.3 t-105 -65.58 -41.91 92.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.938 0.399 . . . . 0.0 110.948 -176.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.47 95.65 8.56 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.235 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.883 0 CA-C-O 118.854 -0.97 . . . . 0.0 111.831 -178.942 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 120.899 0.381 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -91.68 92.16 8.32 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.091 0.472 . . . . 0.0 111.495 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -161.23 101.86 1.24 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.618 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.61 138.33 52.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.965 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -138.35 147.9 43.97 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -162.18 136.64 6.77 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.944 0.402 . . . . 0.0 110.689 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -99.98 -78.88 0.5 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 62.16 40.41 98.93 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.701 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -128.85 -148.85 6.76 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.223 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 352' ' ' LEU . 10.4 p -102.63 170.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.449 ' H ' HG22 ' A' ' 351' ' ' VAL . 5.4 mp -139.63 153.27 47.29 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 122.202 -0.311 . . . . 0.0 110.371 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 355' ' ' GLN . 52.5 t -57.48 135.67 81.96 Favored Pre-proline 0 N--CA 1.452 -0.372 0 O-C-N 123.502 0.501 . . . . 0.0 110.058 177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.29 0.09 8.96 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.649 2.233 . . . . 0.0 112.083 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.512 ' HB3' ' SG ' ' A' ' 353' ' ' CYS . 56.8 tp60 -86.41 122.64 72.0 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.016 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.56 -20.9 70.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.639 2.226 . . . . 0.0 112.169 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' GLY . . . . . 0.406 ' H ' ' HG3' ' A' ' 355' ' ' GLN . . . -76.89 -17.33 79.94 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.587 177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 66.2 m -100.82 -176.54 3.21 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.062 0.458 . . . . 0.0 110.862 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 156.42 37.8 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.443 ' HE1' ' SG ' ' A' ' 373' ' ' CYS . 2.1 mpp? -82.76 -36.11 25.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 0.0 110.407 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.403 ' HA2' ' HG ' ' A' ' 352' ' ' LEU . . . 101.17 121.35 4.79 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.413 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.24 111.65 24.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.451 0.643 . . . . 0.0 110.081 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -83.6 109.17 17.21 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.076 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.56 HG21 ' HB2' ' A' ' 383' ' ' ARG . 2.7 p -85.63 110.5 19.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.48 0.657 . . . . 0.0 111.658 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -97.58 150.85 37.22 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.298 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.64 -22.94 63.13 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.313 2.009 . . . . 0.0 110.995 175.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.52 -35.93 75.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.487 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.7 t -78.39 120.73 23.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.84 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -111.76 -8.85 14.13 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.251 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 108.38 11.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.548 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 381' ' ' PHE . 2.5 t -89.88 120.33 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 CA-C-N 116.366 -0.379 . . . . 0.0 109.98 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 86.2 m -152.24 139.61 19.49 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.52 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.443 ' SG ' ' HE1' ' A' ' 360' ' ' MET . 47.8 t -72.54 74.45 1.06 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.372 0.606 . . . . 0.0 110.292 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -85.13 -6.59 59.29 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.278 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -106.66 -11.37 15.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.176 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -117.45 -77.47 0.61 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.407 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 10.8 p -125.19 -102.12 0.37 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.038 0.447 . . . . 0.0 110.925 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -172.47 106.36 0.23 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -160.53 129.63 4.89 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 58.1 t -95.22 110.52 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.447 ' O ' ' HB ' ' A' ' 371' ' ' VAL . 34.3 p90 -127.32 -177.24 3.99 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.141 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 10.9 t -82.2 177.24 8.9 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.214 0.53 . . . . 0.0 110.782 -176.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.56 ' HB2' HG21 ' A' ' 364' ' ' VAL . 38.6 ptt180 -96.34 -27.81 14.78 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.889 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.45 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 25.9 t-20 -104.43 -30.85 9.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.987 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.568 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 6.6 p -133.81 -172.96 3.11 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.255 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 352' ' ' LEU . 3.0 mm? -112.67 29.69 7.74 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.121 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' GLN . . . . . 0.568 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 9.3 mm100 -79.66 15.85 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 77.79 25.16 63.09 Favored Glycine 0 C--O 1.229 -0.209 0 C-N-CA 120.514 -0.851 . . . . 0.0 113.538 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 37.7 t80 72.1 134.52 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.397 0.679 . . . . 0.0 112.252 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -156.59 175.0 14.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.111 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 8.7 tp -93.13 144.95 8.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 102.13 -158.06 18.34 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.907 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -120.95 164.55 16.54 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 1.4 m -119.65 151.42 38.73 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.883 0.373 . . . . 0.0 111.631 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 395' ' ' LEU . 2.6 pt? -136.24 148.47 64.53 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.21 155.51 50.9 Favored 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.599 2.199 . . . . 0.0 111.923 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.17 143.31 15.25 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.022 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 171.35 138.96 2.65 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.773 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 30.9 m -152.4 108.77 3.42 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -110.06 88.61 0.52 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.921 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -153.48 -175.41 5.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 19.5 t 63.65 91.47 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.982 0.513 . . . . 0.0 111.603 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -161.44 102.89 1.22 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 5.2 t -153.21 146.26 24.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -134.75 133.62 40.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.326 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 19.9 p -123.39 135.37 54.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.754 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 50.8 t -172.97 136.34 0.66 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.193 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -148.71 140.55 23.73 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -133.62 140.45 47.11 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 50.5 m -152.64 137.28 16.9 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.862 0.363 . . . . 0.0 111.371 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.78 155.38 41.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.576 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -109.12 132.5 21.18 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.212 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.41 -169.04 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.688 2.259 . . . . 0.0 110.879 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -151.55 158.78 44.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.99 0.424 . . . . 0.0 110.781 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -130.03 158.42 39.65 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -128.34 135.72 49.96 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.134 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -145.7 131.03 18.57 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.675 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.35 159.19 42.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.802 0.334 . . . . 0.0 111.181 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -160.33 96.4 1.18 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.528 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -76.22 124.6 27.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.088 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 49.4 p-90 -113.37 136.82 52.35 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.503 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -128.74 138.66 52.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.099 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.4 13.11 30.76 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -86.75 79.8 8.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.393 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.0 p 175.74 92.78 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.375 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -133.35 88.86 2.53 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.962 0.41 . . . . 0.0 110.53 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 56.2 t -117.34 119.57 62.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.996 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.4 t -97.56 159.15 15.1 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.868 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 32.9 pt -99.65 -179.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 120.691 0.281 . . . . 0.0 110.893 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -79.39 155.94 28.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.128 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 31.4 t -80.82 89.11 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.293 0.568 . . . . 0.0 111.173 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 13.4 p -112.87 4.61 16.99 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.982 0.896 . . . . 0.0 108.735 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.6 p -95.09 142.68 27.27 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.002 -177.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.31 136.17 25.94 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.907 177.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.31 128.59 10.57 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.172 1.915 . . . . 0.0 112.238 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 35.6 t -57.98 142.08 80.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.08 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 4.8 Cg_exo -76.4 -6.2 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.441 2.094 . . . . 0.0 111.536 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -108.97 -65.25 1.16 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.395 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.4 p -99.62 -4.75 30.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.787 0.327 . . . . 0.0 111.772 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 0.0 OUTLIER 63.09 23.41 13.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.229 178.282 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 25.4 p -80.03 155.07 75.23 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-O 120.614 0.245 . . . . 0.0 111.062 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.8 107.48 2.48 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.659 2.239 . . . . 0.0 113.529 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 41.7 m -107.1 126.06 51.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.85 144.2 55.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.79 0.328 . . . . 0.0 110.419 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -99.79 169.76 9.02 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.435 0.636 . . . . 0.0 112.326 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.45 162.47 13.44 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.819 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -66.63 -57.4 10.08 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -144.2 42.8 1.02 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.234 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 46.7 t -109.84 135.99 49.86 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -78.89 -10.28 59.76 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -77.38 99.78 5.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.978 0.418 . . . . 0.0 110.919 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' MET . . . . . 0.503 ' CG ' ' HE3' ' A' ' 465' ' ' TRP . 27.4 mmt -120.86 95.45 4.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.435 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.474 ' CG1' ' HG3' ' A' ' 462' ' ' GLU . 3.6 m -128.99 144.6 37.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.021 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 7.5 t -73.7 135.25 43.66 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.138 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.9 t -113.34 87.72 2.67 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 122.254 1.026 . . . . 0.0 109.96 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.453 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -132.4 130.44 40.63 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.31 92.57 0.09 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.984 0.421 . . . . 0.0 110.726 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 128.69 -18.91 5.63 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.45 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 45.0 t -93.51 -83.38 0.32 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.665 0.269 . . . . 0.0 110.585 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.01 51.75 32.26 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.669 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -102.39 122.38 44.17 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.861 0.362 . . . . 0.0 111.425 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.474 ' HG3' ' CG1' ' A' ' 453' ' ' VAL . 13.4 mp0 -90.32 140.25 29.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.99 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -143.23 167.36 22.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.252 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 56.6 m -81.44 143.08 32.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.45 0.643 . . . . 0.0 112.168 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 465' ' ' TRP . . . . . 0.503 ' HE3' ' CG ' ' A' ' 452' ' ' MET . 15.0 t-105 -75.66 -41.3 54.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.237 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.61 -64.56 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.705 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 25.3 p -91.82 177.44 6.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 110.49 15.92 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.658 0.742 . . . . 0.0 110.438 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 15.1 t -157.76 178.16 10.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.443 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.15 135.81 33.52 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' TRP . . . . . 0.417 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 36.3 t90 -60.45 106.53 0.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.161 0.505 . . . . 0.0 109.768 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.5 p -136.28 -176.86 4.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.707 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -73.45 -24.15 60.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.19 -56.49 14.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.45 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -99.61 16.96 21.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.722 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -56.12 -57.86 10.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.07 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 480' ' ' TRP . . . -135.4 17.85 3.97 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.69 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.52 -28.54 69.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.931 0.396 . . . . 0.0 111.541 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -143.78 -6.59 0.77 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.439 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' TRP . . . . . 0.401 ' HB3' ' HA2' ' A' ' 477' ' ' GLY . 65.5 t-105 -59.91 99.63 0.07 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.776 -175.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -150.26 127.97 11.66 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.462 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.501 0 CA-C-O 118.696 -1.058 . . . . 0.0 111.066 -179.894 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.728 0.299 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -89.02 108.01 19.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.774 0.321 . . . . 0.0 110.281 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -122.81 172.6 8.33 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.69 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 85.3 t -72.8 -37.15 54.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.548 . . . . 0.0 109.773 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 346' ' ' LEU . 2.3 pt? -90.48 156.75 17.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.214 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -157.66 132.93 8.89 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -76.74 81.91 3.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.197 0.522 . . . . 0.0 111.514 -178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -106.06 -8.92 33.1 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -141.96 123.85 2.32 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 362' ' ' LEU . 10.6 p -98.39 168.09 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.411 ' H ' HG22 ' A' ' 351' ' ' VAL . 2.9 mm? -125.95 145.26 50.36 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 122.011 -0.431 . . . . 0.0 110.686 -176.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' CYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 354' ' ' PRO . 50.5 t -63.01 130.71 94.34 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 353' ' ' CYS . 9.5 Cg_exo -70.88 -12.1 30.29 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.829 2.353 . . . . 0.0 113.159 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -82.16 119.75 75.68 Favored Pre-proline 0 C--N 1.317 -0.828 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.21 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.79 129.28 33.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.567 2.178 . . . . 0.0 111.128 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 116.12 -21.97 11.7 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 35.4 m -90.97 -97.0 0.11 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.034 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 53.31 29.72 38.49 Favored Glycine 0 C--O 1.225 -0.466 0 O-C-N 123.404 0.44 . . . . 0.0 112.507 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 25.7 mtm -74.96 -67.19 0.67 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.935 0.398 . . . . 0.0 110.433 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLY . . . . . 0.4 ' HA2' HD13 ' A' ' 352' ' ' LEU . . . 147.14 120.02 1.18 Allowed Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.427 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.421 ' HB2' HG13 ' A' ' 351' ' ' VAL . 4.2 mm? -110.76 116.95 32.17 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.43 122.29 19.36 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.956 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.83 100.28 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.102 0.477 . . . . 0.0 110.863 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -89.4 135.71 30.8 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.236 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.07 -36.45 99.25 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.543 2.162 . . . . 0.0 111.303 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -77.98 -22.38 49.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 41.3 t -75.48 114.45 14.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.222 0.534 . . . . 0.0 110.98 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -114.81 -0.88 13.36 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.502 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -136.35 111.56 9.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.345 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 381' ' ' PHE . 0.8 OUTLIER -105.9 151.31 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.839 -176.69 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.2 m -154.09 143.21 21.25 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.637 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 41.5 t -72.67 71.98 1.02 Allowed 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.486 0.66 . . . . 0.0 109.927 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -85.18 -6.59 59.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.0 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -88.95 -17.74 28.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.852 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -138.07 -88.13 0.19 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.048 -1.073 . . . . 0.0 113.169 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' A' ' 378' ' ' GLY . 25.2 p -99.14 -109.34 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.198 0.523 . . . . 0.0 111.755 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' A' ' 377' ' ' CYS . . . -172.08 108.05 0.27 Allowed Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -160.03 145.7 15.41 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.18 113.45 44.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.492 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' PHE . . . . . 0.486 ' O ' HG22 ' A' ' 371' ' ' VAL . 13.5 p90 -129.84 -174.68 3.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.144 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' CYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 29.3 t -81.2 172.09 14.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -97.42 -19.05 18.71 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.478 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.494 HD21 ' HB2' ' A' ' 395' ' ' LEU . 28.6 t-20 -104.74 -31.74 9.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.296 0.57 . . . . 0.0 110.008 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.562 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 21.1 p -135.72 179.9 6.05 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.237 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.5 mp -108.62 31.49 5.58 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.482 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' GLN . . . . . 0.509 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 77.9 mm-40 -74.66 4.42 6.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.176 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 82.3 30.36 34.16 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.132 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 31.2 t80 72.17 128.03 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.828 0.451 . . . . 0.0 110.414 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -161.67 178.59 8.88 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.217 0.532 . . . . 0.0 111.756 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 47.4 mt -98.86 150.05 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.801 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 109.87 -164.03 12.39 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.089 -1.053 . . . . 0.0 112.736 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -116.42 149.62 39.14 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.786 0.326 . . . . 0.0 110.714 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 1.2 m -119.68 -72.63 0.68 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 384' ' ' ASN . 94.5 mt -140.01 89.36 11.27 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.72 -16.63 12.91 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 C-N-CA 122.701 2.267 . . . . 0.0 113.079 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 59.42 28.04 17.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.331 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 161.64 131.07 1.18 Allowed Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 9.5 t -119.05 2.37 11.46 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 117.295 0.547 . . . . 0.0 111.935 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.0 -74.86 2.35 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.585 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -69.4 117.97 11.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.952 0.406 . . . . 0.0 110.349 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 47.7 m -148.74 112.78 5.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.564 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -140.55 -172.51 3.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.201 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 11.9 t -125.47 148.51 48.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 120.984 0.421 . . . . 0.0 111.029 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -131.16 80.28 1.93 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.483 0.659 . . . . 0.0 109.518 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 7.8 p -131.23 128.2 39.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.648 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 60.7 m -136.08 91.0 2.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.974 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -157.56 127.57 6.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.209 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -177.31 119.19 0.11 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.159 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 8.3 t -144.72 132.33 21.01 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.031 0.443 . . . . 0.0 110.972 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 52.5 t -119.28 103.77 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.492 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -110.08 117.26 52.13 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.542 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.13 144.36 81.35 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.994 2.463 . . . . 0.0 112.638 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -86.01 -77.31 0.31 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.681 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -161.48 138.03 8.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.371 . . . . 0.0 111.362 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.29 98.34 1.7 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.79 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -163.35 103.77 0.96 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.635 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.03 137.23 6.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.115 175.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -157.88 124.94 5.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.675 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -113.13 170.21 8.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.929 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -162.45 144.05 10.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.775 0.321 . . . . 0.0 110.851 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -154.68 120.67 5.23 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.839 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 423' ' ' GLU . 0.0 OUTLIER -91.81 -22.68 20.01 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.405 -178.643 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 53.3 70.28 0.61 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.525 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 13.7 p -78.27 125.54 29.5 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.499 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -149.82 114.91 5.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.76 148.79 15.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.914 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.7 t -153.19 173.07 16.0 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 13.4 tt -161.52 145.79 4.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.55 131.96 12.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.016 0.436 . . . . 0.0 111.219 178.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.16 84.09 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 4.7 m -79.61 -38.82 33.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.007 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.1 174.18 11.82 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.288 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.467 ' HD3' ' HD2' ' A' ' 435' ' ' PRO . 17.2 tppt? -116.6 115.96 39.13 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' PRO . . . . . 0.467 ' HD2' ' HD3' ' A' ' 434' ' ' LYS . 17.8 Cg_endo -61.28 123.36 12.67 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.925 1.75 . . . . 0.0 111.361 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 44.2 t -58.41 136.52 85.5 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.369 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.05 -3.7 14.11 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.46 2.106 . . . . 0.0 111.621 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -109.72 -68.44 0.92 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.916 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 7.6 p -95.09 -2.71 49.5 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 12.3 tpt180 62.17 23.7 14.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.009 0.524 . . . . 0.0 111.578 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.3 p -84.87 160.65 55.15 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.263 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.67 93.81 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.224 1.949 . . . . 0.0 111.809 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 4.7 m -83.7 126.02 32.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.186 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -104.63 151.74 23.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.504 ' HB3' ' HE1' ' A' ' 452' ' ' MET . 15.2 ptt180 -119.74 156.97 29.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.23 0.538 . . . . 0.0 111.458 -178.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -129.57 145.23 51.5 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.802 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 73.29 -141.6 30.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.208 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.15 72.39 0.25 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.675 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.2 p -123.71 175.71 6.69 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.41 ' HA ' ' HB3' ' A' ' 465' ' ' TRP . 47.4 mtt -97.83 -0.64 44.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.037 0.446 . . . . 0.0 110.328 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -80.03 99.41 7.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.972 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' MET . . . . . 0.504 ' HE1' ' HB3' ' A' ' 445' ' ' ARG . 96.5 mmm -112.94 97.36 6.48 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.908 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.4 t -109.42 113.93 45.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.24 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.64 111.16 14.43 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.531 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 11.9 p -93.55 90.78 6.8 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 121.411 0.624 . . . . 0.0 109.514 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.535 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 4.7 tmt_? -132.13 139.36 48.41 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.029 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.35 105.68 0.97 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.889 0.376 . . . . 0.0 110.668 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 101.33 7.14 49.86 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.249 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 53.4 t -104.51 -90.19 0.4 Allowed 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.721 -0.282 . . . . 0.0 110.592 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.29 46.2 80.65 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -113.27 130.18 56.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.908 0.385 . . . . 0.0 110.944 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -98.87 140.61 32.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.025 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 28.1 p-90 -151.35 149.95 29.92 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.413 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 53.4 m -74.24 149.66 40.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.412 0.625 . . . . 0.0 112.012 -178.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' TRP . . . . . 0.41 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 32.6 t-105 -74.71 -58.74 3.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.939 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.97 -47.29 76.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 8.1 p -104.21 125.25 50.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -75.34 110.6 9.83 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.7 p -153.51 177.85 10.47 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.476 -176.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -102.22 157.24 17.03 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -56.7 108.6 0.51 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.478 0.656 . . . . 0.0 111.189 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 476' ' ' MET . 61.1 p -123.74 175.73 6.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.532 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -85.21 -29.95 24.28 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.685 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -67.54 -28.02 67.45 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.332 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 47.1 m -93.36 -30.28 15.19 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 472' ' ' THR . 1.9 tmt? -51.08 -52.3 44.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.352 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -99.38 20.06 51.34 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.563 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -111.17 -65.63 1.15 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -139.43 16.84 2.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -55.81 -38.62 70.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.253 0.549 . . . . 0.0 110.034 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -120.45 99.33 6.5 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.04 0 CA-C-O 118.434 -1.203 . . . . 0.0 111.803 -179.465 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 60.95 90.03 0.07 Allowed 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.792 0.683 . . . . 0.0 111.577 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -123.43 137.09 54.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.047 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 74.6 t -88.22 99.6 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 121.273 0.558 . . . . 0.0 110.269 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 1.4 pp -105.33 6.37 32.65 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.148 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -92.13 138.41 31.55 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.143 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -156.83 -75.28 0.09 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.386 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -151.86 140.86 8.06 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.64 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -144.48 106.71 0.41 Allowed Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.01 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 24.4 m -107.91 178.5 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.009 0.433 . . . . 0.0 110.334 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 6.2 mp -134.08 152.37 51.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.567 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.4 t -52.55 134.82 44.25 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.001 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.0 -16.93 48.65 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.116 2.544 . . . . 0.0 113.025 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -87.73 117.94 69.13 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.8 -27.66 84.54 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.017 2.478 . . . . 0.0 112.426 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -72.22 -16.18 76.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.543 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.2 t -86.8 -77.71 0.31 Allowed 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.05 30.4 66.79 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.024 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 9.0 ttm -70.49 -76.72 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.009 0.433 . . . . 0.0 111.174 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 143.48 121.88 1.62 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.064 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.59 130.32 55.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.11 0.481 . . . . 0.0 110.772 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.406 HD13 ' N ' ' A' ' 364' ' ' VAL . 1.7 tm? -95.69 128.89 42.94 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.677 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.406 ' N ' HD13 ' A' ' 363' ' ' LEU . 62.9 t -114.91 103.86 15.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.286 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -84.42 154.44 62.67 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.125 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.6 -9.85 26.8 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.052 1.835 . . . . 0.0 112.335 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -99.57 -14.43 19.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 52.8 t -125.07 136.85 54.06 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.936 0.398 . . . . 0.0 110.774 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.09 10.46 8.14 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.103 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -87.5 91.26 8.67 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.626 0.727 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' VAL . . . . . 0.518 HG21 ' C ' ' A' ' 382' ' ' CYS . 0.0 OUTLIER -85.0 113.77 24.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.509 178.285 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 91.4 m -153.19 139.87 18.9 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.245 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.453 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 4.7 t -76.44 67.48 2.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -66.45 -17.8 65.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.374 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -101.91 11.49 38.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -166.08 -126.09 0.81 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.164 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.453 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -83.2 91.08 7.18 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -69.06 108.88 2.64 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.693 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -114.09 143.62 44.48 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.457 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 14.0 m -83.58 102.02 9.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.445 0.64 . . . . 0.0 111.413 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -133.82 172.33 12.93 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' CYS . . . . . 0.518 ' C ' HG21 ' A' ' 371' ' ' VAL . 10.7 t -95.62 175.98 6.33 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.059 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' ARG . . . . . 0.452 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 5.7 ptp85 -78.06 -45.26 24.05 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.879 -175.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.596 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 20.3 m120 -105.33 -9.88 17.35 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.984 0.421 . . . . 0.0 111.197 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 26.4 p -140.21 176.07 9.06 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.919 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.81 32.64 5.7 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -72.63 -1.34 15.8 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 96.39 27.33 10.02 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.465 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 46.1 t80 66.42 103.99 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.23 0.612 . . . . 0.0 111.181 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -118.42 162.34 18.48 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.087 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 48.4 mm -91.69 120.93 41.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 132.96 -140.26 11.67 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -132.97 148.93 52.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.815 0.34 . . . . 0.0 110.635 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 1.3 m -89.35 -40.04 13.03 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.48 0.657 . . . . 0.0 109.905 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -74.78 125.79 89.13 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.656 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -90.31 -167.65 0.26 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.962 2.441 . . . . 0.0 111.076 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.0 -27.9 60.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.01 0.433 . . . . 0.0 110.896 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 153.35 -134.03 4.24 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 9.0 t -134.69 157.74 45.88 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.902 0.351 . . . . 0.0 110.27 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -157.68 63.95 0.31 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.288 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.0 116.43 32.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.99 0.424 . . . . 0.0 110.594 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 49.7 m -145.31 110.31 5.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.767 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -67.66 114.45 6.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.696 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 11.8 p -124.53 124.63 42.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.203 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -146.64 159.91 42.86 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 40.3 m -137.0 135.25 37.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.954 0.407 . . . . 0.0 111.401 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 55.7 m -87.37 169.29 12.39 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.749 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 72.25 152.19 0.12 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.585 0.553 . . . . 0.0 110.447 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.445 ' O ' ' HB ' ' A' ' 410' ' ' THR . 1.8 p90 -147.49 -53.27 0.21 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.644 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 409' ' ' TYR . 14.7 t 171.91 149.65 0.05 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.888 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.33 143.28 41.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.264 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -87.05 143.29 34.71 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.302 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.15 123.06 9.61 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.646 2.23 . . . . 0.0 113.299 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -103.72 126.59 50.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.136 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' ARG . . . . . 0.496 ' HD2' ' C ' ' A' ' 415' ' ' ARG . 0.0 OUTLIER -133.61 166.07 23.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.845 0.355 . . . . 0.0 111.293 -177.461 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -112.05 134.68 53.45 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.989 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -112.44 162.64 15.36 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -141.19 140.22 33.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.705 0.288 . . . . 0.0 111.084 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -147.89 111.95 5.16 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.241 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.67 156.97 22.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.422 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -92.75 -35.36 13.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.413 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -63.28 97.9 0.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.825 0.345 . . . . 0.0 111.327 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.91 -35.0 7.45 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.533 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -139.85 172.09 13.28 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.208 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 49.1 p -111.73 -26.37 9.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.849 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.45 46.18 7.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.118 0.967 . . . . 0.0 112.975 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 52.6 t -62.4 120.86 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.566 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 7.4 m -87.43 130.86 34.52 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.635 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 16.0 tt -95.82 139.09 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.79 0.329 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -88.41 154.9 20.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.425 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.569 HG22 ' H ' ' A' ' 433' ' ' THR . 14.9 p -75.53 139.35 19.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.291 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.1 p -96.47 -11.54 25.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.96 0.41 . . . . 0.0 111.788 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' THR . . . . . 0.569 ' H ' HG22 ' A' ' 431' ' ' VAL . 5.1 p -110.4 170.63 7.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.874 0.369 . . . . 0.0 111.005 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 434' ' ' LYS . 33.1 ttmt -131.51 125.43 20.65 Favored Pre-proline 0 N--CA 1.436 -1.135 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.77 136.41 57.57 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.753 2.302 . . . . 0.0 113.156 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 31.2 t -63.36 141.18 97.81 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.761 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 7.1 Cg_exo -73.77 -2.23 11.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.524 2.149 . . . . 0.0 111.78 176.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -117.4 -69.92 0.82 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.578 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 17.7 p -86.33 -10.61 54.1 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.63 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 71.5 mtt85 66.52 21.46 10.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.149 0.579 . . . . 0.0 112.17 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 42.2 p -82.01 149.7 63.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.462 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.28 99.81 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.3 2.0 . . . . 0.0 111.802 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 20.3 m -81.04 125.93 30.8 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.992 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -82.35 134.7 35.26 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.248 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -91.04 143.44 26.7 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.253 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -146.37 160.81 41.56 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.264 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -67.24 148.8 50.49 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.723 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 179.36 -154.75 14.37 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.078 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' CYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 450' ' ' MET . 61.1 m -108.45 49.87 0.8 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.924 0.392 . . . . 0.0 110.337 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.719 ' SD ' ' HA ' ' A' ' 480' ' ' TRP . 14.0 ptp 57.92 11.2 1.34 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.874 1.27 . . . . 0.0 112.925 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 451' ' ' HIS . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 480' ' ' TRP . 2.9 t60 -94.48 94.78 8.42 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 49.0 tpp -108.07 128.3 54.56 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.025 0.44 . . . . 0.0 110.776 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 462' ' ' GLU . 3.2 m -129.86 150.34 34.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 454' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 456' ' ' ARG . 12.9 t -69.36 111.7 5.42 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.477 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.3 t -83.7 87.43 7.05 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 122.5 1.143 . . . . 0.0 109.452 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.531 ' HB2' ' SG ' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -133.16 128.1 35.29 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.367 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 91.75 0.09 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.86 0.362 . . . . 0.0 110.565 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 124.93 -11.51 7.79 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.709 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' CYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 23.6 t -98.1 -77.8 0.5 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.49 32.35 83.12 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.942 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' PHE . . . . . 0.449 ' HB2' ' SG ' ' A' ' 459' ' ' CYS . 29.8 t80 -75.58 120.02 20.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.475 ' HG2' ' CG1' ' A' ' 453' ' ' VAL . 45.0 mt-10 -91.48 138.43 31.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -156.48 160.23 39.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.961 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' CYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 44.8 t -69.99 138.05 51.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.427 0.632 . . . . 0.0 112.129 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -75.18 -41.63 57.55 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.614 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 41.9 t -77.06 -64.52 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.844 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.7 p -102.29 96.91 7.27 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -74.93 109.92 8.79 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.67 1.224 . . . . 0.0 112.56 -170.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.2 t -160.18 173.67 15.4 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.551 -1.659 . . . . 0.0 106.736 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.64 111.66 12.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.445 -0.902 . . . . 0.0 108.877 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 471' ' ' TRP . . . . . 0.457 ' CE3' ' HB3' ' A' ' 474' ' ' ASP . 1.3 m95 -158.24 145.05 17.66 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.752 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 476' ' ' MET . 10.5 p -134.45 -72.03 0.49 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 473' ' ' ARG . . . . . 0.495 ' NH1' ' HG2' ' A' ' 476' ' ' MET . 29.8 mmm180 -85.13 -29.2 25.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 474' ' ' ASP . . . . . 0.457 ' HB3' ' CE3' ' A' ' 471' ' ' TRP . 8.0 t70 -66.0 -51.75 55.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.118 0.485 . . . . 0.0 111.051 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.6 t -78.83 -10.7 59.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.824 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' MET . . . . . 0.584 ' HA ' ' HB3' ' A' ' 480' ' ' TRP . 47.7 tpp -57.61 -53.09 62.14 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.858 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -84.75 -10.54 78.95 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.325 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -71.12 -62.55 1.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.821 0.344 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -148.0 -12.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.836 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' TRP . . . . . 0.719 ' HA ' ' SD ' ' A' ' 450' ' ' MET . 2.3 t-105 -54.92 -41.3 70.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.354 0.597 . . . . 0.0 110.321 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -70.88 96.59 1.29 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.17 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.022 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.006 -179.292 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -96.85 105.48 17.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.138 0.495 . . . . 0.0 111.03 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -112.52 128.58 56.38 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.781 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.68 ' O ' HD23 ' A' ' 346' ' ' LEU . 57.8 t -95.4 -47.77 12.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.406 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 345' ' ' VAL . 0.5 OUTLIER 47.1 15.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.718 1.607 . . . . 0.0 114.351 178.761 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 347' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 345' ' ' VAL . 86.6 mm-40 -92.78 143.21 26.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.833 0.349 . . . . 0.0 110.753 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -106.66 -171.7 1.94 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.496 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 142.07 60.97 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.772 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -129.48 161.72 22.77 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.881 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 352' ' ' LEU . 7.2 p -122.21 177.53 3.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.607 ' H ' HG22 ' A' ' 351' ' ' VAL . 98.4 mt -117.11 149.82 39.7 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 120.791 0.329 . . . . 0.0 110.963 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 353' ' ' CYS . . . . . 0.557 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 44.9 t -68.09 145.46 97.67 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.823 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' PRO . . . . . 0.557 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 27.6 Cg_endo -63.5 -14.85 44.94 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.812 2.342 . . . . 0.0 112.298 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -86.59 118.84 70.84 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.36 -30.55 91.55 Favored 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 123.159 2.573 . . . . 0.0 113.581 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -82.03 -10.22 84.2 Favored Glycine 0 C--O 1.236 0.247 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.27 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' CYS . . . . . 0.488 ' SG ' ' HE2' ' A' ' 360' ' ' MET . 47.1 t -74.24 -82.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.692 0.282 . . . . 0.0 110.289 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 60.32 22.12 58.06 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.441 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' MET . . . . . 0.488 ' HE2' ' SG ' ' A' ' 358' ' ' CYS . 34.9 mtm -74.2 -41.44 61.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.184 0.516 . . . . 0.0 110.785 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 106.51 115.02 3.97 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.569 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.42 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.5 mm? -99.37 144.91 27.94 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 122.528 0.331 . . . . 0.0 110.601 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.98 118.51 27.58 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 364' ' ' VAL . 9.1 p -122.03 77.71 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 122.023 0.916 . . . . 0.0 112.339 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -97.98 154.5 37.74 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.13 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.81 -14.73 42.47 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.415 2.077 . . . . 0.0 111.331 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -85.46 -2.59 58.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.066 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 46.0 t -110.12 115.47 29.8 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.637 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.4 1.88 26.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.052 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -136.48 96.58 3.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.896 0.379 . . . . 0.0 111.175 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.8 120.38 40.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.423 0.63 . . . . 0.0 110.535 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 97.1 m -152.24 143.92 23.56 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.597 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' CYS . . . . . 0.46 ' HB3' ' HA2' ' A' ' 378' ' ' GLY . 3.7 t -76.51 67.02 2.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.474 0.654 . . . . 0.0 109.688 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -72.14 -6.12 40.4 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.501 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -106.41 -12.89 15.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.066 0.46 . . . . 0.0 110.793 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' GLY . . . . . 0.418 ' N ' ' HE1' ' A' ' 360' ' ' MET . . . -144.64 -124.1 1.72 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.921 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.453 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -74.53 86.57 2.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.825 0.345 . . . . 0.0 110.553 178.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 378' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 373' ' ' CYS . . . -67.77 109.09 2.72 Favored Glycine 0 CA--C 1.495 -1.157 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.574 -172.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -147.85 134.77 20.18 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.3 p -83.64 133.16 29.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -142.03 166.62 24.22 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 11.3 t -79.87 160.13 26.16 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.236 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -92.79 -13.25 29.45 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.537 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -104.82 -30.62 9.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.277 0.56 . . . . 0.0 109.511 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 6.7 p -140.84 -165.88 2.03 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.241 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 65.1 mt -116.96 25.68 10.34 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.019 0.437 . . . . 0.0 110.942 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -75.97 20.36 0.19 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 78.89 16.85 78.32 Favored Glycine 0 N--CA 1.461 0.363 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.201 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 382' ' ' CYS . 0.3 OUTLIER 67.41 114.18 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.751 0.82 . . . . 0.0 111.477 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -141.06 -53.97 0.48 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.429 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 393' ' ' GLU . 40.8 mt -125.29 146.3 31.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -66.11 -23.75 71.5 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.292 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' GLU . . . . . 0.51 ' H ' HG22 ' A' ' 391' ' ' ILE . 31.6 mt-10 -135.36 134.76 40.11 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.45 0.3 . . . . 0.0 110.414 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 74.8 m -138.12 177.94 7.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.04 0.448 . . . . 0.0 111.498 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 27.2 tp -142.33 127.27 10.24 Favored Pre-proline 0 N--CA 1.435 -1.219 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.952 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 395' ' ' LEU . 41.2 Cg_exo -61.26 166.13 11.57 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 123.084 2.523 . . . . 0.0 112.333 177.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.85 115.49 15.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.179 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -152.46 48.15 0.55 Allowed Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 17.3 p -136.66 -178.76 5.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.616 0.246 . . . . 0.0 111.268 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.19 72.85 0.93 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.842 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -145.57 114.22 6.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.691 0.282 . . . . 0.0 110.697 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.7 p -153.76 148.05 25.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.576 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -142.54 165.81 26.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.604 0.24 . . . . 0.0 110.881 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 5.9 t -157.78 114.11 2.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.338 0.589 . . . . 0.0 110.913 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -112.93 144.68 42.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.381 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.8 p -157.05 130.48 7.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.007 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 41.9 t -161.51 102.29 1.2 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.605 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -136.44 115.75 12.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.789 0.328 . . . . 0.0 110.894 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -161.76 148.89 14.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.884 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 1.2 p -138.94 103.29 4.76 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.996 0.427 . . . . 0.0 110.796 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' VAL . . . . . 0.412 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 30.4 t -88.83 112.58 24.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -104.21 105.9 51.23 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.472 -177.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 411' ' ' VAL . 16.0 Cg_exo -70.21 140.58 41.29 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.542 2.162 . . . . 0.0 110.907 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -133.87 121.89 22.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.741 0.305 . . . . 0.0 111.036 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.97 160.95 40.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.704 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -156.06 93.38 1.43 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.582 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -164.37 124.23 2.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.12 152.64 37.67 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.725 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -167.62 156.52 9.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.268 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.46 138.74 5.39 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -164.99 151.22 10.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.065 0.459 . . . . 0.0 111.491 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -144.05 135.27 25.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.885 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.53 4.63 28.36 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.355 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -64.92 115.34 5.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.598 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.0 t -133.78 115.63 14.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.72 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -133.2 130.29 38.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.771 0.32 . . . . 0.0 110.814 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 23.0 t -107.85 135.56 46.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.88 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.5 t -96.97 153.28 18.0 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 48.0 mm -106.19 117.56 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 120.918 0.389 . . . . 0.0 110.64 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -128.48 162.15 27.87 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.695 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.33 92.15 2.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.109 0.481 . . . . 0.0 110.137 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.5 p -92.5 -15.63 26.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.551 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 444' ' ' GLU . 1.1 p -102.49 163.47 12.21 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.807 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' LYS . . . . . 0.451 ' HD3' ' HD2' ' A' ' 435' ' ' PRO . 5.4 tppp? -115.66 118.52 38.94 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' PRO . . . . . 0.451 ' HD2' ' HD3' ' A' ' 434' ' ' LYS . 29.2 Cg_endo -63.58 134.16 43.07 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.249 1.966 . . . . 0.0 112.526 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 436' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 35.3 t -61.26 140.33 94.48 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.424 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.48 -11.52 31.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.341 2.027 . . . . 0.0 111.616 177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -102.45 -67.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.752 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 6.2 p -96.98 -1.25 45.97 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 440' ' ' ARG . 65.8 ttt180 61.69 23.73 13.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.284 0.564 . . . . 0.0 111.557 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 17.5 p -79.13 142.22 59.14 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.975 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 11.8 Cg_exo -67.41 102.28 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.295 1.997 . . . . 0.0 111.252 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 17.7 m -106.03 128.05 53.58 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.631 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' GLU . . . . . 0.479 ' HB3' HG22 ' A' ' 433' ' ' THR . 10.2 pt-20 -117.68 171.84 7.76 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 120.904 0.383 . . . . 0.0 110.892 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' ARG . . . . . 0.564 ' HD3' ' CZ2' ' A' ' 465' ' ' TRP . 33.8 ptt-85 -103.5 161.99 13.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.167 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.37 114.31 25.71 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 71.88 -115.89 5.74 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.468 -176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.69 38.82 1.64 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.914 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 61.2 m -71.68 141.94 49.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.824 0.345 . . . . 0.0 111.181 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 65.4 mtt -94.2 -21.36 19.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.875 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -75.33 95.74 3.26 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.155 0.502 . . . . 0.0 110.197 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 48.5 tpp -104.08 96.63 6.79 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.287 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' VAL . . . . . 0.452 ' HB ' ' HG3' ' A' ' 462' ' ' GLU . 3.8 p -112.97 129.5 68.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.197 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.22 116.84 6.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.376 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 7.9 p -100.81 92.39 5.05 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.495 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' ARG . . . . . 0.449 ' C ' ' H ' ' A' ' 458' ' ' GLY . 0.0 OUTLIER -130.43 148.15 52.21 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -71.28 14.74 0.15 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.097 0.475 . . . . 0.0 111.413 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 456' ' ' ARG . . . -160.61 34.63 0.42 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 459' ' ' CYS . . . . . . . . . . . . . 10.0 t -154.6 -152.09 0.39 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 136.16 74.12 0.07 OUTLIER Glycine 0 C--N 1.279 -2.638 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.762 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -137.48 130.41 30.36 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.628 0.251 . . . . 0.0 111.101 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 453' ' ' VAL . 1.9 mp0 -87.78 127.42 35.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.941 177.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -134.2 161.56 34.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.61 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' CYS . . . . . 0.43 ' HA ' ' CZ3' ' A' ' 480' ' ' TRP . 8.2 t -68.41 133.39 48.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.264 0.554 . . . . 0.0 111.666 -175.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' TRP . . . . . 0.564 ' CZ2' ' HD3' ' A' ' 445' ' ' ARG . 23.5 t-105 -76.68 -55.35 5.58 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.463 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.68 -56.56 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 28.5 p -101.17 -161.06 0.83 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -131.32 110.11 10.84 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.795 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.6 p -155.5 151.44 27.7 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.646 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.48 156.76 38.95 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -50.02 109.01 0.25 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.309 0.576 . . . . 0.0 110.82 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 2.3 p -133.73 161.63 34.17 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.579 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' ARG . . . . . 0.536 ' HA ' ' HG2' ' A' ' 476' ' ' MET . 64.4 ttt180 -73.07 -22.06 60.67 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.742 178.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.4 -51.75 68.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.375 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 98.7 m -88.11 -23.41 23.69 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' MET . . . . . 0.536 ' HG2' ' HA ' ' A' ' 473' ' ' ARG . 5.4 ptp -49.48 -36.44 22.89 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -174.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -137.95 34.83 2.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.369 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.97 -65.85 1.12 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.809 0.338 . . . . 0.0 111.304 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -127.52 20.3 6.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 111.105 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' TRP . . . . . 0.43 ' CZ3' ' HA ' ' A' ' 464' ' ' CYS . 10.1 t-105 -79.88 -9.48 59.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.604 0.716 . . . . 0.0 109.407 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -104.99 133.42 49.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.77 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.546 -1.141 . . . . 0.0 111.943 -179.46 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.918 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.537 HG22 ' H ' ' A' ' 352' ' ' LEU . 9.8 p -166.39 174.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.537 ' H ' HG22 ' A' ' 351' ' ' VAL . 6.4 mp -125.85 151.74 46.43 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.1 t -63.26 126.39 89.13 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.4 ' HD3' ' CE2' ' A' ' 381' ' ' PHE . 73.0 Cg_endo -78.87 16.97 1.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.961 2.441 . . . . 0.0 113.623 -176.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 357' ' ' GLY . 32.3 tt0 -86.46 132.99 41.22 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.21 -20.56 62.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.729 2.286 . . . . 0.0 112.656 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' A' ' 355' ' ' GLN . . . -100.25 3.61 56.79 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.685 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 9.5 t -115.35 -147.93 0.42 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.362 0.601 . . . . 0.0 110.422 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.13 23.65 5.14 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.009 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.517 ' HE1' ' HA3' ' A' ' 376' ' ' GLY . 39.7 mtm -61.0 -44.93 96.7 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.975 0.417 . . . . 0.0 110.505 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.39 129.37 3.28 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.145 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.01 127.09 53.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.238 0.542 . . . . 0.0 110.384 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -100.85 114.29 27.99 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.467 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.25 119.4 50.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 120.97 0.414 . . . . 0.0 110.703 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 368' ' ' CYS . 8.6 mm-40 -81.07 149.72 67.04 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.032 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.72 -30.0 87.57 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.594 2.196 . . . . 0.0 112.243 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -101.11 15.18 29.57 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.463 0.649 . . . . 0.0 110.812 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 365' ' ' GLU . 51.6 t -104.09 134.63 47.02 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.09 -0.381 . . . . 0.0 110.046 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 29.63 5.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 370' ' ' LYS . 1.9 tpmt? -144.47 102.3 3.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.781 0.324 . . . . 0.0 110.423 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.48 124.38 51.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.239 0.542 . . . . 0.0 110.845 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.5 m -152.38 141.38 21.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.92 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 3.5 t -76.86 62.03 2.0 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.16 -22.7 67.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.134 0.492 . . . . 0.0 110.749 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -88.21 -13.3 41.42 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.041 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . 0.517 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -143.11 -124.31 1.86 Allowed Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.297 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -76.42 85.14 3.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.141 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -70.9 109.48 2.86 Favored Glycine 0 N--CA 1.435 -1.404 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -147.12 144.82 29.3 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' A' ' 389' ' ' TYR . 18.1 t -84.88 136.23 23.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.098 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.426 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 11.7 p90 -146.01 -175.67 4.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 19.4 t -94.81 162.56 13.71 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.884 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -86.25 -20.4 28.52 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.038 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.537 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 82.4 m-20 -105.47 -26.47 11.91 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.627 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 4.8 p -141.24 178.84 7.13 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.416 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.78 30.76 6.02 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -70.47 -2.74 14.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.312 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 82.94 27.4 41.4 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.537 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.412 ' HB2' HG12 ' A' ' 380' ' ' VAL . 53.1 t80 76.62 138.51 0.06 Allowed 'General case' 0 C--N 1.338 0.108 0 C-N-CA 124.402 1.081 . . . . 0.0 111.514 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -161.04 176.32 11.49 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 50.6 mm -114.6 132.15 64.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 129.66 -156.58 21.44 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.218 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -90.54 159.34 16.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.407 0.622 . . . . 0.0 111.801 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.7 p . . . . . 0 CA--C 1.501 -0.935 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.402 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 121.066 0.46 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.8 p -117.2 -2.25 11.68 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.19 0.519 . . . . 0.0 111.014 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 20.4 p -105.84 149.14 26.79 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -114.08 141.64 26.64 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.028 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.7 129.9 20.87 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.352 2.034 . . . . 0.0 112.738 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 24.3 t -59.1 140.32 87.34 Favored Pre-proline 0 C--N 1.333 -0.119 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.573 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.31 -16.71 39.64 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.127 1.885 . . . . 0.0 111.962 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -101.3 -66.64 0.9 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.542 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 15.6 p -93.57 -10.8 33.51 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 26.6 mmm180 70.03 20.57 6.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.074 0.55 . . . . 0.0 111.922 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 42.4 p -81.23 149.44 65.85 Favored Pre-proline 0 C--N 1.322 -0.622 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.703 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 16.2 Cg_exo -65.71 103.12 0.55 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.605 2.203 . . . . 0.0 112.403 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 89.8 m -95.87 122.69 38.93 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -95.75 156.77 16.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.61 156.4 18.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.724 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.78 107.58 16.26 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.182 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -57.95 124.9 37.71 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.003 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.87 -13.2 13.03 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.224 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 11.0 p -142.56 142.59 32.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.713 0.292 . . . . 0.0 110.96 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.686 ' O ' ' HB3' ' A' ' 465' ' ' TRP . 14.2 ptp -99.36 29.83 3.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.31 0.576 . . . . 0.0 111.338 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 480' ' ' TRP . 29.0 p-80 -123.38 138.25 54.64 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.433 174.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 3.7 ptp -143.06 124.54 14.79 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.18 0.514 . . . . 0.0 110.656 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 8.5 m -114.38 150.82 16.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.3 t -85.38 101.41 12.56 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.472 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 21.2 p -87.7 92.51 9.13 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.61 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.7 OUTLIER -128.83 146.98 50.77 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -177.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -50.74 -44.03 58.3 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.324 0.39 . . . . 0.0 111.809 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . 0.405 ' H ' ' HD3' ' A' ' 456' ' ' ARG . . . -124.6 61.37 0.6 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.612 178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 36.4 t -151.34 -90.61 0.06 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.605 0.241 . . . . 0.0 110.519 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 73.45 38.78 51.95 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.704 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -99.55 118.65 36.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.94 0.4 . . . . 0.0 111.016 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -90.33 139.94 30.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.738 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -148.72 154.44 39.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 49.2 t -73.09 139.49 46.52 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.008 0.432 . . . . 0.0 111.191 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . 0.686 ' HB3' ' O ' ' A' ' 450' ' ' MET . 11.3 t-105 -75.02 -51.58 13.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.602 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.45 -51.48 71.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.017 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.551 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.8 p -120.87 107.11 12.31 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -74.23 111.35 9.31 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.875 0.845 . . . . 0.0 111.246 -174.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.0 p -154.67 169.92 22.76 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.542 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.69 143.46 36.23 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.006 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -61.55 104.29 0.41 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.407 0.622 . . . . 0.0 110.46 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.5 p -134.43 -163.7 1.41 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.114 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 50.6 mmm-85 -80.75 -21.9 40.67 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.972 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.44 -59.27 4.89 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 13.2 t -120.57 83.65 2.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 46.1 ttp -88.2 5.68 40.34 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.752 0.787 . . . . 0.0 109.209 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' A' ' 480' ' ' TRP . . . 118.39 37.9 0.82 Allowed Glycine 0 N--CA 1.428 -1.852 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.83 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -57.34 -39.55 76.13 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.185 0.517 . . . . 0.0 110.743 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -118.59 37.28 4.11 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.061 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . 0.528 ' HB2' ' CA ' ' A' ' 477' ' ' GLY . 20.5 t-105 -82.41 45.45 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.306 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -146.51 124.78 12.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.478 . . . . 0.0 111.279 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.223 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.548 179.422 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.268 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.587 HG22 ' H ' ' A' ' 352' ' ' LEU . 9.3 p -142.92 177.37 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.587 ' H ' HG22 ' A' ' 351' ' ' VAL . 71.0 mt -130.37 145.72 51.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.647 0.261 . . . . 0.0 110.9 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.33 132.23 94.35 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.34 -7.93 22.32 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.035 2.49 . . . . 0.0 113.502 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -72.96 124.35 90.62 Favored Pre-proline 0 N--CA 1.447 -0.588 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.746 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.75 -30.78 77.58 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.934 2.423 . . . . 0.0 112.509 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -79.79 -17.19 75.71 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.875 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.514 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 33.8 t -89.03 -96.71 0.1 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.797 0.298 . . . . 0.0 110.679 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.09 19.36 59.12 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 35.7 ttp -65.7 -67.37 0.45 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.994 0.518 . . . . 0.0 111.544 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.452 ' HA2' HD23 ' A' ' 352' ' ' LEU . . . 147.12 122.5 1.36 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.109 -1.043 . . . . 0.0 112.346 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.45 135.85 54.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.954 0.406 . . . . 0.0 110.269 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -97.04 118.97 34.64 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.895 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 56.2 t -88.42 97.5 6.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.0 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.92 141.09 97.43 Favored Pre-proline 0 C--N 1.312 -1.027 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -51.9 -20.49 10.13 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.785 2.323 . . . . 0.0 112.639 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -114.97 24.11 12.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 45.8 t -71.16 110.87 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.42 . . . . 0.0 110.491 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -83.92 -39.9 19.23 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.025 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -140.26 108.28 5.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.108 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 12.8 p -83.08 128.47 38.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.386 0.612 . . . . 0.0 110.468 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 86.7 m -153.11 144.56 23.3 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.518 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 1.8 t -76.16 61.99 1.66 Allowed 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -69.96 -8.73 51.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.619 0.723 . . . . 0.0 109.888 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.73 0.17 32.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.871 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -155.93 -124.66 0.87 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 0.8 OUTLIER -85.42 98.84 10.81 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.9 111.12 3.74 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 114.434 0.534 . . . . 0.0 114.434 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -141.8 143.6 33.51 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.05 129.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.03 0.443 . . . . 0.0 110.969 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.415 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 20.0 p90 -143.93 -175.84 4.76 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 17.2 t -80.75 168.61 18.62 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.85 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -101.64 -13.86 17.64 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.506 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.58 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 4.3 m-20 -104.23 -26.32 12.55 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 21.1 p -145.5 -164.46 1.95 Allowed 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.384 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.05 27.07 9.5 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.614 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -87.25 32.75 0.69 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 70.37 18.31 75.11 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 121.073 -0.584 . . . . 0.0 114.286 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 69.19 121.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.632 0.773 . . . . 0.0 110.382 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -145.89 -176.25 5.07 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.4 tt -112.67 153.15 14.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 99.24 -146.76 18.17 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.139 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -102.13 154.01 19.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.895 0.379 . . . . 0.0 110.99 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 35.0 m . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.537 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.414 0.626 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.502 ' O ' ' HE3' ' A' ' 434' ' ' LYS . 18.1 m -82.27 -29.07 31.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.237 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . 0.623 ' HA ' ' HB2' ' A' ' 444' ' ' GLU . 5.8 p -78.8 150.2 32.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.346 0.593 . . . . 0.0 112.036 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.502 ' HE3' ' O ' ' A' ' 432' ' ' SER . 15.8 mmtp -99.93 147.52 33.57 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.694 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -82.62 129.78 5.78 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.03 1.82 . . . . 0.0 112.073 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 42.0 t -66.88 140.95 96.45 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.43 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.407 ' HD2' ' SG ' ' A' ' 436' ' ' CYS . 36.6 Cg_endo -67.51 -19.28 48.93 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.25 1.967 . . . . 0.0 112.241 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -103.24 -73.56 0.66 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 10.0 p -79.15 -17.71 54.51 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 44.5 mtt180 62.18 33.71 16.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.416 0.627 . . . . 0.0 111.126 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.2 p -90.44 154.34 46.4 Favored Pre-proline 0 N--CA 1.434 -1.24 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.782 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.78 110.53 1.7 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.73 2.287 . . . . 0.0 111.787 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 88.7 m -129.49 123.14 30.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.339 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 433' ' ' THR . 4.7 tp10 -134.6 142.67 46.99 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.431 ' NH1' ' HE2' ' A' ' 451' ' ' HIS . 9.7 tpt180 -111.92 106.61 15.36 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.107 0.48 . . . . 0.0 110.677 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -90.81 102.4 15.16 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.997 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 81.61 149.19 6.91 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.306 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 123.87 -165.58 16.66 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.285 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 8.2 t -82.99 -175.77 6.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.031 0.443 . . . . 0.0 110.787 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -80.14 50.04 1.18 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.075 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . 0.431 ' HE2' ' NH1' ' A' ' 445' ' ' ARG . 50.8 p-80 -119.48 139.34 52.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.346 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 1.1 mmt -119.78 80.25 1.56 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 36.4 t -94.87 117.51 38.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.257 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 48.0 t -80.86 99.7 8.46 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.46 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 2.1 p -82.2 89.14 6.48 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.611 0.719 . . . . 0.0 109.136 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.587 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 1.4 tmt_? -132.16 135.82 46.64 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.826 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.459 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -65.07 105.73 1.12 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.913 0.387 . . . . 0.0 110.2 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 106.54 -1.02 36.85 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.365 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 47.6 t -110.22 -90.89 0.47 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.34 . . . . 0.0 110.236 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 73.77 28.27 65.38 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.113 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -96.73 131.13 43.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.97 0.414 . . . . 0.0 110.083 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -117.27 136.87 52.78 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.117 0.484 . . . . 0.0 111.073 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -131.63 177.7 7.31 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.551 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 60.6 m -81.3 142.04 33.48 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -175.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -76.32 -56.62 4.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.566 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . 0.473 HG23 ' H ' ' A' ' 467' ' ' CYS . 3.2 m -71.26 -60.23 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.473 ' H ' HG23 ' A' ' 466' ' ' VAL . 16.1 p -93.73 170.15 9.78 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -111.63 109.22 19.0 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.245 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.52 160.12 40.28 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.586 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.15 149.89 25.88 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -56.41 108.12 0.45 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.627 0.727 . . . . 0.0 110.942 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 p -132.97 -179.17 5.32 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.121 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -70.21 -22.69 62.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.244 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.17 -54.07 7.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.186 0.517 . . . . 0.0 110.771 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 480' ' ' TRP . 85.1 m -85.01 8.25 18.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.933 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.5 ttt -53.95 -53.47 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.78 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -137.59 -0.47 2.61 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.031 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -58.84 -64.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.463 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -113.56 -4.88 13.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.88 0.372 . . . . 0.0 110.709 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . 0.414 ' HB2' ' O ' ' A' ' 475' ' ' CYS . 35.0 t-105 -68.19 -28.73 67.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.369 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -97.45 106.39 18.7 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.525 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 CA-C-O 118.886 -0.952 . . . . 0.0 111.887 -179.58 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . 0.482 ' HA2' HG12 ' A' ' 364' ' ' VAL . . . . . . . . 0 N--CA 1.434 -1.451 0 CA-C-O 121.307 0.393 . . . . 0.0 113.424 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 352' ' ' LEU . 10.5 p -129.63 175.06 11.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.517 ' H ' HG22 ' A' ' 351' ' ' VAL . 6.5 mp -130.79 151.7 50.94 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.796 -0.565 . . . . 0.0 111.865 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . 0.507 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 34.3 t -57.12 141.01 77.47 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.398 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.507 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 28.2 Cg_endo -61.75 -10.81 18.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.417 2.745 . . . . 0.0 114.515 -176.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -111.02 136.46 20.8 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.129 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.76 -19.83 30.88 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.053 2.502 . . . . 0.0 112.437 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -70.26 -17.44 74.13 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.253 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 41.1 t -86.55 -82.79 0.2 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.42 -0.39 . . . . 0.0 110.467 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 61.28 27.48 67.67 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.182 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -75.45 -40.09 57.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.653 0.263 . . . . 0.0 111.26 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.7 121.37 4.25 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.974 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -111.11 109.93 20.22 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.267 0.556 . . . . 0.0 110.411 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -88.01 112.48 22.65 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.65 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.482 HG12 ' HA2' ' A' ' 350' ' ' GLY . 7.7 p -83.63 104.73 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 121.865 0.84 . . . . 0.0 110.661 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 368' ' ' CYS . 8.6 pt-20 -90.26 159.79 41.22 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.667 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.81 -20.78 72.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.464 2.109 . . . . 0.0 111.305 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -99.37 3.67 46.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.418 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.53 ' N ' ' HG3' ' A' ' 365' ' ' GLU . 53.5 t -63.38 106.05 0.85 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 111.044 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . 0.685 ' H ' ' NE ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -80.11 -37.92 32.65 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.069 0.462 . . . . 0.0 110.562 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -145.12 143.86 30.6 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.521 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.61 119.95 50.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.294 0.569 . . . . 0.0 110.137 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 50.5 m -152.26 139.69 19.56 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.646 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 12.6 t -77.81 47.47 0.63 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 121.14 0.495 . . . . 0.0 110.266 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.19 -11.9 45.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.925 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -96.23 -10.67 27.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.028 0.442 . . . . 0.0 110.739 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -133.42 -79.79 0.15 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.441 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 3.4 m -100.4 -131.28 0.24 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -168.87 104.11 0.2 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 173.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -162.66 145.98 11.22 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 17.8 m -108.28 127.58 64.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -141.39 -177.7 5.27 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.097 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 44.5 t -80.99 159.97 24.72 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.611 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.463 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 29.0 ptt180 -88.41 -15.42 35.53 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.215 0.531 . . . . 0.0 109.628 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.463 ' OD1' ' HG3' ' A' ' 383' ' ' ARG . 4.6 m-20 -106.03 -29.62 9.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.112 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 31.4 p -143.02 -159.66 1.0 Allowed 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.159 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.13 18.48 14.56 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.064 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -76.18 25.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 72.76 31.34 62.58 Favored Glycine 0 N--CA 1.463 0.485 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.53 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.4 100.49 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.407 0.622 . . . . 0.0 111.252 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -126.61 161.12 28.78 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.223 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 391' ' ' ILE . 1.9 pp -85.29 160.43 3.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.478 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.61 -146.29 25.75 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.88 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -124.11 162.28 23.88 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.739 0.304 . . . . 0.0 110.804 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.32 -0.717 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.066 -179.901 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 121.509 0.671 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.8 p -96.51 2.09 52.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.696 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 8.6 p -117.04 -177.0 3.1 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.135 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -122.83 110.77 31.39 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -63.69 125.84 16.29 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.968 1.778 . . . . 0.0 111.84 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 38.9 t -56.03 139.13 71.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.787 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.39 -1.83 11.82 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.205 1.937 . . . . 0.0 111.729 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . 0.419 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 1.7 tppm? -109.87 -61.25 1.68 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.557 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 23.9 p -101.46 -10.94 19.73 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.794 0.331 . . . . 0.0 111.375 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 69.0 mtt180 67.4 28.53 7.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.621 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 25.2 p -85.96 147.95 46.86 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.484 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.64 98.26 0.57 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.494 2.129 . . . . 0.0 112.355 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 16.9 m -85.96 124.34 32.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.027 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.35 131.05 35.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.394 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -95.7 98.76 10.71 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.271 0.558 . . . . 0.0 111.271 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -107.49 155.3 20.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.132 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 80.85 -82.71 1.5 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.241 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 127.65 3.29 6.05 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.168 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 7.0 p -68.56 161.18 28.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.564 0.221 . . . . 0.0 110.426 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.58 ' SD ' ' HA3' ' A' ' 482' ' ' GLY . 67.3 mtt -78.01 -10.29 59.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.143 0.497 . . . . 0.0 110.77 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -96.72 105.6 17.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.46 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 5.9 ptp -147.1 135.88 22.15 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.549 173.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.06 140.74 44.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.159 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 35.0 t -59.54 103.16 0.18 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.993 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 6.3 t -85.61 90.81 8.09 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 122.408 1.099 . . . . 0.0 109.559 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -129.45 138.22 51.31 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.414 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -52.67 -47.12 67.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.809 0.337 . . . . 0.0 111.183 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -104.0 49.43 0.93 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.97 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 21.5 t -152.09 -90.33 0.06 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.941 0.371 . . . . 0.0 111.508 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.14 38.16 63.54 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -90.85 118.3 30.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.747 0.308 . . . . 0.0 110.905 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -87.35 122.52 31.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.226 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -129.62 156.46 44.18 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 42.4 t -67.34 136.58 55.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.622 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -75.07 -36.96 61.76 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.543 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.19 -64.04 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.873 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.9 p -109.48 155.51 21.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.36 107.8 8.87 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 118.687 -1.205 . . . . 0.0 108.256 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.12 151.77 23.62 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.337 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.33 158.37 24.75 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -48.35 110.56 0.35 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.627 0.727 . . . . 0.0 111.382 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.6 m -138.87 154.7 48.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.639 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 476' ' ' MET . 46.7 mtp180 -61.99 -36.58 81.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.05 -32.1 72.58 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.222 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 88.0 m -87.72 -37.21 16.87 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . 0.412 ' HB3' ' HA ' ' A' ' 473' ' ' ARG . 43.9 tpp -50.72 -54.65 21.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.272 -177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -90.56 7.47 81.32 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.169 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -111.13 -64.77 1.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -137.62 31.22 2.55 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -91.36 -34.04 15.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.03 0.443 . . . . 0.0 110.873 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -96.28 100.16 11.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.002 0.43 . . . . 0.0 110.978 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . 0.58 ' HA3' ' SD ' ' A' ' 450' ' ' MET . . . . . . . . 0 N--CA 1.437 -1.239 0 CA-C-O 118.425 -1.208 . . . . 0.0 112.072 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.558 0 N-CA-C 112.329 -0.308 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 352' ' ' LEU . 10.0 p -124.81 177.64 4.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.617 ' H ' HG22 ' A' ' 351' ' ' VAL . 85.9 mt -126.77 149.45 49.63 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 122.126 -0.359 . . . . 0.0 111.026 -177.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 355' ' ' GLN . 51.0 t -65.19 138.07 97.13 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.692 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.83 -14.25 40.95 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.924 2.416 . . . . 0.0 112.279 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.495 ' HB2' ' SG ' ' A' ' 353' ' ' CYS . 1.4 mp0 -75.48 123.68 88.66 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-O 120.92 0.39 . . . . 0.0 110.766 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.3 -22.21 46.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.097 2.532 . . . . 0.0 112.959 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -88.64 1.85 84.11 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.697 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.468 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 48.3 t -104.47 -93.56 0.35 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.921 0.391 . . . . 0.0 110.585 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.15 23.51 64.13 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.307 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.448 ' HB2' ' HE3' ' A' ' 360' ' ' MET . 47.4 mtm -61.74 -72.49 0.12 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.859 0.361 . . . . 0.0 110.844 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.447 ' HA2' HD23 ' A' ' 352' ' ' LEU . . . 145.9 109.92 0.63 Allowed Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.117 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -101.75 109.98 21.87 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 364' ' ' VAL . 3.0 tt -82.91 135.67 34.84 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.017 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.509 ' N ' HD23 ' A' ' 363' ' ' LEU . 39.2 t -90.96 86.6 2.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.263 0.554 . . . . 0.0 109.986 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 366' ' ' PRO . 6.9 mm-40 -80.97 139.56 49.71 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.634 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 365' ' ' GLU . 31.2 Cg_exo -60.62 -21.76 70.18 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.514 2.143 . . . . 0.0 111.308 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -88.58 -7.47 56.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.46 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 7.5 t -107.82 105.0 14.61 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.715 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -93.76 15.18 17.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -155.76 144.34 20.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.017 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.22 120.96 64.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.434 0.635 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . 0.483 ' OG1' HG12 ' A' ' 380' ' ' VAL . 62.1 m -147.47 136.96 22.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.916 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.6 t -78.2 67.16 3.96 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.171 0.51 . . . . 0.0 109.969 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -85.43 -7.01 59.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.381 0.61 . . . . 0.0 109.816 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -90.44 -17.11 27.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.441 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -140.17 -78.65 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.49 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 3.2 m -89.03 -127.2 0.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -171.21 104.55 0.2 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 381' ' ' PHE . 55.1 t80 -163.24 137.43 6.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.484 0.142 . . . . 0.0 111.115 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.483 HG12 ' OG1' ' A' ' 372' ' ' THR . 35.1 m -100.29 128.82 51.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.436 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 7.4 p90 -142.56 -176.68 4.95 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.326 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 31.6 t -86.85 171.71 10.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.405 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 16.2 ptt180 -97.33 -16.37 20.31 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.486 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.481 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 4.6 m-20 -105.01 -28.31 11.14 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.753 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 24.5 p -143.21 -170.79 3.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.159 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.9 mp -110.62 24.06 13.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.912 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -75.58 15.58 0.47 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 76.33 29.1 58.8 Favored Glycine 0 N--CA 1.46 0.282 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.579 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 19.1 t80 63.2 101.05 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.335 0.654 . . . . 0.0 110.756 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -127.11 179.75 5.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.579 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.85 166.21 5.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.106 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.65 -132.19 11.1 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.618 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.33 149.65 49.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.781 0.324 . . . . 0.0 110.379 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 6.6 m . . . . . 0 C--N 1.317 -0.811 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.698 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 121.145 0.497 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.6 m -104.56 -15.07 15.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.573 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.5 p -94.12 138.91 31.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.552 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -108.76 140.24 21.65 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.31 125.29 11.19 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.228 1.952 . . . . 0.0 112.708 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 42.0 t -58.13 139.68 83.45 Favored Pre-proline 0 N--CA 1.456 -0.126 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.278 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 4.5 Cg_exo -70.39 -20.91 31.27 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.942 1.762 . . . . 0.0 111.335 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 438' ' ' LYS . 0.1 OUTLIER -96.29 -67.49 0.85 Allowed 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.08 -177.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . 0.532 ' SG ' ' HG3' ' A' ' 456' ' ' ARG . 21.3 p -93.09 -8.33 43.03 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.704 ' O ' ' HD3' ' A' ' 440' ' ' ARG . 1.0 OUTLIER 65.23 23.05 12.21 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.586 0.754 . . . . 0.0 111.435 177.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 39.2 p -82.56 162.74 54.83 Favored Pre-proline 0 C--N 1.31 -1.122 0 O-C-N 121.967 -0.458 . . . . 0.0 110.359 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -79.21 100.7 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.243 1.962 . . . . 0.0 112.53 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 12.1 m -92.42 128.21 38.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.193 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -86.55 160.03 19.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.607 0.242 . . . . 0.0 110.97 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.422 ' HD2' ' C ' ' A' ' 445' ' ' ARG . 7.0 tmm_? -118.06 108.69 15.54 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.61 141.95 33.69 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.315 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 71.92 -143.52 35.04 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.568 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -139.53 26.64 2.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.685 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 8.8 p -87.21 155.76 19.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.853 0.358 . . . . 0.0 111.088 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -82.79 -16.31 48.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.096 0.474 . . . . 0.0 109.932 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -86.38 96.89 10.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.199 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 3.7 ptp -117.59 111.07 18.71 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.06 129.15 41.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.177 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 43.0 t -70.39 105.2 2.95 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.645 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 5.1 t -87.01 90.27 8.29 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 122.073 0.939 . . . . 0.0 108.948 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.57 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -130.97 139.18 49.99 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.406 -177.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.65 87.31 0.13 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.872 0.368 . . . . 0.0 110.247 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.45 39.69 1.45 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.088 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 461' ' ' PHE . 19.5 t -145.78 -91.9 0.09 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.624 -0.339 . . . . 0.0 110.921 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.57 27.19 69.9 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . 0.627 ' HB2' ' SG ' ' A' ' 459' ' ' CYS . 9.8 t80 -72.6 128.2 34.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.06 0.457 . . . . 0.0 110.887 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.53 134.75 49.18 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -150.5 159.12 44.71 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.875 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 76.4 m -70.3 140.99 52.39 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.215 0.531 . . . . 0.0 110.951 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -74.31 -40.22 62.38 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.221 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 23.1 t -85.53 -58.87 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.202 -174.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 6.9 p -91.81 152.87 19.92 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -93.45 110.05 21.62 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.345 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . 0.509 HG21 ' SG ' ' A' ' 475' ' ' CYS . 13.0 t -157.65 178.48 10.22 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.609 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.22 156.89 22.47 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 32.2 p-90 -51.89 117.74 2.94 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.332 0.587 . . . . 0.0 110.362 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 10.8 t -156.99 179.15 9.58 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.53 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -71.5 -23.38 61.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.978 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -62.64 -54.19 43.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.819 0.342 . . . . 0.0 111.3 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . 0.509 ' SG ' HG21 ' A' ' 469' ' ' THR . 70.8 m -98.94 24.56 7.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.631 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -61.26 -36.92 81.33 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.896 0.379 . . . . 0.0 111.271 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -167.9 26.15 0.13 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.773 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -78.32 -62.12 1.78 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.195 0.521 . . . . 0.0 110.681 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -110.77 -4.82 15.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.788 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -73.86 86.18 1.73 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.76 95.64 2.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.653 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.225 0 CA-C-O 118.321 -1.266 . . . . 0.0 111.042 -178.611 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . 0.437 ' HA2' HG23 ' A' ' 364' ' ' VAL . . . . . . . . 0 N--CA 1.436 -1.361 0 N-CA-C 112.556 -0.218 . . . . 0.0 112.556 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 352' ' ' LEU . 7.8 p -155.81 175.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.495 ' H ' HG22 ' A' ' 351' ' ' VAL . 6.7 mp -129.14 150.85 50.36 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.784 -0.572 . . . . 0.0 111.337 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 354' ' ' PRO . 43.3 t -63.75 128.33 92.67 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.446 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 353' ' ' CYS . 17.8 Cg_exo -67.38 -9.38 25.08 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.19 2.593 . . . . 0.0 113.129 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 358' ' ' CYS . 10.3 tm0? -65.0 122.53 80.06 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.1 -28.6 51.7 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 123.765 2.977 . . . . 0.0 114.964 -174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -108.19 16.97 35.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.702 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.751 ' SG ' ' HG3' ' A' ' 360' ' ' MET . 12.2 t -106.04 -97.27 0.34 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.27 32.38 71.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.078 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.751 ' HG3' ' SG ' ' A' ' 358' ' ' CYS . 0.6 OUTLIER -65.86 -32.98 74.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.83 107.63 2.94 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.955 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.41 HD22 ' SD ' ' A' ' 360' ' ' MET . 3.9 mm? -99.45 135.46 40.83 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.82 128.68 55.11 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.437 HG23 ' HA2' ' A' ' 350' ' ' GLY . 79.7 t -77.9 91.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.409 0.623 . . . . 0.0 109.781 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 368' ' ' CYS . 16.2 mm-40 -90.07 148.29 39.11 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.368 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.67 -22.75 74.26 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.478 2.119 . . . . 0.0 111.62 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -99.52 9.85 42.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.419 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 365' ' ' GLU . 37.2 t -89.7 78.95 6.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.445 0.64 . . . . 0.0 109.698 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . 0.478 ' H ' ' HD2' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -72.76 -22.59 60.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.758 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 370' ' ' LYS . 3.7 mmmp? -135.26 113.63 11.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.169 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.84 112.66 23.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.566 0.698 . . . . 0.0 110.041 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 94.9 m -147.44 138.86 23.86 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.92 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.422 ' SG ' ' HA3' ' A' ' 376' ' ' GLY . 21.6 t -74.86 76.8 2.13 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.225 0.536 . . . . 0.0 109.69 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -86.08 -38.7 17.53 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.048 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.53 -18.35 54.86 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.098 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . 0.422 ' HA3' ' SG ' ' A' ' 373' ' ' CYS . . . -101.32 -89.98 2.08 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.925 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.2 p -124.7 -91.52 0.54 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.013 0.435 . . . . 0.0 110.567 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -172.52 107.23 0.25 Allowed Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -161.02 131.81 5.31 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.872 0.336 . . . . 0.0 110.308 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.88 124.38 65.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.42 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 6.2 p90 -152.66 179.49 8.56 Favored 'General case' 0 C--O 1.21 -0.999 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.253 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 24.5 t -84.43 167.78 16.12 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -95.4 -16.6 22.19 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.323 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -104.31 -32.8 8.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.872 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 27.8 p -137.59 -166.38 1.93 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.101 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.401 ' HG ' ' HG3' ' A' ' 354' ' ' PRO . 10.9 mp -115.06 27.51 9.35 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.774 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -78.16 16.03 0.83 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 79.18 17.47 76.51 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.609 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 73.45 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.512 0.725 . . . . 0.0 111.244 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -148.23 -46.81 0.16 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.045 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.9 tt -150.3 158.04 5.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -87.91 6.24 83.75 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.767 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -136.03 115.59 12.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.136 0.468 . . . . 0.0 111.327 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 59.2 m . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.949 -179.053 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 121.264 0.554 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.1 m -107.63 -31.22 8.18 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.693 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.2 p -80.12 -178.58 6.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.234 0.54 . . . . 0.0 111.413 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.541 ' HG2' ' CH2' ' A' ' 463' ' ' TRP . 1.6 tpmt? -112.84 108.82 53.27 Favored Pre-proline 0 C--N 1.312 -1.047 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 434' ' ' LYS . 24.9 Cg_endo -63.05 130.69 29.81 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.117 1.878 . . . . 0.0 111.739 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 45.5 t -57.36 134.93 81.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.358 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.36 -7.64 21.47 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.365 2.043 . . . . 0.0 111.746 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -107.59 -63.99 1.25 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.83 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 6.2 p -95.47 -3.11 47.41 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 60.7 26.05 15.82 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 21.4 p -87.22 143.11 34.13 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.73 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -63.75 104.73 0.48 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.345 2.03 . . . . 0.0 111.449 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 37.9 m -96.4 133.6 40.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.939 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.21 163.98 23.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.761 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -120.58 162.43 19.64 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.122 0.487 . . . . 0.0 111.647 -176.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -99.79 162.57 12.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.059 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -63.04 -50.87 59.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.854 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -151.3 52.8 0.49 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.351 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 61.6 m -118.91 137.35 53.52 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -17.45 27.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.85 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.32 96.95 10.53 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 70.0 mmm -106.51 112.53 25.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 462' ' ' GLU . 21.3 t -115.6 141.37 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.996 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 28.8 t -83.03 125.66 31.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.06 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 19.9 p -101.54 89.96 3.9 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 121.833 0.825 . . . . 0.0 110.338 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.531 ' HB3' ' HB2' ' A' ' 459' ' ' CYS . 2.7 tmt_? -131.97 135.39 46.54 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.41 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -62.33 97.65 0.1 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.695 0.284 . . . . 0.0 110.954 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.06 22.24 8.44 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.581 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 456' ' ' ARG . 51.4 t -114.36 -80.93 0.6 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.429 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.72 24.12 76.45 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.25 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -93.91 139.25 31.13 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.421 ' HB3' HG13 ' A' ' 453' ' ' VAL . 7.3 pt-20 -126.55 157.71 38.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.301 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . 0.541 ' CH2' ' HG2' ' A' ' 434' ' ' LYS . 7.4 p-90 -147.4 163.43 36.51 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.12 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 43.9 t -70.49 143.24 51.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.682 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -75.75 -42.09 51.44 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.609 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.79 -48.05 24.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 27.4 p -118.96 143.79 46.83 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.52 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -77.09 111.65 12.91 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.378 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 3.7 p -152.85 174.99 13.39 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.995 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -96.48 152.44 18.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . 0.4 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 35.4 t-105 -54.1 122.9 11.17 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.02 0.438 . . . . 0.0 111.748 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.8 t -160.43 153.62 21.78 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.592 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -66.67 -25.42 66.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.3 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.83 -34.71 69.98 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.472 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.65 -27.59 14.72 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.7 ttt -53.81 -44.6 70.34 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.452 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -100.85 20.25 48.73 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.669 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -105.71 -64.94 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.681 -0.306 . . . . 0.0 111.44 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -148.68 28.76 0.85 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.275 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -69.45 -29.86 67.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.176 0.512 . . . . 0.0 109.884 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -92.9 111.67 23.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.445 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.038 0 CA-C-O 118.461 -1.188 . . . . 0.0 112.058 -179.161 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.914 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 362' ' ' LEU . 9.9 p -126.72 167.68 21.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.407 ' H ' HG22 ' A' ' 351' ' ' VAL . 5.8 mp -137.41 152.28 49.45 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.914 0.388 . . . . 0.0 111.716 -177.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 18.5 t -59.41 135.68 88.77 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.698 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 379' ' ' TYR . 42.7 Cg_endo -66.73 -15.57 47.77 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.913 2.409 . . . . 0.0 113.785 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -99.0 134.45 21.42 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 120.822 0.344 . . . . 0.0 111.788 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.81 -15.65 44.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.216 2.611 . . . . 0.0 112.729 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -79.71 16.12 12.25 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.831 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.7 t -126.68 -87.3 0.59 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 64.43 21.13 66.32 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.827 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 37.5 ttp -67.59 -43.65 80.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.832 0.348 . . . . 0.0 111.172 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.72 118.92 4.44 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.007 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.458 ' HB2' HG13 ' A' ' 351' ' ' VAL . 4.0 mm? -112.8 155.62 24.29 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.796 0.332 . . . . 0.0 110.456 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.409 ' HG ' ' N ' ' A' ' 364' ' ' VAL . 26.7 tp -102.61 157.06 17.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.66 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.409 ' N ' ' HG ' ' A' ' 363' ' ' LEU . 48.8 t -121.85 90.88 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 120.954 0.407 . . . . 0.0 110.563 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.33 152.22 96.6 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.41 -30.15 86.63 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.073 1.849 . . . . 0.0 111.139 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.57 15.0 28.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.115 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.35 101.77 3.54 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -111.7 -3.32 15.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 370' ' ' LYS . 5.5 mmpt? -144.95 91.53 2.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.835 177.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.78 129.06 46.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.5 0.667 . . . . 0.0 110.513 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.6 m -152.45 145.11 24.23 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.296 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 8.7 t -76.12 45.99 0.38 Allowed 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 121.326 0.584 . . . . 0.0 109.786 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -63.75 -12.38 34.49 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -98.62 -2.64 37.99 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -143.13 -75.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.101 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.1 m -99.72 -132.64 0.25 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -170.83 103.97 0.2 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.422 ' CD2' ' HG3' ' A' ' 354' ' ' PRO . 54.7 t80 -162.14 139.56 8.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 26.2 m -95.04 126.11 47.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.438 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 16.7 p90 -138.51 -176.57 4.51 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 16.4 t -82.27 164.05 21.42 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.706 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -92.28 -18.9 22.75 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.097 0.475 . . . . 0.0 110.352 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.577 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 62.0 t30 -106.57 -29.22 9.78 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.174 0.511 . . . . 0.0 109.927 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 29.3 p -136.39 -165.2 1.68 Allowed 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.739 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 62.8 mt -117.51 25.71 10.23 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.878 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -86.55 30.41 0.72 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 70.26 23.16 77.52 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.573 175.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.92 113.03 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.762 0.825 . . . . 0.0 112.14 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -131.91 168.44 17.87 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.841 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.71 147.87 6.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.273 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 100.02 173.97 30.35 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.445 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -100.44 128.97 46.36 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.803 0.335 . . . . 0.0 110.214 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 1.3 m . . . . . 0 C--N 1.316 -0.879 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.386 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 121.048 0.451 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 22.2 m -91.32 -13.38 32.69 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.844 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 4.0 p -82.92 138.72 33.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.591 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.441 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 1.7 tpmt? -90.91 124.67 61.35 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 5.8 Cg_exo -73.54 122.71 8.08 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.097 1.865 . . . . 0.0 111.764 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 440' ' ' ARG . 35.1 t -53.25 136.66 49.81 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.103 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.85 -14.69 46.42 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.712 2.275 . . . . 0.0 112.4 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.69 -67.86 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 7.8 p -86.45 -8.5 57.56 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 436' ' ' CYS . 18.7 mmm180 64.14 26.01 13.81 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.643 0.377 . . . . 0.0 111.628 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 29.3 p -87.29 141.82 32.95 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.632 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 11.9 Cg_exo -69.49 104.36 1.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.597 2.198 . . . . 0.0 112.094 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 18.0 m -81.16 119.69 23.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.335 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.64 95.44 4.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.362 0.601 . . . . 0.0 109.711 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 445' ' ' ARG . 20.7 mtp180 -137.07 156.58 48.22 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.741 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.18 151.39 22.72 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -81.95 59.04 4.9 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.34 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -72.38 -35.61 59.89 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 27.1 p -140.34 175.46 9.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.498 ' HA ' ' HB3' ' A' ' 465' ' ' TRP . 1.0 OUTLIER -83.72 0.89 45.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.781 0.324 . . . . 0.0 111.271 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -93.2 100.48 12.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.774 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . 0.416 ' HG2' ' HB2' ' A' ' 465' ' ' TRP . 10.3 mmt -100.1 107.01 18.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.345 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' A' ' 462' ' ' GLU . 21.7 t -105.73 124.8 61.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.044 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 52.4 t -78.83 99.7 6.85 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.994 0.426 . . . . 0.0 109.954 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 13.0 p -83.49 90.25 7.19 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 121.623 0.725 . . . . 0.0 110.111 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.484 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 4.0 tmm_? -130.76 145.61 52.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.462 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -69.61 93.26 0.69 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.769 0.318 . . . . 0.0 110.683 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 111.66 13.22 13.11 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.748 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.484 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 49.6 t -114.12 -88.4 0.56 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 122.788 -0.242 . . . . 0.0 110.566 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.16 27.17 70.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.145 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -88.28 142.91 27.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.918 0.39 . . . . 0.0 110.451 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.474 ' HG2' HG22 ' A' ' 453' ' ' VAL . 51.7 mt-10 -114.85 133.24 56.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.296 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -133.74 164.75 26.54 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.976 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 13.8 t -77.97 136.01 37.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.316 0.579 . . . . 0.0 111.962 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . 0.498 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 21.4 t-105 -77.51 -44.1 29.88 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.274 177.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 22.7 m -78.57 -17.18 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -173.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 18.5 p -145.19 148.99 34.15 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -82.52 108.67 16.1 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.718 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.3 p -155.82 178.1 10.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.246 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.04 157.62 17.39 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . 0.467 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 45.6 t90 -53.04 104.45 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 109.897 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 p -134.07 152.82 52.01 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.07 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . 0.592 ' HG3' ' SD ' ' A' ' 476' ' ' MET . 14.9 ttm180 -70.12 -23.0 62.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.102 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.0 -28.46 68.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.23 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 2.8 t -100.47 -27.34 13.49 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . 0.592 ' SD ' ' HG3' ' A' ' 473' ' ' ARG . 14.2 ptm -55.74 -29.49 59.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.858 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -111.04 12.1 29.19 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.216 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -100.16 -65.91 0.94 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.805 0.336 . . . . 0.0 110.841 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -146.27 21.42 1.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.662 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -72.87 -11.75 60.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.776 0.798 . . . . 0.0 108.878 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -119.56 151.82 38.02 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.767 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.476 -1.18 . . . . 0.0 112.131 -179.548 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.358 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 6.2 p -101.32 166.01 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.86 141.5 47.82 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 30.0 t -66.6 118.58 55.54 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.925 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.563 ' CG ' HD11 ' A' ' 386' ' ' LEU . 92.3 Cg_endo -81.9 4.98 6.62 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.518 2.812 . . . . 0.0 112.195 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -87.12 121.2 71.6 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.79 111.9 0.98 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.928 2.419 . . . . 0.0 112.816 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 126.39 3.07 6.8 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.343 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.702 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 36.6 t -113.08 -90.22 0.52 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 120.768 0.318 . . . . 0.0 111.089 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 60.55 22.85 59.8 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 43.5 ttp -72.37 -73.1 0.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.489 0.316 . . . . 0.0 111.36 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 148.36 121.63 1.2 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.737 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.5 129.11 56.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.973 0.416 . . . . 0.0 110.201 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 51.9 tp -86.51 129.82 34.72 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.676 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.22 87.43 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.485 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.61 166.58 44.09 Favored Pre-proline 0 C--N 1.313 -0.989 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.781 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.26 -23.88 64.65 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.236 1.957 . . . . 0.0 111.75 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.24 2.5 42.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.128 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.76 86.84 7.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -104.69 21.7 16.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.1 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -156.0 110.89 2.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.382 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.8 128.07 60.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.609 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 48.9 m -152.64 137.24 16.87 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.218 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 2.4 t -79.82 61.23 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.193 0.52 . . . . 0.0 110.17 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -70.71 -6.39 36.93 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.296 0.57 . . . . 0.0 110.187 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -99.67 -3.83 32.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.519 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -158.67 -115.79 0.44 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.964 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.3 p -86.66 94.89 9.61 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.84 113.77 5.45 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.922 -0.581 . . . . 0.0 114.495 -172.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -150.92 133.76 15.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.79 133.51 29.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 120.828 0.347 . . . . 0.0 110.08 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 389' ' ' TYR . 30.8 p90 -148.38 176.04 10.61 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 29.8 t -85.98 151.7 23.52 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -80.76 -11.59 59.59 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.028 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.466 ' CG ' ' H ' ' A' ' 394' ' ' CYS . 13.5 m-80 -105.47 -37.91 6.64 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.888 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.41 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 27.0 p -140.52 -159.21 0.93 Allowed 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.93 -176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.563 HD11 ' CG ' ' A' ' 354' ' ' PRO . 3.9 mm? -116.33 23.6 11.99 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . 0.538 ' HB2' ' CD2' ' A' ' 390' ' ' HIS . 75.2 mm-40 -83.07 28.0 0.53 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 69.5 25.5 75.44 Favored Glycine 0 N--CA 1.469 0.891 0 C-N-CA 121.478 -0.391 . . . . 0.0 114.05 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 381' ' ' PHE . 13.7 t80 63.31 105.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.409 0.684 . . . . 0.0 110.92 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.547 ' CG ' ' H ' ' A' ' 391' ' ' ILE . 2.3 p80 -132.63 -72.97 0.51 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.529 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.547 ' H ' ' CG ' ' A' ' 390' ' ' HIS . 50.7 mm -88.49 149.4 4.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -57.78 -54.23 38.97 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.81 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -130.72 122.41 27.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.877 0.37 . . . . 0.0 110.661 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.466 ' H ' ' CG ' ' A' ' 384' ' ' ASN . 62.3 m . . . . . 0 C--N 1.313 -0.992 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.069 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.651 0.262 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 19.9 m -72.46 -28.64 63.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.873 0.368 . . . . 0.0 110.6 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 11.8 p -78.73 115.33 18.35 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.197 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -92.39 143.89 28.04 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.304 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.58 127.25 15.25 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.461 2.107 . . . . 0.0 111.87 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 30.3 t -57.08 139.29 79.21 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.949 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.2 -15.74 46.92 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.134 1.889 . . . . 0.0 112.055 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -103.2 -60.17 1.6 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.0 p -99.68 -8.04 24.88 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 440' ' ' ARG . 3.1 mpt_? 63.4 24.77 14.3 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 34.3 p -82.95 157.68 65.98 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.84 103.85 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.121 1.881 . . . . 0.0 111.22 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 26.9 m -77.27 112.47 14.01 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.571 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.15 108.93 14.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.975 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -111.25 125.81 54.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.176 0.512 . . . . 0.0 110.73 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -141.87 104.05 4.44 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 78.4 52.48 5.15 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -53.03 126.35 33.04 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.357 -0.422 . . . . 0.0 112.895 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 13.1 t -93.83 24.57 4.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.73 0.3 . . . . 0.0 110.365 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 43.1 ttm 72.82 -40.19 0.47 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.851 0.86 . . . . 0.0 111.271 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -84.32 105.0 14.82 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 87.2 mmm -98.73 120.51 39.29 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.725 0.298 . . . . 0.0 111.169 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.57 128.41 76.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.348 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.5 t -92.73 106.21 18.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.994 0.426 . . . . 0.0 110.403 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.0 p -87.87 90.77 8.51 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.296 0.57 . . . . 0.0 110.129 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.556 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 2.5 tmm_? -130.74 138.94 50.21 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -62.36 98.43 0.11 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.719 0.295 . . . . 0.0 110.59 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.71 9.11 29.25 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.086 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.556 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 45.2 t -113.86 -91.8 0.5 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 122.431 -0.452 . . . . 0.0 110.758 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.71 23.95 77.35 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . 0.41 ' CD2' ' HZ3' ' A' ' 471' ' ' TRP . 27.5 t80 -84.2 108.77 17.28 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.158 0.504 . . . . 0.0 110.372 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 471' ' ' TRP . 6.3 pt-20 -97.98 126.24 43.3 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.731 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -128.86 166.44 19.07 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.791 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 27.2 t -78.77 144.04 35.54 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.311 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -76.5 -39.21 53.73 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.165 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.71 -8.18 9.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 17.9 p -148.95 155.87 41.46 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -91.38 107.74 19.41 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.104 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 5.0 p -155.6 169.98 23.04 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.223 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -96.14 157.05 16.08 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . 0.479 ' HB3' ' HG3' ' A' ' 462' ' ' GLU . 20.3 p90 -48.92 111.97 0.55 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.595 0.712 . . . . 0.0 111.333 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 5.4 p -134.35 148.9 50.8 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.107 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 473' ' ' ARG . 14.5 mmt180 -74.95 -22.14 58.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.129 0.49 . . . . 0.0 110.055 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.82 -50.51 70.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.913 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 18.7 t -74.68 -30.19 61.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.628 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . 0.552 ' HA ' ' CB ' ' A' ' 480' ' ' TRP . 28.1 ttt -52.76 -38.04 60.42 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.729 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -100.83 13.05 59.33 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.159 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.41 -66.17 1.08 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.818 -0.225 . . . . 0.0 111.346 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -153.79 12.45 0.45 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.892 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . 0.552 ' CB ' ' HA ' ' A' ' 476' ' ' MET . 76.6 t-105 -56.64 -43.24 80.08 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.273 0.559 . . . . 0.0 110.497 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -147.44 89.4 1.78 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.019 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.115 0 CA-C-O 118.573 -1.126 . . . . 0.0 111.449 -178.319 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.562 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.572 HG22 ' H ' ' A' ' 352' ' ' LEU . 5.8 p -122.66 176.19 4.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.572 ' H ' HG22 ' A' ' 351' ' ' VAL . 3.6 mm? -112.88 146.7 38.46 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.3 t -62.49 138.97 96.64 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.23 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.64 -4.21 14.93 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.856 2.371 . . . . 0.0 112.304 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -86.46 124.76 69.27 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.239 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.45 112.99 3.48 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.563 2.176 . . . . 0.0 112.012 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 120.29 -6.39 11.84 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.831 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.403 ' SG ' ' HG3' ' A' ' 360' ' ' MET . 47.5 t -84.5 -79.92 0.21 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.43 20.88 52.77 Favored Glycine 0 C--O 1.228 -0.236 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.648 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.569 ' HE1' ' HA3' ' A' ' 376' ' ' GLY . 34.2 mtm -68.01 -56.95 7.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.012 0.406 . . . . 0.0 111.024 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 124.67 114.16 2.03 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.71 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.3 mm? -98.45 134.77 40.97 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.058 0.456 . . . . 0.0 111.355 -177.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -93.03 124.08 36.75 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.35 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.28 116.97 48.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.975 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.31 155.5 66.51 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -42.91 -51.12 5.67 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.36 2.707 . . . . 0.0 113.656 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -106.86 28.8 7.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.852 0.358 . . . . 0.0 111.85 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 37.1 t -67.31 -52.79 36.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.613 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 67.03 -59.42 0.38 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.672 0.789 . . . . 0.0 111.98 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -72.98 116.73 13.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.44 0.638 . . . . 0.0 111.126 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 381' ' ' PHE . 0.0 OUTLIER -116.79 125.19 73.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.819 176.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 81.6 m -153.07 142.22 21.42 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.279 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.492 ' HA ' HD11 ' A' ' 362' ' ' LEU . 5.2 t -73.22 74.52 1.29 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.34 -18.8 61.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.393 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -99.3 -11.04 21.6 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.131 0.491 . . . . 0.0 110.807 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . 0.569 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -141.79 -129.6 2.45 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.759 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.41 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.9 OUTLIER -74.98 91.18 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.829 0.452 . . . . 0.0 111.017 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.72 119.23 9.75 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.9 -174.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -142.2 139.82 32.16 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.516 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 14.5 m -83.09 124.65 39.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.204 0.526 . . . . 0.0 111.186 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 371' ' ' VAL . 5.4 p90 -141.36 -176.9 4.89 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.469 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 36.4 t -105.46 169.96 8.16 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.46 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 7.1 ptt180 -87.93 -27.02 22.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.285 0.564 . . . . 0.0 109.805 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.46 ' OD1' ' HG3' ' A' ' 383' ' ' ARG . 5.6 m-20 -103.55 -19.73 14.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.431 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 394' ' ' CYS . 1.4 m -138.02 165.86 25.54 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.378 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.3 mp -111.89 34.83 3.98 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -86.97 2.13 50.49 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 100.67 27.75 7.38 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 119.565 -1.303 . . . . 0.0 114.04 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 47.2 t80 72.73 121.35 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.291 0.636 . . . . 0.0 111.921 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -167.92 176.86 5.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.932 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.47 ' O ' HD12 ' A' ' 391' ' ' ILE . 2.4 pp -139.51 148.93 22.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.757 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.95 -33.62 2.63 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.657 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -70.97 -20.26 62.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.567 0.698 . . . . 0.0 111.346 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.551 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 2.7 p . . . . . 0 C--N 1.291 -1.938 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.977 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.984 0.421 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 47.9 m -113.55 -0.49 14.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.379 0.609 . . . . 0.0 110.541 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 7.4 p -101.97 172.43 6.93 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.696 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -122.1 127.58 25.87 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.367 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.18 122.88 10.75 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.161 1.907 . . . . 0.0 111.77 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.61 ' O ' ' HD3' ' A' ' 440' ' ' ARG . 41.6 t -56.41 137.26 76.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.465 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.22 -14.8 41.43 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.212 1.941 . . . . 0.0 111.605 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -99.79 -78.04 0.51 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.667 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.0 p -81.41 -9.37 59.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.61 ' HD3' ' O ' ' A' ' 436' ' ' CYS . 38.4 mmt180 64.98 25.59 12.69 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.777 0.431 . . . . 0.0 111.875 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 39.3 p -88.76 151.88 48.18 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.44 102.12 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.525 2.15 . . . . 0.0 111.944 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 51.7 m -94.11 130.23 40.38 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.396 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -74.75 146.32 42.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.014 0.435 . . . . 0.0 111.051 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -95.71 162.13 13.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.134 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -117.9 141.77 48.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -97.82 4.12 61.11 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.118 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -127.17 -49.23 0.17 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.656 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.7 t -96.16 136.43 36.64 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.856 0.36 . . . . 0.0 110.548 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.76 19.81 3.3 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.574 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -104.01 111.97 24.75 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . 0.494 ' HG2' ' HB2' ' A' ' 465' ' ' TRP . 79.2 mmm -99.83 111.83 24.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 0.0 110.923 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.84 130.07 60.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.823 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.1 t -91.38 130.39 37.24 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 3.4 p -109.62 88.85 2.84 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 121.561 0.696 . . . . 0.0 110.084 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.46 135.78 44.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.52 95.25 0.32 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.961 0.41 . . . . 0.0 110.086 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 123.94 -9.99 8.44 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.527 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . . . . . . . . . 48.1 t -97.22 -88.34 0.3 Allowed 'General case' 0 C--O 1.239 0.503 0 O-C-N 122.673 -0.31 . . . . 0.0 111.009 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.27 31.43 63.69 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.821 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -95.18 142.12 28.0 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.973 0.416 . . . . 0.0 110.514 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.01 135.97 55.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.583 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -143.45 165.92 26.21 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.523 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 61.2 m -73.59 144.72 45.89 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.312 0.577 . . . . 0.0 112.018 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . 0.494 ' HB2' ' HG2' ' A' ' 452' ' ' MET . 26.1 t-105 -76.7 -51.33 11.67 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.046 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.36 -35.7 63.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 26.3 p -116.74 -161.65 0.81 Allowed 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -142.62 109.55 5.51 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . 0.458 HG21 ' SG ' ' A' ' 475' ' ' CYS . 13.4 t -158.02 177.88 10.83 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.386 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -87.74 150.43 23.6 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -52.74 101.73 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.584 0.707 . . . . 0.0 110.14 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.8 p -130.57 171.9 12.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.621 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -73.93 -21.73 59.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.144 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.96 -52.76 63.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.495 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 478' ' ' ALA . 72.5 m -84.0 -18.7 36.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.112 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 24.2 ttt -46.68 -54.13 10.24 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.728 0.643 . . . . 0.0 111.632 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -97.98 17.77 58.22 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.356 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 475' ' ' CYS . . . -110.01 -66.28 1.08 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.695 0.283 . . . . 0.0 111.4 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -144.67 12.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -68.09 -28.17 67.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.484 0.659 . . . . 0.0 109.812 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -132.14 105.73 7.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.386 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-O 118.712 -1.049 . . . . 0.0 112.502 -178.173 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.085 0 CA-C-O 120.958 0.199 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 362' ' ' LEU . 29.6 m -120.58 -178.25 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 C-N-CA 123.339 0.656 . . . . 0.0 109.879 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 22.4 mt -126.6 150.45 48.87 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 54.0 t -57.98 137.37 83.79 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.436 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.02 -17.16 51.0 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.984 2.456 . . . . 0.0 112.299 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 358' ' ' CYS . 34.7 tt0 -72.45 121.29 84.44 Favored Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.3 -39.46 91.14 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.094 2.53 . . . . 0.0 112.599 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -78.69 -10.75 85.92 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.348 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 355' ' ' GLN . 7.1 t -88.58 -76.65 0.39 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.971 0.415 . . . . 0.0 110.03 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 68.72 27.23 74.0 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.645 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.432 ' HB3' ' HE2' ' A' ' 360' ' ' MET . 35.2 ttp -88.62 153.09 21.39 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -88.6 115.16 4.37 Favored Glycine 0 C--N 1.284 -2.335 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.534 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.495 ' HB2' HG23 ' A' ' 351' ' ' VAL . 4.5 mm? -94.59 134.22 37.39 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.511 HD13 ' N ' ' A' ' 364' ' ' VAL . 1.1 tm? -92.68 139.63 30.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.511 ' N ' HD13 ' A' ' 363' ' ' LEU . 43.7 t -108.89 91.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 120.851 0.357 . . . . 0.0 110.262 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -71.38 145.92 91.17 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.57 -22.47 58.33 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 121.948 1.765 . . . . 0.0 110.341 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -108.38 23.05 15.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.066 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 51.5 t -56.51 124.07 16.93 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.461 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -83.19 -48.63 10.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.692 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -148.72 118.19 6.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.633 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 381' ' ' PHE . 2.0 p -84.6 111.8 20.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.483 0.659 . . . . 0.0 109.539 176.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 91.4 m -152.78 144.22 23.33 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.98 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 19.9 t -75.57 69.66 2.33 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.345 0.593 . . . . 0.0 110.064 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -83.8 -6.55 59.45 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.567 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -111.25 5.77 20.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.934 -177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -133.79 -75.87 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.566 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.5 p -124.6 -102.72 0.37 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.873 0.368 . . . . 0.0 110.37 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -173.0 106.07 0.22 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -163.39 123.36 2.19 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.97 129.26 49.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.467 ' O ' HG13 ' A' ' 371' ' ' VAL . 8.1 p90 -140.0 -177.34 4.95 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.887 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 27.9 t -83.44 172.78 12.11 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -100.42 -14.66 18.23 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.639 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.537 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 8.6 t30 -105.21 -26.86 11.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.434 0.635 . . . . 0.0 109.483 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 28.8 p -143.31 -169.84 3.14 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.724 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 11.1 mp -116.47 26.4 9.91 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.561 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -76.56 11.54 1.6 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 86.62 21.07 52.52 Favored Glycine 0 N--CA 1.459 0.205 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.398 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 72.95 120.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.696 0.798 . . . . 0.0 111.631 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -150.6 166.6 29.81 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.791 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.71 143.09 24.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 111.41 23.08 5.86 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.087 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 61.64 -178.88 0.12 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.5 0.72 . . . . 0.0 111.827 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 2.5 m . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.196 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 121.35 0.595 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.434 ' O ' ' HD2' ' A' ' 445' ' ' ARG . 3.2 p -115.26 3.63 14.31 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.45 0.643 . . . . 0.0 110.489 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.68 152.14 20.96 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.097 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 434' ' ' LYS . 0.0 OUTLIER -118.93 119.15 32.51 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 10.7 Cg_exo -68.52 126.18 13.8 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 122.006 1.804 . . . . 0.0 112.206 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 438' ' ' LYS . 43.6 t -57.91 131.26 83.08 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.431 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.497 ' HG2' ' CE2' ' A' ' 461' ' ' PHE . 64.6 Cg_endo -74.64 -1.24 10.83 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.322 2.014 . . . . 0.0 111.391 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . 0.572 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 27.7 tptp -102.81 -64.7 1.05 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.971 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 11.0 p -103.59 -3.46 25.17 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 22.0 mmm180 68.58 29.16 5.6 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 34.7 p -90.27 141.38 27.56 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 2.4 Cg_endo -75.63 94.52 0.99 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.916 1.744 . . . . 0.0 111.398 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 30.4 m -89.64 128.21 36.02 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.016 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.62 151.11 44.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.904 0.383 . . . . 0.0 111.338 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.516 ' HD3' ' H ' ' A' ' 445' ' ' ARG . 0.3 OUTLIER -82.57 146.14 29.34 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.574 177.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -117.43 89.45 3.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.88 0.371 . . . . 0.0 110.955 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 60.03 -134.88 50.68 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.623 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -112.99 18.24 21.79 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.681 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 43.3 t -63.95 129.46 40.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.418 ' HA ' ' HB3' ' A' ' 465' ' ' TRP . 60.6 mtt -75.99 -25.68 56.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.977 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -79.22 96.2 5.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 40.6 mmm -118.43 109.68 16.53 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.68 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.413 ' CG1' ' HG2' ' A' ' 462' ' ' GLU . 4.0 m -121.66 150.87 24.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 120.952 0.406 . . . . 0.0 110.275 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 456' ' ' ARG . 42.8 t -83.68 100.65 11.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.499 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 5.9 p -81.45 92.15 6.42 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -128.9 139.64 52.04 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -177.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -45.71 -45.57 14.38 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.486 0.491 . . . . 0.0 112.231 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -122.56 59.34 0.59 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.749 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 45.4 t -146.38 -83.54 0.13 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.83 0.315 . . . . 0.0 110.793 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.88 49.52 41.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.375 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . 0.497 ' CE2' ' HG2' ' A' ' 437' ' ' PRO . 65.1 t80 -99.8 120.53 39.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.825 0.345 . . . . 0.0 111.097 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.413 ' HG2' ' CG1' ' A' ' 453' ' ' VAL . 41.1 mt-10 -94.22 134.17 36.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.842 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -144.29 161.28 39.33 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.889 0.376 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . 0.792 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 19.8 m -76.61 137.35 39.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.313 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 15.9 t-105 -68.45 -45.55 72.19 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.689 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.39 -63.92 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.237 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.792 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 17.1 p -98.79 126.34 44.39 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.55 109.37 7.97 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.579 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.5 156.21 36.28 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.046 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -85.97 135.84 33.5 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -55.76 106.97 0.29 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.2 p -140.52 -164.96 1.83 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.589 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -73.58 -29.31 62.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 109.817 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -72.06 -58.45 3.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.158 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 34.3 m -97.54 70.05 2.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.497 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.58 4.15 53.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.46 0.648 . . . . 0.0 109.453 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 480' ' ' TRP . . . 121.38 12.68 5.58 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.271 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -61.93 -19.42 62.71 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -121.91 9.46 10.02 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.178 0.513 . . . . 0.0 109.911 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . 0.407 ' HB2' ' HA2' ' A' ' 477' ' ' GLY . 9.3 t-105 -86.43 86.24 7.33 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.166 -175.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -149.9 121.19 7.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.385 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.101 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.227 179.09 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.972 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.01 165.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.74 148.26 33.87 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 122.207 -0.308 . . . . 0.0 110.965 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 34.2 t -68.53 122.04 83.09 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.499 ' CG ' HD11 ' A' ' 386' ' ' LEU . 92.4 Cg_endo -79.5 0.03 10.34 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.936 2.424 . . . . 0.0 112.748 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 8.5 tt0 -81.06 120.2 78.04 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 355' ' ' GLN . 39.1 Cg_exo -58.0 106.52 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.796 2.331 . . . . 0.0 112.325 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 128.39 -6.54 6.69 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.768 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.3 t -94.42 -94.04 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.898 0.349 . . . . 0.0 110.557 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 71.07 16.21 74.83 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.006 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.404 ' HE2' ' HB3' ' A' ' 360' ' ' MET . 41.6 ttp -67.06 -54.88 17.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.98 0.419 . . . . 0.0 111.198 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.63 122.49 2.56 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.653 -0.785 . . . . 0.0 111.695 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.608 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.3 mm? -109.03 132.61 53.95 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.515 0.674 . . . . 0.0 111.325 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.81 106.22 18.22 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.778 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 11.4 p -116.41 127.42 74.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.289 0.566 . . . . 0.0 110.25 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -94.49 162.61 25.37 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.992 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.04 -26.32 81.21 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.472 2.115 . . . . 0.0 111.645 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.18 5.63 40.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.305 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 46.6 t -88.18 108.04 19.08 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.954 0.407 . . . . 0.0 110.693 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . 0.437 ' O ' ' HE1' ' A' ' 389' ' ' TYR . 0.7 OUTLIER -94.08 -33.13 13.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.656 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -85.75 104.6 15.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.207 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 14.4 p -103.7 122.81 56.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.267 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 96.7 m -153.27 139.49 18.43 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.075 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.608 ' HA ' HD11 ' A' ' 362' ' ' LEU . 2.5 t -74.83 69.89 1.88 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -68.7 -13.26 62.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.559 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -103.9 -3.72 24.41 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.96 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -154.63 -124.63 0.93 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.87 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 373' ' ' CYS . 1.7 p -74.85 91.68 2.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.885 0.374 . . . . 0.0 111.12 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.99 124.09 19.56 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.827 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -151.9 132.8 14.18 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 26.6 m -90.36 124.81 43.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.953 0.406 . . . . 0.0 110.67 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.402 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 27.8 p90 -145.6 -175.77 4.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.169 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . 0.558 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 42.8 t -88.47 141.23 28.71 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -66.47 -22.13 66.2 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.616 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -105.93 -28.63 10.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.836 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 5.4 m -134.11 178.73 6.74 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 121.286 0.565 . . . . 0.0 111.779 -174.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.499 HD11 ' CG ' ' A' ' 354' ' ' PRO . 4.2 mm? -110.04 30.2 6.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -77.27 3.05 13.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.716 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 76.33 40.26 28.99 Favored Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.54 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.437 ' HE1' ' O ' ' A' ' 369' ' ' ARG . 37.0 t80 69.76 110.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.787 0.835 . . . . 0.0 111.638 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -134.68 -169.13 2.28 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.456 HG12 ' H ' ' A' ' 393' ' ' GLU . 0.2 OUTLIER -57.52 159.91 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.824 178.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.69 9.6 2.58 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-N 116.277 -0.42 . . . . 0.0 114.048 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . 0.456 ' H ' HG12 ' A' ' 391' ' ' ILE . 46.1 mt-10 -115.59 111.81 21.22 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.168 0.508 . . . . 0.0 111.093 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.548 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 1.9 m . . . . . 0 C--N 1.314 -0.951 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.597 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 121.417 0.627 . . . . 0.0 111.683 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 31.3 m -96.77 4.96 51.48 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.3 p -115.57 155.05 28.3 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.913 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 30.3 mmmt -121.52 134.43 24.55 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 5.1 Cg_exo -74.34 118.14 5.25 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.802 1.668 . . . . 0.0 111.938 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 37.2 t -55.32 138.72 67.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.528 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.31 -1.17 10.95 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.577 2.185 . . . . 0.0 112.031 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -111.68 -60.21 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . 0.405 ' SG ' ' HG3' ' A' ' 456' ' ' ARG . 5.3 p -100.58 -3.31 30.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.78 33.7 23.53 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.072 0.463 . . . . 0.0 111.166 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 36.4 p -97.81 154.89 37.67 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.16 99.34 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.181 1.921 . . . . 0.0 112.302 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 5.8 m -85.96 121.05 28.04 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -76.21 124.35 27.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.965 0.412 . . . . 0.0 110.357 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.431 ' HD3' ' O ' ' A' ' 445' ' ' ARG . 0.0 OUTLIER -96.19 155.4 16.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.015 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -140.7 148.86 41.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -85.43 115.1 4.09 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.791 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 136.46 -12.59 4.03 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.793 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 57.9 m -112.94 110.24 20.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.417 ' HA ' ' CD1' ' A' ' 465' ' ' TRP . 0.7 OUTLIER -82.54 -12.73 57.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.195 0.521 . . . . 0.0 110.224 176.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -101.0 96.4 7.22 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 46.3 tpp -104.13 129.77 51.84 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 120.942 0.401 . . . . 0.0 111.05 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 18.6 t -134.37 137.27 51.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 48.1 t -86.52 95.04 9.59 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 20.6 p -81.96 90.23 6.46 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.515 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 0.1 OUTLIER -131.27 141.97 50.06 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.791 -176.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.451 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -64.42 106.06 1.05 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.808 0.337 . . . . 0.0 110.141 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 101.69 4.69 51.97 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.414 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.515 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 44.2 t -113.21 -90.19 0.52 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.743 0.271 . . . . 0.0 110.599 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 70.4 34.25 68.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.567 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -94.76 134.23 37.59 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.951 0.405 . . . . 0.0 111.07 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.37 128.85 52.28 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -138.58 157.98 45.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.048 0.451 . . . . 0.0 111.752 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 28.5 m -65.92 136.07 55.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.044 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . 0.417 ' CD1' ' HA ' ' A' ' 450' ' ' MET . 23.9 t-105 -74.33 -49.44 22.86 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.265 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 13.4 t -73.24 -64.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.822 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.672 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 13.9 p -93.32 133.81 36.18 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -76.8 107.64 9.27 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.798 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -155.76 176.53 12.51 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.956 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -113.9 140.84 48.04 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 63.9 t90 -59.75 103.97 0.25 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.799 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 473' ' ' ARG . 0.7 OUTLIER -142.41 -152.47 0.41 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . 0.484 ' H ' HG22 ' A' ' 472' ' ' THR . 33.4 ptt180 -82.94 -23.98 33.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.058 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.85 -50.39 56.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.901 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 66.1 m -110.89 81.17 1.39 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.116 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 92.4 mtp -89.46 -35.53 15.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.818 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . 159.26 40.45 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.555 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -90.83 -3.0 57.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.098 0.475 . . . . 0.0 110.973 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . 0.414 ' CE1' ' SG ' ' A' ' 464' ' ' CYS . 19.2 p80 -143.88 19.5 1.8 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.135 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . 0.461 ' CZ3' ' HA ' ' A' ' 464' ' ' CYS . 9.5 t-105 -87.85 3.36 48.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.299 0.571 . . . . 0.0 110.093 -176.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -64.81 115.77 5.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.091 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-O 118.677 -1.068 . . . . 0.0 111.469 179.744 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-O 121.035 0.241 . . . . 0.0 112.622 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 352' ' ' LEU . 30.0 t -100.38 163.76 2.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.423 ' N ' HG12 ' A' ' 351' ' ' VAL . 4.2 mm? -113.76 143.89 43.89 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 354' ' ' PRO . 44.5 t -64.95 139.68 97.87 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.779 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 353' ' ' CYS . 7.8 Cg_exo -74.66 -10.83 22.0 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.557 2.171 . . . . 0.0 112.402 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -71.42 136.13 83.94 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 110.857 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.1 -43.13 16.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.986 2.457 . . . . 0.0 113.223 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -82.27 7.14 65.04 Favored Glycine 0 CA--C 1.51 -0.279 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.3 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.586 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 43.9 t -92.4 -103.42 0.12 Allowed 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 122.667 -0.314 . . . . 0.0 110.866 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 70.03 27.91 72.4 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 37.5 ttp -79.44 -69.7 0.56 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.913 0.387 . . . . 0.0 110.643 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 139.92 131.38 2.77 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.957 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.36 140.79 48.81 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.952 0.406 . . . . 0.0 110.661 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -105.86 123.37 47.85 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.619 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 59.6 t -118.89 114.47 44.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.873 0.368 . . . . 0.0 110.629 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.67 142.64 70.47 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -46.32 -42.75 22.15 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.345 2.697 . . . . 0.0 114.014 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -80.21 -3.62 49.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 43.6 t -123.58 158.38 31.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.102 0.477 . . . . 0.0 111.131 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -134.74 9.23 3.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.064 0.459 . . . . 0.0 109.779 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -71.95 108.09 5.03 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.525 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.487 HG21 ' C ' ' A' ' 382' ' ' CYS . 0.0 OUTLIER -115.36 112.15 38.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.175 177.27 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.3 m -153.71 135.15 14.24 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.438 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.447 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 3.4 t -74.76 69.57 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.465 0.65 . . . . 0.0 109.738 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -76.03 -9.8 58.9 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.395 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -104.99 5.97 33.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.497 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -161.11 -123.0 0.65 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.583 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.1 p -84.58 92.6 8.17 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.676 0.39 . . . . 0.0 110.67 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -69.52 108.95 2.66 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.896 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -128.08 141.88 51.37 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.75 122.8 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.259 0.552 . . . . 0.0 111.88 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -151.94 -177.5 6.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.824 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . 0.487 ' C ' HG21 ' A' ' 371' ' ' VAL . 19.5 t -108.57 175.46 5.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -82.54 -39.0 22.94 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.935 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.624 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 5.2 m-20 -104.44 -5.33 21.74 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -177.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 21.3 p -151.84 173.2 15.06 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.243 0.544 . . . . 0.0 111.397 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 8.9 mp -110.36 35.38 3.46 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.992 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -79.08 3.84 16.3 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.327 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 83.79 27.58 37.8 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.941 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 25.7 t80 70.08 125.89 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.468 0.707 . . . . 0.0 111.036 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -143.96 -175.72 4.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 43.6 mm -105.52 145.49 13.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.8 -163.41 27.03 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.775 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -91.24 166.53 12.89 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.889 0.376 . . . . 0.0 110.365 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.0 m . . . . . 0 C--N 1.308 -1.213 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.768 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.451 -0.41 0 CA-C-O 121.433 0.635 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.0 m -114.82 2.04 14.26 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.675 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.1 p -105.83 126.04 51.7 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.877 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 5.2 mptp? -90.48 144.97 31.52 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 1.1 Cg_endo -80.46 121.14 4.17 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.013 1.809 . . . . 0.0 111.822 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 440' ' ' ARG . 37.1 t -54.99 135.2 67.27 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.609 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.53 -15.62 38.06 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.159 1.906 . . . . 0.0 111.651 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . 0.499 ' HA ' ' HE3' ' A' ' 438' ' ' LYS . 0.9 OUTLIER -91.85 -70.49 0.69 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.493 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.1 p -97.6 -6.09 34.12 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 436' ' ' CYS . 23.9 mmt180 67.11 26.1 8.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.771 0.429 . . . . 0.0 111.664 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 26.9 p -86.19 158.81 54.89 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.902 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.02 101.53 1.34 Allowed 'Trans proline' 0 C--O 1.239 0.53 0 C-N-CA 122.428 2.085 . . . . 0.0 112.224 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 7.3 m -90.32 113.16 24.96 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -104.09 141.1 36.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 445' ' ' ARG . 6.6 ptm180 -85.74 95.04 9.27 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.633 0.73 . . . . 0.0 110.057 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -135.47 115.3 12.98 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.892 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 84.16 20.34 59.24 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.78 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -149.89 129.2 2.91 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 76.5 m -81.84 -73.1 0.4 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.754 0.311 . . . . 0.0 110.893 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -112.3 -6.52 14.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.502 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -96.65 96.5 8.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.959 0.409 . . . . 0.0 110.546 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 80.0 mmm -89.51 91.85 8.87 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 23.7 t -99.95 116.76 43.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.89 99.55 12.48 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 1.3 t -87.24 92.78 9.18 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.604 0.716 . . . . 0.0 110.471 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.589 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -130.3 148.22 52.1 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.427 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -46.41 -64.76 0.68 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -93.78 37.5 3.39 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.773 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 51.1 t -130.97 -100.36 0.3 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.851 0.357 . . . . 0.0 111.073 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 78.81 22.53 66.2 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -89.28 114.88 26.3 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.361 0.601 . . . . 0.0 111.076 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.482 ' HG3' ' HB3' ' A' ' 471' ' ' TRP . 4.1 pt-20 -105.58 146.19 29.97 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.62 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -146.45 159.38 43.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.941 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 41.8 m -62.51 146.95 50.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.472 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -74.87 -54.54 7.08 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.468 176.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.01 -63.83 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.626 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.521 ' HG ' ' CE1' ' A' ' 479' ' ' HIS . 28.0 p -98.67 165.96 11.55 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -106.6 111.42 23.96 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.729 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.4 p -150.64 154.75 38.06 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.387 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -73.85 154.36 39.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . 0.482 ' HB3' ' HG3' ' A' ' 462' ' ' GLU . 5.3 p-90 -60.7 91.87 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.887 0.851 . . . . 0.0 111.981 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.2 t -134.77 141.08 46.36 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.761 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . 0.499 ' HA ' ' HB3' ' A' ' 476' ' ' MET . 36.3 mtp180 -63.48 -29.38 70.67 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -174.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 4.9 p-10 -65.51 -18.32 65.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.293 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 8.2 t -110.61 -40.6 4.54 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . 0.499 ' HB3' ' HA ' ' A' ' 473' ' ' ARG . 10.8 tpt -52.99 -41.02 64.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.26 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -106.03 16.8 42.3 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.169 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 474' ' ' ASP . . . -92.78 -65.54 0.99 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.75 0.309 . . . . 0.0 110.828 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 480' ' ' TRP . 9.5 p80 -108.32 -69.62 0.84 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.031 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . 0.593 ' H ' ' CG ' ' A' ' 479' ' ' HIS . 22.0 t-105 63.51 -71.81 0.06 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.332 1.053 . . . . 0.0 111.734 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -70.23 137.07 50.54 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.416 0.286 . . . . 0.0 110.395 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.295 0 CA-C-O 118.435 -1.203 . . . . 0.0 111.876 -179.658 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.393 0 CA-C-O 120.896 0.164 . . . . 0.0 112.846 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.34 -179.03 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 C-N-CA 123.094 0.558 . . . . 0.0 110.3 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 7.5 mp -124.35 151.53 44.24 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.872 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.9 t -54.61 138.67 60.91 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.694 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.501 ' HG3' ' CD1' ' A' ' 379' ' ' TYR . 18.6 Cg_endo -59.56 -19.69 53.63 Favored 'Trans proline' 0 N--CA 1.473 0.281 0 C-N-CA 123.195 2.597 . . . . 0.0 112.396 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -84.93 113.09 47.76 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.03 -28.22 74.44 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.46 2.106 . . . . 0.0 111.842 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -67.86 -25.3 74.24 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 40.0 t -73.95 -73.08 0.24 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 53.24 31.53 42.11 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.249 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 47.9 ttp -70.96 -62.55 1.35 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.168 0.508 . . . . 0.0 110.8 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 125.8 123.62 2.7 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.75 130.11 56.52 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.237 0.542 . . . . 0.0 110.478 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.521 HD12 ' HG2' ' A' ' 365' ' ' GLU . 0.8 OUTLIER -89.62 124.66 34.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.859 -178.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.405 ' N ' HD13 ' A' ' 363' ' ' LEU . 100.0 t -93.75 100.99 12.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.102 0.477 . . . . 0.0 110.673 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.521 ' HG2' HD12 ' A' ' 363' ' ' LEU . 6.0 mm-40 -94.89 153.73 39.91 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.369 177.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.82 -11.34 31.76 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 121.785 1.657 . . . . 0.0 109.821 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -102.98 24.99 9.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.182 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . 0.403 ' SG ' ' HD2' ' A' ' 383' ' ' ARG . 27.1 p -71.83 74.67 0.87 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.556 0.693 . . . . 0.0 110.823 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . 0.633 ' HD3' ' H ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -64.88 -23.07 67.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.196 179.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -162.11 109.47 1.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.168 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 381' ' ' PHE . 0.6 OUTLIER -92.64 113.67 28.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.659 0.742 . . . . 0.0 110.326 176.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . 0.43 ' OG1' HG12 ' A' ' 380' ' ' VAL . 92.2 m -152.54 144.93 24.03 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.443 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 9.3 t -74.62 73.24 1.98 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.444 0.64 . . . . 0.0 109.335 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -84.87 -19.48 32.3 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.988 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -96.81 -16.88 20.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.044 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -108.91 -101.26 2.68 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.918 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 4.0 p -100.2 -100.91 0.24 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.774 0.321 . . . . 0.0 110.618 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -173.32 107.06 0.24 Allowed Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.214 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.501 ' CD1' ' HG3' ' A' ' 354' ' ' PRO . 23.8 t80 -161.89 135.55 6.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.833 0.316 . . . . 0.0 110.648 177.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.43 HG12 ' OG1' ' A' ' 372' ' ' THR . 29.1 m -101.01 125.95 54.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.568 ' O ' HG13 ' A' ' 371' ' ' VAL . 23.6 p90 -146.94 -175.12 4.69 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.537 -177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 34.2 t -77.2 -178.07 4.88 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.403 ' HD2' ' SG ' ' A' ' 368' ' ' CYS . 11.3 ptm180 -95.94 -32.71 12.48 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.837 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -105.57 -7.78 18.38 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.505 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.04 -170.58 3.68 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.451 0.643 . . . . 0.0 111.462 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.81 28.59 8.66 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.145 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -81.09 18.37 1.07 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 72.07 45.43 41.04 Favored Glycine 0 C--O 1.227 -0.282 0 C-N-CA 120.843 -0.694 . . . . 0.0 114.603 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 5.2 t80 59.71 94.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -133.96 -163.12 1.32 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.43 157.31 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -75.33 46.93 1.95 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.5 -0.381 . . . . 0.0 113.77 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.61 107.68 7.18 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.311 -1.068 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.643 -176.677 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 121.828 0.823 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.7 p -100.63 4.43 43.3 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.359 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.5 p -95.56 154.35 17.25 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.665 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.48 ' HA ' ' HE3' ' A' ' 434' ' ' LYS . 0.0 OUTLIER -117.15 140.45 27.15 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.24 124.59 4.88 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.969 1.779 . . . . 0.0 112.499 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 438' ' ' LYS . 41.2 t -64.3 134.93 96.13 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.075 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.16 -4.87 16.01 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.108 1.872 . . . . 0.0 111.492 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . 0.646 ' HB2' ' SG ' ' A' ' 436' ' ' CYS . 6.0 mmmm -100.68 -74.46 0.61 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.101 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 3.6 p -94.99 -7.67 39.13 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.163 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 52.2 mtt180 61.57 31.93 18.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.278 0.561 . . . . 0.0 111.479 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 20.7 p -84.96 154.2 60.71 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.102 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.75 93.66 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.32 2.013 . . . . 0.0 112.855 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 14.8 m -82.92 122.55 28.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.583 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.54 155.93 39.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.584 0.231 . . . . 0.0 110.877 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -116.32 157.79 24.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.025 0.44 . . . . 0.0 111.476 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -143.06 138.04 29.65 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -88.74 51.51 3.86 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.139 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -137.88 -56.09 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.102 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.4 p -83.36 -178.97 7.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.083 0.468 . . . . 0.0 110.483 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.479 ' HE3' ' HB2' ' A' ' 450' ' ' MET . 35.8 ttm -135.57 -14.89 1.9 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.295 0.569 . . . . 0.0 110.062 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -88.56 95.18 10.14 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . 0.401 ' CG ' ' HB2' ' A' ' 465' ' ' TRP . 70.7 mmm -100.0 115.96 30.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.476 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.84 144.84 33.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.369 0.604 . . . . 0.0 110.939 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 42.5 t -84.41 108.87 17.46 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.774 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 15.3 p -91.64 88.64 6.81 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.624 0.726 . . . . 0.0 109.351 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -132.06 126.96 35.1 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.413 ' HB3' ' NH2' ' A' ' 456' ' ' ARG . . . -49.6 -31.88 11.59 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -109.29 25.04 19.24 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.178 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 31.8 t -133.56 -81.18 0.47 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.148 0.474 . . . . 0.0 111.215 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.13 65.63 3.0 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -124.27 121.61 35.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.889 0.376 . . . . 0.0 111.692 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.51 157.37 18.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.577 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -166.62 158.99 13.73 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.761 0.315 . . . . 0.0 111.291 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 52.2 t -71.89 134.78 46.25 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.851 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . 0.401 ' HB2' ' CG ' ' A' ' 452' ' ' MET . 14.0 t-105 -69.37 -43.77 72.9 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.005 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 43.1 t -69.85 -63.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 5.6 p -105.74 143.86 33.29 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.359 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -75.22 113.91 13.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.638 0.732 . . . . 0.0 110.58 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.6 p -142.85 178.03 7.93 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.682 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.31 117.88 35.28 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 65.3 m95 63.76 -168.6 0.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.593 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 476' ' ' MET . 7.0 m -109.83 30.93 6.24 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.659 0.742 . . . . 0.0 109.3 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -85.57 -57.61 2.99 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -70.28 -24.73 63.1 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.372 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 478' ' ' ALA . 93.8 m -89.0 -8.82 53.35 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.893 176.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 472' ' ' THR . 25.8 ttt -50.59 -57.85 7.21 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.754 0.659 . . . . 0.0 111.491 -176.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -109.73 12.9 32.52 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.371 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 475' ' ' CYS . . . -88.31 -64.94 1.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.921 0.391 . . . . 0.0 110.585 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . 0.456 ' CG ' ' H ' ' A' ' 480' ' ' TRP . 6.6 p80 -137.74 -65.39 0.52 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.104 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . 0.456 ' H ' ' CG ' ' A' ' 479' ' ' HIS . 21.4 t-105 54.53 31.27 14.57 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.984 0.897 . . . . 0.0 110.114 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -142.05 151.18 42.15 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.351 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.273 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.834 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 352' ' ' LEU . 4.2 t -110.03 175.41 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.598 ' H ' HG12 ' A' ' 351' ' ' VAL . 5.8 mp -137.53 152.37 49.4 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.5 t -56.01 130.64 73.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.74 9.99 1.77 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.99 2.46 . . . . 0.0 113.312 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -98.56 145.56 30.1 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.638 0.256 . . . . 0.0 110.875 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.22 -26.3 30.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.833 2.355 . . . . 0.0 112.789 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.15 -28.34 64.46 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.962 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 86.7 m -95.08 -151.9 0.34 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 120.929 0.395 . . . . 0.0 110.667 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 118.96 19.48 4.37 Favored Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -65.9 -66.14 0.59 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 110.32 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 151.31 130.56 1.69 Allowed Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.164 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.06 109.94 17.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.432 0.634 . . . . 0.0 109.909 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -88.31 106.86 18.51 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.433 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 48.6 t -82.45 105.55 12.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.947 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.49 152.66 95.37 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.468 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.07 -20.53 70.05 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.002 1.801 . . . . 0.0 111.175 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.45 12.09 33.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.758 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 47.4 t -70.73 101.28 2.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.258 0.552 . . . . 0.0 110.243 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . 0.693 ' HD3' ' H ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -91.3 0.61 57.49 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.772 -178.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -162.35 110.36 1.36 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 381' ' ' PHE . 2.7 p -101.09 124.96 55.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.226 0.536 . . . . 0.0 110.348 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.3 m -152.2 147.88 26.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.452 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 29.6 t -69.73 74.99 0.43 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-O 121.563 0.697 . . . . 0.0 109.154 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.52 -20.42 29.68 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.863 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -98.36 13.07 32.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.647 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -142.41 -104.8 0.53 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.158 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 378' ' ' GLY . 20.6 p -97.49 -102.45 0.19 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.233 0.539 . . . . 0.0 110.735 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.462 ' N ' ' SG ' ' A' ' 377' ' ' CYS . . . -171.85 106.55 0.24 Allowed Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -160.21 117.88 2.56 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.95 132.76 38.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 389' ' ' TYR . 30.0 p90 -140.66 176.26 8.94 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.153 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 46.9 t -88.66 165.65 14.63 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 383' ' ' ARG . 11.5 ptt180 -88.55 -30.51 19.25 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.25 0.548 . . . . 0.0 110.127 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.509 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 0.9 OUTLIER -105.79 -11.05 16.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.196 178.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 394' ' ' CYS . 5.6 m -145.29 -179.13 6.44 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -174.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 386' ' ' LEU . 8.0 tp -118.23 22.46 12.15 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.986 177.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -81.27 28.97 0.36 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 71.97 32.48 63.42 Favored Glycine 0 N--CA 1.465 0.576 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.596 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 381' ' ' PHE . 20.8 t80 57.95 73.5 0.47 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.334 0.588 . . . . 0.0 111.061 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.46 ' CD2' ' H ' ' A' ' 390' ' ' HIS . 0.3 OUTLIER -77.13 145.2 37.93 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.092 179.034 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 6.7 tp -77.2 131.01 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.798 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 104.95 -158.98 15.93 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.344 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -87.34 146.66 25.82 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.117 0.484 . . . . 0.0 111.162 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 3.7 m . . . . . 0 C--N 1.314 -0.953 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.168 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.442 -0.86 0 CA-C-O 121.403 0.62 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 23.6 m -86.28 -21.11 27.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.744 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.19 132.58 35.24 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.325 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -99.92 111.39 61.88 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.08 127.39 24.78 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.238 1.959 . . . . 0.0 111.94 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 44.5 t -50.96 138.12 25.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.07 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.61 -2.44 12.44 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.264 1.976 . . . . 0.0 111.476 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 29.4 tptp -109.71 -61.16 1.68 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.413 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 11.8 p -102.69 -3.88 25.9 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 29.5 ttp180 65.19 21.19 12.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.66 0.784 . . . . 0.0 112.33 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.3 p -82.76 140.41 43.82 Favored Pre-proline 0 C--N 1.314 -0.963 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.082 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.4 101.97 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.467 2.111 . . . . 0.0 112.213 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 45.0 m -77.55 123.48 26.66 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.74 114.46 5.04 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.598 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -96.58 105.87 18.03 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.306 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.58 128.29 55.85 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.207 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 66.43 -116.24 8.16 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.371 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -155.81 42.99 0.56 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.945 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 47.7 t -71.67 123.77 23.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.784 0.326 . . . . 0.0 110.254 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.652 ' SD ' ' HA ' ' A' ' 480' ' ' TRP . 43.3 ttm -75.31 -20.43 59.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.781 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -86.02 96.4 9.83 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 21.5 mmt -97.34 113.44 25.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.081 0.467 . . . . 0.0 110.684 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.26 117.44 55.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.648 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 40.7 t -78.92 99.8 6.96 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.545 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 30.8 p -83.7 90.55 7.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.597 0.713 . . . . 0.0 109.35 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.571 ' HD2' ' N ' ' A' ' 457' ' ' ALA . 3.1 tmm_? -130.46 137.54 49.84 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.571 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -63.91 95.66 0.12 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.152 0.501 . . . . 0.0 110.602 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 106.39 24.14 6.93 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.383 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 29.7 t -131.02 -85.06 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.967 0.384 . . . . 0.0 110.51 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.58 35.42 91.91 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -84.92 124.68 31.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.907 0.384 . . . . 0.0 110.529 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.74 133.72 46.03 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.056 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -143.69 147.22 33.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.748 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 52.5 t -70.65 141.9 51.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.089 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 26.9 t-105 -68.31 -45.22 73.57 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.644 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 51.0 t -75.93 -59.47 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.078 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 7.4 p -101.89 99.06 9.22 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -74.14 110.94 8.83 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.448 0.642 . . . . 0.0 109.96 -175.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.77 175.45 13.71 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.544 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -74.71 139.32 43.37 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -52.7 109.9 0.46 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.074 0.464 . . . . 0.0 110.184 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 13.9 p -146.8 -163.46 1.76 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.244 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -74.92 -21.73 59.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.395 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -46.66 -58.64 3.65 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.762 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 2.1 t -123.38 56.75 1.18 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.268 0.556 . . . . 0.0 109.903 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 60.2 ttp -70.12 -27.82 64.89 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -177.66 40.49 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.693 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -72.38 -64.31 0.97 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.093 0.473 . . . . 0.0 110.996 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -126.83 17.06 7.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.832 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . 0.652 ' HA ' ' SD ' ' A' ' 450' ' ' MET . 35.6 t-105 -62.73 -27.08 69.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.316 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -76.23 104.81 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.256 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.041 0 CA-C-O 118.855 -0.969 . . . . 0.0 111.838 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.212 0 N-CA-C 112.322 -0.311 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 352' ' ' LEU . 15.6 t -124.08 176.92 4.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.595 ' H ' HG12 ' A' ' 351' ' ' VAL . 82.8 mt -118.78 151.01 38.83 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . 0.556 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 35.2 t -58.66 142.99 82.76 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.488 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.556 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 56.3 Cg_endo -70.32 -8.94 24.81 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.149 2.566 . . . . 0.0 112.442 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.422 HE21 ' HB2' ' A' ' 355' ' ' GLN . 5.1 mt-30 -94.24 130.7 33.25 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.67 -23.75 63.14 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.264 2.643 . . . . 0.0 113.087 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -83.21 5.87 74.72 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.882 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 26.5 t -119.2 -99.43 0.44 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 58.63 22.05 51.71 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.273 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.663 ' HE1' ' HA3' ' A' ' 376' ' ' GLY . 40.8 mtm -70.75 -58.95 3.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.917 0.389 . . . . 0.0 111.117 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.405 ' HA2' HD23 ' A' ' 352' ' ' LEU . . . 156.45 125.66 0.9 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.25 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.6 mm? -115.35 126.87 54.95 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.076 0.465 . . . . 0.0 110.051 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -84.46 104.41 14.44 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.555 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.09 104.39 16.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.274 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.25 148.24 91.02 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.939 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.93 -47.09 22.61 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 123.774 2.983 . . . . 0.0 114.146 -176.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.59 -7.8 49.14 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.884 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 51.6 t -76.94 128.41 34.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . 0.558 ' HA ' ' HD3' ' A' ' 383' ' ' ARG . 0.0 OUTLIER -114.08 19.18 16.66 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -116.53 140.77 49.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.334 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 383' ' ' ARG . 0.0 OUTLIER -135.88 130.93 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.544 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 27.4 m -153.67 131.46 11.6 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.158 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.502 ' HA ' HD11 ' A' ' 362' ' ' LEU . 4.3 t -80.29 74.66 7.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.327 0.584 . . . . 0.0 109.73 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -81.15 -6.8 59.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.647 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -95.11 -16.89 22.29 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.07 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . 0.663 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -153.88 -117.26 0.64 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.082 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.2 p -90.13 104.13 16.73 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.097 0.559 . . . . 0.0 111.33 -178.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 373' ' ' CYS . . . -69.95 109.9 3.08 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.97 -176.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -127.78 144.33 51.09 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.96 99.84 8.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.186 0.517 . . . . 0.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -127.76 -179.0 4.71 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 7.6 t -86.83 -176.2 5.68 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.558 ' HD3' ' HA ' ' A' ' 369' ' ' ARG . 17.9 ptt180 -94.24 -36.0 12.2 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.469 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.467 HD21 ' CB ' ' A' ' 394' ' ' CYS . 21.7 p-10 -104.7 -28.16 11.37 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.214 0.531 . . . . 0.0 110.759 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.48 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 23.1 p -130.73 -174.24 3.31 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.698 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.416 ' HG ' ' HB3' ' A' ' 354' ' ' PRO . 10.5 mp -113.27 33.63 4.98 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.479 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . 0.48 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 12.8 mm100 -81.17 19.17 0.95 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.979 0.418 . . . . 0.0 112.029 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 71.36 31.46 65.92 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 114.35 0.5 . . . . 0.0 114.35 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 30.9 t80 67.66 110.39 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.045 0.538 . . . . 0.0 111.425 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.458 ' HE2' ' HG ' ' A' ' 394' ' ' CYS . 1.8 p80 -146.65 -53.45 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 16.7 tt -148.74 156.5 8.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.44 -47.73 48.93 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.64 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.51 110.16 21.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.142 0.496 . . . . 0.0 111.394 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.467 ' CB ' HD21 ' A' ' 384' ' ' ASN . 4.7 m . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.309 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.016 0.436 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 50.2 m -124.9 2.52 8.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.067 0.461 . . . . 0.0 110.956 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 444' ' ' GLU . 2.1 p -80.24 143.63 33.56 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.135 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 434' ' ' LYS . 11.5 mmpt? -105.68 131.73 21.5 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.9 126.87 13.71 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.274 1.983 . . . . 0.0 112.449 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 437' ' ' PRO . 36.0 t -63.13 136.61 96.77 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.501 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 12.4 Cg_exo -69.82 -17.0 37.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.479 2.119 . . . . 0.0 111.614 177.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 438' ' ' LYS . 0.5 OUTLIER -96.93 -60.37 1.6 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.3 p -107.67 -3.36 19.28 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 440' ' ' ARG . 15.5 tpp85 68.1 21.13 8.8 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.153 0.501 . . . . 0.0 111.892 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 17.9 p -77.49 152.28 80.97 Favored Pre-proline 0 C--N 1.308 -1.202 0 O-C-N 122.175 -0.328 . . . . 0.0 111.157 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.58 92.57 0.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.28 1.987 . . . . 0.0 111.05 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 25.1 m -93.3 114.01 26.35 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.127 0.489 . . . . 0.0 111.339 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . 0.453 ' HB2' HG22 ' A' ' 433' ' ' THR . 2.5 tm-20 -102.74 121.07 41.7 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -82.71 100.69 10.39 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.225 0.536 . . . . 0.0 111.373 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -89.88 107.23 18.99 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 123.21 129.55 3.51 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -67.84 96.21 0.36 Allowed Glycine 0 C--N 1.322 -0.211 0 C-N-CA 121.465 -0.398 . . . . 0.0 113.142 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 79.9 m -153.08 144.31 23.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 122.591 0.356 . . . . 0.0 110.168 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.703 ' SD ' HG23 ' A' ' 466' ' ' VAL . 46.5 tpp -84.89 -31.29 23.79 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -85.6 96.95 9.82 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -120.26 129.66 54.14 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.766 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.492 HG11 ' HG3' ' A' ' 462' ' ' GLU . 5.7 m -124.18 152.5 29.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.711 -175.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.7 t -83.87 115.51 22.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 7.7 t -98.36 91.67 5.32 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 122.2 1.0 . . . . 0.0 109.942 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -129.81 132.06 46.38 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.47 98.37 0.09 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.898 0.38 . . . . 0.0 110.514 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 117.55 -4.13 17.54 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.945 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 47.7 t -108.67 -86.58 0.51 Allowed 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.713 0.292 . . . . 0.0 110.797 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 62.48 56.28 22.52 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -105.28 129.04 53.72 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.937 0.398 . . . . 0.0 111.045 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.492 ' HG3' HG11 ' A' ' 453' ' ' VAL . 13.5 mp0 -95.85 140.02 31.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.871 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -161.62 167.25 25.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.476 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 3.9 m -86.71 148.8 25.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.047 0.451 . . . . 0.0 110.831 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -68.63 -50.49 50.96 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.612 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . 0.703 HG23 ' SD ' ' A' ' 450' ' ' MET . 94.7 t -70.72 -64.33 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 21.7 p -90.15 133.19 35.04 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.526 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -77.57 110.0 12.01 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 119.539 -0.864 . . . . 0.0 108.806 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.1 p -153.9 178.12 10.27 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.045 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -101.79 149.91 23.69 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . 0.432 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 44.3 t90 -62.43 98.17 0.11 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 474' ' ' ASP . 11.7 t -141.99 -168.73 2.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 120.927 0.394 . . . . 0.0 111.419 -175.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -69.54 -22.09 63.59 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.541 0.736 . . . . 0.0 112.755 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . 0.528 ' H ' HG23 ' A' ' 472' ' ' THR . 26.3 t70 -67.69 -58.54 4.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.906 0.384 . . . . 0.0 111.245 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 84.2 m -91.48 15.85 11.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.653 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 24.3 ptm -51.43 -32.26 26.07 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -150.6 33.51 0.98 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -88.64 -64.78 1.09 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -142.16 67.75 1.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -85.73 -7.83 58.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.548 0.689 . . . . 0.0 109.306 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -144.4 134.62 24.27 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.507 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.363 0 CA-C-O 118.772 -1.015 . . . . 0.0 110.999 -178.411 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 113.627 0.211 . . . . 0.0 113.627 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.47 ' H ' ' HB ' ' A' ' 364' ' ' VAL . 9.4 p -75.61 168.21 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.48 ' HB3' ' HA2' ' A' ' 361' ' ' GLY . 1.0 OUTLIER -141.11 155.41 46.12 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 13.9 t -51.65 130.72 36.44 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.142 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.16 3.36 4.66 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.217 2.611 . . . . 0.0 112.934 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -101.39 122.82 46.74 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.08 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.96 -26.68 83.57 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.055 2.503 . . . . 0.0 113.191 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.24 -13.8 67.9 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.948 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.406 ' SG ' ' HG3' ' A' ' 360' ' ' MET . 42.0 t -92.62 -85.75 0.26 Allowed 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.628 0.252 . . . . 0.0 110.581 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.34 23.5 64.52 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.704 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.474 ' HE1' ' HA3' ' A' ' 376' ' ' GLY . 36.3 mtm -76.01 -48.51 20.73 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.562 -0.376 . . . . 0.0 111.302 -177.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 352' ' ' LEU . . . 109.46 129.51 5.81 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.832 -177.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.66 176.97 4.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.892 0.377 . . . . 0.0 110.751 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 364' ' ' VAL . 1.7 tt -101.8 148.8 24.86 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.534 ' H ' HD23 ' A' ' 363' ' ' LEU . 4.7 p -130.95 8.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.461 ' H ' ' CD2' ' A' ' 363' ' ' LEU . 43.3 mm-40 -57.58 151.18 41.74 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.917 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.86 -22.72 38.89 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.967 2.444 . . . . 0.0 112.475 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.58 -7.26 54.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.471 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.68 99.65 1.04 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -64.15 -42.41 96.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.753 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -156.32 125.3 6.02 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.485 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.8 p -90.32 124.31 42.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.21 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.6 m -150.47 141.99 23.47 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.235 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 16.1 t -74.73 70.96 1.92 Allowed 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.374 0.606 . . . . 0.0 109.891 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -84.71 -6.48 59.36 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.856 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -100.02 -4.8 29.22 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.828 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . 0.474 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -153.5 -65.84 0.01 OUTLIER Glycine 0 C--O 1.234 0.154 0 C-N-CA 119.37 -1.395 . . . . 0.0 113.603 -178.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 4.7 m -100.3 -131.39 0.24 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.202 0.525 . . . . 0.0 109.67 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -170.3 104.75 0.21 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 381' ' ' PHE . 50.6 t80 -162.13 130.49 4.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 32.9 t -97.8 120.65 47.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.409 ' HB3' ' CE2' ' A' ' 379' ' ' TYR . 9.2 p90 -136.3 -175.54 4.03 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.234 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 42.4 t -85.64 168.29 14.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.496 ' HB2' HG23 ' A' ' 364' ' ' VAL . 16.8 ptt180 -97.98 -14.31 20.65 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.748 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.585 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 84.1 m-20 -103.33 -32.42 9.57 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.6 p -134.23 -171.12 2.67 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.873 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.57 28.03 8.7 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.857 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -85.56 11.08 11.4 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.86 29.47 15.58 Favored Glycine 0 C--N 1.319 -0.404 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.838 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 48.4 t80 72.86 135.1 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.518 0.727 . . . . 0.0 112.573 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -165.26 171.54 13.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.593 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.95 146.65 9.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 96.53 -162.48 22.45 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.698 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.64 173.52 7.57 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.959 0.409 . . . . 0.0 110.971 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.2 m . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.926 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--O 1.237 0.424 0 CA-C-O 121.34 0.59 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 445' ' ' ARG . 9.9 m -120.58 0.6 10.49 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.468 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 16.7 p -120.68 148.42 43.96 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.273 0.559 . . . . 0.0 112.106 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -112.64 131.89 22.48 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.36 118.9 5.95 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.083 1.855 . . . . 0.0 112.256 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 43.4 t -56.45 133.81 76.76 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.375 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.539 ' HG2' ' CE1' ' A' ' 461' ' ' PHE . 57.4 Cg_endo -72.24 -9.18 24.02 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.247 1.964 . . . . 0.0 111.445 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 29.3 tptp -98.67 -70.92 0.71 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.147 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.8 p -92.62 -12.53 31.42 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 17.0 tpp180 69.17 29.54 4.63 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.554 0.742 . . . . 0.0 111.528 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 41.4 p -89.35 158.58 45.98 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.978 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -80.85 100.22 1.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.218 1.945 . . . . 0.0 112.367 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 11.4 m -84.59 118.53 24.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.855 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -64.51 121.06 13.52 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 432' ' ' SER . 36.7 ptt180 -93.51 146.67 23.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.569 -176.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -125.49 120.04 29.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.536 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -67.11 124.18 22.54 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.932 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.9 -48.24 0.98 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.318 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 24.9 p -75.18 136.94 41.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.719 0.295 . . . . 0.0 110.591 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 59.8 mtt -97.66 -17.68 19.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.012 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -121.85 96.16 4.95 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.064 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 14.1 ptp -109.08 133.17 53.35 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.44 ' CB ' ' HB3' ' A' ' 462' ' ' GLU . 1.2 m -111.75 150.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.353 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.5 t -86.29 100.42 12.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.0 t -83.39 89.01 6.97 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.321 1.058 . . . . 0.0 109.276 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.53 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -131.22 114.26 14.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.598 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.465 ' HB3' HH21 ' A' ' 456' ' ' ARG . . . -56.52 107.37 0.37 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.33 13.17 19.93 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.123 -0.561 . . . . 0.0 111.843 -177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.53 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 43.8 t -123.64 -73.71 0.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 61.21 57.23 19.42 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . 0.539 ' CE1' ' HG2' ' A' ' 437' ' ' PRO . 50.0 t80 -136.45 129.39 31.05 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.908 0.385 . . . . 0.0 111.277 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.44 ' HB3' ' CB ' ' A' ' 453' ' ' VAL . 0.0 OUTLIER -120.13 155.85 32.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 174.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -140.56 174.78 10.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 48.2 t -76.73 133.91 39.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.36 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -70.13 -56.73 6.11 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.4 -62.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.492 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 13.9 p -103.74 126.37 50.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -73.41 112.03 9.09 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 122.038 0.923 . . . . 0.0 109.549 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.0 p -150.1 177.74 9.61 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.321 -175.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 461' ' ' PHE . 39.2 tt0 -92.89 156.66 16.81 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -51.05 107.75 0.2 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.334 0.588 . . . . 0.0 110.472 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 474' ' ' ASP . 9.0 m -134.3 142.11 47.17 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.39 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 476' ' ' MET . 2.4 tmm_? -62.4 -21.32 65.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.406 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . 0.505 ' H ' HG22 ' A' ' 472' ' ' THR . 33.5 t70 -59.84 -58.79 7.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.762 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 480' ' ' TRP . 97.3 m -63.48 -26.46 68.73 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.594 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . 0.482 ' HB3' ' O ' ' A' ' 473' ' ' ARG . 19.2 ttt -41.76 -46.53 3.87 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.08 0.863 . . . . 0.0 112.997 -177.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -136.89 17.63 3.63 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.19 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -86.81 -56.78 3.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.926 0.363 . . . . 0.0 111.167 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -132.56 10.01 4.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.603 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . 0.472 ' HB2' ' O ' ' A' ' 475' ' ' CYS . 61.1 t-105 -75.05 -41.31 59.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.954 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -73.88 100.79 3.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.119 0.485 . . . . 0.0 111.351 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.059 0 CA-C-O 118.934 -0.926 . . . . 0.0 111.533 179.256 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.984 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.412 HG23 ' CG1' ' A' ' 364' ' ' VAL . 89.2 t -130.13 154.73 40.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 68.7 mt -114.92 148.05 39.18 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 38.6 t -60.75 128.86 89.32 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.02 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.541 ' HG2' ' CD2' ' A' ' 379' ' ' TYR . 43.1 Cg_endo -68.74 1.41 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.927 2.418 . . . . 0.0 112.705 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.445 ' HG3' ' SG ' ' A' ' 377' ' ' CYS . 14.7 mm-40 -73.84 120.63 82.25 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.98 105.66 0.25 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.634 2.223 . . . . 0.0 112.106 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 109.85 -2.99 30.32 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.724 -0.751 . . . . 0.0 113.024 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 52.2 t -81.24 -82.58 0.12 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.921 0.36 . . . . 0.0 110.258 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 57.31 25.36 54.42 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.567 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -59.17 -48.93 79.8 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.7 0.286 . . . . 0.0 111.18 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 122.62 108.96 1.98 Allowed Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.621 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.15 139.46 46.51 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.349 0.595 . . . . 0.0 111.049 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 64.3 tp -92.76 134.67 34.82 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.8 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 364' ' ' VAL . 12.4 p -127.84 100.49 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 122.032 0.92 . . . . 0.0 111.497 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -97.42 143.55 26.37 Favored Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.315 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.29 -31.41 76.58 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.39 2.06 . . . . 0.0 111.87 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -85.22 -16.51 40.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.038 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.8 t -93.05 101.27 13.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.092 0.472 . . . . 0.0 109.853 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . 0.563 ' NH2' ' HA3' ' A' ' 392' ' ' GLY . 17.7 ttt180 -92.31 -11.85 34.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.324 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -96.48 134.63 39.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.115 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.6 126.37 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.072 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 52.6 m -152.91 136.37 15.91 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.29 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.485 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 4.1 t -77.01 64.14 2.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.64 -6.38 40.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.893 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -116.3 9.32 14.47 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.363 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -150.84 -95.78 0.13 Allowed Glycine 0 C--O 1.238 0.351 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.601 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.485 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 6.6 p -135.88 111.89 9.6 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 122.717 0.407 . . . . 0.0 110.23 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.2 108.37 2.43 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.001 -174.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . 0.541 ' CD2' ' HG2' ' A' ' 354' ' ' PRO . 89.8 t80 -120.16 151.33 39.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.455 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 11.0 m -89.03 114.63 27.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.312 0.577 . . . . 0.0 111.957 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -153.17 167.23 29.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.047 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 47.8 t -90.16 172.57 8.71 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -88.42 -23.68 23.25 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.336 0.588 . . . . 0.0 109.758 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.456 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 44.6 t30 -104.36 -37.57 7.17 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.889 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 12.5 p -129.44 -170.61 2.32 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.144 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.69 35.75 4.45 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.303 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . 0.467 ' HA ' ' OE1' ' A' ' 387' ' ' GLN . 12.7 mm-40 -79.91 13.41 2.21 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 80.66 23.76 59.59 Favored Glycine 0 N--CA 1.463 0.444 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.505 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 33.0 t80 68.23 117.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.603 0.761 . . . . 0.0 110.688 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -146.54 -162.49 1.54 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.991 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.577 ' H ' HD13 ' A' ' 391' ' ' ILE . 0.2 OUTLIER -65.84 166.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . 0.563 ' HA3' ' NH2' ' A' ' 369' ' ' ARG . . . -76.54 47.73 2.46 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 121.012 -0.613 . . . . 0.0 114.066 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -141.42 96.66 3.02 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.201 0.524 . . . . 0.0 111.042 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 3.7 m . . . . . 0 C--N 1.302 -1.459 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.254 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 120.93 0.395 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.3 t -120.63 -10.24 9.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.916 0.389 . . . . 0.0 110.472 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 3.0 p -85.91 132.82 34.01 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.519 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 434' ' ' LYS . 0.3 OUTLIER -97.9 148.27 34.24 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.33 134.5 19.12 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.324 2.016 . . . . 0.0 113.156 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 15.5 t -67.44 141.64 95.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.945 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 3.6 Cg_exo -75.77 -13.99 19.68 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.296 1.997 . . . . 0.0 111.976 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -96.76 -64.0 1.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.056 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 1.5 p -109.87 3.45 20.66 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 15.9 ttm180 60.92 25.15 15.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.361 0.665 . . . . 0.0 112.403 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.467 ' H ' ' HB3' ' A' ' 436' ' ' CYS . 2.9 p -82.74 142.34 45.41 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.361 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 21.1 Cg_exo -63.47 105.97 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.377 2.051 . . . . 0.0 112.225 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 17.7 m -78.25 125.73 29.77 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.049 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -92.24 131.25 37.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.569 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -85.2 94.95 9.02 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -109.99 123.86 50.39 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.17 -80.22 0.96 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.933 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.66 13.46 5.63 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.012 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.7 m -81.87 38.29 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.353 . . . . 0.0 110.813 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.532 ' HG2' ' O ' ' A' ' 479' ' ' HIS . 2.1 mpt? 64.11 16.92 10.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.377 0.671 . . . . 0.0 111.499 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -88.6 96.36 10.61 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 6.7 mmt -113.69 82.13 1.63 Allowed 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.43 171.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 2.2 m -126.8 142.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.05 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 52.6 t -96.04 108.15 20.53 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.92 0.39 . . . . 0.0 111.592 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 18.7 p -89.11 90.34 8.34 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.44 ' HG3' HG21 ' A' ' 441' ' ' THR . 4.6 tmt_? -130.2 145.17 51.7 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.724 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.7 94.64 0.31 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 0.0 110.483 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 109.38 24.5 5.89 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.671 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.44 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 50.0 t -126.27 -95.4 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.735 0.303 . . . . 0.0 110.632 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 70.74 46.84 43.8 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.626 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -112.1 130.36 55.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 111.488 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -100.39 137.78 38.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.999 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -139.72 155.6 47.25 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 79.1 m -66.27 130.71 44.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -75.08 -46.44 34.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.268 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 479' ' ' HIS . 21.3 t -69.61 -65.12 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.993 -176.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 10.1 p -95.43 133.98 38.78 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -79.47 109.81 14.19 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.836 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.9 t -156.82 158.1 36.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.858 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -87.0 113.73 23.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.223 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 25.14 81.77 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.963 1.305 . . . . 0.0 113.158 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 14.8 m -117.21 110.13 17.76 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.949 0.404 . . . . 0.0 110.841 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -71.63 -22.46 61.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.49 -49.66 74.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.568 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . 0.403 ' HB2' ' CD2' ' A' ' 479' ' ' HIS . 2.5 p -91.79 -15.24 28.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.387 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . 0.429 ' O ' ' HB3' ' A' ' 480' ' ' TRP . 25.0 ttt -54.75 -45.55 74.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.555 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -71.98 0.86 35.47 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.534 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.91 -60.08 1.84 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 117.164 0.482 . . . . 0.0 112.072 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . 0.532 ' O ' ' HG2' ' A' ' 450' ' ' MET . 17.6 p80 -94.89 -25.61 16.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . 0.429 ' HB3' ' O ' ' A' ' 476' ' ' MET . 31.3 t-105 -65.58 -41.91 92.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.938 0.399 . . . . 0.0 110.948 -176.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.47 95.65 8.56 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.235 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.883 0 CA-C-O 118.854 -0.97 . . . . 0.0 111.831 -178.942 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.95 0 N-CA-C 112.223 -0.351 . . . . 0.0 112.223 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 352' ' ' LEU . 10.4 p -102.63 170.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.449 ' H ' HG22 ' A' ' 351' ' ' VAL . 5.4 mp -139.63 153.27 47.29 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 122.202 -0.311 . . . . 0.0 110.371 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 355' ' ' GLN . 52.5 t -57.48 135.67 81.96 Favored Pre-proline 0 N--CA 1.452 -0.372 0 O-C-N 123.502 0.501 . . . . 0.0 110.058 177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.29 0.09 8.96 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.649 2.233 . . . . 0.0 112.083 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.512 ' HB3' ' SG ' ' A' ' 353' ' ' CYS . 7.6 tp-100 -86.41 122.64 72.0 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.016 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.56 -20.9 70.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.639 2.226 . . . . 0.0 112.169 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . 0.406 ' H ' ' HG3' ' A' ' 355' ' ' GLN . . . -76.89 -17.33 79.94 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.587 177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 66.2 m -100.82 -176.54 3.21 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.062 0.458 . . . . 0.0 110.862 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 156.42 37.8 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.423 ' HB2' ' HE2' ' A' ' 360' ' ' MET . 2.1 mpp? -82.76 -36.11 25.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 0.0 110.407 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.403 ' HA2' ' HG ' ' A' ' 352' ' ' LEU . . . 101.17 121.35 4.79 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.413 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.24 111.65 24.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.451 0.643 . . . . 0.0 110.081 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -83.6 109.17 17.21 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.076 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.56 HG21 ' HB2' ' A' ' 383' ' ' ARG . 2.7 p -85.63 110.5 19.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.48 0.657 . . . . 0.0 111.658 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -97.58 150.85 37.22 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.298 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.64 -22.94 63.13 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.313 2.009 . . . . 0.0 110.995 175.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.52 -35.93 75.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.487 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.7 t -78.39 120.73 23.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.84 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -111.76 -8.85 14.13 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.251 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 108.38 11.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.548 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 381' ' ' PHE . 2.5 t -89.88 120.33 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 CA-C-N 116.366 -0.379 . . . . 0.0 109.98 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 86.2 m -152.24 139.61 19.49 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.52 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 47.8 t -72.54 74.45 1.06 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.372 0.606 . . . . 0.0 110.292 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -85.13 -6.59 59.29 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.278 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -106.66 -11.37 15.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.176 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -117.45 -77.47 0.61 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.407 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 10.8 p -125.19 -102.12 0.37 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.038 0.447 . . . . 0.0 110.925 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -172.47 106.36 0.23 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -160.53 129.63 4.89 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 58.1 t -95.22 110.52 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.447 ' O ' ' HB ' ' A' ' 371' ' ' VAL . 34.3 p90 -127.32 -177.24 3.99 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.141 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 10.9 t -82.2 177.24 8.9 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.214 0.53 . . . . 0.0 110.782 -176.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.56 ' HB2' HG21 ' A' ' 364' ' ' VAL . 38.6 ptt180 -96.34 -27.81 14.78 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.889 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.45 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 6.7 t30 -104.43 -30.85 9.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.987 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.568 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 6.6 p -133.81 -172.96 3.11 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.255 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 352' ' ' LEU . 3.0 mm? -112.67 29.69 7.74 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.121 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . 0.568 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 9.3 mm100 -79.66 15.85 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 77.79 25.16 63.09 Favored Glycine 0 C--O 1.229 -0.209 0 C-N-CA 120.514 -0.851 . . . . 0.0 113.538 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 37.7 t80 72.1 134.52 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.397 0.679 . . . . 0.0 112.252 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -156.59 175.0 14.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.111 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 8.7 tp -93.13 144.95 8.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 102.13 -158.06 18.34 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.907 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -120.95 164.55 16.54 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 1.4 m . . . . . 0 C--N 1.319 -0.752 0 CA-C-O 120.883 0.373 . . . . 0.0 111.631 -174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 31.4 t . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.293 0.568 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 13.4 p -112.87 4.61 16.99 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.982 0.896 . . . . 0.0 108.735 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.6 p -95.09 142.68 27.27 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.002 -177.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.31 136.17 25.94 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.907 177.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.31 128.59 10.57 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.172 1.915 . . . . 0.0 112.238 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 35.6 t -57.98 142.08 80.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.08 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 4.8 Cg_exo -76.4 -6.2 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.441 2.094 . . . . 0.0 111.536 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -108.97 -65.25 1.16 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.395 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.4 p -99.62 -4.75 30.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.787 0.327 . . . . 0.0 111.772 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 0.0 OUTLIER 63.09 23.41 13.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.229 178.282 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 25.4 p -80.03 155.07 75.23 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-O 120.614 0.245 . . . . 0.0 111.062 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.8 107.48 2.48 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.659 2.239 . . . . 0.0 113.529 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 41.7 m -107.1 126.06 51.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.85 144.2 55.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.79 0.328 . . . . 0.0 110.419 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -99.79 169.76 9.02 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.435 0.636 . . . . 0.0 112.326 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.45 162.47 13.44 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.819 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -66.63 -57.4 10.08 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -144.2 42.8 1.02 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.234 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 46.7 t -109.84 135.99 49.86 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -78.89 -10.28 59.76 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -77.38 99.78 5.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.978 0.418 . . . . 0.0 110.919 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . 0.503 ' CG ' ' HE3' ' A' ' 465' ' ' TRP . 27.4 mmt -120.86 95.45 4.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.435 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.474 ' CG1' ' HG3' ' A' ' 462' ' ' GLU . 3.6 m -128.99 144.6 37.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.021 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 7.5 t -73.7 135.25 43.66 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.138 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.9 t -113.34 87.72 2.67 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 122.254 1.026 . . . . 0.0 109.96 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.453 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -132.4 130.44 40.63 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.31 92.57 0.09 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.984 0.421 . . . . 0.0 110.726 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 128.69 -18.91 5.63 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.45 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 45.0 t -93.51 -83.38 0.32 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.665 0.269 . . . . 0.0 110.585 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.01 51.75 32.26 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.669 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -102.39 122.38 44.17 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.861 0.362 . . . . 0.0 111.425 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.474 ' HG3' ' CG1' ' A' ' 453' ' ' VAL . 13.4 mp0 -90.32 140.25 29.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.99 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -143.23 167.36 22.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.252 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 56.6 m -81.44 143.08 32.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.45 0.643 . . . . 0.0 112.168 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . 0.503 ' HE3' ' CG ' ' A' ' 452' ' ' MET . 15.0 t-105 -75.66 -41.3 54.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.237 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.61 -64.56 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.705 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 25.3 p -91.82 177.44 6.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 110.49 15.92 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.658 0.742 . . . . 0.0 110.438 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 15.1 t -157.76 178.16 10.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.443 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.15 135.81 33.52 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . 0.417 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 36.3 t90 -60.45 106.53 0.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.161 0.505 . . . . 0.0 109.768 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.5 p -136.28 -176.86 4.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.707 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -73.45 -24.15 60.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.19 -56.49 14.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.45 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -99.61 16.96 21.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.722 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -56.12 -57.86 10.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.07 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 480' ' ' TRP . . . -135.4 17.85 3.97 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.69 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.52 -28.54 69.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.931 0.396 . . . . 0.0 111.541 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -143.78 -6.59 0.77 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.439 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . 0.401 ' HB3' ' HA2' ' A' ' 477' ' ' GLY . 65.5 t-105 -59.91 99.63 0.07 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.776 -175.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -150.26 127.97 11.66 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.462 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.501 0 CA-C-O 118.696 -1.058 . . . . 0.0 111.066 -179.894 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.519 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 362' ' ' LEU . 10.6 p -98.39 168.09 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.411 ' H ' HG22 ' A' ' 351' ' ' VAL . 2.9 mm? -125.95 145.26 50.36 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 122.011 -0.431 . . . . 0.0 110.686 -176.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 354' ' ' PRO . 50.5 t -63.01 130.71 94.34 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 353' ' ' CYS . 9.5 Cg_exo -70.88 -12.1 30.29 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.829 2.353 . . . . 0.0 113.159 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -82.16 119.75 75.68 Favored Pre-proline 0 C--N 1.317 -0.828 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.21 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.79 129.28 33.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.567 2.178 . . . . 0.0 111.128 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 116.12 -21.97 11.7 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 35.4 m -90.97 -97.0 0.11 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.034 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 53.31 29.72 38.49 Favored Glycine 0 C--O 1.225 -0.466 0 O-C-N 123.404 0.44 . . . . 0.0 112.507 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 25.7 mtm -74.96 -67.19 0.67 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.935 0.398 . . . . 0.0 110.433 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . 0.4 ' HA2' HD13 ' A' ' 352' ' ' LEU . . . 147.14 120.02 1.18 Allowed Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.427 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.421 ' HB2' HG13 ' A' ' 351' ' ' VAL . 4.2 mm? -110.76 116.95 32.17 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.43 122.29 19.36 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.956 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.83 100.28 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.102 0.477 . . . . 0.0 110.863 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -89.4 135.71 30.8 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.236 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.07 -36.45 99.25 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.543 2.162 . . . . 0.0 111.303 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -77.98 -22.38 49.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 41.3 t -75.48 114.45 14.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.222 0.534 . . . . 0.0 110.98 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -114.81 -0.88 13.36 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.502 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -136.35 111.56 9.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.345 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 381' ' ' PHE . 0.8 OUTLIER -105.9 151.31 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.839 -176.69 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.2 m -154.09 143.21 21.25 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.637 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 41.5 t -72.67 71.98 1.02 Allowed 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.486 0.66 . . . . 0.0 109.927 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -85.18 -6.59 59.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.0 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -88.95 -17.74 28.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.852 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -138.07 -88.13 0.19 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.048 -1.073 . . . . 0.0 113.169 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' A' ' 378' ' ' GLY . 25.2 p -99.14 -109.34 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.198 0.523 . . . . 0.0 111.755 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' A' ' 377' ' ' CYS . . . -172.08 108.05 0.27 Allowed Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -160.03 145.7 15.41 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.18 113.45 44.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.492 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . 0.486 ' O ' HG22 ' A' ' 371' ' ' VAL . 13.5 p90 -129.84 -174.68 3.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.144 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 29.3 t -81.2 172.09 14.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -97.42 -19.05 18.71 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.478 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -104.74 -31.74 9.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.296 0.57 . . . . 0.0 110.008 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.562 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 21.1 p -135.72 179.9 6.05 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.237 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.5 mp -108.62 31.49 5.58 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.482 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . 0.509 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 77.9 mm-40 -74.66 4.42 6.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.176 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 82.3 30.36 34.16 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.132 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 31.2 t80 72.17 128.03 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.828 0.451 . . . . 0.0 110.414 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -161.67 178.59 8.88 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.217 0.532 . . . . 0.0 111.756 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 47.4 mt -98.86 150.05 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.801 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 109.87 -164.03 12.39 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.089 -1.053 . . . . 0.0 112.736 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -116.42 149.62 39.14 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.786 0.326 . . . . 0.0 110.714 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.318 -0.77 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.969 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 4.7 m -79.61 -38.82 33.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.007 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.1 174.18 11.82 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.288 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.467 ' HD3' ' HD2' ' A' ' 435' ' ' PRO . 17.2 tppt? -116.6 115.96 39.13 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . 0.467 ' HD2' ' HD3' ' A' ' 434' ' ' LYS . 17.8 Cg_endo -61.28 123.36 12.67 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.925 1.75 . . . . 0.0 111.361 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 44.2 t -58.41 136.52 85.5 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.369 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.05 -3.7 14.11 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.46 2.106 . . . . 0.0 111.621 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -109.72 -68.44 0.92 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.916 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 7.6 p -95.09 -2.71 49.5 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 12.3 tpt180 62.17 23.7 14.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.009 0.524 . . . . 0.0 111.578 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.3 p -84.87 160.65 55.15 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.263 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.67 93.81 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.224 1.949 . . . . 0.0 111.809 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 4.7 m -83.7 126.02 32.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.186 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -104.63 151.74 23.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.504 ' HB3' ' HE1' ' A' ' 452' ' ' MET . 15.2 ptt180 -119.74 156.97 29.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.23 0.538 . . . . 0.0 111.458 -178.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -129.57 145.23 51.5 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.802 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 73.29 -141.6 30.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.208 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.15 72.39 0.25 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.675 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.2 p -123.71 175.71 6.69 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.41 ' HA ' ' HB3' ' A' ' 465' ' ' TRP . 47.4 mtt -97.83 -0.64 44.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.037 0.446 . . . . 0.0 110.328 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -80.03 99.41 7.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.972 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . 0.504 ' HE1' ' HB3' ' A' ' 445' ' ' ARG . 96.5 mmm -112.94 97.36 6.48 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.908 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.4 t -109.42 113.93 45.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.24 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.64 111.16 14.43 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.531 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 11.9 p -93.55 90.78 6.8 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 121.411 0.624 . . . . 0.0 109.514 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.535 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 4.7 tmt_? -132.13 139.36 48.41 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.029 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.35 105.68 0.97 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.889 0.376 . . . . 0.0 110.668 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 101.33 7.14 49.86 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.249 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 53.4 t -104.51 -90.19 0.4 Allowed 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.721 -0.282 . . . . 0.0 110.592 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.29 46.2 80.65 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -113.27 130.18 56.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.908 0.385 . . . . 0.0 110.944 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -98.87 140.61 32.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.025 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 28.1 p-90 -151.35 149.95 29.92 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.413 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 53.4 m -74.24 149.66 40.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.412 0.625 . . . . 0.0 112.012 -178.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . 0.41 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 32.6 t-105 -74.71 -58.74 3.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.939 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.97 -47.29 76.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 8.1 p -104.21 125.25 50.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -75.34 110.6 9.83 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.7 p -153.51 177.85 10.47 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.476 -176.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -102.22 157.24 17.03 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -56.7 108.6 0.51 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.478 0.656 . . . . 0.0 111.189 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 476' ' ' MET . 61.1 p -123.74 175.73 6.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.532 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -85.21 -29.95 24.28 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.685 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -67.54 -28.02 67.45 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.332 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 47.1 m -93.36 -30.28 15.19 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 472' ' ' THR . 1.9 tmt? -51.08 -52.3 44.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.352 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -99.38 20.06 51.34 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.563 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -111.17 -65.63 1.15 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -139.43 16.84 2.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -55.81 -38.62 70.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.253 0.549 . . . . 0.0 110.034 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -120.45 99.33 6.5 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.04 0 CA-C-O 118.434 -1.203 . . . . 0.0 111.803 -179.465 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.118 0 N-CA-C 112.01 -0.436 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 24.4 m -107.91 178.5 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.009 0.433 . . . . 0.0 110.334 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 6.2 mp -134.08 152.37 51.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.567 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.4 t -52.55 134.82 44.25 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.001 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.0 -16.93 48.65 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.116 2.544 . . . . 0.0 113.025 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -87.73 117.94 69.13 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.8 -27.66 84.54 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.017 2.478 . . . . 0.0 112.426 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -72.22 -16.18 76.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.543 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.2 t -86.8 -77.71 0.31 Allowed 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.05 30.4 66.79 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.024 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 9.0 ttm -70.49 -76.72 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.009 0.433 . . . . 0.0 111.174 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 143.48 121.88 1.62 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.064 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.59 130.32 55.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.11 0.481 . . . . 0.0 110.772 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.406 HD13 ' N ' ' A' ' 364' ' ' VAL . 1.7 tm? -95.69 128.89 42.94 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.677 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.406 ' N ' HD13 ' A' ' 363' ' ' LEU . 62.9 t -114.91 103.86 15.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.286 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -84.42 154.44 62.67 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.125 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.6 -9.85 26.8 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.052 1.835 . . . . 0.0 112.335 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -99.57 -14.43 19.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 52.8 t -125.07 136.85 54.06 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.936 0.398 . . . . 0.0 110.774 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.09 10.46 8.14 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.103 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -87.5 91.26 8.67 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.626 0.727 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . 0.518 HG21 ' C ' ' A' ' 382' ' ' CYS . 0.0 OUTLIER -85.0 113.77 24.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.509 178.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 91.4 m -153.19 139.87 18.9 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.245 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.453 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 4.7 t -76.44 67.48 2.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -66.45 -17.8 65.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.374 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -101.91 11.49 38.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -166.08 -126.09 0.81 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.164 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.453 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -83.2 91.08 7.18 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -69.06 108.88 2.64 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.693 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -114.09 143.62 44.48 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.457 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 14.0 m -83.58 102.02 9.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.445 0.64 . . . . 0.0 111.413 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -133.82 172.33 12.93 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . 0.518 ' C ' HG21 ' A' ' 371' ' ' VAL . 10.7 t -95.62 175.98 6.33 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.059 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . 0.452 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 5.7 ptp85 -78.06 -45.26 24.05 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.879 -175.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.596 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 20.3 m120 -105.33 -9.88 17.35 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.984 0.421 . . . . 0.0 111.197 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 26.4 p -140.21 176.07 9.06 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.919 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.81 32.64 5.7 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -72.63 -1.34 15.8 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 96.39 27.33 10.02 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.465 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 46.1 t80 66.42 103.99 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.23 0.612 . . . . 0.0 111.181 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -118.42 162.34 18.48 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.087 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 48.4 mm -91.69 120.93 41.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 132.96 -140.26 11.67 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -132.97 148.93 52.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.815 0.34 . . . . 0.0 110.635 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 1.3 m . . . . . 0 C--N 1.319 -0.722 0 CA-C-O 121.48 0.657 . . . . 0.0 109.905 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.569 HG22 ' H ' ' A' ' 433' ' ' THR . 14.9 p . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.81 0.338 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.1 p -96.47 -11.54 25.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.96 0.41 . . . . 0.0 111.788 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . 0.569 ' H ' HG22 ' A' ' 431' ' ' VAL . 5.1 p -110.4 170.63 7.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.874 0.369 . . . . 0.0 111.005 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 434' ' ' LYS . 33.1 ttmt -131.51 125.43 20.65 Favored Pre-proline 0 N--CA 1.436 -1.135 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.77 136.41 57.57 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.753 2.302 . . . . 0.0 113.156 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 31.2 t -63.36 141.18 97.81 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.761 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 7.1 Cg_exo -73.77 -2.23 11.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.524 2.149 . . . . 0.0 111.78 176.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -117.4 -69.92 0.82 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.578 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 17.7 p -86.33 -10.61 54.1 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.63 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 71.5 mtt85 66.52 21.46 10.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.149 0.579 . . . . 0.0 112.17 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 42.2 p -82.01 149.7 63.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.462 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.28 99.81 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.3 2.0 . . . . 0.0 111.802 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 20.3 m -81.04 125.93 30.8 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.992 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -82.35 134.7 35.26 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.248 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -91.04 143.44 26.7 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.253 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -146.37 160.81 41.56 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.264 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -67.24 148.8 50.49 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.723 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 179.36 -154.75 14.37 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.078 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 450' ' ' MET . 61.1 m -108.45 49.87 0.8 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.924 0.392 . . . . 0.0 110.337 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.719 ' SD ' ' HA ' ' A' ' 480' ' ' TRP . 14.0 ptp 57.92 11.2 1.34 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.874 1.27 . . . . 0.0 112.925 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 480' ' ' TRP . 2.9 t60 -94.48 94.78 8.42 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 49.0 tpp -108.07 128.3 54.56 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.025 0.44 . . . . 0.0 110.776 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 462' ' ' GLU . 3.2 m -129.86 150.34 34.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 456' ' ' ARG . 12.9 t -69.36 111.7 5.42 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.477 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.3 t -83.7 87.43 7.05 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 122.5 1.143 . . . . 0.0 109.452 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.531 ' HB2' ' SG ' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -133.16 128.1 35.29 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 91.75 0.09 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.86 0.362 . . . . 0.0 110.565 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 124.93 -11.51 7.79 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.709 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 23.6 t -98.1 -77.8 0.5 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.49 32.35 83.12 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.942 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . 0.449 ' HB2' ' SG ' ' A' ' 459' ' ' CYS . 29.8 t80 -75.58 120.02 20.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.475 ' HG2' ' CG1' ' A' ' 453' ' ' VAL . 45.0 mt-10 -91.48 138.43 31.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -156.48 160.23 39.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.961 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 44.8 t -69.99 138.05 51.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.427 0.632 . . . . 0.0 112.129 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -75.18 -41.63 57.55 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.614 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 41.9 t -77.06 -64.52 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.844 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.7 p -102.29 96.91 7.27 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -74.93 109.92 8.79 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.67 1.224 . . . . 0.0 112.56 -170.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.2 t -160.18 173.67 15.4 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.551 -1.659 . . . . 0.0 106.736 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.64 111.66 12.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.445 -0.902 . . . . 0.0 108.877 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . 0.457 ' CE3' ' HB3' ' A' ' 474' ' ' ASP . 1.3 m95 -158.24 145.05 17.66 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.752 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 476' ' ' MET . 10.5 p -134.45 -72.03 0.49 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . 0.495 ' NH1' ' HG2' ' A' ' 476' ' ' MET . 29.8 mmm180 -85.13 -29.2 25.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . 0.457 ' HB3' ' CE3' ' A' ' 471' ' ' TRP . 8.0 t70 -66.0 -51.75 55.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.118 0.485 . . . . 0.0 111.051 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.6 t -78.83 -10.7 59.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.824 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . 0.584 ' HA ' ' HB3' ' A' ' 480' ' ' TRP . 47.7 tpp -57.61 -53.09 62.14 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.858 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -84.75 -10.54 78.95 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.325 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -71.12 -62.55 1.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.821 0.344 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -148.0 -12.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.836 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . 0.719 ' HA ' ' SD ' ' A' ' 450' ' ' MET . 2.3 t-105 -54.92 -41.3 70.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.354 0.597 . . . . 0.0 110.321 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -70.88 96.59 1.29 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.17 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.022 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.006 -179.292 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.561 0 CA-C-O 121.012 0.229 . . . . 0.0 112.881 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 352' ' ' LEU . 7.2 p -122.21 177.53 3.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.607 ' H ' HG22 ' A' ' 351' ' ' VAL . 98.4 mt -117.11 149.82 39.7 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 120.791 0.329 . . . . 0.0 110.963 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . 0.557 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 44.9 t -68.09 145.46 97.67 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.823 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' PRO . . . . . 0.557 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 27.6 Cg_endo -63.5 -14.85 44.94 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.812 2.342 . . . . 0.0 112.298 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -86.59 118.84 70.84 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.36 -30.55 91.55 Favored 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 123.159 2.573 . . . . 0.0 113.581 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -82.03 -10.22 84.2 Favored Glycine 0 C--O 1.236 0.247 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.27 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . 0.468 ' SG ' ' HE2' ' A' ' 360' ' ' MET . 47.1 t -74.24 -82.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.692 0.282 . . . . 0.0 110.289 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 60.32 22.12 58.06 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.441 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' MET . . . . . 0.468 ' HE2' ' SG ' ' A' ' 358' ' ' CYS . 34.9 mtm -74.2 -41.44 61.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.184 0.516 . . . . 0.0 110.785 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 106.51 115.02 3.97 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.569 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' LEU . . . . . 0.42 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.5 mm? -99.37 144.91 27.94 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 122.528 0.331 . . . . 0.0 110.601 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.98 118.51 27.58 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 364' ' ' VAL . 9.1 p -122.03 77.71 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 122.023 0.916 . . . . 0.0 112.339 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -97.98 154.5 37.74 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.13 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.81 -14.73 42.47 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.415 2.077 . . . . 0.0 111.331 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -85.46 -2.59 58.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.066 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 46.0 t -110.12 115.47 29.8 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.637 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.4 1.88 26.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.052 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -136.48 96.58 3.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.896 0.379 . . . . 0.0 111.175 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.8 120.38 40.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.423 0.63 . . . . 0.0 110.535 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 97.1 m -152.24 143.92 23.56 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.597 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' CYS . . . . . 0.46 ' HB3' ' HA2' ' A' ' 378' ' ' GLY . 3.7 t -76.51 67.02 2.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.474 0.654 . . . . 0.0 109.688 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -72.14 -6.12 40.4 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.501 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -106.41 -12.89 15.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.066 0.46 . . . . 0.0 110.793 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -144.64 -124.1 1.72 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.921 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' CYS . . . . . 0.453 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -74.53 86.57 2.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.825 0.345 . . . . 0.0 110.553 178.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 373' ' ' CYS . . . -67.77 109.09 2.72 Favored Glycine 0 CA--C 1.495 -1.157 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.574 -172.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -147.85 134.77 20.18 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.3 p -83.64 133.16 29.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -142.03 166.62 24.22 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 11.3 t -79.87 160.13 26.16 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.236 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -92.79 -13.25 29.45 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.537 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -104.82 -30.62 9.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.277 0.56 . . . . 0.0 109.511 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 6.7 p -140.84 -165.88 2.03 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.241 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 65.1 mt -116.96 25.68 10.34 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.019 0.437 . . . . 0.0 110.942 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -75.97 20.36 0.19 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 78.89 16.85 78.32 Favored Glycine 0 N--CA 1.461 0.363 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.201 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 382' ' ' CYS . 0.3 OUTLIER 67.41 114.18 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.751 0.82 . . . . 0.0 111.477 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.409 ' HE2' ' HG ' ' A' ' 394' ' ' CYS . 1.4 p80 -141.06 -53.97 0.48 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.429 -177.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 393' ' ' GLU . 40.8 mt -125.29 146.3 31.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -66.11 -23.75 71.5 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.292 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' GLU . . . . . 0.51 ' H ' HG22 ' A' ' 391' ' ' ILE . 31.6 mt-10 -135.36 134.76 40.11 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.45 0.3 . . . . 0.0 110.414 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' CYS . . . . . 0.409 ' HG ' ' HE2' ' A' ' 390' ' ' HIS . 74.8 m . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 121.04 0.448 . . . . 0.0 111.498 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.109 0.481 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.5 p -92.5 -15.63 26.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.551 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 444' ' ' GLU . 1.1 p -102.49 163.47 12.21 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.807 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' LYS . . . . . 0.451 ' HD3' ' HD2' ' A' ' 435' ' ' PRO . 5.4 tppp? -115.66 118.52 38.94 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' PRO . . . . . 0.451 ' HD2' ' HD3' ' A' ' 434' ' ' LYS . 29.2 Cg_endo -63.58 134.16 43.07 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.249 1.966 . . . . 0.0 112.526 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 35.3 t -61.26 140.33 94.48 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.424 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.48 -11.52 31.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.341 2.027 . . . . 0.0 111.616 177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -102.45 -67.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.752 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 6.2 p -96.98 -1.25 45.97 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 440' ' ' ARG . 65.8 ttt180 61.69 23.73 13.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.284 0.564 . . . . 0.0 111.557 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 17.5 p -79.13 142.22 59.14 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.975 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 11.8 Cg_exo -67.41 102.28 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.295 1.997 . . . . 0.0 111.252 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 17.7 m -106.03 128.05 53.58 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.631 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' GLU . . . . . 0.479 ' HB3' HG22 ' A' ' 433' ' ' THR . 10.2 pt-20 -117.68 171.84 7.76 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 120.904 0.383 . . . . 0.0 110.892 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' ARG . . . . . 0.564 ' HD3' ' CZ2' ' A' ' 465' ' ' TRP . 33.8 ptt-85 -103.5 161.99 13.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.167 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.37 114.31 25.71 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 71.88 -115.89 5.74 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.468 -176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.69 38.82 1.64 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.914 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 61.2 m -71.68 141.94 49.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.824 0.345 . . . . 0.0 111.181 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 65.4 mtt -94.2 -21.36 19.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.875 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -75.33 95.74 3.26 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.155 0.502 . . . . 0.0 110.197 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 48.5 tpp -104.08 96.63 6.79 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.287 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . 0.452 ' HB ' ' HG3' ' A' ' 462' ' ' GLU . 3.8 p -112.97 129.5 68.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.197 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.22 116.84 6.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.376 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 7.9 p -100.81 92.39 5.05 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.495 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' ARG . . . . . 0.449 ' C ' ' H ' ' A' ' 458' ' ' GLY . 0.0 OUTLIER -130.43 148.15 52.21 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -71.28 14.74 0.15 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.097 0.475 . . . . 0.0 111.413 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 456' ' ' ARG . . . -160.61 34.63 0.42 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' CYS . . . . . . . . . . . . . 10.0 t -154.6 -152.09 0.39 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 136.16 74.12 0.07 OUTLIER Glycine 0 C--N 1.279 -2.638 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.762 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -137.48 130.41 30.36 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.628 0.251 . . . . 0.0 111.101 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 453' ' ' VAL . 1.9 mp0 -87.78 127.42 35.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.941 177.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -134.2 161.56 34.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.61 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . 0.43 ' HA ' ' CZ3' ' A' ' 480' ' ' TRP . 8.2 t -68.41 133.39 48.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.264 0.554 . . . . 0.0 111.666 -175.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' TRP . . . . . 0.564 ' CZ2' ' HD3' ' A' ' 445' ' ' ARG . 23.5 t-105 -76.68 -55.35 5.58 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.463 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.68 -56.56 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 28.5 p -101.17 -161.06 0.83 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -131.32 110.11 10.84 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.795 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.6 p -155.5 151.44 27.7 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.646 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.48 156.76 38.95 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -50.02 109.01 0.25 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.309 0.576 . . . . 0.0 110.82 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 2.3 p -133.73 161.63 34.17 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.579 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' ARG . . . . . 0.536 ' HA ' ' HG2' ' A' ' 476' ' ' MET . 64.4 ttt180 -73.07 -22.06 60.67 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.742 178.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.4 -51.75 68.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.375 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 98.7 m -88.11 -23.41 23.69 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' MET . . . . . 0.536 ' HG2' ' HA ' ' A' ' 473' ' ' ARG . 5.4 ptp -49.48 -36.44 22.89 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -174.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -137.95 34.83 2.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.369 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.97 -65.85 1.12 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.809 0.338 . . . . 0.0 111.304 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -127.52 20.3 6.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 111.105 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' TRP . . . . . 0.43 ' CZ3' ' HA ' ' A' ' 464' ' ' CYS . 10.1 t-105 -79.88 -9.48 59.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.604 0.716 . . . . 0.0 109.407 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -104.99 133.42 49.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.77 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.546 -1.141 . . . . 0.0 111.943 -179.46 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 121.02 0.438 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -142.14 80.5 1.71 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.624 0.726 . . . . 0.0 110.082 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -145.06 125.38 13.86 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.289 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.8 p -84.68 120.12 34.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.393 0.616 . . . . 0.0 111.046 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.2 pp -137.58 -176.85 4.55 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.516 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -145.67 147.29 31.83 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.807 0.337 . . . . 0.0 110.196 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -109.02 -174.76 2.59 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.146 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -79.09 127.49 8.03 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.906 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -93.2 -158.42 34.15 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.812 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.537 HG22 ' H ' ' A' ' 352' ' ' LEU . 9.8 p -166.39 174.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.537 ' H ' HG22 ' A' ' 351' ' ' VAL . 6.4 mp -125.85 151.74 46.43 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.1 t -63.26 126.39 89.13 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.4 ' HD3' ' CE2' ' A' ' 381' ' ' PHE . 73.0 Cg_endo -78.87 16.97 1.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.961 2.441 . . . . 0.0 113.623 -176.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 357' ' ' GLY . 32.3 tt0 -86.46 132.99 41.22 Favored Pre-proline 0 C--N 1.314 -0.939 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.21 -20.56 62.59 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.729 2.286 . . . . 0.0 112.656 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' A' ' 355' ' ' GLN . . . -100.25 3.61 56.79 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.685 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 9.5 t -115.35 -147.93 0.42 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.362 0.601 . . . . 0.0 110.422 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.13 23.65 5.14 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.009 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.479 ' HE1' ' HA3' ' A' ' 376' ' ' GLY . 39.7 mtm -61.0 -44.93 96.7 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.975 0.417 . . . . 0.0 110.505 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.39 129.37 3.28 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.145 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.01 127.09 53.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.238 0.542 . . . . 0.0 110.384 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -100.85 114.29 27.99 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.467 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 47.7 t -102.25 119.4 50.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 120.97 0.414 . . . . 0.0 110.703 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 368' ' ' CYS . 8.6 mm-40 -81.07 149.72 67.04 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.032 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.72 -30.0 87.57 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.594 2.196 . . . . 0.0 112.243 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -101.11 15.18 29.57 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.463 0.649 . . . . 0.0 110.812 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 365' ' ' GLU . 51.6 t -104.09 134.63 47.02 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.09 -0.381 . . . . 0.0 110.046 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.49 29.63 5.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 370' ' ' LYS . 1.9 tpmt? -144.47 102.3 3.81 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.781 0.324 . . . . 0.0 110.423 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.48 124.38 51.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.239 0.542 . . . . 0.0 110.845 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.5 m -152.38 141.38 21.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.92 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 3.5 t -76.86 62.03 2.0 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -64.16 -22.7 67.04 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.134 0.492 . . . . 0.0 110.749 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -88.21 -13.3 41.42 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.041 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . 0.479 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -143.11 -124.31 1.86 Allowed Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.297 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -76.42 85.14 3.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.141 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -70.9 109.48 2.86 Favored Glycine 0 N--CA 1.435 -1.404 0 N-CA-C 115.461 0.944 . . . . 0.0 115.461 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -147.12 144.82 29.3 Favored 'General case' 0 N--CA 1.425 -1.678 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' A' ' 389' ' ' TYR . 18.1 t -84.88 136.23 23.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.098 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.426 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 11.7 p90 -146.01 -175.67 4.84 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 19.4 t -94.81 162.56 13.71 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.884 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -86.25 -20.4 28.52 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.038 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.537 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 82.4 m-20 -105.47 -26.47 11.91 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.627 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 4.8 p -141.24 178.84 7.13 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.416 -178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.78 30.76 6.02 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -70.47 -2.74 14.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.312 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 82.94 27.4 41.4 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.537 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.412 ' HB2' HG12 ' A' ' 380' ' ' VAL . 53.1 t80 76.62 138.51 0.06 Allowed 'General case' 0 C--N 1.338 0.108 0 C-N-CA 124.402 1.081 . . . . 0.0 111.514 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -161.04 176.32 11.49 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 50.6 mm -114.6 132.15 64.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 129.66 -156.58 21.44 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.218 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -90.54 159.34 16.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.407 0.622 . . . . 0.0 111.801 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.7 p -174.99 145.61 0.83 Allowed 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.402 177.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 3.2 tt -142.66 130.41 11.26 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.14 154.17 70.6 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.389 2.059 . . . . 0.0 111.507 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.77 21.02 12.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.75 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 97.01 143.96 16.12 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.233 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 25.7 p -78.49 -24.84 45.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.889 0.375 . . . . 0.0 111.257 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 76.57 32.14 51.85 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.859 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -122.65 107.36 11.87 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.74 0.305 . . . . 0.0 110.422 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 35.9 t -99.75 -35.38 9.81 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.295 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -153.82 176.0 12.66 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.477 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 22.2 m -148.88 -88.59 0.08 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.894 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -146.57 136.77 23.63 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 120.736 0.303 . . . . 0.0 111.119 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.2 t -166.56 97.27 0.57 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.807 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 13.2 p -159.72 123.18 3.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.22 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.02 113.31 7.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.144 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -163.56 131.05 3.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.756 0.313 . . . . 0.0 110.563 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 5.5 t -126.18 146.19 50.07 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.298 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 12.8 m -121.05 157.65 24.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.504 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -103.39 145.07 29.91 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.44 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.75 -167.79 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.732 2.288 . . . . 0.0 111.784 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -117.16 -70.77 0.77 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.646 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 60.72 28.04 17.77 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.955 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -123.54 117.71 25.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.86 0.362 . . . . 0.0 111.059 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -146.51 167.46 23.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.25 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.95 155.33 36.97 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.536 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -147.16 133.31 19.35 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.669 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -150.17 165.98 31.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.153 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -169.13 131.3 1.22 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.887 0.375 . . . . 0.0 111.075 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -105.53 130.8 53.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.625 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.91 -69.82 0.28 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -169.95 177.08 4.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.698 0.285 . . . . 0.0 111.133 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 13.4 t -149.13 146.04 27.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.124 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.3 t30 72.02 117.67 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.715 0.806 . . . . 0.0 112.226 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.79 106.48 13.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.064 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 21.2 m -101.26 118.87 37.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 55.8 mt -110.75 138.97 36.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.761 0.315 . . . . 0.0 110.405 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -120.13 160.03 23.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.742 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.19 123.86 72.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.191 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.8 p -117.2 -2.25 11.68 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.19 0.519 . . . . 0.0 111.014 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 20.4 p -105.84 149.14 26.79 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -114.08 141.64 26.64 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.028 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.7 129.9 20.87 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.352 2.034 . . . . 0.0 112.738 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 24.3 t -59.1 140.32 87.34 Favored Pre-proline 0 C--N 1.333 -0.119 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.573 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.31 -16.71 39.64 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.127 1.885 . . . . 0.0 111.962 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -101.3 -66.64 0.9 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.542 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 15.6 p -93.57 -10.8 33.51 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 26.6 mmm180 70.03 20.57 6.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.074 0.55 . . . . 0.0 111.922 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 42.4 p -81.23 149.44 65.85 Favored Pre-proline 0 C--N 1.322 -0.622 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.703 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 16.2 Cg_exo -65.71 103.12 0.55 Allowed 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.605 2.203 . . . . 0.0 112.403 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 89.8 m -95.87 122.69 38.93 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -95.75 156.77 16.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.61 156.4 18.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.724 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.78 107.58 16.26 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.182 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -57.95 124.9 37.71 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.003 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.87 -13.2 13.03 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.224 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 11.0 p -142.56 142.59 32.21 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.713 0.292 . . . . 0.0 110.96 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.686 ' O ' ' HB3' ' A' ' 465' ' ' TRP . 14.2 ptp -99.36 29.83 3.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.31 0.576 . . . . 0.0 111.338 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 480' ' ' TRP . 29.0 p-80 -123.38 138.25 54.64 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.433 174.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 3.7 ptp -143.06 124.54 14.79 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.18 0.514 . . . . 0.0 110.656 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 8.5 m -114.38 150.82 16.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.3 t -85.38 101.41 12.56 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.472 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 21.2 p -87.7 92.51 9.13 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.61 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.7 OUTLIER -128.83 146.98 50.77 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -177.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -50.74 -44.03 58.3 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.324 0.39 . . . . 0.0 111.809 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . 0.405 ' H ' ' HD3' ' A' ' 456' ' ' ARG . . . -124.6 61.37 0.6 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.612 178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 36.4 t -151.34 -90.61 0.06 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.605 0.241 . . . . 0.0 110.519 178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 73.45 38.78 51.95 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.704 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -99.55 118.65 36.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.94 0.4 . . . . 0.0 111.016 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -90.33 139.94 30.17 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.738 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -148.72 154.44 39.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 49.2 t -73.09 139.49 46.52 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.008 0.432 . . . . 0.0 111.191 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . 0.686 ' HB3' ' O ' ' A' ' 450' ' ' MET . 11.3 t-105 -75.02 -51.58 13.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.602 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.45 -51.48 71.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.017 -176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.551 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.8 p -120.87 107.11 12.31 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -74.23 111.35 9.31 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.875 0.845 . . . . 0.0 111.246 -174.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.0 p -154.67 169.92 22.76 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.542 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -78.69 143.46 36.23 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.006 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.8 t90 -61.55 104.29 0.41 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.407 0.622 . . . . 0.0 110.46 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.5 p -134.43 -163.7 1.41 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.114 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 50.6 mmm-85 -80.75 -21.9 40.67 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.972 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.44 -59.27 4.89 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 13.2 t -120.57 83.65 2.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 46.1 ttp -88.2 5.68 40.34 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.752 0.787 . . . . 0.0 109.209 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' A' ' 480' ' ' TRP . . . 118.39 37.9 0.82 Allowed Glycine 0 N--CA 1.428 -1.852 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.83 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -57.34 -39.55 76.13 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.185 0.517 . . . . 0.0 110.743 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -118.59 37.28 4.11 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.061 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . 0.528 ' HB2' ' CA ' ' A' ' 477' ' ' GLY . 20.5 t-105 -82.41 45.45 0.96 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.306 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -146.51 124.78 12.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.103 0.478 . . . . 0.0 111.279 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.223 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.548 179.422 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 120.781 0.324 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -82.19 144.64 30.56 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.65 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -72.73 166.98 21.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.195 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.5 p -150.79 137.16 12.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.601 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.77 147.26 11.68 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.179 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -113.36 104.56 12.43 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -124.62 70.4 1.12 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.986 0.422 . . . . 0.0 110.112 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -89.06 -25.24 29.64 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.706 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -160.5 -162.66 12.7 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.313 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.587 HG22 ' H ' ' A' ' 352' ' ' LEU . 9.3 p -142.92 177.37 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.587 ' H ' HG22 ' A' ' 351' ' ' VAL . 71.0 mt -130.37 145.72 51.84 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.647 0.261 . . . . 0.0 110.9 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.33 132.23 94.35 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.34 -7.93 22.32 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.035 2.49 . . . . 0.0 113.502 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -72.96 124.35 90.62 Favored Pre-proline 0 N--CA 1.447 -0.588 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.746 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.75 -30.78 77.58 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.934 2.423 . . . . 0.0 112.509 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -79.79 -17.19 75.71 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.875 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.514 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 33.8 t -89.03 -96.71 0.1 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.797 0.298 . . . . 0.0 110.679 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.09 19.36 59.12 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 35.7 ttp -65.7 -67.37 0.45 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.994 0.518 . . . . 0.0 111.544 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.452 ' HA2' HD23 ' A' ' 352' ' ' LEU . . . 147.12 122.5 1.36 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.109 -1.043 . . . . 0.0 112.346 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.45 135.85 54.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.954 0.406 . . . . 0.0 110.269 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -97.04 118.97 34.64 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.895 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 56.2 t -88.42 97.5 6.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.0 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.92 141.09 97.43 Favored Pre-proline 0 C--N 1.312 -1.027 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -51.9 -20.49 10.13 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.785 2.323 . . . . 0.0 112.639 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -114.97 24.11 12.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.864 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 45.8 t -71.16 110.87 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.983 0.42 . . . . 0.0 110.491 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -83.92 -39.9 19.23 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.025 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -140.26 108.28 5.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.108 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 12.8 p -83.08 128.47 38.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.386 0.612 . . . . 0.0 110.468 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 86.7 m -153.11 144.56 23.3 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.518 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 1.8 t -76.16 61.99 1.66 Allowed 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -69.96 -8.73 51.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.619 0.723 . . . . 0.0 109.888 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.73 0.17 32.54 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.871 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -155.93 -124.66 0.87 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 0.8 OUTLIER -85.42 98.84 10.81 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.9 111.12 3.74 Favored Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 114.434 0.534 . . . . 0.0 114.434 -172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -141.8 143.6 33.51 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.05 129.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.03 0.443 . . . . 0.0 110.969 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.415 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 20.0 p90 -143.93 -175.84 4.76 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 17.2 t -80.75 168.61 18.62 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.85 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -101.64 -13.86 17.64 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.506 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.58 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 4.3 m-20 -104.23 -26.32 12.55 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 21.1 p -145.5 -164.46 1.95 Allowed 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.384 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.05 27.07 9.5 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.614 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -87.25 32.75 0.69 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 70.37 18.31 75.11 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 121.073 -0.584 . . . . 0.0 114.286 174.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 69.19 121.98 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.632 0.773 . . . . 0.0 110.382 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -145.89 -176.25 5.07 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.4 tt -112.67 153.15 14.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 99.24 -146.76 18.17 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.139 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -102.13 154.01 19.4 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 120.895 0.379 . . . . 0.0 110.99 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 35.0 m -103.1 163.18 12.38 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.537 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.63 ' H ' HD23 ' A' ' 395' ' ' LEU . 2.6 pt? -115.91 146.17 36.37 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.066 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -88.02 162.03 7.32 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.538 2.159 . . . . 0.0 112.119 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -97.54 -47.14 5.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.484 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 139.81 -129.34 4.26 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.342 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 24.2 p -113.98 168.21 10.0 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -134.05 -72.02 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.16 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . 59.53 80.16 0.21 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.22 0.533 . . . . 0.0 111.522 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.4 t -84.32 158.27 21.23 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.037 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -133.62 175.25 9.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.818 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 12.1 t -130.73 147.53 52.41 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.914 0.388 . . . . 0.0 110.467 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -101.96 126.52 48.9 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.9 t -149.08 139.04 22.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.535 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 45.0 t -154.59 158.22 39.42 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 408' ' ' GLU . 0.6 OUTLIER -89.33 -175.79 4.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.038 0.447 . . . . 0.0 111.102 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -132.23 133.82 44.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.942 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 9.0 t -97.68 139.52 33.44 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.752 0.31 . . . . 0.0 110.311 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 22.3 m -107.47 149.82 10.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.135 0.493 . . . . 0.0 111.841 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -110.92 145.6 32.74 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.389 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.22 162.26 41.06 Favored 'Trans proline' 0 C--O 1.238 0.51 0 C-N-CA 122.217 1.945 . . . . 0.0 110.335 174.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -74.61 -83.53 0.05 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.591 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 4.1 ppt_? -172.61 178.97 2.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.67 0.271 . . . . 0.0 111.172 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -107.02 165.54 11.27 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.98 0.419 . . . . 0.0 110.911 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -128.66 127.2 41.72 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.221 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.06 159.53 34.03 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.236 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -107.51 149.44 27.97 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.394 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -136.49 168.05 20.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.269 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -130.56 171.59 12.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.712 0.291 . . . . 0.0 110.599 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.4 117.75 15.53 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.066 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -100.99 -14.1 17.99 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.747 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -86.94 148.42 25.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.814 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 14.0 t -152.29 145.59 24.73 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -63.33 118.62 8.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.198 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.83 134.82 37.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.671 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 11.2 m -73.93 111.59 9.24 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.183 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.6 pp -110.01 173.91 2.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.055 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 430' ' ' LYS . 2.5 mmmp? -122.66 144.3 49.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.456 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.6 p -86.6 109.0 18.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.414 0.626 . . . . 0.0 110.763 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.502 ' O ' ' HE3' ' A' ' 434' ' ' LYS . 18.1 m -82.27 -29.07 31.44 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.237 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . 0.623 ' HA ' ' HB2' ' A' ' 444' ' ' GLU . 5.8 p -78.8 150.2 32.39 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.346 0.593 . . . . 0.0 112.036 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.502 ' HE3' ' O ' ' A' ' 432' ' ' SER . 15.8 mmtp -99.93 147.52 33.57 Favored Pre-proline 0 C--N 1.31 -1.129 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.694 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -82.62 129.78 5.78 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.03 1.82 . . . . 0.0 112.073 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 42.0 t -66.88 140.95 96.45 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.43 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.407 ' HD2' ' SG ' ' A' ' 436' ' ' CYS . 36.6 Cg_endo -67.51 -19.28 48.93 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.25 1.967 . . . . 0.0 112.241 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -103.24 -73.56 0.66 Allowed 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 10.0 p -79.15 -17.71 54.51 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 44.5 mtt180 62.18 33.71 16.64 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.416 0.627 . . . . 0.0 111.126 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.2 p -90.44 154.34 46.4 Favored Pre-proline 0 N--CA 1.434 -1.24 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.782 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.78 110.53 1.7 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.73 2.287 . . . . 0.0 111.787 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 88.7 m -129.49 123.14 30.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.339 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 433' ' ' THR . 4.7 tp10 -134.6 142.67 46.99 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.431 ' NH1' ' HE2' ' A' ' 451' ' ' HIS . 9.7 tpt180 -111.92 106.61 15.36 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.107 0.48 . . . . 0.0 110.677 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -90.81 102.4 15.16 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.997 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 81.61 149.19 6.91 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.306 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 123.87 -165.58 16.66 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.285 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 8.2 t -82.99 -175.77 6.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.031 0.443 . . . . 0.0 110.787 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -80.14 50.04 1.18 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.075 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . 0.431 ' HE2' ' NH1' ' A' ' 445' ' ' ARG . 50.8 p-80 -119.48 139.34 52.24 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.346 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 1.1 mmt -119.78 80.25 1.56 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 36.4 t -94.87 117.51 38.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.257 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 48.0 t -80.86 99.7 8.46 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.46 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 2.1 p -82.2 89.14 6.48 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.611 0.719 . . . . 0.0 109.136 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.587 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 1.4 tmt_? -132.16 135.82 46.64 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.826 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.459 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -65.07 105.73 1.12 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.913 0.387 . . . . 0.0 110.2 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 106.54 -1.02 36.85 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.365 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 47.6 t -110.22 -90.89 0.47 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.34 . . . . 0.0 110.236 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 73.77 28.27 65.38 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.113 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -96.73 131.13 43.73 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.97 0.414 . . . . 0.0 110.083 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -117.27 136.87 52.78 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.117 0.484 . . . . 0.0 111.073 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -131.63 177.7 7.31 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.551 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 60.6 m -81.3 142.04 33.48 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -175.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -76.32 -56.62 4.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.566 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . 0.473 HG23 ' H ' ' A' ' 467' ' ' CYS . 3.2 m -71.26 -60.23 2.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.473 ' H ' HG23 ' A' ' 466' ' ' VAL . 16.1 p -93.73 170.15 9.78 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -111.63 109.22 19.0 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.245 175.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -155.52 160.12 40.28 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.586 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.15 149.89 25.88 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -56.41 108.12 0.45 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.627 0.727 . . . . 0.0 110.942 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 p -132.97 -179.17 5.32 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.121 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -70.21 -22.69 62.9 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.244 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -75.17 -54.07 7.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.186 0.517 . . . . 0.0 110.771 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 480' ' ' TRP . 85.1 m -85.01 8.25 18.47 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.933 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.5 ttt -53.95 -53.47 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.78 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -137.59 -0.47 2.61 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.031 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -58.84 -64.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.463 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -113.56 -4.88 13.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.88 0.372 . . . . 0.0 110.709 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . 0.414 ' HB2' ' O ' ' A' ' 475' ' ' CYS . 35.0 t-105 -68.19 -28.73 67.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.369 -178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -97.45 106.39 18.7 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.525 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 CA-C-O 118.886 -0.952 . . . . 0.0 111.887 -179.58 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.695 0.283 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.27 141.39 55.89 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.782 0.325 . . . . 0.0 110.247 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -88.19 97.22 10.89 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.277 0.561 . . . . 0.0 111.544 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 31.2 t -111.35 97.37 5.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.689 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.61 174.9 11.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.06 -178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . 0.422 HE22 HD11 ' A' ' 363' ' ' LEU . 4.4 pp0? -134.19 151.28 51.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.744 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -115.54 34.05 5.13 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -82.03 113.99 3.75 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.494 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . 0.482 ' HA2' HG12 ' A' ' 364' ' ' VAL . . . -153.57 -174.31 23.69 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.424 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.517 HG22 ' H ' ' A' ' 352' ' ' LEU . 10.5 p -129.63 175.06 11.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.517 ' H ' HG22 ' A' ' 351' ' ' VAL . 6.5 mp -130.79 151.7 50.94 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.796 -0.565 . . . . 0.0 111.865 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . 0.507 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 34.3 t -57.12 141.01 77.47 Favored Pre-proline 0 N--CA 1.45 -0.435 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.398 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.507 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 28.2 Cg_endo -61.75 -10.81 18.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.417 2.745 . . . . 0.0 114.515 -176.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -111.02 136.46 20.8 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.129 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.76 -19.83 30.88 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.053 2.502 . . . . 0.0 112.437 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -70.26 -17.44 74.13 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.253 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 41.1 t -86.55 -82.79 0.2 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.42 -0.39 . . . . 0.0 110.467 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 61.28 27.48 67.67 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.182 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -75.45 -40.09 57.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.653 0.263 . . . . 0.0 111.26 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 97.7 121.37 4.25 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.974 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -111.11 109.93 20.22 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.267 0.556 . . . . 0.0 110.411 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.422 HD11 HE22 ' A' ' 347' ' ' GLN . 1.9 tm? -88.01 112.48 22.65 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.65 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.482 HG12 ' HA2' ' A' ' 350' ' ' GLY . 7.7 p -83.63 104.73 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 121.865 0.84 . . . . 0.0 110.661 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 368' ' ' CYS . 8.6 pt-20 -90.26 159.79 41.22 Favored Pre-proline 0 C--N 1.307 -1.244 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.667 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.81 -20.78 72.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.464 2.109 . . . . 0.0 111.305 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -99.37 3.67 46.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.418 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.53 ' N ' ' HG3' ' A' ' 365' ' ' GLU . 53.5 t -63.38 106.05 0.85 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.802 0.334 . . . . 0.0 111.044 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . 0.685 ' H ' ' NE ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -80.11 -37.92 32.65 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.069 0.462 . . . . 0.0 110.562 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -145.12 143.86 30.6 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.521 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.61 119.95 50.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.294 0.569 . . . . 0.0 110.137 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 50.5 m -152.26 139.69 19.56 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.646 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 12.6 t -77.81 47.47 0.63 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 121.14 0.495 . . . . 0.0 110.266 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.19 -11.9 45.52 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.925 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -96.23 -10.67 27.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.028 0.442 . . . . 0.0 110.739 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -133.42 -79.79 0.15 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.441 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 3.4 m -100.4 -131.28 0.24 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -168.87 104.11 0.2 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 173.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -162.66 145.98 11.22 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 17.8 m -108.28 127.58 64.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -141.39 -177.7 5.27 Favored 'General case' 0 C--O 1.212 -0.87 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.097 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 44.5 t -80.99 159.97 24.72 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.611 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.463 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 29.0 ptt180 -88.41 -15.42 35.53 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.215 0.531 . . . . 0.0 109.628 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.463 ' OD1' ' HG3' ' A' ' 383' ' ' ARG . 4.6 m-20 -106.03 -29.62 9.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.112 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 31.4 p -143.02 -159.66 1.0 Allowed 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.159 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.13 18.48 14.56 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.064 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -76.18 25.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -175.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 72.76 31.34 62.58 Favored Glycine 0 N--CA 1.463 0.485 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.53 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.4 100.49 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.407 0.622 . . . . 0.0 111.252 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -126.61 161.12 28.78 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.223 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 391' ' ' ILE . 1.9 pp -85.29 160.43 3.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.478 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.61 -146.29 25.75 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.88 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -124.11 162.28 23.88 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.739 0.304 . . . . 0.0 110.804 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 3.1 m -85.66 143.19 28.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.066 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 3.9 pp -140.26 153.41 68.85 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.19 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.05 179.12 6.2 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.755 2.303 . . . . 0.0 112.999 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -135.42 123.69 23.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.284 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -172.23 124.82 1.11 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.174 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 4.9 p -136.36 169.95 16.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.564 0.221 . . . . 0.0 110.932 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 143.99 128.72 2.17 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.157 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -158.21 143.79 16.86 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 122.346 0.258 . . . . 0.0 110.452 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.8 t -155.81 133.34 11.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.782 0.325 . . . . 0.0 110.673 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -128.09 153.98 46.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.911 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 63.0 m -153.78 130.23 10.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.834 0.349 . . . . 0.0 111.276 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -127.57 105.03 8.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.986 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 2.5 p -86.38 127.97 34.88 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.776 0.322 . . . . 0.0 111.132 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 9.6 p -137.62 152.61 49.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.029 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -146.2 174.13 11.6 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.276 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -151.31 141.15 21.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.434 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 7.9 p -107.76 154.12 21.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.975 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.43 130.15 74.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -89.63 120.21 69.53 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-O 121.14 0.495 . . . . 0.0 110.732 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.1 132.48 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.715 2.277 . . . . 0.0 111.428 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -127.44 144.17 51.1 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -166.05 109.24 0.78 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.357 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -147.75 118.4 7.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.806 0.336 . . . . 0.0 110.878 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -151.19 106.26 3.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.335 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -96.17 161.25 14.04 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.417 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -154.33 145.38 22.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.18 118.19 2.61 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -131.9 156.4 46.18 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 120.734 0.302 . . . . 0.0 110.918 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -159.27 117.91 2.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.015 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -104.86 -39.34 6.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.48 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 58.41 34.43 23.98 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.026 0.53 . . . . 0.0 111.858 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 23.7 m -67.49 123.71 21.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.678 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -165.63 152.73 10.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.093 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 16.6 m -134.72 171.79 17.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.903 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.6 t -138.61 133.43 32.45 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.695 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 46.4 pt -122.49 -172.3 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.924 0.392 . . . . 0.0 111.181 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -137.06 156.57 48.23 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.37 109.19 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.509 0.671 . . . . 0.0 111.23 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.8 p -96.51 2.09 52.1 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.696 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 8.6 p -117.04 -177.0 3.1 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.135 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -122.83 110.77 31.39 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -63.69 125.84 16.29 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.968 1.778 . . . . 0.0 111.84 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 38.9 t -56.03 139.13 71.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.787 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.39 -1.83 11.82 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.205 1.937 . . . . 0.0 111.729 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . 0.419 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 1.7 tppm? -109.87 -61.25 1.68 Allowed 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.557 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 23.9 p -101.46 -10.94 19.73 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.794 0.331 . . . . 0.0 111.375 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 69.0 mtt180 67.4 28.53 7.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.621 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 25.2 p -85.96 147.95 46.86 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.484 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.64 98.26 0.57 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.494 2.129 . . . . 0.0 112.355 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 16.9 m -85.96 124.34 32.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.027 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.35 131.05 35.08 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.394 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 15.1 ptt-85 -95.7 98.76 10.71 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.271 0.558 . . . . 0.0 111.271 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -107.49 155.3 20.22 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.132 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 80.85 -82.71 1.5 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.241 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 127.65 3.29 6.05 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.168 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 7.0 p -68.56 161.18 28.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.564 0.221 . . . . 0.0 110.426 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.58 ' SD ' ' HA3' ' A' ' 482' ' ' GLY . 67.3 mtt -78.01 -10.29 59.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.143 0.497 . . . . 0.0 110.77 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -96.72 105.6 17.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.46 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 5.9 ptp -147.1 135.88 22.15 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.549 173.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.06 140.74 44.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.159 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 35.0 t -59.54 103.16 0.18 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.993 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 6.3 t -85.61 90.81 8.09 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 122.408 1.099 . . . . 0.0 109.559 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -129.45 138.22 51.31 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.414 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -52.67 -47.12 67.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.809 0.337 . . . . 0.0 111.183 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -104.0 49.43 0.93 Allowed Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.97 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 21.5 t -152.09 -90.33 0.06 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.941 0.371 . . . . 0.0 111.508 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.14 38.16 63.54 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -90.85 118.3 30.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.747 0.308 . . . . 0.0 110.905 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -87.35 122.52 31.21 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.226 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -129.62 156.46 44.18 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 42.4 t -67.34 136.58 55.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.622 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -75.07 -36.96 61.76 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.543 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.19 -64.04 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.873 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.9 p -109.48 155.51 21.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.36 107.8 8.87 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 118.687 -1.205 . . . . 0.0 108.256 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.12 151.77 23.62 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.337 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.33 158.37 24.75 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -48.35 110.56 0.35 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.627 0.727 . . . . 0.0 111.382 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.6 m -138.87 154.7 48.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.639 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 476' ' ' MET . 46.7 mtp180 -61.99 -36.58 81.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -62.05 -32.1 72.58 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.982 -0.287 . . . . 0.0 111.222 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 88.0 m -87.72 -37.21 16.87 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . 0.412 ' HB3' ' HA ' ' A' ' 473' ' ' ARG . 43.9 tpp -50.72 -54.65 21.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.272 -177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -90.56 7.47 81.32 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.169 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -111.13 -64.77 1.24 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -137.62 31.22 2.55 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -91.36 -34.04 15.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.03 0.443 . . . . 0.0 110.873 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -96.28 100.16 11.81 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.002 0.43 . . . . 0.0 110.978 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . 0.58 ' HA3' ' SD ' ' A' ' 450' ' ' MET . . . . . . . . 0 N--CA 1.437 -1.239 0 CA-C-O 118.425 -1.208 . . . . 0.0 112.072 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 120.905 0.384 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.04 -174.54 3.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.715 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -115.98 17.31 15.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 9.0 p 46.58 26.04 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 124.116 0.966 . . . . 0.0 111.739 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 52.2 tp -112.23 116.99 31.32 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.271 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -117.22 -54.25 2.41 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -110.5 124.2 51.36 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.998 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -161.28 31.44 0.34 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -143.92 155.42 26.19 Favored Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.329 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 352' ' ' LEU . 10.0 p -124.81 177.64 4.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.617 ' H ' HG22 ' A' ' 351' ' ' VAL . 85.9 mt -126.77 149.45 49.63 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 122.126 -0.359 . . . . 0.0 111.026 -177.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 355' ' ' GLN . 51.0 t -65.19 138.07 97.13 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.692 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.83 -14.25 40.95 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.924 2.416 . . . . 0.0 112.279 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.495 ' HB2' ' SG ' ' A' ' 353' ' ' CYS . 1.4 mp0 -75.48 123.68 88.66 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-O 120.92 0.39 . . . . 0.0 110.766 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.3 -22.21 46.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.097 2.532 . . . . 0.0 112.959 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -88.64 1.85 84.11 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.697 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.465 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 48.3 t -104.47 -93.56 0.35 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.921 0.391 . . . . 0.0 110.585 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.15 23.51 64.13 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.307 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.422 ' HG3' ' SG ' ' A' ' 358' ' ' CYS . 47.4 mtm -61.74 -72.49 0.12 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.859 0.361 . . . . 0.0 110.844 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.447 ' HA2' HD23 ' A' ' 352' ' ' LEU . . . 145.9 109.92 0.63 Allowed Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.117 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -101.75 109.98 21.87 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 364' ' ' VAL . 3.0 tt -82.91 135.67 34.84 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.017 -177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.509 ' N ' HD23 ' A' ' 363' ' ' LEU . 39.2 t -90.96 86.6 2.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.263 0.554 . . . . 0.0 109.986 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 366' ' ' PRO . 6.9 mm-40 -80.97 139.56 49.71 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.634 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 365' ' ' GLU . 31.2 Cg_exo -60.62 -21.76 70.18 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.514 2.143 . . . . 0.0 111.308 177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -88.58 -7.47 56.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.46 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 7.5 t -107.82 105.0 14.61 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.715 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -93.76 15.18 17.08 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -155.76 144.34 20.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.017 177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.22 120.96 64.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-O 121.434 0.635 . . . . 0.0 110.838 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . 0.483 ' OG1' HG12 ' A' ' 380' ' ' VAL . 62.1 m -147.47 136.96 22.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.916 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 25.6 t -78.2 67.16 3.96 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.171 0.51 . . . . 0.0 109.969 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -85.43 -7.01 59.16 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.381 0.61 . . . . 0.0 109.816 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -90.44 -17.11 27.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.441 -176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -140.17 -78.65 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.49 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 3.2 m -89.03 -127.2 0.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -171.21 104.55 0.2 Allowed Glycine 0 N--CA 1.436 -1.349 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 381' ' ' PHE . 55.1 t80 -163.24 137.43 6.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.484 0.142 . . . . 0.0 111.115 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.483 HG12 ' OG1' ' A' ' 372' ' ' THR . 35.1 m -100.29 128.82 51.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.436 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 7.4 p90 -142.56 -176.68 4.95 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.326 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 31.6 t -86.85 171.71 10.64 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.405 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 16.2 ptt180 -97.33 -16.37 20.31 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.486 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.481 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 4.6 m-20 -105.01 -28.31 11.14 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.753 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 24.5 p -143.21 -170.79 3.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.159 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.9 mp -110.62 24.06 13.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.912 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -75.58 15.58 0.47 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 76.33 29.1 58.8 Favored Glycine 0 N--CA 1.46 0.282 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.579 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 19.1 t80 63.2 101.05 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.335 0.654 . . . . 0.0 110.756 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -127.11 179.75 5.27 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.579 -177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 2.7 pp -110.85 166.21 5.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.106 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.65 -132.19 11.1 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.618 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.33 149.65 49.03 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.781 0.324 . . . . 0.0 110.379 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 6.6 m -88.77 -63.06 1.35 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.698 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.53 126.08 69.9 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.1 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -90.79 -174.16 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.8 2.333 . . . . 0.0 112.197 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -145.8 140.79 27.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -98.41 -173.64 32.52 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.817 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 12.6 t -177.63 -177.06 0.64 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 167.09 167.97 28.58 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -160.16 174.45 14.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 11.0 p -152.13 153.12 33.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.702 0.287 . . . . 0.0 110.961 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -128.92 174.64 9.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.525 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 10.0 t -171.83 133.15 0.73 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.96 0.41 . . . . 0.0 110.994 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -110.34 153.76 24.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 19.3 p -138.56 130.23 27.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.794 0.331 . . . . 0.0 111.176 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 43.3 t -162.96 141.47 8.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -139.59 176.85 8.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.021 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -158.03 176.16 12.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.501 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 14.7 t -154.38 160.3 41.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.617 0.246 . . . . 0.0 110.473 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.98 171.08 2.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.73 0.3 . . . . 0.0 110.626 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -109.15 148.26 37.6 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.011 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.14 148.55 27.5 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.614 2.209 . . . . 0.0 112.174 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -102.47 178.16 4.66 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -140.74 144.69 35.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.995 0.426 . . . . 0.0 111.576 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -155.49 129.07 8.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.009 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -143.54 84.23 1.8 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.193 0.52 . . . . 0.0 110.606 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -92.71 150.46 20.65 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -159.07 124.27 4.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.838 0.352 . . . . 0.0 110.845 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -125.24 144.24 50.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.57 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 30.7 m-90 -116.31 150.4 37.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.769 0.318 . . . . 0.0 110.815 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.85 125.74 41.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.542 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -106.18 -21.38 13.13 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.045 0.45 . . . . 0.0 110.31 178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -61.04 119.85 9.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.827 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 25.6 t -147.92 142.55 26.58 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -82.21 128.68 34.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.933 0.397 . . . . 0.0 110.497 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.72 105.37 7.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.495 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.7 t -102.57 154.81 18.76 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 6.1 tp -82.31 117.54 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-O 121.664 0.745 . . . . 0.0 111.47 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -131.73 121.57 24.43 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.01 127.49 73.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.145 0.497 . . . . 0.0 111.734 -176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.6 m -104.56 -15.07 15.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.573 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.5 p -94.12 138.91 31.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.552 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -108.76 140.24 21.65 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.31 125.29 11.19 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 122.228 1.952 . . . . 0.0 112.708 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 42.0 t -58.13 139.68 83.45 Favored Pre-proline 0 N--CA 1.456 -0.126 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.278 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 4.5 Cg_exo -70.39 -20.91 31.27 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.942 1.762 . . . . 0.0 111.335 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . 0.622 ' HA ' ' HE3' ' A' ' 438' ' ' LYS . 0.1 OUTLIER -96.29 -67.49 0.85 Allowed 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.08 -177.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . 0.532 ' SG ' ' HG3' ' A' ' 456' ' ' ARG . 21.3 p -93.09 -8.33 43.03 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.704 ' O ' ' HD3' ' A' ' 440' ' ' ARG . 1.0 OUTLIER 65.23 23.05 12.21 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.586 0.754 . . . . 0.0 111.435 177.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 39.2 p -82.56 162.74 54.83 Favored Pre-proline 0 C--N 1.31 -1.122 0 O-C-N 121.967 -0.458 . . . . 0.0 110.359 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -79.21 100.7 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.243 1.962 . . . . 0.0 112.53 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 12.1 m -92.42 128.21 38.19 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.193 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -86.55 160.03 19.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.607 0.242 . . . . 0.0 110.97 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.422 ' HD2' ' C ' ' A' ' 445' ' ' ARG . 7.0 tmm_? -118.06 108.69 15.54 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -101.61 141.95 33.69 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.315 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 71.92 -143.52 35.04 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.568 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -139.53 26.64 2.65 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.685 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 8.8 p -87.21 155.76 19.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.853 0.358 . . . . 0.0 111.088 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -82.79 -16.31 48.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.096 0.474 . . . . 0.0 109.932 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -86.38 96.89 10.16 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.199 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 3.7 ptp -117.59 111.07 18.71 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.06 129.15 41.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.177 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 43.0 t -70.39 105.2 2.95 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.645 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 5.1 t -87.01 90.27 8.29 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 122.073 0.939 . . . . 0.0 108.948 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.57 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -130.97 139.18 49.99 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.406 -177.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.65 87.31 0.13 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.872 0.368 . . . . 0.0 110.247 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 110.45 39.69 1.45 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.088 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 461' ' ' PHE . 19.5 t -145.78 -91.9 0.09 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 122.624 -0.339 . . . . 0.0 110.921 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.57 27.19 69.9 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . 0.627 ' HB2' ' SG ' ' A' ' 459' ' ' CYS . 9.8 t80 -72.6 128.2 34.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.06 0.457 . . . . 0.0 110.887 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.53 134.75 49.18 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -150.5 159.12 44.71 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.875 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 76.4 m -70.3 140.99 52.39 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.215 0.531 . . . . 0.0 110.951 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -74.31 -40.22 62.38 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.221 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 23.1 t -85.53 -58.87 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.202 -174.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 6.9 p -91.81 152.87 19.92 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -93.45 110.05 21.62 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.345 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . 0.509 HG21 ' SG ' ' A' ' 475' ' ' CYS . 13.0 t -157.65 178.48 10.22 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.609 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.22 156.89 22.47 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 32.2 p-90 -51.89 117.74 2.94 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.332 0.587 . . . . 0.0 110.362 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 10.8 t -156.99 179.15 9.58 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.53 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -71.5 -23.38 61.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.978 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -62.64 -54.19 43.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.819 0.342 . . . . 0.0 111.3 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . 0.509 ' SG ' HG21 ' A' ' 469' ' ' THR . 70.8 m -98.94 24.56 7.58 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.631 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -61.26 -36.92 81.33 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.896 0.379 . . . . 0.0 111.271 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -167.9 26.15 0.13 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.773 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -78.32 -62.12 1.78 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.195 0.521 . . . . 0.0 110.681 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -110.77 -4.82 15.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.788 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -73.86 86.18 1.73 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.053 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.76 95.64 2.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.653 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.225 0 CA-C-O 118.321 -1.266 . . . . 0.0 111.042 -178.611 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 121.047 0.451 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -155.05 79.13 1.05 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.336 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -86.25 109.0 18.64 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.378 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 52.6 t -118.36 111.09 32.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.395 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.74 106.05 17.01 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -84.26 112.71 20.54 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.607 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -113.67 -168.52 1.36 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.142 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 150.24 -125.47 1.95 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.356 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . 0.437 ' HA2' HG23 ' A' ' 364' ' ' VAL . . . -158.82 -149.76 5.6 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.556 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 352' ' ' LEU . 7.8 p -155.81 175.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.495 ' H ' HG22 ' A' ' 351' ' ' VAL . 6.7 mp -129.14 150.85 50.36 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.784 -0.572 . . . . 0.0 111.337 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 354' ' ' PRO . 43.3 t -63.75 128.33 92.67 Favored Pre-proline 0 N--CA 1.441 -0.892 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.446 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 353' ' ' CYS . 17.8 Cg_exo -67.38 -9.38 25.08 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.19 2.593 . . . . 0.0 113.129 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 358' ' ' CYS . 10.3 tm0? -65.0 122.53 80.06 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.1 -28.6 51.7 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 123.765 2.977 . . . . 0.0 114.964 -174.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -108.19 16.97 35.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.702 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.751 ' SG ' ' HG3' ' A' ' 360' ' ' MET . 12.2 t -106.04 -97.27 0.34 Allowed 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.27 32.38 71.94 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.078 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.751 ' HG3' ' SG ' ' A' ' 358' ' ' CYS . 0.6 OUTLIER -65.86 -32.98 74.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 111.83 107.63 2.94 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.955 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.41 HD22 ' SD ' ' A' ' 360' ' ' MET . 3.9 mm? -99.45 135.46 40.83 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.82 128.68 55.11 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.437 HG23 ' HA2' ' A' ' 350' ' ' GLY . 79.7 t -77.9 91.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-O 121.409 0.623 . . . . 0.0 109.781 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 368' ' ' CYS . 16.2 mm-40 -90.07 148.29 39.11 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.368 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.67 -22.75 74.26 Favored 'Trans proline' 0 CA--C 1.528 0.216 0 C-N-CA 122.478 2.119 . . . . 0.0 111.62 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -99.52 9.85 42.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.419 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 365' ' ' GLU . 37.2 t -89.7 78.95 6.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.445 0.64 . . . . 0.0 109.698 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . 0.478 ' H ' ' HD2' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -72.76 -22.59 60.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.758 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 370' ' ' LYS . 3.7 mmmp? -135.26 113.63 11.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.169 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.84 112.66 23.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.566 0.698 . . . . 0.0 110.041 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 94.9 m -147.44 138.86 23.86 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.92 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.422 ' SG ' ' HA3' ' A' ' 376' ' ' GLY . 21.6 t -74.86 76.8 2.13 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.225 0.536 . . . . 0.0 109.69 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -86.08 -38.7 17.53 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.048 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.53 -18.35 54.86 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.098 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . 0.422 ' HA3' ' SG ' ' A' ' 373' ' ' CYS . . . -101.32 -89.98 2.08 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.925 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.2 p -124.7 -91.52 0.54 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.013 0.435 . . . . 0.0 110.567 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -172.52 107.23 0.25 Allowed Glycine 0 N--CA 1.433 -1.537 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -161.02 131.81 5.31 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.872 0.336 . . . . 0.0 110.308 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.88 124.38 65.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.42 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 6.2 p90 -152.66 179.49 8.56 Favored 'General case' 0 C--O 1.21 -0.999 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.253 -175.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 24.5 t -84.43 167.78 16.12 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -95.4 -16.6 22.19 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.323 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -104.31 -32.8 8.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.872 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 27.8 p -137.59 -166.38 1.93 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.101 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.401 ' HG ' ' HG3' ' A' ' 354' ' ' PRO . 10.9 mp -115.06 27.51 9.35 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.774 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -78.16 16.03 0.83 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 79.18 17.47 76.51 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.609 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 73.45 120.71 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.512 0.725 . . . . 0.0 111.244 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -148.23 -46.81 0.16 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.045 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 19.9 tt -150.3 158.04 5.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -87.91 6.24 83.75 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.767 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -136.03 115.59 12.82 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.136 0.468 . . . . 0.0 111.327 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 59.2 m -129.43 165.76 20.92 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.949 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.47 152.04 87.55 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.526 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.49 176.07 3.02 Favored 'Trans proline' 0 C--O 1.241 0.664 0 C-N-CA 122.673 2.248 . . . . 0.0 112.392 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -76.96 100.76 5.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.466 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -113.81 -59.33 0.39 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.096 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 8.4 m -93.32 91.93 7.44 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 120.954 0.407 . . . . 0.0 110.568 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -136.52 10.56 4.04 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -90.3 141.6 28.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 47.8 m -82.06 92.64 6.85 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.195 0.522 . . . . 0.0 111.191 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -88.07 -36.35 17.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.186 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.5 m -76.58 102.99 6.33 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.541 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -79.23 -43.36 23.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.639 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 14.9 m -74.24 164.24 26.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.19 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 8.9 p -158.24 153.31 25.41 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.723 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -86.18 143.12 28.16 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.203 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -121.79 154.51 36.89 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.531 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 11.9 t -138.43 166.97 22.92 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 32.6 m -81.59 168.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 120.847 0.356 . . . . 0.0 110.268 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -93.83 125.32 53.69 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.32 108.07 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.694 2.263 . . . . 0.0 111.395 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -79.08 177.49 8.76 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.157 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -106.84 124.34 49.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.03 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -80.94 -44.86 17.59 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.23 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . 62.76 100.9 0.03 OUTLIER 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.626 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.25 148.54 32.16 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.419 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -145.22 130.88 18.93 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.048 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -98.41 144.95 27.23 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.772 0.32 . . . . 0.0 110.391 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -123.19 38.29 4.22 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.291 0.567 . . . . 0.0 109.845 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -85.95 122.04 29.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.191 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.79 -13.15 15.62 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 60.76 32.4 20.19 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.455 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 18.7 p -83.73 112.65 20.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.868 0.366 . . . . 0.0 110.323 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -102.92 118.83 37.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.128 -178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.49 154.26 22.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.882 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 8.8 t -86.45 129.07 34.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.084 0.468 . . . . 0.0 110.285 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 429' ' ' ILE . 3.0 mp -77.72 122.51 32.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.661 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -96.53 135.0 39.02 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p -67.21 123.98 21.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.264 0.554 . . . . 0.0 110.689 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.1 m -107.63 -31.22 8.18 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.693 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.2 p -80.12 -178.58 6.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.234 0.54 . . . . 0.0 111.413 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.541 ' HG2' ' CH2' ' A' ' 463' ' ' TRP . 1.6 tpmt? -112.84 108.82 53.27 Favored Pre-proline 0 C--N 1.312 -1.047 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 434' ' ' LYS . 24.9 Cg_endo -63.05 130.69 29.81 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.117 1.878 . . . . 0.0 111.739 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 45.5 t -57.36 134.93 81.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.358 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.36 -7.64 21.47 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.365 2.043 . . . . 0.0 111.746 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -107.59 -63.99 1.25 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.83 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 6.2 p -95.47 -3.11 47.41 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 60.7 26.05 15.82 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 21.4 p -87.22 143.11 34.13 Favored Pre-proline 0 C--N 1.315 -0.935 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.73 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -63.75 104.73 0.48 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.345 2.03 . . . . 0.0 111.449 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 37.9 m -96.4 133.6 40.6 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.939 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.21 163.98 23.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.761 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -120.58 162.43 19.64 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.122 0.487 . . . . 0.0 111.647 -176.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -99.79 162.57 12.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.059 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -63.04 -50.87 59.77 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.854 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -151.3 52.8 0.49 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.351 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 61.6 m -118.91 137.35 53.52 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -90.32 -17.45 27.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.85 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.32 96.95 10.53 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 70.0 mmm -106.51 112.53 25.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 462' ' ' GLU . 21.3 t -115.6 141.37 33.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.996 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 28.8 t -83.03 125.66 31.69 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.06 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 19.9 p -101.54 89.96 3.9 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 121.833 0.825 . . . . 0.0 110.338 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.531 ' HB3' ' HB2' ' A' ' 459' ' ' CYS . 2.7 tmt_? -131.97 135.39 46.54 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.41 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -62.33 97.65 0.1 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.695 0.284 . . . . 0.0 110.954 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 105.06 22.24 8.44 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.581 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 456' ' ' ARG . 51.4 t -114.36 -80.93 0.6 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.429 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 69.72 24.12 76.45 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.25 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -93.91 139.25 31.13 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.421 ' HB3' HG13 ' A' ' 453' ' ' VAL . 7.3 pt-20 -126.55 157.71 38.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.301 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . 0.541 ' CH2' ' HG2' ' A' ' 434' ' ' LYS . 7.4 p-90 -147.4 163.43 36.51 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.12 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 43.9 t -70.49 143.24 51.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.682 -177.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 22.5 t-105 -75.75 -42.09 51.44 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.609 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.79 -48.05 24.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 27.4 p -118.96 143.79 46.83 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.52 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -77.09 111.65 12.91 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.378 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 3.7 p -152.85 174.99 13.39 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.995 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -96.48 152.44 18.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . 0.4 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 35.4 t-105 -54.1 122.9 11.17 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.02 0.438 . . . . 0.0 111.748 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.8 t -160.43 153.62 21.78 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.592 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -66.67 -25.42 66.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.3 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.83 -34.71 69.98 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.472 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.65 -27.59 14.72 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 27.7 ttt -53.81 -44.6 70.34 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.452 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -100.85 20.25 48.73 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.669 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -105.71 -64.94 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.681 -0.306 . . . . 0.0 111.44 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -148.68 28.76 0.85 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.275 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -69.45 -29.86 67.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.176 0.512 . . . . 0.0 109.884 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -92.9 111.67 23.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.445 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.038 0 CA-C-O 118.461 -1.188 . . . . 0.0 112.058 -179.161 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -171.24 134.18 0.89 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -81.07 73.56 8.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.187 0.518 . . . . 0.0 111.4 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.1 p -121.25 98.38 5.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.558 0.694 . . . . 0.0 110.725 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 346' ' ' LEU . 3.7 mm? -105.29 104.78 14.58 Favored 'General case' 0 CA--C 1.483 -1.617 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -154.85 148.52 25.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.711 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -155.43 167.61 29.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.048 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 130.72 -18.12 5.16 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.761 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -173.86 174.23 46.17 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.634 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 362' ' ' LEU . 9.9 p -126.72 167.68 21.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.407 ' H ' HG22 ' A' ' 351' ' ' VAL . 5.8 mp -137.41 152.28 49.45 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.914 0.388 . . . . 0.0 111.716 -177.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 18.5 t -59.41 135.68 88.77 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.698 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.422 ' HG3' ' CD2' ' A' ' 379' ' ' TYR . 42.7 Cg_endo -66.73 -15.57 47.77 Favored 'Trans proline' 0 C--N 1.331 -0.381 0 C-N-CA 122.913 2.409 . . . . 0.0 113.785 -176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -99.0 134.45 21.42 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-O 120.822 0.344 . . . . 0.0 111.788 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.81 -15.65 44.46 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.216 2.611 . . . . 0.0 112.729 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -79.71 16.12 12.25 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.831 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.7 t -126.68 -87.3 0.59 Allowed 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 64.43 21.13 66.32 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.827 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 37.5 ttp -67.59 -43.65 80.0 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.832 0.348 . . . . 0.0 111.172 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 101.72 118.92 4.44 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.007 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.458 ' HB2' HG13 ' A' ' 351' ' ' VAL . 4.0 mm? -112.8 155.62 24.29 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.796 0.332 . . . . 0.0 110.456 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.409 ' HG ' ' N ' ' A' ' 364' ' ' VAL . 26.7 tp -102.61 157.06 17.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.66 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.409 ' N ' ' HG ' ' A' ' 363' ' ' LEU . 48.8 t -121.85 90.88 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 120.954 0.407 . . . . 0.0 110.563 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.33 152.22 96.6 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.41 -30.15 86.63 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.073 1.849 . . . . 0.0 111.139 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.57 15.0 28.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.115 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.35 101.77 3.54 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -111.7 -3.32 15.05 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.545 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 370' ' ' LYS . 5.5 mmpt? -144.95 91.53 2.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.835 177.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 13.2 p -95.78 129.06 46.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.5 0.667 . . . . 0.0 110.513 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.6 m -152.45 145.11 24.23 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.296 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 8.7 t -76.12 45.99 0.38 Allowed 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 121.326 0.584 . . . . 0.0 109.786 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -63.75 -12.38 34.49 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -98.62 -2.64 37.99 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.179 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -143.13 -75.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.101 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.1 m -99.72 -132.64 0.25 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -170.83 103.97 0.2 Allowed Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.422 ' CD2' ' HG3' ' A' ' 354' ' ' PRO . 54.7 t80 -162.14 139.56 8.46 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 26.2 m -95.04 126.11 47.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.438 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 16.7 p90 -138.51 -176.57 4.51 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 16.4 t -82.27 164.05 21.42 Favored 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.706 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -92.28 -18.9 22.75 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.097 0.475 . . . . 0.0 110.352 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.577 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 62.0 t30 -106.57 -29.22 9.78 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.174 0.511 . . . . 0.0 109.927 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 29.3 p -136.39 -165.2 1.68 Allowed 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.739 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 62.8 mt -117.51 25.71 10.23 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.878 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -86.55 30.41 0.72 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 70.26 23.16 77.52 Favored Glycine 0 N--CA 1.467 0.738 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.573 175.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.92 113.03 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.762 0.825 . . . . 0.0 112.14 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -131.91 168.44 17.87 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.841 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.6 tt -80.71 147.87 6.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.273 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 100.02 173.97 30.35 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.445 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -100.44 128.97 46.36 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.803 0.335 . . . . 0.0 110.214 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 1.3 m -83.52 154.73 23.7 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.386 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.9 145.0 31.63 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.582 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -92.51 -160.05 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.908 2.405 . . . . 0.0 111.11 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -79.04 95.76 5.6 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -116.92 64.16 0.36 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.678 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 17.3 p -82.72 149.04 27.52 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.819 0.342 . . . . 0.0 111.021 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -142.31 143.92 13.44 Favored Glycine 0 C--O 1.24 0.488 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -168.38 -178.39 3.55 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.726 0.263 . . . . 0.0 111.024 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 31.6 t 72.99 115.94 0.05 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.044 0.937 . . . . 0.0 112.215 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -147.91 137.29 22.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.162 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 14.1 t -100.48 154.84 18.21 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.009 0.433 . . . . 0.0 111.324 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -131.68 160.63 34.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.763 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 19.5 m -149.01 165.71 30.84 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 120.635 0.255 . . . . 0.0 111.312 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 24.3 p -166.6 150.09 7.07 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.849 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.08 164.5 37.13 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.567 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -149.62 169.2 21.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 33.7 m -156.89 122.31 4.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 21.4 m -112.2 142.49 24.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.886 0.374 . . . . 0.0 110.999 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -100.86 152.93 37.97 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.417 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -84.39 150.26 11.81 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.8 2.334 . . . . 0.0 111.931 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -91.67 157.32 17.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.961 0.41 . . . . 0.0 111.194 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 30.7 mmm-85 -132.17 173.12 11.57 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.19 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.0 116.7 3.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.304 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -127.3 141.22 51.77 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.49 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.24 175.39 10.79 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.053 0.454 . . . . 0.0 111.147 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -156.79 120.09 4.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.452 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -128.56 145.01 51.25 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.848 0.356 . . . . 0.0 111.234 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -148.38 162.39 39.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.658 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -101.56 149.42 24.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.222 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -104.9 13.01 31.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.397 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -65.12 122.61 17.45 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.224 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 5.6 t -165.49 145.57 6.78 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.561 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -152.64 101.14 2.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.188 0.518 . . . . 0.0 110.783 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 32.9 m -111.84 175.84 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.69 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 7.6 t -154.67 125.07 6.88 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.341 0.591 . . . . 0.0 111.074 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.45 ' O ' HD12 ' A' ' 429' ' ' ILE . 2.2 pp -119.37 149.48 21.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -137.18 148.41 46.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.554 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 47.9 t -90.19 104.36 15.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.819 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 22.2 m -91.32 -13.38 32.69 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.844 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 4.0 p -82.92 138.72 33.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.591 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.441 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 1.7 tpmt? -90.91 124.67 61.35 Favored Pre-proline 0 C--N 1.312 -1.044 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 5.8 Cg_exo -73.54 122.71 8.08 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 122.097 1.865 . . . . 0.0 111.764 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 440' ' ' ARG . 35.1 t -53.25 136.66 49.81 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.103 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.85 -14.69 46.42 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 122.712 2.275 . . . . 0.0 112.4 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -106.69 -67.86 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 7.8 p -86.45 -8.5 57.56 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 436' ' ' CYS . 18.7 mmm180 64.14 26.01 13.81 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.643 0.377 . . . . 0.0 111.628 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 29.3 p -87.29 141.82 32.95 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.632 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 11.9 Cg_exo -69.49 104.36 1.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.597 2.198 . . . . 0.0 112.094 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 18.0 m -81.16 119.69 23.91 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.335 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.64 95.44 4.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.362 0.601 . . . . 0.0 109.711 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 445' ' ' ARG . 20.7 mtp180 -137.07 156.58 48.22 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.741 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -88.18 151.39 22.72 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -81.95 59.04 4.9 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.34 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -72.38 -35.61 59.89 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 27.1 p -140.34 175.46 9.58 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.498 ' HA ' ' HB3' ' A' ' 465' ' ' TRP . 1.0 OUTLIER -83.72 0.89 45.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.781 0.324 . . . . 0.0 111.271 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -93.2 100.48 12.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.774 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . 0.416 ' HG2' ' HB2' ' A' ' 465' ' ' TRP . 10.3 mmt -100.1 107.01 18.8 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.345 177.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' A' ' 462' ' ' GLU . 21.7 t -105.73 124.8 61.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.044 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 52.4 t -78.83 99.7 6.85 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.994 0.426 . . . . 0.0 109.954 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 13.0 p -83.49 90.25 7.19 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 121.623 0.725 . . . . 0.0 110.111 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.484 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 4.0 tmm_? -130.76 145.61 52.0 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.462 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -69.61 93.26 0.69 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.769 0.318 . . . . 0.0 110.683 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 111.66 13.22 13.11 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.748 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.484 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 49.6 t -114.12 -88.4 0.56 Allowed 'General case' 0 C--O 1.234 0.259 0 O-C-N 122.788 -0.242 . . . . 0.0 110.566 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.16 27.17 70.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.145 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -88.28 142.91 27.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.918 0.39 . . . . 0.0 110.451 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.474 ' HG2' HG22 ' A' ' 453' ' ' VAL . 51.7 mt-10 -114.85 133.24 56.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.296 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 18.0 p-90 -133.74 164.75 26.54 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.976 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 13.8 t -77.97 136.01 37.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.316 0.579 . . . . 0.0 111.962 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . 0.498 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 21.4 t-105 -77.51 -44.1 29.88 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.274 177.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 22.7 m -78.57 -17.18 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -173.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 18.5 p -145.19 148.99 34.15 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -82.52 108.67 16.1 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.718 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.3 p -155.82 178.1 10.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.246 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.04 157.62 17.39 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 174.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . 0.467 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 45.6 t90 -53.04 104.45 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 109.897 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 p -134.07 152.82 52.01 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.07 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . 0.592 ' HG3' ' SD ' ' A' ' 476' ' ' MET . 14.9 ttm180 -70.12 -23.0 62.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.102 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -67.0 -28.46 68.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.23 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 2.8 t -100.47 -27.34 13.49 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.444 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . 0.592 ' SD ' ' HG3' ' A' ' 473' ' ' ARG . 14.2 ptm -55.74 -29.49 59.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.858 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -111.04 12.1 29.19 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.216 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -100.16 -65.91 0.94 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.805 0.336 . . . . 0.0 110.841 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -146.27 21.42 1.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.662 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -72.87 -11.75 60.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.776 0.798 . . . . 0.0 108.878 176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -119.56 151.82 38.02 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.767 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.476 -1.18 . . . . 0.0 112.131 -179.548 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.824 0.345 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -69.31 99.29 1.16 Allowed 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.109 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -89.21 80.74 6.84 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.328 0.585 . . . . 0.0 109.688 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.88 114.08 30.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.963 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.445 ' H ' HD23 ' A' ' 346' ' ' LEU . 2.5 pt? -138.99 -4.85 1.51 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.933 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -108.57 152.68 24.44 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.409 -177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -93.43 -3.92 52.26 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.441 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 76.91 -124.41 6.99 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.734 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -146.03 142.3 10.44 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.662 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 6.2 p -101.32 166.01 2.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.86 141.5 47.82 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 30.0 t -66.6 118.58 55.54 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.925 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.563 ' CG ' HD11 ' A' ' 386' ' ' LEU . 92.3 Cg_endo -81.9 4.98 6.62 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.518 2.812 . . . . 0.0 112.195 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -87.12 121.2 71.6 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.79 111.9 0.98 Allowed 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.928 2.419 . . . . 0.0 112.816 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 126.39 3.07 6.8 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.343 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.697 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 36.6 t -113.08 -90.22 0.52 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 120.768 0.318 . . . . 0.0 111.089 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 60.55 22.85 59.8 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 43.5 ttp -72.37 -73.1 0.21 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.489 0.316 . . . . 0.0 111.36 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 148.36 121.63 1.2 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.737 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.5 129.11 56.15 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.973 0.416 . . . . 0.0 110.201 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 51.9 tp -86.51 129.82 34.72 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.676 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.22 87.43 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.485 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.61 166.58 44.09 Favored Pre-proline 0 C--N 1.313 -0.989 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.781 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.26 -23.88 64.65 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.236 1.957 . . . . 0.0 111.75 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.24 2.5 42.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.128 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.76 86.84 7.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -104.69 21.7 16.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.1 -177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -156.0 110.89 2.9 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.382 177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.8 128.07 60.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.609 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 48.9 m -152.64 137.24 16.87 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.218 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 377' ' ' CYS . 2.4 t -79.82 61.23 3.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.193 0.52 . . . . 0.0 110.17 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -70.71 -6.39 36.93 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.296 0.57 . . . . 0.0 110.187 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -99.67 -3.83 32.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.519 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -158.67 -115.79 0.44 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.016 -0.611 . . . . 0.0 111.964 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.3 p -86.66 94.89 9.61 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.84 113.77 5.45 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.922 -0.581 . . . . 0.0 114.495 -172.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -150.92 133.76 15.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.9 p -86.79 133.51 29.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 120.828 0.347 . . . . 0.0 110.08 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 389' ' ' TYR . 30.8 p90 -148.38 176.04 10.61 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 29.8 t -85.98 151.7 23.52 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -80.76 -11.59 59.59 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.028 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.466 ' CG ' ' H ' ' A' ' 394' ' ' CYS . 13.5 m-80 -105.47 -37.91 6.64 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.888 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.41 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 27.0 p -140.52 -159.21 0.93 Allowed 'General case' 0 C--O 1.214 -0.794 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.93 -176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.563 HD11 ' CG ' ' A' ' 354' ' ' PRO . 3.9 mm? -116.33 23.6 11.99 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . 0.538 ' HB2' ' CD2' ' A' ' 390' ' ' HIS . 75.2 mm-40 -83.07 28.0 0.53 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -176.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 69.5 25.5 75.44 Favored Glycine 0 N--CA 1.469 0.891 0 C-N-CA 121.478 -0.391 . . . . 0.0 114.05 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 381' ' ' PHE . 13.7 t80 63.31 105.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.409 0.684 . . . . 0.0 110.92 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.547 ' CG ' ' H ' ' A' ' 391' ' ' ILE . 2.3 p80 -132.63 -72.97 0.51 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.529 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.547 ' H ' ' CG ' ' A' ' 390' ' ' HIS . 50.7 mm -88.49 149.4 4.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -57.78 -54.23 38.97 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.81 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -130.72 122.41 27.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.877 0.37 . . . . 0.0 110.661 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.466 ' H ' ' CG ' ' A' ' 384' ' ' ASN . 62.3 m -104.0 -176.69 3.15 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.069 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 79.7 mt -89.07 150.55 45.41 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.106 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.63 -170.06 0.82 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.376 2.051 . . . . 0.0 111.666 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.96 -50.36 72.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.015 0.436 . . . . 0.0 110.378 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 70.21 -96.24 0.54 Allowed Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 14.8 t -124.55 0.99 8.25 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.058 0.456 . . . . 0.0 110.07 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 77.35 33.77 42.91 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.261 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -85.92 94.82 9.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.065 0.46 . . . . 0.0 110.291 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 10.0 t -78.5 89.41 4.46 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.385 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -164.76 110.86 0.98 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.167 -0.924 . . . . 0.0 108.697 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 20.9 p -129.87 145.35 51.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.138 0.494 . . . . 0.0 112.303 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -129.76 152.34 49.36 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 37.9 t -141.41 -48.67 0.4 Allowed 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.71 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 34.4 m -92.44 20.14 6.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.954 -175.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -89.46 96.85 10.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.875 0.369 . . . . 0.0 110.088 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -160.53 126.01 3.91 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.925 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 50.2 m -153.68 96.8 2.04 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.914 0.388 . . . . 0.0 110.489 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 8.4 p -108.02 -6.82 10.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.56 0.695 . . . . 0.0 109.936 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -85.1 149.7 53.47 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.969 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.25 111.99 1.09 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.01 2.473 . . . . 0.0 113.447 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -93.27 112.24 24.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.679 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.77 160.97 43.12 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.431 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -152.91 106.08 3.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.749 0.309 . . . . 0.0 110.617 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -134.79 111.14 9.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.487 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -167.17 133.1 2.16 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.896 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -171.28 140.23 1.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.266 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -135.61 172.25 13.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -157.12 109.49 2.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -129.92 114.03 15.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.662 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -105.65 2.13 27.87 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.4 0.619 . . . . 0.0 110.262 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -92.47 -173.08 3.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.428 -177.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 40.4 t -149.23 153.04 37.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.93 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -81.89 153.03 26.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.47 141.56 15.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.114 0.483 . . . . 0.0 110.63 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 31.4 m -124.78 127.97 48.01 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.754 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 51.1 mt -91.46 -35.13 6.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.178 0.513 . . . . 0.0 110.175 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -84.32 43.76 0.98 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.384 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 12.1 m -76.28 160.13 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.411 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 19.9 m -72.46 -28.64 63.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.873 0.368 . . . . 0.0 110.6 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 11.8 p -78.73 115.33 18.35 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.197 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -92.39 143.89 28.04 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.304 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.58 127.25 15.25 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.461 2.107 . . . . 0.0 111.87 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 30.3 t -57.08 139.29 79.21 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.949 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.2 -15.74 46.92 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.134 1.889 . . . . 0.0 112.055 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -103.2 -60.17 1.6 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.0 p -99.68 -8.04 24.88 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 440' ' ' ARG . 3.1 mpt_? 63.4 24.77 14.3 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 34.3 p -82.95 157.68 65.98 Favored Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.84 103.85 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.121 1.881 . . . . 0.0 111.22 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 26.9 m -77.27 112.47 14.01 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.571 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -80.15 108.93 14.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.975 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -111.25 125.81 54.22 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.176 0.512 . . . . 0.0 110.73 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -141.87 104.05 4.44 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 78.4 52.48 5.15 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -53.03 126.35 33.04 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 115.357 -0.422 . . . . 0.0 112.895 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 13.1 t -93.83 24.57 4.09 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.73 0.3 . . . . 0.0 110.365 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 43.1 ttm 72.82 -40.19 0.47 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.851 0.86 . . . . 0.0 111.271 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -84.32 105.0 14.82 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 87.2 mmm -98.73 120.51 39.29 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.725 0.298 . . . . 0.0 111.169 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.57 128.41 76.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.348 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.5 t -92.73 106.21 18.22 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.994 0.426 . . . . 0.0 110.403 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 24.0 p -87.87 90.77 8.51 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.296 0.57 . . . . 0.0 110.129 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.556 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 2.5 tmm_? -130.74 138.94 50.21 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -62.36 98.43 0.11 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.719 0.295 . . . . 0.0 110.59 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 107.71 9.11 29.25 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.086 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.556 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 45.2 t -113.86 -91.8 0.5 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 122.431 -0.452 . . . . 0.0 110.758 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 71.71 23.95 77.35 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . 0.41 ' CD2' ' HZ3' ' A' ' 471' ' ' TRP . 27.5 t80 -84.2 108.77 17.28 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.158 0.504 . . . . 0.0 110.372 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.479 ' HG3' ' HB3' ' A' ' 471' ' ' TRP . 6.3 pt-20 -97.98 126.24 43.3 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.731 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -128.86 166.44 19.07 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.791 -175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 27.2 t -78.77 144.04 35.54 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.311 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -76.5 -39.21 53.73 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.417 -0.811 . . . . 0.0 112.165 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.71 -8.18 9.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -172.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 17.9 p -148.95 155.87 41.46 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -91.38 107.74 19.41 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 118.904 -1.119 . . . . 0.0 110.104 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 5.0 p -155.6 169.98 23.04 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.223 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -96.14 157.05 16.08 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . 0.479 ' HB3' ' HG3' ' A' ' 462' ' ' GLU . 20.3 p90 -48.92 111.97 0.55 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.595 0.712 . . . . 0.0 111.333 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 5.4 p -134.35 148.9 50.8 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.107 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 473' ' ' ARG . 14.5 mmt180 -74.95 -22.14 58.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.129 0.49 . . . . 0.0 110.055 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.82 -50.51 70.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.913 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 18.7 t -74.68 -30.19 61.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.628 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . 0.552 ' HA ' ' CB ' ' A' ' 480' ' ' TRP . 28.1 ttt -52.76 -38.04 60.42 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.729 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -100.83 13.05 59.33 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.159 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.41 -66.17 1.08 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.818 -0.225 . . . . 0.0 111.346 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -153.79 12.45 0.45 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.892 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . 0.552 ' CB ' ' HA ' ' A' ' 476' ' ' MET . 76.6 t-105 -56.64 -43.24 80.08 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.273 0.559 . . . . 0.0 110.497 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -147.44 89.4 1.78 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.019 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.115 0 CA-C-O 118.573 -1.126 . . . . 0.0 111.449 -178.319 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 120.604 0.24 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -74.6 108.39 7.32 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 120.864 0.364 . . . . 0.0 110.439 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -134.08 135.25 43.13 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.196 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 7.6 p -131.81 125.1 54.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.286 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 346' ' ' LEU . 1.5 pp -154.76 146.46 23.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.009 0.433 . . . . 0.0 111.783 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -156.66 138.44 14.26 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.711 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -118.1 98.98 6.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.162 0.506 . . . . 0.0 110.82 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 177.86 38.72 0.06 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.706 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -100.87 -178.78 29.28 Favored Glycine 0 N--CA 1.433 -1.562 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.113 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.572 HG22 ' H ' ' A' ' 352' ' ' LEU . 5.8 p -122.66 176.19 4.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.572 ' H ' HG22 ' A' ' 351' ' ' VAL . 3.6 mm? -112.88 146.7 38.46 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.3 t -62.49 138.97 96.64 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.23 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.64 -4.21 14.93 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.856 2.371 . . . . 0.0 112.304 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -86.46 124.76 69.27 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.239 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.45 112.99 3.48 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.563 2.176 . . . . 0.0 112.012 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 120.29 -6.39 11.84 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.831 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.456 ' SG ' ' HE2' ' A' ' 360' ' ' MET . 47.5 t -84.5 -79.92 0.21 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.43 20.88 52.77 Favored Glycine 0 C--O 1.228 -0.236 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.648 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.456 ' HE2' ' SG ' ' A' ' 358' ' ' CYS . 34.2 mtm -68.01 -56.95 7.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.012 0.406 . . . . 0.0 111.024 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 124.67 114.16 2.03 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.71 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.3 mm? -98.45 134.77 40.97 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.058 0.456 . . . . 0.0 111.355 -177.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -93.03 124.08 36.75 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.35 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.28 116.97 48.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.975 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -83.31 155.5 66.51 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 175.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -42.91 -51.12 5.67 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.36 2.707 . . . . 0.0 113.656 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -106.86 28.8 7.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.852 0.358 . . . . 0.0 111.85 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 37.1 t -67.31 -52.79 36.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.613 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 13.0 tpp180 67.03 -59.42 0.38 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.672 0.789 . . . . 0.0 111.98 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -72.98 116.73 13.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.44 0.638 . . . . 0.0 111.126 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 381' ' ' PHE . 0.0 OUTLIER -116.79 125.19 73.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.819 176.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 81.6 m -153.07 142.22 21.42 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.279 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.492 ' HA ' HD11 ' A' ' 362' ' ' LEU . 5.2 t -73.22 74.52 1.29 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.34 -18.8 61.73 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.393 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -99.3 -11.04 21.6 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.131 0.491 . . . . 0.0 110.807 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -141.79 -129.6 2.45 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.759 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.41 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.9 OUTLIER -74.98 91.18 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.829 0.452 . . . . 0.0 111.017 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.72 119.23 9.75 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.9 -174.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -142.2 139.82 32.16 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.516 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 14.5 m -83.09 124.65 39.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.204 0.526 . . . . 0.0 111.186 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 371' ' ' VAL . 5.4 p90 -141.36 -176.9 4.89 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.469 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 36.4 t -105.46 169.96 8.16 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.46 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 7.1 ptt180 -87.93 -27.02 22.4 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.285 0.564 . . . . 0.0 109.805 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.46 ' OD1' ' HG3' ' A' ' 383' ' ' ARG . 5.6 m-20 -103.55 -19.73 14.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.431 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' ' 394' ' ' CYS . 1.4 m -138.02 165.86 25.54 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.378 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.3 mp -111.89 34.83 3.98 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -86.97 2.13 50.49 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 100.67 27.75 7.38 Favored Glycine 0 CA--C 1.517 0.174 0 C-N-CA 119.565 -1.303 . . . . 0.0 114.04 175.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 47.2 t80 72.73 121.35 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.291 0.636 . . . . 0.0 111.921 177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -167.92 176.86 5.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.932 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.47 ' O ' HD12 ' A' ' 391' ' ' ILE . 2.4 pp -139.51 148.93 22.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.757 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.95 -33.62 2.63 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.657 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -70.97 -20.26 62.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.567 0.698 . . . . 0.0 111.346 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.546 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 2.7 p -121.21 152.95 38.23 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.977 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.3 158.58 48.29 Favored Pre-proline 0 C--N 1.311 -1.073 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.967 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.87 -167.58 0.51 Allowed 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.643 2.228 . . . . 0.0 111.124 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 397' ' ' GLU . 1.6 mp0 -58.34 132.79 54.68 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.111 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -108.5 144.93 16.34 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.055 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 28.1 m -99.83 -43.0 6.58 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.7 0.286 . . . . 0.0 110.847 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.89 159.75 31.27 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.026 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -148.58 156.17 42.07 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.691 0.246 . . . . 0.0 110.498 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 6.4 t -168.93 139.24 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -138.93 166.74 23.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.8 0.334 . . . . 0.0 111.118 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.6 p -125.36 165.99 17.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.587 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -160.7 120.62 2.76 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.2 t -126.19 136.2 52.54 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.299 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 56.8 m -125.63 122.23 35.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.625 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -124.47 134.15 53.13 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.131 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -156.91 103.54 2.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.009 0.433 . . . . 0.0 111.201 178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 8.6 t -144.2 138.99 28.45 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.374 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 30.7 m -132.61 179.49 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.817 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -107.49 147.65 35.71 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.349 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.69 -175.23 2.62 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.732 2.288 . . . . 0.0 111.524 177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -153.18 142.22 21.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.568 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.77 164.26 22.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.209 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -85.3 177.03 7.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.088 0.471 . . . . 0.0 111.591 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -135.26 166.79 22.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.04 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -79.39 161.74 25.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.99 0.424 . . . . 0.0 111.172 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -141.48 134.33 28.83 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.799 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -122.52 110.54 15.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.003 0.43 . . . . 0.0 111.984 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -129.54 74.23 1.57 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.324 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.56 134.69 27.39 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.966 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -106.54 -43.07 4.83 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.447 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 49.77 55.6 9.15 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.553 0.533 . . . . 0.0 111.586 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.7 p -153.43 147.01 25.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.05 0.452 . . . . 0.0 111.898 -177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -149.79 130.26 13.89 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 40.9 t -101.09 146.27 9.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 0.0 111.429 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.1 t -74.54 166.58 23.3 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.764 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 47.6 pt -106.22 -3.05 9.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.443 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -71.55 145.21 49.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.944 0.402 . . . . 0.0 111.19 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.21 130.93 9.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.647 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 47.9 m -113.55 -0.49 14.37 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.379 0.609 . . . . 0.0 110.541 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 7.4 p -101.97 172.43 6.93 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.696 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -122.1 127.58 25.87 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.367 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.18 122.88 10.75 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.161 1.907 . . . . 0.0 111.77 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.61 ' O ' ' HD3' ' A' ' 440' ' ' ARG . 41.6 t -56.41 137.26 76.01 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.465 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.22 -14.8 41.43 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.212 1.941 . . . . 0.0 111.605 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -99.79 -78.04 0.51 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.667 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.0 p -81.41 -9.37 59.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.61 ' HD3' ' O ' ' A' ' 436' ' ' CYS . 38.4 mmt180 64.98 25.59 12.69 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 122.777 0.431 . . . . 0.0 111.875 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 39.3 p -88.76 151.88 48.18 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.44 102.12 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.525 2.15 . . . . 0.0 111.944 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 51.7 m -94.11 130.23 40.38 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.396 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -74.75 146.32 42.27 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.014 0.435 . . . . 0.0 111.051 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -95.71 162.13 13.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.134 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -117.9 141.77 48.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -97.82 4.12 61.11 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.118 -178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -127.17 -49.23 0.17 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.656 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.7 t -96.16 136.43 36.64 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.856 0.36 . . . . 0.0 110.548 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -87.76 19.81 3.3 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.574 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -104.01 111.97 24.75 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . 0.494 ' HG2' ' HB2' ' A' ' 465' ' ' TRP . 79.2 mmm -99.83 111.83 24.13 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 0.0 110.923 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.84 130.07 60.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.823 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 50.1 t -91.38 130.39 37.24 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 3.4 p -109.62 88.85 2.84 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-O 121.561 0.696 . . . . 0.0 110.084 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.46 135.78 44.74 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.52 95.25 0.32 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.961 0.41 . . . . 0.0 110.086 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 123.94 -9.99 8.44 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.527 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . . . . . . . . . 48.1 t -97.22 -88.34 0.3 Allowed 'General case' 0 C--O 1.239 0.503 0 O-C-N 122.673 -0.31 . . . . 0.0 111.009 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 72.27 31.43 63.69 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.821 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -95.18 142.12 28.0 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.973 0.416 . . . . 0.0 110.514 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.01 135.97 55.09 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.583 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -143.45 165.92 26.21 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.523 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 61.2 m -73.59 144.72 45.89 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 121.312 0.577 . . . . 0.0 112.018 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . 0.494 ' HB2' ' HG2' ' A' ' 452' ' ' MET . 26.1 t-105 -76.7 -51.33 11.67 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.046 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.36 -35.7 63.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 26.3 p -116.74 -161.65 0.81 Allowed 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -142.62 109.55 5.51 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . 0.458 HG21 ' SG ' ' A' ' 475' ' ' CYS . 13.4 t -158.02 177.88 10.83 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.386 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -87.74 150.43 23.6 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -52.74 101.73 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.584 0.707 . . . . 0.0 110.14 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.8 p -130.57 171.9 12.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.621 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -73.93 -21.73 59.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.144 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.96 -52.76 63.63 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.495 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 478' ' ' ALA . 72.5 m -84.0 -18.7 36.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.112 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 24.2 ttt -46.68 -54.13 10.24 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.728 0.643 . . . . 0.0 111.632 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -97.98 17.77 58.22 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.356 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 475' ' ' CYS . . . -110.01 -66.28 1.08 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.695 0.283 . . . . 0.0 111.4 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -144.67 12.64 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -68.09 -28.17 67.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.484 0.659 . . . . 0.0 109.812 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -132.14 105.73 7.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.386 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.144 0 CA-C-O 118.712 -1.049 . . . . 0.0 112.502 -178.173 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.813 0.34 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.8 178.28 4.67 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.461 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -106.34 160.15 15.59 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.451 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.427 HG11 ' ND2' ' A' ' 384' ' ' ASN . 51.0 t -68.45 -54.15 23.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -173.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 346' ' ' LEU . 2.4 pt? -135.44 -174.79 3.73 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.395 0.617 . . . . 0.0 112.117 -175.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -132.79 141.19 48.37 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.067 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -61.11 135.23 57.7 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 123.358 0.411 . . . . 0.0 111.57 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 147.77 -95.45 0.17 Allowed Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.931 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -151.77 162.17 29.56 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.755 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 362' ' ' LEU . 29.6 m -120.58 -178.25 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 C-N-CA 123.339 0.656 . . . . 0.0 109.879 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 22.4 mt -126.6 150.45 48.87 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 54.0 t -57.98 137.37 83.79 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.436 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.02 -17.16 51.0 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.984 2.456 . . . . 0.0 112.299 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 358' ' ' CYS . 34.7 tt0 -72.45 121.29 84.44 Favored Pre-proline 0 N--CA 1.45 -0.444 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.3 -39.46 91.14 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.094 2.53 . . . . 0.0 112.599 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -78.69 -10.75 85.92 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.348 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 355' ' ' GLN . 7.1 t -88.58 -76.65 0.39 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.971 0.415 . . . . 0.0 110.03 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 68.72 27.23 74.0 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.645 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.416 ' HB3' ' HE2' ' A' ' 360' ' ' MET . 35.2 ttp -88.62 153.09 21.39 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . -88.6 115.16 4.37 Favored Glycine 0 C--N 1.284 -2.335 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.534 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.495 ' HB2' HG23 ' A' ' 351' ' ' VAL . 4.5 mm? -94.59 134.22 37.39 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.511 HD13 ' N ' ' A' ' 364' ' ' VAL . 1.1 tm? -92.68 139.63 30.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.511 ' N ' HD13 ' A' ' 363' ' ' LEU . 43.7 t -108.89 91.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 120.851 0.357 . . . . 0.0 110.262 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -71.38 145.92 91.17 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -65.57 -22.47 58.33 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 121.948 1.765 . . . . 0.0 110.341 175.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -108.38 23.05 15.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.066 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 51.5 t -56.51 124.07 16.93 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.461 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -83.19 -48.63 10.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.692 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -148.72 118.19 6.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.633 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 381' ' ' PHE . 2.0 p -84.6 111.8 20.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.483 0.659 . . . . 0.0 109.539 176.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 91.4 m -152.78 144.22 23.33 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.98 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 19.9 t -75.57 69.66 2.33 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.345 0.593 . . . . 0.0 110.064 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -83.8 -6.55 59.45 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.567 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -111.25 5.77 20.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.934 -177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -133.79 -75.87 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.566 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 5.5 p -124.6 -102.72 0.37 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.873 0.368 . . . . 0.0 110.37 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -173.0 106.07 0.22 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 176.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -163.39 123.36 2.19 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.97 129.26 49.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.467 ' O ' HG13 ' A' ' 371' ' ' VAL . 8.1 p90 -140.0 -177.34 4.95 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.887 -176.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 27.9 t -83.44 172.78 12.11 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -100.42 -14.66 18.23 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.639 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.537 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 8.6 t30 -105.21 -26.86 11.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.434 0.635 . . . . 0.0 109.483 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 28.8 p -143.31 -169.84 3.14 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.724 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 11.1 mp -116.47 26.4 9.91 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.561 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -76.56 11.54 1.6 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 86.62 21.07 52.52 Favored Glycine 0 N--CA 1.459 0.205 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.398 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 72.95 120.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.696 0.798 . . . . 0.0 111.631 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -150.6 166.6 29.81 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.791 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 45.8 mt -113.71 143.09 24.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 111.41 23.08 5.86 Favored Glycine 0 CA--C 1.507 -0.445 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.087 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 61.64 -178.88 0.12 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.5 0.72 . . . . 0.0 111.827 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 2.5 m -125.06 -59.18 1.42 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.196 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 395' ' ' LEU . 2.7 pt? -62.89 146.56 95.12 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.941 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.16 176.17 6.03 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.691 2.26 . . . . 0.0 112.143 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -105.93 -49.74 3.33 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.744 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 89.56 176.72 45.72 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.598 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 14.0 t -160.57 158.93 29.93 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -147.49 126.5 2.4 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -123.15 134.62 54.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.882 0.372 . . . . 0.0 111.346 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.4 p -103.82 132.45 50.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.341 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -149.3 130.25 14.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.858 0.361 . . . . 0.0 110.669 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.4 t -159.34 147.25 17.5 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.525 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -140.35 132.79 28.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.818 0.342 . . . . 0.0 110.86 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 9.5 m -134.14 113.79 12.43 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.013 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 73.2 m -111.2 131.44 55.11 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.832 0.348 . . . . 0.0 110.746 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -91.96 156.84 17.16 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.314 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -141.9 134.51 28.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.858 0.361 . . . . 0.0 111.149 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 11.4 p -118.24 159.49 23.26 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.55 161.87 29.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.461 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.94 115.62 56.86 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -98.12 -176.42 0.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.281 2.654 . . . . 0.0 111.564 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -112.36 -178.38 3.4 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.233 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -131.02 -75.11 0.53 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.3 170.82 21.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.616 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -107.75 -171.32 1.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.842 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -89.36 166.12 13.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.458 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -164.21 120.91 1.64 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.899 0.38 . . . . 0.0 111.236 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -131.33 117.31 18.75 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -112.99 157.72 21.16 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.14 0.495 . . . . 0.0 111.64 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -130.7 128.52 41.03 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.06 -71.62 0.45 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.57 -174.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -173.53 -174.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.055 0.455 . . . . 0.0 111.216 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 9.1 m -138.33 149.84 46.02 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.585 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -141.8 107.13 5.0 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.065 0.46 . . . . 0.0 110.665 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.37 87.68 2.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.719 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 6.1 t -101.78 119.23 38.46 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.88 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 39.3 pt -129.63 164.8 31.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.471 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -154.93 114.45 3.71 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.57 113.03 22.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.35 0.595 . . . . 0.0 111.456 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.434 ' O ' ' HD2' ' A' ' 445' ' ' ARG . 3.2 p -115.26 3.63 14.31 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.45 0.643 . . . . 0.0 110.489 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.68 152.14 20.96 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.097 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 434' ' ' LYS . 0.0 OUTLIER -118.93 119.15 32.51 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 10.7 Cg_exo -68.52 126.18 13.8 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 122.006 1.804 . . . . 0.0 112.206 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 438' ' ' LYS . 43.6 t -57.91 131.26 83.08 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.431 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.497 ' HG2' ' CE2' ' A' ' 461' ' ' PHE . 64.6 Cg_endo -74.64 -1.24 10.83 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.322 2.014 . . . . 0.0 111.391 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . 0.572 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 27.7 tptp -102.81 -64.7 1.05 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.971 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 11.0 p -103.59 -3.46 25.17 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 22.0 mmm180 68.58 29.16 5.6 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 34.7 p -90.27 141.38 27.56 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 2.4 Cg_endo -75.63 94.52 0.99 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.916 1.744 . . . . 0.0 111.398 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 30.4 m -89.64 128.21 36.02 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.016 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.62 151.11 44.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.904 0.383 . . . . 0.0 111.338 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.516 ' HD3' ' H ' ' A' ' 445' ' ' ARG . 0.3 OUTLIER -82.57 146.14 29.34 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.574 177.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -117.43 89.45 3.12 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.88 0.371 . . . . 0.0 110.955 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 60.03 -134.88 50.68 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.623 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -112.99 18.24 21.79 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.681 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 43.3 t -63.95 129.46 40.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.418 ' HA ' ' HB3' ' A' ' 465' ' ' TRP . 60.6 mtt -75.99 -25.68 56.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.977 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -79.22 96.2 5.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 40.6 mmm -118.43 109.68 16.53 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.68 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.413 ' CG1' ' HG2' ' A' ' 462' ' ' GLU . 4.0 m -121.66 150.87 24.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 120.952 0.406 . . . . 0.0 110.275 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 456' ' ' ARG . 42.8 t -83.68 100.65 11.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.499 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 5.9 p -81.45 92.15 6.42 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -128.9 139.64 52.04 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -177.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -45.71 -45.57 14.38 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.486 0.491 . . . . 0.0 112.231 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -122.56 59.34 0.59 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.749 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 45.4 t -146.38 -83.54 0.13 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.83 0.315 . . . . 0.0 110.793 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.88 49.52 41.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.375 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . 0.497 ' CE2' ' HG2' ' A' ' 437' ' ' PRO . 65.1 t80 -99.8 120.53 39.88 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.825 0.345 . . . . 0.0 111.097 -177.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.413 ' HG2' ' CG1' ' A' ' 453' ' ' VAL . 41.1 mt-10 -94.22 134.17 36.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.842 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -144.29 161.28 39.33 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.889 0.376 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . 0.792 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 19.8 m -76.61 137.35 39.43 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.313 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 15.9 t-105 -68.45 -45.55 72.19 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.689 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.39 -63.92 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.237 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.792 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 17.1 p -98.79 126.34 44.39 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.55 109.37 7.97 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.579 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.5 156.21 36.28 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.046 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -85.97 135.84 33.5 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -55.76 106.97 0.29 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.2 p -140.52 -164.96 1.83 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.589 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -73.58 -29.31 62.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 109.817 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -72.06 -58.45 3.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.158 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 34.3 m -97.54 70.05 2.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.497 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.58 4.15 53.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.46 0.648 . . . . 0.0 109.453 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' A' ' 480' ' ' TRP . . . 121.38 12.68 5.58 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.271 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -61.93 -19.42 62.71 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -121.91 9.46 10.02 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.178 0.513 . . . . 0.0 109.911 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . 0.407 ' HB2' ' HA2' ' A' ' 477' ' ' GLY . 9.3 t-105 -86.43 86.24 7.33 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.166 -175.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -149.9 121.19 7.84 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.385 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.101 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.227 179.09 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -129.98 139.75 51.01 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.006 0.432 . . . . 0.0 110.984 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -129.47 94.93 3.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.357 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.554 HG13 ' H ' ' A' ' 346' ' ' LEU . 3.5 p -59.6 -60.8 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.28 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.554 ' H ' HG13 ' A' ' 345' ' ' VAL . 0.6 OUTLIER 174.16 129.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.487 0.492 . . . . 0.0 110.64 176.529 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . 0.438 ' N ' HD13 ' A' ' 346' ' ' LEU . 28.0 tt0 -165.91 116.08 1.01 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -160.9 161.92 31.92 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.688 0.28 . . . . 0.0 110.926 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -82.74 61.61 4.73 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.599 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -98.03 -149.49 25.12 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.434 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.01 165.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.74 148.26 33.87 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 122.207 -0.308 . . . . 0.0 110.965 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 34.2 t -68.53 122.04 83.09 Favored Pre-proline 0 N--CA 1.442 -0.869 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.499 ' CG ' HD11 ' A' ' 386' ' ' LEU . 92.4 Cg_endo -79.5 0.03 10.34 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.936 2.424 . . . . 0.0 112.748 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 356' ' ' PRO . 8.5 tt0 -81.06 120.2 78.04 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 355' ' ' GLN . 39.1 Cg_exo -58.0 106.52 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.796 2.331 . . . . 0.0 112.325 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 128.39 -6.54 6.69 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.768 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.3 t -94.42 -94.04 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.898 0.349 . . . . 0.0 110.557 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 71.07 16.21 74.83 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.006 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.404 ' HE2' ' HB3' ' A' ' 360' ' ' MET . 41.6 ttp -67.06 -54.88 17.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.98 0.419 . . . . 0.0 111.198 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 126.63 122.49 2.56 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.653 -0.785 . . . . 0.0 111.695 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.608 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.3 mm? -109.03 132.61 53.95 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.515 0.674 . . . . 0.0 111.325 -178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.81 106.22 18.22 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.778 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 11.4 p -116.41 127.42 74.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.289 0.566 . . . . 0.0 110.25 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -94.49 162.61 25.37 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.992 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.04 -26.32 81.21 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.472 2.115 . . . . 0.0 111.645 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.18 5.63 40.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.305 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 46.6 t -88.18 108.04 19.08 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.954 0.407 . . . . 0.0 110.693 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . 0.437 ' O ' ' HE1' ' A' ' 389' ' ' TYR . 0.7 OUTLIER -94.08 -33.13 13.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.656 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -85.75 104.6 15.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.207 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 14.4 p -103.7 122.81 56.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.267 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 96.7 m -153.27 139.49 18.43 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.075 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.608 ' HA ' HD11 ' A' ' 362' ' ' LEU . 2.5 t -74.83 69.89 1.88 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -68.7 -13.26 62.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.559 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -103.9 -3.72 24.41 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.96 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -154.63 -124.63 0.93 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.87 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 373' ' ' CYS . 1.7 p -74.85 91.68 2.46 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.885 0.374 . . . . 0.0 111.12 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -67.99 124.09 19.56 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.827 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -151.9 132.8 14.18 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 26.6 m -90.36 124.81 43.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.953 0.406 . . . . 0.0 110.67 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.402 ' HA ' ' HA2' ' A' ' 388' ' ' GLY . 27.8 p90 -145.6 -175.77 4.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.169 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . 0.558 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 42.8 t -88.47 141.23 28.71 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -66.47 -22.13 66.2 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.616 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -105.93 -28.63 10.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.836 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 5.4 m -134.11 178.73 6.74 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 121.286 0.565 . . . . 0.0 111.779 -174.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.499 HD11 ' CG ' ' A' ' 354' ' ' PRO . 4.2 mm? -110.04 30.2 6.94 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -77.27 3.05 13.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.716 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 381' ' ' PHE . . . 76.33 40.26 28.99 Favored Glycine 0 CA--C 1.502 -0.765 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.54 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.437 ' HE1' ' O ' ' A' ' 369' ' ' ARG . 37.0 t80 69.76 110.26 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.787 0.835 . . . . 0.0 111.638 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -134.68 -169.13 2.28 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.456 HG12 ' H ' ' A' ' 393' ' ' GLU . 0.2 OUTLIER -57.52 159.91 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.824 178.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.69 9.6 2.58 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-N 116.277 -0.42 . . . . 0.0 114.048 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . 0.456 ' H ' HG12 ' A' ' 391' ' ' ILE . 46.1 mt-10 -115.59 111.81 21.22 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.168 0.508 . . . . 0.0 111.093 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.542 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 1.9 m -113.07 147.04 38.08 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.597 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 95.3 mt -122.2 152.41 60.39 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.032 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -70.18 175.95 7.74 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.735 2.29 . . . . 0.0 112.022 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -115.72 137.66 51.86 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.702 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 126.16 117.39 2.14 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.494 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 8.8 t -148.87 162.66 39.4 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 172.92 139.84 2.97 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.444 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -151.84 143.22 23.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.743 0.306 . . . . 0.0 110.381 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 5.1 p -120.55 153.81 36.22 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.103 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -160.3 137.24 9.16 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.984 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 26.2 m -157.92 143.36 16.94 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.216 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -155.4 148.08 24.2 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 t -150.15 157.43 43.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 58.5 m -140.39 116.07 10.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.879 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -130.65 138.64 50.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.367 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -164.83 138.97 5.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.509 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 9.3 t -132.08 155.26 48.41 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.856 0.36 . . . . 0.0 110.552 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.62 126.97 74.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.019 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -87.3 148.31 44.39 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.669 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.12 -178.47 2.49 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.068 2.512 . . . . 0.0 113.106 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -119.36 173.76 6.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.512 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -133.51 135.02 44.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.528 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -125.04 144.14 50.55 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.912 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -129.95 141.97 50.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.707 0.289 . . . . 0.0 111.248 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -99.51 -175.37 2.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.311 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -138.37 170.11 16.6 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.692 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -118.54 155.83 30.2 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.209 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -119.85 159.47 24.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.959 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -113.59 133.1 55.47 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.1 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.514 ' CD ' ' H ' ' A' ' 423' ' ' GLU . 0.1 OUTLIER -92.47 -32.93 14.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.864 178.044 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 56.55 77.59 0.25 Allowed 'General case' 0 C--N 1.341 0.218 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.766 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 30.1 t -88.87 113.09 24.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.205 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -85.49 179.41 7.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.608 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.64 151.83 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.7 t -89.93 152.82 21.04 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.642 HD13 ' H ' ' A' ' 429' ' ' ILE . 0.2 OUTLIER -115.79 167.42 8.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.639 0.257 . . . . 0.0 111.001 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 430' ' ' LYS . 0.0 OUTLIER -86.62 159.52 19.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.955 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 33.1 m -82.36 132.39 31.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.417 0.627 . . . . 0.0 111.683 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 31.3 m -96.77 4.96 51.48 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.3 p -115.57 155.05 28.3 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.913 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 30.3 mmmt -121.52 134.43 24.55 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 5.1 Cg_exo -74.34 118.14 5.25 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.802 1.668 . . . . 0.0 111.938 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . . . . . . . . . 37.2 t -55.32 138.72 67.06 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.528 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.31 -1.17 10.95 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.577 2.185 . . . . 0.0 112.031 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -111.68 -60.21 1.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . 0.405 ' SG ' ' HG3' ' A' ' 456' ' ' ARG . 5.3 p -100.58 -3.31 30.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.78 33.7 23.53 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.072 0.463 . . . . 0.0 111.166 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 36.4 p -97.81 154.89 37.67 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.437 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.16 99.34 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.181 1.921 . . . . 0.0 112.302 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 5.8 m -85.96 121.05 28.04 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -76.21 124.35 27.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.965 0.412 . . . . 0.0 110.357 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.431 ' HD3' ' O ' ' A' ' 445' ' ' ARG . 0.0 OUTLIER -96.19 155.4 16.78 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.015 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -140.7 148.86 41.43 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -85.43 115.1 4.09 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.791 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 136.46 -12.59 4.03 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.793 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 57.9 m -112.94 110.24 20.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.417 ' HA ' ' CD1' ' A' ' 465' ' ' TRP . 0.7 OUTLIER -82.54 -12.73 57.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.195 0.521 . . . . 0.0 110.224 176.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -101.0 96.4 7.22 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 46.3 tpp -104.13 129.77 51.84 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 120.942 0.401 . . . . 0.0 111.05 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 18.6 t -134.37 137.27 51.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 48.1 t -86.52 95.04 9.59 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 20.6 p -81.96 90.23 6.46 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.515 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 0.1 OUTLIER -131.27 141.97 50.06 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.791 -176.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.451 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -64.42 106.06 1.05 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.808 0.337 . . . . 0.0 110.141 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 101.69 4.69 51.97 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.414 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.515 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 44.2 t -113.21 -90.19 0.52 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.743 0.271 . . . . 0.0 110.599 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 70.4 34.25 68.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.567 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -94.76 134.23 37.59 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.951 0.405 . . . . 0.0 111.07 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.37 128.85 52.28 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -138.58 157.98 45.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.048 0.451 . . . . 0.0 111.752 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 28.5 m -65.92 136.07 55.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.044 -177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . 0.417 ' CD1' ' HA ' ' A' ' 450' ' ' MET . 23.9 t-105 -74.33 -49.44 22.86 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.265 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 13.4 t -73.24 -64.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.822 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.672 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 13.9 p -93.32 133.81 36.18 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -76.8 107.64 9.27 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.798 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -155.76 176.53 12.51 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.956 -176.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -113.9 140.84 48.04 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 63.9 t90 -59.75 103.97 0.25 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.799 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 473' ' ' ARG . 0.7 OUTLIER -142.41 -152.47 0.41 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . 0.484 ' H ' HG22 ' A' ' 472' ' ' THR . 33.4 ptt180 -82.94 -23.98 33.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.058 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.85 -50.39 56.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.901 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 66.1 m -110.89 81.17 1.39 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.116 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 92.4 mtp -89.46 -35.53 15.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.818 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . 159.26 40.45 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.555 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -90.83 -3.0 57.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.098 0.475 . . . . 0.0 110.973 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . 0.414 ' CE1' ' SG ' ' A' ' 464' ' ' CYS . 19.2 p80 -143.88 19.5 1.8 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.135 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . 0.461 ' CZ3' ' HA ' ' A' ' 464' ' ' CYS . 9.5 t-105 -87.85 3.36 48.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.299 0.571 . . . . 0.0 110.093 -176.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -64.81 115.77 5.64 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.091 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-O 118.677 -1.068 . . . . 0.0 111.469 179.744 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 N--CA 1.468 0.47 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -104.86 128.91 53.25 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.963 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -102.69 127.03 49.99 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 5.8 p -94.65 113.05 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.771 HD13 ' H ' ' A' ' 346' ' ' LEU . 0.0 OUTLIER -107.84 153.56 22.83 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.214 0.53 . . . . 0.0 112.297 -176.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -159.9 172.09 18.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.227 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -157.08 -171.46 3.65 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -77.86 74.71 1.95 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -83.83 -150.01 10.14 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.622 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 352' ' ' LEU . 30.0 t -100.38 163.76 2.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.423 ' N ' HG12 ' A' ' 351' ' ' VAL . 4.2 mm? -113.76 143.89 43.89 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 354' ' ' PRO . 44.5 t -64.95 139.68 97.87 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.779 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 353' ' ' CYS . 7.8 Cg_exo -74.66 -10.83 22.0 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.557 2.171 . . . . 0.0 112.402 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -71.42 136.13 83.94 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 120.872 0.368 . . . . 0.0 110.857 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.1 -43.13 16.08 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.986 2.457 . . . . 0.0 113.223 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -82.27 7.14 65.04 Favored Glycine 0 CA--C 1.51 -0.279 0 C-N-CA 120.638 -0.791 . . . . 0.0 113.3 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.586 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 43.9 t -92.4 -103.42 0.12 Allowed 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 122.667 -0.314 . . . . 0.0 110.866 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 70.03 27.91 72.4 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 37.5 ttp -79.44 -69.7 0.56 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.913 0.387 . . . . 0.0 110.643 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 139.92 131.38 2.77 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.957 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.36 140.79 48.81 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.952 0.406 . . . . 0.0 110.661 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -105.86 123.37 47.85 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.619 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 59.6 t -118.89 114.47 44.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 120.873 0.368 . . . . 0.0 110.629 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.67 142.64 70.47 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -46.32 -42.75 22.15 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.345 2.697 . . . . 0.0 114.014 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -80.21 -3.62 49.82 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 43.6 t -123.58 158.38 31.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.102 0.477 . . . . 0.0 111.131 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -134.74 9.23 3.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.064 0.459 . . . . 0.0 109.779 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -71.95 108.09 5.03 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.525 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.487 HG21 ' C ' ' A' ' 382' ' ' CYS . 0.0 OUTLIER -115.36 112.15 38.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.175 177.27 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.3 m -153.71 135.15 14.24 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.438 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.447 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 3.4 t -74.76 69.57 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.465 0.65 . . . . 0.0 109.738 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -76.03 -9.8 58.9 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.395 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -104.99 5.97 33.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.497 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -161.11 -123.0 0.65 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.583 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.1 p -84.58 92.6 8.17 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.676 0.39 . . . . 0.0 110.67 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -69.52 108.95 2.66 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.896 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -128.08 141.88 51.37 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.7 m -83.75 122.8 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.259 0.552 . . . . 0.0 111.88 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -151.94 -177.5 6.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.824 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . 0.487 ' C ' HG21 ' A' ' 371' ' ' VAL . 19.5 t -108.57 175.46 5.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -82.54 -39.0 22.94 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.935 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.624 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 5.2 m-20 -104.44 -5.33 21.74 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -177.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 21.3 p -151.84 173.2 15.06 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.243 0.544 . . . . 0.0 111.397 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 8.9 mp -110.36 35.38 3.46 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.992 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -79.08 3.84 16.3 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.327 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 83.79 27.58 37.8 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.33 -0.938 . . . . 0.0 112.941 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 25.7 t80 70.08 125.89 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.468 0.707 . . . . 0.0 111.036 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -143.96 -175.72 4.71 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 43.6 mm -105.52 145.49 13.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 92.8 -163.41 27.03 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.775 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -91.24 166.53 12.89 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.889 0.376 . . . . 0.0 110.365 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.0 m -96.58 -58.24 2.1 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.768 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.33 124.57 82.4 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.21 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -80.82 -171.15 1.17 Allowed 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.687 2.258 . . . . 0.0 111.555 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.44 -64.51 1.04 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.722 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 68.1 66.73 2.21 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.48 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 45.5 m -106.75 119.0 38.16 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.945 0.403 . . . . 0.0 110.936 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -125.53 117.81 3.04 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 121.045 -0.597 . . . . 0.0 111.936 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -93.84 -55.39 3.25 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.597 0.237 . . . . 0.0 110.607 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 45.9 p 50.15 84.87 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.776 0.83 . . . . 0.0 111.998 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.78 119.29 6.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.681 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.0 t -165.84 135.75 3.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.994 0.425 . . . . 0.0 111.206 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -147.86 167.59 24.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.911 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.5 p -134.88 -70.13 0.5 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.728 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 18.4 t 54.36 85.9 0.05 Allowed 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.795 0.684 . . . . 0.0 111.085 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -136.22 132.6 36.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.239 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -175.51 132.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.711 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 15.3 t -138.29 155.22 48.8 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.753 0.311 . . . . 0.0 110.743 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.38 150.42 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.129 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -109.49 150.6 41.39 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.384 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -90.44 171.61 3.58 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.882 2.388 . . . . 0.0 112.594 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -148.04 145.28 28.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.556 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -154.61 130.55 10.16 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.226 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.26 134.51 10.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.443 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -164.94 119.45 1.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.479 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.4 145.46 29.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.751 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -147.19 139.95 24.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.713 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -142.68 137.26 29.78 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -135.27 156.7 48.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.764 0.316 . . . . 0.0 111.404 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -108.87 122.72 47.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.184 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -104.7 -26.53 12.26 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.212 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -62.35 120.18 10.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.984 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.5 t -163.04 146.61 10.9 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -162.27 132.74 4.82 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.118 0.485 . . . . 0.0 110.861 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 67.6 t -130.44 124.64 57.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 40.6 m -142.25 125.85 16.85 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.962 0.411 . . . . 0.0 111.02 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.14 162.51 23.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.374 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -104.96 132.99 50.5 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.311 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.1 p -56.93 110.97 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.433 0.635 . . . . 0.0 111.184 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.0 m -114.82 2.04 14.26 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.675 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.1 p -105.83 126.04 51.7 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.877 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 435' ' ' PRO . 5.2 mptp? -90.48 144.97 31.52 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 434' ' ' LYS . 1.1 Cg_endo -80.46 121.14 4.17 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.013 1.809 . . . . 0.0 111.822 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 440' ' ' ARG . 37.1 t -54.99 135.2 67.27 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.609 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.53 -15.62 38.06 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.159 1.906 . . . . 0.0 111.651 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . 0.499 ' HA ' ' HE3' ' A' ' 438' ' ' LYS . 0.9 OUTLIER -91.85 -70.49 0.69 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.493 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 8.1 p -97.6 -6.09 34.12 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 436' ' ' CYS . 23.9 mmt180 67.11 26.1 8.95 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.771 0.429 . . . . 0.0 111.664 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 26.9 p -86.19 158.81 54.89 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.902 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.02 101.53 1.34 Allowed 'Trans proline' 0 C--O 1.239 0.53 0 C-N-CA 122.428 2.085 . . . . 0.0 112.224 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 7.3 m -90.32 113.16 24.96 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -104.09 141.1 36.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 445' ' ' ARG . 6.6 ptm180 -85.74 95.04 9.27 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.633 0.73 . . . . 0.0 110.057 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -135.47 115.3 12.98 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.892 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 84.16 20.34 59.24 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.78 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -149.89 129.2 2.91 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 76.5 m -81.84 -73.1 0.4 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.754 0.311 . . . . 0.0 110.893 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -112.3 -6.52 14.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.502 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -96.65 96.5 8.67 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.959 0.409 . . . . 0.0 110.546 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 80.0 mmm -89.51 91.85 8.87 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 23.7 t -99.95 116.76 43.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.89 99.55 12.48 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 1.3 t -87.24 92.78 9.18 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.604 0.716 . . . . 0.0 110.471 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.589 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -130.3 148.22 52.1 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.427 ' N ' ' HD3' ' A' ' 456' ' ' ARG . . . -46.41 -64.76 0.68 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -93.78 37.5 3.39 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.773 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 51.1 t -130.97 -100.36 0.3 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 120.851 0.357 . . . . 0.0 111.073 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 78.81 22.53 66.2 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -89.28 114.88 26.3 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.361 0.601 . . . . 0.0 111.076 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.482 ' HG3' ' HB3' ' A' ' 471' ' ' TRP . 4.1 pt-20 -105.58 146.19 29.97 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.62 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -146.45 159.38 43.48 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.941 -177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 41.8 m -62.51 146.95 50.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.472 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -74.87 -54.54 7.08 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.468 176.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.01 -63.83 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.626 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 28.0 p -98.67 165.96 11.55 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -106.6 111.42 23.96 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.137 -1.025 . . . . 0.0 108.729 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.4 p -150.64 154.75 38.06 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.387 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -73.85 154.36 39.5 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . 0.482 ' HB3' ' HG3' ' A' ' 462' ' ' GLU . 5.3 p-90 -60.7 91.87 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.887 0.851 . . . . 0.0 111.981 178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 9.2 t -134.77 141.08 46.36 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.761 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . 0.499 ' HA ' ' HB3' ' A' ' 476' ' ' MET . 36.3 mtp180 -63.48 -29.38 70.67 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -174.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 478' ' ' ALA . 4.9 p-10 -65.51 -18.32 65.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.293 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 8.2 t -110.61 -40.6 4.54 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . 0.499 ' HB3' ' HA ' ' A' ' 473' ' ' ARG . 10.8 tpt -52.99 -41.02 64.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.26 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -106.03 16.8 42.3 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.169 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 474' ' ' ASP . . . -92.78 -65.54 0.99 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.75 0.309 . . . . 0.0 110.828 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 480' ' ' TRP . 9.5 p80 -108.32 -69.62 0.84 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.031 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . 0.593 ' H ' ' CG ' ' A' ' 479' ' ' HIS . 22.0 t-105 63.51 -71.81 0.06 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.332 1.053 . . . . 0.0 111.734 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -70.23 137.07 50.54 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 122.416 0.286 . . . . 0.0 110.395 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.295 0 CA-C-O 118.435 -1.203 . . . . 0.0 111.876 -179.658 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.595 0.236 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.73 143.92 49.99 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -97.03 83.3 3.34 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.286 0.565 . . . . 0.0 109.94 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.43 ' O ' HD22 ' A' ' 346' ' ' LEU . 3.3 p -127.07 98.38 4.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.508 0.67 . . . . 0.0 111.192 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 346' ' ' LEU . 3.3 mm? -125.46 164.87 19.52 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.17 175.79 10.23 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.715 177.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -134.63 155.46 50.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.394 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 79.81 -68.97 3.13 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.259 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -173.28 -150.25 7.35 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.846 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 18.7 m -119.34 -179.03 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 C-N-CA 123.094 0.558 . . . . 0.0 110.3 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 7.5 mp -124.35 151.53 44.24 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.872 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.9 t -54.61 138.67 60.91 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.694 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.501 ' HG3' ' CD1' ' A' ' 379' ' ' TYR . 18.6 Cg_endo -59.56 -19.69 53.63 Favored 'Trans proline' 0 N--CA 1.473 0.281 0 C-N-CA 123.195 2.597 . . . . 0.0 112.396 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -84.93 113.09 47.76 Favored Pre-proline 0 N--CA 1.439 -1.0 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.03 -28.22 74.44 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.46 2.106 . . . . 0.0 111.842 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -67.86 -25.3 74.24 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.531 -0.627 . . . . 0.0 111.531 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 40.0 t -73.95 -73.08 0.24 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 53.24 31.53 42.11 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.249 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 47.9 ttp -70.96 -62.55 1.35 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.168 0.508 . . . . 0.0 110.8 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 125.8 123.62 2.7 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.75 130.11 56.52 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.237 0.542 . . . . 0.0 110.478 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.521 HD12 ' HG2' ' A' ' 365' ' ' GLU . 0.8 OUTLIER -89.62 124.66 34.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.859 -178.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.405 ' N ' HD13 ' A' ' 363' ' ' LEU . 100.0 t -93.75 100.99 12.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.102 0.477 . . . . 0.0 110.673 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.521 ' HG2' HD12 ' A' ' 363' ' ' LEU . 6.0 mm-40 -94.89 153.73 39.91 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.369 177.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.82 -11.34 31.76 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 121.785 1.657 . . . . 0.0 109.821 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -102.98 24.99 9.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.182 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . 0.403 ' SG ' ' HD2' ' A' ' 383' ' ' ARG . 27.1 p -71.83 74.67 0.87 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.556 0.693 . . . . 0.0 110.823 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . 0.633 ' HD3' ' H ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -64.88 -23.07 67.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.196 179.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -162.11 109.47 1.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.168 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 381' ' ' PHE . 0.6 OUTLIER -92.64 113.67 28.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.659 0.742 . . . . 0.0 110.326 176.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . 0.43 ' OG1' HG12 ' A' ' 380' ' ' VAL . 92.2 m -152.54 144.93 24.03 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.443 -178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 9.3 t -74.62 73.24 1.98 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.444 0.64 . . . . 0.0 109.335 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -84.87 -19.48 32.3 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.988 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -96.81 -16.88 20.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.044 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -108.91 -101.26 2.68 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.918 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 4.0 p -100.2 -100.91 0.24 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 120.774 0.321 . . . . 0.0 110.618 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -173.32 107.06 0.24 Allowed Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.214 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.501 ' CD1' ' HG3' ' A' ' 354' ' ' PRO . 23.8 t80 -161.89 135.55 6.47 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.833 0.316 . . . . 0.0 110.648 177.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.43 HG12 ' OG1' ' A' ' 372' ' ' THR . 29.1 m -101.01 125.95 54.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.568 ' O ' HG13 ' A' ' 371' ' ' VAL . 23.6 p90 -146.94 -175.12 4.69 Favored 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.537 -177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 34.2 t -77.2 -178.07 4.88 Favored 'General case' 0 C--O 1.216 -0.697 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.403 ' HD2' ' SG ' ' A' ' 368' ' ' CYS . 11.3 ptm180 -95.94 -32.71 12.48 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.837 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -105.57 -7.78 18.38 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.505 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 26.1 p -152.04 -170.58 3.68 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.451 0.643 . . . . 0.0 111.462 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.81 28.59 8.66 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.145 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -81.09 18.37 1.07 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 72.07 45.43 41.04 Favored Glycine 0 C--O 1.227 -0.282 0 C-N-CA 120.843 -0.694 . . . . 0.0 114.603 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 5.2 t80 59.71 94.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -133.96 -163.12 1.32 Allowed 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.43 157.31 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -75.33 46.93 1.95 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.5 -0.381 . . . . 0.0 113.77 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.61 107.68 7.18 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 1.6 m -136.33 -67.6 0.51 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.643 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 98.8 mt -114.13 132.32 22.78 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.822 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.78 -164.22 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.674 2.249 . . . . 0.0 111.56 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -80.56 142.66 33.89 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.187 0.518 . . . . 0.0 111.406 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -123.29 97.05 0.56 Allowed Glycine 0 N--CA 1.433 -1.526 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.226 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 78.4 m -115.49 116.22 27.83 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -119.98 178.3 16.49 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.834 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -157.31 155.84 31.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.738 0.304 . . . . 0.0 110.491 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 17.1 p -81.85 156.44 24.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.471 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -71.55 163.57 27.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.803 0.335 . . . . 0.0 110.762 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 23.3 m -85.44 103.48 14.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.422 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -73.59 121.26 20.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.531 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.0 t -86.7 144.46 27.1 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.777 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 19.0 p -123.54 134.92 53.79 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.747 0.308 . . . . 0.0 110.735 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -122.9 169.11 11.47 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.224 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -139.17 164.58 29.42 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 120.948 0.404 . . . . 0.0 111.175 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 14.8 m -134.12 98.22 4.07 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 10.8 p -107.71 142.84 19.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.766 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.54 136.44 67.83 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.406 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.45 110.19 2.43 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.52 2.147 . . . . 0.0 111.093 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -77.92 126.14 30.4 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.084 0.469 . . . . 0.0 111.529 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -95.32 114.77 26.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.579 177.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -137.2 137.21 38.88 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.892 0.377 . . . . 0.0 111.086 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -126.92 145.02 50.83 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.343 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -96.45 -178.34 4.25 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.175 0.512 . . . . 0.0 111.674 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -141.39 137.92 32.62 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.805 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -158.14 133.45 8.76 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 32.9 m-90 -113.13 -25.06 9.09 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.449 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.2 171.46 19.16 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -95.26 -71.21 0.68 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 179.21 149.1 0.25 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.388 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 22.7 t -123.47 155.67 37.05 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -138.65 174.27 10.7 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.034 0.445 . . . . 0.0 111.569 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.25 -51.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.453 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.9 t -164.46 151.68 11.58 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.751 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 9.5 tp -103.59 136.64 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.005 0.431 . . . . 0.0 110.87 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -83.48 138.9 33.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.067 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 6.0 p -72.91 97.71 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.828 0.823 . . . . 0.0 110.951 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.7 p -100.63 4.43 43.3 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.359 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.5 p -95.56 154.35 17.25 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.665 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.48 ' HA ' ' HE3' ' A' ' 434' ' ' LYS . 0.0 OUTLIER -117.15 140.45 27.15 Favored Pre-proline 0 C--N 1.311 -1.07 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.24 124.59 4.88 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.969 1.779 . . . . 0.0 112.499 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 438' ' ' LYS . 41.2 t -64.3 134.93 96.13 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.075 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.16 -4.87 16.01 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 122.108 1.872 . . . . 0.0 111.492 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . 0.646 ' HB2' ' SG ' ' A' ' 436' ' ' CYS . 6.0 mmmm -100.68 -74.46 0.61 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.101 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 3.6 p -94.99 -7.67 39.13 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.163 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 52.2 mtt180 61.57 31.93 18.75 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.278 0.561 . . . . 0.0 111.479 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 20.7 p -84.96 154.2 60.71 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.102 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.75 93.66 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.32 2.013 . . . . 0.0 112.855 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 14.8 m -82.92 122.55 28.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.583 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.54 155.93 39.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.584 0.231 . . . . 0.0 110.877 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -116.32 157.79 24.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.025 0.44 . . . . 0.0 111.476 -176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -143.06 138.04 29.65 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -88.74 51.51 3.86 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.139 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -137.88 -56.09 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.102 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.4 p -83.36 -178.97 7.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.083 0.468 . . . . 0.0 110.483 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.479 ' HE3' ' HB2' ' A' ' 450' ' ' MET . 35.8 ttm -135.57 -14.89 1.9 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.295 0.569 . . . . 0.0 110.062 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -88.56 95.18 10.14 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . 0.401 ' CG ' ' HB2' ' A' ' 465' ' ' TRP . 70.7 mmm -100.0 115.96 30.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.476 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 3.5 m -124.84 144.84 33.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.369 0.604 . . . . 0.0 110.939 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 42.5 t -84.41 108.87 17.46 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.774 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 15.3 p -91.64 88.64 6.81 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.624 0.726 . . . . 0.0 109.351 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -132.06 126.96 35.1 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.413 ' HB3' ' NH2' ' A' ' 456' ' ' ARG . . . -49.6 -31.88 11.59 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . -109.29 25.04 19.24 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.178 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 31.8 t -133.56 -81.18 0.47 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.148 0.474 . . . . 0.0 111.215 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 63.13 65.63 3.0 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -124.27 121.61 35.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.889 0.376 . . . . 0.0 111.692 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -89.51 157.37 18.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.577 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -166.62 158.99 13.73 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.761 0.315 . . . . 0.0 111.291 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 52.2 t -71.89 134.78 46.25 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.851 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . 0.401 ' HB2' ' CG ' ' A' ' 452' ' ' MET . 14.0 t-105 -69.37 -43.77 72.9 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.005 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 43.1 t -69.85 -63.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 5.6 p -105.74 143.86 33.29 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.359 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -75.22 113.91 13.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.638 0.732 . . . . 0.0 110.58 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.6 p -142.85 178.03 7.93 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.682 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.31 117.88 35.28 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 65.3 m95 63.76 -168.6 0.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.593 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 476' ' ' MET . 7.0 m -109.83 30.93 6.24 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.659 0.742 . . . . 0.0 109.3 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -85.57 -57.61 2.99 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -70.28 -24.73 63.1 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.372 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 478' ' ' ALA . 93.8 m -89.0 -8.82 53.35 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.893 176.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 472' ' ' THR . 25.8 ttt -50.59 -57.85 7.21 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.754 0.659 . . . . 0.0 111.491 -176.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -109.73 12.9 32.52 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.371 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 475' ' ' CYS . . . -88.31 -64.94 1.07 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.921 0.391 . . . . 0.0 110.585 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . 0.456 ' CG ' ' H ' ' A' ' 480' ' ' TRP . 6.6 p80 -137.74 -65.39 0.52 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.104 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . 0.456 ' H ' ' CG ' ' A' ' 479' ' ' HIS . 21.4 t-105 54.53 31.27 14.57 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.984 0.897 . . . . 0.0 110.114 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -142.05 151.18 42.15 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.351 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.273 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -178.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -100.03 150.35 22.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.906 0.384 . . . . 0.0 111.445 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -143.21 100.31 3.6 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.084 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.66 115.15 2.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.072 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 346' ' ' LEU . 0.6 OUTLIER -112.34 107.81 16.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.637 0.732 . . . . 0.0 111.323 178.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -151.36 129.33 11.75 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.063 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -171.48 -177.74 2.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.811 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -86.37 42.16 3.14 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.274 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -90.15 -173.17 44.95 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.12 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 352' ' ' LEU . 4.2 t -110.03 175.41 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.598 ' H ' HG12 ' A' ' 351' ' ' VAL . 5.8 mp -137.53 152.37 49.4 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.5 t -56.01 130.64 73.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.74 9.99 1.77 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.99 2.46 . . . . 0.0 113.312 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -98.56 145.56 30.1 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.638 0.256 . . . . 0.0 110.875 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.22 -26.3 30.23 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.833 2.355 . . . . 0.0 112.789 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -74.15 -28.34 64.46 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.962 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 86.7 m -95.08 -151.9 0.34 Allowed 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 120.929 0.395 . . . . 0.0 110.667 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 118.96 19.48 4.37 Favored Glycine 0 N--CA 1.437 -1.298 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -65.9 -66.14 0.59 Allowed 'General case' 0 CA--C 1.519 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 110.32 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 151.31 130.56 1.69 Allowed Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.164 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.06 109.94 17.59 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.432 0.634 . . . . 0.0 109.909 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -88.31 106.86 18.51 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.433 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 48.6 t -82.45 105.55 12.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.947 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.49 152.66 95.37 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.468 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.07 -20.53 70.05 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.002 1.801 . . . . 0.0 111.175 177.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -104.45 12.09 33.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.758 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 47.4 t -70.73 101.28 2.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.258 0.552 . . . . 0.0 110.243 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . 0.693 ' HD3' ' H ' ' A' ' 369' ' ' ARG . 0.0 OUTLIER -91.3 0.61 57.49 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.772 -178.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -162.35 110.36 1.36 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 381' ' ' PHE . 2.7 p -101.09 124.96 55.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.226 0.536 . . . . 0.0 110.348 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 61.3 m -152.2 147.88 26.93 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.452 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 29.6 t -69.73 74.99 0.43 Allowed 'General case' 0 C--N 1.342 0.25 0 CA-C-O 121.563 0.697 . . . . 0.0 109.154 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -85.52 -20.42 29.68 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.863 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -98.36 13.07 32.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.647 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -142.41 -104.8 0.53 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.158 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.462 ' SG ' ' N ' ' A' ' 378' ' ' GLY . 20.6 p -97.49 -102.45 0.19 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.233 0.539 . . . . 0.0 110.735 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.462 ' N ' ' SG ' ' A' ' 377' ' ' CYS . . . -171.85 106.55 0.24 Allowed Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -160.21 117.88 2.56 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.95 132.76 38.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 389' ' ' TYR . 30.0 p90 -140.66 176.26 8.94 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.153 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 46.9 t -88.66 165.65 14.63 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 383' ' ' ARG . 11.5 ptt180 -88.55 -30.51 19.25 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.25 0.548 . . . . 0.0 110.127 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.509 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 0.9 OUTLIER -105.79 -11.05 16.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.196 178.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 394' ' ' CYS . 5.6 m -145.29 -179.13 6.44 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -174.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 386' ' ' LEU . 8.0 tp -118.23 22.46 12.15 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.986 177.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -81.27 28.97 0.36 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 71.97 32.48 63.42 Favored Glycine 0 N--CA 1.465 0.576 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.596 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 381' ' ' PHE . 20.8 t80 57.95 73.5 0.47 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.334 0.588 . . . . 0.0 111.061 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.46 ' CD2' ' H ' ' A' ' 390' ' ' HIS . 0.3 OUTLIER -77.13 145.2 37.93 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.092 179.034 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 6.7 tp -77.2 131.01 35.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.798 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 104.95 -158.98 15.93 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.344 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -87.34 146.66 25.82 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.117 0.484 . . . . 0.0 111.162 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.755 ' HB3' ' SG ' ' A' ' 385' ' ' CYS . 3.7 m -79.48 -44.23 21.67 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.168 -177.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.57 131.72 82.04 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.452 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.21 175.32 10.96 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.989 2.46 . . . . 0.0 112.694 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -118.37 175.02 5.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.18 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -142.04 96.93 0.2 Allowed Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.48 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 9.0 t -147.18 163.96 34.68 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 163.13 70.77 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.255 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -131.63 100.72 5.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 56.8 m -155.2 139.88 17.04 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.39 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -158.19 107.48 2.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.789 0.328 . . . . 0.0 110.766 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 50.7 m -87.19 131.44 34.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.695 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -113.3 152.75 29.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.274 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 35.5 t -119.84 154.83 33.73 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.269 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 71.1 m -84.8 124.72 31.89 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.963 0.411 . . . . 0.0 110.366 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -83.63 116.63 22.71 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -114.89 115.13 26.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.971 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 11.0 t -96.71 151.95 19.14 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.097 0.475 . . . . 0.0 110.987 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 33.0 m -81.39 170.55 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.517 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.16 121.92 86.33 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.408 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.16 -164.51 0.22 Allowed 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 123.155 2.57 . . . . 0.0 112.872 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 69.68 104.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.345 0.658 . . . . 0.0 110.58 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -151.71 151.06 30.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.038 -178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -86.39 93.02 9.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.964 0.411 . . . . 0.0 110.06 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -155.56 144.75 20.83 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.725 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -108.3 119.32 39.15 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.108 0.48 . . . . 0.0 110.972 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -142.9 174.13 10.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.357 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -93.6 102.38 14.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.984 0.421 . . . . 0.0 110.514 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 42.9 p-90 -161.28 156.0 23.4 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.932 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -148.55 160.17 43.35 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.028 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -102.17 -50.87 3.52 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.252 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 63.91 17.21 10.4 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.235 0.614 . . . . 0.0 112.435 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 38.6 m -104.3 132.05 50.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.555 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -151.22 95.64 2.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.331 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 31.9 m -100.14 158.91 3.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.008 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 19.7 m -104.97 83.92 2.06 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.132 0.491 . . . . 0.0 110.247 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 45.0 mm -129.51 113.87 29.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.132 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt 61.38 45.15 8.84 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.087 0.47 . . . . 0.0 110.768 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 7.2 p -74.08 110.68 8.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.37 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 23.6 m -86.28 -21.11 27.52 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.744 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.19 132.58 35.24 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.325 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -99.92 111.39 61.88 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.08 127.39 24.78 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 122.238 1.959 . . . . 0.0 111.94 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 44.5 t -50.96 138.12 25.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.07 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.61 -2.44 12.44 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.264 1.976 . . . . 0.0 111.476 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 29.4 tptp -109.71 -61.16 1.68 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.413 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 11.8 p -102.69 -3.88 25.9 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 29.5 ttp180 65.19 21.19 12.09 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.66 0.784 . . . . 0.0 112.33 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.3 p -82.76 140.41 43.82 Favored Pre-proline 0 C--N 1.314 -0.963 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.082 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -62.4 101.97 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.467 2.111 . . . . 0.0 112.213 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 45.0 m -77.55 123.48 26.66 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.74 114.46 5.04 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.598 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -96.58 105.87 18.03 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.306 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.58 128.29 55.85 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.207 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 66.43 -116.24 8.16 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.371 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -155.81 42.99 0.56 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.945 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 47.7 t -71.67 123.77 23.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.784 0.326 . . . . 0.0 110.254 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.652 ' SD ' ' HA ' ' A' ' 480' ' ' TRP . 43.3 ttm -75.31 -20.43 59.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.781 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -86.02 96.4 9.83 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 21.5 mmt -97.34 113.44 25.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.081 0.467 . . . . 0.0 110.684 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.26 117.44 55.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.648 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 40.7 t -78.92 99.8 6.96 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.545 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 30.8 p -83.7 90.55 7.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.597 0.713 . . . . 0.0 109.35 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.571 ' HD2' ' N ' ' A' ' 457' ' ' ALA . 3.1 tmm_? -130.46 137.54 49.84 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.571 ' N ' ' HD2' ' A' ' 456' ' ' ARG . . . -63.91 95.66 0.12 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.152 0.501 . . . . 0.0 110.602 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 106.39 24.14 6.93 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.383 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 29.7 t -131.02 -85.06 0.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.967 0.384 . . . . 0.0 110.51 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 64.58 35.42 91.91 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -84.92 124.68 31.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.907 0.384 . . . . 0.0 110.529 -177.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.74 133.72 46.03 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.056 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 34.6 p-90 -143.69 147.22 33.95 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.748 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 52.5 t -70.65 141.9 51.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.089 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 26.9 t-105 -68.31 -45.22 73.57 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.644 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 51.0 t -75.93 -59.47 3.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.078 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 7.4 p -101.89 99.06 9.22 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -74.14 110.94 8.83 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.448 0.642 . . . . 0.0 109.96 -175.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -154.77 175.45 13.71 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.647 -1.161 . . . . 0.0 109.544 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -74.71 139.32 43.37 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 86.1 t90 -52.7 109.9 0.46 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.074 0.464 . . . . 0.0 110.184 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 13.9 p -146.8 -163.46 1.76 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.244 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -74.92 -21.73 59.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.395 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -46.66 -58.64 3.65 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.762 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 2.1 t -123.38 56.75 1.18 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.268 0.556 . . . . 0.0 109.903 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 60.2 ttp -70.12 -27.82 64.89 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -177.66 40.49 0.09 OUTLIER Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.693 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -72.38 -64.31 0.97 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.093 0.473 . . . . 0.0 110.996 -178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -126.83 17.06 7.4 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.832 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . 0.652 ' HA ' ' SD ' ' A' ' 450' ' ' MET . 35.6 t-105 -62.73 -27.08 69.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.316 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -76.23 104.81 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.256 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.041 0 CA-C-O 118.855 -0.969 . . . . 0.0 111.838 179.924 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 120.729 0.3 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.05 146.55 47.58 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -80.88 83.73 6.55 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.3 0.571 . . . . 0.0 109.78 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 46.3 t -79.46 127.68 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.944 -177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -153.82 162.6 41.1 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -156.71 128.91 7.41 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.804 0.335 . . . . 0.0 110.651 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -84.52 159.02 20.79 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.702 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -90.42 155.24 24.03 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.955 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -159.62 -150.09 5.73 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.322 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 352' ' ' LEU . 15.6 t -124.08 176.92 4.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.595 ' H ' HG12 ' A' ' 351' ' ' VAL . 82.8 mt -118.78 151.01 38.83 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . 0.556 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 35.2 t -58.66 142.99 82.76 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.488 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.556 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 56.3 Cg_endo -70.32 -8.94 24.81 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.149 2.566 . . . . 0.0 112.442 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.422 HE21 ' HB2' ' A' ' 355' ' ' GLN . 5.1 mt-30 -94.24 130.7 33.25 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.67 -23.75 63.14 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.264 2.643 . . . . 0.0 113.087 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -83.21 5.87 74.72 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.882 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.529 ' HB2' ' SG ' ' A' ' 377' ' ' CYS . 26.5 t -119.2 -99.43 0.44 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 58.63 22.05 51.71 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.273 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.694 ' HE1' ' HA3' ' A' ' 376' ' ' GLY . 40.8 mtm -70.75 -58.95 3.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.917 0.389 . . . . 0.0 111.117 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.405 ' HA2' HD23 ' A' ' 352' ' ' LEU . . . 156.45 125.66 0.9 Allowed Glycine 0 N--CA 1.436 -1.319 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.25 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.6 mm? -115.35 126.87 54.95 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.076 0.465 . . . . 0.0 110.051 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -84.46 104.41 14.44 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.555 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.09 104.39 16.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.274 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.25 148.24 91.02 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.939 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -48.93 -47.09 22.61 Favored 'Trans proline' 0 N--CA 1.478 0.563 0 C-N-CA 123.774 2.983 . . . . 0.0 114.146 -176.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -91.59 -7.8 49.14 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.884 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 51.6 t -76.94 128.41 34.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . 0.558 ' HA ' ' HD3' ' A' ' 383' ' ' ARG . 0.0 OUTLIER -114.08 19.18 16.66 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 -178.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -116.53 140.77 49.01 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.334 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 383' ' ' ARG . 0.0 OUTLIER -135.88 130.93 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.544 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 27.4 m -153.67 131.46 11.6 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.158 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.502 ' HA ' HD11 ' A' ' 362' ' ' LEU . 4.3 t -80.29 74.66 7.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.327 0.584 . . . . 0.0 109.73 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -81.15 -6.8 59.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.647 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -95.11 -16.89 22.29 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.07 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . 0.694 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -153.88 -117.26 0.64 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.082 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 358' ' ' CYS . 1.2 p -90.13 104.13 16.73 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.097 0.559 . . . . 0.0 111.33 -178.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 373' ' ' CYS . . . -69.95 109.9 3.08 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.97 -176.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -127.78 144.33 51.09 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.96 99.84 8.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.186 0.517 . . . . 0.0 111.54 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -127.76 -179.0 4.71 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 7.6 t -86.83 -176.2 5.68 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.558 ' HD3' ' HA ' ' A' ' 369' ' ' ARG . 17.9 ptt180 -94.24 -36.0 12.2 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.469 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.467 HD21 ' CB ' ' A' ' 394' ' ' CYS . 21.7 p-10 -104.7 -28.16 11.37 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.214 0.531 . . . . 0.0 110.759 -177.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.48 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 23.1 p -130.73 -174.24 3.31 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.698 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.416 ' HG ' ' HB3' ' A' ' 354' ' ' PRO . 10.5 mp -113.27 33.63 4.98 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.479 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . 0.48 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 12.8 mm100 -81.17 19.17 0.95 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.979 0.418 . . . . 0.0 112.029 -178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 71.36 31.46 65.92 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 114.35 0.5 . . . . 0.0 114.35 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 30.9 t80 67.66 110.39 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.045 0.538 . . . . 0.0 111.425 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.432 ' CD2' ' HB2' ' A' ' 387' ' ' GLN . 1.8 p80 -146.65 -53.45 0.24 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 16.7 tt -148.74 156.5 8.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -69.44 -47.73 48.93 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 121.066 -0.587 . . . . 0.0 112.64 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -108.51 110.16 21.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.142 0.496 . . . . 0.0 111.394 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.467 ' CB ' HD21 ' A' ' 384' ' ' ASN . 4.7 m -105.02 136.52 44.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.309 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 10.2 mp -118.7 133.58 23.59 Favored Pre-proline 0 C--N 1.3 -1.568 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.141 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.66 173.22 14.83 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.697 2.264 . . . . 0.0 111.196 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -136.86 173.66 11.46 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.498 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 147.67 52.91 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.072 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 27.3 p -125.39 129.92 50.86 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -158.39 155.3 26.34 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.483 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -139.34 174.74 10.2 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 120.624 0.25 . . . . 0.0 110.359 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.8 m -144.88 155.96 43.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.49 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -139.83 146.14 39.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.634 0.254 . . . . 0.0 110.686 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 11.4 t -135.97 157.62 46.4 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.443 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -136.13 134.0 37.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.651 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.3 p -146.2 128.0 15.33 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.955 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 49.5 m -143.85 145.96 32.7 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.477 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -151.93 133.63 14.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.721 0.296 . . . . 0.0 110.963 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -143.96 133.77 23.84 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 12.0 p -122.63 139.39 53.98 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.653 0.263 . . . . 0.0 110.761 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.99 160.26 9.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.131 0.491 . . . . 0.0 111.494 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.64 149.24 39.62 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.478 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.6 -162.08 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.72 2.28 . . . . 0.0 111.419 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -145.17 158.04 43.93 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -146.4 120.69 9.58 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.846 0.355 . . . . 0.0 110.616 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -136.17 160.16 39.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.837 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -146.4 163.96 33.95 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.22 144.91 43.05 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -153.91 115.35 4.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.97 0.414 . . . . 0.0 111.946 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -133.16 161.04 35.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -152.93 167.76 28.05 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.878 0.37 . . . . 0.0 110.919 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -93.68 141.62 28.28 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -75.9 -70.22 0.45 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -168.75 -168.02 0.83 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 111.73 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 5.2 p -149.14 175.72 11.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.609 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -155.46 147.94 23.97 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.65 0.262 . . . . 0.0 111.158 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 9.2 p -159.4 144.52 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.456 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 10.1 t -149.28 147.21 28.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.671 0.272 . . . . 0.0 110.421 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.5 pp -136.24 175.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.106 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -118.55 -177.49 3.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.013 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.0 p -141.32 124.81 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.016 0.436 . . . . 0.0 111.203 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 50.2 m -124.9 2.52 8.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.067 0.461 . . . . 0.0 110.956 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 444' ' ' GLU . 2.1 p -80.24 143.63 33.56 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.135 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 434' ' ' LYS . 11.5 mmpt? -105.68 131.73 21.5 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.9 126.87 13.71 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.274 1.983 . . . . 0.0 112.449 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 437' ' ' PRO . 36.0 t -63.13 136.61 96.77 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.501 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 12.4 Cg_exo -69.82 -17.0 37.56 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.479 2.119 . . . . 0.0 111.614 177.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 438' ' ' LYS . 0.5 OUTLIER -96.93 -60.37 1.6 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.3 p -107.67 -3.36 19.28 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 440' ' ' ARG . 15.5 tpp85 68.1 21.13 8.8 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.153 0.501 . . . . 0.0 111.892 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 17.9 p -77.49 152.28 80.97 Favored Pre-proline 0 C--N 1.308 -1.202 0 O-C-N 122.175 -0.328 . . . . 0.0 111.157 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.58 92.57 0.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.28 1.987 . . . . 0.0 111.05 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 25.1 m -93.3 114.01 26.35 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.127 0.489 . . . . 0.0 111.339 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . 0.453 ' HB2' HG22 ' A' ' 433' ' ' THR . 2.5 tm-20 -102.74 121.07 41.7 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -82.71 100.69 10.39 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.225 0.536 . . . . 0.0 111.373 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -89.88 107.23 18.99 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 123.21 129.55 3.51 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -67.84 96.21 0.36 Allowed Glycine 0 C--N 1.322 -0.211 0 C-N-CA 121.465 -0.398 . . . . 0.0 113.142 -177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 79.9 m -153.08 144.31 23.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 122.591 0.356 . . . . 0.0 110.168 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.703 ' SD ' HG23 ' A' ' 466' ' ' VAL . 46.5 tpp -84.89 -31.29 23.79 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -85.6 96.95 9.82 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -120.26 129.66 54.14 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.766 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.492 HG11 ' HG3' ' A' ' 462' ' ' GLU . 5.7 m -124.18 152.5 29.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.711 -175.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.7 t -83.87 115.51 22.3 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 7.7 t -98.36 91.67 5.32 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 122.2 1.0 . . . . 0.0 109.942 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -129.81 132.06 46.38 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -178.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.47 98.37 0.09 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.898 0.38 . . . . 0.0 110.514 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 117.55 -4.13 17.54 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.945 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 47.7 t -108.67 -86.58 0.51 Allowed 'General case' 0 C--O 1.242 0.707 0 CA-C-O 120.713 0.292 . . . . 0.0 110.797 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 62.48 56.28 22.52 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.089 -0.805 . . . . 0.0 111.089 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -105.28 129.04 53.72 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.937 0.398 . . . . 0.0 111.045 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.492 ' HG3' HG11 ' A' ' 453' ' ' VAL . 13.5 mp0 -95.85 140.02 31.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.871 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -161.62 167.25 25.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.476 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 3.9 m -86.71 148.8 25.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.047 0.451 . . . . 0.0 110.831 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 32.4 t-105 -68.63 -50.49 50.96 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.612 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . 0.703 HG23 ' SD ' ' A' ' 450' ' ' MET . 94.7 t -70.72 -64.33 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -175.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 21.7 p -90.15 133.19 35.04 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.526 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -77.57 110.0 12.01 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 119.539 -0.864 . . . . 0.0 108.806 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.1 p -153.9 178.12 10.27 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.045 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -101.79 149.91 23.69 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . 0.432 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 44.3 t90 -62.43 98.17 0.11 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 474' ' ' ASP . 11.7 t -141.99 -168.73 2.76 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 120.927 0.394 . . . . 0.0 111.419 -175.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -69.54 -22.09 63.59 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.541 0.736 . . . . 0.0 112.755 -177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . 0.528 ' H ' HG23 ' A' ' 472' ' ' THR . 26.3 t70 -67.69 -58.54 4.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.906 0.384 . . . . 0.0 111.245 -178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 84.2 m -91.48 15.85 11.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.653 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 24.3 ptm -51.43 -32.26 26.07 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -150.6 33.51 0.98 Allowed Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -88.64 -64.78 1.09 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -142.16 67.75 1.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -85.73 -7.83 58.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.548 0.689 . . . . 0.0 109.306 175.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -144.4 134.62 24.27 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.507 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.363 0 CA-C-O 118.772 -1.015 . . . . 0.0 110.999 -178.411 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 120.719 0.295 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -88.27 -18.2 29.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.084 0.469 . . . . 0.0 110.405 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -80.5 100.97 8.82 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.766 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 6.7 p -90.02 132.38 34.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.186 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.46 137.49 42.23 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.64 -173.9 4.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.925 0.393 . . . . 0.0 110.518 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -85.46 176.52 8.2 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.114 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -69.39 96.88 0.51 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.548 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -54.03 130.92 44.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.795 -0.241 . . . . 0.0 113.627 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.47 ' H ' ' HB ' ' A' ' 364' ' ' VAL . 9.4 p -75.61 168.21 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.48 ' HB3' ' HA2' ' A' ' 361' ' ' GLY . 1.0 OUTLIER -141.11 155.41 46.12 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 13.9 t -51.65 130.72 36.44 Favored Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.142 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.16 3.36 4.66 Favored 'Trans proline' 0 N--CA 1.473 0.282 0 C-N-CA 123.217 2.611 . . . . 0.0 112.934 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -101.39 122.82 46.74 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.08 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.96 -26.68 83.57 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.055 2.503 . . . . 0.0 113.191 -177.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -69.24 -13.8 67.9 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.948 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.454 ' SG ' ' HE2' ' A' ' 360' ' ' MET . 42.0 t -92.62 -85.75 0.26 Allowed 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.628 0.252 . . . . 0.0 110.581 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 62.34 23.5 64.52 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.704 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.454 ' HE2' ' SG ' ' A' ' 358' ' ' CYS . 36.3 mtm -76.01 -48.51 20.73 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.562 -0.376 . . . . 0.0 111.302 -177.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 352' ' ' LEU . . . 109.46 129.51 5.81 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.832 -177.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.66 176.97 4.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.892 0.377 . . . . 0.0 110.751 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 364' ' ' VAL . 1.7 tt -101.8 148.8 24.86 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.534 ' H ' HD23 ' A' ' 363' ' ' LEU . 4.7 p -130.95 8.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.461 ' H ' ' CD2' ' A' ' 363' ' ' LEU . 43.3 mm-40 -57.58 151.18 41.74 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.917 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.86 -22.72 38.89 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.967 2.444 . . . . 0.0 112.475 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -76.58 -7.26 54.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.471 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.68 99.65 1.04 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -64.15 -42.41 96.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.753 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -156.32 125.3 6.02 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.485 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 2.8 p -90.32 124.31 42.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.21 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.6 m -150.47 141.99 23.47 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.235 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 16.1 t -74.73 70.96 1.92 Allowed 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.374 0.606 . . . . 0.0 109.891 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -84.71 -6.48 59.36 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.856 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -100.02 -4.8 29.22 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.828 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . 0.418 ' HA3' ' HE1' ' A' ' 360' ' ' MET . . . -153.5 -65.84 0.01 OUTLIER Glycine 0 C--O 1.234 0.154 0 C-N-CA 119.37 -1.395 . . . . 0.0 113.603 -178.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 4.7 m -100.3 -131.39 0.24 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.202 0.525 . . . . 0.0 109.67 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -170.3 104.75 0.21 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 381' ' ' PHE . 50.6 t80 -162.13 130.49 4.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 32.9 t -97.8 120.65 47.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.409 ' HB3' ' CE2' ' A' ' 379' ' ' TYR . 9.2 p90 -136.3 -175.54 4.03 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.234 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . . . . . . . . . 42.4 t -85.64 168.29 14.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.496 ' HB2' HG23 ' A' ' 364' ' ' VAL . 16.8 ptt180 -97.98 -14.31 20.65 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.748 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.585 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 84.1 m-20 -103.33 -32.42 9.57 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 29.6 p -134.23 -171.12 2.67 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.873 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -117.57 28.03 8.7 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.857 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -85.56 11.08 11.4 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 89.86 29.47 15.58 Favored Glycine 0 C--N 1.319 -0.404 0 C-N-CA 119.576 -1.297 . . . . 0.0 113.838 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 48.4 t80 72.86 135.1 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.518 0.727 . . . . 0.0 112.573 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -165.26 171.54 13.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.593 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 18.5 tt -100.95 146.65 9.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 96.53 -162.48 22.45 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.698 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -94.64 173.52 7.57 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.959 0.409 . . . . 0.0 110.971 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 4.2 m -113.43 140.93 47.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.926 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 6.6 mp -131.37 127.92 21.85 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.85 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 395' ' ' LEU . 50.2 Cg_exo -60.07 151.93 69.0 Favored 'Trans proline' 0 C--O 1.238 0.521 0 C-N-CA 123.014 2.476 . . . . 0.0 112.272 177.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -87.28 149.03 24.83 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.224 -177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -111.99 175.84 17.56 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.811 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 1.7 p -137.44 169.58 17.54 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.654 0.264 . . . . 0.0 111.541 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -171.19 -175.63 39.8 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.104 -0.569 . . . . 0.0 111.797 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -150.0 141.94 23.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.677 0.275 . . . . 0.0 110.537 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 48.0 t -140.7 124.15 16.85 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.456 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -136.32 90.9 2.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.213 -0.448 . . . . 0.0 109.961 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 19.7 p -126.12 124.68 41.09 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.582 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -124.52 -79.64 0.61 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.655 0.264 . . . . 0.0 111.172 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 9.4 p -162.14 170.0 19.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.581 0.229 . . . . 0.0 110.988 -177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 5.9 p -134.45 -65.49 0.64 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.528 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -83.95 143.44 29.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.089 0.471 . . . . 0.0 111.847 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.557 ' O ' HG22 ' A' ' 410' ' ' THR . 90.7 t80 -117.91 -27.73 6.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.394 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 409' ' ' TYR . 0.7 OUTLIER 62.14 169.55 0.12 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.622 1.169 . . . . 0.0 112.672 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 22.6 m -130.75 171.51 17.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.014 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -105.88 154.26 39.53 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.804 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.49 159.94 49.93 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.167 2.578 . . . . 0.0 112.846 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -110.02 179.32 4.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.359 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -144.41 157.11 44.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.726 0.298 . . . . 0.0 110.998 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -136.18 83.99 2.05 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.041 0.448 . . . . 0.0 110.531 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -160.88 144.45 13.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.13 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -144.17 167.55 22.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -79.06 157.53 28.01 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.287 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 69.77 104.17 0.06 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.659 0.783 . . . . 0.0 112.709 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -116.04 -19.24 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.818 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -137.87 154.22 49.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.1 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -94.05 -25.1 17.34 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 53.08 73.32 0.37 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.263 0.554 . . . . 0.0 111.745 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 54.4 m -149.99 103.44 3.2 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.382 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -88.39 124.19 33.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.816 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 27.6 m -74.96 132.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.311 0.577 . . . . 0.0 112.274 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 31.4 m -147.88 122.24 9.66 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.516 177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 12.2 tt -113.79 136.29 50.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 0.0 111.383 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -105.5 131.81 52.44 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.405 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 9.2 p -67.85 125.79 26.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.34 0.59 . . . . 0.0 110.608 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 445' ' ' ARG . 9.9 m -120.58 0.6 10.49 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.468 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 16.7 p -120.68 148.42 43.96 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.273 0.559 . . . . 0.0 112.106 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -112.64 131.89 22.48 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.36 118.9 5.95 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.083 1.855 . . . . 0.0 112.256 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 43.4 t -56.45 133.81 76.76 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.375 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.539 ' HG2' ' CE1' ' A' ' 461' ' ' PHE . 57.4 Cg_endo -72.24 -9.18 24.02 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.247 1.964 . . . . 0.0 111.445 177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 436' ' ' CYS . 29.3 tptp -98.67 -70.92 0.71 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.147 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.8 p -92.62 -12.53 31.42 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 17.0 tpp180 69.17 29.54 4.63 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.554 0.742 . . . . 0.0 111.528 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 41.4 p -89.35 158.58 45.98 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.978 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -80.85 100.22 1.19 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.218 1.945 . . . . 0.0 112.367 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 11.4 m -84.59 118.53 24.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.855 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -64.51 121.06 13.52 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 432' ' ' SER . 36.7 ptt180 -93.51 146.67 23.61 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.569 -176.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -125.49 120.04 29.84 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.536 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -67.11 124.18 22.54 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.932 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 125.9 -48.24 0.98 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.318 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 24.9 p -75.18 136.94 41.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.719 0.295 . . . . 0.0 110.591 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 59.8 mtt -97.66 -17.68 19.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.012 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -121.85 96.16 4.95 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.064 178.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 14.1 ptp -109.08 133.17 53.35 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.44 ' CB ' ' HB3' ' A' ' 462' ' ' GLU . 1.2 m -111.75 150.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.353 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 41.5 t -86.29 100.42 12.26 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.0 t -83.39 89.01 6.97 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.321 1.058 . . . . 0.0 109.276 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.53 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -131.22 114.26 14.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.598 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.465 ' HB3' HH21 ' A' ' 456' ' ' ARG . . . -56.52 107.37 0.37 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 108.33 13.17 19.93 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.123 -0.561 . . . . 0.0 111.843 -177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.53 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 43.8 t -123.64 -73.71 0.64 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 61.21 57.23 19.42 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . 0.539 ' CE1' ' HG2' ' A' ' 437' ' ' PRO . 50.0 t80 -136.45 129.39 31.05 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.908 0.385 . . . . 0.0 111.277 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.44 ' HB3' ' CB ' ' A' ' 453' ' ' VAL . 0.0 OUTLIER -120.13 155.85 32.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.531 174.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -140.56 174.78 10.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 48.2 t -76.73 133.91 39.34 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.36 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 26.2 t-105 -70.13 -56.73 6.11 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.4 -62.29 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.492 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 13.9 p -103.74 126.37 50.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -73.41 112.03 9.09 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 122.038 0.923 . . . . 0.0 109.549 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 2.0 p -150.1 177.74 9.61 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.321 -175.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 461' ' ' PHE . 39.2 tt0 -92.89 156.66 16.81 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 175.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -51.05 107.75 0.2 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.334 0.588 . . . . 0.0 110.472 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 474' ' ' ASP . 9.0 m -134.3 142.11 47.17 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.39 -177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 476' ' ' MET . 2.4 tmm_? -62.4 -21.32 65.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.406 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . 0.505 ' H ' HG22 ' A' ' 472' ' ' THR . 33.5 t70 -59.84 -58.79 7.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.762 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 480' ' ' TRP . 97.3 m -63.48 -26.46 68.73 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.594 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . 0.482 ' HB3' ' O ' ' A' ' 473' ' ' ARG . 19.2 ttt -41.76 -46.53 3.87 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.08 0.863 . . . . 0.0 112.997 -177.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -136.89 17.63 3.63 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.91 -1.138 . . . . 0.0 113.19 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -86.81 -56.78 3.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.926 0.363 . . . . 0.0 111.167 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -132.56 10.01 4.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.603 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . 0.472 ' HB2' ' O ' ' A' ' 475' ' ' CYS . 61.1 t-105 -75.05 -41.31 59.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.954 -176.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -73.88 100.79 3.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.119 0.485 . . . . 0.0 111.351 -177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.059 0 CA-C-O 118.934 -0.926 . . . . 0.0 111.533 179.256 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.987 0.423 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.62 173.9 13.31 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.285 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -144.08 54.49 1.29 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.294 0.569 . . . . 0.0 110.015 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 45.7 t -79.95 121.6 33.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.371 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 346' ' ' LEU . 3.6 pp -133.74 133.14 41.41 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.335 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -158.13 145.1 17.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.761 0.315 . . . . 0.0 110.374 -178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -105.97 110.28 22.5 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -80.23 124.17 6.37 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.926 -0.655 . . . . 0.0 112.167 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -101.76 -168.48 27.43 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.412 HG23 ' CG1' ' A' ' 364' ' ' VAL . 89.2 t -130.13 154.73 40.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 68.7 mt -114.92 148.05 39.18 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 38.6 t -60.75 128.86 89.32 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.02 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.541 ' HG2' ' CD2' ' A' ' 379' ' ' TYR . 43.1 Cg_endo -68.74 1.41 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.927 2.418 . . . . 0.0 112.705 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.445 ' HG3' ' SG ' ' A' ' 377' ' ' CYS . 14.7 mm-40 -73.84 120.63 82.25 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 176.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.98 105.66 0.25 Allowed 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.634 2.223 . . . . 0.0 112.106 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 109.85 -2.99 30.32 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.724 -0.751 . . . . 0.0 113.024 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 52.2 t -81.24 -82.58 0.12 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.921 0.36 . . . . 0.0 110.258 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 57.31 25.36 54.42 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.567 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -59.17 -48.93 79.8 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.7 0.286 . . . . 0.0 111.18 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 122.62 108.96 1.98 Allowed Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.621 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.15 139.46 46.51 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.349 0.595 . . . . 0.0 111.049 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 64.3 tp -92.76 134.67 34.82 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.8 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 364' ' ' VAL . 12.4 p -127.84 100.49 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 122.032 0.92 . . . . 0.0 111.497 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -97.42 143.55 26.37 Favored Pre-proline 0 C--N 1.299 -1.59 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.315 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.29 -31.41 76.58 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.39 2.06 . . . . 0.0 111.87 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -85.22 -16.51 40.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.038 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.8 t -93.05 101.27 13.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.092 0.472 . . . . 0.0 109.853 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . 0.563 ' NH2' ' HA3' ' A' ' 392' ' ' GLY . 17.7 ttt180 -92.31 -11.85 34.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.324 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -96.48 134.63 39.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.115 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.6 126.37 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.072 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 52.6 m -152.91 136.37 15.91 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.29 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.485 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 4.1 t -77.01 64.14 2.43 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.64 -6.38 40.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.893 -178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -116.3 9.32 14.47 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.363 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -150.84 -95.78 0.13 Allowed Glycine 0 C--O 1.238 0.351 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.601 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.485 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 6.6 p -135.88 111.89 9.6 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 122.717 0.407 . . . . 0.0 110.23 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -68.2 108.37 2.43 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.001 -174.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.541 ' CD2' ' HG2' ' A' ' 354' ' ' PRO . 89.8 t80 -120.16 151.33 39.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.455 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 11.0 m -89.03 114.63 27.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.312 0.577 . . . . 0.0 111.957 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -153.17 167.23 29.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.047 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 47.8 t -90.16 172.57 8.71 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -88.42 -23.68 23.25 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.336 0.588 . . . . 0.0 109.758 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.456 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 44.6 t30 -104.36 -37.57 7.17 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.889 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 12.5 p -129.44 -170.61 2.32 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.144 -177.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.69 35.75 4.45 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.303 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . 0.467 ' HA ' ' OE1' ' A' ' 387' ' ' GLN . 12.7 mm-40 -79.91 13.41 2.21 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 80.66 23.76 59.59 Favored Glycine 0 N--CA 1.463 0.444 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.505 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 33.0 t80 68.23 117.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.603 0.761 . . . . 0.0 110.688 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -146.54 -162.49 1.54 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.991 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.577 ' H ' HD13 ' A' ' 391' ' ' ILE . 0.2 OUTLIER -65.84 166.55 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 175.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.563 ' HA3' ' NH2' ' A' ' 369' ' ' ARG . . . -76.54 47.73 2.46 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 121.012 -0.613 . . . . 0.0 114.066 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -141.42 96.66 3.02 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.201 0.524 . . . . 0.0 111.042 177.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 3.7 m -93.01 152.46 19.3 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.254 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 84.0 mt -109.08 110.23 60.72 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.74 -176.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.52 177.14 8.36 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.471 2.114 . . . . 0.0 110.564 175.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.42 114.37 17.43 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.033 0.444 . . . . 0.0 111.744 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -177.25 81.68 0.07 OUTLIER Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.904 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 10.1 t -168.51 133.27 1.65 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.942 0.401 . . . . 0.0 110.811 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 157.12 99.34 0.16 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.439 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -136.41 109.03 7.45 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.674 0.273 . . . . 0.0 110.81 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 33.9 t -160.65 112.69 1.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.17 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -146.17 97.28 2.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.849 0.357 . . . . 0.0 110.912 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 9.5 t -169.85 141.69 2.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.305 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -131.56 -50.24 0.99 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.012 0.434 . . . . 0.0 110.804 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 12.6 p -107.02 170.23 8.07 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.125 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 6.2 p -151.37 -64.83 0.18 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.804 0.335 . . . . 0.0 111.38 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -133.81 131.83 39.73 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.58 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -79.48 133.93 36.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.119 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 11.6 t -113.56 154.08 27.72 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.782 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 46.8 t 74.59 92.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.151 0.58 . . . . 0.0 111.293 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -98.38 148.53 34.65 Favored Pre-proline 0 C--N 1.31 -1.122 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.908 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.77 150.55 87.78 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.58 2.187 . . . . 0.0 112.367 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -141.61 137.53 31.94 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.835 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -75.87 133.04 40.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.79 0.329 . . . . 0.0 110.691 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -116.37 132.31 56.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.193 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -95.69 165.28 12.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.905 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -144.62 173.38 11.87 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.466 0.174 . . . . 0.0 110.779 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -136.33 118.06 15.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.78 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -83.48 143.36 30.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.334 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -120.76 -175.83 3.12 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.935 0.398 . . . . 0.0 110.942 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -119.69 129.24 54.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.047 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -83.85 -43.44 15.35 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.855 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 55.75 35.37 25.2 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.002 0.429 . . . . 0.0 111.125 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 23.3 p -68.85 161.19 29.14 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.531 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -87.65 172.74 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.36 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.92 115.54 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.906 0.384 . . . . 0.0 111.133 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.3 t -83.36 137.65 33.86 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.23 174.44 3.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.55 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -115.89 179.68 3.91 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.677 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 8.1 p -156.48 132.22 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.93 0.395 . . . . 0.0 110.645 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.3 t -120.63 -10.24 9.24 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.916 0.389 . . . . 0.0 110.472 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 3.0 p -85.91 132.82 34.01 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.519 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 434' ' ' LYS . 0.3 OUTLIER -97.9 148.27 34.24 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.33 134.5 19.12 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.324 2.016 . . . . 0.0 113.156 -178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 15.5 t -67.44 141.64 95.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.945 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 3.6 Cg_exo -75.77 -13.99 19.68 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.296 1.997 . . . . 0.0 111.976 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -96.76 -64.0 1.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.056 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 1.5 p -109.87 3.45 20.66 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 15.9 ttm180 60.92 25.15 15.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.361 0.665 . . . . 0.0 112.403 176.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.467 ' H ' ' HB3' ' A' ' 436' ' ' CYS . 2.9 p -82.74 142.34 45.41 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.361 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 21.1 Cg_exo -63.47 105.97 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.377 2.051 . . . . 0.0 112.225 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 17.7 m -78.25 125.73 29.77 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.049 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -92.24 131.25 37.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.569 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -85.2 94.95 9.02 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -109.99 123.86 50.39 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.422 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 94.17 -80.22 0.96 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.933 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.66 13.46 5.63 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.012 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.7 m -81.87 38.29 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.84 0.353 . . . . 0.0 110.813 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.532 ' HG2' ' O ' ' A' ' 479' ' ' HIS . 2.1 mpt? 64.11 16.92 10.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.377 0.671 . . . . 0.0 111.499 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -88.6 96.36 10.61 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 6.7 mmt -113.69 82.13 1.63 Allowed 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.43 171.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 2.2 m -126.8 142.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.05 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 52.6 t -96.04 108.15 20.53 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.92 0.39 . . . . 0.0 111.592 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 18.7 p -89.11 90.34 8.34 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.44 ' HG3' HG21 ' A' ' 441' ' ' THR . 4.6 tmt_? -130.2 145.17 51.7 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.724 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -66.7 94.64 0.31 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.929 0.395 . . . . 0.0 110.483 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 109.38 24.5 5.89 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.671 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.44 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 50.0 t -126.27 -95.4 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.735 0.303 . . . . 0.0 110.632 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 70.74 46.84 43.8 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.626 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -112.1 130.36 55.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 111.488 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -100.39 137.78 38.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.999 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 19.9 p-90 -139.72 155.6 47.25 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 79.1 m -66.27 130.71 44.15 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -176.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -75.08 -46.44 34.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.268 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 479' ' ' HIS . 21.3 t -69.61 -65.12 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.993 -176.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 10.1 p -95.43 133.98 38.78 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -79.47 109.81 14.19 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.836 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.9 t -156.82 158.1 36.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.858 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -87.0 113.73 23.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.223 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 25.14 81.77 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.963 1.305 . . . . 0.0 113.158 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 14.8 m -117.21 110.13 17.76 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.949 0.404 . . . . 0.0 110.841 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -71.63 -22.46 61.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.49 -49.66 74.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.568 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . 0.403 ' HB2' ' CD2' ' A' ' 479' ' ' HIS . 2.5 p -91.79 -15.24 28.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.387 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . 0.429 ' O ' ' HB3' ' A' ' 480' ' ' TRP . 25.0 ttt -54.75 -45.55 74.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.555 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -71.98 0.86 35.47 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.534 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.91 -60.08 1.84 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 117.164 0.482 . . . . 0.0 112.072 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . 0.532 ' O ' ' HG2' ' A' ' 450' ' ' MET . 17.6 p80 -94.89 -25.61 16.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . 0.429 ' HB3' ' O ' ' A' ' 476' ' ' MET . 31.3 t-105 -65.58 -41.91 92.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.938 0.399 . . . . 0.0 110.948 -176.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.47 95.65 8.56 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.235 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.883 0 CA-C-O 118.854 -0.97 . . . . 0.0 111.831 -178.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 120.899 0.381 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -91.68 92.16 8.32 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.091 0.472 . . . . 0.0 111.495 -177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -161.23 101.86 1.24 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.618 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 8.5 p -121.61 138.33 52.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.965 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -138.35 147.9 43.97 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -162.18 136.64 6.77 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.944 0.402 . . . . 0.0 110.689 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -99.98 -78.88 0.5 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.604 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 62.16 40.41 98.93 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.701 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -128.85 -148.85 6.76 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.223 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 352' ' ' LEU . 10.4 p -102.63 170.41 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.449 ' H ' HG22 ' A' ' 351' ' ' VAL . 5.4 mp -139.63 153.27 47.29 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 122.202 -0.311 . . . . 0.0 110.371 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 355' ' ' GLN . 52.5 t -57.48 135.67 81.96 Favored Pre-proline 0 N--CA 1.452 -0.372 0 O-C-N 123.502 0.501 . . . . 0.0 110.058 177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.29 0.09 8.96 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.649 2.233 . . . . 0.0 112.083 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.512 ' HB3' ' SG ' ' A' ' 353' ' ' CYS . 7.6 tp-100 -86.41 122.64 72.0 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.016 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.56 -20.9 70.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.639 2.226 . . . . 0.0 112.169 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . 0.406 ' H ' ' HG3' ' A' ' 355' ' ' GLN . . . -76.89 -17.33 79.94 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.587 177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 66.2 m -100.82 -176.54 3.21 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 121.062 0.458 . . . . 0.0 110.862 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 156.42 37.8 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.443 ' HE1' ' SG ' ' A' ' 373' ' ' CYS . 2.1 mpp? -82.76 -36.11 25.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 0.0 110.407 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.403 ' HA2' ' HG ' ' A' ' 352' ' ' LEU . . . 101.17 121.35 4.79 Favored Glycine 0 N--CA 1.439 -1.128 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.413 -178.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.24 111.65 24.34 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.451 0.643 . . . . 0.0 110.081 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -83.6 109.17 17.21 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.076 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.56 HG21 ' HB2' ' A' ' 383' ' ' ARG . 2.7 p -85.63 110.5 19.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.48 0.657 . . . . 0.0 111.658 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -97.58 150.85 37.22 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.298 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.64 -22.94 63.13 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.313 2.009 . . . . 0.0 110.995 175.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.52 -35.93 75.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.487 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 49.7 t -78.39 120.73 23.55 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.84 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -111.76 -8.85 14.13 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.251 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 108.38 11.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.548 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 381' ' ' PHE . 2.5 t -89.88 120.33 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 CA-C-N 116.366 -0.379 . . . . 0.0 109.98 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 86.2 m -152.24 139.61 19.49 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.52 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.443 ' SG ' ' HE1' ' A' ' 360' ' ' MET . 47.8 t -72.54 74.45 1.06 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 121.372 0.606 . . . . 0.0 110.292 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -85.13 -6.59 59.29 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.278 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -106.66 -11.37 15.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.176 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -117.45 -77.47 0.61 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.407 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 10.8 p -125.19 -102.12 0.37 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.038 0.447 . . . . 0.0 110.925 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -172.47 106.36 0.23 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -160.53 129.63 4.89 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 58.1 t -95.22 110.52 24.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.447 ' O ' ' HB ' ' A' ' 371' ' ' VAL . 34.3 p90 -127.32 -177.24 3.99 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.141 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 10.9 t -82.2 177.24 8.9 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.214 0.53 . . . . 0.0 110.782 -176.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.56 ' HB2' HG21 ' A' ' 364' ' ' VAL . 38.6 ptt180 -96.34 -27.81 14.78 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.889 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.45 ' HB3' ' SG ' ' A' ' 394' ' ' CYS . 6.7 t30 -104.43 -30.85 9.8 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.987 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.568 ' SG ' ' HG2' ' A' ' 387' ' ' GLN . 6.6 p -133.81 -172.96 3.11 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.255 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 352' ' ' LEU . 3.0 mm? -112.67 29.69 7.74 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.121 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . 0.568 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 9.3 mm100 -79.66 15.85 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -175.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 77.79 25.16 63.09 Favored Glycine 0 C--O 1.229 -0.209 0 C-N-CA 120.514 -0.851 . . . . 0.0 113.538 175.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 37.7 t80 72.1 134.52 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.397 0.679 . . . . 0.0 112.252 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -156.59 175.0 14.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.111 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 8.7 tp -93.13 144.95 8.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 102.13 -158.06 18.34 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.907 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -120.95 164.55 16.54 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 384' ' ' ASN . 1.4 m -119.65 151.42 38.73 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.883 0.373 . . . . 0.0 111.631 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.425 ' H ' HD23 ' A' ' 395' ' ' LEU . 2.6 pt? -136.24 148.47 64.53 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.21 155.51 50.9 Favored 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 122.599 2.199 . . . . 0.0 111.923 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.17 143.31 15.25 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.022 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 171.35 138.96 2.65 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.773 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 30.9 m -152.4 108.77 3.42 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -110.06 88.61 0.52 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.739 -0.744 . . . . 0.0 111.921 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -153.48 -175.41 5.34 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 19.5 t 63.65 91.47 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.982 0.513 . . . . 0.0 111.603 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -161.44 102.89 1.22 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 5.2 t -153.21 146.26 24.59 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -134.75 133.62 40.11 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.326 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 19.9 p -123.39 135.37 54.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.754 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 50.8 t -172.97 136.34 0.66 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.193 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -148.71 140.55 23.73 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -133.62 140.45 47.11 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 50.5 m -152.64 137.28 16.9 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.862 0.363 . . . . 0.0 111.371 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.78 155.38 41.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.576 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -109.12 132.5 21.18 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.212 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.41 -169.04 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.688 2.259 . . . . 0.0 110.879 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -151.55 158.78 44.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.99 0.424 . . . . 0.0 110.781 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -130.03 158.42 39.65 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -128.34 135.72 49.96 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.134 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -145.7 131.03 18.57 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.675 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.35 159.19 42.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.802 0.334 . . . . 0.0 111.181 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -160.33 96.4 1.18 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.528 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -76.22 124.6 27.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.088 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 49.4 p-90 -113.37 136.82 52.35 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.503 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -128.74 138.66 52.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.099 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.4 13.11 30.76 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -176.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -86.75 79.8 8.73 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.393 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.0 p 175.74 92.78 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.375 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -133.35 88.86 2.53 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.962 0.41 . . . . 0.0 110.53 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 56.2 t -117.34 119.57 62.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.996 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.4 t -97.56 159.15 15.1 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.868 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 32.9 pt -99.65 -179.52 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 120.691 0.281 . . . . 0.0 110.893 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -79.39 155.94 28.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.128 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 31.4 t -80.82 89.11 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.293 0.568 . . . . 0.0 111.173 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 13.4 p -112.87 4.61 16.99 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.982 0.896 . . . . 0.0 108.735 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 2.6 p -95.09 142.68 27.27 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.002 -177.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.31 136.17 25.94 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.907 177.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.31 128.59 10.57 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.172 1.915 . . . . 0.0 112.238 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 35.6 t -57.98 142.08 80.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.08 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 4.8 Cg_exo -76.4 -6.2 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.441 2.094 . . . . 0.0 111.536 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -108.97 -65.25 1.16 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.395 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 9.4 p -99.62 -4.75 30.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 120.787 0.327 . . . . 0.0 111.772 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 0.0 OUTLIER 63.09 23.41 13.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.229 178.282 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 25.4 p -80.03 155.07 75.23 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-O 120.614 0.245 . . . . 0.0 111.062 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.8 107.48 2.48 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.659 2.239 . . . . 0.0 113.529 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 41.7 m -107.1 126.06 51.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.85 144.2 55.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.79 0.328 . . . . 0.0 110.419 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -99.79 169.76 9.02 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.435 0.636 . . . . 0.0 112.326 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.45 162.47 13.44 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.819 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -66.63 -57.4 10.08 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.367 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -144.2 42.8 1.02 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.234 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 46.7 t -109.84 135.99 49.86 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -78.89 -10.28 59.76 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -77.38 99.78 5.71 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.978 0.418 . . . . 0.0 110.919 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . 0.503 ' CG ' ' HE3' ' A' ' 465' ' ' TRP . 27.4 mmt -120.86 95.45 4.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.435 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.474 ' CG1' ' HG3' ' A' ' 462' ' ' GLU . 3.6 m -128.99 144.6 37.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.021 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 7.5 t -73.7 135.25 43.66 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.138 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.9 t -113.34 87.72 2.67 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 122.254 1.026 . . . . 0.0 109.96 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.453 ' HB3' ' HB3' ' A' ' 459' ' ' CYS . 0.0 OUTLIER -132.4 130.44 40.63 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.31 92.57 0.09 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.984 0.421 . . . . 0.0 110.726 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 128.69 -18.91 5.63 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.45 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 456' ' ' ARG . 45.0 t -93.51 -83.38 0.32 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.665 0.269 . . . . 0.0 110.585 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.01 51.75 32.26 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.669 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -102.39 122.38 44.17 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.861 0.362 . . . . 0.0 111.425 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.474 ' HG3' ' CG1' ' A' ' 453' ' ' VAL . 13.4 mp0 -90.32 140.25 29.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.99 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 2.8 p-90 -143.23 167.36 22.3 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.252 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 56.6 m -81.44 143.08 32.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.45 0.643 . . . . 0.0 112.168 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . 0.503 ' HE3' ' CG ' ' A' ' 452' ' ' MET . 15.0 t-105 -75.66 -41.3 54.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.237 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 49.0 t -84.61 -64.56 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.705 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 25.3 p -91.82 177.44 6.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.92 110.49 15.92 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.658 0.742 . . . . 0.0 110.438 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 15.1 t -157.76 178.16 10.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.443 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.15 135.81 33.52 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . 0.417 ' HB2' ' O ' ' A' ' 462' ' ' GLU . 36.3 t90 -60.45 106.53 0.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.161 0.505 . . . . 0.0 109.768 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.5 p -136.28 -176.86 4.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.707 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -73.45 -24.15 60.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.19 -56.49 14.37 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.45 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -99.61 16.96 21.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.722 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -56.12 -57.86 10.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.07 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 480' ' ' TRP . . . -135.4 17.85 3.97 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.69 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -62.52 -28.54 69.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.931 0.396 . . . . 0.0 111.541 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -143.78 -6.59 0.77 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.439 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . 0.401 ' HB3' ' HA2' ' A' ' 477' ' ' GLY . 65.5 t-105 -59.91 99.63 0.07 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.776 -175.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -150.26 127.97 11.66 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.462 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.501 0 CA-C-O 118.696 -1.058 . . . . 0.0 111.066 -179.894 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.728 0.299 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -89.02 108.01 19.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.774 0.321 . . . . 0.0 110.281 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -122.81 172.6 8.33 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.69 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 85.3 t -72.8 -37.15 54.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.252 0.548 . . . . 0.0 109.773 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 346' ' ' LEU . 2.3 pt? -90.48 156.75 17.97 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.214 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -157.66 132.93 8.89 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -76.74 81.91 3.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.197 0.522 . . . . 0.0 111.514 -178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -106.06 -8.92 33.1 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -141.96 123.85 2.32 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 362' ' ' LEU . 10.6 p -98.39 168.09 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.411 ' H ' HG22 ' A' ' 351' ' ' VAL . 2.9 mm? -125.95 145.26 50.36 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 122.011 -0.431 . . . . 0.0 110.686 -176.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 354' ' ' PRO . 50.5 t -63.01 130.71 94.34 Favored Pre-proline 0 C--O 1.234 0.252 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 174.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 353' ' ' CYS . 9.5 Cg_exo -70.88 -12.1 30.29 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.829 2.353 . . . . 0.0 113.159 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -82.16 119.75 75.68 Favored Pre-proline 0 C--N 1.317 -0.828 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.21 -177.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.79 129.28 33.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.567 2.178 . . . . 0.0 111.128 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 116.12 -21.97 11.7 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 35.4 m -90.97 -97.0 0.11 Allowed 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.034 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 53.31 29.72 38.49 Favored Glycine 0 C--O 1.225 -0.466 0 O-C-N 123.404 0.44 . . . . 0.0 112.507 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 25.7 mtm -74.96 -67.19 0.67 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.935 0.398 . . . . 0.0 110.433 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . 0.4 ' HA2' HD13 ' A' ' 352' ' ' LEU . . . 147.14 120.02 1.18 Allowed Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.427 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.421 ' HB2' HG13 ' A' ' 351' ' ' VAL . 4.2 mm? -110.76 116.95 32.17 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -70.43 122.29 19.36 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.956 -176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 62.1 t -85.83 100.28 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.102 0.477 . . . . 0.0 110.863 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -89.4 135.71 30.8 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.236 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.07 -36.45 99.25 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.543 2.162 . . . . 0.0 111.303 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -77.98 -22.38 49.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.086 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 41.3 t -75.48 114.45 14.05 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.222 0.534 . . . . 0.0 110.98 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -114.81 -0.88 13.36 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.502 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -136.35 111.56 9.05 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.345 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 381' ' ' PHE . 0.8 OUTLIER -105.9 151.31 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.839 -176.69 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 88.2 m -154.09 143.21 21.25 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.637 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . . . . . . . . . 41.5 t -72.67 71.98 1.02 Allowed 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 121.486 0.66 . . . . 0.0 109.927 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -85.18 -6.59 59.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.0 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -88.95 -17.74 28.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.852 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -138.07 -88.13 0.19 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.048 -1.073 . . . . 0.0 113.169 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.448 ' SG ' ' N ' ' A' ' 378' ' ' GLY . 25.2 p -99.14 -109.34 0.19 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.198 0.523 . . . . 0.0 111.755 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.448 ' N ' ' SG ' ' A' ' 377' ' ' CYS . . . -172.08 108.05 0.27 Allowed Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -160.03 145.7 15.41 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.18 113.45 44.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.492 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . 0.486 ' O ' HG22 ' A' ' 371' ' ' VAL . 13.5 p90 -129.84 -174.68 3.38 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.144 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 29.3 t -81.2 172.09 14.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -97.42 -19.05 18.71 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.478 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.494 HD21 ' HB2' ' A' ' 395' ' ' LEU . 28.6 t-20 -104.74 -31.74 9.2 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.296 0.57 . . . . 0.0 110.008 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.562 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 21.1 p -135.72 179.9 6.05 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.237 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 10.5 mp -108.62 31.49 5.58 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.482 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . 0.509 ' HG2' ' SG ' ' A' ' 385' ' ' CYS . 77.9 mm-40 -74.66 4.42 6.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.176 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 82.3 30.36 34.16 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.132 176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 31.2 t80 72.17 128.03 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.828 0.451 . . . . 0.0 110.414 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -161.67 178.59 8.88 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.217 0.532 . . . . 0.0 111.756 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 47.4 mt -98.86 150.05 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.801 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 109.87 -164.03 12.39 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.089 -1.053 . . . . 0.0 112.736 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -116.42 149.62 39.14 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.786 0.326 . . . . 0.0 110.714 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 1.2 m -119.68 -72.63 0.68 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.494 ' HB2' HD21 ' A' ' 384' ' ' ASN . 94.5 mt -140.01 89.36 11.27 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.72 -16.63 12.91 Favored 'Trans proline' 0 CA--C 1.509 -0.762 0 C-N-CA 122.701 2.267 . . . . 0.0 113.079 -176.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 59.42 28.04 17.31 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.331 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 161.64 131.07 1.18 Allowed Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 9.5 t -119.05 2.37 11.46 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 117.295 0.547 . . . . 0.0 111.935 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.0 -74.86 2.35 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.585 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -69.4 117.97 11.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.952 0.406 . . . . 0.0 110.349 178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 47.7 m -148.74 112.78 5.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.564 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -140.55 -172.51 3.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.201 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 11.9 t -125.47 148.51 48.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 120.984 0.421 . . . . 0.0 111.029 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -131.16 80.28 1.93 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.483 0.659 . . . . 0.0 109.518 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 7.8 p -131.23 128.2 39.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.648 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 60.7 m -136.08 91.0 2.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.974 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -157.56 127.57 6.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.209 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -177.31 119.19 0.11 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.159 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 8.3 t -144.72 132.33 21.01 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.031 0.443 . . . . 0.0 110.972 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 52.5 t -119.28 103.77 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.492 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -110.08 117.26 52.13 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.542 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.13 144.36 81.35 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.994 2.463 . . . . 0.0 112.638 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -86.01 -77.31 0.31 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.681 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -161.48 138.03 8.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.371 . . . . 0.0 111.362 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.29 98.34 1.7 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.79 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -163.35 103.77 0.96 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.635 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.03 137.23 6.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.115 175.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -157.88 124.94 5.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.675 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -113.13 170.21 8.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.929 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -162.45 144.05 10.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.775 0.321 . . . . 0.0 110.851 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -154.68 120.67 5.23 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.839 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 423' ' ' GLU . 0.0 OUTLIER -91.81 -22.68 20.01 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.405 -178.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . 53.3 70.28 0.61 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.525 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 13.7 p -78.27 125.54 29.5 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.499 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -149.82 114.91 5.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.519 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.76 148.79 15.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.914 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.7 t -153.19 173.07 16.0 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 13.4 tt -161.52 145.79 4.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.55 131.96 12.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.016 0.436 . . . . 0.0 111.219 178.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.16 84.09 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 4.7 m -79.61 -38.82 33.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.007 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.1 174.18 11.82 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.288 177.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.467 ' HD3' ' HD2' ' A' ' 435' ' ' PRO . 17.2 tppt? -116.6 115.96 39.13 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . 0.467 ' HD2' ' HD3' ' A' ' 434' ' ' LYS . 17.8 Cg_endo -61.28 123.36 12.67 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.925 1.75 . . . . 0.0 111.361 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 44.2 t -58.41 136.52 85.5 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.369 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.05 -3.7 14.11 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.46 2.106 . . . . 0.0 111.621 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -109.72 -68.44 0.92 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.916 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 7.6 p -95.09 -2.71 49.5 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 12.3 tpt180 62.17 23.7 14.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.009 0.524 . . . . 0.0 111.578 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 37.3 p -84.87 160.65 55.15 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.263 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -79.67 93.81 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.224 1.949 . . . . 0.0 111.809 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 4.7 m -83.7 126.02 32.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.186 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -104.63 151.74 23.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.504 ' HB3' ' HE1' ' A' ' 452' ' ' MET . 15.2 ptt180 -119.74 156.97 29.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.23 0.538 . . . . 0.0 111.458 -178.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -129.57 145.23 51.5 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.802 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 73.29 -141.6 30.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.208 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.15 72.39 0.25 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.453 -0.879 . . . . 0.0 112.675 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.2 p -123.71 175.71 6.69 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.41 ' HA ' ' HB3' ' A' ' 465' ' ' TRP . 47.4 mtt -97.83 -0.64 44.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.037 0.446 . . . . 0.0 110.328 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -80.03 99.41 7.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.972 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . 0.504 ' HE1' ' HB3' ' A' ' 445' ' ' ARG . 96.5 mmm -112.94 97.36 6.48 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.908 178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 59.4 t -109.42 113.93 45.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.24 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 47.8 t -78.64 111.16 14.43 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.531 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 11.9 p -93.55 90.78 6.8 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-O 121.411 0.624 . . . . 0.0 109.514 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.535 ' HB3' ' CB ' ' A' ' 459' ' ' CYS . 4.7 tmt_? -132.13 139.36 48.41 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.029 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.35 105.68 0.97 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.889 0.376 . . . . 0.0 110.668 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 101.33 7.14 49.86 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.249 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 53.4 t -104.51 -90.19 0.4 Allowed 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.721 -0.282 . . . . 0.0 110.592 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 66.29 46.2 80.65 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -113.27 130.18 56.32 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.908 0.385 . . . . 0.0 110.944 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -98.87 140.61 32.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.025 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 28.1 p-90 -151.35 149.95 29.92 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.413 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 467' ' ' CYS . 53.4 m -74.24 149.66 40.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.412 0.625 . . . . 0.0 112.012 -178.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . 0.41 ' HB3' ' HA ' ' A' ' 450' ' ' MET . 32.6 t-105 -74.71 -58.74 3.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.939 178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.97 -47.29 76.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 464' ' ' CYS . 8.1 p -104.21 125.25 50.34 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -75.34 110.6 9.83 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.7 p -153.51 177.85 10.47 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.476 -176.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -102.22 157.24 17.03 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -56.7 108.6 0.51 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.478 0.656 . . . . 0.0 111.189 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 476' ' ' MET . 61.1 p -123.74 175.73 6.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.532 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -85.21 -29.95 24.28 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.685 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -67.54 -28.02 67.45 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.332 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 47.1 m -93.36 -30.28 15.19 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 472' ' ' THR . 1.9 tmt? -51.08 -52.3 44.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.352 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -99.38 20.06 51.34 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.563 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -111.17 -65.63 1.15 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -139.43 16.84 2.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -174.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -55.81 -38.62 70.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.253 0.549 . . . . 0.0 110.034 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -120.45 99.33 6.5 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.04 0 CA-C-O 118.434 -1.203 . . . . 0.0 111.803 -179.465 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 60.95 90.03 0.07 Allowed 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.792 0.683 . . . . 0.0 111.577 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -123.43 137.09 54.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.047 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 74.6 t -88.22 99.6 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 121.273 0.558 . . . . 0.0 110.269 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 1.4 pp -105.33 6.37 32.65 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.148 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -92.13 138.41 31.55 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.143 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -156.83 -75.28 0.09 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.386 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . -151.86 140.86 8.06 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.64 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -144.48 106.71 0.41 Allowed Glycine 0 N--CA 1.439 -1.118 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.01 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . . . . . . . . . 24.4 m -107.91 178.5 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.009 0.433 . . . . 0.0 110.334 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 6.2 mp -134.08 152.37 51.81 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.567 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 49.4 t -52.55 134.82 44.25 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.001 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.0 -16.93 48.65 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.116 2.544 . . . . 0.0 113.025 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -87.73 117.94 69.13 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.8 -27.66 84.54 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.017 2.478 . . . . 0.0 112.426 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -72.22 -16.18 76.96 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.543 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.2 t -86.8 -77.71 0.31 Allowed 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 59.05 30.4 66.79 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.024 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . . . . . . . . . 9.0 ttm -70.49 -76.72 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.009 0.433 . . . . 0.0 111.174 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 143.48 121.88 1.62 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.064 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.59 130.32 55.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.11 0.481 . . . . 0.0 110.772 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.406 HD13 ' N ' ' A' ' 364' ' ' VAL . 1.7 tm? -95.69 128.89 42.94 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.677 -178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.406 ' N ' HD13 ' A' ' 363' ' ' LEU . 62.9 t -114.91 103.86 15.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.213 0.53 . . . . 0.0 110.286 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -84.42 154.44 62.67 Favored Pre-proline 0 C--N 1.306 -1.301 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.125 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.6 -9.85 26.8 Favored 'Trans proline' 0 C--N 1.33 -0.431 0 C-N-CA 122.052 1.835 . . . . 0.0 112.335 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -99.57 -14.43 19.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 52.8 t -125.07 136.85 54.06 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 120.936 0.398 . . . . 0.0 110.774 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.09 10.46 8.14 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.103 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -87.5 91.26 8.67 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.626 0.727 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . 0.518 HG21 ' C ' ' A' ' 382' ' ' CYS . 0.0 OUTLIER -85.0 113.77 24.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.509 178.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 91.4 m -153.19 139.87 18.9 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.245 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.453 ' HB3' ' C ' ' A' ' 377' ' ' CYS . 4.7 t -76.44 67.48 2.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -66.45 -17.8 65.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.374 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -101.91 11.49 38.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.988 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . -166.08 -126.09 0.81 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.164 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.453 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -83.2 91.08 7.18 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . -69.06 108.88 2.64 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.693 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -114.09 143.62 44.48 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.457 ' O ' ' HA2' ' A' ' 388' ' ' GLY . 14.0 m -83.58 102.02 9.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.445 0.64 . . . . 0.0 111.413 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -133.82 172.33 12.93 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . 0.518 ' C ' HG21 ' A' ' 371' ' ' VAL . 10.7 t -95.62 175.98 6.33 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.059 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . 0.452 ' HG3' ' OD1' ' A' ' 384' ' ' ASN . 5.7 ptp85 -78.06 -45.26 24.05 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.879 -175.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.596 ' HB2' ' SG ' ' A' ' 394' ' ' CYS . 20.3 m120 -105.33 -9.88 17.35 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.984 0.421 . . . . 0.0 111.197 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . . . . . . . . . 26.4 p -140.21 176.07 9.06 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.919 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.81 32.64 5.7 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.634 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -72.63 -1.34 15.8 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 380' ' ' VAL . . . 96.39 27.33 10.02 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.465 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . . . . . . . . . 46.1 t80 66.42 103.99 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.23 0.612 . . . . 0.0 111.181 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -118.42 162.34 18.48 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.087 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . . . . . . . . . 48.4 mm -91.69 120.93 41.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 132.96 -140.26 11.67 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -132.97 148.93 52.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.815 0.34 . . . . 0.0 110.635 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 384' ' ' ASN . 1.3 m -89.35 -40.04 13.03 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.48 0.657 . . . . 0.0 109.905 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -74.78 125.79 89.13 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.656 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -90.31 -167.65 0.26 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.962 2.441 . . . . 0.0 111.076 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.0 -27.9 60.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.01 0.433 . . . . 0.0 110.896 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . 153.35 -134.03 4.24 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 9.0 t -134.69 157.74 45.88 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.902 0.351 . . . . 0.0 110.27 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -157.68 63.95 0.31 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.288 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.0 116.43 32.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.99 0.424 . . . . 0.0 110.594 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 49.7 m -145.31 110.31 5.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.767 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -67.66 114.45 6.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.696 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 11.8 p -124.53 124.63 42.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.203 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -146.64 159.91 42.86 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 40.3 m -137.0 135.25 37.45 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.954 0.407 . . . . 0.0 111.401 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 55.7 m -87.37 169.29 12.39 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.749 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 72.25 152.19 0.12 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.585 0.553 . . . . 0.0 110.447 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.445 ' O ' ' HB ' ' A' ' 410' ' ' THR . 1.8 p90 -147.49 -53.27 0.21 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.644 -177.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 409' ' ' TYR . 14.7 t 171.91 149.65 0.05 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.888 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.33 143.28 41.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.264 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -87.05 143.29 34.71 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.302 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.15 123.06 9.61 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.646 2.23 . . . . 0.0 113.299 -177.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -103.72 126.59 50.96 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.136 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . 0.496 ' C ' ' HD2' ' A' ' 415' ' ' ARG . 0.0 OUTLIER -133.61 166.07 23.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.845 0.355 . . . . 0.0 111.293 -177.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -112.05 134.68 53.45 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.989 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -112.44 162.64 15.36 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -141.19 140.22 33.97 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.705 0.288 . . . . 0.0 111.084 -178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -147.89 111.95 5.16 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.241 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.67 156.97 22.38 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.422 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -92.75 -35.36 13.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.413 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -63.28 97.9 0.14 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.825 0.345 . . . . 0.0 111.327 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.91 -35.0 7.45 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.533 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -139.85 172.09 13.28 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.208 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 49.1 p -111.73 -26.37 9.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.849 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.45 46.18 7.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.118 0.967 . . . . 0.0 112.975 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 52.6 t -62.4 120.86 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.566 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 7.4 m -87.43 130.86 34.52 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.635 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 16.0 tt -95.82 139.09 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.79 0.329 . . . . 0.0 110.522 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -88.41 154.9 20.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.425 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.569 HG22 ' H ' ' A' ' 433' ' ' THR . 14.9 p -75.53 139.35 19.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.291 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 11.1 p -96.47 -11.54 25.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.96 0.41 . . . . 0.0 111.788 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . 0.569 ' H ' HG22 ' A' ' 431' ' ' VAL . 5.1 p -110.4 170.63 7.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.874 0.369 . . . . 0.0 111.005 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 434' ' ' LYS . 33.1 ttmt -131.51 125.43 20.65 Favored Pre-proline 0 N--CA 1.436 -1.135 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.77 136.41 57.57 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.753 2.302 . . . . 0.0 113.156 -177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 31.2 t -63.36 141.18 97.81 Favored Pre-proline 0 N--CA 1.451 -0.423 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.761 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 436' ' ' CYS . 7.1 Cg_exo -73.77 -2.23 11.92 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.524 2.149 . . . . 0.0 111.78 176.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -117.4 -69.92 0.82 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.578 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 17.7 p -86.33 -10.61 54.1 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.63 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 436' ' ' CYS . 71.5 mtt85 66.52 21.46 10.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.149 0.579 . . . . 0.0 112.17 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 42.2 p -82.01 149.7 63.49 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.638 -0.255 . . . . 0.0 110.462 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.28 99.81 0.62 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.3 2.0 . . . . 0.0 111.802 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 20.3 m -81.04 125.93 30.8 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.992 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -82.35 134.7 35.26 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.248 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -91.04 143.44 26.7 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.253 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -146.37 160.81 41.56 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.264 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . -67.24 148.8 50.49 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.723 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 179.36 -154.75 14.37 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.078 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 450' ' ' MET . 61.1 m -108.45 49.87 0.8 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.924 0.392 . . . . 0.0 110.337 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.719 ' SD ' ' HA ' ' A' ' 480' ' ' TRP . 14.0 ptp 57.92 11.2 1.34 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.874 1.27 . . . . 0.0 112.925 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 480' ' ' TRP . 2.9 t60 -94.48 94.78 8.42 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 49.0 tpp -108.07 128.3 54.56 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-O 121.025 0.44 . . . . 0.0 110.776 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 462' ' ' GLU . 3.2 m -129.86 150.34 34.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 456' ' ' ARG . 12.9 t -69.36 111.7 5.42 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.477 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 4.3 t -83.7 87.43 7.05 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-O 122.5 1.143 . . . . 0.0 109.452 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.531 ' HB2' ' SG ' ' A' ' 454' ' ' CYS . 0.0 OUTLIER -133.16 128.1 35.29 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.62 91.75 0.09 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.86 0.362 . . . . 0.0 110.565 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . . . . . . . . . . . 124.93 -11.51 7.79 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.709 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 456' ' ' ARG . 23.6 t -98.1 -77.8 0.5 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 65.49 32.35 83.12 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.942 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . 0.449 ' HB2' ' SG ' ' A' ' 459' ' ' CYS . 29.8 t80 -75.58 120.02 20.43 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 -177.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.475 ' HG2' ' CG1' ' A' ' 453' ' ' VAL . 45.0 mt-10 -91.48 138.43 31.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -156.48 160.23 39.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.961 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 467' ' ' CYS . 44.8 t -69.99 138.05 51.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.427 0.632 . . . . 0.0 112.129 -177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -75.18 -41.63 57.55 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.614 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 41.9 t -77.06 -64.52 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.844 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 464' ' ' CYS . 1.7 p -102.29 96.91 7.27 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -74.93 109.92 8.79 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.67 1.224 . . . . 0.0 112.56 -170.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 9.2 t -160.18 173.67 15.4 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.551 -1.659 . . . . 0.0 106.736 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.64 111.66 12.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.445 -0.902 . . . . 0.0 108.877 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . 0.457 ' CE3' ' HB3' ' A' ' 474' ' ' ASP . 1.3 m95 -158.24 145.05 17.66 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.752 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 476' ' ' MET . 10.5 p -134.45 -72.03 0.49 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.088 178.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . 0.495 ' NH1' ' HG2' ' A' ' 476' ' ' MET . 29.8 mmm180 -85.13 -29.2 25.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . 0.457 ' HB3' ' CE3' ' A' ' 471' ' ' TRP . 8.0 t70 -66.0 -51.75 55.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.118 0.485 . . . . 0.0 111.051 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.6 t -78.83 -10.7 59.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.824 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . 0.584 ' HA ' ' HB3' ' A' ' 480' ' ' TRP . 47.7 tpp -57.61 -53.09 62.14 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.858 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -84.75 -10.54 78.95 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.325 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -71.12 -62.55 1.36 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.821 0.344 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -148.0 -12.23 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.836 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . 0.719 ' HA ' ' SD ' ' A' ' 450' ' ' MET . 2.3 t-105 -54.92 -41.3 70.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.354 0.597 . . . . 0.0 110.321 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -70.88 96.59 1.29 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.17 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.022 0 CA-C-O 118.825 -0.986 . . . . 0.0 112.006 -179.292 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -96.85 105.48 17.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.138 0.495 . . . . 0.0 111.03 -178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -112.52 128.58 56.38 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.781 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.68 ' O ' HD23 ' A' ' 346' ' ' LEU . 57.8 t -95.4 -47.77 12.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.406 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.68 HD23 ' O ' ' A' ' 345' ' ' VAL . 0.5 OUTLIER 47.1 15.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.718 1.607 . . . . 0.0 114.351 178.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 345' ' ' VAL . 86.6 mm-40 -92.78 143.21 26.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.833 0.349 . . . . 0.0 110.753 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ALA . . . . . . . . . . . . . . . -106.66 -171.7 1.94 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.496 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . . . . . . . . . . . 142.07 60.97 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.772 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' GLY . . . . . . . . . . . . . . . -129.48 161.72 22.77 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.881 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 352' ' ' LEU . 7.2 p -122.21 177.53 3.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.607 ' H ' HG22 ' A' ' 351' ' ' VAL . 98.4 mt -117.11 149.82 39.7 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 120.791 0.329 . . . . 0.0 110.963 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . 0.557 ' SG ' ' HD2' ' A' ' 354' ' ' PRO . 44.9 t -68.09 145.46 97.67 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.823 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' PRO . . . . . 0.557 ' HD2' ' SG ' ' A' ' 353' ' ' CYS . 27.6 Cg_endo -63.5 -14.85 44.94 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.812 2.342 . . . . 0.0 112.298 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -86.59 118.84 70.84 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.36 -30.55 91.55 Favored 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 123.159 2.573 . . . . 0.0 113.581 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . -82.03 -10.22 84.2 Favored Glycine 0 C--O 1.236 0.247 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.27 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . 0.488 ' SG ' ' HE2' ' A' ' 360' ' ' MET . 47.1 t -74.24 -82.73 0.06 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.692 0.282 . . . . 0.0 110.289 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 60.32 22.12 58.06 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 116.24 -0.436 . . . . 0.0 113.441 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' MET . . . . . 0.488 ' HE2' ' SG ' ' A' ' 358' ' ' CYS . 34.9 mtm -74.2 -41.44 61.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.184 0.516 . . . . 0.0 110.785 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' GLY . . . . . . . . . . . . . . . 106.51 115.02 3.97 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.569 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.42 HD11 ' HA ' ' A' ' 373' ' ' CYS . 4.5 mm? -99.37 144.91 27.94 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 122.528 0.331 . . . . 0.0 110.601 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -87.98 118.51 27.58 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 364' ' ' VAL . 9.1 p -122.03 77.71 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 122.023 0.916 . . . . 0.0 112.339 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -97.98 154.5 37.74 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.13 175.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.81 -14.73 42.47 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.415 2.077 . . . . 0.0 111.331 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -85.46 -2.59 58.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.066 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' CYS . . . . . . . . . . . . . 46.0 t -110.12 115.47 29.8 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.637 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.4 1.88 26.02 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.052 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -136.48 96.58 3.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.896 0.379 . . . . 0.0 111.175 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.8 120.38 40.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.423 0.63 . . . . 0.0 110.535 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' THR . . . . . . . . . . . . . 97.1 m -152.24 143.92 23.56 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.597 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' CYS . . . . . 0.46 ' HB3' ' HA2' ' A' ' 378' ' ' GLY . 3.7 t -76.51 67.02 2.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.474 0.654 . . . . 0.0 109.688 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -72.14 -6.12 40.4 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.501 -177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -106.41 -12.89 15.51 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.066 0.46 . . . . 0.0 110.793 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . 0.418 ' N ' ' HE1' ' A' ' 360' ' ' MET . . . -144.64 -124.1 1.72 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.921 -178.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.453 ' C ' ' HB3' ' A' ' 373' ' ' CYS . 0.8 OUTLIER -74.53 86.57 2.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.825 0.345 . . . . 0.0 110.553 178.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 373' ' ' CYS . . . -67.77 109.09 2.72 Favored Glycine 0 CA--C 1.495 -1.157 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.574 -172.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -147.85 134.77 20.18 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.3 p -83.64 133.16 29.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -142.03 166.62 24.22 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 385' ' ' CYS . 11.3 t -79.87 160.13 26.16 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.236 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -92.79 -13.25 29.45 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.537 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -104.82 -30.62 9.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.277 0.56 . . . . 0.0 109.511 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 382' ' ' CYS . 6.7 p -140.84 -165.88 2.03 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.241 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 65.1 mt -116.96 25.68 10.34 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.019 0.437 . . . . 0.0 110.942 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -75.97 20.36 0.19 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLY . . . . . . . . . . . . . . . 78.89 16.85 78.32 Favored Glycine 0 N--CA 1.461 0.363 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.201 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 382' ' ' CYS . 0.3 OUTLIER 67.41 114.18 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.751 0.82 . . . . 0.0 111.477 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -141.06 -53.97 0.48 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.429 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 393' ' ' GLU . 40.8 mt -125.29 146.3 31.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -66.11 -23.75 71.5 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.292 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' GLU . . . . . 0.51 ' H ' HG22 ' A' ' 391' ' ' ILE . 31.6 mt-10 -135.36 134.76 40.11 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 122.45 0.3 . . . . 0.0 110.414 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' CYS . . . . . . . . . . . . . 74.8 m -138.12 177.94 7.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.04 0.448 . . . . 0.0 111.498 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 27.2 tp -142.33 127.27 10.24 Favored Pre-proline 0 N--CA 1.435 -1.219 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.952 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 395' ' ' LEU . 41.2 Cg_exo -61.26 166.13 11.57 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 123.084 2.523 . . . . 0.0 112.333 177.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.85 115.49 15.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.179 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' GLY . . . . . . . . . . . . . . . -152.46 48.15 0.55 Allowed Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' THR . . . . . . . . . . . . . 17.3 p -136.66 -178.76 5.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.616 0.246 . . . . 0.0 111.268 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.19 72.85 0.93 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.842 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -145.57 114.22 6.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.691 0.282 . . . . 0.0 110.697 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.7 p -153.76 148.05 25.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.576 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -142.54 165.81 26.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.604 0.24 . . . . 0.0 110.881 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 5.9 t -157.78 114.11 2.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.338 0.589 . . . . 0.0 110.913 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -112.93 144.68 42.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.381 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 10.8 p -157.05 130.48 7.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.007 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' CYS . . . . . . . . . . . . . 41.9 t -161.51 102.29 1.2 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.605 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -136.44 115.75 12.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.789 0.328 . . . . 0.0 110.894 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -161.76 148.89 14.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.884 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 1.2 p -138.94 103.29 4.76 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.996 0.427 . . . . 0.0 110.796 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' VAL . . . . . 0.412 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 30.4 t -88.83 112.58 24.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -104.21 105.9 51.23 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.472 -177.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 411' ' ' VAL . 16.0 Cg_exo -70.21 140.58 41.29 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.542 2.162 . . . . 0.0 110.907 176.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -133.87 121.89 22.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.741 0.305 . . . . 0.0 111.036 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.97 160.95 40.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.704 178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -156.06 93.38 1.43 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.582 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -164.37 124.23 2.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.12 152.64 37.67 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.725 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -167.62 156.52 9.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.268 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.46 138.74 5.39 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -164.99 151.22 10.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.065 0.459 . . . . 0.0 111.491 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -144.05 135.27 25.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.885 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.53 4.63 28.36 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.355 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -64.92 115.34 5.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.598 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.0 t -133.78 115.63 14.75 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.72 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -133.2 130.29 38.9 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.771 0.32 . . . . 0.0 110.814 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 23.0 t -107.85 135.56 46.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.88 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 14.5 t -96.97 153.28 18.0 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 48.0 mm -106.19 117.56 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 120.918 0.389 . . . . 0.0 110.64 -178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -128.48 162.15 27.87 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.695 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 39.6 t -99.33 92.15 2.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.109 0.481 . . . . 0.0 110.137 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.5 p -92.5 -15.63 26.8 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.551 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' THR . . . . . 0.479 HG22 ' HB3' ' A' ' 444' ' ' GLU . 1.1 p -102.49 163.47 12.21 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.807 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' LYS . . . . . 0.451 ' HD3' ' HD2' ' A' ' 435' ' ' PRO . 5.4 tppp? -115.66 118.52 38.94 Favored Pre-proline 0 C--N 1.307 -1.247 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . 0.451 ' HD2' ' HD3' ' A' ' 434' ' ' LYS . 29.2 Cg_endo -63.58 134.16 43.07 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 122.249 1.966 . . . . 0.0 112.526 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 440' ' ' ARG . 35.3 t -61.26 140.33 94.48 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.424 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.48 -11.52 31.38 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.341 2.027 . . . . 0.0 111.616 177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -102.45 -67.89 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.752 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' CYS . . . . . . . . . . . . . 6.2 p -96.98 -1.25 45.97 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 440' ' ' ARG . 65.8 ttt180 61.69 23.73 13.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.284 0.564 . . . . 0.0 111.557 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 442' ' ' PRO . 17.5 p -79.13 142.22 59.14 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.975 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 441' ' ' THR . 11.8 Cg_exo -67.41 102.28 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.295 1.997 . . . . 0.0 111.252 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 17.7 m -106.03 128.05 53.58 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.631 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' GLU . . . . . 0.479 ' HB3' HG22 ' A' ' 433' ' ' THR . 10.2 pt-20 -117.68 171.84 7.76 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 120.904 0.383 . . . . 0.0 110.892 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' ARG . . . . . 0.564 ' HD3' ' CZ2' ' A' ' 465' ' ' TRP . 33.8 ptt-85 -103.5 161.99 13.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.167 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -114.37 114.31 25.71 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' GLY . . . . . . . . . . . . . . . 71.88 -115.89 5.74 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.468 -176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.69 38.82 1.64 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.914 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 61.2 m -71.68 141.94 49.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.824 0.345 . . . . 0.0 111.181 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . . . . . . . . . 65.4 mtt -94.2 -21.36 19.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.875 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -75.33 95.74 3.26 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.155 0.502 . . . . 0.0 110.197 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 48.5 tpp -104.08 96.63 6.79 Favored 'General case' 0 N--CA 1.405 -2.713 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.287 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . 0.452 ' HB ' ' HG3' ' A' ' 462' ' ' GLU . 3.8 p -112.97 129.5 68.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.197 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.22 116.84 6.99 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.376 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 7.9 p -100.81 92.39 5.05 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.495 176.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . 0.449 ' C ' ' H ' ' A' ' 458' ' ' GLY . 0.0 OUTLIER -130.43 148.15 52.21 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -71.28 14.74 0.15 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.097 0.475 . . . . 0.0 111.413 178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 456' ' ' ARG . . . -160.61 34.63 0.42 Allowed Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' CYS . . . . . . . . . . . . . 10.0 t -154.6 -152.09 0.39 Allowed 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 136.16 74.12 0.07 OUTLIER Glycine 0 C--N 1.279 -2.638 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.762 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -137.48 130.41 30.36 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.628 0.251 . . . . 0.0 111.101 -178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.452 ' HG3' ' HB ' ' A' ' 453' ' ' VAL . 1.9 mp0 -87.78 127.42 35.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.941 177.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -134.2 161.56 34.58 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.61 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . 0.43 ' HA ' ' CZ3' ' A' ' 480' ' ' TRP . 8.2 t -68.41 133.39 48.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.264 0.554 . . . . 0.0 111.666 -175.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' TRP . . . . . 0.564 ' CZ2' ' HD3' ' A' ' 445' ' ' ARG . 23.5 t-105 -76.68 -55.35 5.58 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.463 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.68 -56.56 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -174.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 28.5 p -101.17 -161.06 0.83 Allowed 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -131.32 110.11 10.84 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.795 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' THR . . . . . . . . . . . . . 1.6 p -155.5 151.44 27.7 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.646 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -70.48 156.76 38.95 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -50.02 109.01 0.25 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.309 0.576 . . . . 0.0 110.82 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 2.3 p -133.73 161.63 34.17 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.579 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' ARG . . . . . 0.536 ' HA ' ' HG2' ' A' ' 476' ' ' MET . 64.4 ttt180 -73.07 -22.06 60.67 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.742 178.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -57.4 -51.75 68.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.375 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 98.7 m -88.11 -23.41 23.69 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' MET . . . . . 0.536 ' HG2' ' HA ' ' A' ' 473' ' ' ARG . 5.4 ptp -49.48 -36.44 22.89 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -174.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' GLY . . . . . . . . . . . . . . . -137.95 34.83 2.1 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.369 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' ALA . . . . . . . . . . . . . . . -109.97 -65.85 1.12 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.809 0.338 . . . . 0.0 111.304 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -127.52 20.3 6.69 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.949 0.404 . . . . 0.0 111.105 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' TRP . . . . . 0.43 ' CZ3' ' HA ' ' A' ' 464' ' ' CYS . 10.1 t-105 -79.88 -9.48 59.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.604 0.716 . . . . 0.0 109.407 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -104.99 133.42 49.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.77 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.546 -1.141 . . . . 0.0 111.943 -179.46 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_